Citrus Sinensis ID: 035768
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 388 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LYN8 | 1192 | Leucine-rich repeat recep | yes | no | 0.987 | 0.321 | 0.521 | 1e-116 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.981 | 0.326 | 0.382 | 3e-72 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.953 | 0.317 | 0.382 | 3e-72 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.925 | 0.351 | 0.367 | 1e-66 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.987 | 0.317 | 0.374 | 1e-66 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.987 | 0.317 | 0.374 | 1e-66 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.922 | 0.355 | 0.372 | 4e-66 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.984 | 0.319 | 0.365 | 3e-65 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.963 | 0.327 | 0.370 | 8e-64 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.824 | 0.451 | 0.360 | 2e-62 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 219/420 (52%), Positives = 277/420 (65%), Gaps = 37/420 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKL-- 58
+C LPNL +LNLA N L GEVP G+CQ+ S L+GNK+LCG+++GSDCKI KL
Sbjct: 768 ICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKI-EGTKLRS 826
Query: 59 --ALVGIVVGSVLVIAIIVSVL--WWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+ G+++G +++ + V L W +R ++ DPE ES+ DQN +S
Sbjct: 827 AWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSR 886
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L K+ IV T+ F ++N+IG GGFGTV+K +P KTVA
Sbjct: 887 SR---EPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVA 943
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG+REF AEMETLG VKH NLV LLGYCS EEKLLVYEYMV GSLD WLR
Sbjct: 944 VKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLR 1003
Query: 235 NQAASL---DWGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
NQ L DW KR KI ASNILL+ DFE K++DFG
Sbjct: 1004 NQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFG 1063
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CESHVSTV+AGT GY+PPEYG + +AT +GDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1064 LARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDF 1123
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV W + + +A +V+DP +++ K + L++LQIA C++ P RP ML
Sbjct: 1124 KESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNML 1183
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 163/426 (38%), Positives = 239/426 (56%), Gaps = 45/426 (10%)
Query: 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG---KIMGSDCKILTFGKLA 59
SL L L++++N L G +P G + N LCG + GS + ++
Sbjct: 709 SLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIH 768
Query: 60 LVGIVVGSVLVIAIIVSVLWW-----WIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
V + ++ I S + + + R + E+ RE S+ S
Sbjct: 769 AKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCS---WK 825
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S++ E LSIN+A FE L+KLT+ ++ TN F E ++G GGFG V+K + DG VA
Sbjct: 826 LSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVA 885
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
+KKL + TGQGDREF AEMET+G +KH+NLV LLGYC V EE+LLVYEYM GSL+ L
Sbjct: 886 IKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLH 945
Query: 235 NQAAS-----LDWGKRCKIV------------------------ASNILLNDDFEAKISD 265
+++ L+W R KI +SN+LL++DFEA++SD
Sbjct: 946 EKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSD 1005
Query: 266 FGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324
FG+ARL+S ++H+S + +AGT GYVPPEY + + T +GDVYS+GVILLEL++GK+P
Sbjct: 1006 FGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPID 1065
Query: 325 P-EFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT-MLKMLQIATGCISNDPTV 382
P EF + + NLV W + + ++ E+LDP ++ S + L+IA+ C+ + P
Sbjct: 1066 PGEFGEDN--NLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFK 1123
Query: 383 RPTMLH 388
RPTM+
Sbjct: 1124 RPTMIQ 1129
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 161/421 (38%), Positives = 234/421 (55%), Gaps = 51/421 (12%)
Query: 10 LNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIM------------GSDCKILTFGK 57
L++++N L G +P G + N LCG + + K +
Sbjct: 716 LDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSGSRPTRSHAHPKKQSIAT 775
Query: 58 LALVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSA 117
GIV + ++ +I++ + R+ + E+ RE S+ S S+
Sbjct: 776 GMSAGIVFSFMCIVMLIMA-----LYRARKVQKKEKQREKYIESLPTS---GSSSWKLSS 827
Query: 118 LMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKK 177
+ E LSIN+A FE L+KLT+ ++ TN F +++IG GGFG V+K + DG VA+KK
Sbjct: 828 VHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKK 887
Query: 178 LSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQA 237
L Q TGQGDREF AEMET+G +KH+NLV LLGYC + EE+LLVYEYM GSL+ L +
Sbjct: 888 LIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKT 947
Query: 238 AS----LDWGKRCKIV------------------------ASNILLNDDFEAKISDFGLA 269
LDW R KI +SN+LL+ DF A++SDFG+A
Sbjct: 948 KKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMA 1007
Query: 270 RLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFE 328
RL+S ++H+S + +AGT GYVPPEY + + T +GDVYS+GVILLEL++GK+P PE E
Sbjct: 1008 RLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPE-E 1066
Query: 329 DKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT-MLKMLQIATGCISNDPTVRPTML 387
+ NLV W + + ++ E+LDP ++ S +L L+IA+ C+ + P RPTM+
Sbjct: 1067 FGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMI 1126
Query: 388 H 388
Sbjct: 1127 Q 1127
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 152/414 (36%), Positives = 221/414 (53%), Gaps = 55/414 (13%)
Query: 10 LNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLA---------- 59
++A N+L G +P Q S GN+ LCG+ S C I
Sbjct: 610 FSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGE-HASPCHITDQSPHGSAVKSKKNIR 668
Query: 60 -LVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSAL 118
+V + VG+ L +++V I R+ + + + +++ + I +R
Sbjct: 669 KIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGSR----------- 717
Query: 119 MEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKL 178
S+ L + S +L+ D I+ T+ F + N+IG GGFG V+K T+PDG VA+K+L
Sbjct: 718 ----SVVLFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRL 773
Query: 179 SQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQA- 237
S TGQ DREF AE+ETL +H NLV LLGYC+ +KLL+Y YM GSLD WL +
Sbjct: 774 SGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVD 833
Query: 238 --ASLDWGKRCKIV------------------------ASNILLNDDFEAKISDFGLARL 271
SLDW R +I +SNILL+D F A ++DFGLARL
Sbjct: 834 GPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARL 893
Query: 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
I ++HV+T + GT+GY+PPEYG AT +GDVYSFGV+LLEL+TG++P + +
Sbjct: 894 ILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMD-VCKPRG 952
Query: 332 GENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
+L+ WVL M ++ E+ DP + + + ML +L+IA C+ +P RPT
Sbjct: 953 SRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPT 1006
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 161/430 (37%), Positives = 239/430 (55%), Gaps = 47/430 (10%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDC---------- 50
+ SL L ++L++N L G +P S N LCG + C
Sbjct: 731 LTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRF-ANNSLCGYPLPIPCSSGPKSDANQ 789
Query: 51 -KILTFGKLALVG-IVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRK 108
+ + +L G + +G + + I ++ I+ R+ E E+ + S
Sbjct: 790 HQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATA 849
Query: 109 SISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP 168
+ + + +SA E LSINLA FE L+KLT+ ++ TN F ++++G GGFG V+K +
Sbjct: 850 NSAWKFTSA-REALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLK 908
Query: 169 DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228
DG VA+KKL +GQGDREF AEMET+G +KH+NLV LLGYC V EE+LLVYEYM GS
Sbjct: 909 DGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGS 968
Query: 229 LDDWLRNQ---AASLDWGKRCKIV------------------------ASNILLNDDFEA 261
L+D L ++ L+W R KI +SN+LL+++ EA
Sbjct: 969 LEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEA 1028
Query: 262 KISDFGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK 320
++SDFG+ARL+S ++H+S + +AGT GYVPPEY + + + +GDVYS+GV+LLEL+TGK
Sbjct: 1029 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1088
Query: 321 QPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL--NANSKPTMLKMLQIATGCISN 378
QPT + D NLV WV K + D V D +L +A+ + +L+ L++A C+ +
Sbjct: 1089 QPT--DSADFGDNNLVGWVKLHAKGKITD-VFDRELLKEDASIEIELLQHLKVACACLDD 1145
Query: 379 DPTVRPTMLH 388
RPTM+
Sbjct: 1146 RHWKRPTMIQ 1155
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 161/430 (37%), Positives = 240/430 (55%), Gaps = 47/430 (10%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDC---------- 50
+ SL L ++L++N L G +P S N LCG + C
Sbjct: 731 LTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRF-ANNSLCGYPLPLPCSSGPKSDANQ 789
Query: 51 -KILTFGKLALVG-IVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRK 108
+ + +L G + +G + + I ++ I+ R+ E E+ + S
Sbjct: 790 HQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATA 849
Query: 109 SISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP 168
+ + + +SA E LSINLA FE L+KLT+ ++ TN F ++++G GGFG V+K +
Sbjct: 850 NSAWKFTSA-REALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLK 908
Query: 169 DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228
DG VA+KKL +GQGDREF AEMET+G +KH+NLV LLGYC V EE+LLVYEYM GS
Sbjct: 909 DGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGS 968
Query: 229 LDDWLRNQAAS---LDWGKRCKIV------------------------ASNILLNDDFEA 261
L+D L ++ + L+W R KI +SN+LL+++ EA
Sbjct: 969 LEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEA 1028
Query: 262 KISDFGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK 320
++SDFG+ARL+S ++H+S + +AGT GYVPPEY + + + +GDVYS+GV+LLEL+TGK
Sbjct: 1029 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1088
Query: 321 QPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL--NANSKPTMLKMLQIATGCISN 378
QPT + D NLV WV K + D V D +L +A+ + +L+ L++A C+ +
Sbjct: 1089 QPT--DSADFGDNNLVGWVKLHAKGKITD-VFDRELLKEDASIEIELLQHLKVACACLDD 1145
Query: 379 DPTVRPTMLH 388
RPTM+
Sbjct: 1146 RHWKRPTMIQ 1155
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 155/416 (37%), Positives = 229/416 (55%), Gaps = 58/416 (13%)
Query: 10 LNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIM-----GSDCKILTFGKLA----- 59
++A N L G +P G Q S N LCG+ G++ ++ + +
Sbjct: 600 FSVAYNNLSGVIPSGGQFQTFPNSSFESNH-LCGEHRFPCSEGTESALIKRSRRSRGGDI 658
Query: 60 --LVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPE-ETRESKRNSISDQNRKSISDRSSS 116
+GI GSV ++ ++ ++ +RS + DPE E ES NRK + + S
Sbjct: 659 GMAIGIAFGSVFLLTLLSLIVLRARRRSG-EVDPEIEESES-------MNRKELGEIGSK 710
Query: 117 ALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVK 176
++ +F+ + ++L+YD ++ TN F + N+IG GGFG V+K T+PDGK VA+K
Sbjct: 711 LVV--------LFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIK 762
Query: 177 KLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ 236
KLS GQ +REF AE+ETL +H NLV L G+C ++LL+Y YM GSLD WL +
Sbjct: 763 KLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHER 822
Query: 237 ---AASLDWGKRCKIV------------------------ASNILLNDDFEAKISDFGLA 269
A L W R +I +SNILL+++F + ++DFGLA
Sbjct: 823 NDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLA 882
Query: 270 RLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED 329
RL+S E+HVST + GT+GY+PPEYG AT +GDVYSFGV+LLEL+T K+P +
Sbjct: 883 RLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVD-MCKP 941
Query: 330 KDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
K +L+ WV+ M +A EV DP + + + M ++L+IA C+S +P RPT
Sbjct: 942 KGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPT 997
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 159/435 (36%), Positives = 241/435 (55%), Gaps = 53/435 (12%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIM---------GSDCK 51
M +L L ++L++N L G +P G + N LCG + G
Sbjct: 722 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 781
Query: 52 ILTFGKL-------ALVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISD 104
+ G+ +G++ V + +I+ +R ++++ E E NS D
Sbjct: 782 QRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNS-GD 840
Query: 105 QNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFK 164
+ + ++ + + E LSINLA FE L+KLT+ ++ TN F +++IG GGFG V+K
Sbjct: 841 RTANN-TNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYK 899
Query: 165 GTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224
+ DG VA+KKL +GQGDREF AEMET+G +KH+NLV LLGYC V +E+LLVYE+M
Sbjct: 900 AILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFM 959
Query: 225 VKGSLDDWL---RNQAASLDWGKRCKIV------------------------ASNILLND 257
GSL+D L + L+W R KI +SN+LL++
Sbjct: 960 KYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDE 1019
Query: 258 DFEAKISDFGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLEL 316
+ EA++SDFG+ARL+S ++H+S + +AGT GYVPPEY + + + +GDVYS+GV+LLEL
Sbjct: 1020 NLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLEL 1079
Query: 317 VTGKQPT-GPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS--KPTMLKMLQIAT 373
+TGK+PT P+F D NLV WV K +D V DP ++ + + +L+ L++A
Sbjct: 1080 LTGKRPTDSPDFGDN---NLVGWVKQHAKLRISD-VFDPELMKEDPALEIELLQHLKVAV 1135
Query: 374 GCISNDPTVRPTMLH 388
C+ + RPTM+
Sbjct: 1136 ACLDDRAWRRPTMVQ 1150
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 165/445 (37%), Positives = 236/445 (53%), Gaps = 71/445 (15%)
Query: 7 LLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKI--------LTFGKL 58
L+ ++L++N L G +P+ G L N LCG + +CK GK
Sbjct: 685 LVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPL-PECKNGNNQLPAGTEEGKR 743
Query: 59 ALVG---------IVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKS 109
A G IV+G ++ A + ++ W I R+ D ++ + S Q S
Sbjct: 744 AKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLH----SLQAVNS 799
Query: 110 ISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPD 169
+ E LSIN+A F+ L+KL + Q++ TN F ++IG GGFG VFK T+ D
Sbjct: 800 ATTWKIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKD 859
Query: 170 GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229
G +VA+KKL + + QGDREF AEMETLG +KH+NLV LLGYC + EE+LLVYE+M GSL
Sbjct: 860 GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSL 919
Query: 230 DDWLRNQAAS-----LDWGKRCKIV------------------------ASNILLNDDFE 260
++ L L W +R KI +SN+LL+ D E
Sbjct: 920 EEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDME 979
Query: 261 AKISDFGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTG 319
A++SDFG+ARLIS ++H+S + +AGT GYVPPEY + + T +GDVYS GV++LE+++G
Sbjct: 980 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSG 1039
Query: 320 KQPTGP-EFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT-------------- 364
K+PT EF D NLV W + + EV+D +L S +
Sbjct: 1040 KRPTDKEEFGDT---NLVGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVK 1096
Query: 365 -MLKMLQIATGCISNDPTVRPTMLH 388
ML+ L+IA C+ + P+ RP ML
Sbjct: 1097 EMLRYLEIALRCVDDFPSKRPNMLQ 1121
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (611), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 136/377 (36%), Positives = 205/377 (54%), Gaps = 57/377 (15%)
Query: 56 GKLALVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSIS----DQNRKSIS 111
G A+VGI V LV+ + + W +++ RE + +++S + S +
Sbjct: 277 GTGAVVGISVAVALVVFTLFGIFVWCLRK----------REKRLSAVSGGDVTPSPMSST 326
Query: 112 DRSSSALMEHLS---INLAMFEPSLQK-----------LTYDQIVAGTNKFCEENVIGGG 157
RS SA S + + S Q +Y+++V TN F +EN++G G
Sbjct: 327 ARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEG 386
Query: 158 GFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217
GFG V+KG +PDG+ VAVK+L GQGDREF AE+ETL + H++LV ++G+C + +
Sbjct: 387 GFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRR 446
Query: 218 LLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------------------------SNI 253
LL+Y+Y+ L L + + LDW R KI A SNI
Sbjct: 447 LLIYDYVSNNDLYFHLHGEKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 506
Query: 254 LLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVIL 313
LL D+F+A++SDFGLARL DC +H++T V GT GY+ PEY +GK TE+ DV+SFGV+L
Sbjct: 507 LLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVL 566
Query: 314 LELVTGKQPTGPEFEDKDGENLVDW----VLHMMKNEQADEVLDPAVLNANSKPTMLKML 369
LEL+TG++P D E+LV+W + H ++ E+ D + DP + + M +M+
Sbjct: 567 LELITGRKPVDTSQPLGD-ESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMI 625
Query: 370 QIATGCISNDPTVRPTM 386
+ A C+ + T RP M
Sbjct: 626 EAAGACVRHLATKRPRM 642
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 388 | ||||||
| 224120068 | 1237 | predicted protein [Populus trichocarpa] | 0.989 | 0.310 | 0.585 | 1e-131 | |
| 297741086 | 961 | unnamed protein product [Vitis vinifera] | 0.992 | 0.400 | 0.587 | 1e-131 | |
| 225455406 | 1299 | PREDICTED: leucine-rich repeat receptor | 0.992 | 0.296 | 0.587 | 1e-131 | |
| 255539505 | 1303 | leucine-rich repeat receptor protein kin | 0.989 | 0.294 | 0.569 | 1e-130 | |
| 224136952 | 1215 | predicted protein [Populus trichocarpa] | 0.987 | 0.315 | 0.590 | 1e-127 | |
| 449446181 | 1298 | PREDICTED: leucine-rich repeat receptor | 0.992 | 0.296 | 0.555 | 1e-124 | |
| 449527203 | 1298 | PREDICTED: leucine-rich repeat receptor | 0.992 | 0.296 | 0.555 | 1e-124 | |
| 356574479 | 1268 | PREDICTED: leucine-rich repeat receptor | 0.987 | 0.302 | 0.562 | 1e-124 | |
| 356534151 | 1269 | PREDICTED: leucine-rich repeat receptor | 0.987 | 0.301 | 0.551 | 1e-122 | |
| 297806755 | 1180 | extra sporogenous cells [Arabidopsis lyr | 0.987 | 0.324 | 0.526 | 1e-116 |
| >gi|224120068|ref|XP_002318234.1| predicted protein [Populus trichocarpa] gi|222858907|gb|EEE96454.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1219), Expect = e-131, Method: Compositional matrix adjust.
Identities = 246/420 (58%), Positives = 294/420 (70%), Gaps = 36/420 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGK--- 57
+C L NL YLNLA+N LEG VPRSGIC NLS +SL GNKDLCG+I+G DC+I +F K
Sbjct: 809 ICVLVNLFYLNLAENSLEGPVPRSGICLNLSKISLAGNKDLCGRILGLDCRIKSFNKSYF 868
Query: 58 ---LALVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
L GI VG ++V L WI R + Q DPEE E K NS D+N +S
Sbjct: 869 LNAWGLAGIAVGCMIVALSTAFALRKWIMRDSGQGDPEEIEERKLNSFIDKNLYFLSSSR 928
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L K+T I+ TN FC+ N+IG GGFGTV+K T+ DGKTVA
Sbjct: 929 SK---EPLSINIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGTVYKATLRDGKTVA 985
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLSQA QGDREF AEMETLG VKHQNLV LLGYCS+ EEKLLVYEYMV GSLD WLR
Sbjct: 986 VKKLSQAKTQGDREFIAEMETLGKVKHQNLVALLGYCSLGEEKLLVYEYMVNGSLDLWLR 1045
Query: 235 NQAASLD---WGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
N++ +LD W KR KI ASNILLN++FE +++DFG
Sbjct: 1046 NRSGALDVLDWPKRFKIATGAACGLAFLHHGFTPHIIHRDIKASNILLNENFEPRVADFG 1105
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+HVST +AGT GY+PPEYG +G++T RGDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1106 LARLISACETHVSTDIAGTFGYIPPEYGQSGRSTSRGDVYSFGVILLELVTGKEPTGPDF 1165
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV +K Q +VLDP VL+A+SKP ML++LQIA C+S++P RPTML
Sbjct: 1166 KEVEGGNLVGWVSQKIKKGQTADVLDPTVLSADSKPMMLQVLQIAAVCLSDNPANRPTML 1225
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741086|emb|CBI31817.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-131, Method: Compositional matrix adjust.
Identities = 248/422 (58%), Positives = 293/422 (69%), Gaps = 37/422 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLA- 59
+CSL NLLYLNLA+NRLEG +PRSG+CQNLS SL GNKDLCG+ +G +C+ TFG+ +
Sbjct: 532 ICSLVNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCGRNLGLECQFKTFGRKSS 591
Query: 60 ------LVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDR 113
L GIVVG L+ I L W+ R++RQSD EE ESK NS DQN +S
Sbjct: 592 LVNTWVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEESKLNSSIDQNLYFLSSS 651
Query: 114 SSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTV 173
S E LSIN+AMFE L KLT I+ TN FC+ NVIG GGFGTV+K +P+GK V
Sbjct: 652 RSK---EPLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGFGTVYKAALPNGKIV 708
Query: 174 AVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL 233
AVKKL+QA QG REF AEMETLG VKH+NLV LLGYCS EEK LVYEYMV GSLD WL
Sbjct: 709 AVKKLNQAKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFLVYEYMVNGSLDLWL 768
Query: 234 RNQAASL---DWGKRCKIV------------------------ASNILLNDDFEAKISDF 266
RN+ +L DW KR KI ASNILLN+DFEAK++DF
Sbjct: 769 RNRTGALEALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASNILLNEDFEAKVADF 828
Query: 267 GLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326
GLARLIS CE+HVST +AGT GY+PPEYG + ++T RGDVYSFGVILLELVTGK+PTGP+
Sbjct: 829 GLARLISACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVILLELVTGKEPTGPD 888
Query: 327 FEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
F+D +G NLV WV M+ +A EVLDP V+ A K ML++LQIA C+S +P RPTM
Sbjct: 889 FKDFEGGNLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIAAICLSENPAKRPTM 948
Query: 387 LH 388
LH
Sbjct: 949 LH 950
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455406|ref|XP_002273978.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-131, Method: Compositional matrix adjust.
Identities = 248/422 (58%), Positives = 293/422 (69%), Gaps = 37/422 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLA- 59
+CSL NLLYLNLA+NRLEG +PRSG+CQNLS SL GNKDLCG+ +G +C+ TFG+ +
Sbjct: 870 ICSLVNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCGRNLGLECQFKTFGRKSS 929
Query: 60 ------LVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDR 113
L GIVVG L+ I L W+ R++RQSD EE ESK NS DQN +S
Sbjct: 930 LVNTWVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEESKLNSSIDQNLYFLSSS 989
Query: 114 SSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTV 173
S E LSIN+AMFE L KLT I+ TN FC+ NVIG GGFGTV+K +P+GK V
Sbjct: 990 RSK---EPLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGFGTVYKAALPNGKIV 1046
Query: 174 AVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL 233
AVKKL+QA QG REF AEMETLG VKH+NLV LLGYCS EEK LVYEYMV GSLD WL
Sbjct: 1047 AVKKLNQAKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFLVYEYMVNGSLDLWL 1106
Query: 234 RNQAASL---DWGKRCKIV------------------------ASNILLNDDFEAKISDF 266
RN+ +L DW KR KI ASNILLN+DFEAK++DF
Sbjct: 1107 RNRTGALEALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASNILLNEDFEAKVADF 1166
Query: 267 GLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326
GLARLIS CE+HVST +AGT GY+PPEYG + ++T RGDVYSFGVILLELVTGK+PTGP+
Sbjct: 1167 GLARLISACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVILLELVTGKEPTGPD 1226
Query: 327 FEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
F+D +G NLV WV M+ +A EVLDP V+ A K ML++LQIA C+S +P RPTM
Sbjct: 1227 FKDFEGGNLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIAAICLSENPAKRPTM 1286
Query: 387 LH 388
LH
Sbjct: 1287 LH 1288
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539505|ref|XP_002510817.1| leucine-rich repeat receptor protein kinase exs precursor, putative [Ricinus communis] gi|223549932|gb|EEF51419.1| leucine-rich repeat receptor protein kinase exs precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1210), Expect = e-130, Method: Compositional matrix adjust.
Identities = 239/420 (56%), Positives = 297/420 (70%), Gaps = 36/420 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLAL 60
+C+L NL YLN A+N LEG VPRSGIC +LS +SL GNK+LCG+I GS C+I FG+L+L
Sbjct: 873 ICTLVNLFYLNFAENNLEGPVPRSGICLSLSKISLAGNKNLCGRITGSACRIRNFGRLSL 932
Query: 61 V------GIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+ G+ VG +++I I VL W R +RQ DPE+ ESK +S DQN +S
Sbjct: 933 LNAWGLAGVAVGCMIIILGIAFVLRRWTTRGSRQGDPEDIEESKLSSFIDQNLYFLSSSR 992
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L K+T I+ TN FC+ N+IG GGFGTV+K +PDG+ VA
Sbjct: 993 SK---EPLSINIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGTVYKAILPDGRRVA 1049
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG+REF AEMETLG VKHQNLV LLGYCS EEKLLVYEYMV GSLD WLR
Sbjct: 1050 VKKLSEAKTQGNREFIAEMETLGKVKHQNLVPLLGYCSFGEEKLLVYEYMVNGSLDLWLR 1109
Query: 235 NQAASLD---WGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
N++ +L+ W KR KI ASNILLN+DFE K++DFG
Sbjct: 1110 NRSGALEILNWTKRLKIAIGSARGLAFLHHGFIPHIIHRDIKASNILLNEDFEPKVADFG 1169
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+HVST +AGT GY+PPEYG +G++T RGDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1170 LARLISACETHVSTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDF 1229
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV +K A +VLDP V+N++SK ML+ L+IA+ C+S++P RPTML
Sbjct: 1230 KEVEGGNLVGWVFQKIKKGHAADVLDPTVVNSDSKQMMLRALKIASRCLSDNPADRPTML 1289
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136952|ref|XP_002322457.1| predicted protein [Populus trichocarpa] gi|222869453|gb|EEF06584.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-127, Method: Compositional matrix adjust.
Identities = 248/420 (59%), Positives = 294/420 (70%), Gaps = 37/420 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGK--- 57
+C+L NL YLNLA+N LEG VP SGIC NLS +SL GNKDLCGKIMG DC+I +F K
Sbjct: 788 LCALVNLFYLNLAENSLEGPVPGSGICLNLSKISLAGNKDLCGKIMGLDCRIKSFDKSYY 847
Query: 58 ---LALVGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
L GI VG ++V I L WI + + Q D +E K NS DQN +S S
Sbjct: 848 LNAWGLAGIAVGCMIVTLSIAFALRKWILKDSGQGDLDE---RKLNSFLDQNLYFLSSSS 904
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S + E LSIN+AMFE L K+T I+ TN FC+ N+IG GGFGTV+K T+PD KTVA
Sbjct: 905 SRS-KEPLSINIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGTVYKATLPDVKTVA 963
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLSQA QG+REF AEMETLG VKHQNLV LLGYCS EEKLLVYEYMV GSLD WLR
Sbjct: 964 VKKLSQAKTQGNREFIAEMETLGKVKHQNLVPLLGYCSFGEEKLLVYEYMVNGSLDLWLR 1023
Query: 235 NQAASLD---WGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
NQ+ +LD W KR KI ASNILLN+DFE K++DFG
Sbjct: 1024 NQSRALDVLDWPKRVKIATGAARGLAFLHHGFTPHIIHRDIKASNILLNEDFEPKVADFG 1083
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+HVST +AGT GY+PPEYG +G++T RGDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1084 LARLISACETHVSTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDF 1143
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV +K QA +VLDP VL+A+SK ML++LQIA C+S++P RPTML
Sbjct: 1144 KEVEGGNLVGWVFQKIKKGQAADVLDPTVLSADSKQMMLQVLQIAAICLSDNPANRPTML 1203
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446181|ref|XP_004140850.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1163), Expect = e-124, Method: Compositional matrix adjust.
Identities = 234/421 (55%), Positives = 288/421 (68%), Gaps = 36/421 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLAL 60
+CSL N+ YLNLA+N LEG +PRSGICQNLS SL GNKDLCG+I+G +C+I + + A+
Sbjct: 870 ICSLVNMFYLNLAENSLEGPIPRSGICQNLSKSSLVGNKDLCGRILGFNCRIKSLERSAV 929
Query: 61 V------GIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+ GI++ SVL++ + + I R SDPEE ESK NS D N +S
Sbjct: 930 LNSWSVAGIIIVSVLIVLTVAFAMRRRIIGIQRDSDPEEMEESKLNSFIDPNLYFLSSSR 989
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L KLT I+ TN FC+ N+IG GGFGTV+K T+PDGK VA
Sbjct: 990 SK---EPLSINVAMFEQPLLKLTLVDILEATNNFCKTNIIGDGGFGTVYKATLPDGKVVA 1046
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG REF AEMET+G VKH NLV LLGYCS+ EEKLLVYEYMV GSLD WLR
Sbjct: 1047 VKKLSEAKTQGHREFIAEMETIGKVKHHNLVPLLGYCSLGEEKLLVYEYMVNGSLDLWLR 1106
Query: 235 NQAASLD---WGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
N+ +L+ W R K+ ASNILLN DFE K++DFG
Sbjct: 1107 NRTGTLEILNWETRFKVASGAARGLAFLHHGFIPHIIHRDVKASNILLNQDFEPKVADFG 1166
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+HV+T +AGT GY+PPEYG +G++T +GDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1167 LARLISACETHVTTEIAGTFGYIPPEYGQSGRSTTKGDVYSFGVILLELVTGKEPTGPDF 1226
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV + QA +VLD VLNA+SK ML+ LQIA C+S +P RP+ML
Sbjct: 1227 KEIEGGNLVGWVFQKINKGQAADVLDATVLNADSKHMMLQTLQIACVCLSENPANRPSML 1286
Query: 388 H 388
Sbjct: 1287 Q 1287
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449527203|ref|XP_004170602.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1162), Expect = e-124, Method: Compositional matrix adjust.
Identities = 234/421 (55%), Positives = 288/421 (68%), Gaps = 36/421 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLAL 60
+CSL N+ YLNLA+N LEG +PRSGICQNLS SL GNKDLCG+I+G +C+I + + A+
Sbjct: 870 ICSLVNMFYLNLAENSLEGPIPRSGICQNLSKSSLVGNKDLCGRILGFNCRIKSLERSAV 929
Query: 61 V------GIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+ GI++ SVL++ + + I R SDPEE ESK NS D N +S
Sbjct: 930 LNSWSVAGIIIVSVLIVLTVAFAMRRRIIGIQRDSDPEEMEESKLNSFIDPNLYFLSSSR 989
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L KLT I+ TN FC+ N+IG GGFGTV+K T+PDGK VA
Sbjct: 990 SK---EPLSINVAMFEQPLLKLTLVDILEATNNFCKTNIIGDGGFGTVYKATLPDGKVVA 1046
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG REF AEMET+G VKH NLV LLGYCS+ EEKLLVYEYMV GSLD WLR
Sbjct: 1047 VKKLSEAKTQGHREFIAEMETIGKVKHHNLVPLLGYCSLGEEKLLVYEYMVNGSLDLWLR 1106
Query: 235 NQAASLD---WGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
N+ +L+ W R K+ ASNILLN DFE K++DFG
Sbjct: 1107 NRTGTLEILNWETRFKVASGAARGLAFLHHGFIPHIIHRDVKASNILLNQDFEPKVADFG 1166
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+HV+T +AGT GY+PPEYG +G++T +GDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1167 LARLISACETHVTTEIAGTFGYIPPEYGQSGRSTTKGDVYSFGVILLELVTGKEPTGPDF 1226
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV + QA +VLD VLNA+SK ML+ LQIA C+S +P RP+ML
Sbjct: 1227 KEIEGGNLVGWVFQKINKGQAADVLDATVLNADSKHMMLQTLQIACVCLSENPANRPSML 1286
Query: 388 H 388
Sbjct: 1287 Q 1287
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574479|ref|XP_003555374.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 237/421 (56%), Positives = 294/421 (69%), Gaps = 38/421 (9%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLAL 60
+CSL NL YL+L+ NRLEG +PR+GICQNLS + L GNK+LCG+++G +C+ + G+ L
Sbjct: 842 LCSLVNLNYLDLSRNRLEGPIPRNGICQNLSRVRLAGNKNLCGQMLGINCQDKSIGRSVL 901
Query: 61 VGIVVGSVLVIAIIVSVLWW------WIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+V+ + II+ L + WI R RQ+DPEE +E K NS D N +S
Sbjct: 902 YNAWRLAVITVTIILLTLSFAFLLHKWISR--RQNDPEELKERKLNSYVDHNLYFLS--- 956
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
SS E LSIN+AMFE L KLT I+ T+ F + N+IG GGFGTV+K T+P+GKTVA
Sbjct: 957 SSRSKEPLSINVAMFEQPLLKLTLVDILEATDNFSKTNIIGDGGFGTVYKATLPNGKTVA 1016
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG REF AEMETLG VKHQNLV LLGYCS+ EEKLLVYEYMV GSLD WLR
Sbjct: 1017 VKKLSEAKTQGHREFMAEMETLGKVKHQNLVALLGYCSIGEEKLLVYEYMVNGSLDLWLR 1076
Query: 235 NQAASL---DWGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
N+ +L DW KR KI ASNILL+ DFE K++DFG
Sbjct: 1077 NRTGALEILDWNKRYKIATGAARGLAFLHHGFTPHIIHRDVKASNILLSGDFEPKVADFG 1136
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+H++T +AGT GY+PPEYG +G++T RGDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1137 LARLISACETHITTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDF 1196
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV +K QA +VLDP VL+A+SK ML+MLQIA CIS++P RPTML
Sbjct: 1197 KEIEGGNLVGWVCQKIKKGQAADVLDPTVLDADSKQMMLQMLQIAGVCISDNPANRPTML 1256
Query: 388 H 388
Sbjct: 1257 Q 1257
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534151|ref|XP_003535621.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-122, Method: Compositional matrix adjust.
Identities = 232/421 (55%), Positives = 295/421 (70%), Gaps = 38/421 (9%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLAL 60
+CSL NL +L+L+ NRLEG +PR+GICQNLS + L GNK+LCG+++G D + + G+ L
Sbjct: 843 LCSLVNLNHLDLSQNRLEGPIPRNGICQNLSRVRLAGNKNLCGQMLGIDSQDKSIGRSIL 902
Query: 61 -----VGIVVGSVLVIAIIVSVLWW-WIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+ ++ +++++++ V+ L WI R RQ+DPEE +E K NS D N +S
Sbjct: 903 YNAWRLAVIAVTIILLSLSVAFLLHKWISR--RQNDPEELKERKLNSYVDHNLYFLSSSR 960
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L KLT I+ T+ F + N+IG GGFGTV+K T+P+GKTVA
Sbjct: 961 SK---EPLSINVAMFEQPLLKLTLVDILEATDNFSKANIIGDGGFGTVYKATLPNGKTVA 1017
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG REF AEMETLG VKH NLV LLGYCS+ EEKLLVYEYMV GSLD WLR
Sbjct: 1018 VKKLSEAKTQGHREFMAEMETLGKVKHHNLVALLGYCSIGEEKLLVYEYMVNGSLDLWLR 1077
Query: 235 NQAASL---DWGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
N+ +L DW KR KI ASNILLN+DFE K++DFG
Sbjct: 1078 NRTGALEILDWNKRYKIATGAARGLAFLHHGFIPHIIHRDVKASNILLNEDFEPKVADFG 1137
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CE+H++T +AGT GY+PPEYG +G++T RGDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1138 LARLISACETHITTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDF 1197
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV W +K QA +VLDP VL+A+SK ML+MLQIA CIS++P RPTML
Sbjct: 1198 KEIEGGNLVGWACQKIKKGQAVDVLDPTVLDADSKQMMLQMLQIACVCISDNPANRPTML 1257
Query: 388 H 388
Sbjct: 1258 Q 1258
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297806755|ref|XP_002871261.1| extra sporogenous cells [Arabidopsis lyrata subsp. lyrata] gi|297317098|gb|EFH47520.1| extra sporogenous cells [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 221/420 (52%), Positives = 280/420 (66%), Gaps = 37/420 (8%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKI----LTFG 56
+C LPNL +LNLA N L GEVP G+CQ+ S L+GNK+LCG+++GSDCKI LT
Sbjct: 756 ICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVIGSDCKIDGTKLTHA 815
Query: 57 KLALVGIVVGSVLVIAIIVSVLWWWI--QRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+ G+++G +++ + V L W+ +R ++ DPE ES+ DQN +S
Sbjct: 816 -WGIAGLMLGFTIIVFVFVFSLRRWVITKRVKQRDDPERMEESRLKGFVDQNLYFLSGSR 874
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVA 174
S E LSIN+AMFE L K+ IV T+ F ++N+IG GGFGTV+K +P GKTVA
Sbjct: 875 SR---EPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGGKTVA 931
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG+REF AEMETLG VKH NLV LLGYCS +EKLLVYEYMV GSLD WLR
Sbjct: 932 VKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSDEKLLVYEYMVNGSLDHWLR 991
Query: 235 NQAASL---DWGKRCKIV------------------------ASNILLNDDFEAKISDFG 267
NQ L DW KR KI ASNILL+ DFE K++DFG
Sbjct: 992 NQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFG 1051
Query: 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF 327
LARLIS CESHVSTV+AGT GY+PPEYG + +AT +GDVYSFGVILLELVTGK+PTGP+F
Sbjct: 1052 LARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDF 1111
Query: 328 EDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ +G NLV WV + +A +VLDP +++ K ++L++LQIA C++ P RP ML
Sbjct: 1112 KESEGGNLVGWVTQKINQGKAVDVLDPLLVSVALKNSLLRLLQIAMVCLAETPANRPNML 1171
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 388 | ||||||
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.628 | 0.204 | 0.482 | 1.3e-97 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.353 | 0.105 | 0.532 | 1.3e-67 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.422 | 0.140 | 0.432 | 5.3e-65 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.350 | 0.116 | 0.468 | 1.8e-64 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.422 | 0.137 | 0.420 | 1.8e-61 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.350 | 0.121 | 0.460 | 2e-58 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.353 | 0.135 | 0.478 | 5.5e-57 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.353 | 0.226 | 0.496 | 5.6e-56 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.353 | 0.232 | 0.474 | 2.2e-55 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.353 | 0.231 | 0.467 | 7.5e-54 |
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 1.3e-97, Sum P(3) = 1.3e-97
Identities = 124/257 (48%), Positives = 148/257 (57%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSDCKI------LT 54
+C LPNL +LNLA N L GEVP G+CQ+ S L+GNK+LCG+++GSDCKI
Sbjct: 768 ICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSA 827
Query: 55 FGKXXXXXXXXXXXXXXXXXXXXXWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRS 114
+G W +R ++ DPE ES+ DQN +S
Sbjct: 828 WG-IAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSR 886
Query: 115 SSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIXXXXXXXXXXXXMPDGKTVA 174
S E LSIN+AMFE L K+ IV T+ F ++N+I +P KTVA
Sbjct: 887 SR---EPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVA 943
Query: 175 VKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
VKKLS+A QG+REF AEMETLG VKH NLV LLGYCS EEKLLVYEYMV GSLD WLR
Sbjct: 944 VKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLR 1003
Query: 235 NQAASL---DWGKRCKI 248
NQ L DW KR KI
Sbjct: 1004 NQTGMLEVLDWSKRLKI 1020
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 380 (138.8 bits), Expect = 1.3e-67, Sum P(3) = 1.3e-67
Identities = 74/139 (53%), Positives = 105/139 (75%)
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSF 309
+SNILL+++FE ++SDFGLAR+IS CE+HVST +AGT GY+PPEYG T K+T +GDVYSF
Sbjct: 1132 SSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSF 1191
Query: 310 GVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV-LNANSKPTMLKM 368
GV++LEL+TG+ PTG E E + G NLV WV M+ + +E+ DP + +++ + M ++
Sbjct: 1192 GVVMLELLTGRPPTGQE-EVQGGGNLVGWVRWMIARGKQNELFDPCLPVSSVWREQMARV 1250
Query: 369 LQIATGCISNDPTVRPTML 387
L IA C +++P RPTML
Sbjct: 1251 LAIARDCTADEPFKRPTML 1269
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 5.3e-65, Sum P(3) = 5.3e-65
Identities = 74/171 (43%), Positives = 98/171 (57%)
Query: 82 IQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQI 141
+ R+ + E+ RE S+ S S++ E LSIN+A FE L+KLT+ +
Sbjct: 795 LYRARKVQKKEKQREKYIESLPTSGSSSWK---LSSVHEPLSINVATFEKPLRKLTFAHL 851
Query: 142 VAGTNKFCEENVIXXXXXXXXXXXXMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKH 201
+ TN F +++I + DG VA+KKL Q TGQGDREF AEMET+G +KH
Sbjct: 852 LEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKH 911
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS----LDWGKRCKI 248
+NLV LLGYC + EE+LLVYEYM GSL+ L + LDW R KI
Sbjct: 912 RNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKI 962
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 325 (119.5 bits), Expect = 1.8e-64, Sum P(3) = 1.8e-64
Identities = 66/141 (46%), Positives = 100/141 (70%)
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYS 308
+SN+LL++DFEA++SDFG+ARL+S ++H+S + +AGT GYVPPEY + + T +GDVYS
Sbjct: 990 SSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS 1049
Query: 309 FGVILLELVTGKQPTGP-EFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML- 366
+GVILLEL++GK+P P EF + + NLV W + + ++ E+LDP ++ S L
Sbjct: 1050 YGVILLELLSGKKPIDPGEFGEDN--NLVGWAKQLYREKRGAEILDPELVTDKSGDVELF 1107
Query: 367 KMLQIATGCISNDPTVRPTML 387
L+IA+ C+ + P RPTM+
Sbjct: 1108 HYLKIASQCLDDRPFKRPTMI 1128
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 320 (117.7 bits), Expect = 1.8e-61, Sum P(3) = 1.8e-61
Identities = 71/169 (42%), Positives = 101/169 (59%)
Query: 83 QRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIV 142
+R ++++ E E NS D+ + ++ + + E LSINLA FE L+KLT+ ++
Sbjct: 820 RRRKKEAELEMYAEGHGNS-GDRTANN-TNWKLTGVKEALSINLAAFEKPLRKLTFADLL 877
Query: 143 AGTNKFCEENVIXXXXXXXXXXXXMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ 202
TN F +++I + DG VA+KKL +GQGDREF AEMET+G +KH+
Sbjct: 878 QATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHR 937
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWL---RNQAASLDWGKRCKI 248
NLV LLGYC V +E+LLVYE+M GSL+D L + L+W R KI
Sbjct: 938 NLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKI 986
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 300 (110.7 bits), Expect = 2.0e-58, Sum P(3) = 2.0e-58
Identities = 65/141 (46%), Positives = 95/141 (67%)
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYS 308
+SN+L+++ EA++SDFG+ARL+S ++H+S + +AGT GYVPPEY + + T +GDVYS
Sbjct: 936 SSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYS 995
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM--L 366
+GV+LLEL+TGK PT +D NLV WV K + D V DP +L + + L
Sbjct: 996 YGVVLLELLTGKPPTDSADFGEDN-NLVGWVKQHTKLKITD-VFDPELLKEDPSVELELL 1053
Query: 367 KMLQIATGCISNDPTVRPTML 387
+ L+IA C+ + P+ RPTML
Sbjct: 1054 EHLKIACACLDDRPSRRPTML 1074
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 340 (124.7 bits), Expect = 5.5e-57, Sum P(3) = 5.5e-57
Identities = 66/138 (47%), Positives = 95/138 (68%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
I +SNILL+++F + ++DFGLARL+S E+HVST + GT+GY+PPEYG AT +GDVY
Sbjct: 861 IKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVY 920
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
SFGV+LLEL+T K+P + K +L+ WV+ M +A EV DP + + + M +
Sbjct: 921 SFGVVLLELLTDKRPVDM-CKPKGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFR 979
Query: 368 MLQIATGCISNDPTVRPT 385
+L+IA C+S +P RPT
Sbjct: 980 VLEIACLCLSENPKQRPT 997
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 339 (124.4 bits), Expect = 5.6e-56, Sum P(3) = 5.6e-56
Identities = 69/139 (49%), Positives = 98/139 (70%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
I +SNILLND E ++SDFGLA+L+ D ++HV+TVVAGT GY+ PEY G+ATE+ DVY
Sbjct: 439 IKSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAPEYLQNGRATEKSDVY 498
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
SFGV+LLELVTGK+PT P F K G N+V W+ ++K + ++V+D + + + ++
Sbjct: 499 SFGVLLLELVTGKRPTDPIFV-KRGLNVVGWMNTVLKENRLEDVIDKRCTDVDEE-SVEA 556
Query: 368 MLQIATGCISNDPTVRPTM 386
+L+IA C +P RP M
Sbjct: 557 LLEIAERCTDANPENRPAM 575
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 338 (124.0 bits), Expect = 2.2e-55, Sum P(3) = 2.2e-55
Identities = 66/139 (47%), Positives = 100/139 (71%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
I +SNILL+ + EA++SDFGLA+L+ D ESH++T+VAGT GY+ PEY +G+ATE+ DVY
Sbjct: 428 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 487
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
SFGV++LE+++GK PT F +K G N+V W+ ++ +A E++D + + ++
Sbjct: 488 SFGVLVLEVLSGKLPTDASFIEK-GFNIVGWLNFLISENRAKEIVDLSCEGVE-RESLDA 545
Query: 368 MLQIATGCISNDPTVRPTM 386
+L IAT C+S+ P RPTM
Sbjct: 546 LLSIATKCVSSSPDERPTM 564
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 7.5e-54, Sum P(3) = 7.5e-54
Identities = 65/139 (46%), Positives = 100/139 (71%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
I +SNILL+ + EA++SDFGLA+L+ D ESH++T+VAGT GY+ PEY +G+ATE+ DVY
Sbjct: 431 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 490
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
SFGV++LE+++GK+PT F +K G N+V W+ ++ ++ +++DP + ++
Sbjct: 491 SFGVLVLEVLSGKRPTDASFIEK-GLNVVGWLKFLISEKRPRDIVDPNCEGMQME-SLDA 548
Query: 368 MLQIATGCISNDPTVRPTM 386
+L IAT C+S P RPTM
Sbjct: 549 LLSIATQCVSPSPEERPTM 567
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 388 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-36 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.002 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.002 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.003 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 6e-41
Identities = 76/264 (28%), Positives = 114/264 (43%), Gaps = 45/264 (17%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGKT---VAVKKL-SQATGQGDREFAAEMETLGMVKHQNL 204
+G G FG V+KG GK VAVK L A+ Q EF E + + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV--------------- 249
V+LLG C+ +E +V EYM G L +LR L
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNF 123
Query: 250 ------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATER 303
A N L+ ++ KISDFGL+R + D + + I ++ PE GK T +
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 304 GDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
DV+SFGV+L E+ T G+QP + E +++++ + + Q P +
Sbjct: 184 SDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLEYLKNGYRLPQ------PP-----NC 228
Query: 363 PTMLKMLQIATGCISNDPTVRPTM 386
P ++ + C + DP RPT
Sbjct: 229 PP--ELYDLMLQCWAEDPEDRPTF 250
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 74/275 (26%), Positives = 113/275 (41%), Gaps = 61/275 (22%)
Query: 152 NVIGGGGFGTVFKGTMPDGKT----VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVE 206
+G G FG V+KG + VAVK L + + +R +F E + + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR--------------------- 245
LLG C+ +E LV EYM G L D+LR ++
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 246 ---CKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----P 292
K V A N L+ +D KISDFGL+R + D + + T G +P P
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRWMAP 176
Query: 293 EYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351
E G T + DV+SFGV+L E+ T G P + E +++++ + + +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGYRLPKPEYC 232
Query: 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
D ++ ++ C DP RPT
Sbjct: 233 PD-------------ELYELMLSCWQLDPEDRPTF 254
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 46/265 (17%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK-----TVAVKKL-SQATGQGDREFAAEMETLGMVKHQNL 204
+G G FG V+KGT+ VAVK L A+ Q EF E + + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLR-NQAASLDWGKRCKIV-------------- 249
V+LLG C+ +E ++V EYM G L D+LR N+ L
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 250 -------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
A N L+ ++ KISDFGL+R + D + + I ++ PE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 303 RGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
+ DV+SFGV+L E+ T G++P + +++++ + + P +
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEP----YPGMSNAEVLEYLKKGYRLPK------PP-----N 228
Query: 362 KPTMLKMLQIATGCISNDPTVRPTM 386
P ++ ++ C + DP RPT
Sbjct: 229 CPP--ELYKLMLQCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-38
Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 41/227 (18%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGYC 211
+G GGFGTV+ GK VA+K + + E E+E L + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------------------A 250
+ LV EY GSL D L+ L + +I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 251 SNILL-NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYS 308
NILL +D+ + K++DFGL++L++ +S + T+V GT Y+ PE G G +E+ D++S
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE--QADEVLD 353
GVIL EL PE +D L+ +L + A E+L+
Sbjct: 180 LGVILYEL--------PELKD-----LIRKMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 75/259 (28%), Positives = 111/259 (42%), Gaps = 44/259 (16%)
Query: 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFA-AEMETLGMVKHQNLVELLG 209
+G G FG V+ GK VA+K + + + DRE E++ L +KH N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAA-SLDWGKRC--------------KIV----- 249
+++ LV EY G L D L+ + S D + IV
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLK 124
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKATERGDV 306
NILL++D K++DFGLAR + T GT Y+ PE G GKA D+
Sbjct: 125 PENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYGKAV---DI 179
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
+S GVIL EL+TGK P F G++ + + + + ++ +K +
Sbjct: 180 WSLGVILYELLTGKPP----F---PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 367 KMLQIATGCISNDPTVRPT 385
K+L DP R T
Sbjct: 233 KLLVK-------DPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 79/272 (29%), Positives = 115/272 (42%), Gaps = 64/272 (23%)
Query: 153 VIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVE 206
+G G FG V+KGT+ VAVK L + + +R EF E + + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS------------ 251
LLG C+ E +V EYM G L D+LR L ++ +A
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 252 ------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGKA 300
N L+ ++ KISDFGL+R I + + + G +P PE GK
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR----GGGKLPIKWMAPESLKDGKF 181
Query: 301 TERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWV---LHMMKNEQADEVLDPAV 356
T + DV+SFGV+L E+ T G+QP + E +++ + + + E
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLELLEDGYRLPRPENC-------- 229
Query: 357 LNANSKPTMLK--MLQIATGCISNDPTVRPTM 386
P L MLQ C + DP RPT
Sbjct: 230 ------PDELYELMLQ----CWAYDPEDRPTF 251
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-36
Identities = 72/261 (27%), Positives = 105/261 (40%), Gaps = 38/261 (14%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
+G G FGTV+K GK VAVK L + D+ E+ L + H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------------------- 250
+ LV EY G L D+L L + KI
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124
Query: 251 --SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVY 307
NILL+++ KI+DFGLA+ + S T GT Y+ PE G + DV+
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
S GVIL EL+TGK P F ++ + L +++ + +
Sbjct: 184 SLGVILYELLTGKPP----FSGENILD----QLQLIRRILGPPLEFD---EPKWSSGSEE 232
Query: 368 MLQIATGCISNDPTVRPTMLH 388
+ C++ DP+ RPT
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEE 253
|
Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 30/201 (14%)
Query: 151 ENVIGGGGFGTVFKGTM--PDGK--TVAVKKL-SQATGQGDREFAAEMETLGMVKHQNLV 205
E VIGGG FG V +G + P K VA+K L + ++ + +F E +G H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------------- 249
L G + +++ EYM GSLD +LR G+ ++
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG--YVPPEYGGTGKATE 302
A NIL+N + K+SDFGL+R + D E+ T G I + PE K T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 303 RGDVYSFGVILLELVT-GKQP 322
DV+SFG+++ E+++ G++P
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 45/271 (16%)
Query: 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQ-NLVELL 208
+G G FG V+ D K VA+K L++ + F E++ L + H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQ------------------AASLDWGKRCKIV- 249
+ + LV EY+ GSL+D L+ ++L++ I+
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 250 ----ASNILLN-DDFEAKISDFGLARLISDCESHVS-----TVVAGTIGYVPPEY---GG 296
NILL+ D K+ DFGLA+L+ D S S + GT GY+ PE
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356
A+ D++S G+ L EL+TG P FE + + L ++ + P
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSATSQTLKIILELPTPSLASP-- 238
Query: 357 LNANSKPTMLKMLQ-IATGCISNDPTVRPTM 386
L+ ++ + K + ++ DP R +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 28/198 (14%)
Query: 152 NVIGGGGFGTVFKGTMPD-GKTVAVKK--LSQATGQGDREFAAEMETLGMVKHQNLVELL 208
++G G FG+V+ D G+ +AVK LS + + E+ L ++H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 209 GYCSVDEEKLLVY---EYMVKGSLDDWLRNQAA---------------SLDWGKRCKIV- 249
G DEEK + EY+ GSL L+ L + IV
Sbjct: 66 G-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 250 ----ASNILLNDDFEAKISDFGLARLISD-CESHVSTVVAGTIGYVPPEYGGTGKATERG 304
+NIL++ D K++DFG A+ + D + V GT ++ PE +
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184
Query: 305 DVYSFGVILLELVTGKQP 322
D++S G ++E+ TGK P
Sbjct: 185 DIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
F IG GGFG V+K GK VA+K + + + + E++ L KH N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLD---WGKRCK--------------- 247
+ G +E +V E+ GSL D L++ +L CK
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTG 298
I A+NILL D E K+ DFGL+ +SD ++ + V GT ++ PE Y
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD--Y 176
Query: 299 KATERGDVYSFGVILLELVTGKQP 322
KA D++S G+ +EL GK P
Sbjct: 177 KA----DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 66/192 (34%), Positives = 95/192 (49%), Gaps = 24/192 (12%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V+ GT VAVK L T + F E + + ++H LV+L CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 214 DEEKLLVYEYMVKGSLDDWLRN----------------QAAS-LDWGKRCKIV-----AS 251
+E +V EYM KGSL D+L++ Q A + + + + A
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAAR 132
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGV 311
NIL+ ++ KI+DFGLARLI D E I + PE G+ T + DV+SFG+
Sbjct: 133 NILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGI 192
Query: 312 ILLELVT-GKQP 322
+L E+VT G+ P
Sbjct: 193 LLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 47/262 (17%)
Query: 153 VIGGGGFGTVFKGT-MPDGKT----VAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVE 206
V+G G FGTV+KG +P+G+ VA+K L + T + ++E E + V H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLD------WG------------KRC-- 246
LLG C + + L+ + M G L D++RN ++ W KR
Sbjct: 74 LLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132
Query: 247 -KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT-IGYVPPEYGGTGKATERG 304
+ A N+L+ KI+DFGLA+L+ E I ++ E T +
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKS 192
Query: 305 DVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363
DV+S+GV + EL+T G +P +E + D + E+ + + P + +
Sbjct: 193 DVWSYGVTVWELMTFGAKP----YEGIPAVEIPDLL------EKGERLPQPPICTIDVYM 242
Query: 364 TMLKMLQIATGCISNDPTVRPT 385
++K C D RPT
Sbjct: 243 VLVK-------CWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 28/200 (14%)
Query: 148 FCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
F E +G G FG V++G + VA+K L ++F E++ L ++H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRN------QAASL-DWGKRC----------KIV- 249
CSV E ++ E M KGSL +LR+ ASL D + +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY--VPPEYGGTGKATER 303
A NIL+ +D K++DFGLARLI + V I Y PE G + +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKE---DVYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 304 GDVYSFGVILLELVT-GKQP 322
DV+SFG++L E+ T G+ P
Sbjct: 185 SDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 58/186 (31%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
IG G FG V G G+ VAVK L + F AE + ++H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC------------------KIV-----A 250
+V EYM KGSL D+LR++ ++ V A
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEYLEEKNFVHRDLAA 130
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
N+L+++D AK+SDFGLA+ + S + + + PE K + + DV+SFG
Sbjct: 131 RNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVWSFG 186
Query: 311 VILLEL 316
++L E+
Sbjct: 187 ILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 103/406 (25%), Positives = 177/406 (43%), Gaps = 65/406 (16%)
Query: 6 NLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGSD---CKILTFGKL--AL 60
+L+ +N++ N L G +P +G ++ ++ GN DLCG S CK +
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFY 631
Query: 61 VGIVVGSVLVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALME 120
+ +G+ LV+A++ + R E KR D
Sbjct: 632 ITCTLGAFLVLALVAFGFVF--IRGRNNL------ELKRVENEDG--------------- 668
Query: 121 HLSINLAMFEPSLQK-LTYDQIVAGTNKFCEENVIGGGGFGTVFKG-TMPDGKTVAVKKL 178
+ L F+ + K +T + I++ EENVI G G +KG ++ +G VK++
Sbjct: 669 --TWELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 179 SQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA 238
+ E A +G ++H N+V+L+G C ++ L++EY+ +L + LRN
Sbjct: 724 NDVNSIPSSEIA----DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 239 SLDWGKRCKIV--------------ASNILLNDDFEAKISDFG--LARLISDCESHVSTV 282
L W +R KI + +++ + KI G L + T
Sbjct: 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD 835
Query: 283 VAGTI--GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
I YV PE T TE+ D+Y FG+IL+EL+TGK P EF ++V+W
Sbjct: 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWAR 893
Query: 341 HMMKNEQADEVLDPAVLNANS--KPTMLKMLQIATGCISNDPTVRP 384
+ + D +DP++ S + +++++ +A C + DPT RP
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-23
Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 59/264 (22%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V++G + VAVK L T +F AE + + ++H L++L C++
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---------VAS------------- 251
+E +V E M GSL ++L+ A G+ K+ VAS
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 252 -----NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
N+L+ ++ K++DFGLAR+I + I + PE + + + DV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 307 YSFGVILLELVT-GKQP----TGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
+SFG++L E+VT G+ P T E VL + +Q + P
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAE------------VLQQV--DQGYRMPCP----PGC 229
Query: 362 KPTMLKMLQIATGCISNDPTVRPT 385
+ I C DP RPT
Sbjct: 230 PKE---LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 57/192 (29%), Positives = 83/192 (43%), Gaps = 29/192 (15%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGYCS 212
IG G FG V+KG + VAVK + F E E L H N+V+L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 213 VDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK-----------------RCKI----VAS 251
+ +V E + GSL +LR + L K + I A
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT----IGYVPPEYGGTGKATERGDVY 307
N L+ ++ KISDFG++R + E + TV G I + PE G+ T DV+
Sbjct: 123 NCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 308 SFGVILLELVTG 319
S+G++L E +
Sbjct: 180 SYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-22
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 146 NKFCEENVIGGGGFGTVFKGT--MPDGK--TVAVKKLSQATGQGDR-EFAAEMETLGMVK 200
+ ++ VIG G FG VF+G MP K VA+K L + R +F +E +G
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK 244
H N++ L G + + +++ EYM G+LD +LR+ AA + +
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 245 RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG--YVPPEYGGT 297
V A NIL+N + E K+SDFGL+R++ D T G I + PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 298 GKATERGDVYSFGVILLELVT-GKQP 322
K T DV+SFG+++ E+++ G++P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-22
Identities = 69/193 (35%), Positives = 96/193 (49%), Gaps = 27/193 (13%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V+ GT VAVK L T F E + + ++H LV+L Y V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 214 DEEKL-LVYEYMVKGSLDDWLRNQ-----------------AASLDWGKRCKIV-----A 250
EE + +V EYM KGSL D+L++ AA + + +R + +
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRS 130
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
+NIL+ D KI+DFGLARLI D E I + PE G+ T + DV+SFG
Sbjct: 131 ANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 311 VILLELVT-GKQP 322
++L ELVT G+ P
Sbjct: 191 ILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-22
Identities = 66/193 (34%), Positives = 97/193 (50%), Gaps = 27/193 (13%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V+ GT VA+K L T F E + + ++H+ LV+L Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 214 DEEKL-LVYEYMVKGSLDDWLRNQ-----------------AASLDWGKRCKIV-----A 250
EE + +V EYM KGSL D+L+ + A+ + + +R V A
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 130
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
+NIL+ ++ K++DFGLARLI D E I + PE G+ T + DV+SFG
Sbjct: 131 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 311 VILLELVT-GKQP 322
++L EL T G+ P
Sbjct: 191 ILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 63/269 (23%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQNLVELLG 209
V+G G G V+K P GK A+KK+ G + ++ E++TL + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 210 -YCSVDEEKLLVYEYMVKGSLDDWLR-------NQAAS--------LDW--GKRCKIV-- 249
+ + E +V EYM GSL D L+ A LD+ KR I+
Sbjct: 67 AFYK-EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR-HIIHR 124
Query: 250 ---ASNILLNDDFEAKISDFGLARLISD----CESHVSTVVAGTIGYVPPE------YGG 296
SN+L+N E KI+DFG+++++ + C + V GT+ Y+ PE Y
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGESYSY 179
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356
D++S G+ LLE GK P F + + +M + D
Sbjct: 180 A------ADIWSLGLTLLECALGKFP----FLPPGQPSFFE----LM-----QAICDGPP 220
Query: 357 LNANSKPTMLKMLQIATGCISNDPTVRPT 385
+ ++ + + C+ DP RP+
Sbjct: 221 PSLPAEEFSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 49/216 (22%)
Query: 153 VIGGGGFGTVFKGTMPDGKT------VAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
+G G FG VF G + VAVK L + R+ F E E L +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRN---QAASLDWGKR----------CKI---V 249
+ G C+ + ++V+EYM G L+ +LR+ AA L +I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 250 AS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT----I 287
AS N L+ D KI DFG++R + + + V G I
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPI 188
Query: 288 GYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
++PPE K T DV+SFGV+L E+ T GKQP
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 152 NVIGGGGFGTVFKGTM--PDGKT---VAVKKLSQATG-QGDREFAAEMETLGMVKHQNLV 205
+G G FG V T VAVK L+ + Q +F E+E L + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 206 ELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAASLDWGKR-------CK--------- 247
+ G C + L+ EY+ GSL D+L+ ++ + CK
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 248 -----IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT----IGYVPPEYGGTG 298
+ A NIL+ + KISDFGLA+++ E V I + PE T
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLP--EDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 299 KATERGDVYSFGVILLELVT 318
K + DV+SFGV L EL T
Sbjct: 188 KFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 53/214 (24%)
Query: 154 IGGGGFGTVFKGT------MPDGKTVAVKKL-SQATGQGDREFAAEMETLGMV-KHQNLV 205
+G G FG V K + TVAVK L AT + + +EME + M+ KH+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR-----NQAASLDW------------------ 242
LLG C+ + +V EY G+L D+LR + AS D
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 243 ----------GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289
K+C + A N+L+ +D KI+DFGLAR I + + T T G
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT----TNGR 195
Query: 290 VP-----PEYGGTGKATERGDVYSFGVILLELVT 318
+P PE T + DV+SFGV+L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 154 IGGGGFGTVFKGT--MPDGK--TVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELL 208
+G G FG+V KG M GK VAVK L Q G +EF E + + H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQ-----------AASLDWG----KRCKIV---- 249
G C E +LV E G L +L+ + A + G + V
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKATERGDV 306
A N+LL + +AKISDFG++R + + AG + + PE GK + + DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 307 YSFGVILLELVT-GKQP----TGPE 326
+S+GV L E + G +P G E
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKGAE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-20
Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V+ G VA+K L Q + + F AE + ++H LV L Y V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 214 DEEKL-LVYEYMVKGSLDDWLRNQAAS-------LDWGKRCK---------------IVA 250
+E + ++ EYM GSL D+L+ +D + + A
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRA 130
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
+NIL+++ KI+DFGLARLI D E I + PE G T + DV+SFG
Sbjct: 131 ANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 190
Query: 311 VILLELVT-GKQP----TGPE 326
++L E+VT G+ P T PE
Sbjct: 191 ILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 9e-20
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V G VA+K + + D +F E + + + H NLV+L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAASLDWG-------KRCK--------------IVASN 252
+V EYM G L ++LR + L C+ + A N
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130
Query: 253 ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVI 312
L+ +D K+SDFGLAR + D + S + + PPE + + + DV+SFGV+
Sbjct: 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVL 190
Query: 313 LLELVT-GKQP 322
+ E+ + GK P
Sbjct: 191 MWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 60/192 (31%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V+ G + VAVK L T + F E + ++H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAAS-------LDWGKRC---------------KIVAS 251
+E ++ EYM KGSL D+L++ +D+ + + A+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 132
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGV 311
N+L+++ KI+DFGLAR+I D E I + PE G T + DV+SFG+
Sbjct: 133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 192
Query: 312 ILLELVT-GKQP 322
+L E+VT GK P
Sbjct: 193 LLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 30/194 (15%)
Query: 151 ENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
++ +GGG +G V++G TVAVK L + T + + EF E + +KH NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRN----------------QAAS-LDWGKRCKIV--- 249
C+ + ++ E+M G+L D+LR Q +S +++ ++ +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGKATERG 304
A N L+ ++ K++DFGL+RL++ T AG I + PE K + +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 305 DVYSFGVILLELVT 318
DV++FGV+L E+ T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 82/271 (30%), Positives = 122/271 (45%), Gaps = 49/271 (18%)
Query: 154 IGGGGFGTVFK---GTMPD--GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELL 208
+G G FG+V + D G+ VAVKKL +T + R+F E+E L ++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 209 GYC-SVDEEKL-LVYEYMVKGSLDDWLRNQAASLDW------------------GKRC-- 246
G C S L LV EY+ GSL D+L+ LD KR
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 247 -KIVASNILLNDDFEAKISDFGLARLI-SDCESHVSTVVAGT-IGYVPPEYGGTGKATER 303
+ NIL+ + KI DFGL +++ D E + + I + PE K +
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA 191
Query: 304 GDVYSFGVILLELVT----GKQPTGPEF-----EDKDGENLVDWVLHMMKNEQADEVLDP 354
DV+SFGV+L EL T P EF DK G+ +V ++ ++KN P
Sbjct: 192 SDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELLKNNGR----LP 246
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
A ++ + M + C +NDP+ RP+
Sbjct: 247 APPGCPAEIYAI-MKE----CWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-19
Identities = 69/193 (35%), Positives = 96/193 (49%), Gaps = 27/193 (13%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V+ GT VA+K L T F E + + ++H LV L Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 214 DEEKL-LVYEYMVKGSLDDWLR-------------NQAASLDWG----KRCKIV-----A 250
EE + +V E+M KGSL D+L+ + AA + G +R + A
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
+NIL+ D+ KI+DFGLARLI D E I + PE G+ T + DV+SFG
Sbjct: 131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 311 VILLELVT-GKQP 322
++L ELVT G+ P
Sbjct: 191 ILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 62/276 (22%)
Query: 154 IGGGGFGTVFKGTM-----PDGKT-VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVE 206
+G G FG V++G + +T VA+K +++ +R EF E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLR---------------------NQAASLDWGK- 244
LLG S + L+V E M KG L +LR AA + G
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 245 --------RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYG 295
+ A N ++ +D KI DFG+ R I + + + + ++ PE
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 296 GTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVL---HMMKNEQADEV 351
G T + DV+SFGV+L E+ T +QP ++ E ++ +V+ H+ E +
Sbjct: 194 KDGVFTTKSDVWSFGVVLWEMATLAEQP----YQGLSNEEVLKFVIDGGHLDLPENCPD- 248
Query: 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
K+L++ C +P +RPT L
Sbjct: 249 ---------------KLLELMRMCWQYNPKMRPTFL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 49/222 (22%)
Query: 147 KFCEENVIGGGGFGTVFKG--TMPDGK----TVAVKKLSQ-ATGQGDREFAAEMETLGMV 199
+F EE +G G FG V+KG T P+ + +VA+K L + A + +EF E E + +
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 200 KHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL---------------RNQAASLDWGK 244
+H N+V LLG C+ ++ +++EY+ G L ++L +SLD
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 245 RCKIV---------------------ASNILLNDDFEAKISDFGLARLI--SDCESHVST 281
I A N L+ + KISDFGL+R I +D S
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+ + ++PPE GK T D++SFGV+L E+ + G QP
Sbjct: 186 SLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 45/213 (21%)
Query: 154 IGGGGFGTVF----KGTMPDGKT--VAVKKLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG VF +P+ VAVK L +A+ ++F E E L +++HQ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA------------------------------ 237
G C+ L+V+EYM G L+ +LR+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 238 ------ASLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYV 290
ASL + R + N L+ KI DFG++R I + + V I ++
Sbjct: 133 SGMVYLASLHFVHR-DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 291 PPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
PPE K T D++SFGV+L E+ T GKQP
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-18
Identities = 65/231 (28%), Positives = 99/231 (42%), Gaps = 50/231 (21%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKK--LSQATGQGDREFA-AEMETLGMVKHQ 202
K+ IG G FG V+ DGK +K+ LS + + +RE A E++ L + H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHP 59
Query: 203 NLVELLGYCS-VDEEKLL-VYEYMVKGSLDDWLRNQAAS---------LDW------GKR 245
N+++ Y S ++ KL V EY G L ++ Q LDW +
Sbjct: 60 NIIKY--YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 246 C----KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--- 293
KI+ NI L + K+ DFG+++++S TVV GT Y+ PE
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 294 ---YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
Y + D++S G +L EL T K P FE ++ L +L
Sbjct: 177 NKPY------NYKSDIWSLGCVLYELCTLKHP----FEGENLLELALKILK 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 69/257 (26%), Positives = 105/257 (40%), Gaps = 46/257 (17%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V G VA+K + + + D EF E + + + H+ LV+L G C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAASLDWGK---RCKIV------------------ASN 252
+V EYM G L ++LR + CK V A N
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130
Query: 253 ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVI 312
L++D K+SDFGL+R + D E S + + PPE K + + DV++FGV+
Sbjct: 131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVL 190
Query: 313 LLELVT-GKQPTGPEFEDKDGENLVDWV---LHMMKNEQADEVLDPAVLNANSKPTMLKM 368
+ E+ + GK P +E + V+ V L + + A E K+
Sbjct: 191 MWEVYSLGKMP----YERFNNSETVEKVSQGLRLYRPHLASE----------------KV 230
Query: 369 LQIATGCISNDPTVRPT 385
I C RPT
Sbjct: 231 YAIMYSCWHEKAEERPT 247
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 79/264 (29%), Positives = 120/264 (45%), Gaps = 46/264 (17%)
Query: 152 NVIGGGGFGTVFKGTM--PDGKTV--AVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVE 206
VIG G FG V+ GT+ DG+ + AVK L++ T + E F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 207 LLGYCSVDE-EKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGKRCKIV 249
LLG C E L+V YM G L +++R++ A +++ K V
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCE---SHVSTVVAGTIGYVPPEYGGTGKAT 301
A N +L++ F K++DFGLAR I D E H T + ++ E T K T
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT 180
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
+ DV+SFGV+L EL+T P P D D ++ ++L + Q + DP
Sbjct: 181 TKSDVWSFGVLLWELMTRGAPPYP---DVDSFDITVYLLQGRRLLQPEYCPDP------- 230
Query: 362 KPTMLKMLQIATGCISNDPTVRPT 385
+ ++ C P +RPT
Sbjct: 231 ------LYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-18
Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 151 ENVIGGGGFGTVFKGTMP-DGK---TVAVKKLSQA-TGQGDREFAAEMETLGMVKHQNLV 205
E VIG G FG V G + GK VA+K L T + R+F +E +G H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL--------------------DWGKR 245
L G + + ++V EYM GSLD +LR D G
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 246 CK-IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG--YVPPEYGGTGKATE 302
+ + A NIL+N + K+SDFGL+R++ D T G I + PE K T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188
Query: 303 RGDVYSFGVILLELVT-GKQP 322
DV+S+G+++ E+++ G++P
Sbjct: 189 ASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-18
Identities = 78/261 (29%), Positives = 113/261 (43%), Gaps = 48/261 (18%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
IG G FG V G G VAVK + + AT Q F AE + ++H NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG 66
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR--------CK------------- 247
++ L +V EYM KGSL D+LR++ S+ G C+
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 248 -IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
+ A N+L+++D AK+SDFGL + S + V T PE K + + DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDV 182
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
+SFG++L E+ + + P KD +V V K + D P V +
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDGC-PPVVYD-------- 230
Query: 367 KMLQIATGCISNDPTVRPTML 387
+ C D RP+ L
Sbjct: 231 ----VMKQCWHLDAATRPSFL 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 23/191 (12%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
IG G FG V+ G + + VA+K + + + +F E + + + H LV+L G C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAASLD-----------------WGKRCKI----VASN 252
LV+E+M G L D+LR Q I A N
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130
Query: 253 ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVI 312
L+ ++ K+SDFG+ R + D + ST + + PE K + + DV+SFGV+
Sbjct: 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVL 190
Query: 313 LLELVT-GKQP 322
+ E+ + GK P
Sbjct: 191 MWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 36/206 (17%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
+ IG G G V+K T GK VA+KK+ Q E+ + KH N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPN 76
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN--------QAAS--------LDW--GKR 245
+V+ V +E +V EYM GSL D + Q A L++ +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 246 C---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGG 296
I + NILL+ D K++DFG A ++ +S ++VV GT ++ PE YG
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYG- 194
Query: 297 TGKATERGDVYSFGVILLELVTGKQP 322
+ D++S G++ +E+ G+ P
Sbjct: 195 -----PKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 24/194 (12%)
Query: 152 NVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQNLVELL 208
++IG G FG V+KG + G VA+K++S + + + E++ L +KH N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLR-------NQAAS--------LDWGKRCKIV---- 249
G + ++ EY GSL ++ + A L + ++
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
A+NIL D K++DFG+A ++D S V GT ++ PE A+ D++S
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGASTASDIWS 184
Query: 309 FGVILLELVTGKQP 322
G ++EL+TG P
Sbjct: 185 LGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 33/204 (16%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGK---TVAVKKLSQA-TGQGDREFAAEMETLGMVKHQNLV 205
E VIG G FG V +G + GK VA+K L T + R+F +E +G H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGKRCKIV 249
L G + +++ E+M G+LD +LR AA + + V
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGK 299
A NIL+N + K+SDFGL+R + D S T + G +P PE K
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 300 ATERGDVYSFGVILLELVT-GKQP 322
T DV+S+G+++ E+++ G++P
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-17
Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 70/284 (24%)
Query: 154 IGGGGFGTVFKGTMP------DGKTVAVKKLSQ-ATGQGDREFAAEMETLGMVKHQNLVE 206
IG G FG VF+ P VAVK L + A+ +F E + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLR-----NQAASLDWGKRCK-------------- 247
LLG C+V + L++EYM G L+++LR Q + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 248 -----------------------IVASNILLNDDFEAKISDFGLARLISDCESH-VSTVV 283
+ N L+ ++ KI+DFGL+R I + + S
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM 342
A I ++PPE + T DV+++GV+L E+ + G QP +
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-----------------YYG 235
Query: 343 MKNEQA-DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
M +E+ V D VL+ L++ + C S P+ RP+
Sbjct: 236 MAHEEVIYYVRDGNVLSCPDN-CPLELYNLMRLCWSKLPSDRPS 278
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 43/244 (17%)
Query: 153 VIGGGGFGTVFKGT-MPDGKT----VAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVE 206
++G G FGTV KG +P+G + VA+K + +G Q +E M +G + H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLD------WGKRC-------------- 246
LLG C +L V + GSL D +R SLD W +
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132
Query: 247 -KIVASNILLNDDFEAKISDFGLARLI-SDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
+ A NILL D +I+DFG+A L+ D + + + I ++ E G+ T +
Sbjct: 133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQS 192
Query: 305 DVYSFGVILLELVT-GKQPTG----PEFED--KDGENL-------VDWVLHMMKNEQADE 350
DV+S+GV + E+++ G +P E D + GE L +D + M+K DE
Sbjct: 193 DVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDE 252
Query: 351 VLDP 354
+ P
Sbjct: 253 NVRP 256
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 45/215 (20%)
Query: 132 SLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLS-QATGQGDREFA 190
+LQKLT +I IG G FG V +G G+ VAVK + T Q F
Sbjct: 4 NLQKLTLGEI------------IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FL 47
Query: 191 AEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------------- 236
E + + H+NLV LLG + +V E M KG+L ++LR +
Sbjct: 48 EETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106
Query: 237 ---AASLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288
A +++ + K+V A NIL+++D AK+SDFGLAR+ S +
Sbjct: 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK 162
Query: 289 YVPPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+ PE K + + DV+S+GV+L E+ + G+ P
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 8e-16
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 45/220 (20%)
Query: 154 IGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLVE 206
+G G FG V K T GK A+K L + +E E L + H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 207 LLGYCSV-DEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKIV 249
L + + EEKL LV EY G L L + AA +L++ I+
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKAT 301
NILL+ D K++DFGLA+ +S S +T GT Y+ PE G GKA
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAV 174
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
D +S GV+L E++TGK P F +D + + + +L
Sbjct: 175 ---DWWSLGVLLYEMLTGKPP----FYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 40/200 (20%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDRE-----FAAEMETLGMVKHQNLVEL 207
IG G +G V+K G+ VA+KK+ + ++E E++ L ++H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 208 LGYCSVDEEK---LLVYEYM------------VKGSLDD---WLRNQAASLDWGKRCKIV 249
+ K +V+EYM VK + +++ L + I+
Sbjct: 64 KEIV-TSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVST--VVAGTIGYVPPE--YGGTGKA 300
SNIL+N+D K++DFGLAR + S T V+ T+ Y PPE G T
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLLGATRYG 180
Query: 301 TERGDVYSFGVILLELVTGK 320
E D++S G IL EL GK
Sbjct: 181 PEV-DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 82/281 (29%), Positives = 120/281 (42%), Gaps = 69/281 (24%)
Query: 152 NVIGGGGFGTVFKGTMPD-------GKTVAVKKLSQ-ATGQGDREFAAEMETLGMVKHQN 203
N +G G FG V++GT D VAVK L + AT Q +EF E + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS----------------LDWGKRC- 246
+V+LLG C ++E + ++ E M G L +LR+ LD K C
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 247 ----------KIVASNILLND-----DFEAKISDFGLARLISDCESHVSTVVAG----TI 287
+ A N L+++ D KI DFGLAR D G +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLPV 177
Query: 288 GYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNE 346
++ PE GK T + DV+SFGV++ E++T G+QP P +++ VL +
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-PALNNQE-------VLQHVTAG 229
Query: 347 QADEVLDPAVLNANSKPTML--KMLQIATGCISNDPTVRPT 385
+ KP K+ Q+ T C + DP+ RPT
Sbjct: 230 GRLQ-----------KPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 66/260 (25%), Positives = 107/260 (41%), Gaps = 45/260 (17%)
Query: 153 VIGGGGFGTVFKGTMPDGK----TVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVEL 207
IG G FG V++G + VAVK T RE F E + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDW------------------GKRC--- 246
+G + + +V E G L +L+ SLD KR
Sbjct: 73 IGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR 131
Query: 247 KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
I A N+L++ K+ DFGL+R + D + ++ I ++ PE + T DV
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV 191
Query: 307 YSFGVILLE-LVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
+ FGV + E L+ G +P F+ +++ + E + + P N PT+
Sbjct: 192 WMFGVCMWEILMLGVKP----FQGVKNNDVI------GRIENGERLPMP----PNCPPTL 237
Query: 366 LKMLQIATGCISNDPTVRPT 385
++ T C + DP+ RP
Sbjct: 238 YSLM---TKCWAYDPSKRPR 254
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 63/228 (27%)
Query: 153 VIGGGGFGTVFKGT------MPDGKTVAVKKLSQATGQGD-REFAAEMETLGMVKHQNLV 205
+G G FG V K T TVAVK L + + R+ +E L V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR---------------NQAASLD--------- 241
+L G CS D LL+ EY GSL +LR ++ LD
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 242 -------WGKRCK--------------IVASNILLNDDFEAKISDFGLARLISDCESHVS 280
W + + + A N+L+ + + KISDFGL+R + + +S+V
Sbjct: 127 GDLISFAW-QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 281 TVVAGTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+ G +P E T + DV+SFGV+L E+VT G P
Sbjct: 186 R----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV 213
+G G FG V G VA+K +++ + +F E + + + H LV+L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 214 DEEKLLVYEYMVKGSLDDWLRNQAASL----------------DWGKRCKIV-----ASN 252
+ +V E+M G L ++LR + L ++ +R + A N
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130
Query: 253 ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVI 312
L++ K+SDFG+ R + D E S+ + + PPE K + + DV+SFGV+
Sbjct: 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVL 190
Query: 313 LLELVT-GKQPTGPEFEDKDGENLVDWV 339
+ E+ T GK P FE K +V+ +
Sbjct: 191 MWEVFTEGKMP----FEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 31/201 (15%)
Query: 152 NVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQNLVELL 208
N IGGG FG V+ + G+ +AVK++ +E A EM+ L ++KH NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 209 GYCSVDEEKLLVY-EYMVKGSLDDWLRNQAA---------------SLDWGKRCKIV--- 249
G V EK+ ++ EY G+L++ L + L + IV
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG---YVPPEYGGTGKATERG 304
+NI L+ + K+ DFG A + + + + V G Y+ PE GK G
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 305 ---DVYSFGVILLELVTGKQP 322
D++S G ++LE+ TGK+P
Sbjct: 185 RAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 22/185 (11%)
Query: 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVELLGYC 211
++G G FG VFKGT+ D VAVK + Q + +F +E L H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDW--GKRC---KIVA 250
+ + +V E + G +LR + AA + + K C + A
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
N L+ ++ KISDFG++R D S + I + PE G+ + DV+S+G
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 311 VILLE 315
++L E
Sbjct: 182 ILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 57/265 (21%)
Query: 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLS-QATGQGDREFA-------AEMETLGMVKHQ 202
N IG G FG VFK D + A+K++ + +RE A A++++ ++++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 203 NLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAAS-----------------LDWGK 244
+D+ KL +V EY G L L+ Q L
Sbjct: 66 E-------SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 245 RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
KI+ + N+ L+ KI D G+A+L+SD + +T+V GT Y+ PE
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
E+ DV++ GV+L E TGK P D N +L +++ V P
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF-------DANNQGALILKIIRG-----VFPPV---- 221
Query: 360 NSKPTMLKMLQIATGCISNDPTVRP 384
S+ ++ Q+ C++ D RP
Sbjct: 222 -SQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 44/206 (21%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD----REFAAEMETLGMVKHQNLVE 206
N IG G GTV+K P G+ A+K + G + R+ E+E L V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLD-----------DWLRNQAASLDWGKRCKIV-----A 250
+ E ++ E+M GSL+ D R + + + R IV
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKP 196
Query: 251 SNILLNDDFEAKISDFGLARLISD----CESHVSTVVAGTIGYVPPEYGGT--------G 298
SN+L+N KI+DFG++R+++ C S V GTI Y+ PE T G
Sbjct: 197 SNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTDLNHGAYDG 251
Query: 299 KATERGDVYSFGVILLELVTGKQPTG 324
A GD++S GV +LE G+ P G
Sbjct: 252 YA---GDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 71/286 (24%), Positives = 106/286 (37%), Gaps = 68/286 (23%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLS--QATGQGDREFAA-EMETLGMVK-H 201
KF + IG G F TV K A+K L Q + ++ E E L + H
Sbjct: 4 KFGKI--IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 202 QNLVELLGYCSV-DEEKL-LVYEYMVKGSL-----------DDWLRNQAA----SLDWGK 244
+++L Y + DEE L V EY G L + R AA +L++
Sbjct: 62 PGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 245 RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA--------------- 284
I+ NILL+ D KI+DFG A+++ S S
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 285 ----GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
GT YV PE A + D+++ G I+ +++TGK P F E L
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGS-NEYLT---- 230
Query: 341 HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ E P ++K + K+L + DP R +
Sbjct: 231 --FQKILKLEYSFPPNFPPDAKDLIEKLLVL-------DPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
E +G G FG V+ T VAVK + + F AE + ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAAS-------LDWGKRC---------------KI 248
+ E ++ E+M KGSL D+L++ S +D+ + +
Sbjct: 70 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 249 VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
A+NIL++ KI+DFGLAR+I D E I + PE G T + DV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 309 FGVILLELVT-GKQP 322
FG++L+E+VT G+ P
Sbjct: 189 FGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 41/210 (19%)
Query: 154 IGGGGFGTVFKGTM------PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG VF D VAVK L A+ ++F E E L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLR------------------NQAASLDWGKRC--- 246
G C + ++V+EYM G L+ +LR Q+ L ++
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 247 ------------KIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPE 293
+ N L+ ++ KI DFG++R + + + V I ++PPE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 294 YGGTGKATERGDVYSFGVILLELVT-GKQP 322
K T DV+S GV+L E+ T GKQP
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 66/209 (31%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKK--LSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G G VFK G+TVA+KK L + G + E++ L +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWG--KR-----CKIVA------------- 250
+LV EYM L + LR++ L K K VA
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126
Query: 251 -SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--YGGTGKATERGDVY 307
+N+L++ D KI+DFGLARL S+ E + + T Y PE YG K D++
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPGVDLW 185
Query: 308 SFGVILLELVTGKQPTGPEFE-DKDGENL 335
+ G I EL+ G P F + D E L
Sbjct: 186 AVGCIFAELLNG----SPLFPGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 72/295 (24%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGD-REFAA-EMETLGMVKHQ 202
NK+ V+G G +G V K G+ VA+KK ++ D ++ A E++ L ++H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA---------------SLDWGKRCK 247
N+V L LV+EY+ + L+ + ++ +
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 248 IV-----ASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE----YGGT 297
I+ NIL+++ K+ DFG AR + S ++ VA T Y PE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNY 179
Query: 298 GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP--- 354
GK DV++ G I+ EL+ G +P P G++ +D + + K L P
Sbjct: 180 GKPV---DVWAIGCIMAELLDG-EPLFP------GDSDIDQLYLIQK------CLGPLPP 223
Query: 355 ---AVLNANSK------PTMLKM---------------LQIATGCISNDPTVRPT 385
+ ++N + P + L C+ DP R T
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 65/205 (31%), Positives = 89/205 (43%), Gaps = 42/205 (20%)
Query: 152 NVIGGGGFGTVFKGT---MPDGKT---VAVKKLSQ-ATGQGDREFAAEMETLGMVK--HQ 202
+G G FG V++G VAVK L + + Q + +F ME L M K HQ
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL--MEALIMSKFNHQ 69
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR------NQAASL----------DWGKRC 246
N+V L+G + ++ E M G L +LR + +SL D K C
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 247 K-----------IVASNILLND---DFEAKISDFGLARLISDCESHVSTVVAG-TIGYVP 291
K I A N LL AKI+DFG+AR I + A I ++P
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 292 PEYGGTGKATERGDVYSFGVILLEL 316
PE G T + DV+SFGV+L E+
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 72/283 (25%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 147 KFCEENVIGGGGFGTVFKG-----TMPDGKTVAVKKLSQ-ATGQGDREFAAEMETLGMVK 200
+F EE +G FG ++KG M + VA+K L Q EF E + +
Sbjct: 8 RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQA----------------ASLDWGK 244
H N+V LLG + ++ +++EY+ +G L ++L ++ +SLD G
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 245 RCKI---------------------VASNILLNDDFEAKISDFGLARLISDCESH-VSTV 282
I A NIL+ + KISD GL+R I + + V
Sbjct: 126 FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLH 341
I ++PPE GK + D++SFGV+L E+ + G QP +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-----------------YY 228
Query: 342 MMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRP 384
N++ E++ L S+ +M + T C P+ RP
Sbjct: 229 GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 46/214 (21%)
Query: 154 IGGGGFGTVFKGT------MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG VF D VAVK L T ++F E E L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA------------------------------ 237
G C + ++V+EYM G L+ +LR
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 238 -------ASLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGY 289
AS + R + N L+ + KI DFG++R + + + V I +
Sbjct: 133 ASGMVYLASQHFVHR-DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
Query: 290 VPPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+PPE K T DV+SFGVIL E+ T GKQP
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 41/206 (19%)
Query: 152 NVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLVELLG 209
VIG G V+ +P+ + VA+K++ Q + E++ + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64
Query: 210 YCS--VDEEKLLVYEYMVKGSLDD------------------WLRNQAASLDWGKRCK-- 247
Y S V +E LV Y+ GSL D L+ L++
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 248 ---IVASNILLNDDFEAKISDFGLARLIS---DCESHVSTVVAGTIGYVPPE-----YGG 296
I A NILL +D KI+DFG++ ++ D V GT ++ PE +G
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 297 TGKATERGDVYSFGVILLELVTGKQP 322
KA D++SFG+ +EL TG P
Sbjct: 185 DFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 25/192 (13%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
+G G +G+V+K G+ VA+K + + +E E+ L +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 212 SVDEEKLLVYEYMVKGSLDDWLR--------NQAAS--------LDWGKRCKIV-----A 250
+ + +V EY GS+ D ++ + A+ L++ K + A
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
NILLN++ +AK++DFG++ ++D + +TV+ GT ++ PE + D++S G
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 311 VILLELVTGKQP 322
+ +E+ GK P
Sbjct: 187 ITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (173), Expect = 1e-13
Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 53/205 (25%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMVKHQNLVELL 208
+G G +G V+K G+ VA+KK+ + + E+ L +KH N+V+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 209 GYCSVDEEKL-LVYEYM---VKGSLDDWLRNQAASLDWGKR-----------C---KIV- 249
E KL LV+EY +K LD R S + K C +I+
Sbjct: 65 DVI-HTERKLYLVFEYCDMDLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 250 ----ASNILLNDDFEAKISDFGLARLIS---DCESHVSTVVAGTIGYVPPE-------YG 295
NIL+N D K++DFGLAR +H VV T+ Y PE Y
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE--VV--TLWYRAPEILLGSKHY- 176
Query: 296 GTGKATERGDVYSFGVILLELVTGK 320
T D++S G I E++TGK
Sbjct: 177 STAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 30/199 (15%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTV----AVKKLSQATG-QGDREFAAEMETLGMVKHQNLVE 206
V+G G FGTV+KG +P+G+TV A+K L++ TG + + EF E + + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS------LDWGKRC-------------- 246
LLG C + LV + M G L D++ + L+W +
Sbjct: 74 LLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 247 -KIVASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
+ A N+L+ KI+DFGLARL+ D + + + I ++ E K T +
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192
Query: 305 DVYSFGVILLELVT-GKQP 322
DV+S+GV + EL+T G +P
Sbjct: 193 DVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 56/221 (25%)
Query: 154 IGGGGFGTVFKGTM-------PDGKT-VAVKKL-SQATGQGDREFAAEMETLGMV-KHQN 203
+G G FG V P+ T VAVK L S AT + + +EME + M+ KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ--------------------------- 236
++ LLG C+ D ++ EY KG+L ++LR +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 237 ----AASLDW--GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287
A +++ K+C + A N+L+ +D KI+DFGLAR I H+ T
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKKTTN 201
Query: 288 GYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
G +P PE T + DV+SFGV+L E+ T G P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 40/191 (20%)
Query: 172 TVAVKKLSQ-ATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229
TVAVK L AT + + +EME + M+ KH+N++ LLG C+ D ++ EY KG+L
Sbjct: 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 230 DDWLR-NQAASLDW--------------------------------GKRC---KIVASNI 253
++LR + +D+ ++C + A N+
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165
Query: 254 LLNDDFEAKISDFGLARLISDCESHVSTVVAG-TIGYVPPEYGGTGKATERGDVYSFGVI 312
L+ +D KI+DFGLAR + + + + T + ++ PE T + DV+SFGV+
Sbjct: 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 225
Query: 313 LLELVT-GKQP 322
L E+ T G P
Sbjct: 226 LWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 42/260 (16%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKK-LSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
+G G G V K P GK +AVK + ++ E++ L +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRN------------------QAASLDWGKRCKIV-- 249
+ + + EYM GSLD L+ + + K KI+
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH-KIIHR 125
Query: 250 ---ASNILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
SNIL+N + K+ DFG++ +L++ ++ GT Y+ PE + + D
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
++S G+ L+EL TG+ P P E+ + + + +L + NE P L S
Sbjct: 182 IWSLGLSLIELATGRFPYPP--ENDPPDGIFE-LLQYIVNE------PPPRL--PSGKFS 230
Query: 366 LKMLQIATGCISNDPTVRPT 385
C+ DP RP+
Sbjct: 231 PDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 56/221 (25%)
Query: 154 IGGGGFGTVFKG-------TMPD-GKTVAVKKLS-QATGQGDREFAAEMETLGMV-KHQN 203
+G G FG V + + PD TVAVK L AT + + +EME + ++ KH+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ--------------------------- 236
++ LLG C+ + ++ EY KG+L ++LR +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 237 ----AASLDW--GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287
A +++ +RC + A N+L+ +D KI+DFGLAR + D + + T +
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT----SN 195
Query: 288 GYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
G +P PE T + DV+SFG+++ E+ T G P
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 48/267 (17%)
Query: 151 ENVIGGGGFGTVFKG--TMPDGKT--VAVKKL-SQATGQGDREFAAEMETLGMVKHQNLV 205
E ++G G FG + +G +P + VA+ L + + + R F AE TLG H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK--------------------- 244
L G + ++V EYM G+LD +LR L G+
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129
Query: 245 RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG--TIGYVPPEYGGTGKATE 302
+ A +L+N D KIS F RL D + T ++G + + PE +
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 303 RGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
DV+SFG+++ E+++ G++P + D G++++ V D PA N
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP----YWDMSGQDVIKAV--------EDGFRLPAPRNC-- 233
Query: 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388
P +L L + C + RP
Sbjct: 234 -PNLLHQLML--DCWQKERGERPRFSQ 257
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 74/270 (27%), Positives = 106/270 (39%), Gaps = 58/270 (21%)
Query: 153 VIGGGGFGTVFKGTMPD-GKT-----VAVKKLSQATGQGDREFAAEMETLGMV----KHQ 202
+G G FG V + T K+ VAVK L +RE A M L ++ H+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE--ALMSELKIMSHLGNHE 99
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS-LDW------------------G 243
N+V LLG C++ L++ EY G L ++LR + S L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 244 KRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT----IGYVPPEYGG 296
K C + A N+LL KI DFGLAR D + + VV G + ++ PE
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 297 TGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355
T DV+S+G++L E+ + G P D L+ M + E A
Sbjct: 217 NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA----- 271
Query: 356 VLNANSKPTMLKMLQIATGCISNDPTVRPT 385
++ I C DP RPT
Sbjct: 272 -----------EIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 67/220 (30%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 154 IGGGGFGTVFKG--TMPDGKT--VAVKKLS--QATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG V +G + GK VAVK L + + D +F E + + H+NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRL 61
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS-------LDWG------------KRC-- 246
G + ++V E GSL D LR A D+ KR
Sbjct: 62 YGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 247 -KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKATER 303
+ A NILL D + KI DFGL R + E H + PE T +
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA 180
Query: 304 GDVYSFGVILLELVT-GKQP----TGPEFE---DKDGENL 335
DV+ FGV L E+ T G++P +G + DK+GE L
Sbjct: 181 SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL 220
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 53/214 (24%)
Query: 151 ENVIGGGGFGTVFKGTM-PDG--KTVAVKKLSQATGQGD-REFAAEMETL-GMVKHQNLV 205
++VIG G FG V K + DG A+K++ + + D R+FA E+E L + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR--------------NQAAS------------ 239
LLG C L EY G+L D+LR N AS
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 240 -----LDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289
+D+ + + + A NIL+ +++ AKI+DFGL+R V T+G
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 184
Query: 290 VPPEYGGTGKA-----TERGDVYSFGVILLELVT 318
+P + T DV+S+GV+L E+V+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 67/260 (25%), Positives = 117/260 (45%), Gaps = 47/260 (18%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGD-----REFAAEMETLGMVKHQNLVEL 207
+G G FG+V++G + DG AVK++S A ++ E+ L ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 208 LGYCSVDEEKLLVY-EYMVKGSLDDWL---------------RNQAASLDWGKRCKIV-- 249
LG +E+ L ++ E + GSL L R L++ V
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY-GGTGKATERGD 305
+NIL++ + K++DFG+A+ + E + G+ ++ PE G D
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
++S G +LE+ TGK P + E V V + ++++ + P L+ +K +
Sbjct: 185 IWSLGCTVLEMATGKPPWS-QLEG------VAAVFKIGRSKELPPI--PDHLSDEAKDFI 235
Query: 366 LKMLQIATGCISNDPTVRPT 385
LK LQ DP++RPT
Sbjct: 236 LKCLQR-------DPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 50/207 (24%)
Query: 150 EENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD------REFAAEMETLGMVKHQ 202
E IG G +GTV+K + G+ VA+KK+ + RE A ++ L +H
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHP 61
Query: 203 NLVELLGYCSV--DEEKL---LVYEYMVKGSLDDWLRNQAAS-----------------L 240
N+V LL C + +L LV+E+ V L +L +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 241 DWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-- 293
D+ +IV NIL+ D + KI+DFGLAR I E +++VV T+ Y PE
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-TLWYRAPEVL 178
Query: 294 ----YGGTGKATERGDVYSFGVILLEL 316
Y D++S G I EL
Sbjct: 179 LQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 48/217 (22%)
Query: 154 IGGGGFGTVF--------KGTMPDGKTVAVKKLS-QATGQGDREFAAEMETLGMV-KHQN 203
+G G FG V K + TVAVK L AT + + +EME + M+ KH+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ--------------------------- 236
++ LLG C+ D ++ EY KG+L ++LR +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 237 ----AASLDW--GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG-T 286
A +++ ++C + A N+L+ ++ KI+DFGLAR +++ + + T
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+ ++ PE T + DV+SFGV++ E+ T G P
Sbjct: 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 42/211 (19%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKT----VAVKKLSQATG-QGDREFAAEMETLGMVK 200
+F + V+G G FGTV+KG +P+G+ VA+K+L +AT + ++E E + V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS------LDWGKRC-------- 246
+ ++ LLG C +L + + M G L D++R + L+W +
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 247 -------KIVASNILLNDDFEAKISDFGLARLIS--DCESHVSTVVAGTIGYVPPEYGGT 297
+ A N+L+ KI+DFGLA+L+ + E H G VP ++
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG------GKVPIKWMAL 180
Query: 298 GKA-----TERGDVYSFGVILLELVT-GKQP 322
T + DV+S+GV + EL+T G +P
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 37/207 (17%)
Query: 153 VIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQG-DREFAAEMETLGMVKHQNLV 205
+G G FG VF V VK L + + EF E++ + H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK--------------------- 244
LLG C E ++ EY G L +LR + + K
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 245 ---RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGG 296
+ V A N L++ E K+S L++ + + E + + ++ PE
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191
Query: 297 TGKATERGDVYSFGVILLELVT-GKQP 322
+ + DV+SFGV++ E+ T G+ P
Sbjct: 192 EDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 41/208 (19%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT-GQGDRE-FAAEMETLGMVKHQNLVELL 208
IG G FGTV K DGK + K++ + +++ +E+ L +KH N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 209 GYCS--VDEEKLLVY---EYMVKGSLDDWLRN---QAASLD----WG---------KRC- 246
Y +D +Y EY G L ++ + ++ W C
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 247 -KIVAS-----------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY 294
+ NI L+ + K+ DFGLA+++ S T V GT Y+ PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQ 181
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQP 322
E+ D++S G ++ EL P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 53/214 (24%)
Query: 151 ENVIGGGGFGTVFKGTMP-DGK--TVAVKKLSQATGQGD-REFAAEMETL-GMVKHQNLV 205
E+VIG G FG V + + DG A+K L + + D R+FA E+E L + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCK--- 247
LLG C + EY G+L D+LR A++L + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 248 ------------------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289
+ A N+L+ ++ +KI+DFGL+R V T+G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKTMGR 179
Query: 290 VPPEYGGTGKA-----TERGDVYSFGVILLELVT 318
+P + T + DV+SFGV+L E+V+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 35/198 (17%)
Query: 153 VIGGGGFGTVF--------KGTMPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQN 203
V+G G FG V GT G+ VAVK L + GQ + + E+ L + H+N
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 204 LVELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAASLDW-----GKRCK--------- 247
+V+ G CS K L+ EY+ GSL D+L +L + C+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 248 -----IVASNILLNDDFEAKISDFGLARLISDCESH--VSTVVAGTIGYVPPEYGGTGKA 300
+ A N+LL++D KI DFGLA+ + + + V + + E K
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187
Query: 301 TERGDVYSFGVILLELVT 318
+ DV+SFGV L EL+T
Sbjct: 188 SYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 42/205 (20%)
Query: 153 VIGGGGFGTVFKGT-MPDGKT----VAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVE 206
V+G G FGTV+KG +PDG+ VA+K L + T + ++E E + V +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGKRCKIV- 249
LLG C +L V + M G L D++R A + + + ++V
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 250 ----ASNILLNDDFEAKISDFGLARL--ISDCESHVSTVVAGTIGYVPPEYGGTG----- 298
A N+L+ KI+DFGLARL I + E H G VP ++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG------GKVPIKWMALESILHR 186
Query: 299 KATERGDVYSFGVILLELVT-GKQP 322
+ T + DV+S+GV + EL+T G +P
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 40/200 (20%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMVKHQNLVEL 207
+G G + V+K G+ VA+KK+ + ++ F A E++ L +KH N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 208 LGYCSVDEEKLLVYEYM---VKGSLDD------------WLRNQAASLDWGKRCKIV--- 249
L LV+E+M ++ + D ++ L++ I+
Sbjct: 68 LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD 127
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-------YGGTGKA 300
+N+L+ D K++DFGLAR ++ V T Y PE YG
Sbjct: 128 LKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYGVG--- 183
Query: 301 TERGDVYSFGVILLELVTGK 320
D++S G I EL+
Sbjct: 184 ---VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 60/259 (23%), Positives = 107/259 (41%), Gaps = 45/259 (17%)
Query: 153 VIGGGGFG--TVFKGTMPDGKTVAVKK--LSQATGQGDREFAAEMETLGMVKHQNLVELL 208
V+G G FG T+++ T D V K+ L++ + + R+ E+ L +++H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL------DW--GKRCKIVA---------- 250
+ D L+ EY G+L D + Q L W + V+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 251 ----SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
NI L K+ DFG+++++ S TVV GT Y+ PE K + D+
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFKSDI 184
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
++ G +L EL+T K+ D N ++ V+ +++ V
Sbjct: 185 WALGCVLYELLTLKRTF-------DATNPLNLVVKIVQGNYTPVV----------SVYSS 227
Query: 367 KMLQIATGCISNDPTVRPT 385
+++ + + DP RPT
Sbjct: 228 ELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 37/206 (17%)
Query: 153 VIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDRE---------FAAEMETLGMVKHQ 202
+IG G FG+V+ G G+ +AVK++ + + A E+ L ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 203 NLVELLGYCSVDEEKLLVY-EYMVKGSLDDWLRNQAA---------------SLDWGKRC 246
N+V+ LG S+D + L ++ EY+ GS+ L N A L++
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 247 KIV-----ASNILLNDDFEAKISDFGL-----ARLISDCESHVSTVVAGTIGYVPPEYGG 296
I+ +NIL+++ KISDFG+ A +S + + G++ ++ PE
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 297 TGKATERGDVYSFGVILLELVTGKQP 322
T + D++S G +++E++TGK P
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 59/257 (22%), Positives = 99/257 (38%), Gaps = 56/257 (21%)
Query: 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGD------REFAAEMETLGMVKHQNLV 205
V+G G +GTV+ G G+ +AVK++ T + E++ L +KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK------------------ 247
+ LG C D + E++ GS+ L N+ L CK
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVS-----TVVAGTIGYVPPEYGGTGK 299
I +N++L + K+ DFG AR ++ H + + GT ++ PE
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 300 ATERGDVYSFGVILLELVTGKQPTG------------------PEFEDKDGENLVDWVLH 341
+ D++S G + E+ TGK P P D +D+V
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTS 244
Query: 342 MMKNEQ-----ADEVLD 353
+ +Q A ++L
Sbjct: 245 CLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 55/220 (25%), Positives = 83/220 (37%), Gaps = 47/220 (21%)
Query: 154 IGGGGFGTVFKGTMPDGKTVA---VKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
IG G FG V G G + A VK+L + AT F E++ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQ--------------------AASLDWGKRCKIV 249
C LLV E+ G L ++LR+ A+ L W + +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 250 AS-----NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGG-------- 296
S N L D KI D+GLA + + VP +
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLAL----EQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 297 ----TGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKD 331
T++ +++S GV + EL T QP P+ D+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 28/201 (13%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREF-AAEMETLGMVKHQN 203
F IG G FG V+K + VA+K + + + E E++ L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 204 LVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKRCKIV------------- 249
+ + G + KL ++ EY GS D L+ LD I+
Sbjct: 61 ITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHEE 117
Query: 250 --------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKAT 301
A+NILL+++ + K++DFG++ ++ S +T V GT ++ PE
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 302 ERGDVYSFGVILLELVTGKQP 322
E+ D++S G+ +EL G+ P
Sbjct: 177 EKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 68/283 (24%)
Query: 149 CEENVIGGGGFGTVFKGTM-------PDGKTVAVKKLSQATGQGDR-EFAAEMETLGMVK 200
E +G G FG V++G P+ + VA+K +++A +R EF E +
Sbjct: 11 SRE--LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFN 67
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR-------------------------- 234
++V LLG S + L++ E M +G L +LR
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 235 --NQAASLDWGKRC--KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290
+ A L+ K + A N ++ +DF KI DFG+ R I + + + G G +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLL 183
Query: 291 P-----PEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMK 344
P PE G T DV+SFGV+L E+ T +QP ++ E ++ +V+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGMSNEQVLRFVMEGGL 239
Query: 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
++ D P ML ++ C +P +RP+ L
Sbjct: 240 LDKPDNC-----------PDML--FELMRMCWQYNPKMRPSFL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 154 IGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVELLGYC 211
IG G FG VF G + D VAVK + + +F E L H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDW--GKRC---KIVA 250
+ + +V E + G +LR + AA +++ K C + A
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT----IGYVPPEYGGTGKATERGDV 306
N L+ + KISDFG++R + E V G + + PE G+ + DV
Sbjct: 123 RNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 307 YSFGVILLE 315
+SFG++L E
Sbjct: 180 WSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 49/217 (22%)
Query: 154 IGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLVE 206
I G +G VF K T G A+K + +A + E + L + +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 207 LLGYCSVDEEK--LLVYEYMVKGSL-----------DDWLRNQAA----SLDWGKRCKIV 249
L Y S +K LV EY+ G L +D R A +L++ I+
Sbjct: 58 L--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 250 -----ASNILLNDDFEAKISDFGLARL--------ISDCESHVSTVVAGTIGYVPPEY-- 294
NIL++ + K++DFGL+++ ++D E +V GT Y+ PE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVIL 174
Query: 295 -GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK 330
G K D +S G IL E + G P E ++
Sbjct: 175 GQGHSKTV---DWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 70/262 (26%), Positives = 110/262 (41%), Gaps = 45/262 (17%)
Query: 148 FCEENVIGGGGFGTVFKGTMPDGKT---VAVKKLSQATGQGDRE-FAAEMETLGMVKHQN 203
F + IG G FG VFKG D +T VA+K + + + E E+ L
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWL--------------RNQAASLDWGKRCK-- 247
+ + G D + ++ EY+ GS D L R LD+ K
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
I A+N+LL++ E K++DFG+A ++D + +T V GT ++ PE +
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 182
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN-SKP 363
D++S G+ +EL G+ P LH MK +P L N SKP
Sbjct: 183 DIWSLGITAIELAKGEPPHSE--------------LHPMKVLFLIPKNNPPTLEGNYSKP 228
Query: 364 TMLKMLQIATGCISNDPTVRPT 385
+ + C++ +P+ RPT
Sbjct: 229 ----LKEFVEACLNKEPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 60/205 (29%), Positives = 81/205 (39%), Gaps = 47/205 (22%)
Query: 152 NVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA-------EMETLGMVKHQN 203
N IG G +G V++ G+ VA+KK+ D E E+ L ++H N
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLREITLLLNLRHPN 67
Query: 204 LVELL---------------GYCSVDEEKLL------VYEYMVKGSLDDWLRNQAASLDW 242
+VEL YC D LL E VK + LR L +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR----GLQY 123
Query: 243 GKRCKIV-----ASNILLNDDFEAKISDFGLARLISD-CESHVSTVVAGTIGYVPPE-YG 295
I+ SN+LL D KI+DFGLAR + VV T+ Y PE
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLL 181
Query: 296 GTGKATERGDVYSFGVILLELVTGK 320
G T D+++ G IL EL+ K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 64/203 (31%), Positives = 92/203 (45%), Gaps = 34/203 (16%)
Query: 152 NVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELL 208
IG G +G V+K D G+ VA+KK+ + A E++ L + H+N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 209 GYC-----SVDEEK-----LLVYEYM-------VKGSLDDWLRNQAAS-----LDWGKRC 246
++D +K LV+EYM ++ L + + S L+ C
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 247 --------KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGT 297
I SNILLN+ + K++DFGLARL + ES T T+ Y PPE G
Sbjct: 133 HKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192
Query: 298 GKATERGDVYSFGVILLELVTGK 320
+ DV+S G IL EL T K
Sbjct: 193 ERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 62/275 (22%)
Query: 153 VIGGGGFGTVFKGTMPD-GKTVAVKK--LSQATGQGDRE--------FAAEMETLGMVKH 201
+IG G +G V+ G+ +AVK+ L +E+ETL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQA------------------ASLD-- 241
N+V+ LG+ + +E + EY+ GS+ LR A L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 242 --WGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV-VAGTIGYVPPE----- 293
+ K A N+L++ D KISDFG+++ D + + + G++ ++ PE
Sbjct: 128 GILHRDLK--ADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK--NEQADE 350
G + K D++S G ++LE+ G++P E + + M K N+++
Sbjct: 186 SQGYSAKV----DIWSLGCVVLEMFAGRRPWSDE----------EAIAAMFKLGNKRSAP 231
Query: 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
+ P V S L C + +P RPT
Sbjct: 232 PIPPDVSMNLSPVA----LDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 34/200 (17%)
Query: 153 VIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
V+G G +G V+ + +A+K++ + + + E+ +KH+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 212 SVDEEKLLVYEYMVKGSLDDWLR--------NQAASLDWGKRC----------KIV---- 249
S + + E + GSL LR N+ + + K+ +IV
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 250 -ASNILLND-DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY-----GGTGKATE 302
N+L+N KISDFG ++ ++ T GT+ Y+ PE G G
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGAP-- 191
Query: 303 RGDVYSFGVILLELVTGKQP 322
D++S G ++E+ TGK P
Sbjct: 192 -ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 70/280 (25%)
Query: 154 IGGGGFGTVFKGTMPD------GKTVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVE 206
+G G FG V++G D VAVK ++++ +R EF E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLR----------------------------NQAA 238
LLG S + L+V E M G L +LR + A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 239 SLDWGKRC--KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP----- 291
L+ K + A N ++ DF KI DFG+ R I + + + G G +P
Sbjct: 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVRWMA 189
Query: 292 PEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350
PE G T D++SFGV+L E+ + +QP + NEQ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLK 232
Query: 351 -VLDPAVLN--ANSKPTMLKMLQIATGCISNDPTVRPTML 387
V+D L+ N + ++++ C +P +RPT L
Sbjct: 233 FVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 33/206 (16%)
Query: 153 VIGGGGFGTVF---KGTMPD-GKTVAVKKLSQATGQGDREFAAEME--TLGMVKHQNLVE 206
V+G G FG VF K T PD G+ A+K L +AT + +ME L V H +V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSL------------DD---WLRNQAASLDWGKRCKIV- 249
L Y E KL L+ +++ G L +D +L A +LD I+
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
NILL+++ K++DFGL++ D E + GT+ Y+ PE T+ D
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEYMAPEVVNRRGHTQSAD 180
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKD 331
+SFGV++ E++TG P F+ KD
Sbjct: 181 WWSFGVLMFEMLTGSLP----FQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 33/218 (15%)
Query: 152 NVIGGGGFGTVFKGTMPDGKTV-AVKKLSQATGQGDREFAA---EMETLGMVKHQNLVEL 207
VIG G FG V D K + A+K +++ E L + H LV L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 208 LGYCSVDEEKL-LVYEYMVKGSL---------------DDWLRNQAASLDWGKRCKIV-- 249
Y DEE + LV + ++ G L W+ +L++ I+
Sbjct: 66 W-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
NILL++ I+DF +A ++ ++T +GT GY+ PE + D
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGYMAPEVLCRQGYSVAVDW 182
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
+S GV E + GK+P + + D + +
Sbjct: 183 WSLGVTAYECLRGKRP----YRGHSRT-IRDQIRAKQE 215
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
K+ IG G GTVF + G+ VA+K+++ E+ + +K+ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR----NQAASLDWGKRC--------------- 246
L V +E +V EY+ GSL D + ++A + C
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 247 KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
I + N+LL D K++DFG I+ +S ST+V GT ++ PE + D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 307 YSFGVILLELVTGKQP 322
+S G++ +E+V G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 153 VIGGGGFGTVF--KGTMPDGKTVAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELL 208
V+G G FG V + D K V +K++ D AA E + L ++ H N++E
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS-------LDWGKRCKIV------------ 249
D+ ++V EY G+L ++++ + S L + + +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 250 ---ASNILLND-DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
NILL+ KI DFG+++++S +S TVV GT Y+ PE ++ D
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVV-GTPCYISPELCEGKPYNQKSD 183
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348
+++ G +L EL + K+ FE NL VL +M A
Sbjct: 184 IWALGCVLYELASLKRA----FE---AANLPALVLKIMSGTFA 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 53/213 (24%)
Query: 152 NVIGGGGFGTVFKGTMP-DG--KTVAVKKLSQATGQGD-REFAAEMETLGMVKHQ-NLVE 206
+VIG G FG V K + DG A+K++ + + D R+FA E+E L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCK---- 247
LLG C L EY G+L D+LR A++L +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 248 -----------------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290
+ A NIL+ +++ AKI+DFGL+R V T+G +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRL 173
Query: 291 PPEYGGTGKA-----TERGDVYSFGVILLELVT 318
P + T DV+S+GV+L E+V+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 59/202 (29%), Positives = 84/202 (41%), Gaps = 44/202 (21%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQA----TGQGDREFAAEMETLGMVKHQNL 204
+G G FG V KG+ GK A+K LS+A Q + E L ++H L
Sbjct: 8 TLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIRHPFL 63
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLR-NQAASLDWGK--------------RCKI 248
V L G D+ L LV EY+ G L LR + + I
Sbjct: 64 VNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
V N+LL+ D KI+DFG A+ + T+ GT Y+ PE G GKA
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLC-GTPEYLAPEIILSKGYGKA 178
Query: 301 TERGDVYSFGVILLELVTGKQP 322
D ++ G+++ E++ G P
Sbjct: 179 V---DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 52/213 (24%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKT---VAVKKLS---QATGQGDREFAAEMETLGMV 199
+++ + +G G +G V D KT VA+KKLS Q+ R + E+ L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAF--DTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHM 71
Query: 200 KHQNLVELLGYCSVDEEK------LLVYEYMVKGSLDDWLRNQAAS-------------- 239
H+N++ LL + LV M L++ ++ Q S
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 240 LDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
L + I+ SNI +N+D E KI DFGLAR + ++ VA T Y PE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVA-TRWYRAPEI 186
Query: 294 ------YGGTGKATERGDVYSFGVILLELVTGK 320
Y + D++S G I+ EL+TGK
Sbjct: 187 MLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 25/198 (12%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
K+ IG G GTV+ + G+ VA+K+++ E+ + KH N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK---RCK--------------- 247
L V +E +V EY+ GSL D + +D G+ C+
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
I + NILL D K++DFG I+ +S ST+V GT ++ PE +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 305 DVYSFGVILLELVTGKQP 322
D++S G++ +E+V G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 64/264 (24%), Positives = 104/264 (39%), Gaps = 49/264 (18%)
Query: 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G +G V+K G+ VA+K + G E+ L +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASL--------------------DWGK--RCKI 248
++ +V EY GSL D + L + GK R I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR-DI 127
Query: 249 VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG---GTGKATERGD 305
+NILL +D + K++DFG++ ++ + + + GT ++ PE G + D
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKCD 186
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ--ADEVLDPAVLNANSK- 362
+++ G+ +EL QP P F+ LH M+ + P L K
Sbjct: 187 IWALGITAIELAEL-QP--PMFD-----------LHPMRALFLISKSNFPPPKLKDKEKW 232
Query: 363 -PTMLKMLQIATGCISNDPTVRPT 385
P ++ C++ DP RPT
Sbjct: 233 SPVFHDFIKK---CLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 48/208 (23%)
Query: 152 NVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAA----EMETLGMVKHQNLVE 206
IG G +G V G+ VA+KK+S D A E++ L ++H+N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIG 63
Query: 207 L---LGYCSVDEEK--LLVYEYMVKGS-LDDWLR-NQAASLDWGK--------------R 245
L L S ++ +V E M + L ++ Q + D +
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 246 CKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVST----VVAGTIGYVPPE--- 293
++ SNIL+N + + KI DFGLAR + E VV T Y PE
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--TRWYRAPELLL 179
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGK 320
KA D++S G I EL+T K
Sbjct: 180 SSSRYTKAI---DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 8e-10
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 147 KFCEENVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
K+ IG G GTV+ + G+ VA+K+++ E+ + K+ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWL--------------RNQAASLDWGKRCKIV-- 249
L V +E +V EY+ GSL D + R +LD+ +++
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
+ NILL D K++DFG I+ +S ST+V GT ++ PE + D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 307 YSFGVILLELVTGKQP 322
+S G++ +E+V G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 53/266 (19%)
Query: 148 FCEENVIGGGGFGTVFKGTMPDGKT---VAVKKLSQATGQGDRE-FAAEMETLGMVKHQN 203
F + IG G FG VFKG D +T VA+K + + + E E+ L
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN------QAAS--------LDWGKRCK-- 247
+ + G + ++ EY+ GS D LR Q A+ LD+ K
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
I A+N+LL++ + K++DFG+A ++D + +T V GT ++ PE +
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKA 182
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
D++S G+ +EL G+ P +H M+ VL ++ N+ PT
Sbjct: 183 DIWSLGITAIELAKGEPPNSD--------------MHPMR------VL--FLIPKNNPPT 220
Query: 365 ML-----KMLQIATGCISNDPTVRPT 385
+ + C++ DP+ RPT
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 59/256 (23%), Positives = 105/256 (41%), Gaps = 36/256 (14%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLS-QATGQGDREFAAEMETLGMVKHQNLVELL 208
+ ++G G GTV+K + + +AVK + T + ++ +E+E L ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLD-------------WGKRC---KIVASN 252
G V+ + E+M GSLD + + L W + + SN
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 253 ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVI 312
+L+N + K+ DFG++ + + ++ GT Y+ PE + DV+S G+
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGIS 182
Query: 313 LLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML---KML 369
+EL G+ P P+ + G + +L + +E DP VL P K +
Sbjct: 183 FMELALGRFPY-PQIQKNQGSLMPLQLLQCIVDE------DPPVL-----PVGQFSEKFV 230
Query: 370 QIATGCISNDPTVRPT 385
T C+ P RP
Sbjct: 231 HFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 251 SNILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSF 309
SNIL+N + K+ DFG++ LI+ S T V GT Y+ PE GK T + DV+S
Sbjct: 133 SNILVNSRGQIKLCDFGVSGELIN---SIADTFV-GTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 310 GVILLELVTGKQPTGPEFEDKDGE----NLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
G+ ++EL GK P D DG+ ++D +L + E P + +++ +
Sbjct: 189 GISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPP-----PRLPSSDFPEDL 242
Query: 366 LKMLQIATGCISNDPTVRPT 385
+ C+ DPT RPT
Sbjct: 243 RDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 31/194 (15%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQAT-GQGDREFA-AEMETLGMVKHQNLVELLGY 210
IG G +G V+K G+ VA+KK+ +G + A E++ L + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV--------------------- 249
+ LV+E+M L ++++ L +
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 250 ASNILLNDDFEAKISDFGLARLI-SDCESHVSTVVAGTIGYVPPE--YGGTGKATERGDV 306
N+L+N + K++DFGLAR S + VV T Y PE G G + D+
Sbjct: 126 PENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAPELLLGDKG-YSTPVDI 182
Query: 307 YSFGVILLELVTGK 320
+S G I EL++ +
Sbjct: 183 WSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 57/261 (21%), Positives = 107/261 (40%), Gaps = 49/261 (18%)
Query: 154 IGGGGFGTVFK-GTMPDGKTVAVKKLS-QATGQGDREFAA-EMETLGMVKHQNLVELLGY 210
+G G +G+V+K + D + A+K++ + Q +RE A E+ L V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY-KE 66
Query: 211 CSVDEEKL-LVYEYMVKGSLDDWLRNQAAS-------LDW--------GKRC----KIV- 249
+D KL +V EY G L + + W G + KI+
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH 126
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
++NILL + KI D G+++++ +++ GT Y+ PE + + D
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
++S G +L E+ T P FE + ++L V + + + P + + +
Sbjct: 184 IWSLGCLLYEMATFAPP----FEARSMQDLRYKV----QRGKYPPI--PPIYSQD----- 228
Query: 366 LKMLQIATGCISNDPTVRPTM 386
+ + P +RP
Sbjct: 229 --LQNFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 38/206 (18%)
Query: 154 IGGGGFGTVFK-GTMPDGKTVAVKKLS----QATGQGDREFAAEMETLGMVKHQNLVELL 208
+G GGFG V +T A+K + TGQ +E E L H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKL- 58
Query: 209 GYCS-VDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR----CKIVA------------ 250
Y + D++ + ++ EY + G L LR++ ++ R C ++A
Sbjct: 59 -YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 251 ----SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKATER 303
N+LL+ + K+ DFG A+ + + + GT YV PE G +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEIILNKGYDFSV-- 173
Query: 304 GDVYSFGVILLELVTGKQPTGPEFED 329
D +S G++L EL+TG+ P G + ED
Sbjct: 174 -DYWSLGILLYELLTGRPPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 38/187 (20%)
Query: 173 VAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231
VAVK L + T +F E++ + +K+ N++ LLG C D+ ++ EYM G L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 232 WLRNQA---------------------------------ASLDWGKRCKIVASNILLNDD 258
+L + ASL++ R + N L+ +
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR-DLATRNCLVGNH 165
Query: 259 FEAKISDFGLAR-LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELV 317
+ KI+DFG++R L S + I ++ E GK T DV++FGV L E+
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 318 T--GKQP 322
T +QP
Sbjct: 226 TLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 47/202 (23%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFA-AEMETLGMVKHQNLVELLGYC 211
IG G G V T G+ VAVKK+ Q RE E+ + +H N+VE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 212 SVDEEKLLVYEYMVKGSLDDWL------RNQAASLDWGKRCK------------------ 247
V +E +V E++ G+L D + Q A++ C
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV-----CLAVLKALSFLHAQGVIHRD 140
Query: 248 IVASNILLNDDFEAKISDFGL-ARLISDCESHVSTVVAGTIGYVPPE------YGGTGKA 300
I + +ILL D K+SDFG A++ + S V GT ++ PE YG
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYG----- 193
Query: 301 TERGDVYSFGVILLELVTGKQP 322
D++S G++++E+V G+ P
Sbjct: 194 -TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 55/216 (25%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVKKLSQATGQGDREFAAEMETLGMVKHQ----NLVE 206
+G G FG V KG K VA+K L + R+ EM + HQ +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIVR 59
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVASNI------------- 253
++G C E +LV E G L+ +L GK+ +I SN+
Sbjct: 60 MIGVCEA-EALMLVMEMASGGPLNKFLS--------GKKDEITVSNVVELMHQVSMGMKY 110
Query: 254 ----------------LLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYG 295
LL + AKISDFGL++ + +S+ AG + + PE
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 296 GTGKATERGDVYSFGVILLELVT-GKQP----TGPE 326
K + R DV+S+G+ + E + G++P GPE
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 43/210 (20%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKK-----LSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG V+ D G+ +AVK+ S T + E++ L ++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 208 LGYCSVDEEKLLVY-EYMVKGSLDDWLRNQAA---------------SLDWGKRCKIV-- 249
G C D+E L ++ EYM GS+ D L+ A +++ IV
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTV--VAGTIGYVPPE------YGGTG 298
+NIL + K+ DFG ++ + S + + V GT ++ PE YG
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG--- 185
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEFE 328
+ DV+S G ++E++T K P EFE
Sbjct: 186 ---RKADVWSVGCTVVEMLTEKPPWA-EFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 170 GKTVAVKKLSQATGQGD-REFAAEMETLGMVKHQNLVELLGYCSVDEEK--LLVYEYMVK 226
G+ VAVK L +G + E+E L + H+N+V+ G C+ D L+ E++
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 227 GSLDDWL-RNQA---------------ASLDW-GKRCKI----VASNILLNDDFEAKISD 265
GSL ++L RN+ +D+ G R + A N+L+ + + KI D
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 152
Query: 266 FGLARLISDCESH--VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT 318
FGL + I + + V + + + PE K DV+SFGV L EL+T
Sbjct: 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 61/212 (28%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 153 VIGGGGFGT------VFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVE 206
V+G G FG V K + + K S A + R+ E L +KH N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRK---EAVLLAKMKHPNIVA 62
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL-------DW------------GKRC- 246
D +V EY G L ++ Q L W KR
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 247 --KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
I + NI L + + K+ DFG ARL++ ++ T V GT YVPPE +
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKS 181
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336
D++S G IL EL T K P F+ +NL+
Sbjct: 182 DIWSLGCILYELCTLKHP----FQANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 28/192 (14%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLVELLGYC 211
+G G + TV+KG + VA+K++ +G A E+ L +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 212 SVDEEKLLVYEYM---VKGSLDD------------WLRNQAASLDWGKRCKIV-----AS 251
++ LV+EY+ +K LDD +L L++ R K++
Sbjct: 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQ 133
Query: 252 NILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE--YGGTGKATERGDVYS 308
N+L+N+ E K++DFGLAR S +++ + VV T+ Y PP+ G T +T+ D++
Sbjct: 134 NLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQI-DMWG 190
Query: 309 FGVILLELVTGK 320
G I E+ TG+
Sbjct: 191 VGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 63/255 (24%), Positives = 102/255 (40%), Gaps = 59/255 (23%)
Query: 173 VAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231
VAVK L A+ +F E++ L + N+ LLG C+VD ++ EYM G L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 232 WLRNQAASLDWGKRCKI--------------VAS------------------NILLNDDF 259
+L+ + + G C +AS N L+ ++
Sbjct: 109 FLQ-KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167
Query: 260 EAKISDFGLAR-LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT 318
KI+DFG++R L S V I ++ E GK T + DV++FGV L E++T
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
Query: 319 --GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK------MLQ 370
+QP +E + +++ H +++ L +P ML+
Sbjct: 228 LCREQP----YEHLTDQQVIENAGHFFRDDGRQIYLP--------RPPNCPKDIYELMLE 275
Query: 371 IATGCISNDPTVRPT 385
C D RPT
Sbjct: 276 ----CWRRDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 28/192 (14%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLVELLGYC 211
+G G + TVFKG + VA+K++ +G A E+ L +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 212 SVDEEKLLVYEYM---VKGSLDD------------WLRNQAASLDWGKRCKIV-----AS 251
+ LV+EY+ +K LD+ ++ L + + KI+
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132
Query: 252 NILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE--YGGTGKATERGDVYS 308
N+L+N+ E K++DFGLAR S +++ + VV T+ Y PP+ G T +T D++
Sbjct: 133 NLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTPI-DMWG 189
Query: 309 FGVILLELVTGK 320
G IL E+ TG+
Sbjct: 190 VGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 36/200 (18%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGD------REFAAEMETLGMVKHQNLVE 206
IG G +GTV+K P G VA+K + T + RE A ++ L H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66
Query: 207 LLGYCS---VDEEK--LLVYEYM---VKGSLD-------------DWLRNQAASLDWGKR 245
L+ C+ D E LV+E++ ++ LD D +R LD+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 246 CKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKA 300
IV NIL+ + K++DFGLAR+ S C+ ++ VV T+ Y PE
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV-TLWYRAPEVLLQSTY 184
Query: 301 TERGDVYSFGVILLELVTGK 320
D++S G I E+ K
Sbjct: 185 ATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 153 VIGGGGFGTVFKGTMPDG----KTVAVKKLSQAT---GQGDREFA-AEMETLGMVKHQNL 204
V+G GG+G VF+ G K A+K L +AT Q D AE L VKH +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSL-----------DD----WLRNQAASLDWGKRCKIV 249
V+L+ + L+ EY+ G L +D +L + +L+ + I+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII 122
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKAT 301
NILL+ K++DFGL + S E V+ GTI Y+ PE G GKA
Sbjct: 123 YRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181
Query: 302 ERGDVYSFGVILLELVTGKQP 322
D +S G ++ +++TG P
Sbjct: 182 ---DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLVELLGYC 211
+G G + TV+KG G+ VA+K++ +G A E+ + +KH+N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 212 SVDEEKLLVYEYM------------VKGSLDDWLRNQAASLDWGKRCKIVA--------- 250
+ + +LV+EYM V+G+LD N S + + K +A
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGALD---PNTVKSFTY-QLLKGIAFCHENRVLH 123
Query: 251 -----SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERG 304
N+L+N E K++DFGLAR + S V T+ Y P+ G+ +
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM 343
D++S G I+ E++TG+ P F + E+ + + +M
Sbjct: 183 DIWSVGCIMAEMITGR----PLFPGTNNEDQLLKIFRIM 217
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 43/205 (20%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLS-QATGQGDREFAA-EMETLGMVKHQNLVELLGY 210
IG G +GTVFK + VA+K++ +G A E+ L +KH+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVAS------------------- 251
D++ LV+EY D L+ S + +IV S
Sbjct: 68 LHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122
Query: 252 ------NILLNDDFEAKISDFGLARLIS---DCESHVSTVVAGTIGYVPPE--YGGTGKA 300
N+L+N + E K++DFGLAR C S VV T+ Y PP+ +G +
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA--EVV--TLWYRPPDVLFGAKLYS 178
Query: 301 TERGDVYSFGVILLELVTGKQPTGP 325
T D++S G I EL +P P
Sbjct: 179 TSI-DMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 39/259 (15%)
Query: 148 FCEENVIGGGGFGTVFKGTMPDGK-TVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
F + IG G FG V+KG K VA+K + + + E E+ L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWL--------------RNQAASLDWGKRCK---- 247
G + ++ EY+ GS D L R LD+ +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 248 -IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
I A+N+LL++ + K++DFG+A ++D + +T V GT ++ PE + D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADI 184
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
+S G+ +EL G+ P + VL ++ P + SKP
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSP-----PTLEGQYSKP--- 228
Query: 367 KMLQIATGCISNDPTVRPT 385
+ C++ DP RPT
Sbjct: 229 -FKEFVEACLNKDPRFRPT 246
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVELLG 209
IG G FG V+ + + VA+KK+S + Q + ++ E+ L ++H N +E G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWL--------RNQAASLDWG---------KRCKI--- 248
C + E LV EY + GS D L + A++ G +I
Sbjct: 83 -CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 249 -VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKATERG 304
A NILL + K++DFG A L+S S V GT ++ PE G+ +
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 195
Query: 305 DVYSFGVILLELVTGKQP 322
DV+S G+ +EL K P
Sbjct: 196 DVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 29/197 (14%)
Query: 154 IGGGGFGTVFKG---TMPDGKTVAVKKLSQATGQG--DREFAAEMETLGMVKHQNLVELL 208
+G G FGTV KG KTVAVK L E E + + + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV---- 249
G C E +LV E G L+ +L+ + + + + V
Sbjct: 63 GICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKATERGDV 306
A N+LL AKISDFGL++ + E++ G + + PE K + + DV
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV 181
Query: 307 YSFGVILLELVT-GKQP 322
+SFGV++ E + G++P
Sbjct: 182 WSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 58/197 (29%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVELLG 209
IG G FG V+ T + VAVKK+S + Q + ++ E++ L +KH N +E G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWL--------RNQAASLDWG---------KRCK----I 248
+ LV EY + GS D L + A++ G I
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 249 VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKATERGD 305
A NILL + + K++DFG A S S V GT ++ PE G+ + D
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVD 202
Query: 306 VYSFGVILLELVTGKQP 322
V+S G+ +EL K P
Sbjct: 203 VWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 26/191 (13%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLVELLGYC 211
+G G + TVFKG + VA+K++ +G A E+ L +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 212 SVDEEKLLVYEYM---VKGSLDD------------WLRNQAASLDWGKRCKIV-----AS 251
D+ LV+EY+ +K +DD +L L + R K++
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQ 133
Query: 252 NILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYSF 309
N+L+N+ E K++DFGLAR S +++ + VV T+ Y PP+ G+ + + + D++
Sbjct: 134 NLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQIDMWGV 191
Query: 310 GVILLELVTGK 320
G I E+ +G+
Sbjct: 192 GCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 58/221 (26%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLS--------QATGQGDREFAAEMETLGMVKHQ 202
+ IG G +G V T P G VA+KK+S Q T + E++ L KH+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-------EIKILRRFKHE 63
Query: 203 NLVELL------GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK--------- 247
N++ +L + S + +V E M + L ++ Q S D +
Sbjct: 64 NIIGILDIIRPPSFESF-NDVYIVQELM-ETDLYKLIKTQHLSND---HIQYFLYQILRG 118
Query: 248 -------------IVASNILLNDDFEAKISDFGLARLISDCESHVSTV---VAGTIGYVP 291
+ SN+LLN + + KI DFGLAR+ H + VA T Y
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-TRWYRA 177
Query: 292 PEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
PE K T+ D++S G IL E+++ + P F KD
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNR----PLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 34/199 (17%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD-REFAAEMETLGMVKH---QNLVEL 207
+IG G +G V++G +P G+ VA+K ++ T D + E+ L ++ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC--------------------- 246
G ++ EY GS+ ++ + ++
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA----EKYISVIIREVLVALKYIHKVGVI 123
Query: 247 --KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE-R 303
I A+NIL+ + K+ DFG+A L++ S ST V GT ++ PE GK + +
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDTK 182
Query: 304 GDVYSFGVILLELVTGKQP 322
D++S G+ + E+ TG P
Sbjct: 183 ADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 68/292 (23%)
Query: 140 QIVAGTNKFCEENVIGGGGFGTVFKG----TMPDGKT--VAVKKLS-QATGQGDREFAAE 192
+I T +F EE +G FG V+KG T P +T VA+K L +A G EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 193 METLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL-----RNQAASLDWGKRCK 247
++H N+V LLG + ++ +++ Y L ++L + S D K K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 248 -------------------------------IVASNILLNDDFEAKISDFGLARLISDCE 276
+ N+L+ D KISD GL R + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
Query: 277 SHVSTVVAGT---IGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDG 332
+ ++ + I ++ PE GK + D++S+GV+L E+ + G QP + ++D
Sbjct: 179 YY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC-GYSNQD- 234
Query: 333 ENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRP 384
V+ M++N Q + + P + L + C + P+ RP
Sbjct: 235 ------VIEMIRNRQ-------VLPCPDDCPAWVYTLMLE--CWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 39/203 (19%)
Query: 153 VIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELLG 209
+G G + TV+KG + G+ VA+K++ +G F A E L +KH N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 210 YCSVDEEKLLVYEYM-------------------VKGSLDDWLRNQAASLDWGKRCKIV- 249
+ LV+EY+ V+ L LR L + + +++
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR----GLAYCHQRRVLH 126
Query: 250 ----ASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE--YGGTGKATE 302
N+L+++ E K++DFGLAR S +++ + VV T+ Y PP+ G T +T
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTS 184
Query: 303 RGDVYSFGVILLELVTGKQPTGP 325
D++ G I E+ TG +P P
Sbjct: 185 L-DMWGVGCIFYEMATG-RPLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 36/225 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKT-VAVKKLSQATGQGDREFAA--EMETLGMVKHQ 202
NKF V+G G +G V K + K VA+KK + + + E++ L +K +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 203 NLVEL-----------LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL----DWGKRCK 247
N+VEL L + V++ L + E M G + +R+ L W +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 248 IV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGK 299
IV N+L++ + K+ DFG AR +S+ + T T Y PE GK
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
A D++S G IL EL G QP P GE+ +D + + K
Sbjct: 181 AV---DMWSVGCILGELSDG-QPLFP------GESEIDQLFTIQK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 33/199 (16%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELLGY 210
+G G + TV+KG + +G+ VA+K +S T +G F A E L +KH N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLD----------------WGKRCKIV----- 249
E V+EYM L ++ L + I+
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130
Query: 250 ASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE--YGGTGKATERGDV 306
N+L++ E K++DFGLAR S +++ S VV T+ Y PP+ G T ++ D+
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSAL-DI 187
Query: 307 YSFGVILLELVTGKQPTGP 325
+ G I +E++ G QP P
Sbjct: 188 WGAGCIFIEMLQG-QPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 54/257 (21%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA----AEMETLGMVKHQNL 204
V+G G +G VF G GK A+K L +AT + A E + L V+
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSL-----------DDWLRNQAA----SLDWGKRCKI 248
+ L Y + KL L+ +Y+ G L + +R A +LD + I
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI 126
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY--GGTGKAT 301
+ NILL+ + ++DFGL++ E + GTI Y+ PE GG+G
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHD 186
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD--------EVLD 353
+ D +S GV+ EL+TG P F DGE +N Q++ +
Sbjct: 187 KAVDWWSLGVLTFELLTGASP----FT-VDGE----------QNSQSEISRRILKSKPPF 231
Query: 354 PAVLNANSKPTMLKMLQ 370
P ++A ++ + K+L+
Sbjct: 232 PKTMSAEARDFIQKLLE 248
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 69/271 (25%), Positives = 104/271 (38%), Gaps = 43/271 (15%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQN 203
K E + +G G G+V K + + + K D ++ E+E K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 204 LVELLGYCSVDEEKLLVY---EYMVKGSLDDWLRN--------------QAAS-----LD 241
+V+ G +DE + EY GSLD + + A L
Sbjct: 61 IVKYYGAF-LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 242 WGKRCKIV-----ASNILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPEYG 295
+ KI+ SNILL + K+ DFG++ L+ S T GT Y+ PE
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSFYMAPERI 175
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGE-NLVDWVLHMMKNEQADEVLDP 354
+ DV+S G+ LLE+ + P PE E G L+ ++++M E DE P
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---P 232
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
S+ C+ DPT RPT
Sbjct: 233 GNGIKWSEE----FKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 18/139 (12%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDV 306
I ++NILL + K+ DFG +++ + S V GT YV PE +++ D+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM 228
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
+S GV+L EL+T K+P DGEN+ + V+H + DP L + P
Sbjct: 229 FSLGVLLYELLTLKRPF-------DGENMEE-VMHKTLAGR----YDP--LPPSISP--- 271
Query: 367 KMLQIATGCISNDPTVRPT 385
+M +I T +S+DP RP+
Sbjct: 272 EMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 60/211 (28%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
IG G FG V G + G T V VK+L A+ Q +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQ--AASLDWGKR------CKIVAS---------- 251
C+ LLV E+ G L +LR+ A + C+I
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 252 -------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PE-----Y 294
N LL D KI D+GL S + V +VP PE +
Sbjct: 123 HSDLALRNCLLTADLTVKIGDYGL----SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 295 GG--TGKATERGDVYSFGVILLELVT-GKQP 322
G T+ +V+S GV + EL G QP
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 58/216 (26%), Positives = 84/216 (38%), Gaps = 30/216 (13%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLG 209
+G GGFG V + GK A KKL + +G++ E + L V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWLRNQ-------------AASLDWG----KRCKIV-- 249
Y ++ L LV M G L + N AA + G + +IV
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
N+LL+D +ISD GLA + + AGT GY+ PE D
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM 342
++ G L E++ G+ P E + E L L M
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 154 IGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS 212
IG G G V T+ GK VAVKK+ Q E+ + +H+N+VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 213 VDEEKLLVYEYMVKGSLDDWLRN----------------QAASLDWGKRC---KIVASNI 253
V +E +V E++ G+L D + + +A S+ + I + +I
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147
Query: 254 LLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVIL 313
LL D K+SDFG +S E + GT ++ PE D++S G+++
Sbjct: 148 LLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206
Query: 314 LELVTGKQP 322
+E+V G+ P
Sbjct: 207 IEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 49/240 (20%)
Query: 154 IGGGGFGTVFKG---TMPDGKTVAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
IG G FG V T V VK+L + A+ + EF + + +++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 210 YCSVDEEKLLVYEYMVKGSL------DDWLRNQAASLDWGKR-CKIVAS----------- 251
C LLV+EY G L + W R + L + C+I A
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122
Query: 252 ------NILLNDDFEAKISDFGL--ARLISD-CESHVSTVVAGTIGYVPPEYGG------ 296
N L D K+ D+G+ +R D E+ V + ++ PE G
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LRWLAPELVGEFHGGL 180
Query: 297 -TGKATERGDVYSFGVILLELV-TGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
T + T+ +V++ GV L EL QP D++ VL+ + +Q ++ P
Sbjct: 181 ITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDRE-------VLNHVIKDQQVKLFKP 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 34/206 (16%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGD---REFAA-EMETLGMVKHQNLVELL 208
IG G +G VFK + G+ VA+KK ++ + D ++ A E+ L +KH NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVAS----------------- 251
+ LV+EY L++ +N + KI+
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 252 ----NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY--GGTGKATERGD 305
NIL+ + K+ DFG AR+++ + VA T Y PE G T D
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVGDTQYGPPV-D 183
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKD 331
V++ G + EL+TG QP P D D
Sbjct: 184 VWAIGCVFAELLTG-QPLWPGKSDVD 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 62/238 (26%), Positives = 89/238 (37%), Gaps = 63/238 (26%)
Query: 152 NVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDRE------------FAA--EMETL 196
+G G +G V K GK VA+KK+ D F E++ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 197 GMVKHQNLVELLG-YCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC---KIV--- 249
+KH+N++ L+ Y D L V + M L + + + +C +I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINL-VMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 250 --------------ASNILLNDDFEAKISDFGLAR------LISDC---------ESHVS 280
+NI +N KI+DFGLAR E S
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 281 TVVAGTIGYVPPE-YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVD 337
VV T+ Y PE G K D++S G I EL+TGK P P GEN +D
Sbjct: 193 KVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFP------GENEID 241
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 40/207 (19%)
Query: 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQN 203
F + V+G GGFG V + GK A K+L + +G+ E + L V Q
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 204 LVEL----------------------------LGYCSVDEEKLLVYEYMVKGSLDDWLRN 235
+V L +G +EE+ L Y + L+D R
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 236 QAASLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295
D + NILL+D +ISD GLA I + ES V GT+GY+ PE
Sbjct: 122 NTVYRD------LKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVL 173
Query: 296 GTGKATERGDVYSFGVILLELVTGKQP 322
+ T D + G ++ E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 6e-08
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 34/203 (16%)
Query: 148 FCEENVIGGGGFGTV-FKGTMPDGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQN 203
F + IG G FG V F + + VA+KK+S + Q + ++ E++ L +KH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV-------------- 249
+E G + LV EY + GS D L L + I
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 250 -------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGK 299
A NILL + + K++DFG A + S S V GT ++ PE G+
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQ 200
Query: 300 ATERGDVYSFGVILLELVTGKQP 322
+ DV+S G+ +EL K P
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 35/205 (17%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD-REFAAEMETLGMVKHQNLVELLGYC 211
+G G +G+V+K P G T+A+K++ + + E++ L +V+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 212 SVDEEKLLVYEYMVKGSLD--------------DWLRNQAASLDWGKRC----------K 247
++ + EYM GSLD D LR ++ G +
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG--- 304
+ +N+L+N + + K+ DFG++ + + ++ G Y+ PE +G +
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYT 185
Query: 305 ---DVYSFGVILLELVTGKQPTGPE 326
DV+S G+ +LE+ G+ P PE
Sbjct: 186 VQSDVWSLGLSILEMALGRYPYPPE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 6e-08
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
K+ IG G GTV+ + G+ VA+++++ E+ + K+ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWL--------------RNQAASLDWGKRCKIV-- 249
L V +E +V EY+ GSL D + R +L++ +++
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
+ NILL D K++DFG I+ +S ST+V GT ++ PE + D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 307 YSFGVILLELVTGKQP 322
+S G++ +E++ G+ P
Sbjct: 200 WSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 62/272 (22%), Positives = 100/272 (36%), Gaps = 66/272 (24%)
Query: 154 IGGGGFGTVFKGTM---PDGKTVA----VKKLSQATGQGDREFAAEMETLGM---VKHQN 203
+G G F ++KG + D V V + + G R+ A ET + + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS------------LDWG------KR 245
LV+L G C V +E ++V EY+ G LD +L + + L K+
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 246 C---KIVASNILL-NDDFE------AKISDFGLARLISDCESHVSTVVAGTIGYVPPEY- 294
+ NIL+ K+SD G+ + E V I ++ PE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWIAPECI 176
Query: 295 -GGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352
G T D +SFG LLE+ + G++P L + D+
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEP------------LSTLSSSEKERFYQDQ-- 222
Query: 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRP 384
L + ++ C + DPT RP
Sbjct: 223 --HRLPMPDCAELANLI---NQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQ--ATGQGDREFAAEMETLGMVKH 201
TN++ + +G G FG V G+ VA+KK+ + +T + E++ L ++H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 202 QNLVELLG-YCSVDEEKLLVYEYM--------VKGSLDD-----WLRNQAASLDWGKRCK 247
+N++ L + S E+ V E + L+ +L L +
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 248 IV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT-GKAT 301
+V SNIL+N++ + KI DFGLAR+ + T T Y PE T K
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
D++S G I E++ GK P F KD N
Sbjct: 185 VEVDIWSAGCIFAEMLEGK----PLFPGKDHVN 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 62/266 (23%), Positives = 101/266 (37%), Gaps = 50/266 (18%)
Query: 148 FCEENVIGGGGFGTV-FKGTMPDGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQN 203
F + IG G FG V F + + + VA+KK+S + Q + ++ E+ L ++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV-------------- 249
++ G + LV EY + GS D L L + +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 250 -------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGK 299
A NILL++ K+ DFG A +++ V GT ++ PE G+
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQ 190
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
+ DV+S G+ +EL K P N + + H+ +NE L +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNES-------PALQS 236
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPT 385
+ C+ P RPT
Sbjct: 237 GHWSEYFR--NFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 19/132 (14%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGV 311
N+LL+ D KI+DFG+ + + E ST GT Y+ PE K E D +SFGV
Sbjct: 126 NVLLDKDGHIKIADFGMCKENMNGEGKASTF-CGTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 312 ILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQI 371
+L E++ G+ P F +D + L D +L+ D P ++ +K + K+ +
Sbjct: 185 LLYEMLIGQSP----FHGEDEDELFDSILN-------DRPHFPRWISKEAKDCLSKLFE- 232
Query: 372 ATGCISNDPTVR 383
DPT R
Sbjct: 233 ------RDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 36/209 (17%)
Query: 153 VIGGGGFGTVF---KGTMPD-GKTVAVKKLSQAT----GQGDREFAAEMETLGMVKHQNL 204
V+G G +G VF K T D GK A+K L +A + E L V+
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSL-----------DDWLRNQAA----SLDWGKRCKI 248
+ L Y E KL L+ +Y+ G + +D +R + +L+ + I
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY----GGTGK 299
V NILL+ + ++DFGL++ E + GTI Y+ PE GG GK
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFE 328
A D +S G+++ EL+TG P E E
Sbjct: 187 AV---DWWSLGILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 8/77 (10%)
Query: 251 SNILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPEY----GGTGKATERGD 305
SNILL+ K+ DFG++ RL+ +S T AG Y+ PE K R D
Sbjct: 144 SNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRAD 200
Query: 306 VYSFGVILLELVTGKQP 322
V+S G+ L+EL TG+ P
Sbjct: 201 VWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 45/210 (21%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETL-GMVKHQNLVELLGY 210
VIG G +G V+K G+ VA+K + + E E L H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 211 -----CSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKRCK----------------- 247
++++L LV E GS+ D ++ GKR K
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKG---LRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 248 ----------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---- 293
I NILL + E K+ DFG++ + +T + GT ++ PE
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIAC 187
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQP 322
R DV+S G+ +EL GK P
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 63/269 (23%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGYCS 212
+G G FG V+K + A K+ Q + + E F E++ L KH N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 213 VDEEKLLVYEYMVKGSLDDWL----------------RNQAASLDWGKRCKIV-----AS 251
+ + ++ E+ G+LD + R +L++ K++ A
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE--------- 302
NILL D + K++DFG++ T + GT ++ PE A E
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEV----VACETFKDNPYDY 187
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL------DPAV 356
+ D++S G+ L+EL + P L+ M+ VL +P
Sbjct: 188 KADIWSLGITLIELAQMEPPHHE--------------LNPMR------VLLKILKSEPPT 227
Query: 357 LNANSKPTMLKMLQIATGCISNDPTVRPT 385
L+ SK + C+ DP RPT
Sbjct: 228 LDQPSKWSS-SFNDFLKSCLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 55/272 (20%)
Query: 153 VIGGGGFGTVFKGTM--PDGKT--VAVK--KLSQATGQGDREFAAEMETLGMVKHQNLVE 206
++G G FG+V +G + DG VAVK KL T EF +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 207 LLGYCSVDEEK------LLVYEYMVKGSLDDWL---RNQAAS------------LDWGKR 245
L+G C +++ +M G L +L R +D
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 246 CK-----------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT-IGYVPPE 293
+ + A N +L +D ++DFGL++ I + + +A + ++ E
Sbjct: 126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
T + DV++FGV + E+ T Q P E+ + + D++ H + +Q ++ LD
Sbjct: 186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRHGNRLKQPEDCLD 242
Query: 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
++ + C DP RPT
Sbjct: 243 -------------ELYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/213 (27%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 153 VIGGGGFGTVF--KGTMPDGKTVAVKKLSQATGQGDREFAAEMET--LGMVKHQNLVELL 208
IG G FG ++ K D + +K++ + A++ E L +KH N+V
Sbjct: 7 KIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 209 GYCSVDEEKLL--VYEYMVKGSLDDWLRNQAAS-------LDWGKRCK------------ 247
+ S E L V EY G L + Q L W +
Sbjct: 65 -FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123
Query: 248 ---IVASNILLNDD-FEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATER 303
I + NI L+ + AK+ DFG+AR ++D T V GT Y+ PE +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRPYNNK 182
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336
D++S G +L EL T K P FE + LV
Sbjct: 183 TDIWSLGCVLYELCTLKHP----FEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 63/205 (30%), Positives = 82/205 (40%), Gaps = 35/205 (17%)
Query: 154 IGGGGFGTVFKGTMP-DGKTVAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVELL- 208
IG G FG V+ T P DGK VA+KK+ Q R F E++ L KH N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 209 ----GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK-------------------- 244
+ EE +V E M + Q S D K
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 245 RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATER 303
R I N+L+N + KI DFGLAR+ ES T T Y PE G+ T
Sbjct: 127 R-DIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA 185
Query: 304 GDVYSFGVILLELVTGK---QPTGP 325
D++S G I EL+ + Q P
Sbjct: 186 VDIWSVGCIFAELLGRRILFQAQSP 210
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 153 VIGGGGFGTVF---KGTMPD-GKTVAVKKLSQAT----GQGDREFAAEMETLGMVKHQNL 204
V+G G +G VF K + D GK A+K L +AT + E + L ++
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKI 248
+ L Y + KL L+ +Y+ G L L + +L+ + I
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY--GGTGKAT 301
+ NILL+ + ++DFGL++ + E + GTI Y+ P+ GG G
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 302 ERGDVYSFGVILLELVTGKQP 322
+ D +S GV++ EL+TG P
Sbjct: 187 KAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 37/245 (15%)
Query: 110 ISDRSSSALMEHLSIN--LAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTM 167
+ D AL ++ +I+ L+ +E + +K+T ++ A F VIG G FG V
Sbjct: 7 VYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKA--EDFDVIKVIGRGAFGEVQLVRH 64
Query: 168 PDGKTV-AVKKLSQATGQGDREFAAEMETLGMVKHQN---LVELLGYCSVDEEKLL--VY 221
K V A+K LS+ + A E ++ H N +V+L + + ++K L V
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVM 122
Query: 222 EYMVKGSLDDWLRNQAASLDWGK--RCKIVAS-----------------NILLNDDFEAK 262
EYM G L + + N W + ++V + N+LL+ K
Sbjct: 123 EYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182
Query: 263 ISDFGLA-RLISDCESHVSTVVAGTIGYVPPEY----GGTGKATERGDVYSFGVILLELV 317
++DFG ++ ++ T V GT Y+ PE GG G D +S GV L E++
Sbjct: 183 LADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 318 TGKQP 322
G P
Sbjct: 242 VGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 40/220 (18%)
Query: 153 VIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGD-REFAA-EMETLGMVKHQNLVELLG 209
++G G +G V K + G+ VA+KK ++ ++ A E+ L ++H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK---------------------I 248
+ LV+E++ LDD L LD + K I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126
Query: 249 VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY--GGT--GKATERG 304
NIL++ K+ DFG AR ++ + VA T Y PE G T G+A
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYGRAV--- 182
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
D+++ G ++ E++TG +P P G++ +D + H++K
Sbjct: 183 DIWAVGCLVTEMLTG-EPLFP------GDSDIDQLYHIIK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 40/207 (19%)
Query: 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQN 203
F + V+G GGFG V + GK A KKL + +G+ E + L V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 204 LVEL----------------------------LGYCSVDEEKLLVYEYMVKGSLDDWLRN 235
+V L +G +E + + Y + L+D +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 236 QAASLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295
+ D + NILL+D +ISD GLA + + ++ V GT+GY+ PE
Sbjct: 122 RIVYRD------LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVV 173
Query: 296 GTGKATERGDVYSFGVILLELVTGKQP 322
+ T D ++ G +L E++ G+ P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 37/198 (18%)
Query: 154 IGGGGFGTVFKGTMPDGK--TVAVKKLSQAT----GQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG V T + VA+K+ ++ Q D F+ E + L + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-----------AASL----DWGKRCKIV--- 249
G + LV E+++ G +LR AA + ++ + IV
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKATERG 304
N+LL+ D K++DFG A+++ ++ T + GT Y+ PE G GKA
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHGKA---A 209
Query: 305 DVYSFGVILLELVTGKQP 322
D ++ G+ + E++ G P
Sbjct: 210 DWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 54/202 (26%), Positives = 81/202 (40%), Gaps = 40/202 (19%)
Query: 153 VIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVEL- 207
V+G GGFG V + GK A KKL + +G+ E L V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 208 ---------------------------LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL 240
+G DE++ + Y + L+D R +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 241 DWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKA 300
D + NILL+D +ISD GLA I + E+ V GT+GY+ PE K
Sbjct: 127 D------LKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKY 178
Query: 301 TERGDVYSFGVILLELVTGKQP 322
T D + G ++ E++ G+ P
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 251 SNILLNDDFEAKISDFGLARLIS----DCESHVSTVVAGTIGYVPPE----YGGTGKATE 302
N+L+N D E KI DFGLAR S + ++ VA T Y PE + KA
Sbjct: 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAPEIMLSFQSYTKAI- 191
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM 343
DV+S G IL EL+ K P F+ KD + ++ +L ++
Sbjct: 192 --DVWSVGCILAELLGRK----PVFKGKDYVDQLNQILQVL 226
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 7e-07
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELLGY 210
+G G + TV+KG + +GK VA+K + +G F A E L +KH N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLD---------------------WGKRCKIV 249
E LV+EY V L ++ L + +
Sbjct: 72 IHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYS 308
N+L++D E K++DFGLAR S SH + T+ Y PP+ G+ + + D++
Sbjct: 131 PQNLLISDTGELKLADFGLARAKS-VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWG 189
Query: 309 FGVILLELVTG 319
G I +E++ G
Sbjct: 190 VGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 148 FCEENVIGGGGFGTV-FKGTMPDGKTVAVKKLSQATGQGDREFAAEMET--LGMVKHQNL 204
+C V+G G +G V DGK +KKL+ AAE E L +KH N+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 205 VE--------------LLGYCS-------VDEEKLLVYEYMVKGSLDDWLRNQAASLDWG 243
V ++G+C + E+K + + + + +W A +L +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYL 118
Query: 244 KRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG 298
I+ N+ L K+ D G+AR++ + ST++ GT Y+ PE
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNK 177
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336
+ DV++ G + E+ T K F KD +LV
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHA----FNAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 154 IGGGGFG-TVFKGTMPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G FG + + DGK +K++ S+ + + E E+ L +KH N+V+ Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---Y 64
Query: 211 CSVDEEK---LLVYEYMVKGSLDDWLRNQAAS-------LDWGKR-C------------- 246
EE +V +Y G L + Q LDW + C
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 247 -KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
I + NI L D K+ DFG+AR+++ T + GT Y+ PE + D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSD 183
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLV 336
+++ G +L E+ T K FE + +NLV
Sbjct: 184 IWALGCVLYEMCTLKHA----FEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-07
Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYC 211
++G G +G V+KG +A K+ TG + E E+ L H+N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 212 ------SVDEEKLLVYEYMVKGSLDDWLRNQAASL---DW-GKRCK-------------- 247
+D++ LV E+ GS+ D ++N + +W C+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV 132
Query: 248 ----IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE- 302
I N+LL ++ E K+ DFG++ + +T + GT ++ PE + +
Sbjct: 133 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDA 191
Query: 303 ----RGDVYSFGVILLELVTGKQP 322
+ D++S G+ +E+ G P
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 252 NILLNDDFEAKISDFGLARL-ISDCESHVS-TVVAGTIGYVPPEYGGT--GKATERGDVY 307
NIL N D + KI DFGLAR+ +D + + T T Y PE G+ K T D++
Sbjct: 133 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM-----------KNEQADEVL---- 352
S G I E++TGK P F K+ + +D + ++ +NE+A L
Sbjct: 193 SIGCIFAEVLTGK----PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMR 248
Query: 353 --DPAVLNA---NSKPTMLKMLQIATGCISNDPTVRPT 385
P + N+ P L++L+ ++ DP RPT
Sbjct: 249 KKQPVPFSQKFPNADPLALRLLE---RLLAFDPKDRPT 283
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 46/204 (22%)
Query: 152 NVIGGGGFGTV----FKGTMPDGKTVAVKKLSQ----ATGQGDREFAAEMETLGMVKHQN 203
+G G FG V KGT G+ A+K L + Q A E L + H
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSHPF 79
Query: 204 LVELLGYCS-VDEEKL-LVYEYMVKGSLDDWLR------NQAA---------SLDWGKRC 246
+V + CS DE ++ + E++V G L LR N A + ++
Sbjct: 80 IVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 247 KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTG 298
I+ N+LL++ K++DFG A+ + D + + GT Y+ PE G G
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTLCGTPEYLAPEVIQSKGHG 193
Query: 299 KATERGDVYSFGVILLELVTGKQP 322
KA D ++ GV+L E + G P
Sbjct: 194 KAV---DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 153 VIGGGGFGTVFKGTMPD-GKTVAVKKL-----SQATGQGDREFAAEMETLGMVKHQNLVE 206
++G G FG V+ D G+ +AVK++ SQ T + E++ L ++H +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 207 LLGYCSVD--EEKLLVY-EYMVKGSLDDWLRNQAASLDWGKRC----------------- 246
G C D E+KL ++ EYM GS+ D L+ A + R
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 247 ---KIVASNILLNDDFEAKISDFGLARLISD-CESHVS-TVVAGTIGYVPPEYGGTGKAT 301
I +NIL + K+ DFG ++ I C S V GT ++ PE
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG 187
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFE 328
+ DV+S ++E++T K P E+E
Sbjct: 188 RKADVWSVACTVVEMLTEKPPWA-EYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 29/71 (40%), Positives = 43/71 (60%), Gaps = 2/71 (2%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGV 311
NI+L +D + I+DFGLA+ ES +++VV GTI Y PE E+ DV++FG
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV-GTILYSCPEIVKNEPYGEKADVWAFGC 201
Query: 312 ILLELVTGKQP 322
IL ++ T + P
Sbjct: 202 ILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 55/209 (26%)
Query: 154 IGGGGFGTVFKGTMPD---GKTVAVKKLSQATG-QGD--REFAAEMETLGMVKHQNLVEL 207
+G G +G V+K D + VA+KK+ A D R F M + H N+V+L
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 208 LGYCSVDEEK--LLVYEYM------V--KGSLDDWLRNQAASLDWGKRC------KIVA- 250
L + +K LV+EYM V L+D KR K +
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV----------HKRYIMYQLLKALKY 122
Query: 251 -------------SNILLNDDFEAKISDFGLARLISDCESHVST-----VVAGTIGYVPP 292
SNILLN D K++DFGLAR +S+ E + VA T Y P
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-TRWYRAP 181
Query: 293 E-YGGTGKATERGDVYSFGVILLELVTGK 320
E G+ + T+ D++S G IL E++ GK
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 33/195 (16%)
Query: 154 IGGGGFGTV-FKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS 212
IG G G V G+ VAVK + Q E+ + +HQN+VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 213 VDEEKLLVYEYMVKGSLDDWL------RNQAASLDWGKRCK------------------I 248
V EE ++ E++ G+L D + Q A++ C+ I
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV-----CESVLQALCYLHSQGVIHRDI 143
Query: 249 VASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
+ +ILL D K+SDFG IS D S V GT ++ PE D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIW 201
Query: 308 SFGVILLELVTGKQP 322
S G++++E+V G+ P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 31/194 (15%)
Query: 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS 212
IG G G V T GK VAVKK+ Q E+ + H+N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 213 VDEEKLLVYEYMVKGSLDD------------------------WLRNQAASLDWGKRCKI 248
V +E +V E++ G+L D +L NQ I
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI-----HRDI 144
Query: 249 VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
+ +ILL D K+SDFG +S E + GT ++ PE D++S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 309 FGVILLELVTGKQP 322
G++++E++ G+ P
Sbjct: 204 LGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 46/205 (22%)
Query: 153 VIGGGGFGTV----FKGTMPDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLV 205
V+G GGFG V + T GK A KKL + +G+ E + L V + +V
Sbjct: 7 VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 206 EL----------------------------LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA 237
L +G DEE+ + Y + L+D R +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 238 ASLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT 297
D + NILL+D +ISD GLA I + E+ V GT+GY+ PE
Sbjct: 124 VYRD------LKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKN 175
Query: 298 GKATERGDVYSFGVILLELVTGKQP 322
+ T D + G ++ E++ GK P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 46/200 (23%), Positives = 86/200 (43%), Gaps = 36/200 (18%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGYCS 212
+G G FG V+K + +A K+ + + E + E++ L H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 213 VDEEKLLVYEYMVKGSLDDWL----------------RNQAASLDWGKRCKIV-----AS 251
+ ++ E+ G++D + + +L++ KI+ A
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAG 132
Query: 252 NILLNDDFEAKISDFGLA----RLISDCESHVSTVVAGTIGYVPPEYGGTGKATER---- 303
NIL D + K++DFG++ R I +S + GT ++ PE + +R
Sbjct: 133 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRPYDY 187
Query: 304 -GDVYSFGVILLELVTGKQP 322
DV+S G+ L+E+ + P
Sbjct: 188 KADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 35/204 (17%)
Query: 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGY- 210
V+G G +G V+KG +A K+ T + E E+ L H+N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 211 -----CSVDEEKLLVYEYMVKGSLDDWLRNQAASL---DW-GKRCK-------------- 247
D++ LV E+ GS+ D ++N + DW C+
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKV 142
Query: 248 ----IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE- 302
I N+LL ++ E K+ DFG++ + +T + GT ++ PE + +
Sbjct: 143 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDA 201
Query: 303 ----RGDVYSFGVILLELVTGKQP 322
R D++S G+ +E+ G P
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 59/263 (22%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLV 205
++G G FG V K T GK A+K L + E A E L +H L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSL-----------DDWLRNQAA----SLDWGKRCKIV 249
L Y ++L V EY G L +D R A +L + C +V
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 250 -----ASNILLNDDFEAKISDFGLARL-ISDCESHVSTVVAGTIGYVPPEY---GGTGKA 300
N++L+ D KI+DFGL + ISD + GT Y+ PE G+A
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
D + GV++ E++ G+ P F ++D E L + +L +E+ P L+
Sbjct: 176 V---DWWGLGVVMYEMMCGRLP----FYNQDHEKLFELIL-------MEEIRFPRTLSPE 221
Query: 361 SKPTMLKMLQIATGCISNDPTVR 383
+K ++L G + DP R
Sbjct: 222 AK-SLL------AGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 46/203 (22%)
Query: 173 VAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231
VAVK L A +F E++ L +K N++ LLG C ++ ++ EYM G L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 232 WLRNQA----------------------------------------ASLDWGKRCKIVAS 251
+L + +SL++ R +
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR-DLATR 167
Query: 252 NILLNDDFEAKISDFGLAR-LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
N L+ ++ KI+DFG++R L + + I ++ E GK T DV++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 311 VILLEL--VTGKQPTGPEFEDKD 331
V L E+ + +QP G E D+
Sbjct: 228 VTLWEILMLCKEQPYG-ELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 47/274 (17%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKK-----LSQATGQGDREFAAEMETLGM 198
F E IG G F V+K + DG+ VA+KK + A + D E++ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD--CLKEIDLLKQ 58
Query: 199 VKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN------------------QAAS- 239
+ H N+++ L + E +V E G L +++ Q S
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 240 LDW--GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY 294
L+ KR I +N+ + K+ D GL R S + ++V GT Y+ PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
+ D++S G +L E+ + P F D NL K E+ D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP----FY-GDKMNLYSLC---KKIEKCDY---- 225
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388
L A+ L+ + + CI+ DP RP + +
Sbjct: 226 PPLPADHYSEELR--DLVSRCINPDPEKRPDISY 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 32/195 (16%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQAT-GQGDREFAA-EMETLGMVKHQNLVELLGY 210
IG G +G V+K G+ VA+KK+ T +G A E+ L + H N+V+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 211 CSVDEEKLLVYEYM--------------------VKGSLDDWLRNQAASLDWGKRC---K 247
+ + LV+E++ +K L L Q + R
Sbjct: 68 IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL--QGLAFCHSHRVLHRD 125
Query: 248 IVASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE-YGGTGKATERGD 305
+ N+L+N + K++DFGLAR ++ VV T+ Y PE G + D
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYYSTAVD 183
Query: 306 VYSFGVILLELVTGK 320
++S G I E+VT +
Sbjct: 184 IWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 31/206 (15%)
Query: 153 VIGGGGFGTVFKGTMPD-GKTVAVKKL-----SQATGQGDREFAAEMETLGMVKHQNLVE 206
++G G FG V+ D G+ +AVK++ S T + E++ L + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 207 LLGYCSVDEEKLL--VYEYMVKGSLDDWLRNQAASLDWGKRC------------------ 246
G E+ L E+M GS+ D L++ A + R
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 247 --KIVASNILLNDDFEAKISDFGLA-RLISDCESHVSTV-VAGTIGYVPPEYGGTGKATE 302
I +NIL + K+ DFG + RL + C S V GT ++ PE
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFE 328
+ D++S G ++E++T K P EFE
Sbjct: 189 KADIWSVGCTVVEMLTEKPPWA-EFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 48/187 (25%), Positives = 71/187 (37%), Gaps = 39/187 (20%)
Query: 170 GKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLVELL--GYCSVDEEKLL--VYE 222
G VA+K L + + + A E + H N+V LL G LL V+E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFE 59
Query: 223 YMVKGSLDDWLRNQAA---------------SLDWGKRCKIV-----ASNILL---NDDF 259
Y+ +L + L A +L IV NI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 260 EAKISDFGLARLISDCESH------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVIL 313
AK+ DFG+ L+ +T V GT Y PE T D+Y++G+I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 314 LELVTGK 320
LE +TG+
Sbjct: 180 LECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 6/76 (7%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY---GGTGKATE-RGDV 306
SN+L+N + + K+ DFG++ + D S T+ AG Y+ PE K + + DV
Sbjct: 133 SNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190
Query: 307 YSFGVILLELVTGKQP 322
+S G+ ++EL TG+ P
Sbjct: 191 WSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 57/197 (28%), Positives = 84/197 (42%), Gaps = 37/197 (18%)
Query: 154 IGGGGFGTVFKGT--MPDGKTVAVKKLSQATGQGD------REFAAEMETLGMVKHQNLV 205
IG G +G VFK G+ VA+K++ TG+ RE A + L +H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67
Query: 206 ELLGYCSVD----EEKL-LVYE--------YMVKG--------SLDDWLRNQAASLDWGK 244
L C+V E KL LV+E Y+ K ++ D + LD+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 245 RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
++V NIL+ + K++DFGLAR+ S T V T+ Y PE
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQSS 185
Query: 300 ATERGDVYSFGVILLEL 316
D++S G I E+
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 3/76 (3%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
SNIL+N E K+ DFG++ + D S ++ V GT Y+ PE T + D++S G
Sbjct: 129 SNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 311 VILLELVTGKQPTGPE 326
+ L+E+ G+ P P
Sbjct: 186 LSLVEMAIGRYPIPPP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 64/247 (25%), Positives = 97/247 (39%), Gaps = 44/247 (17%)
Query: 153 VIGGGGFGTV----FKGTMPDGKTVAVKKLSQATGQGDREFAAEM------ETLGMVKHQ 202
V+G G FG V +K T G+ A+K L + E + M ET +H
Sbjct: 6 VLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSL------DDWLRNQAA--------SLDWGKRCKI 248
LV L ++ V EY G L D + +A L + KI
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATER 303
V N+LL+ + KI+DFGL + ST GT ++ PE T
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTETSYTRA 181
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363
D + GV++ E++ G+ P F D E + D ++ DEV P L+ +
Sbjct: 182 VDWWGLGVLIYEMLVGESP----FPGDDEEEVFDSIV-------NDEVRYPRFLSREAIS 230
Query: 364 TMLKMLQ 370
M ++L+
Sbjct: 231 IMRRLLR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 42/203 (20%)
Query: 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGYCS 212
+G G FG V+K + +A K+ + + + E + E+E L H +V+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 213 VDEEKLLVYEYMVKGSLDDWL----------------RNQAASLDWGKRCKIV-----AS 251
D + ++ E+ G++D + R +L + KI+ A
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139
Query: 252 NILLNDDFEAKISDFGLA----RLISDCESHVST--------VVAGTIGYVPPEYGGTGK 299
N+LL D + K++DFG++ + + +S + T V+ T+ P +Y
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY----- 194
Query: 300 ATERGDVYSFGVILLELVTGKQP 322
+ D++S G+ L+E+ + P
Sbjct: 195 ---KADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 29/81 (35%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
SN+LLN + + KI DFGLAR S+ ++ V P + T DV+S G
Sbjct: 137 SNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG 196
Query: 311 VILLELVTGKQPTGPEFEDKD 331
I EL+ K P F KD
Sbjct: 197 CIFAELLGRK----PLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 32/201 (15%)
Query: 153 VIGGGGFGTVFKGTMPD-GKTVAVKKL-----SQATGQGDREFAAEMETLGMVKHQNLVE 206
++G G FG V+ D G+ +A K++ S T + E++ L ++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 207 LLGYCSVD--EEKLLVY-EYMVKGSLDDWLRNQAASLDWGKRC----------------- 246
G C D E+ L ++ EYM GS+ D L+ A + R
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 247 ---KIVASNILLNDDFEAKISDFGLA-RLISDCESHVST-VVAGTIGYVPPEYGGTGKAT 301
I +NIL + K+ DFG + RL + C S V GT ++ PE
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 302 ERGDVYSFGVILLELVTGKQP 322
+ DV+S G ++E++T K P
Sbjct: 188 RKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYSF 309
SN+LLN+ KI DFGLAR + +V T+ Y PE G + + D++S
Sbjct: 135 SNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 310 GVILLELVTGKQ 321
G I EL+T K
Sbjct: 194 GCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK---HQNLVELLG 209
+G G +G V+K + G+ AVK + GD +F+ + + MVK H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGD-DFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 210 YCSVDEEKLLVYEYMVKGSLDD--WLRNQAASLDWGKRCK------------------IV 249
E+ + EY GSL D + + L C+ I
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGG---TGKATERGDV 306
+NILL D+ + K++DFG+A I+ + + + GT ++ PE G + D+
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQLCDI 192
Query: 307 YSFGVILLELVTGKQP 322
++ G+ +EL + P
Sbjct: 193 WAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 53/238 (22%), Positives = 103/238 (43%), Gaps = 41/238 (17%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVK--KLSQATGQGDREFAAEMETLGMVKHQNLVELL 208
+G G FG+V +G + + VAVK K++ T +F +E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 209 GYCSVDEEK------LLVYEYMVKGSLDDWL---------------------RNQAASLD 241
G C E +++ +M G L +L + A+ ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 242 W--GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT-IGYVPPEYG 295
+ K + A N +LN++ ++DFGL++ I + + + +A + ++ E
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
T + DV+SFGV + E+ T Q P E+ + + D++ + +Q + LD
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQGNRLKQPPDCLD 241
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 173 VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231
VAVK L + + R +F E++ + +K N++ LL C + ++ EYM G L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 232 WL-RNQA-------------------------------ASLDWGKRCKIVASNILLNDDF 259
+L R++ +SL++ R + N L+ ++
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR-DLATRNCLVGKNY 167
Query: 260 EAKISDFGLAR-LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT 318
KI+DFG++R L S + I ++ E GK T DV++FGV L E++T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 48/212 (22%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELLG- 209
+G G FG V+K + G+ VA+KK+ + A E++ L +KH N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 210 -YCSVDEEK------LLVYEYMVKGSLDDWLRNQAASLDW-GKRC--------------- 246
D+ K +V YM L L N + L +C
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134
Query: 247 -----KIVASNILLNDDFEAKISDFGLARLISDC------------ESHVSTVVAGTIGY 289
I A+NIL+++ KI+DFGLAR + + VV T Y
Sbjct: 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV--TRWY 192
Query: 290 VPPEY-GGTGKATERGDVYSFGVILLELVTGK 320
PPE G + T D++ G + E+ T +
Sbjct: 193 RPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 4/73 (5%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE-RGDVYSF 309
+NILL++ +ISD GLA S + H S GT GY+ PE G A + D +S
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSL 182
Query: 310 GVILLELVTGKQP 322
G +L +L+ G P
Sbjct: 183 GCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 65/256 (25%), Positives = 102/256 (39%), Gaps = 45/256 (17%)
Query: 153 VIGGGGFGTV-FKGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLVELL 208
++G G FG V GK A+K L + E A E L +H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 209 GYCSVDEEKLLVYEYMVKGSL-----------DDWLRNQAA----SLDWGKRCKIV---- 249
+ V EY+ G L +D R A +LD+ KIV
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 250 -ASNILLNDDFEAKISDFGLARL-ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
N++L+ D KI+DFGL + I+D + GT Y+ PE D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
GV++ E++ G+ P F ++D E L + +L +++ P L+A++K +
Sbjct: 180 GLGVVMYEMMCGRLP----FYNQDHEKLFELIL-------MEDIKFPRTLSADAKSLL-- 226
Query: 368 MLQIATGCISNDPTVR 383
+G + DP R
Sbjct: 227 -----SGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 8/103 (7%)
Query: 146 NKFCEENVIGGGGFGTVFKGTM-----PDGK-TVAVKKLSQATGQGDRE-FAAEMETLGM 198
N+ +G G FG V + T D TVAVK L + +RE +E++ L
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 199 V-KHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL 240
+ H N+V LLG C+V L++ EY G L ++LR + S
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 150 EENVIGGGGFGTVFKGTM---PDGKTVAVKKLSQATGQGD-REFAAEMETLGMVKHQNLV 205
+ IG G FGTV K M P G +AVK++ + + + +++ + ++ +
Sbjct: 8 DLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCP 63
Query: 206 ELL---------GYC-------SVDEEKLLVYEYMV-KGSLDDWLRNQAA-----SLDWG 243
++ G C + +K Y Y V K + + + + A +L++
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 244 KR-CKIV-----ASNILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPEYGG 296
K KI+ SNILL+ + K+ DFG++ +L+ +S T AG Y+ PE
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERID 180
Query: 297 TGKATE---RGDVYSFGVILLELVTGKQP 322
R DV+S G+ L E+ TGK P
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 1/79 (1%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGV 311
N++L+ D KI+DFG+ + ++ ST GT Y+ PE K T D +SFGV
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 312 ILLELVTGKQPTGPEFEDK 330
+L E++ G+ P + ED+
Sbjct: 185 LLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 4/73 (5%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE-RGDVYSF 309
+NILL++ +ISD GLA S + H S GT GY+ PE G A + D +S
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYDSSADWFSL 182
Query: 310 GVILLELVTGKQP 322
G +L +L+ G P
Sbjct: 183 GCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 16/120 (13%)
Query: 252 NILLNDDFEAKISDFGLAR--LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSF 309
NILL+ D KI+DFG+ + ++ D ++ GT Y+ PE K D +SF
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQKYNTSVDWWSF 182
Query: 310 GVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKML 369
GV+L E++ G+ P F D E L + + D P L +K ++K+
Sbjct: 183 GVLLYEMLIGQSP----FHGHDEEELFQSI-------RMDNPCYPRWLTREAKDILVKLF 231
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 53/199 (26%), Positives = 79/199 (39%), Gaps = 31/199 (15%)
Query: 153 VIGGGGFGTV-FKGTMPDGKTVAVKKLS--QATGQGDREFA-AEMETLGMVKHQNLVELL 208
VIG G FG V K A+K LS + + D F E + + +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108
Query: 209 GYCSVDEEKLL--VYEYMVKGSLDDWLRNQAASLDWGK--RCKIVAS------------- 251
+C+ ++K L V EYM G L + + N W K ++V +
Sbjct: 109 -FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167
Query: 252 ----NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY----GGTGKATER 303
N+LL+ K++DFG + + GT Y+ PE GG G
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 304 GDVYSFGVILLELVTGKQP 322
D +S GV L E++ G P
Sbjct: 228 CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 64/265 (24%), Positives = 102/265 (38%), Gaps = 43/265 (16%)
Query: 148 FCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLS---QATGQGDREFAAEMETLGMVKHQN 203
F E IG G F V++ T + D K VA+KK+ + ++ E++ L + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN---------------------QAASLDW 242
+++ L D E +V E G L ++ A
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 243 GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
+R I +N+ + K+ D GL R S + ++V GT Y+ PE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
+ D++S G +L E+ + P + DK NL K EQ D P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPF---YGDK--MNLFSLC---QKIEQCD--YPPLPTEH 232
Query: 360 NSKPTMLKMLQIATGCISNDPTVRP 384
S+ K+ ++ + CI DP RP
Sbjct: 233 YSE----KLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 58/272 (21%), Positives = 107/272 (39%), Gaps = 63/272 (23%)
Query: 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAV---KKLSQATGQGDREFAAEMETLGMVKHQN 203
K ++N I G F + K V + KK + E++ L + N
Sbjct: 29 KENDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNN 79
Query: 204 LVELLGY---CSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR-------CK----- 247
++++ G+ D +L L+ EY +G L + L + L + + CK
Sbjct: 80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNL 138
Query: 248 ----------IVASNILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGG 296
+ + + L+ ++++ KI GL +++S +V+ +V Y +
Sbjct: 139 YKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLN 193
Query: 297 T--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
+ T + D+YS GV+L E+ TGK P FE+ + + D ++ N+ L
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGKIP----FENLTTKEIYD----LIINKNNSLKLPL 245
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
P +K I C S+D RP +
Sbjct: 246 ------DCPLEIK--CIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 48/254 (18%)
Query: 164 KGTMPDGKTVAVKKLSQATGQGDREFA-AEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222
+G+ P K VA K + +A +E+ L H +V+ D++ LL+ E
Sbjct: 88 RGSDPKEKVVA--KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145
Query: 223 YMVKGSLDDWLRNQ-------------------AASLD-WGKRC----KIVASNILLNDD 258
Y G L+ ++ + +LD R + ++NI L
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 259 FEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELV 317
K+ DFG ++ SD S V++ GT Y+ PE + +++ D++S GVIL EL+
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 318 TGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCIS 377
T +P F+ ++ VL+ DP +S M + +S
Sbjct: 266 TLHRP----FKGPSQREIMQQVLYGK--------YDPFPCPVSS-----GMKALLDPLLS 308
Query: 378 NDPTVRPT---MLH 388
+P +RPT +LH
Sbjct: 309 KNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 45/175 (25%), Positives = 68/175 (38%), Gaps = 42/175 (24%)
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSL---------------DDWLRNQAASLDWGKRCK 247
N+V L Y ++ LV ++ G L W +LD R
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 248 IVA-----SNILLNDDFEAKISDFGLARLISD--CESHVSTVVAGTIGYVPPEYGGTGKA 300
IV +NILL+D +++ F + D V + Y PE GG +
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVGGISEE 159
Query: 301 TERGDVYSFGVILLELVTGK-----QPTG---------PEFEDKDGENLVDWVLH 341
TE D +S G IL EL+TGK P+G PE+ ++ +L+ +L
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQ 214
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 154 IGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEM---ETLGMVKHQNLVELLG 209
+G GGFG V M GK A KKL++ + + + M L V + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRN---QAASLDWGKRC----------------KIV- 249
+ LV M G L + N + + C +I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
N+LL++D +ISD GLA + D +S AGT G++ PE + D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG-YAGTPGFMAPELLQGEEYDFSVD 179
Query: 306 VYSFGVILLELVTGKQP---TGPEFEDKD 331
++ GV L E++ + P G + E+K+
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKE 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 32/170 (18%)
Query: 229 LDDWLR---NQAASLDW--GKRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVS 280
LDD LR A +D+ K C + A N+LL D AKI DFGLAR D + +
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSN 267
Query: 281 TVVAGT----IGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENL 335
VV G + ++ PE T + DV+S+G++L E+ + GK P + +
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
Query: 336 VDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
V M + + A ++ I C + +PT RPT
Sbjct: 328 VKRGYQMSRPDFA----------------PPEIYSIMKMCWNLEPTERPT 361
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 50/182 (27%), Positives = 71/182 (39%), Gaps = 36/182 (19%)
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC---KIVASNILLNDDFEAKISDFGL 268
++D E LL + Y V + S K C + A NILL KI DFGL
Sbjct: 210 ALDTEDLLSFSYQVA---------KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 269 ARLISDCESHVSTVVAGT----IGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPT 323
AR D + + VV G + ++ PE T DV+S+G++L E+ + G P
Sbjct: 261 AR---DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
Query: 324 GPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVR 383
D ++ M+ E A P+ +M I C DP R
Sbjct: 318 PGMPVDSKFYKMIKEGYRMLSPECA-----PS-----------EMYDIMKSCWDADPLKR 361
Query: 384 PT 385
PT
Sbjct: 362 PT 363
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 50/204 (24%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G +G+V D KT VAVKKLS Q+ R + E+ L +KH+N++ L
Sbjct: 25 VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 81
Query: 208 LGYCSVD---EEKLLVY--EYMVKGSLDDWLRNQAAS--------------LDWGKRCKI 248
L + EE VY +++ L++ ++ Q + L + I
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-------YGG 296
+ SN+ +N+D E KI DFGLAR D ++ VA T Y PE Y
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVA-TRWYRAPEIMLNWMHYNQ 197
Query: 297 TGKATERGDVYSFGVILLELVTGK 320
T D++S G I+ EL+TG+
Sbjct: 198 T------VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 26/195 (13%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLVELLGYC 211
+G G G VFK + P G +A K + R + E++ L +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQAASLD--WGK--------------RCKIV-----A 250
D E + E+M GSLD L+ + GK + KI+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 132
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
SNIL+N E K+ DFG++ + D ++ GT Y+ PE + + D++S G
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 311 VILLELVTGKQPTGP 325
+ L+E+ G+ P P
Sbjct: 190 LSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 41/180 (22%), Positives = 76/180 (42%), Gaps = 38/180 (21%)
Query: 192 EMETLGMVKHQNLVELLGYCSVDEEKLL--VYEYMVKGSLDDWLRNQA------------ 237
E L V H ++ L + + +++ L + EY+ G L +LRN
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 238 ---ASLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289
+L++ +IV NILL+ + K++DFG A+ + D + + GT Y
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----RTWTLCGTPEY 164
Query: 290 VPPEY---GGTGKATERGDVYSFGVILLELVTGKQP----TGPEFEDKDGENLVDWVLHM 342
+ PE G KA D ++ G+++ E++ G P +K +++ H+
Sbjct: 165 LAPEVIQSKGHNKAV---DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 47/228 (20%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKK-LSQATGQGDREFA-AEMETLGMVKHQN-LVELLG 209
IG G +G V+K GK VA+KK + +G A E+ L M+ +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 210 YCSVDEEK-----LLVYEYM---VKGSLDDWLRNQAASLDWG-------KRCKIVA---- 250
V+E+ LV+EY+ +K +D R L + K VA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 251 ----------SNILLNDDFEA-KISDFGLARLIS-DCESHVSTVVAGTIGYVPPE--YGG 296
N+L++ KI+D GL R S +S+ +V T+ Y PE G
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRAPEVLLGS 186
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
T +T D++S G I E+ KQP P G++ + +LH+ K
Sbjct: 187 THYSTPV-DIWSVGCIFAEMSR-KQPLFP------GDSELQQLLHIFK 226
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 40/140 (28%), Positives = 59/140 (42%), Gaps = 18/140 (12%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG-TIGYVPPEYGGTGKATERGDV 306
+ A NILL+++ KI DFGLAR I +V A + ++ PE T + DV
Sbjct: 199 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDV 258
Query: 307 YSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
+SFGV+L E+ + G P D++ + M E A
Sbjct: 259 WSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATP--------------- 303
Query: 366 LKMLQIATGCISNDPTVRPT 385
++ I C N+P RPT
Sbjct: 304 -EIYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
SNIL+N E K+ DFG++ + D ++ GT Y+ PE + + D++S G
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 311 VILLELVTGKQPTGP----EFEDKDGENLVD 337
+ L+EL G+ P P E E G +VD
Sbjct: 190 LSLVELAIGRYPIPPPDAKELEAIFGRPVVD 220
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 51/215 (23%)
Query: 152 NVIGGGGFGTVFKGTMPDGKT-----VAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
+++ G FG +F G + D K V VK + + E L + HQN++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 206 ELLGYCSVDEEKLLV-YEYMVKGSLDDWLRN---------QAAS--------------LD 241
+L C D E V Y YM G+L +L+ QA S +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 242 WGKRCKIV-----ASNILLNDDFEAKISDFGLAR--------LISDCESHVSTVVAGTIG 288
+ + ++ A N +++++ + KI+D L+R + D E+ +
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-------PVK 184
Query: 289 YVPPEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
++ E + + DV+SFGV+L EL+T G+ P
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 47/202 (23%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGD-----REFAAEMETLGMVKHQNLVEL 207
+G G FG+V+ + G+ VA+KK+ + + RE + + + +H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRK---LNEHPNIVKL 63
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK-----IVAS----------- 251
++E V+EYM +G+L ++++ + I+
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122
Query: 252 ------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-------YGGTG 298
N+L++ KI+DFGLAR I + T T Y PE Y
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEILLRSTSY---- 176
Query: 299 KATERGDVYSFGVILLELVTGK 320
+ D+++ G I+ EL T +
Sbjct: 177 --SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 68/286 (23%), Positives = 101/286 (35%), Gaps = 75/286 (26%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDR---EFAAEMETLGMVKHQNLVELLG 209
IG GG G V+ P + VA+KK+ + + F E + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 210 YCSVDEEKLLVYEYM--VKG-SLDDWLRN--QAASLD---------------WGKRCKIV 249
CS + VY M ++G +L L++ Q SL + K C +
Sbjct: 70 ICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 250 A--------------SNILLNDDFEAKISDFGLARLISDCE--------------SHVST 281
NILL E I D+G A E T
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 282 V---VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338
+ + GT Y+ PE A+E D+Y+ GVIL +++T P + K G +
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP----YRRKKGRKISY- 241
Query: 339 VLHMMKNEQADEVLDPA-VLNANSKPTMLKMLQIATGCISNDPTVR 383
D +L P V P L QIA ++ DP R
Sbjct: 242 ---------RDVILSPIEVAPYREIPPFLS--QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 51/217 (23%)
Query: 147 KFCEENVIGGGGFGTVFKG---TMPDGKTVAVKKLSQATGQGD-------REFAAEMETL 196
K+ E IG G +G V+K DGK A+KK Q RE A E
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE-- 58
Query: 197 GMVKHQNLVELLGYCSVDEEKL--LVYEY-----------------------MVKGSLDD 231
+KH+N+V L+ +K L+++Y MVK SL
Sbjct: 59 --LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLW 115
Query: 232 WLRNQAASL--DWGKRCKIVASNILLNDDFEA----KISDFGLARLISD---CESHVSTV 282
+ N L +W + +NIL+ + KI D GLARL + + + V
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 283 VAGTIGYVPPE-YGGTGKATERGDVYSFGVILLELVT 318
V TI Y PE G T+ D+++ G I EL+T
Sbjct: 176 VV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 52/205 (25%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G +G+V D + VAVKKLS Q+ R + E+ L +KH+N++ L
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79
Query: 208 LGY----CSVDE--EKLLVYEYMVKGSLDDWLRNQAAS--------------LDWGKRCK 247
L S++ E LV M L++ ++ Q S L +
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 248 IV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-------YG 295
I+ SN+ +N+D E +I DFGLAR D ++ VA T Y PE Y
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVA-TRWYRAPEIMLNWMHYN 194
Query: 296 GTGKATERGDVYSFGVILLELVTGK 320
T D++S G I+ EL+ GK
Sbjct: 195 QT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 16/141 (11%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGV 311
NILL+ + K++DFG+ + +T GT Y+ PE + D ++ GV
Sbjct: 126 NILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184
Query: 312 ILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS----KPTMLK 367
++ E++ G+ P FE + ++L + +LH D+VL P L+ + K M K
Sbjct: 185 LMYEMMAGQ----PPFEADNEDDLFESILH-------DDVLYPVWLSKEAVSILKAFMTK 233
Query: 368 MLQIATGCISNDPTVRPTMLH 388
GC+++ H
Sbjct: 234 NPNKRLGCVASQGGEDAIKQH 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 45/222 (20%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G +GTV D +T VA+KKL Q+ R + E+ L +KH+N++ L
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGL 79
Query: 208 LGYCSVDEE-------------------KLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI 248
L + D KL+ +E + + + + L + I
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGI 139
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY-GGTGKATE 302
+ N+ +N+D E KI DFGLAR +S ++ V T Y PE T+
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAPEVILNWMHYTQ 195
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
D++S G I+ E++TGK P F+ G + +D ++ +MK
Sbjct: 196 TVDIWSVGCIMAEMLTGK----PLFK---GHDHLDQLMEIMK 230
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 21/92 (22%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHV-----STVVAGTIGYVPPE---YGGTGKATER 303
N++L+ + KI+DFG+ C+ ++ + GT Y+ PE Y GK+
Sbjct: 131 NVMLDAEGHIKIADFGM------CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV-- 182
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
D ++FGV+L E++ G+ P F+ +D + L
Sbjct: 183 -DWWAFGVLLYEMLAGQPP----FDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 153 VIGGGGFGTVFKGTMPD-GK-----TVAVKKLSQATGQGDREFAAEMETLGMV----KHQ 202
+G G FG V + T GK VAVK L +A+ D E A M L ++ +H+
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTD-EREALMSELKILSHLGQHK 102
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQA 237
N+V LLG C+ L++ EY G L ++LR +A
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 55/257 (21%), Positives = 104/257 (40%), Gaps = 46/257 (17%)
Query: 153 VIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEM---ETLGMVKHQNLVELL 208
V+G G FG V + G+ AVK L + D + M L + ++ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 209 GYCSVDEEKLL-VYEYMVKGSLDDWLRNQAASLDWGKRCKIVAS---------------- 251
C ++L V E++ G L ++ ++ D + A
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 252 -----NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
N+LL+ + K++DFG+ + ++ GT Y+ PE D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
++ GV+L E++ G P FE ++ ++L + +L+ DEV+ P L+ ++
Sbjct: 180 WAMGVLLYEMLCGHAP----FEAENEDDLFEAILN-------DEVVYPTWLSQDA----- 223
Query: 367 KMLQIATGCISNDPTVR 383
+ I ++ +PT+R
Sbjct: 224 --VDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 56/201 (27%), Positives = 80/201 (39%), Gaps = 35/201 (17%)
Query: 153 VIGGGGFGTV----FKGTMPDGKTVAVKKLS--QATGQGDREFAAEMETLGMVKHQNLVE 206
VIG G FG V K T K A+K LS + + D F E + + V
Sbjct: 50 VIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGK--RCKIVAS------------ 251
L Y D+ L +V EYM G L + + N W + ++V +
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 166
Query: 252 -----NILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPEY----GGTGKAT 301
N+LL+ K++DFG ++ + T V GT Y+ PE GG G
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG 225
Query: 302 ERGDVYSFGVILLELVTGKQP 322
D +S GV L E++ G P
Sbjct: 226 RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 42/193 (21%), Positives = 78/193 (40%), Gaps = 25/193 (12%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS 212
IG G +G V+K + G+ A+K + G+ E+ + KH N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 213 VDEEKLLVYEYMVKGSLDD--WLRNQAASLDWGKRCK------------------IVASN 252
++ + E+ GSL D + + + I +N
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGAN 136
Query: 253 ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT---GKATERGDVYSF 309
ILL D+ K++DFG++ I+ + + + GT ++ PE G + D+++
Sbjct: 137 ILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLCDIWAV 195
Query: 310 GVILLELVTGKQP 322
G+ +EL + P
Sbjct: 196 GITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 60/215 (27%), Positives = 85/215 (39%), Gaps = 32/215 (14%)
Query: 153 VIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDRE---FAAEMETL-GMVKHQNLVEL 207
VIG G FG V DGK AVK L + +E AE L VKH LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 208 LGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV-- 249
Y +KL V +Y+ G L L+ + A++L + I+
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
NILL+ ++DFGL + + ST GT Y+ PE D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
+ G +L E++ G P F +D + D +L+
Sbjct: 180 WCLGAVLYEMLYGL----PPFYSRDTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 40/201 (19%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLS-QATGQGDREFAA-EMETLGMVKHQNLVELLGY 210
IG G +G V+KG G+ VA+KK+ ++ +G A E+ L ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC--KIVAS----------------- 251
+ L++E++ S+D L+ SL G+ ++V S
Sbjct: 68 LMQESRLYLIFEFL---SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--YGGTGKAT 301
N+L+++ K++DFGLAR V T T+ Y PE G +T
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 302 ERGDVYSFGVILLELVTGKQP 322
D++S G I E+ T K+P
Sbjct: 182 PV-DIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 30/210 (14%)
Query: 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVELLG 209
+G GG+G VF D G+ VA+K++ ++ R E + L K + LV+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR-------CKIVA----------- 250
Y D+E L L EY+ G L N + R + A
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 251 --SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
N L++ K++DFGL+ ++ ++VV G+ Y+ PE D +S
Sbjct: 128 KPENFLIDASGHIKLTDFGLS---KGIVTYANSVV-GSPDYMAPEVLRGKGYDFTVDYWS 183
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDW 338
G +L E + G P ++ ENL W
Sbjct: 184 LGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 58/199 (29%), Positives = 82/199 (41%), Gaps = 38/199 (19%)
Query: 153 VIGGGGFGTVFKG-TMPDGKTVAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVELL 208
IG G G V G+ VA+KKLS Q R + E+ + +V H+N++ LL
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLL 81
Query: 209 GYC----SVDE--EKLLVYEYM-------VKGSLDDWLRNQAASLDWGKRCKI------- 248
S++E + LV E M ++ LD + + L + C I
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD---HERMSYLLYQMLCGIKHLHSAG 138
Query: 249 ------VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY-GGTGKAT 301
SNI++ D KI DFGLAR VV T Y PE G G
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMG-YK 195
Query: 302 ERGDVYSFGVILLELVTGK 320
E D++S G I+ E++ G
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 42/141 (29%), Positives = 62/141 (43%), Gaps = 20/141 (14%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG-TIGYVPPEYGGTGKATERGDV 306
+ A NILL+++ KI DFGLAR I +V A + ++ PE T + DV
Sbjct: 200 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDV 259
Query: 307 YSFGVILLELVT-GKQP-TGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
+SFGV+L E+ + G P G + ++ + L D +A E P +
Sbjct: 260 WSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-----RMRAPENATPEI-------- 306
Query: 365 MLKMLQIATGCISNDPTVRPT 385
+I C DP RPT
Sbjct: 307 ----YRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 51/218 (23%)
Query: 147 KFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
++ + +G G G VF D K VAVKK+ Q + E++ + + H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 206 ---ELLGYCSVDEEKLL-----------VYEYMVKGSLDDWLRNQAASLDWGKR------ 245
E+LG D + + V EYM + L + L S + +
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLL 124
Query: 246 --CKIVAS-----------NILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIG--Y 289
K + S N+ +N +D KI DFGLAR++ SH + G + Y
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 290 VPPE-------YGGTGKATERGDVYSFGVILLELVTGK 320
P Y T+ D+++ G I E++TGK
Sbjct: 185 RSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 17/87 (19%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHV-----STVVAGTIGYVPPE---YGGTGKATER 303
N++L+ + KI+DFG+ C+ H+ + GT Y+ PE Y GK+
Sbjct: 131 NVMLDSEGHIKIADFGM------CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV-- 182
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDK 330
D +++GV+L E++ G+ P E ED+
Sbjct: 183 -DWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 69/231 (29%)
Query: 147 KFCEE-------NVIGGGGFGTVFKG-TMPDGKTVAVKKLSQATGQGDREFAA------- 191
FC+E IG G FG VFK + VA+KK+ + E
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALR 60
Query: 192 EMETLGMVKHQNLVELLGYCSVDEEK--------LLVYEY------------MVKGSLDD 231
E++ L ++KH+N+V L+ C LV+E+ VK +L +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 232 ---WLRNQAASLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLIS-----DCESH 278
++ L + R KI+ A+NIL+ D K++DFGLAR S +
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 279 VSTVVAGTIGYVPPE-------YGGTGKATERGDVYSFGVILLELVTGKQP 322
+ VV T+ Y PPE YG D++ G I+ E+ T + P
Sbjct: 181 TNRVV--TLWYRPPELLLGERDYG------PPIDMWGAGCIMAEMWT-RSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 21/133 (15%)
Query: 252 NILLNDDFEAKISDFGLARL-ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
N++L+ D KI+DFGL + ISD + + T GT Y+ PE D + G
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISD-GATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 311 VILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQ 370
V++ E++ G+ P F ++D E L + +L +E+ P L+ +K +
Sbjct: 183 VVMYEMMCGRLP----FYNQDHERLFELIL-------MEEIRFPRTLSPEAKSLL----- 226
Query: 371 IATGCISNDPTVR 383
G + DP R
Sbjct: 227 --AGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 43/211 (20%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQ----ATGQGD--REFAAEMETLGMVKHQNLV 205
+G G F + ++ + G +AVK+++ ++ Q + E+ + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA---------------SLDWGKRCKIV- 249
+LG D L E+M GS+ L A L + +I+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 250 ----ASNILLNDDFE-AKISDFGLA-RLISDCE--SHVSTVVAGTIGYVPPE------YG 295
+N+L++ + +I+DFG A RL + + GTI ++ PE YG
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPE 326
DV+S G +++E+ T K P E
Sbjct: 187 ------RSCDVWSVGCVIIEMATAKPPWNAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 151 ENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQ-ATGQGDREFAAEMETLGMVKHQ- 202
+G G FG V + + +TVAVK L + AT + E++ L + H
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71
Query: 203 NLVELLGYCSVDEEKLLV-YEYMVKGSLDDWLR 234
N+V LLG C+ L+V EY G+L ++LR
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 33/138 (23%), Positives = 54/138 (39%), Gaps = 25/138 (18%)
Query: 219 LVYEYMVKGSL-----------DDWLRNQAASL-----DWGKRC----KIVASNILLNDD 258
LV EY+ G +DW + A + D +R I N+L++
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133
Query: 259 FEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT 318
K++DFGL+R + GT Y+ PE + D +S G ++ E +
Sbjct: 134 GHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188
Query: 319 GKQPTGPEFEDKDGENLV 336
G P E D +N++
Sbjct: 189 GYPPFHAETPDAVFDNIL 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 25/135 (18%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKATERGDVYS 308
N+LL+ + KI+DFG+ + ++ GT Y+ PE Y G A D ++
Sbjct: 126 NVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEILSYQPYGPAV---DWWA 181
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368
GV+L E++ G+ P FE D + L +L DEV P L SK
Sbjct: 182 LGVLLYEMLAGQSP----FEGDDEDELFQSILE-------DEVRYPRWL---SKEAK--- 224
Query: 369 LQIATGCISNDPTVR 383
I ++ +P R
Sbjct: 225 -SILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 9/83 (10%)
Query: 252 NILLNDDFEAKISDFGLARLISDCESHVST-VVAGTIGYVPPE---YGGTGKATERGDVY 307
N++L+ + KI+DFG+ + + V+T GT Y+ PE Y GK+ D +
Sbjct: 131 NVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV---DWW 185
Query: 308 SFGVILLELVTGKQPTGPEFEDK 330
+FGV+L E++ G+ P E ED+
Sbjct: 186 AFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 43/147 (29%), Positives = 64/147 (43%), Gaps = 26/147 (17%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT----IGYVPPEYGGTGKATER 303
+ A N+LL KI DFGLAR I ++VS G+ + ++ PE T
Sbjct: 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GSTFLPVKWMAPESIFDNLYTTL 319
Query: 304 GDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQA-DEVLDPAVLNANS 361
DV+S+G++L E+ + G P D N + M K + A EV D
Sbjct: 320 SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYD-------- 371
Query: 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388
M+K C +++P RP+ LH
Sbjct: 372 --IMVK-------CWNSEPEKRPSFLH 389
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 72/283 (25%), Positives = 115/283 (40%), Gaps = 87/283 (30%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVELLG 209
+G G +G+V G+ VA+KKLS Q+ R + E+ L ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 210 -------------------YCSVD----------EEKL--LVYEYMVKGSLDDWLRNQAA 238
Y D E+K+ LVY+ M+ G L+ +
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ-MLCG-----LKYIHS 135
Query: 239 SLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE----- 293
+ + K N+ +N+D E KI DFGLAR +D E V T Y PE
Sbjct: 136 AGIIHRDLK--PGNLAVNEDCELKILDFGLARH-ADAEMTGYVV---TRWYRAPEVILNW 189
Query: 294 --YGGTGKATERGDVYSFGVILLELVTGK----------QPT---------GPEF----E 328
Y + D++S G I+ E++TGK Q T GPEF E
Sbjct: 190 MHY------NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
Query: 329 DKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQI 371
DK ++ + + + + + L P + + + KML++
Sbjct: 244 DKAAKSYIKSLPKYPRKDFS--TLFPKA-SPQAVDLLEKMLEL 283
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 153 VIGGGGFGTVFKGTM------PDGKTVAVKKLSQ-ATGQGDREFAAEMETLGMV-KHQNL 204
V+G G FG V + + TVAVK L + AT + +E++ L + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 205 VELLGYCSVDEEKLLV-YEYMVKGSLDDWLR 234
V LLG C+ L+V E+ G+L ++LR
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 59/198 (29%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 154 IGGGGFGTV---FKGTMPDGKTVAVKKLS---QATGQGDREFAAEMETLGMVKHQNLVEL 207
IG G G V F + G VAVKKLS Q R + E+ L V H+N++ L
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85
Query: 208 LGYCSVD------EEKLLVYEYM-------VKGSLDDWLRNQAASLDWGKRCKI------ 248
L + ++ LV E M + LD + + L + C I
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD---HERMSYLLYQMLCGIKHLHSA 142
Query: 249 -------VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKAT 301
SNI++ D KI DFGLAR + C + + T T Y PE
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYK 200
Query: 302 ERGDVYSFGVILLELVTG 319
E D++S G I+ ELV G
Sbjct: 201 ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 60/215 (27%), Positives = 85/215 (39%), Gaps = 32/215 (14%)
Query: 153 VIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDRE----FAAEMETLGMVKHQNLVEL 207
VIG G FG V DG AVK L + T +E A L +KH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 208 LGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV-- 249
Y EKL V +Y+ G L L+ + A+++ + I+
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDV 306
NILL+ ++DFGL + + E ST GT Y+ PE D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
+ G +L E++ G P F +D + D +LH
Sbjct: 180 WCLGAVLYEMLYGL----PPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 6/76 (7%)
Query: 251 SNILLNDDFEAKISDFGLARLIS----DCESHVSTVVAGTIGYVPPEYGGT-GKATERGD 305
SN+L+N+D E +I DFG+AR +S + + ++ VA T Y PE + + T D
Sbjct: 136 SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAPELLLSLPEYTTAID 194
Query: 306 VYSFGVILLELVTGKQ 321
++S G I E++ +Q
Sbjct: 195 MWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 42/206 (20%)
Query: 153 VIGGGGFGTVFKGTMPDGKTV-AVKKLSQATGQGDREFAAEMETLGMVKHQNL------- 204
VIG G FG V M + + A+K L++ E ET + +N+
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKW------EMLKRAETACFREERNVLVNGDCQ 61
Query: 205 -VELLGYCSVDEEKL-LVYEYMVKGSL-------DDWLRNQAASLDWGKRCKIVAS---- 251
+ L Y DE L LV +Y V G L +D L A + + S
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 252 ----------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY-----GG 296
N+LL+ + +++DFG ++ + S+V GT Y+ PE G
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 297 TGKATERGDVYSFGVILLELVTGKQP 322
GK D +S GV + E++ G+ P
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 21/133 (15%)
Query: 252 NILLNDDFEAKISDFGLARL-ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310
N++L+ D KI+DFGL + I D GT Y+ PE D + G
Sbjct: 126 NLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 311 VILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQ 370
V++ E++ G+ P F ++D E L + +L +E+ P L+ +K +
Sbjct: 184 VVMYEMMCGRLP----FYNQDHEKLFELIL-------MEEIRFPRTLSPEAKSLL----- 227
Query: 371 IATGCISNDPTVR 383
+G + DP R
Sbjct: 228 --SGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG-TIGYVPPEYGGTGKATERGDV 306
+ A NILL+++ KI DFGLAR I +V A + ++ PE T + DV
Sbjct: 205 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 264
Query: 307 YSFGVILLELVT-GKQP 322
+SFGV+L E+ + G P
Sbjct: 265 WSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 36/197 (18%)
Query: 154 IGGGGFGTVFKG-TMPDGKTVAVKKLS-QATGQGDREFAA-EMETLGMVKHQNLVELLGY 210
IG G +G V+K G+ VA+KK+ + +G A E+ L + H N+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 211 CSVDEEKLLVYEYMVKGSLD-----DWLRNQAASLDWGKR-----CKIVA---------- 250
+ + LV+E++ LD D K + +A
Sbjct: 67 VHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123
Query: 251 ----SNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE--YGGTGKATER 303
N+L++ + K++DFGLAR ++ VV T+ Y PE G +T
Sbjct: 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYSTPV 181
Query: 304 GDVYSFGVILLELVTGK 320
D++S G I E+V +
Sbjct: 182 -DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 63/244 (25%), Positives = 85/244 (34%), Gaps = 82/244 (33%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQAT----GQGDREFAAEMETLGMVK 200
+ F VIG G FG V+ D G+ A+K L ++ Q AE + L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 201 HQNLVELLGYCSV-DEEKL-LVYEYMVKGSL-----------DDWLR----------NQA 237
+V+L Y S DEE L LV EYM G L ++ R +
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 238 ASLDWGKRCKIVASNILLNDDFEAKISDFGLA---------------------------- 269
L + R I NIL++ D K++DFGL
Sbjct: 118 HKLGFIHR-DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 270 -----RLISDCESHVSTVVAGTIGYVPPE------YGGTGKATERGDVYSFGVILLELVT 318
+ S V GT Y+ PE YG D +S GVIL E++
Sbjct: 177 RRDHKQRRVRANSTV-----GTPDYIAPEVLRGTPYG------LECDWWSLGVILYEMLY 225
Query: 319 GKQP 322
G P
Sbjct: 226 GFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 58/211 (27%), Positives = 81/211 (38%), Gaps = 34/211 (16%)
Query: 154 IGGGGFGTV----FKGTMPDGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVE 206
+G GGFG V K T GK A KKL + + G++ E E L V +V
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRN-------------QAASLDWG----KRCKIV 249
L LV M G L + N +A + G IV
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
N+LL+D ++SD GLA + D ++ T AGT GY+ PE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
D ++ G + E+V G+ P E E L
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 4 LPNLLYLNLADNRLEGEVPRS--GICQNLSIMSLTGNKDLCGKIMGSDCKILTFGKLALV 61
L +L LNL N L G VP + G + + + T N LCG I G A +
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACGPHLSVGAKI 547
Query: 62 GIVVG-SVLVIAIIVSVLWWWIQRSN 86
GI G SV + +++ + WW +R N
Sbjct: 548 GIAFGVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 388 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.63 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.61 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.59 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.59 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.54 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.51 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.51 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.46 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.45 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.37 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.36 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.32 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.22 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.18 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.88 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.64 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.56 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.36 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.06 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 96.89 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 96.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.81 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 96.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.15 | |
| PF13504 | 17 | LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO | 95.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 95.89 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 95.47 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 95.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 94.97 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 94.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 94.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 94.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 94.15 | |
| smart00369 | 26 | LRR_TYP Leucine-rich repeats, typical (most popula | 94.03 | |
| smart00370 | 26 | LRR Leucine-rich repeats, outliers. | 94.03 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 93.64 | |
| PF13516 | 24 | LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI | 93.6 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 93.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 92.55 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 92.33 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 91.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.58 | |
| smart00364 | 26 | LRR_BAC Leucine-rich repeats, bacterial type. | 89.55 | |
| smart00368 | 28 | LRR_RI Leucine rich repeat, ribonuclease inhibitor | 89.06 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 88.26 | |
| smart00365 | 26 | LRR_SD22 Leucine-rich repeat, SDS22-like subfamily | 88.19 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 87.97 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 87.4 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 86.94 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 86.76 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=385.65 Aligned_cols=256 Identities=47% Similarity=0.847 Sum_probs=218.8
Q ss_pred CcccccHHHHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEE
Q 035768 132 SLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211 (388)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 211 (388)
....|+++++..||++|...+.||+|+||.||+|.+++|..||||++.........+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34679999999999999999999999999999999999999999988765433155699999999999999999999999
Q ss_pred EeCC-eeEEEEeccCCCCHHHHHhccCC-CCCHHhh------------------------hccccCCeeecCCCCEEEcc
Q 035768 212 SVDE-EKLLVYEYMVKGSLDDWLRNQAA-SLDWGKR------------------------CKIVASNILLNDDFEAKISD 265 (388)
Q Consensus 212 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~------------------------~~i~~~NiLl~~~~~~kl~D 265 (388)
.+.+ +.+||||||++|+|.++|+.... .|+|..| +||+++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999987665 6777553 46779999999999999999
Q ss_pred cccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc
Q 035768 266 FGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN 345 (388)
Q Consensus 266 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 345 (388)
||+|+..........+...||.+|+|||+...+..+.|+|||||||+|+||+||+.|.+... ......+.+|+...+..
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHHC
Confidence 99997654311111111179999999999999999999999999999999999998876432 23445599999999988
Q ss_pred ccccccCCcccc-CCCCH-HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 EQADEVLDPAVL-NANSK-PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+++||.+. ..... .++.++..++.+|++.+|.+||+|.|
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 899999999987 44443 68889999999999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=356.39 Aligned_cols=222 Identities=33% Similarity=0.523 Sum_probs=182.8
Q ss_pred CCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 148 FCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
+...+.||+|.||.||.|.+.....||+|.++... ...++|.+|+++|++|+|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34467899999999999999887899999997653 34568999999999999999999999999988999999999999
Q ss_pred CHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 228 SLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 228 ~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
+|.+||+.. +.++.|+. |+|++++|||++++..+||+|||+|+...++.+.......-
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf 366 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF 366 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence 999999852 23445554 56889999999999999999999999776666555554455
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|.|||.+..++++.|||||||||+||||+| |+.||..+ +..++++.+.+..+-.... .+
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m----sn~ev~~~le~GyRlp~P~-------------~C 429 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM----SNEEVLELLERGYRLPRPE-------------GC 429 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC----CHHHHHHHHhccCcCCCCC-------------CC
Confidence 779999999999999999999999999999999 99996543 4455555555444333222 23
Q ss_pred HHHHHHHHHhcccCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+..+.++|..||+.+|++|||++
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHH
Confidence 34799999999999999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.72 Aligned_cols=238 Identities=29% Similarity=0.531 Sum_probs=187.4
Q ss_pred ccHHHHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 035768 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD 214 (388)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 214 (388)
++++++. ..|...++||+|+||.||+|.. .++..||||+++..... ...|++.+++++|||||+++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3444444 3467788999999999999996 57899999998754322 23568899999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhc------------cCCCCCHHh--------hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRN------------QAASLDWGK--------RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~------------~~~~l~~~~--------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
+..++||||+++|+|.++++. .+.++.|+| |+||+|+||+++.++.+++. ||.+.....
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999999999998853 234677777 46899999999999988876 666544321
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
. ....||+.|+|||++....++.++|||||||++|||+||+.||+..+. ....+.+|.+..........++|+
T Consensus 835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCc
Confidence 1 123578999999999999999999999999999999999999865433 345677787665555445556666
Q ss_pred cccC--CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLN--ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~--~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. ....++..++.+++.+||+.||++||||.|
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 5533 234567778999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.22 Aligned_cols=226 Identities=30% Similarity=0.487 Sum_probs=182.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
.+....+.||+|+||+||+|+.. +.+.||||.++..... ...+|.+|++++..++|||||+|+|+|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455678999999999999853 3567999999876655 6778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhccCC-------------CCC----------------HH-----hhhccccCCeeecCCCCEEEc
Q 035768 219 LVYEYMVKGSLDDWLRNQAA-------------SLD----------------WG-----KRCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~~-------------~l~----------------~~-----~~~~i~~~NiLl~~~~~~kl~ 264 (388)
||+|||..|||.+||+-... .|. |+ .|+|++.+|+|+.++..+||+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEec
Confidence 99999999999999973211 122 22 167999999999999999999
Q ss_pred ccccceeccCCCcceee-ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHh
Q 035768 265 DFGLARLISDCESHVST-VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
|||++|.....+++... ...-+.+|||||.+..++||++||||||||+|||++| |+.||+.. ..++.++.++.
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl----Sn~EVIe~i~~- 720 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL----SNQEVIECIRA- 720 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc----chHHHHHHHHc-
Confidence 99999987665554332 2334679999999999999999999999999999999 99998653 44555554433
Q ss_pred hccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.... .++.++.++.+||..||+.+|++||+++|
T Consensus 721 ---g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 721 ---GQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred ---CCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 33211 23445668999999999999999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=325.57 Aligned_cols=226 Identities=26% Similarity=0.419 Sum_probs=181.6
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC-CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccC
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA-TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-EKLLVYEYMV 225 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~ 225 (388)
+..+.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||.+||.|..+. ...++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34678999999999999975 6889999999543 3344578999999999999999999999999998 5999999999
Q ss_pred CCCHHHHHhc---------------cCCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRN---------------QAASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~---------------~~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+|+|.+++.. ...+|.|+| |+||||+|||++..|++||||||.++.+.+. ....+.
T Consensus 162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfv 238 (364)
T KOG0581|consen 162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFV 238 (364)
T ss_pred CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccccc
Confidence 9999998873 134678887 5799999999999999999999999988654 445678
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
||..|||||.+.+..|+.++||||||++++|+++|+.||.+. ......+.+.+.....+. . |.+... .+
T Consensus 239 GT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~p-p-----P~lP~~---~f 307 (364)
T KOG0581|consen 239 GTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEP-P-----PRLPEG---EF 307 (364)
T ss_pred ccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCC-C-----CCCCcc---cC
Confidence 999999999999999999999999999999999999998754 122233333332222211 1 111111 23
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++..++..|+++||.+|||++|
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHH
Confidence 347889999999999999999764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=332.36 Aligned_cols=223 Identities=32% Similarity=0.470 Sum_probs=172.8
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcC--hHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccC
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG--DREFAAEMETLGMVKHQNLVELLGYCSVDE-EKLLVYEYMV 225 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~ 225 (388)
...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.... ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3345699999999999999655559999997643222 458999999999999999999999999887 7899999999
Q ss_pred CCCHHHHHhcc-----------------CCCCCHHhh------hccccCCeeecCCC-CEEEcccccceeccCCCcceee
Q 035768 226 KGSLDDWLRNQ-----------------AASLDWGKR------CKIVASNILLNDDF-EAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 226 ~g~L~~~l~~~-----------------~~~l~~~~~------~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+|+|.++++.. +.++.|+|. +|++++|||++.++ ++||+|||+++...... ...+
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~ 202 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMT 202 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cccc
Confidence 99999999652 234566664 46679999999997 99999999998875432 2233
Q ss_pred ccccccCccCccccC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 282 VVAGTIGYVPPEYGG--TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
...||+.|||||++. ...|+.|+|||||||+||||+||+.||... ....+...+. .......+
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~----~~~~~~~~v~---~~~~Rp~~-------- 267 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL----APVQVASAVV---VGGLRPPI-------- 267 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC----CHHHHHHHHH---hcCCCCCC--------
Confidence 367999999999999 569999999999999999999999998643 2222222222 11111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+..+...+..++.+||+.||+.||++.|
T Consensus 268 -p~~~~~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 268 -PKECPPHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred -CccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence 1113346888999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=318.97 Aligned_cols=188 Identities=29% Similarity=0.480 Sum_probs=159.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.+|...+.||+|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||+++++++.++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777888999999999999975 5889999999766 33445568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCC------CCEEEcccccceeccCCC
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDD------FEAKISDFGLARLISDCE 276 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~------~~~kl~DfG~a~~~~~~~ 276 (388)
||.+|||.+|++.. +.++.++| |+|+||.||||+.. -.+||+|||+|+.+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~- 168 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG- 168 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-
Confidence 99999999998754 34566665 67899999999865 56899999999998643
Q ss_pred cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHH
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 339 (388)
......||++.|||||++...+|+.|+|+||.|+++||+++|+.||+. .+..++...+
T Consensus 169 -~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a----~t~~eL~~~~ 226 (429)
T KOG0595|consen 169 -SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA----ETPKELLLYI 226 (429)
T ss_pred -hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc----cCHHHHHHHH
Confidence 344568999999999999999999999999999999999999999753 2444554433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=320.78 Aligned_cols=228 Identities=25% Similarity=0.414 Sum_probs=179.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc-------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ-------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
+.|...+.||+|+||.|-+|.. ++|+.||||++++.... ......+|+++|++|+|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4567788999999999999985 57999999999754221 123357999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCC---CCEEEcccccceeccC
Q 035768 218 LLVYEYMVKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDD---FEAKISDFGLARLISD 274 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~---~~~kl~DfG~a~~~~~ 274 (388)
||||||+.||+|.+++- |...++.|+| |+||+|+|||+..+ ..+||+|||+|+....
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 99999999999999763 3345677888 67889999999766 8899999999998763
Q ss_pred CCcceeeccccccCccCccccCCCCC---CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKA---TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
.....+.|||+.|.|||++....+ ..+.|+||+||+||-+++|.+||.+.+. ...+.+.+.+..- .
T Consensus 332 --~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~sl~eQI~~G~y------~ 400 (475)
T KOG0615|consen 332 --GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPSLKEQILKGRY------A 400 (475)
T ss_pred --ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---CccHHHHHhcCcc------c
Confidence 344567899999999999876543 3478999999999999999999976543 2334444433211 1
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.|. ......++.++++.++|..||++|||++|
T Consensus 401 f~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~e 433 (475)
T KOG0615|consen 401 FGPL----QWDRISEEALDLINWMLVVDPENRPSADE 433 (475)
T ss_pred ccCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence 1111 12334457889999999999999999865
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.96 Aligned_cols=225 Identities=28% Similarity=0.489 Sum_probs=183.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
...+.++||.|.||.||+|+++ ....||||.++.... +...+|+.|+.||.+++||||++|.|+.......+||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999974 245799999987543 44568999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+||+|..||++... ++.|+. |+|++++|||++.+..+|++|||+++.+.++.....
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 99999999999986532 333432 579999999999999999999999998866543333
Q ss_pred ecccc--ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 281 TVVAG--TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 281 ~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
+...| +.+|.|||.+..+++|.+||||||||++||.++ |..||-++ ..++.++.+....+-...
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm----SNQdVIkaIe~gyRLPpP--------- 856 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----SNQDVIKAIEQGYRLPPP--------- 856 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc----chHHHHHHHHhccCCCCC---------
Confidence 33333 469999999999999999999999999999998 99997654 456666666554433222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+++..+.+||+.||++|-.+||++.|
T Consensus 857 ----mDCP~aL~qLMldCWqkdR~~RP~F~q 883 (996)
T KOG0196|consen 857 ----MDCPAALYQLMLDCWQKDRNRRPKFAQ 883 (996)
T ss_pred ----CCCcHHHHHHHHHHHHHHhhcCCCHHH
Confidence 233447999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=308.29 Aligned_cols=222 Identities=25% Similarity=0.375 Sum_probs=173.9
Q ss_pred CCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceee-EEEeCCe-eEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLG-YCSVDEE-KLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lv~ 221 (388)
+|.+.+.||+|+||+|||+. ..+|..||.|.++-. +....+....|+.+|++|+|||||++++ .+.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46667889999999999998 568999999998732 2344567889999999999999999999 4445555 78999
Q ss_pred eccCCCCHHHHHhc-------------------cCCCCCHHh---------hhccccCCeeecCCCCEEEcccccceecc
Q 035768 222 EYMVKGSLDDWLRN-------------------QAASLDWGK---------RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 222 e~~~~g~L~~~l~~-------------------~~~~l~~~~---------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
|||..|||...++. ...+|..+| |+||+|.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999987742 122343344 57999999999999999999999999987
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
.... .....+|||.||+||.+...+|+.||||||+||++|||+.-++||... +-.++.+.+.. +....+.
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~q----gd~~~~p- 249 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQ----GDYPPLP- 249 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHc----CCCCCCc-
Confidence 6433 344577999999999999999999999999999999999999998532 22333332222 2222111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
+..-...+.+|+..|+..||+.||+
T Consensus 250 -------~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 250 -------DEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred -------HHHhhhHHHHHHHHHccCCcccCCC
Confidence 1334457889999999999999997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=322.72 Aligned_cols=224 Identities=22% Similarity=0.385 Sum_probs=182.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..|...++||+|+|+.||+++. .+|+.||+|++.+.. ....+...+|+++.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588899999999999999996 789999999997642 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHh---------------ccCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLR---------------NQAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~---------------~~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|+|++|+|..+++ |...++.|+|. +|++-.|++|++++++||+|||+|..+..... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-rk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-RKK 176 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-ccc
Confidence 9999999988765 34557788884 56667899999999999999999999875433 344
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
+.||||.|+|||++.....+..+||||+||++|-|++|++||.. ++..+....+.. .+..-|.
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~-------~~Y~~P~------ 239 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKL-------NEYSMPS------ 239 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHh-------cCccccc------
Confidence 67899999999999999999999999999999999999999743 233333333322 1111121
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+..+|+.+.|+.||.+|||++|
T Consensus 240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~ 265 (592)
T KOG0575|consen 240 -HLSAEAKDLIRKLLRPNPSERPSLDE 265 (592)
T ss_pred -ccCHHHHHHHHHHhcCCcccCCCHHH
Confidence 12225778999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.97 Aligned_cols=222 Identities=27% Similarity=0.364 Sum_probs=177.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|+..++||+|+||+||.++.+ +++.+|+|++++... .+.+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457889999999999999999964 588999999987532 3456688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+||+.||+|+.+|.+. ..+|.|+|.. |++|+|||||.+|+++|+|||+++...... ..+
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t 182 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DAT 182 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Ccc
Confidence 9999999999988743 3477888854 677999999999999999999999654432 334
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...|||+.|||||++....|+..+|+||+||++|||++|.+||... +..++.....+... ..-|..
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~~I~~~k~---~~~p~~---- 248 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYDKILKGKL---PLPPGY---- 248 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHHHHhcCcC---CCCCcc----
Confidence 4589999999999999999999999999999999999999998532 23333333333220 001110
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
...+..+++.+.+..||++|-
T Consensus 249 ---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 ---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCHHHHHHHHHHhccCHHHhc
Confidence 112567888899999999995
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.22 Aligned_cols=225 Identities=32% Similarity=0.476 Sum_probs=177.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC--C----CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD--G----KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++....+.||+|+||.||+|...+ + ..||||.+++... +...+|.+|+.+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445567889999999999999643 3 3599999987644 45568999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc----------------------CCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 219 LVYEYMVKGSLDDWLRNQ----------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~----------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
|++|||++|||..||++. +.+..|++ |+||+++|+||+....+||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999999864 22344544 679999999999999999999999997
Q ss_pred ccCCCcceeecc-ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 272 ISDCESHVSTVV-AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 272 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
+...++...... .-...|||||.+..+.+|.|+|||||||+|||++| |..||.. .+..++...+...-+-..
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~----~~n~~v~~~~~~ggRL~~-- 925 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS----RSNFEVLLDVLEGGRLDP-- 925 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC----cchHHHHHHHHhCCccCC--
Confidence 655444433322 23469999999999999999999999999999999 8889643 344455443322111111
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+..+..++.++|.+||+.+|++||++.
T Consensus 926 -----------P~~CP~~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 926 -----------PSYCPEKLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred -----------CCCCChHHHHHHHHHccCChhhCccHH
Confidence 223344788999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=312.39 Aligned_cols=234 Identities=26% Similarity=0.425 Sum_probs=186.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+.....+.||+|.||.|..+....+..||||+++.... ...++|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345566788999999999999998889999999987544 4458899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-ee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~ 280 (388)
|++|+|.+|+..+ +.++.|+. |+|++++|||+|.++++||+|||+++-+...+++ ..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999999999654 22344443 5688899999999999999999999977554443 33
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT--GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
....-+++|||||.+..+++|++||||+||+++||+++ ...||... ..+.+++-.-.....+....++.
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l----t~e~vven~~~~~~~~~~~~~l~----- 767 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL----TDEQVVENAGEFFRDQGRQVVLS----- 767 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh----hHHHHHHhhhhhcCCCCcceecc-----
Confidence 34455789999999999999999999999999999877 78897543 33445554444444433322221
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.-+..++.+++.+||..|.++|||+++
T Consensus 768 -~P~~cp~~lyelml~Cw~~es~~RPsFe~ 796 (807)
T KOG1094|consen 768 -RPPACPQGLYELMLRCWRRESEQRPSFEQ 796 (807)
T ss_pred -CCCcCcHHHHHHHHHHhchhhhcCCCHHH
Confidence 12334457889999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=292.37 Aligned_cols=237 Identities=24% Similarity=0.318 Sum_probs=176.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+.|+....+|+|+||+|||++.+ +|+.||||++..+.. .-.+-.++|+++|++++|||+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35666788999999999999976 599999999976533 223457899999999999999999999999999999999
Q ss_pred ccCCCCHHH---------------HHhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDD---------------WLRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~---------------~l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
||+.-=|.+ ++.|...++.|+| |+||+|+|||++.++.+||||||+|+.+.... ...+.
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d~YTD 160 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-DNYTD 160 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-chhhh
Confidence 996543332 4455566788888 67899999999999999999999999987422 33455
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc------------cc--
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN------------EQ-- 347 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------------~~-- 347 (388)
.+.|.+|.|||.+.+ .+|+...||||.||++.||++|.+-|... +..+....++..+.. +.
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 678999999998766 68999999999999999999999887543 222322222222211 00
Q ss_pred ---ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 348 ---ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 348 ---~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+++.-++............-+++++..|++.||.+|++-+
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence 1111111111111122233588999999999999999854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=297.43 Aligned_cols=236 Identities=24% Similarity=0.383 Sum_probs=181.0
Q ss_pred hcCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.+.|+..++||.|.-++||+|+ .+.+..||||++.-..- .+.+.+.+|++.|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578888999999999999999 46789999999975433 335788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce-
Q 035768 223 YMVKGSLDDWLRN-----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV- 279 (388)
Q Consensus 223 ~~~~g~L~~~l~~-----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~- 279 (388)
||.+|++.++++. ...+|+|+| |+|||+.||||+.+|.+||+|||.+..+.+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 9999999997753 345788998 56899999999999999999999988775543221
Q ss_pred -e-eccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 280 -S-TVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 280 -~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
. ....||+.|||||++.. ..|+.|+|||||||+..||.+|..||..... .+.+...+.... ....-..
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~p-p~~~t~~ 256 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDP-PTLLTSG 256 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCC-CCccccc
Confidence 1 45689999999998443 4799999999999999999999999864321 111112222111 1000000
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+...........+.+++..|++.||++|||+++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 111112223347889999999999999999853
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=316.16 Aligned_cols=234 Identities=29% Similarity=0.424 Sum_probs=180.2
Q ss_pred ccHHHHHHhhcCCCcCCeeeccCCceEEEEEcCC--C--CE-EEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccce
Q 035768 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPD--G--KT-VAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l 207 (388)
+..+.++...++....+.||+|+||.||+|++.. + .. ||||..+.. ......+|.+|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3344555555666677999999999999999643 2 23 899998752 23455789999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
||++.....+++|||+|+||+|.+||+.. +.+++|+| |+||+++|||++.++.+||+||
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999999999753 34677777 6799999999999999999999
Q ss_pred ccceeccCCCcceee-ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHH-hh
Q 035768 267 GLARLISDCESHVST-VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLH-MM 343 (388)
Q Consensus 267 G~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~-~~ 343 (388)
|+++.-.. ..... ...-+..|+|||.+....|++++|||||||++||+++ |..||.+. ...++..++.. ..
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~----~~~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM----KNYEVKAKIVKNGY 380 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC----CHHHHHHHHHhcCc
Confidence 99876431 11111 1224679999999999999999999999999999999 88897543 34455555422 11
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+... +......+..++.+||..+|++||||.+
T Consensus 381 r~~~-------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~ 412 (474)
T KOG0194|consen 381 RMPI-------------PSKTPKELAKVMKQCWKKDPEDRPTMST 412 (474)
T ss_pred cCCC-------------CCCCHHHHHHHHHHhccCChhhccCHHH
Confidence 1110 1122335677888999999999999963
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=311.18 Aligned_cols=233 Identities=27% Similarity=0.444 Sum_probs=185.4
Q ss_pred HHHHHHhhcCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 138 YDQIVAGTNKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 138 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
++++.....+......||-|.||.||.|.|+. .-.||||.++... -..++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35565555666777899999999999999865 6789999998654 346789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
.|||+|||..|+|.+||+.. ..++.|+. |+|++++|+|+.++..+||+|||+++++..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999999999753 22344443 568999999999999999999999999977
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
+.+.......-.+.|.|||.+..+.++.|+|||+|||+|||+.| |..||... +...+...+....+...
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----dlSqVY~LLEkgyRM~~------ 487 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYGLLEKGYRMDG------ 487 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHhccccccC------
Confidence 65554444444679999999999999999999999999999999 88897431 22222222222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+..+..++.+||..||+++|++||++.|
T Consensus 488 -------PeGCPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 488 -------PEGCPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred -------CCCCCHHHHHHHHHHhcCCcccCccHHH
Confidence 1223447999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.16 Aligned_cols=224 Identities=23% Similarity=0.362 Sum_probs=181.5
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.|...+.||+|+||.||||.. .+++.||+|++.-... ...++..+|+.++.+++|+||.++||.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466678899999999999995 4688999999976543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 225 VKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 225 ~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
.+|++.+.|+- ...+++|+| |+||++.|||+..+|.+||+|||++..+....... ..++
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 99999998753 234678887 67999999999999999999999999887655544 5678
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
||+.|||||++....|+.|+||||||++.+||++|.+|+.....-.-.. -+..-..|.+.. ..
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~PP~L~~----~~ 235 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAPPRLDG----DF 235 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCCCcccc----cc
Confidence 9999999999998899999999999999999999999986543210000 011111222222 23
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++..|+..||+.||++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHH
Confidence 336889999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.56 Aligned_cols=214 Identities=27% Similarity=0.439 Sum_probs=171.1
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
...+-||.|+.|.||+|++ .++.||||+++... ..+++.|++|+||||+.+.|+|....-++||||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3456799999999999998 56889999986432 357889999999999999999999999999999999999
Q ss_pred HHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccC
Q 035768 229 LDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288 (388)
Q Consensus 229 L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~ 288 (388)
|...|+ +++.++.|+| |+|++.-||||..+..+||+|||.++.+.+. .....++||..
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVa 276 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVA 276 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHh
Confidence 998775 3466788888 5577788999999999999999999987654 44556899999
Q ss_pred ccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHH
Q 035768 289 YVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368 (388)
Q Consensus 289 y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 368 (388)
|||||++...+.++|.||||||||||||+||..||.+.. ...+ + ..+=...+.-..+..++..+
T Consensus 277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----ssAI---I---------wGVGsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----SSAI---I---------WGVGSNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc----hhee---E---------EeccCCcccccCcccCchHH
Confidence 999999999999999999999999999999999975321 1100 0 01101111111223344567
Q ss_pred HHHHHhcccCCCCCCCCCCC
Q 035768 369 LQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 369 ~~l~~~C~~~~P~~RPt~~e 388 (388)
.-|+.+||+..|..||++.|
T Consensus 341 klL~Kqcw~sKpRNRPSFrq 360 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQ 360 (904)
T ss_pred HHHHHHHHhcCCCCCccHHH
Confidence 78899999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=298.47 Aligned_cols=227 Identities=28% Similarity=0.473 Sum_probs=174.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE--EKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~ 223 (388)
++...+.||+|+||+||++... +|...|||.+........+.+.+|+++|++++|||||+++|...... ..++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4556788999999999999965 48999999987653333567899999999999999999999855544 58899999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecC-CCCEEEcccccceeccC--CCcce
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLND-DFEAKISDFGLARLISD--CESHV 279 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~--~~~~~ 279 (388)
+++|+|.+++.... .+|.|+| |+||+|+|||++. ++.+||+|||+++.... .....
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~ 177 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS 177 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence 99999999886532 3567777 6799999999999 79999999999987763 22222
Q ss_pred eeccccccCccCccccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 280 STVVAGTIGYVPPEYGGTGK-ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....||+.|||||++..+. ...++|||||||++.||+||++||... .+...++.........+.+.
T Consensus 178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~ip------ 245 (313)
T KOG0198|consen 178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPEIP------ 245 (313)
T ss_pred cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCCCC------
Confidence 34567999999999988543 345999999999999999999998642 22333333333332222111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+..+++.+|+..+|++|||+.|
T Consensus 246 ---~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 246 ---DSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred ---cccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 112236778999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=307.34 Aligned_cols=227 Identities=24% Similarity=0.374 Sum_probs=184.1
Q ss_pred cCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
..|.....||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||+++..|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457777889999999999998 4578999999998776666677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.|.+.. ...+|.|+| |+||+.+|||++.++.+||+|||++..+...... ....+|
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~TmVG 431 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTMVG 431 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccccC
Confidence 99999997643 345788888 5688899999999999999999999988765443 344679
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|++|||||+.....|++|.||||||++++||+-|++||-.+ +.. +.++ .+......++-.+. ...
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~Pl---rAly-LIa~ng~P~lk~~~-------klS 496 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPL---RALY-LIATNGTPKLKNPE-------KLS 496 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChH---HHHH-HHhhcCCCCcCCcc-------ccC
Confidence 99999999999999999999999999999999999998431 111 1111 22222222332222 223
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.++..+||+.||++||++.|
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHH
Confidence 36889999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=299.13 Aligned_cols=238 Identities=26% Similarity=0.332 Sum_probs=181.3
Q ss_pred hcCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 219 (388)
.+.|+..+.||+|.||.||+|+ ..+|+.||+|+++... .....-..+|+.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567778899999999999999 4679999999997654 23345577999999999999999999998876 68999
Q ss_pred EEeccCCCCHHHH----------------HhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDW----------------LRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~----------------l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|+|||++ ||.-+ ++|...+|+|+| |+||+.+|||||++|.+||+|||+|+.+......
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9999964 55544 445566889998 5789999999999999999999999988766655
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC-----
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL----- 352 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 352 (388)
..+..+-|.+|.|||.+.+ ..|+.+.|+||.||||.||++|++.|.. .+..+..+.+.+.........+.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G----~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG----RTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC----ccHHHHHHHHHHHhCCCChhccccccCC
Confidence 5666778999999997665 5899999999999999999999998643 34444455454443322111111
Q ss_pred -----Ccccc-----CCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 353 -----DPAVL-----NANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 353 -----~~~~~-----~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.|... .+.........++|+..+|..||.+|.|+.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~ 395 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS 395 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence 11000 000112234578889999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.70 Aligned_cols=220 Identities=28% Similarity=0.428 Sum_probs=180.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+... ++.+.+.+|+++++.++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999954 688999999987543 345668999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+.+ +|+.+|.+. ..+|.|+| ++|++|.|||++..+.+|+||||+|+.+.. .....+.
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceeeee
Confidence 9966 999999753 23677777 457889999999999999999999998865 3455667
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
+.||+.|||||...+.+|+..+|.||+||++||+++|++||.. .++.+.+.....+... -| .
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v~----~p-------~ 221 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPVK----PP-------S 221 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCCC----Cc-------c
Confidence 7899999999999999999999999999999999999999852 3455555444443221 11 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
.....+..++...+..||..|.|
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~Rlt 244 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLT 244 (808)
T ss_pred cccHHHHHHHHHHhhcChhhccc
Confidence 22336788888999999999976
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=299.31 Aligned_cols=228 Identities=23% Similarity=0.285 Sum_probs=176.6
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
...++|+..+.||+|+||.||+|+.+ +|..+|+|+++++.- ........|-.+|...++|+||+||..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999999999999954 699999999987643 23455788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhccC---------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC----
Q 035768 219 LVYEYMVKGSLDDWLRNQA---------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD---- 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~---- 274 (388)
|||||+||||+..+|.... .+++-+| |+||+|+|+|||..|++||+|||++..+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999999875421 1233333 569999999999999999999999853311
Q ss_pred ------------------CCcc-----e-------------------eeccccccCccCccccCCCCCCcccchHhHHHH
Q 035768 275 ------------------CESH-----V-------------------STVVAGTIGYVPPEYGGTGKATERGDVYSFGVI 312 (388)
Q Consensus 275 ------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~ 312 (388)
.... . ....+|||.|||||++.+..|+..+|+||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 0 012479999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 313 LLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 313 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
+|||+.|-+||........-..+..|......+.. .+...+..+++.+|+. ||++|--
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999998765444444455555433222111 0111367889999998 9999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=290.10 Aligned_cols=217 Identities=20% Similarity=0.323 Sum_probs=166.9
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcC---hHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEec
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG---DREFAAEMETLGMVKHQNLVELLGYCSV----DEEKLLVYEY 223 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 223 (388)
...||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+.+|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 78899999997654333 3568899999999999999999999977 3467899999
Q ss_pred cCCCCHHHHHhccC---------------CCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQA---------------ASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~~---------------~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++++.. .++.++| |++|+|+|||+++++.+||+|||+++...... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----cc
Confidence 99999999986431 2334444 56899999999999999999999998654321 22
Q ss_pred cccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 283 VAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..|+..|+|||.+.+ ..++.++|||||||++|||++|+.||... +..++...+.. ...... .+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~----~~~~~~~~i~~---~~~~~~-~~------- 244 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL----TTKEIYDLIIN---KNNSLK-LP------- 244 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHh---cCCCCC-CC-------
Confidence 457899999999865 68999999999999999999999998532 22233332211 111000 00
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++||||+|
T Consensus 245 -~~~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 245 -LDCPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred -CcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence 112336889999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=300.59 Aligned_cols=225 Identities=24% Similarity=0.419 Sum_probs=178.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC---C--CEEEEEEcccC-CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD---G--KTVAVKKLSQA-TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
+.....+.||.|-||.||+|.+.+ | -.||||..+.. .....+.|+.|+-+|++++|||||+++|+|. ....|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeE
Confidence 344556789999999999998633 2 35999999874 4455677999999999999999999999997 567899
Q ss_pred EEeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|||.++-|.|..||.+... +|.|++ |+||+++|||+...-.+||+|||+++.+.+....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999999986543 344544 6799999999999999999999999999887766
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
..+...-+..|||||.+....+|.+||||-|||.+||++. |..||..... .+.+ ..+...-.
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----sDVI-------------~~iEnGeR 610 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----SDVI-------------GHIENGER 610 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----cceE-------------EEecCCCC
Confidence 6665556789999999999999999999999999999988 9999854211 1111 01111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.++.++..+..|+.+||+.+|.+||++.|
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence 1223344557889999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.99 Aligned_cols=229 Identities=28% Similarity=0.444 Sum_probs=170.2
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
+.++|...+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999974 2356899999975432 2345689999999999 8999999999987644
Q ss_pred -eeEEEEeccCCCCHHHHHhcc----------------------------------------------------------
Q 035768 216 -EKLLVYEYMVKGSLDDWLRNQ---------------------------------------------------------- 236 (388)
Q Consensus 216 -~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 236 (388)
..++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999988632
Q ss_pred -------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eeeccccccCccC
Q 035768 237 -------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVP 291 (388)
Q Consensus 237 -------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~a 291 (388)
+.++.|+| |+||+|+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 12345566 4588999999999999999999999875432221 1222345678999
Q ss_pred ccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHH
Q 035768 292 PEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQ 370 (388)
Q Consensus 292 PE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 370 (388)
||++....++.++|||||||++|||++ |..||.... ....+... ...+..... + ......+.+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~---~~~~~~~~----~~~~~~~~~--~-------~~~~~~l~~ 308 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ---INEEFCQR----LKDGTRMRA--P-------ENATPEIYR 308 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC---ccHHHHHH----HhcCCCCCC--C-------CCCCHHHHH
Confidence 999988899999999999999999997 999985421 11112211 111111100 1 112236889
Q ss_pred HHHhcccCCCCCCCCCCC
Q 035768 371 IATGCISNDPTVRPTMLH 388 (388)
Q Consensus 371 l~~~C~~~~P~~RPt~~e 388 (388)
++.+||+.||++|||+.|
T Consensus 309 li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 309 IMLACWQGDPKERPTFSA 326 (338)
T ss_pred HHHHHccCChhhCcCHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.24 Aligned_cols=229 Identities=24% Similarity=0.342 Sum_probs=182.5
Q ss_pred HHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 035768 142 VAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEE 216 (388)
Q Consensus 142 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 216 (388)
.....+|...+.||.|+|++|++|+. .+++.+|||++.+... ...+-..+|-.+|.+| .||.|++|+--|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34456789999999999999999995 4699999999976421 2234567888999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
+|+|+||+++|+|.++|+.. ..+++|+| |+||+|+|||||++|++||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999753 34688888 56788999999999999999999999885422
Q ss_pred cc----------ee--eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 277 SH----------VS--TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 277 ~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
.. .. ..++||..|++||++.....++.+|+|+|||+||.|+.|++||... +...+.+.+...--
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIFQKIQALDY 304 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHHHHHHHhcc
Confidence 11 11 4578999999999999999999999999999999999999997543 33444444433211
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+ .....+.+|+.+.+..||.+|+|.+|
T Consensus 305 --~fp~------------~fp~~a~dLv~KLLv~dp~~Rlt~~q 334 (604)
T KOG0592|consen 305 --EFPE------------GFPEDARDLIKKLLVRDPSDRLTSQQ 334 (604)
T ss_pred --cCCC------------CCCHHHHHHHHHHHccCccccccHHH
Confidence 1111 11136778999999999999999753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=294.65 Aligned_cols=225 Identities=26% Similarity=0.391 Sum_probs=177.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC----CC-cChHHHHHHHHHHhcCC-CCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA----TG-QGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 217 (388)
.++|...+.||+|+||+|+.|.+ .++..||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45788899999999999999985 46899999987654 11 23445678999999999 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCC-CCEEEcccccceeccCCC
Q 035768 218 LLVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLISDCE 276 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~~~ 276 (388)
++||||+.+|+|.+++.+ ...+++|+| |+|+||+|||+|.+ +++||+|||++.... ..
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~ 174 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GE 174 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-CC
Confidence 999999999999998865 234677887 45888999999999 999999999999874 22
Q ss_pred cceeeccccccCccCccccCCCC-CC-cccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc-ccccccCC
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGK-AT-ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN-EQADEVLD 353 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 353 (388)
.......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. +...+.. ..... -.+...++
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----~~~~l~~---ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----NVPNLYR---KIRKGEFKIPSYLL 247 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc----cHHHHHH---HHhcCCccCCCCcC
Confidence 23445678999999999998877 75 7899999999999999999998641 2222222 21111 11122220
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++..++.+|+..||.+|+|+.|
T Consensus 248 -----------S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 248 -----------SPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred -----------CHHHHHHHHHHcCCCcccCCCHHH
Confidence 236889999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=293.15 Aligned_cols=236 Identities=21% Similarity=0.273 Sum_probs=177.8
Q ss_pred cCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChH-HHHHHHHHHhcCC-CCCccceeeEEEeCC-eeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDR-EFAAEMETLGMVK-HQNLVELLGYCSVDE-EKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lv~ 221 (388)
++|...+.||.|.||.||+|+ ..++..||||++++......+ .=++|++.|++|+ |||||++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 467778899999999999999 457899999999876544322 2468999999999 999999999999888 899999
Q ss_pred eccCCCCHHHHHh----------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLR----------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~----------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||| ..+|+++++ |..++|+++| |+|++|+|||+.....+||+|||+||.+... ...
T Consensus 90 E~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--pPY 166 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--PPY 166 (538)
T ss_pred Hhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--CCc
Confidence 999 567877664 4456788888 5789999999999999999999999987643 344
Q ss_pred eccccccCccCcccc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC-------
Q 035768 281 TVVAGTIGYVPPEYG-GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL------- 352 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 352 (388)
+..+.|.+|.|||++ ..+.|+.+.|+||+|||++|+.+-++-|.+. +..+.+..+...+.......+.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~----sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA----SEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC----cHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 567789999999975 5678999999999999999999999886543 2222222222222221111111
Q ss_pred -----CccccCC----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 -----DPAVLNA----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 -----~~~~~~~----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
-|...+. -......+..+++.+|+++||.+|||++|
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 0111110 01124457889999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=268.83 Aligned_cols=176 Identities=27% Similarity=0.392 Sum_probs=155.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||.|+||+|.+++.+ +|..+|+|.+++...- ..+...+|..+|+.+.||+++++++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788899999999999999965 5888999999865432 2345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||++||.|+.+|+.. ..+|.|+|++ |++|+|||+|.+|.+||+|||+|+..... ..
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 999999999999863 2368899976 55699999999999999999999987642 45
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
+.|||+.|+|||.+....|+.++|+|||||++|||+.|.+||..
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 68999999999999999999999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=289.22 Aligned_cols=177 Identities=27% Similarity=0.373 Sum_probs=150.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|+..+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57888899999999999999965 688899999875422 2345699999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++... ..++.|+| |.||+|+|||++.++.+||+|||+++...... ...
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~ 161 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 161 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---ccc
Confidence 9999999988542 23456665 45789999999999999999999998664321 223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..||..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 4689999999999888999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.35 Aligned_cols=237 Identities=22% Similarity=0.335 Sum_probs=177.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|.||.||+|+. .+|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566778999999999999994 57999999999754322 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRN----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+ -||...++. ...++.|+| |+|++|.|+|++.+|.+||+|||+|+..........
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~- 159 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT- 159 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc-
Confidence 995 467665543 334555555 789999999999999999999999999865443322
Q ss_pred ccccccCccCcccc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc----
Q 035768 282 VVAGTIGYVPPEYG-GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV---- 356 (388)
Q Consensus 282 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 356 (388)
..+-|..|.|||.+ ....|+...|+||.||++.||+-|.+-|. +++..+....+...+......++.+-..
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 23578999999965 45689999999999999999999886643 3344444444544444333222221100
Q ss_pred ----------cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 ----------LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ----------~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
............++++..++..||.+|+|+.|
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 01011223345689999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=286.47 Aligned_cols=233 Identities=24% Similarity=0.409 Sum_probs=171.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-----------------CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccce
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-----------------GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 207 (388)
++|...+.||+|+||.||+|.+.+ +..||+|.+..... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778999999999999997532 34699999875432 234579999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhcc----------------------------------CCCCCHHh-----hhcc
Q 035768 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQ----------------------------------AASLDWGK-----RCKI 248 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------------------------~~~l~~~~-----~~~i 248 (388)
++++...+..++||||+++|+|.+++... +.++.++| |.||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl 164 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 99999999999999999999999887532 12345556 4578
Q ss_pred ccCCeeecCCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh--CCCCCCC
Q 035768 249 VASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT--GKQPTGP 325 (388)
Q Consensus 249 ~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t--g~~P~~~ 325 (388)
+|+|||++.++.+||+|||+++.+...... ......++..|+|||++....++.++|||||||++|||++ +..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 899999999999999999999876443221 1222345788999999888889999999999999999997 5567643
Q ss_pred CCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 326 EFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ........+.............. ........+.+++.+||+.||++||||.|
T Consensus 245 ~----~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 245 L----TDEQVIENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred C----CHHHHHHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 2 22333333332222111100000 01112246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=282.19 Aligned_cols=223 Identities=28% Similarity=0.333 Sum_probs=170.3
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66678999999999999986 5789999999864321 2234578999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..++.|+| |+||+|+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 159 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVR 159 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--eec
Confidence 9999998876432 22455666 45788999999999999999999998764322 223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+........ .. ..
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~-~~---------~~ 225 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE----RVKREEVDRRVKEDQ-EE---------YS 225 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc----chhHHHHHHHhhccc-cc---------CC
Confidence 35689999999999989999999999999999999999999864321 111111111111110 00 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
......+.+++.+||+.||.+||++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 1122367889999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.99 Aligned_cols=225 Identities=24% Similarity=0.362 Sum_probs=182.2
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 217 (388)
...++|...++||+|+||+|+++..+ +++.+|||.+++... .+.+....|.+++... +||.+++++..|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999965 588999999987643 3445677888888777 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc--------------cCCCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 218 LLVYEYMVKGSLDDWLRN--------------QAASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|.||||+.|||+..+.+. ...+|.|+|.. |+|-+|||||.+|.+||+|||+++...... .
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~ 523 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-D 523 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC-C
Confidence 999999999996555431 12378899976 556899999999999999999999765333 3
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.++++|||+.|||||++.+..|+...|+|||||+||||++|..||. +++.+++.+.+.. .++.-|..
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~----gddEee~FdsI~~-------d~~~yP~~-- 590 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP----GDDEEEVFDSIVN-------DEVRYPRF-- 590 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC----CCCHHHHHHHHhc-------CCCCCCCc--
Confidence 5567899999999999999999999999999999999999999974 3455666665543 22222222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
...+...|+.+.+..+|++|--+
T Consensus 591 -----ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 591 -----LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----ccHHHHHHHHHHhccCcccccCC
Confidence 22367889999999999999866
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=295.06 Aligned_cols=229 Identities=29% Similarity=0.428 Sum_probs=172.3
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
..++|...+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345688889999999999999973 236689999997543 23345688999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhccC----------------------------------------------------------
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQA---------------------------------------------------------- 237 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 237 (388)
..++||||+++|+|.+++++..
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999885321
Q ss_pred --------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce-
Q 035768 238 --------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV- 279 (388)
Q Consensus 238 --------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~- 279 (388)
.++.|+| |.||+|+|||++.++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 1334555 56788999999999999999999998764432211
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....++..|+|||.+....++.++|||||||++|||++ |..||.... ....+.+.+...... ..+.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~---~~~~~~~~~~~~~~~------~~~~--- 340 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP---VDSKFYKMIKEGYRM------LSPE--- 340 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC---chHHHHHHHHhCccC------CCCC---
Confidence 112335678999999988899999999999999999998 888875421 122233332221110 0010
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....++.+++.+||+.||++||||+|
T Consensus 341 ----~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 341 ----CAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHH
Confidence 11236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=274.56 Aligned_cols=225 Identities=26% Similarity=0.476 Sum_probs=174.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999998888899999986432 335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+|+|.+++++.. .++.++| |.+|+|+||++++++.+||+|||+++..............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence 999999986432 2344555 4567899999999999999999999876433322222334
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
++..|+|||......++.++||||||+++|||++ |+.||... +..+....+..... ...+..
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~----~~~~~~~~i~~~~~------~~~~~~------- 225 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK----SNYEVVEMISRGFR------LYRPKL------- 225 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHCCCC------CCCCCC-------
Confidence 5678999999988889999999999999999999 89997432 33333333322111 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.+|++||||+|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHH
Confidence 1236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=287.37 Aligned_cols=219 Identities=21% Similarity=0.311 Sum_probs=172.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999965 58899999986532 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... .
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----F 173 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----c
Confidence 999999999988542 23566777 45788999999999999999999998764322 2
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||.+....++.++|||||||++|||++|+.||... +.....+.+... .......+
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~--~~~~p~~~--------- 238 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----TPFRIYEKILAG--RLKFPNWF--------- 238 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----CHHHHHHHHhcC--CcCCCCCC---------
Confidence 346899999999998888999999999999999999999998532 222222222110 00011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
...+.+++.+||+.||.+||+.
T Consensus 239 ---~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 239 ---DGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCC
Confidence 1257899999999999999973
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=288.91 Aligned_cols=228 Identities=23% Similarity=0.273 Sum_probs=175.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999975 58899999997542 1234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++|+|.+++... ..++.++| |.||+|+|||++.++.+||+|||+++.... ....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~ 157 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANS 157 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCC
Confidence 99999999988532 23566777 457889999999999999999999986543 2234
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....+.............++ ..
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~------~~ 227 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS----TPNETWENLKYWKETLQRPVYDDP------RF 227 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC----CHHHHHHHHHhccccccCCCCCcc------cc
Confidence 56899999999998889999999999999999999999998532 222222222211100000111110 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||..+|.+|||++|
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 12336788999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.38 Aligned_cols=234 Identities=24% Similarity=0.393 Sum_probs=177.0
Q ss_pred HHHHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 138 YDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 138 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
.+++.+..+.+.....||+|+||+||+|.|.. .||||.++.... ...+.|.+|+..+++-||.||+-+.|+|..++
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35666666677778999999999999999743 599999976543 34567999999999999999999999999877
Q ss_pred eeEEEEeccCCCCHHHHHh----------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 216 EKLLVYEYMVKGSLDDWLR----------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~----------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
. .||+.+|+|-+|+.+|| |.+++++|+| |+|++..||++++++++||+|||++..-..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 7 99999999999999886 3466889998 456778999999999999999999864321
Q ss_pred C-CcceeeccccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccc
Q 035768 275 C-ESHVSTVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350 (388)
Q Consensus 275 ~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (388)
- .........|...|||||++. ..+|++.+||||||||+|||+||..||.... .+. +.-+...+
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-----~dq---IifmVGrG---- 608 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-----RDQ---IIFMVGRG---- 608 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-----hhh---eEEEeccc----
Confidence 1 112222345888999999764 4579999999999999999999999985211 111 11111111
Q ss_pred cCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 351 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.|... .....+.+++.+|+..||..++++||.+.
T Consensus 609 ~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~ 644 (678)
T KOG0193|consen 609 YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFP 644 (678)
T ss_pred ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHH
Confidence 1111111 11234455788999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=283.67 Aligned_cols=239 Identities=25% Similarity=0.280 Sum_probs=173.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36788899999999999999975 58899999987542 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|++++.+..+.. +...+|.|+| |.+|+|+||+++.++.+||+|||+++............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 999887665432 2233566777 45788999999999999999999998765433223334
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhc------------cccccc
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK------------NEQADE 350 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~ 350 (388)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+..... ......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES----EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 568999999999988889999999999999999999999986421 1111111111100 000000
Q ss_pred cCCccccCCC------CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 VLDPAVLNAN------SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ~~~~~~~~~~------~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+...... .......+.+++.+||+.||++|||++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 0000000000 0112346899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=275.24 Aligned_cols=226 Identities=24% Similarity=0.379 Sum_probs=171.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+.++++++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999753 356899999976533 2345689999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+++|+|.+++.... .++.++| |++|+|+|||++.++.+|++|||.+..........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence 99999999999986532 2345566 45788999999999999999999876543222111
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....++..|+|||.+....++.++|||||||++||+++ |+.||... ...++.+.+... .... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~----~~~~~~~~~~~~----~~~~--~----- 229 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM----SGQDVIKAVEDG----FRLP--A----- 229 (266)
T ss_pred ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC----CHHHHHHHHHCC----CCCC--C-----
Confidence 122335678999999988899999999999999999875 99997532 222333332211 1000 0
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++|||+.|
T Consensus 230 --~~~~~~~~~~li~~c~~~~p~~RP~~~~ 257 (266)
T cd05064 230 --PRNCPNLLHQLMLDCWQKERGERPRFSQ 257 (266)
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 1112336889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=284.96 Aligned_cols=177 Identities=27% Similarity=0.400 Sum_probs=149.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|+..+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++||||++++++|..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888999999999999999965 688899998865432 2345689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++... ..++.|+| |.+|+|+|||++.++.+||+|||++...... ....
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~ 161 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---cccc
Confidence 9999999988542 22456666 3578899999999999999999999765332 1223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4689999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=290.22 Aligned_cols=222 Identities=24% Similarity=0.329 Sum_probs=176.4
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
-|...+.||+|+-|.|-.|++ .+|+.+|||.+.+... .....+.+|+-+|+-+.|||++++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356678999999999999996 5799999999976522 223458899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHh---------------ccCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLR---------------NQAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~---------------~~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++|.|++++. |...++.|+|+ +|++|+|+|||.+.++||+|||+|..-.++ ....+
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klLeT 170 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLLET 170 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--ccccc
Confidence 999999999874 33446778884 577799999999999999999999875432 33445
Q ss_pred cccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
.||++.|.|||++.+.+| +.++||||.|||||.|+||+.||++ ++-..+...|.+ +.. ++ | .
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~----G~f-~M--P---s--- 233 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQR----GVF-EM--P---S--- 233 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHc----Ccc-cC--C---C---
Confidence 789999999999999988 6789999999999999999999853 222333333322 221 11 1 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+..+|+.+|+..||+.|.|+.|
T Consensus 234 -~Is~eaQdLLr~ml~VDp~~RiT~~e 259 (786)
T KOG0588|consen 234 -NISSEAQDLLRRMLDVDPSTRITTEE 259 (786)
T ss_pred -cCCHHHHHHHHHHhccCccccccHHH
Confidence 11125778999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=259.76 Aligned_cols=222 Identities=24% Similarity=0.355 Sum_probs=179.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|+..+.||+|.||.||.|+.+ ++-.||+|++.++. .....++.+|+++-+.|+||||+++|++|.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357888999999999999999964 57899999997643 23346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 221 YEYMVKGSLDDWLRN-----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~-----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||.++|+|...|+. .+.++.|+| |+||+|+|+|++.++..||+|||-+.... ..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 999999999998862 234566666 45999999999999999999999987643 23
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
...+.|||..|.+||...+..++...|+|++|++.||++.|.+||... ...+..+.+.. .+..+|..
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~----~~~etYkrI~k-------~~~~~p~~-- 244 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ----SHSETYKRIRK-------VDLKFPST-- 244 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh----hhHHHHHHHHH-------ccccCCcc--
Confidence 345678999999999999999999999999999999999999998543 23333333332 22233321
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
......+++.+|+..+|.+|.+..
T Consensus 245 -----is~~a~dlI~~ll~~~p~~r~~l~ 268 (281)
T KOG0580|consen 245 -----ISGGAADLISRLLVKNPIERLALT 268 (281)
T ss_pred -----cChhHHHHHHHHhccCccccccHH
Confidence 122578999999999999998753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.04 Aligned_cols=226 Identities=29% Similarity=0.456 Sum_probs=175.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35678889999999999999998888899999986533 23567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++|+|.++++.. ..++.++| |.+|+|+||+++.++.+||+|||+++............
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 999999988542 12445566 45788999999999999999999998765433222223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..++..|+|||+.....++.++|||||||++|||+| |+.||... ........+...... +. .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~----~~~~~~~~~~~~~~~--------~~-~---- 226 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM----SNSDVMSALQRGYRM--------PR-M---- 226 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC----CHHHHHHHHHcCCCC--------CC-C----
Confidence 345678999999888889999999999999999999 99997532 222333333221110 00 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDY 253 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=281.66 Aligned_cols=214 Identities=24% Similarity=0.291 Sum_probs=166.0
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||+|+||.||+++.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 58899999986532 23345688999999999999999999999999999999999999999
Q ss_pred HHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCc
Q 035768 230 DDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289 (388)
Q Consensus 230 ~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y 289 (388)
.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++...... .......||+.|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEY 159 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCccc
Confidence 9988532 23566777 45788999999999999999999998643322 222345699999
Q ss_pred cCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHH
Q 035768 290 VPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKML 369 (388)
Q Consensus 290 ~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 369 (388)
+|||.+.+..++.++|||||||++|||+||+.||... +...+ ........ . . .. ......+.
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~----~~~~~---~~~~~~~~-~-~-----~~----~~~~~~~~ 221 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE----NVNEM---YRKILQEP-L-R-----FP----DGFDRDAK 221 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC----CHHHH---HHHHHcCC-C-C-----CC----CcCCHHHH
Confidence 9999999889999999999999999999999998532 22222 22211111 0 0 00 11123578
Q ss_pred HHHHhcccCCCCCCCCC
Q 035768 370 QIATGCISNDPTVRPTM 386 (388)
Q Consensus 370 ~l~~~C~~~~P~~RPt~ 386 (388)
+++.+||+.||++||++
T Consensus 222 ~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 222 DLLIGLLSRDPTRRLGY 238 (312)
T ss_pred HHHHHHcCCCHHHcCCC
Confidence 89999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.80 Aligned_cols=230 Identities=29% Similarity=0.436 Sum_probs=171.1
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
...++|...+.||+|+||.||+|.. .++..||+|+++.... .....+.+|+++++.+ +||||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3445788899999999999999874 2345799999975432 2345688999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc----------------------------------------------------------
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ---------------------------------------------------------- 236 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 236 (388)
+..++||||+++|+|.++++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988532
Q ss_pred ---------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eeecc
Q 035768 237 ---------------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVV 283 (388)
Q Consensus 237 ---------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 283 (388)
..++.|+| |+||+|+|||+++++.+||+|||+++........ .....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12344555 5678899999999999999999999876433221 11122
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.++..|||||++....++.++|||||||++|||++ |+.||..... ...+...+ .... ....+. .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~---~~~~~~~~----~~~~--~~~~~~---~--- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV---NSKFYKMV----KRGY--QMSRPD---F--- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc---cHHHHHHH----Hccc--CccCCC---C---
Confidence 35678999999988899999999999999999998 9999854211 11111111 1110 000110 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 340 -~~~~l~~li~~cl~~dp~~RPs~~~ 364 (374)
T cd05106 340 -APPEIYSIMKMCWNLEPTERPTFSQ 364 (374)
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHH
Confidence 1236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=285.90 Aligned_cols=227 Identities=26% Similarity=0.394 Sum_probs=169.2
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3555688999999999999964 689999999865432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHH-----------HHhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccC
Q 035768 225 VKGSLDD-----------WLRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288 (388)
Q Consensus 225 ~~g~L~~-----------~l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~ 288 (388)
++|+|.+ ++.+...+|.|+| |.||+++|||+++++.+||+|||+++.+..... ......||..
T Consensus 155 ~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~ 233 (353)
T PLN00034 155 DGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIA 233 (353)
T ss_pred CCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccCcc
Confidence 9999864 3344556778888 457889999999999999999999987643221 1223468999
Q ss_pred ccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 289 YVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 289 y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
|+|||.+.. ...+.++|||||||++|||++|+.||... ...+............. .. . ...
T Consensus 234 y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~-~~-----~----~~~ 299 (353)
T PLN00034 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG----RQGDWASLMCAICMSQP-PE-----A----PAT 299 (353)
T ss_pred ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC----CCccHHHHHHHHhccCC-CC-----C----CCc
Confidence 999998642 23456899999999999999999998621 11122211111111100 00 0 111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++.+++.+||+.||++|||+.|
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~e 324 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQ 324 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHH
Confidence 2236889999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.92 Aligned_cols=215 Identities=24% Similarity=0.304 Sum_probs=166.9
Q ss_pred CeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468999999987532 123346788999999999999999999999999999999999999
Q ss_pred CHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccccc
Q 035768 228 SLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 228 ~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
+|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+++...... .......||+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCc
Confidence 99988753 233667777 45788999999999999999999997643221 1223456999
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
.|+|||.+.+..++.++|||||||++|||+||+.||... +...+.+.+.. ... .... .....
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~----~~~~~~~~~~~----~~~------~~p~----~~~~~ 221 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFELILM----EEI------RFPR----TLSPE 221 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC----CHHHHHHHHHc----CCC------CCCC----CCCHH
Confidence 999999998889999999999999999999999998532 22222222211 110 0001 11236
Q ss_pred HHHHHHhcccCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPT 385 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt 385 (388)
+.+++.+||+.||++||+
T Consensus 222 ~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHccCCHHHcCC
Confidence 788999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=279.76 Aligned_cols=218 Identities=21% Similarity=0.276 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36778899999999999999965 68899999986432 123456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.++| |.||+|+|||++.++.+||+|||+++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----cc
Confidence 999999999987542 23566777 4578899999999999999999999876432 12
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||... +...+.+.+.... .....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~--~~~~~----------- 219 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD----NPFGIYEKILAGK--LEFPR----------- 219 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCC--cCCCc-----------
Confidence 346899999999998888999999999999999999999998532 2223332222110 00011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
.....+.+++.+||+.||.+||+
T Consensus 220 -~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 220 -HLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred -cCCHHHHHHHHHHcCCCHHHccC
Confidence 11225789999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=296.82 Aligned_cols=224 Identities=25% Similarity=0.352 Sum_probs=173.0
Q ss_pred CCcCCeeeccCCceEEEEEcC-C-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-D-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++|||||++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999853 3 67888998755443444567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-cee
Q 035768 226 KGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-HVS 280 (388)
Q Consensus 226 ~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~ 280 (388)
+|+|.+++++. ..+|.++| |+||+|+|||++.++.+||+|||+++....... ...
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 228 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence 99999877531 22455666 458889999999999999999999987654322 123
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+||+.|+|||++....++.++|||||||++|||++|+.||... +..++...+.. ......
T Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~----~~~~~~~~~~~----~~~~~~--------- 291 (478)
T PTZ00267 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP----SQREIMQQVLY----GKYDPF--------- 291 (478)
T ss_pred cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh----CCCCCC---------
Confidence 3456999999999998889999999999999999999999997532 22223322221 111000
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~ 319 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQ 319 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 0111236889999999999999999753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.18 Aligned_cols=223 Identities=27% Similarity=0.385 Sum_probs=175.4
Q ss_pred CCCcCCeeeccCCceEEEEEcC--CCC--EEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP--DGK--TVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..+..++||+|.||.|++|.|. +|+ .||||+++..... ...+|++|+.+|.+|+|||+++|||+..+ ....||+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3444678999999999999985 344 5899999865443 56789999999999999999999999986 7788999
Q ss_pred eccCCCCHHHHHhc-----------------cCCCCCHH-----hhhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 222 EYMVKGSLDDWLRN-----------------QAASLDWG-----KRCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~~-----------------~~~~l~~~-----~~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+++.|+|.+.|+. .+.++.|+ .|+|++++|+|+-..-.+||+|||+.+.+...+.+.
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999998875 22334443 367999999999999999999999999987655432
Q ss_pred e--eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 280 S--TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 280 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
. ....-...|.|||.+...+++.+||||+|||++|||+| |+.||... .+..+.+.+. ...
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----~g~qIL~~iD-------------~~e 332 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----RGIQILKNID-------------AGE 332 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----CHHHHHHhcc-------------ccc
Confidence 2 22233568999999999999999999999999999999 88998543 3333333221 111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.-.....+.+.+++++..||..+|++|||+.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHH
Confidence 1122345666899999999999999999985
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=270.78 Aligned_cols=226 Identities=27% Similarity=0.432 Sum_probs=174.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|...+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45678889999999999999998778899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++++|.+++.+.. .++.++| |.||+|+||++++++.+||+|||+++............
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 9999999986532 2345555 45788999999999999999999998775332222222
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...+..|+|||+.....++.++||||||+++|||+| |+.||... ....+...+... ... . . .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~~~---~~~-~--~-------~ 226 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM----TNAEVLQQVDQG---YRM-P--C-------P 226 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHcC---CCC-C--C-------C
Confidence 223457999999988899999999999999999999 99997532 222222222111 000 0 0 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|.+||++++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 112246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=288.67 Aligned_cols=229 Identities=25% Similarity=0.398 Sum_probs=171.4
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCC-CCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVK-HQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 215 (388)
..++|...+.||+|+||.||+|+.. .+..||||+++.... ...+.|.+|++++++++ ||||++++++|...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888899999999999999852 134799999975433 23457999999999996 999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc-----------------------------------------------------------
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ----------------------------------------------------------- 236 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 236 (388)
..++|||||++|+|.+++++.
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988642
Q ss_pred ----------------------------------------------------CCCCCHHh-----hhccccCCeeecCCC
Q 035768 237 ----------------------------------------------------AASLDWGK-----RCKIVASNILLNDDF 259 (388)
Q Consensus 237 ----------------------------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~ 259 (388)
+.++.|+| |.+|+|+|||+++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 11234444 457889999999999
Q ss_pred CEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHH
Q 035768 260 EAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 337 (388)
.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+..
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---~~~~~~ 351 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---DSTFYN 351 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch---hHHHHH
Confidence 9999999999876432221 1222346788999999988889999999999999999997 9999754321 111222
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. ..... ........+.+++.+||+.+|++|||+.+
T Consensus 352 ~~~~----~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 352 KIKS----GYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred HHhc----CCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 1111 10000 01112346889999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=281.76 Aligned_cols=226 Identities=25% Similarity=0.321 Sum_probs=170.0
Q ss_pred CCCcCCeeeccCCceEEEEEc----CCCCEEEEEEcccCC----CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 035768 147 KFCEENVIGGGGFGTVFKGTM----PDGKTVAVKKLSQAT----GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 217 (388)
+|...+.||+|+||.||+++. .+++.||+|.+.+.. ....+.+..|++++..+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999875 358899999986432 12234678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++||||+++|+|.+++.+. ..+|.++| |+||+|+|||++.++.+||+|||+++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999987532 33566777 467889999999999999999999986544333
Q ss_pred ceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...........+...+ ... ++..
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~-------~~~~ 230 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI---LKC-------DPPF 230 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH---hcC-------CCCC
Confidence 333345799999999988764 47889999999999999999999986432211111221111 111 1111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
... ....+.+++.+||+.||++||++
T Consensus 231 ~~~----~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 231 PSF----IGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred CCC----CCHHHHHHHHHHcCCCHHHcCCC
Confidence 111 12257889999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=271.63 Aligned_cols=230 Identities=25% Similarity=0.380 Sum_probs=170.8
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhc--CCCCCccceeeEEEeCC----eeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGM--VKHQNLVELLGYCSVDE----EKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv 220 (388)
+....+.||+|.||+||+|.| .|+.||||++.. .+++.+.+|.++.+. |+|+||+.+++.-..++ ++|||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 455678999999999999999 688999999964 345678899998875 59999999998765543 67999
Q ss_pred EeccCCCCHHHHHhcc--------------CCCCCHHh-------------hhccccCCeeecCCCCEEEcccccceecc
Q 035768 221 YEYMVKGSLDDWLRNQ--------------AASLDWGK-------------RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~--------------~~~l~~~~-------------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
++|.++|+|+|||... +.+|.++| |+|||+.|||+..++.+.|+|+|+|-...
T Consensus 288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999999999642 34566665 78999999999999999999999997765
Q ss_pred CCCc---ceeeccccccCccCccccCCCC----C--CcccchHhHHHHHHHHHhC----------CCCCCCCCCCCCccc
Q 035768 274 DCES---HVSTVVAGTIGYVPPEYGGTGK----A--TERGDVYSFGVILLELVTG----------KQPTGPEFEDKDGEN 334 (388)
Q Consensus 274 ~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~S~Gv~l~el~tg----------~~P~~~~~~~~~~~~ 334 (388)
.... ......+||.+|||||++.... + -..+||||||.|+||+.-+ +.||++....+...
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~- 446 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF- 446 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH-
Confidence 4321 2234567999999999875422 1 2358999999999999863 46776644322221
Q ss_pred HHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
+-++......+....++.. -.+.+.+..+.++|..||..+|.-|-|+
T Consensus 447 --eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 447 --EEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred --HHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 1122222222222222221 1256788899999999999999999774
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=283.80 Aligned_cols=217 Identities=22% Similarity=0.325 Sum_probs=169.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC--CCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD--GKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|.+.+ +..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 467888999999999999998543 3689999986432 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+++|+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++..... .
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----c
Confidence 9999999999988542 23556676 4678899999999999999999999876432 2
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +.....+.+.. ... . + | ..
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~~~~~~~i~~----~~~-~-~-p---~~- 250 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN----EPLLIYQKILE----GII-Y-F-P---KF- 250 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC----CHHHHHHHHhc----CCC-C-C-C---CC-
Confidence 2356999999999998888999999999999999999999998532 22222222211 110 0 0 1 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
....+.+++.+|++.||++|+
T Consensus 251 ---~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 251 ---LDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred ---CCHHHHHHHHHHcccCHHHcC
Confidence 112567899999999999996
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=280.60 Aligned_cols=215 Identities=23% Similarity=0.309 Sum_probs=165.6
Q ss_pred CeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
+.||+|+||.||++.. .+|+.||+|.++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987532 223346778999999999999999999999999999999999999
Q ss_pred CHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccccc
Q 035768 228 SLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 228 ~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
+|.+++... ..++.|+| |+||+|+|||+++++.+||+|||+++...... .......||+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCc
Confidence 998877532 33566777 45788999999999999999999987643221 1223356899
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
.|+|||.+.+..++.++|||||||++|||++|+.||... +.....+.+.. ...... . .....
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~~~~--~~~~~p--------~----~~~~~ 221 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELILM--EEIRFP--------R----TLSPE 221 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHhc--CCCCCC--------C----CCCHH
Confidence 999999998889999999999999999999999998532 22222222111 000111 1 11235
Q ss_pred HHHHHHhcccCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPT 385 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt 385 (388)
+.+++.+||+.||++||+
T Consensus 222 ~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHccCCHHHhCC
Confidence 788999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=274.57 Aligned_cols=226 Identities=29% Similarity=0.498 Sum_probs=173.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC------CCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||.||+|...+ ++.||||.++..... ....|.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 456777899999999999998633 478999999765443 3467999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhccC-----------------------------CCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 219 LVYEYMVKGSLDDWLRNQA-----------------------------ASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~-----------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
+||||+++|+|.++++... .++.++| |.+|+|+||+++.++.+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 9999999999999986421 1334455 45788999999999999999
Q ss_pred ccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHh
Q 035768 265 DFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 265 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||... +..+..+.+..
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~----~~~~~~~~~~~- 239 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL----SNEEVIECITQ- 239 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHc-
Confidence 9999986533222 11223345788999999998999999999999999999999 99997432 22333333321
Q ss_pred hccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+..... .......+.+++.+||+.||++|||+.|
T Consensus 240 ---~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e 273 (280)
T cd05049 240 ---GRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKD 273 (280)
T ss_pred ---CCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 111110 0112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.76 Aligned_cols=225 Identities=24% Similarity=0.369 Sum_probs=180.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe-eEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE-KLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 221 (388)
++|...+.+|+|+||.++..+++ +++.+++|++.-.. ....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777899999999999999875 57899999987543 3344568899999999999999999999998888 89999
Q ss_pred eccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 222 EYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
+||+||+|.+.+... ..++.|+| |+|+++.||++..+..+||+|||+|+.+..... .
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-L 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh-h
Confidence 999999999987543 23556666 678999999999999999999999999876543 3
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....||+.||.||.+.+.+|+.|+||||+||++|||++-+++|.. .+...++..+.... .+|
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a----~~m~~Li~ki~~~~--------~~P----- 225 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA----SNMSELILKINRGL--------YSP----- 225 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc----cchHHHHHHHhhcc--------CCC-----
Confidence 3456799999999999999999999999999999999999999743 24444443332221 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.....++..++..|+..+|+.||++.|
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~ 254 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALE 254 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHH
Confidence 12223336888999999999999999753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=278.85 Aligned_cols=215 Identities=27% Similarity=0.410 Sum_probs=165.2
Q ss_pred CeeeccCCceEEEEEc----CCCCEEEEEEcccCC----CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 152 NVIGGGGFGTVFKGTM----PDGKTVAVKKLSQAT----GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+.||+|+||.||+++. .+++.||+|.++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999987532 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+++|+|.+++.+. ..++.|+| |+||+|+|||++.++.+||+|||+++....... .....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTF 160 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-ccccc
Confidence 9999999887532 33566777 457889999999999999999999975433222 22335
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
.||+.|+|||++....++.++|||||||++|||++|+.||... +.......+ ... .. . +.+ .
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~----~~~~~~~~~---~~~-~~-~-~~~----~---- 222 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE----NRKKTIDKI---LKG-KL-N-LPP----Y---- 222 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC----CHHHHHHHH---HcC-CC-C-CCC----C----
Confidence 6999999999998888999999999999999999999998532 222222211 111 10 0 011 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt 385 (388)
....+.+++.+||+.+|++||+
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCC
Confidence 1225789999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=286.62 Aligned_cols=231 Identities=21% Similarity=0.245 Sum_probs=174.2
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
..++|...+.||+|+||.||+++.. +++.||+|.+++.. ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999964 68899999986432 1233457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 220 VYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||||+++|+|.+++++. ..+|.|+| |+||+|+|||++.++.+||+|||+++..........
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 99999999999987642 23566777 457889999999999999999999987654332233
Q ss_pred eccccccCccCccccCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 281 TVVAGTIGYVPPEYGGTG----KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
....||+.|+|||.+... .++.++|||||||++|||++|+.||... +.......+ ......... |.
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i---~~~~~~~~~--~~- 270 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKI---MDHKNSLTF--PD- 270 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC----CHHHHHHHH---HcCCCcCCC--CC-
Confidence 345799999999987543 4789999999999999999999998532 222222222 111110011 10
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCC--CCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTV--RPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~--RPt~~e 388 (388)
.......+.+++.+|++.+|.+ |||++|
T Consensus 271 ----~~~~s~~~~~li~~~L~~~p~r~~R~s~~e 300 (370)
T cd05596 271 ----DIEISKQAKDLICAFLTDREVRLGRNGVDE 300 (370)
T ss_pred ----cCCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence 0011236788999999999987 998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=277.06 Aligned_cols=217 Identities=26% Similarity=0.368 Sum_probs=164.7
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhc-CCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGM-VKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 58899999987532 2233455667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCC
Confidence 9999887532 33566777 45788999999999999999999998653322 223345699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||.+.+..++.++|||||||++|||++|+.||... +...+...+.. . . ..+. . ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~----~~~~~~~~i~~---~-~--~~~~----~----~~~~ 221 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----DEDELFDSILN---D-R--PHFP----R----WISK 221 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHc---C-C--CCCC----C----CCCH
Confidence 9999999998889999999999999999999999998532 22222222211 1 0 0000 1 1122
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 577899999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.36 Aligned_cols=221 Identities=23% Similarity=0.371 Sum_probs=177.1
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcCh---HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+|++.+.||+|.||.|-++.. ..|+.||||.+++....+. -.+.+|++||+.|+||||+.+|.+|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 566778899999999999984 6899999999987654443 347899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|..+|+|+||+.. ...++.|+| |+|++.+|||+|.++++||+|||++..+.+. ....+
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfLqT 211 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFLQT 211 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--cHHHH
Confidence 9999999999854 234567777 4578889999999999999999999877543 33456
Q ss_pred cccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
+||++-|.+||...+.+| ++..|-||+||+||.|+.|..||+.. +...++..+. .+...+ |...
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~----Dhk~lvrQIs----~GaYrE---P~~P---- 276 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR----DHKRLVRQIS----RGAYRE---PETP---- 276 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc----hHHHHHHHhh----cccccC---CCCC----
Confidence 899999999999999888 67899999999999999999998542 3333333332 222222 2111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....-|+.+++..+|++|.|+.|
T Consensus 277 ----SdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 277 ----SDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred ----chHHHHHHHHHhcCcccchhHHH
Confidence 13556888999999999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=279.60 Aligned_cols=215 Identities=24% Similarity=0.323 Sum_probs=166.0
Q ss_pred CeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997532 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccccc
Q 035768 228 SLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 228 ~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++...... .......||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTP 159 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCc
Confidence 998877532 33566777 45788999999999999999999997643221 1223456999
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
.|+|||.+.+..++.++|||||||++|||++|+.||... +...+.+.+. .. . . .+... ....
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~----~~~~~~~~~~---~~-~---~---~~p~~----~~~~ 221 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFELIL---ME-D---I---KFPRT----LSAD 221 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC----CHHHHHHHhc---cC-C---c---cCCCC----CCHH
Confidence 999999998889999999999999999999999998532 2222222211 11 0 0 00011 1235
Q ss_pred HHHHHHhcccCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPT 385 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt 385 (388)
+.+++.+||+.||++||+
T Consensus 222 ~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHHHHHHcCCCHHHcCC
Confidence 788999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.45 Aligned_cols=226 Identities=28% Similarity=0.499 Sum_probs=172.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC------CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||.||+|.... ...||+|.++.... .....|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998533 25799999875432 23456899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCCCCEE
Q 035768 219 LVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDDFEAK 262 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~k 262 (388)
++|||+++|+|.+++... ..++.++| |.+|+|+||++++++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 999999999999988642 11344555 458889999999999999
Q ss_pred EcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHH
Q 035768 263 ISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVL 340 (388)
Q Consensus 263 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~ 340 (388)
|+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||... ...++.+.+.
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~----~~~~~~~~i~ 240 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF----SNQEVIEMIR 240 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHH
Confidence 999999986543221 12223446788999999888899999999999999999998 99997542 2233333332
Q ss_pred HhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...... ......++.+++.+||+.||.+|||+.|
T Consensus 241 ~----~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~ 275 (283)
T cd05048 241 S----RQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKD 275 (283)
T ss_pred c----CCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 2 111111 1122347889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.14 Aligned_cols=221 Identities=22% Similarity=0.333 Sum_probs=166.9
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEE
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETL---GMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
|...+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456788999999999999864 68999999997532 12234566676654 567899999999999999999999
Q ss_pred EeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 221 YEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|||+++|+|..+++.. ..++.|+| |+||+|+||+++.++.+||+|||+++...... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-Cccc
Confidence 9999999998877532 23566677 45788999999999999999999987543222 2223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||... +..++...+.. . .. .-| .
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~----~~~~~~~~i~~---~-~~---~~p---~--- 222 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD----DEEEVFDSIVN---D-EV---RYP---R--- 222 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh---C-CC---CCC---C---
Confidence 456999999999998889999999999999999999999998532 22222222211 1 00 000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.....+.+++.+||+.||.+||++.
T Consensus 223 -~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 223 -FLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred -CCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 1123578899999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=272.28 Aligned_cols=227 Identities=28% Similarity=0.466 Sum_probs=177.4
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+..+|...+.||.|+||.||+|...+++.+|+|.+..........+.+|+++++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567788999999999999999888999999999876555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.++++... .++.++| |.+|+|+||++++++.+||+|||++.......... .
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~-~ 162 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS-S 162 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc-c
Confidence 99999999986421 2345555 45788999999999999999999998764432221 2
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...++..|+|||......++.++||||||+++|||++ |+.||... ...+....+....... .
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~------~------- 225 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM----NNHEVYDQITAGYRMP------C------- 225 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC----CHHHHHHHHHhCCcCC------C-------
Confidence 3345678999999888889999999999999999999 89997432 2233333332111100 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++|||++|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKA 253 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 1112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=266.76 Aligned_cols=224 Identities=28% Similarity=0.429 Sum_probs=172.1
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+|...+.||+|+||.||+|.+.++..+|+|.++... ....+|.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466778899999999999998777789999987543 3356799999999999999999999999988899999999999
Q ss_pred CCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 227 GSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 227 g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
|+|.+++.... .++.++| |.+|+|+||+++.++.+||+|||.++..............+
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCcc
Confidence 99999986432 2345555 45778999999999999999999998764433222222335
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|+|||......++.++|||||||++|||++ |..||... ...++...+...... . .+. ..
T Consensus 164 ~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~----~--~~~-------~~ 226 (256)
T cd05113 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF----NNSETVEKVSQGLRL----Y--RPH-------LA 226 (256)
T ss_pred ChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC----CHHHHHHHHhcCCCC----C--CCC-------CC
Confidence 678999999988889999999999999999999 99997532 222233322211110 0 010 11
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.+|.+|||+.+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQ 250 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHH
Confidence 246889999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=273.03 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=172.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 688999999875432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ |+|.+++... ..+|.++| |+||+|+|||++.++.+||+|||+++....... ....
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~ 162 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSN 162 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccC
Confidence 96 5898877532 23566666 457889999999999999999999986543221 1223
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---cc---------
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---AD--------- 349 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------- 349 (388)
..|++.|+|||.+.+ ..++.++||||+||++|||+||+.||... +..+....+........ ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS----TVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 457899999998754 56899999999999999999999998532 22222222222211110 00
Q ss_pred ccCCccccCCC----CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNAN----SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~----~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+...... ......++.+++.+|++.||.+|||++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 00111100000 0011235789999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=272.04 Aligned_cols=226 Identities=28% Similarity=0.468 Sum_probs=170.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|+..+.||+|+||.||+|.. .++..||+|.+..... .....|.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3466778999999999999984 2467899999975432 233578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc--------------------------------CCCCCHHh-----hhccccCCeeecCCCCEE
Q 035768 220 VYEYMVKGSLDDWLRNQ--------------------------------AASLDWGK-----RCKIVASNILLNDDFEAK 262 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~--------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~k 262 (388)
||||+++|+|.+++... ..++.|+| |.+|+|+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999999988421 22455666 457889999999999999
Q ss_pred EcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHH
Q 035768 263 ISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVL 340 (388)
Q Consensus 263 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~ 340 (388)
|+|||+++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||... ....+.+.+.
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~----~~~~~~~~~~ 240 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF----SNQEVIEMVR 240 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHH
Confidence 999999987543221 12223345678999999988889999999999999999999 88887432 2223333332
Q ss_pred HhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ..... . .......+.+++.+||+.||++||++.+
T Consensus 241 ~----~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 241 K----RQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred c----CCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 2 11110 0 0111236788999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=273.86 Aligned_cols=221 Identities=33% Similarity=0.581 Sum_probs=161.8
Q ss_pred CCeeeccCCceEEEEEcC-----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 151 ENVIGGGGFGTVFKGTMP-----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.+.||.|+||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999975 256899999965433 23578999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhcc-CC----------------CCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccCCCc-ceee
Q 035768 225 VKGSLDDWLRNQ-AA----------------SLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISDCES-HVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~-~~----------------~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~~ 281 (388)
++|+|.++|+.. .. ++.|+|.. ++.++||+++.++.+||+|||+++....... ....
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~ 163 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS 163 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999765 22 34555543 4558999999999999999999988733222 2223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+...|+|||.+....++.++||||||+++|||++ |+.||... +..++...+..... ... +
T Consensus 164 ~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~~~~~~~----~~~--~------ 227 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEKLKQGQR----LPI--P------ 227 (259)
T ss_dssp TSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHHHHTTEE----TTS--B------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccccc----cee--c------
Confidence 3446789999999988889999999999999999999 67886432 33334333322111 110 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++||||.|
T Consensus 228 -~~~~~~~~~li~~C~~~~p~~RPs~~~ 254 (259)
T PF07714_consen 228 -DNCPKDIYSLIQQCWSHDPEKRPSFQE 254 (259)
T ss_dssp -TTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred -cchhHHHHHHHHHHcCCChhhCcCHHH
Confidence 011236889999999999999999864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=283.47 Aligned_cols=173 Identities=22% Similarity=0.246 Sum_probs=145.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
..+|...+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999985 4688999997532 3578999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 224 MVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 224 ~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+ .++|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+|+.............
T Consensus 165 ~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 165 Y-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred C-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 9 4788877643 234677777 568889999999999999999999976433222223345
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
.||+.|+|||++....++.++|||||||++|||+||+.|+.
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 79999999999988899999999999999999999998864
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=272.43 Aligned_cols=228 Identities=26% Similarity=0.450 Sum_probs=171.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
.+++|+..+.||+|+||.||+|.+. .+..||||++..... ....+|.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999998753 256799999864322 234568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhcc-------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ-------------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~-------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
.++||||+++|+|.+++++. +.++.++| |.+++|+||++++++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 99999999999999998642 12344555 4578899999999999999999
Q ss_pred ccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 267 GLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 267 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
|+++......... .....+++.|+|||++....++.++|||||||++|||++ |..||... ......+.+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~----~~~~~~~~~~~--- 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM----SNEQVLRFVME--- 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHc---
Confidence 9998654322211 112345778999999988889999999999999999999 68887432 22233322211
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... .......+.+++.+||+.+|++|||+.|
T Consensus 237 -~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e 270 (277)
T cd05062 237 -GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLE 270 (277)
T ss_pred -CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 111110 0112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=270.78 Aligned_cols=239 Identities=22% Similarity=0.311 Sum_probs=171.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888999999999999999965 688999999875432 223467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|++ ++|.+++.+. ..++.|+| |+||+|+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 161 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYS 161 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCC
Confidence 995 6887776532 23566666 46788999999999999999999997653322 1223
Q ss_pred ccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc--------ccC
Q 035768 282 VVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD--------EVL 352 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 352 (388)
...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... +..+..+.+.......... ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK---DIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc---cHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 3458999999998754 468899999999999999999999986421 1122222222111110000 000
Q ss_pred Ccccc---CCCC-H------HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVL---NANS-K------PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~---~~~~-~------~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
++... .... . .....+.+++.+|++.||++|||+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~ 284 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence 00000 0000 0 01235778999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=283.98 Aligned_cols=225 Identities=22% Similarity=0.299 Sum_probs=169.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999964 68999999997532 223345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc---
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH--- 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~--- 278 (388)
||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999987542 33566777 5578899999999999999999999765321100
Q ss_pred ----------------------------------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 279 ----------------------------------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 279 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
.....+||+.|+|||++....++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112469999999999988899999999999999999999999985
Q ss_pred CCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 325 PEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
.. +.......+... ...... +. .......+.+++.+|+. +|.+|++
T Consensus 241 ~~----~~~~~~~~i~~~---~~~~~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 241 SD----NPQETYRKIINW---KETLQF--PD-----EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CC----CHHHHHHHHHcC---CCccCC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 32 222222222111 000000 10 00112256778888886 8999997
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=283.20 Aligned_cols=185 Identities=25% Similarity=0.319 Sum_probs=153.0
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
+....++|+..+.||+|+||.||+++.. +++.+|+|.+.+.. ......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445578999999999999999999965 58899999986422 2234458899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
.++||||+++|+|.+++.+. ..+|.++| |+||+|+|||+++++.+||+|||+++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999999999988642 23566777 467889999999999999999999987654333
Q ss_pred ceeeccccccCccCccccCCC----CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGTG----KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.......||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 233456799999999987643 378899999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=268.88 Aligned_cols=224 Identities=28% Similarity=0.462 Sum_probs=171.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+|...+.||+|+||.||+|... +++.||+|.+.... ....++.+|++++++++||||+++++++..++..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4667788999999999999965 58899999987542 335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+|+|.+++... ..++.++| |.+|+|+||++++++.+||+|||+++.............
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 165 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence 99999988542 12345555 457889999999999999999999987654322222222
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.++..|+|||...+..++.++|||||||++|||++ |..||... +..+..+.+..... +.. ..
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~~~~~~~~~~~~~~---------~~~----~~ 228 (263)
T cd05052 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKGYR---------MER----PE 228 (263)
T ss_pred CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHCCCC---------CCC----CC
Confidence 34668999999988899999999999999999998 88887432 22222222211110 000 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.+|++|||+.|
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHH
Confidence 12236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=278.44 Aligned_cols=228 Identities=20% Similarity=0.255 Sum_probs=172.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||++... +++.||+|.++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36788899999999999999864 688999999975422 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+++|+|.+++.+. ..+|.++| |+||+|+|||++.++.+||+|||+++.+........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999988653 22455666 567889999999999999999999987754433333
Q ss_pred eccccccCccCccccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 281 TVVAGTIGYVPPEYGG------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
....||+.|+|||++. ...++.++|||||||++|||++|+.||... ....... ............+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~~~---~i~~~~~~~~~~~- 232 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG----TSAKTYN---NIMNFQRFLKFPE- 232 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC----CHHHHHH---HHHcCCCccCCCC-
Confidence 4456899999999875 456789999999999999999999998532 1111111 1111111111100
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++..|+. +|++|||+.+
T Consensus 233 ------~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 233 ------DPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred ------CCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 00112357788899997 9999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=264.75 Aligned_cols=224 Identities=28% Similarity=0.475 Sum_probs=171.0
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+|...+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466788999999999999998777889999986433 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 227 GSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 227 g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|.++++... .++.++| |.+|+|+||++++++.+||+|||+++...+..........+
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCC
Confidence 99999986432 2345555 45788999999999999999999998764322222222224
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|+|||......++.++||||||+++|||++ |+.||... +..+....+..... ...+ ...
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~~~------~~~~-------~~~ 226 (256)
T cd05059 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF----SNSEVVESVSAGYR------LYRP-------KLA 226 (256)
T ss_pred CccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC----CHHHHHHHHHcCCc------CCCC-------CCC
Confidence 467999999988899999999999999999999 78887532 22222222211110 0001 112
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.+|++||||.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHH
Confidence 336889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=270.36 Aligned_cols=219 Identities=25% Similarity=0.315 Sum_probs=165.1
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||+|+||+||++... +++.||+|++..... ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 688999999865322 2234678899999999999999999999999999999999999999
Q ss_pred HHHHhc-------------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 230 DDWLRN-------------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 230 ~~~l~~-------------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
.+++.. ...++.|+| |+||+|+||++++++.+||+|||+++.+...... .....|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccccCC
Confidence 877632 123456666 4578899999999999999999999876443222 233468
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......... .... .......
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~-~~~~----------~~~~~~~ 225 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRIL-NDSV----------TYPDKFS 225 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhc-ccCC----------CCcccCC
Confidence 999999999999999999999999999999999999985421111 1111111111 1100 0011123
Q ss_pred HHHHHHHHhcccCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
..+.+++.+||+.||++||+++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCC
Confidence 3678999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=269.19 Aligned_cols=220 Identities=24% Similarity=0.282 Sum_probs=165.2
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||+|+||.||+++.. +|+.||+|++..... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 589999999864321 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhc-----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccccc
Q 035768 230 DDWLRN-----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 230 ~~~l~~-----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
.+++.. ...++.++| |.+|+|+||++++++.++|+|||++....... ......|+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCC
Confidence 887642 223456666 45788999999999999999999998764422 223346899
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
.|+|||++....++.++|||||||++|||++|+.||....... ........... .... .. ......+
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~-~~~~-~~--------~~~~~~~ 225 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLE-DEVK-FE--------HQNFTEE 225 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhc-cccc-cc--------cccCCHH
Confidence 9999999988889999999999999999999999985421111 11111111111 1100 00 0112235
Q ss_pred HHHHHHhcccCCCCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+++.+||+.||++||+++|
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred HHHHHHHHhccCHhhCCCCcc
Confidence 789999999999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=278.58 Aligned_cols=218 Identities=26% Similarity=0.350 Sum_probs=168.2
Q ss_pred CeeeccCCceEEEEEc----CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 152 NVIGGGGFGTVFKGTM----PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3588999999975322 233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 226 KGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 226 ~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
+|+|.+++.. ...+|.|+| |.||+|+|||++.++.+||+|||+++....... ......|
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCG 160 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceecccC
Confidence 9999988753 233566777 457889999999999999999999986543322 2234568
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|+|||.+....++.++|||||||++|||++|+.||... +.......+.... ..... ...
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~----~~~~~~~~i~~~~--~~~p~------------~~~ 222 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK----DRKETMTMILKAK--LGMPQ------------FLS 222 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC----CHHHHHHHHHcCC--CCCCC------------CCC
Confidence 99999999998888999999999999999999999998532 2222222221100 00111 112
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.||++|||+.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 25778999999999999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=283.50 Aligned_cols=179 Identities=24% Similarity=0.310 Sum_probs=147.7
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.|...+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477788999999999999985 468899999997532 1234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-----
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES----- 277 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~----- 277 (388)
|+++|+|.+++.+. ..++.++| |+||+|+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999987542 23566666 457889999999999999999999864311000
Q ss_pred -----------------------------------------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHH
Q 035768 278 -----------------------------------------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLEL 316 (388)
Q Consensus 278 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el 316 (388)
.......||+.|+|||.+....++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 001234699999999999888899999999999999999
Q ss_pred HhCCCCCCC
Q 035768 317 VTGKQPTGP 325 (388)
Q Consensus 317 ~tg~~P~~~ 325 (388)
+||+.||..
T Consensus 242 ltG~~Pf~~ 250 (381)
T cd05626 242 LVGQPPFLA 250 (381)
T ss_pred HhCCCCCcC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=268.79 Aligned_cols=230 Identities=22% Similarity=0.337 Sum_probs=173.6
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999985 568899999986542 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHH-----------hccCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccC
Q 035768 225 VKGSLDDWL-----------RNQAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288 (388)
Q Consensus 225 ~~g~L~~~l-----------~~~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~ 288 (388)
++|+|..+. .+...++.++|. .+|+|+||+++.++.+||+|||++...... ......||..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~ 158 (279)
T cd06619 82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNA 158 (279)
T ss_pred CCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChh
Confidence 999987543 234456777774 467799999999999999999999866432 1233568999
Q ss_pred ccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHH
Q 035768 289 YVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368 (388)
Q Consensus 289 y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 368 (388)
|+|||.+....++.++||||||+++|||++|+.||.................... .... +.... .....++
T Consensus 159 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~---~~~~~~~ 229 (279)
T cd06619 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDP-----PVLPV---GQFSEKF 229 (279)
T ss_pred hcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCC-----CCCCC---CcCCHHH
Confidence 9999999888899999999999999999999999865332221111111111111 1110 11100 1112357
Q ss_pred HHHHHhcccCCCCCCCCCCC
Q 035768 369 LQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 369 ~~l~~~C~~~~P~~RPt~~e 388 (388)
.+++.+||+.+|++||+++|
T Consensus 230 ~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 230 VHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred HHHHHHHhhCChhhCCCHHH
Confidence 89999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=271.65 Aligned_cols=235 Identities=23% Similarity=0.311 Sum_probs=166.8
Q ss_pred CCCcCCeeeccCCceEEEEEc-C-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcC---CCCCccceeeEEEe-----C
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-P-DGKTVAVKKLSQATG--QGDREFAAEMETLGMV---KHQNLVELLGYCSV-----D 214 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~ 214 (388)
+|...+.||+|+||+||+|+. . +++.||+|.++.... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999986 3 467899999865332 2234567788777665 69999999999853 4
Q ss_pred CeeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceec
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
...++||||++ ++|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 56889999995 6888887532 23556666 5578899999999999999999999876
Q ss_pred cCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc---
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD--- 349 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 349 (388)
... .......||+.|+|||.+....++.++|||||||++|||++|++||... ...+....+..........
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~----~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS----SDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhch
Confidence 432 2223456899999999998888999999999999999999999998542 2222222222221110000
Q ss_pred -------ccCCccccC---CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 -------EVLDPAVLN---ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 -------~~~~~~~~~---~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+.... .........+.+++.+|++.||++|||+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 000000000 000112235679999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=273.02 Aligned_cols=217 Identities=24% Similarity=0.337 Sum_probs=166.1
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhc-CCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGM-VKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||+|... +++.||||.++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987542 2233456778888876 4999999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++....... ......||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeeecCC
Confidence 9999988642 23566676 457889999999999999999999976432221 22345689
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||... +..++.+.+.. .. ... | . ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~~~~~~~~i~~----~~--~~~-~---~----~~~~ 221 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH----DEEELFQSIRM----DN--PCY-P---R----WLTR 221 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh----CC--CCC-C---c----cCCH
Confidence 9999999998889999999999999999999999998532 22333332221 10 000 1 0 1122
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHHHHHHhccCHhhcCCCh
Confidence 577899999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=274.80 Aligned_cols=216 Identities=23% Similarity=0.363 Sum_probs=166.6
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||+|... +++.||||.+++.. ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 58899999987532 23345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGT 159 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccC
Confidence 9999887532 33566777 45788999999999999999999987643222 222345699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||.+....++.++|||||||++|||++|+.||... +...+.+.+.. . . ...+. ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~~~~i~~---~-~---~~~~~-------~~~~ 221 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE----NEDDLFEAILN---D-E---VVYPT-------WLSQ 221 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC----CHHHHHHHHhc---C-C---CCCCC-------CCCH
Confidence 9999999998889999999999999999999999998532 22233322221 1 1 11111 1123
Q ss_pred HHHHHHHhcccCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~ 386 (388)
.+.+++.+|++.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 57889999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=267.19 Aligned_cols=228 Identities=23% Similarity=0.346 Sum_probs=173.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|+.. +++.||||.++... ......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999964 68999999876432 222346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc-------------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 222 EYMVKGSLDDWLRN-------------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~-------------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||+++|+|.+++.. ...++.++|. .+|+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999987742 1224556664 46889999999999999999999987643221
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......|++.|+|||...+..++.++||||||+++|||++|+.||..... +...+.+.+. .... +..
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~----~~~~-----~~~- 228 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKIE----QCDY-----PPL- 228 (267)
T ss_pred -HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHHHHHh----cCCC-----CCC-
Confidence 11234588899999998888899999999999999999999999853211 1122222211 1111 100
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........+.+++.+||+.+|++|||+.|
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 257 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGY 257 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHH
Confidence 01123346889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=263.62 Aligned_cols=226 Identities=28% Similarity=0.474 Sum_probs=172.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|.+.. ...||||.++.... .....|.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998642 45799999875432 2345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~- 278 (388)
|||+++|+|.+++.... .++.++| |.+|+|+||++++++.+||+|||+++........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 99999999999986432 2345555 4578899999999999999999999877522221
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......++..|+|||......++.++||||||+++|||++ |..||... ....+.+.+....... .
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~------~---- 229 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM----SNQDVIKAVEDGYRLP------P---- 229 (266)
T ss_pred eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHHcCCCCC------C----
Confidence 2222335678999999988899999999999999999998 99997432 2233333332211100 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++||++.|
T Consensus 230 ---~~~~~~~l~~li~~cl~~~p~~Rp~~~e 257 (266)
T cd05033 230 ---PMDCPSALYQLMLDCWQKDRNERPTFSQ 257 (266)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 0112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=282.62 Aligned_cols=227 Identities=25% Similarity=0.325 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+|... +++.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999965 68999999987532 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-----
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE----- 276 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~----- 276 (388)
||+++|+|.+++... ..+|.++| |.||+|+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999988543 23566776 45788999999999999999999998764432
Q ss_pred -----------------------cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcc
Q 035768 277 -----------------------SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGE 333 (388)
Q Consensus 277 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~ 333 (388)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~----~~~ 236 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD----TLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC----CHH
Confidence 11223356899999999999889999999999999999999999998542 111
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-CC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT-ML 387 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-~~ 387 (388)
.....+......... |.. ......+.+++.+|+. ||.+||+ ++
T Consensus 237 ~~~~~i~~~~~~~~~-----p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 237 ETYNKIINWKESLRF-----PPD-----PPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred HHHHHHhccCCcccC-----CCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 111111110000000 000 0022367889999997 9999999 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=290.32 Aligned_cols=222 Identities=31% Similarity=0.470 Sum_probs=175.7
Q ss_pred CcCCeeeccCCceEEEEEc-CCC----CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 149 CEENVIGGGGFGTVFKGTM-PDG----KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
...++||+|+||+||+|.+ +.| .+||+|.+..... +...+++.|+-+|.+++|||+++++|+|..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467899999999999985 444 3689999876543 45678999999999999999999999998766 889999
Q ss_pred ccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee-
Q 035768 223 YMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS- 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~- 280 (388)
|||.|+|.+|++.+ +.++.|++ |+|++++|||+..-..+||.|||+|+.+..+.....
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 99999999998754 33555654 678999999999999999999999999866544332
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....-.+.|||-|.+....|+.++|||||||++||++| |..|++.. ...++.+.+....+ ...
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi----~~~eI~dlle~geR------Lsq------ 921 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI----PAEEIPDLLEKGER------LSQ------ 921 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC----CHHHhhHHHhcccc------CCC------
Confidence 22334578999999999999999999999999999999 99997543 34455554433221 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
++.+...+..++.+||..|+..||++++
T Consensus 922 -PpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 922 -PPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred -CCCccHHHHHHHHHHhccCcccCccHHH
Confidence 2233446889999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.84 Aligned_cols=229 Identities=26% Similarity=0.365 Sum_probs=173.5
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC----
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE---- 215 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 215 (388)
...++|...+.||+|+||+||+|+. .+++.||||.+.... ......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 468999999986543 233456889999999999999999988775432
Q ss_pred ----eeEEEEeccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccc
Q 035768 216 ----EKLLVYEYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFG 267 (388)
Q Consensus 216 ----~~~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG 267 (388)
..++||||+++|+|.++++.. ..+|.|+| |+||+|+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 367999999999999988532 23456666 56889999999999999999999
Q ss_pred cceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 268 LARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 268 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
+++....... .......||+.|+|||++....++.++|||||||++|||++|+.||... +..++.. .... .
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~---~~~~-~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMH---KTLA-G 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHH---HHhc-C
Confidence 9987643221 1223456999999999999889999999999999999999999998532 2222222 2111 1
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... +. ......+.+++.+||+.||.+|||+.|
T Consensus 261 ~~~~-~~--------~~~~~~l~~li~~~L~~dP~~RPs~~e 293 (496)
T PTZ00283 261 RYDP-LP--------PSISPEMQEIVTALLSSDPKRRPSSSK 293 (496)
T ss_pred CCCC-CC--------CCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 1110 11 112236889999999999999999753
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=273.92 Aligned_cols=221 Identities=22% Similarity=0.299 Sum_probs=169.5
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQ-NLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ 221 (388)
+|...+.||+|+||.||+|... +++.||||+++... ....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677889999999999999865 57899999987532 23345688899999999765 5888999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Ccee
Confidence 999999999887532 33567777 45788999999999999999999987542221 1223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||++.+..++.++|||||||++|||+||+.||... +..++...+.... .... ..
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~----~~~~~~~~i~~~~--~~~~--------~~-- 223 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----DEDELFQSIMEHN--VSYP--------KS-- 223 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCC--CCCC--------CC--
Confidence 456999999999999889999999999999999999999998532 2223332222110 0001 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
....+.+++.+||+.||.+||+.
T Consensus 224 --~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 224 --LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCC
Confidence 12257889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=271.63 Aligned_cols=226 Identities=27% Similarity=0.488 Sum_probs=171.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.+|...+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999974 2345699999876554555679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhccC----------------------------CCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
||||+++|+|.+++.... .++.++| |++|+|+||++++++.+||+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 999999999999886321 2344555 4578899999999999999999
Q ss_pred ccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 267 GLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 267 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
|+++........ ......++..|+|||.+....++.++|||||||++|||+| |..||... ...+....+..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~----~~~~~~~~i~~--- 237 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL----SNNEVIECITQ--- 237 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHc---
Confidence 999865432211 1122335778999999988889999999999999999999 88887432 22223222211
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... + . .....+.+++.+||+.||.+|||+.|
T Consensus 238 -~~~~~~--~---~----~~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 238 -GRVLQR--P---R----TCPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred -CCcCCC--C---C----CCCHHHHHHHHHHccCChhhCCCHHH
Confidence 111110 0 1 11236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=274.27 Aligned_cols=224 Identities=20% Similarity=0.320 Sum_probs=168.2
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
++||+|+||.||++... +++.||+|.+++... .....+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 688999999975422 2234578899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..++.|+| |.||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCC
Confidence 9999887432 33566777 45788999999999999999999997532211 122345799
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC-CcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK-DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+.|+|||++.+..++.++|||||||++|||+||+.||....... ......++........... + | .. ..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--p---~~----~~ 229 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-I--P---RS----LS 229 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-C--C---CC----CC
Confidence 99999999998899999999999999999999999986321111 1112223333322221110 0 0 11 12
Q ss_pred HHHHHHHHhcccCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~ 386 (388)
..+.+++.+||+.||.+|||+
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCC
Confidence 357889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=260.99 Aligned_cols=220 Identities=26% Similarity=0.411 Sum_probs=167.5
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHH
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLD 230 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 230 (388)
++||+|+||.||+|...+++.+|+|.++..... ....|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998765432 2346889999999999999999999999999999999999999999
Q ss_pred HHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCc
Q 035768 231 DWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289 (388)
Q Consensus 231 ~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y 289 (388)
+++..... ++.++| |.+|+|+||+++.++.+||+|||++...............++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 160 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccc
Confidence 98864322 334445 457889999999999999999999976543222222223346789
Q ss_pred cCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHH
Q 035768 290 VPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368 (388)
Q Consensus 290 ~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 368 (388)
+|||+.....++.++||||||+++||+++ |..||... ........+.. ...... .......+
T Consensus 161 ~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~----~~~~~~~~~~~----~~~~~~---------~~~~~~~~ 223 (250)
T cd05085 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM----TNQQAREQVEK----GYRMSC---------PQKCPDDV 223 (250)
T ss_pred cCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHHHc----CCCCCC---------CCCCCHHH
Confidence 99999988889999999999999999999 99997532 22222222211 100000 01123468
Q ss_pred HHHHHhcccCCCCCCCCCCC
Q 035768 369 LQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 369 ~~l~~~C~~~~P~~RPt~~e 388 (388)
.+++.+||+.+|++|||+.|
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~ 243 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSE 243 (250)
T ss_pred HHHHHHHcccCcccCCCHHH
Confidence 89999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=273.07 Aligned_cols=217 Identities=24% Similarity=0.335 Sum_probs=166.1
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhc-CCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGM-VKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+|+.. +++.||+|.++... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999997532 2234456778888875 4899999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCCC
Confidence 9999887542 23566777 45788999999999999999999987542211 223346699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||... +...+.+.+... ....... ...
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~----~~~~~~~~~~~~--~~~~~~~------------~~~ 221 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD----DEDELFESIRVD--TPHYPRW------------ITK 221 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhC--CCCCCCC------------CCH
Confidence 9999999999889999999999999999999999998532 222333222111 0001111 122
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
++.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 577899999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=264.63 Aligned_cols=227 Identities=21% Similarity=0.317 Sum_probs=172.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-----cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-----QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 4689999999864321 123468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+||+++++|.+++... ..++.++| |.+|+|+||++++++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999887532 23556666 45678999999999999999999998664322211
Q ss_pred e--eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 280 S--TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 280 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
. ....|+..|+|||...+..++.++||||||+++|||++|+.||... +........ ........ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~---~~~~~~~~-----~- 228 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI---ATQPTNPQ-----L- 228 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chHHHHHHH---hccCCCCC-----C-
Confidence 1 2345788999999998888999999999999999999999997532 111111111 11111000 1
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||..+|.+|||+.|
T Consensus 229 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 229 ---PSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred ---CccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 1112236788999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=282.55 Aligned_cols=218 Identities=29% Similarity=0.413 Sum_probs=173.1
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||.|+||.||-++. .+.+.||||++.-+..+ ...+++.|+..|++++|||+|.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 45567899999999999995 46889999999755433 356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHh----------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLR----------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~----------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
| -|+-.|++. +...+|.|+| |+||++.|||+.+.|.+||+|||.|....+ ...
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans 181 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS 181 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence 9 567666653 2234678887 569999999999999999999999987644 345
Q ss_pred cccccCccCcccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 283 VAGTIGYVPPEYG---GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 283 ~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
++|||.|||||++ ..+.|+-|+||||+||+..||...++|+..+ +.+..+........ |.+.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-------NAMSALYHIAQNes------PtLq-- 246 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQNES------PTLQ-- 246 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-------hHHHHHHHHHhcCC------CCCC--
Confidence 7799999999975 4578999999999999999999999997432 33333334333221 1111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
..+....+.+++..|++.-|.+|||..
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse 273 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSE 273 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHH
Confidence 234455788999999999999999964
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=278.69 Aligned_cols=178 Identities=28% Similarity=0.405 Sum_probs=143.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 218 (388)
+|...+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3677889999999999999954 68999999987432 223456889999999999999999999886432 479
Q ss_pred EEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-
Q 035768 219 LVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES- 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~- 277 (388)
+||||+. ++|.+++.. ...+|.|+| |.||+|+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999994 789887753 234677777 457889999999999999999999986532211
Q ss_pred -ceeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 -HVSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 11233568999999998765 6789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=275.11 Aligned_cols=224 Identities=19% Similarity=0.306 Sum_probs=167.6
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+++.. +++.||+|.+++... .....+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 588999999975422 2334577888888776 899999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..++.|+| |+||+|+||+++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCC
Confidence 9998877432 33566777 45788999999999999999999997543221 122345689
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC-CcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK-DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||....... .......++......... . +. ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~p----~~~~ 229 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----IP----RSLS 229 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----CC----CCCC
Confidence 99999999998899999999999999999999999985321111 111222333332222111 0 00 1112
Q ss_pred HHHHHHHHhcccCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~ 386 (388)
..+.+++.+||+.||++|||.
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 357899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=270.50 Aligned_cols=227 Identities=23% Similarity=0.346 Sum_probs=174.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677888999999999999985 468899999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.+++.+. ..++.++| |.+|+|+||+++.++.+||+|||++........ ......|
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 178 (296)
T cd06654 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 178 (296)
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccC
Confidence 999999988642 23456666 457789999999999999999999876543221 1223458
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
++.|+|||......++.++|||||||++|||++|+.||.... ... +........ ...... .....
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~----~~~---~~~~~~~~~-~~~~~~-------~~~~~ 243 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLR---ALYLIATNG-TPELQN-------PEKLS 243 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC----HHH---hHHHHhcCC-CCCCCC-------ccccC
Confidence 899999999988888999999999999999999999985321 111 111111111 001101 11122
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||..+|++|||+.|
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHH
Confidence 35788999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=259.05 Aligned_cols=227 Identities=21% Similarity=0.301 Sum_probs=180.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|+..++||+|.|+.||++.+ ++|+.+|+|.++.. ...+.+++.+|++|.+.|+|||||++...+.+....|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4566678899999999999985 57999999988632 34466789999999999999999999999999999999999
Q ss_pred ccCCCCHHH---------------HHhccCCCCCHHhh-----hccccCCeeecC---CCCEEEcccccceeccCCCcce
Q 035768 223 YMVKGSLDD---------------WLRNQAASLDWGKR-----CKIVASNILLND---DFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 223 ~~~~g~L~~---------------~l~~~~~~l~~~~~-----~~i~~~NiLl~~---~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
+|.||+|.. +++|...+|+|+|. +|++|.|+|+.. .--+||+|||+|..+. ....
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~ 168 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEA 168 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--Cccc
Confidence 999999864 45667778999984 567799999954 3468999999999887 3345
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+|||+|||||++...+|+..+|||+.||+||-|+.|.+||.++ +...+.+.+....-. +++..++.
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rlye~I~~g~yd------~~~~~w~~ 238 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYEQIKAGAYD------YPSPEWDT 238 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhccccC------CCCcccCc
Confidence 55678999999999999999999999999999999999999998542 334444444332111 11211222
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ..+..+|+.+|+..||++|.|+.|
T Consensus 239 i----s~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 239 V----TPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred C----CHHHHHHHHHHhccChhhhccHHH
Confidence 2 225778999999999999999865
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.98 Aligned_cols=225 Identities=27% Similarity=0.443 Sum_probs=169.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCC----EEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGK----TVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.+|+..+.||+|+||.||+|.+. ++. .||+|.++.... ...+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999853 333 489999875432 3456789999999999999999999999764 5789
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||+++|+|.+++++.. .+|.|+| |+||+|+|||+++++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 999999999999886532 2456666 4578899999999999999999999876543222
Q ss_pred e-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 V-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
. .....++..|+|||.+....++.++|||||||++|||++ |+.||... ...++...+. ... ....+
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~----~~~~~~~~~~----~~~--~~~~~-- 233 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE----KGE--RLPQP-- 233 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHh----CCC--CCCCC--
Confidence 1 122234678999999988899999999999999999998 99997532 2222222221 111 00001
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+.|
T Consensus 234 -----~~~~~~~~~li~~cl~~~p~~Rps~~~ 260 (316)
T cd05108 234 -----PICTIDVYMIMVKCWMIDADSRPKFRE 260 (316)
T ss_pred -----CCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 011235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=273.01 Aligned_cols=221 Identities=23% Similarity=0.313 Sum_probs=169.7
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 221 (388)
+|...+.||+|+||.||+|... +++.||+|.+++... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999865 578999999875421 2234567788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cccc
Confidence 999999999887532 33566777 45788999999999999999999998643222 1223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||++....++.++|||||||++|||+||+.||... +...+.+.+... .. . + |
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~i~~~----~~-~-~-p------- 221 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEH----NV-A-Y-P------- 221 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC----CHHHHHHHHHhC----CC-C-C-C-------
Confidence 456999999999999999999999999999999999999998532 233333332221 10 0 0 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.....++.+++.+|++.+|++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112367889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=270.41 Aligned_cols=224 Identities=28% Similarity=0.338 Sum_probs=170.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+|+..+.||+|+||+||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3667789999999999999964 688999999865322 223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+++|+|.+++... ..++.++| |.+|+|+||++++++.++|+|||+++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--I 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--c
Confidence 99999999887532 12455666 457889999999999999999999987643221 2
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....|+..|+|||++....++.++|||||||++|||++|+.||... ......+.+........ .. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~-~~---------~ 224 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR----KEKVKREEVERRVKEDQ-EE---------Y 224 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC----chhhHHHHHHHHhhhcc-cc---------c
Confidence 2346899999999998888999999999999999999999998532 12112122222111111 00 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.......+.+++.+||+.||++||++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGC 250 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCC
Confidence 11123367899999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=277.47 Aligned_cols=215 Identities=23% Similarity=0.310 Sum_probs=165.8
Q ss_pred CeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
+.||+|+||.||++.. .+++.||+|.++... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997532 123356788999999999999999999999999999999999999
Q ss_pred CHHHHHhc---------------cCCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 228 SLDDWLRN---------------QAASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 228 ~L~~~l~~---------------~~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
+|.+++.. ...++.|+|. +||+|+|||++.++.+||+|||+++....... ......||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGT 159 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCC
Confidence 99987743 2345677773 57889999999999999999999976432221 22335699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||+||+.||... +...+.+.+.. ....... . ...
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~----~~~~~~~~i~~--~~~~~p~--------~----~~~ 221 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFELILM--EEIRFPR--------T----LSP 221 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC----CHHHHHHHHhc--CCCCCCC--------C----CCH
Confidence 9999999998889999999999999999999999998532 22222222211 0011111 1 122
Q ss_pred HHHHHHHhcccCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt 385 (388)
.+.+++.+||+.||++||+
T Consensus 222 ~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHHHHHHhhcCHHHhCC
Confidence 5788999999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=264.95 Aligned_cols=224 Identities=31% Similarity=0.470 Sum_probs=170.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||.||+|...+...||+|+++... .....|.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999997543 23467999999999999999999999875 456799999999
Q ss_pred CCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+|+|.+++... ..++.++| |.+|+|+||++++++.+||+|||.++.............
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 99999998642 12445555 457889999999999999999999987654332222233
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.++..|+|||+.....++.++||||||+++|||+| |..||... ........+.. .... ....
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~----~~~~~~~~~~~----~~~~---------~~~~ 226 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVER----GYRM---------PCPP 226 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----ChHHHHHHHhc----CCCC---------CCcc
Confidence 46678999999888889999999999999999999 78887532 22222221111 1000 0012
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.+|++|||+++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~ 252 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEY 252 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHH
Confidence 23346889999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=273.37 Aligned_cols=216 Identities=23% Similarity=0.360 Sum_probs=165.7
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
++||+|+||.||+|+.. +++.||+|.++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 57899999987532 22334577899998866 799999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++.+. ..+|.++| |.||+|+|||++.++.+||+|||+++....... ......||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGT 159 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccccccC
Confidence 9998877532 33566777 457889999999999999999999976433222 22345689
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++....++.++|||||||++|||++|+.||... +.....+.+.. .. ...|.. ...
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~----~~~~~~~~i~~---~~----~~~p~~-------~~~ 221 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD----NEDDLFESILH---DD----VLYPVW-------LSK 221 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC----CHHHHHHHHHc---CC----CCCCCC-------CCH
Confidence 9999999998889999999999999999999999998532 22333322221 11 111110 113
Q ss_pred HHHHHHHhcccCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~ 386 (388)
.+.+++.+||+.||++||+.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred HHHHHHHHHhccCHHHcCCC
Confidence 57889999999999999953
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=273.29 Aligned_cols=217 Identities=27% Similarity=0.368 Sum_probs=164.2
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEME-TLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 122234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-CccccccCC
Confidence 9999887532 33566777 45788999999999999999999987643222 223345689
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||... +..++.+.+. .. .. . +.+ . ...
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~i~---~~-~~-~-~~~----~----~~~ 221 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----DTAEMYDNIL---NK-PL-R-LKP----N----ISV 221 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC----CHHHHHHHHH---cC-CC-C-CCC----C----CCH
Confidence 9999999998889999999999999999999999998532 2222222221 11 10 0 111 1 123
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+|++.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 678999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=280.13 Aligned_cols=187 Identities=25% Similarity=0.299 Sum_probs=154.2
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVD 214 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 214 (388)
.++....++|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555678999999999999999999965 58899999986422 12234578899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
+..++||||+++|+|.+++.+. ..++.++| |+||+|+|||++.++.+||+|||+++.+...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999987542 23566777 4578899999999999999999999877543
Q ss_pred CcceeeccccccCccCccccCCC----CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGTG----KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.........||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 33333456799999999987643 378999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=278.92 Aligned_cols=180 Identities=25% Similarity=0.321 Sum_probs=149.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||++... +++.||+|++++.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888899999999999999854 68899999997532 122346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc----
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES---- 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~---- 277 (388)
||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999988542 23566777 457889999999999999999999976432110
Q ss_pred ------------------------------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 ------------------------------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999888999999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=264.30 Aligned_cols=224 Identities=33% Similarity=0.491 Sum_probs=170.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||.||+|...++..+|+|.++.... ....|.+|+.++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45777889999999999999988888899999876432 3467999999999999999999999875 456899999999
Q ss_pred CCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+++|.+++++. ..++.++| |.+|+|+||++++++.++|+|||++..............
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 99999988642 12445555 457789999999999999999999987644322222223
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.++..|+|||......++.++||||||+++|||++ |..||... +..+..+.+.... . ... ..
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~----~~~~~~~~~~~~~---~-~~~---------~~ 226 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----NNREVLEQVERGY---R-MPC---------PQ 226 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHcCC---C-CCC---------CC
Confidence 35678999999888889999999999999999999 88887532 2233333322111 0 000 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||..+|++|||+.+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~ 252 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEY 252 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHH
Confidence 12236889999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=270.56 Aligned_cols=225 Identities=28% Similarity=0.469 Sum_probs=171.7
Q ss_pred CCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4667789999999999999742 3556999998765555556799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 221 YEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
|||+++++|.+++.... .++.++| |.+|+|+||+++.++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEEC
Confidence 99999999999986421 1334455 45788999999999999999
Q ss_pred ccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHh
Q 035768 265 DFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 265 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
|||+++....... .......++..|+|||++....++.++|||||||++|||+| |+.||... ...+..+.+.
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~~~~~~~~~~-- 239 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL----SNTEVIECIT-- 239 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHh--
Confidence 9999986543221 11223446788999999988899999999999999999999 99997432 2222332221
Q ss_pred hccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... .......+.+++.+||+.+|++|||++|
T Consensus 240 --~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 274 (291)
T cd05094 240 --QGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKE 274 (291)
T ss_pred --CCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 1111110 0112346889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.53 Aligned_cols=227 Identities=28% Similarity=0.422 Sum_probs=162.9
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhc--CCCCCccceeeEEEeCC----eeEEEEe
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGM--VKHQNLVELLGYCSVDE----EKLLVYE 222 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e 222 (388)
...++||+|+||.||||.+ +++.||||++.. ...+.|..|-+|.+. ++|+||++++++-.... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3356799999999999998 459999999964 345678888888765 58999999999876655 8899999
Q ss_pred ccCCCCHHHHHhcc--------------CCCCCHHh--------------hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 223 YMVKGSLDDWLRNQ--------------AASLDWGK--------------RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 223 ~~~~g~L~~~l~~~--------------~~~l~~~~--------------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
|.++|+|.+||... +.+|.|+| |+||+++|||+.+|+++.|+|||+|..+..
T Consensus 289 fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred eccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 99999999999753 33566665 679999999999999999999999998864
Q ss_pred CCcce-eeccccccCccCccccCCCC-C-----CcccchHhHHHHHHHHHhCCCCCC--------CCCCCC-----Cccc
Q 035768 275 CESHV-STVVAGTIGYVPPEYGGTGK-A-----TERGDVYSFGVILLELVTGKQPTG--------PEFEDK-----DGEN 334 (388)
Q Consensus 275 ~~~~~-~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dv~S~Gv~l~el~tg~~P~~--------~~~~~~-----~~~~ 334 (388)
..... ....+||.+|||||++.+.. + -.+.||||+|.|||||+++-.-++ ..|+.. .-.+
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 43322 22367999999999875432 2 236899999999999999643221 112110 1112
Q ss_pred HHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
+.+.+.+ ......+.+ ... ....+..+.+.+..||..||+.|-|+
T Consensus 449 mq~~VV~---kK~RP~~p~-~W~---~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 449 MQELVVR---KKQRPKIPD-AWR---KHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHHHh---hccCCCChh-hhh---cCccHHHHHHHHHHHcCCchhhhhhh
Confidence 2222211 111111111 111 11445678899999999999999886
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=269.96 Aligned_cols=224 Identities=24% Similarity=0.370 Sum_probs=169.0
Q ss_pred CCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 148 FCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
|...+.||+|+||.||+|... +++.||+|+++..... ..+.|.+|+.+++.++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999853 2578999999754332 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-------------------------------cCCCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 221 YEYMVKGSLDDWLRN-------------------------------QAASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~-------------------------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
+||+++++|.+++.. ...++.++| |.||+|+||++++++.+||+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEec
Confidence 999999999998742 122455555 56788999999999999999
Q ss_pred ccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHh
Q 035768 265 DFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 265 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
|||+++........ ......+++.|+|||.+....++.++|||||||++|||++ |..||... ...++.+.+..
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~~~~i~~- 241 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDVIEMIRN- 241 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHc-
Confidence 99999876432221 1223345779999999888889999999999999999998 77887432 22233332222
Q ss_pred hccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... .......+.+++.+||+.+|++||+++|
T Consensus 242 ---~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~ 275 (283)
T cd05091 242 ---RQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKD 275 (283)
T ss_pred ---CCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 111111 1112235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=270.51 Aligned_cols=238 Identities=27% Similarity=0.369 Sum_probs=167.7
Q ss_pred CcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 035768 149 CEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLLV 220 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 220 (388)
...+.||+|+||+||++.. .++..||+|.++.... .....|.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988653 3578899999875432 3356788999999999999999999998653 357899
Q ss_pred EeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc--e
Q 035768 221 YEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH--V 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~--~ 279 (388)
|||+++|+|.+++... ..++.++| |.+|+|+||++++++.+||+|||+++........ .
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 166 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhcc
Confidence 9999999999987542 23556666 4578899999999999999999999876432211 1
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....++..|+|||......++.++||||||+++|||+||..|+..... ...+...............+..+......
T Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05080 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIELLERGMRLP 244 (283)
T ss_pred CCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc--hhhhhhcccccccchhhhhhhhhcCCCCC
Confidence 1223356679999998888899999999999999999999999753211 00011100000000000001111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........+.+++.+||+.+|++|||+++
T Consensus 245 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 273 (283)
T cd05080 245 CPKNCPQEVYILMKNCWETEAKFRPTFRS 273 (283)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCCCHHH
Confidence 11223347899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=266.99 Aligned_cols=221 Identities=24% Similarity=0.381 Sum_probs=177.0
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
|.+...||+|+||.||++.++ +|+.||||++.-. .+.+++..|+.+|++.+.|++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445678999999999999875 6999999998643 4567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 227 GSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 227 g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
|++.+.++-. ..+|.|+| |+||++.|||++.+|.+||+|||.|..+.+.-.. ...+.|
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNTVIG 191 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNTVIG 191 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCcccc
Confidence 9999987532 34677887 6799999999999999999999999887653322 335679
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|||||++..-.|+.++||||+|++..||..|++||.+...-.. + -+........+.. +....
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------I-FMIPT~PPPTF~K-------PE~WS 256 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------I-FMIPTKPPPTFKK-------PEEWS 256 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------e-EeccCCCCCCCCC-------hHhhh
Confidence 9999999999999999999999999999999999999854321000 0 0111111111111 23445
Q ss_pred HHHHHHHHhcccCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.++-+++.+|+-..|++|-|+
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA 277 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTA 277 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHH
Confidence 578999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=281.15 Aligned_cols=230 Identities=24% Similarity=0.371 Sum_probs=170.9
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVK-HQNLVELLGYCSVD 214 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 214 (388)
...++|...+.||+|+||.||+|++. .++.||+|+++..... ..+.+.+|++++.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456777899999999999999853 3468999999764322 2346889999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhccC---------------------------------------------------------
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA--------------------------------------------------------- 237 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 237 (388)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986421
Q ss_pred --------------------------------------------------------CCCCHHh-----hhccccCCeeec
Q 035768 238 --------------------------------------------------------ASLDWGK-----RCKIVASNILLN 256 (388)
Q Consensus 238 --------------------------------------------------------~~l~~~~-----~~~i~~~NiLl~ 256 (388)
.++.|+| |+||+|+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 1233445 457889999999
Q ss_pred CCCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 035768 257 DDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGEN 334 (388)
Q Consensus 257 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~ 334 (388)
+++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||.... ....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~---~~~~ 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP---MNEQ 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC---chHH
Confidence 999999999999986533221 11122346788999999988889999999999999999998 888975321 1111
Q ss_pred HHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+.. +.. ...| ......+.+++.+||+.+|.+||+|+|
T Consensus 351 ~~~~~~~----~~~--~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 351 FYNAIKR----GYR--MAKP-------AHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred HHHHHHc----CCC--CCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1111111 100 0011 111236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=266.58 Aligned_cols=229 Identities=23% Similarity=0.323 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999995 568899999987554444566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
++|+|.+++++. ..++.++|. .+++|+||+++.++.+||+|||+++....... ......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 167 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFI 167 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccc
Confidence 999999987532 235566664 46789999999999999999999987643221 122345
Q ss_pred cccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 285 GTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 285 gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
|+..|+|||.+. ...++.++|||||||++|||++|+.||..... ..... . .... ....+.... .
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~---~~~~~----~-~~~~---~~~~~~~~~--~ 234 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP---MRALF----L-MSKS---NFQPPKLKD--K 234 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hhhhe----e-eecC---CCCCCCCcc--c
Confidence 889999999864 44578899999999999999999999743211 00000 0 0000 000011100 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 112346889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=271.51 Aligned_cols=224 Identities=20% Similarity=0.295 Sum_probs=168.2
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||++... +++.||+|.++.... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 578999999975422 2234578899999888 699999999999999999999999999
Q ss_pred CCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++.. ...++.|+| |+||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGT 159 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCC
Confidence 999887643 233566777 45788999999999999999999997543222 122345699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+++......... . .| . ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-~--~p---~----~~~~ 228 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-PDMNTEDYLFQVILEKPI-R--IP---R----FLSV 228 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC-cccccHHHHHHHHHhCCC-C--CC---C----CCCH
Confidence 9999999998889999999999999999999999998642211 111222222222222111 0 01 0 1123
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+||+.||++||++.
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCC
Confidence 577899999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=263.21 Aligned_cols=225 Identities=29% Similarity=0.434 Sum_probs=172.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|...+.||+|+||.||+|..++++.||+|.+.... .....|.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35677889999999999999998889999999987543 33567999999999999999999999874 56789999999
Q ss_pred CCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++|+|.+++.+. ..++.++| |.+|+|+||++++++.++|+|||++.............
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 999999987542 12345555 45788999999999999999999998765333222223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..++..|+|||+.....++.++||||||+++||+++ |+.||... +..++.+.+...... .. .
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~~~----~~-----~---- 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM----TNPEVIQNLERGYRM----PR-----P---- 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHHHcCCCC----CC-----C----
Confidence 346778999999988889999999999999999999 99997532 222333222111110 00 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....++.+++.+||+.+|++|||+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEY 252 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 111236889999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=262.11 Aligned_cols=224 Identities=26% Similarity=0.387 Sum_probs=173.5
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||+|... +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999964 6889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++++|.++++.. ..++.++| |.+++|+||+++.++.+||+|||+++........ ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-AN 159 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hh
Confidence 9999999998653 12344555 4467899999999999999999999876543222 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|++.|+|||+.....++.++|||||||++|||++|+.||... +.......+.. ...... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~----~~~~~~---------~ 222 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN----NQGALILKIIR----GVFPPV---------S 222 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHc----CCCCCC---------c
Confidence 345889999999998888999999999999999999999998532 22222222211 111110 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++||+|.|
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHH
Confidence 122346889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.42 Aligned_cols=216 Identities=23% Similarity=0.341 Sum_probs=166.0
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||++... +++.||||.+++.. ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999997542 22345577899999887 799999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++.+. ..++.|+| |.+|+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGT 159 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecC
Confidence 9999887533 23566676 45788999999999999999999987532222 122335689
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+.. ... ..| .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~----~~~~~~~~i~~----~~~---~~~-------~~~~~ 221 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD----DEDELFQSILE----DEV---RYP-------RWLSK 221 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC----CHHHHHHHHHc----CCC---CCC-------CcCCH
Confidence 9999999999899999999999999999999999998532 22222222211 110 001 11123
Q ss_pred HHHHHHHhcccCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~ 386 (388)
.+.+++.+||+.||.+|||+
T Consensus 222 ~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHccCCHHHcCCC
Confidence 67899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=275.44 Aligned_cols=228 Identities=28% Similarity=0.423 Sum_probs=168.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC-C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD-E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 215 (388)
.++|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888899999999999999642 357899999875432 2234678899999999 899999999988654 5
Q ss_pred eeEEEEeccCCCCHHHHHhcc-----------------------------------------------------------
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ----------------------------------------------------------- 236 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 236 (388)
..+++|||+++|+|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988531
Q ss_pred -----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eeeccccccCccCcc
Q 035768 237 -----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPE 293 (388)
Q Consensus 237 -----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE 293 (388)
..++.++| |+||+|+|||++.++.+||+|||+++.+...... ......++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 12344555 4578899999999999999999999876432221 122334567899999
Q ss_pred ccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHH
Q 035768 294 YGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIA 372 (388)
Q Consensus 294 ~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 372 (388)
++.+..++.++|||||||++|||++ |..||..... ...+...+ ....... .+ .....++.+++
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~~~~~--~~-------~~~~~~~~~l~ 309 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---DEEFCRRL----KEGTRMR--AP-------EYATPEIYSIM 309 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---cHHHHHHH----hccCCCC--CC-------ccCCHHHHHHH
Confidence 9989999999999999999999998 9999753211 11122111 1111100 01 11223688999
Q ss_pred HhcccCCCCCCCCCCC
Q 035768 373 TGCISNDPTVRPTMLH 388 (388)
Q Consensus 373 ~~C~~~~P~~RPt~~e 388 (388)
.+||+.+|++||++.|
T Consensus 310 ~~cl~~~p~~RPs~~e 325 (337)
T cd05054 310 LDCWHNNPEDRPTFSE 325 (337)
T ss_pred HHHccCChhhCcCHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=267.82 Aligned_cols=229 Identities=25% Similarity=0.338 Sum_probs=173.5
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--------------cChHHHHHHHHHHhcCCCCCcccee
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--------------QGDREFAAEMETLGMVKHQNLVELL 208 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~ 208 (388)
..++|...+.||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346799999999999999999995 4799999999964311 0124688999999999999999999
Q ss_pred eEEEe--CCeeEEEEeccCCCCHH---------------HHHhccCCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 209 GYCSV--DEEKLLVYEYMVKGSLD---------------DWLRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 209 g~~~~--~~~~~lv~e~~~~g~L~---------------~~l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
.+..+ .+..|||+|||..|.+. .|++....+|.|+| |+||+|+|+||+++|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99866 46789999999988653 46666777899998 6789999999999999999999
Q ss_pred ccceeccCCCc----ceeeccccccCccCccccCCCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHH
Q 035768 267 GLARLISDCES----HVSTVVAGTIGYVPPEYGGTGK----ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338 (388)
Q Consensus 267 G~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 338 (388)
|.+........ .......||+.|+|||....+. .+.+.||||+||+||.|+.|+.||-.. ...++.+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----~~~~l~~K 330 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----FELELFDK 330 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----hHHHHHHH
Confidence 99986622211 1112357999999999876532 367899999999999999999998533 22333332
Q ss_pred HHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.. ..+.-+...+....+.+|+.++|.+||+.|.+..|
T Consensus 331 Ivn------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ 368 (576)
T KOG0585|consen 331 IVN------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPD 368 (576)
T ss_pred Hhc------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhh
Confidence 221 11111112234456889999999999999998653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=264.74 Aligned_cols=224 Identities=23% Similarity=0.423 Sum_probs=167.5
Q ss_pred CCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----
Q 035768 148 FCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEE----- 216 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 216 (388)
|...+.||+|+||.||+|.... +..||+|.++.... .....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 46799999875432 234578999999999999999999999876554
Q ss_pred -eEEEEeccCCCCHHHHHhcc---------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 217 -KLLVYEYMVKGSLDDWLRNQ---------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 217 -~~lv~e~~~~g~L~~~l~~~---------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
.++++||+++|+|.+++... ..+|.++| |.+|+|+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 78999999999999887321 22455666 4578899999999999999999999
Q ss_pred eeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 270 RLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 270 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
+........ ......++..|+|||......++.++|||||||++|||++ |..||... ....+.+++....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~----~~~~~~~~~~~~~---- 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV----ENHEIYDYLRHGN---- 232 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCC----
Confidence 876443221 1122335678999999988889999999999999999999 88887432 2333333332211
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... .......+.+++.+||+.||++|||+.|
T Consensus 233 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e 264 (273)
T cd05035 233 RLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTK 264 (273)
T ss_pred CCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0110 1122346889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=266.83 Aligned_cols=225 Identities=29% Similarity=0.481 Sum_probs=170.7
Q ss_pred CCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+|...+.||+|+||.||++... ++..+|+|.+..........|.+|+++++.++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4666789999999999999632 3568999998766555567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEcc
Q 035768 221 YEYMVKGSLDDWLRNQA------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISD 265 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~D 265 (388)
|||+++|+|.++++... .++.|+| |.+|+|+|||+++++.+||+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECC
Confidence 99999999999886421 1345555 457889999999999999999
Q ss_pred cccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhh
Q 035768 266 FGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 266 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
||+++........ ......+++.|+|||......++.++|||||||++|||++ |+.||... ...+....+....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~~~~~ 241 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL----SNTEAIECITQGR 241 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC----CHHHHHHHHHcCc
Confidence 9999865432211 1122335678999999988889999999999999999999 88887432 2222222221111
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .. .+ ......+.+++.+||+.||++||+++|
T Consensus 242 ~----~~--~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 242 E----LE--RP-------RTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred c----CC--CC-------CCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0 00 01 011235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=280.69 Aligned_cols=180 Identities=25% Similarity=0.297 Sum_probs=147.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3678889999999999999985 468999999986432 123356888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc----
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES---- 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~---- 277 (388)
||+++|+|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999988753 233566777 457889999999999999999999964311000
Q ss_pred --------c----------------------------------eeeccccccCccCccccCCCCCCcccchHhHHHHHHH
Q 035768 278 --------H----------------------------------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLE 315 (388)
Q Consensus 278 --------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~e 315 (388)
. .....+||+.|+|||++....++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0012469999999999988899999999999999999
Q ss_pred HHhCCCCCCC
Q 035768 316 LVTGKQPTGP 325 (388)
Q Consensus 316 l~tg~~P~~~ 325 (388)
|+||+.||..
T Consensus 241 lltG~~Pf~~ 250 (377)
T cd05629 241 CLIGWPPFCS 250 (377)
T ss_pred hhcCCCCCCC
Confidence 9999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.91 Aligned_cols=230 Identities=24% Similarity=0.319 Sum_probs=167.9
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv 220 (388)
.|...+++|+|+||.||+|... +++.||||+....... --+|+++|++++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3556789999999999999964 5789999998654421 236999999999999999999886532 23489
Q ss_pred EeccCCCCHHHHHhc-------------------cCCCCCHHh-----hhccccCCeeecCC-CCEEEcccccceeccCC
Q 035768 221 YEYMVKGSLDDWLRN-------------------QAASLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLISDC 275 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~-------------------~~~~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~~ 275 (388)
|||||. +|.+++++ ...++.|+| |+||||.|+|+|.+ |.+||||||.|+.+...
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 999975 88888763 123566777 67899999999976 99999999999998765
Q ss_pred CcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc-----
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD----- 349 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 349 (388)
....+ ..-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+ ++..+....+.+.+......
T Consensus 180 epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG----~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 180 EPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG----DSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC----CCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 54433 346899999997654 5899999999999999999999988754 33433333333333221111
Q ss_pred -----ccCCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 350 -----EVLDPAVLNA-----NSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 350 -----~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+...|.+... .......+.++++.+++..+|.+|.++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 1111222111 1223345688999999999999998764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=279.24 Aligned_cols=237 Identities=25% Similarity=0.296 Sum_probs=169.8
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 218 (388)
+|+..+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999996 4689999999865322 23456889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||||+. ++|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+++........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999996 677776532 234567777 4578899999999999999999999876443333
Q ss_pred eeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc--------
Q 035768 279 VSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD-------- 349 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 349 (388)
......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||... +..+..+.+..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ----SPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC----CHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 33334578999999987664 5799999999999999999999998543 1112222111111100000
Q ss_pred -------ccCC-ccc--cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 -------EVLD-PAV--LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 -------~~~~-~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... +.. ...........+.+++.+||+.||++|||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 284 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH
Confidence 0000 000 00001112346789999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=268.22 Aligned_cols=225 Identities=30% Similarity=0.425 Sum_probs=169.4
Q ss_pred CCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
+|...+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999852 235789998865432 234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------------------------------CCCCCHHh-----hhccccCCeee
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------------------------------AASLDWGK-----RCKIVASNILL 255 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~-----~~~i~~~NiLl 255 (388)
++||+++|+|.+++... ..++.++| |.+|+|+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987532 12344555 56788999999
Q ss_pred cCCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 035768 256 NDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGE 333 (388)
Q Consensus 256 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~ 333 (388)
++++.+||+|||+++........ ......++..|+|||...+..++.++||||||+++|||+| |..||... ...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~ 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI----APE 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC----CHH
Confidence 99999999999999865432221 1222345678999999888889999999999999999999 99997432 233
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+.+....... . .......+.+++.+||+.+|++||+++|
T Consensus 237 ~~~~~~~~~~~~~------~-------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 237 RLFNLLKTGYRME------R-------PENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred HHHHHHhCCCCCC------C-------CCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 3333332211100 0 0112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=269.02 Aligned_cols=228 Identities=26% Similarity=0.431 Sum_probs=171.3
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
.+++|...+.||+|+||.||+|..+ .+..||+|.++.... .....+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999753 245799999865432 223468899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhcc-------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ-------------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~-------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
.++||||+++|+|.+++++. ..++.++| |.+|+|+||++++++.+||+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999999998642 11345555 4578899999999999999999
Q ss_pred ccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 267 GLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 267 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
|+++......... .....++..|+|||......++.++|||||||++|||++ |..||... +..++.+.+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~----~~~~~~~~~~~--- 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL----SNEQVLKFVMD--- 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHc---
Confidence 9998654322211 122235678999999988889999999999999999999 78887432 22233332211
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... .......+.+++.+||+.+|++|||+.|
T Consensus 237 -~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ 270 (288)
T cd05061 237 -GGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLE 270 (288)
T ss_pred -CCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 111000 0111236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=262.02 Aligned_cols=231 Identities=23% Similarity=0.345 Sum_probs=172.2
Q ss_pred HHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 142 VAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 142 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
..+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345666777789999999999999954 5788999998766555566799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC------------------CCCCHHhh-----hccccCCeeecC-CCCEEEcccccceeccCCC
Q 035768 221 YEYMVKGSLDDWLRNQA------------------ASLDWGKR-----CKIVASNILLND-DFEAKISDFGLARLISDCE 276 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~------------------~~l~~~~~-----~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~~~ 276 (388)
+||+++++|.++++... .++.++|. .+++|+||+++. ++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999999986431 23455564 467799999986 6799999999997664322
Q ss_pred cceeeccccccCccCccccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTG--KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
. ......|+..|+|||+.... .++.++||||||+++|||++|+.||.... ......+....... .+
T Consensus 164 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~----~~~~~~~~~~~~~~-------~~ 231 (268)
T cd06624 164 P-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG----EPQAAMFKVGMFKI-------HP 231 (268)
T ss_pred C-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc----ChhhhHhhhhhhcc-------CC
Confidence 2 12233578999999987654 37899999999999999999999975321 11111111100000 01
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+ +......+.+++.+||+.+|++|||+.|
T Consensus 232 ~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 232 EI----PESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred CC----CcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 01 1112236788999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=264.49 Aligned_cols=227 Identities=24% Similarity=0.339 Sum_probs=172.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||++.. .+++.+|||.+..... ....++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999995 5789999998865322 23357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 222 EYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||+++++|.+++... ..++.++| |.+|+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999987531 12455666 456889999999999999999999887643222
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
. .....|+..|+|||......++.++||||||+++|||++|..||..... +.....+.+.. . ..+...
T Consensus 162 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~----~-----~~~~~~ 229 (267)
T cd08229 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQ----C-----DYPPLP 229 (267)
T ss_pred c-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHHhhhhhc----C-----CCCCCC
Confidence 1 2234588999999999888899999999999999999999999853211 11111111111 0 011110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.......+.+++.+||+.+|++||||.
T Consensus 230 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 230 ---SDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred ---cccccHHHHHHHHHhcCCCcccCCCHH
Confidence 112334688999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=278.95 Aligned_cols=179 Identities=24% Similarity=0.308 Sum_probs=147.3
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.|...+.||+|+||+||+|+. .+++.||+|++..... .....+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477789999999999999986 4688999999875321 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC------
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE------ 276 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~------ 276 (388)
|+++|+|.+++.+. ..++.++| |+||+|+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999987542 23566666 45788999999999999999999975321000
Q ss_pred ----------------------------------------cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHH
Q 035768 277 ----------------------------------------SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLEL 316 (388)
Q Consensus 277 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el 316 (388)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0001224689999999999888999999999999999999
Q ss_pred HhCCCCCCC
Q 035768 317 VTGKQPTGP 325 (388)
Q Consensus 317 ~tg~~P~~~ 325 (388)
++|+.||..
T Consensus 242 ltG~~Pf~~ 250 (382)
T cd05625 242 LVGQPPFLA 250 (382)
T ss_pred HhCCCCCCC
Confidence 999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=269.28 Aligned_cols=233 Identities=25% Similarity=0.399 Sum_probs=169.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC---------------CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD---------------GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLG 209 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g 209 (388)
.+|...+.||+|+||.||++.... ...||+|.++.... .....|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467888999999999999987532 23589999875432 23456999999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhcc---------------------------CCCCCHHh-----hhccccCCeeecC
Q 035768 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------------------AASLDWGK-----RCKIVASNILLND 257 (388)
Q Consensus 210 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------------------~~~l~~~~-----~~~i~~~NiLl~~ 257 (388)
++...+..++||||+++++|.+++.+. ..++.|+| |.+|+|+||++++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 999999999999999999999988532 12344555 4578899999999
Q ss_pred CCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCCCCccc
Q 035768 258 DFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT--GKQPTGPEFEDKDGEN 334 (388)
Q Consensus 258 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t--g~~P~~~~~~~~~~~~ 334 (388)
++.+||+|||+++........ ......++..|+|||......++.++|||||||++|||++ |..||... ....
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~----~~~~ 240 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL----SDEQ 240 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc----ChHH
Confidence 999999999999865432211 1122335678999999888889999999999999999998 55676432 2223
Q ss_pred HHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.............. ........+.+++.+||+.+|++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 3322222111111000000 00111236899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=282.95 Aligned_cols=220 Identities=25% Similarity=0.386 Sum_probs=176.6
Q ss_pred eeeccCCceEEEEEcCC-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHH
Q 035768 153 VIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~ 231 (388)
+||+|.||+||-|+..+ ...+|||.+........+-+..|+.+.++++|.|||+++|.|..++..-|.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 55799999987776777778999999999999999999999999999999999999999999
Q ss_pred HHhc------------------cCCCCCHHh-----hhccccCCeeec-CCCCEEEcccccceeccCCCcceeecccccc
Q 035768 232 WLRN------------------QAASLDWGK-----RCKIVASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 232 ~l~~------------------~~~~l~~~~-----~~~i~~~NiLl~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
+|+. ...+|.|+| |+||+-.|+|++ -.|.+||+|||.++.+..-. ..+..+.||.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccccch
Confidence 8863 345788888 568888999996 57899999999999876533 3344577999
Q ss_pred CccCccccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 288 GYVPPEYGGTG--KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 288 ~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
.|||||++..+ .|+.++|||||||++.||.||++||...-. ... .+.+-+ .--..| +.+.+..
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs---pqA------AMFkVG--myKvHP----~iPeels 805 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS---PQA------AMFKVG--MYKVHP----PIPEELS 805 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC---hhH------hhhhhc--ceecCC----CCcHHHH
Confidence 99999998765 589999999999999999999999864321 110 111111 011122 2345566
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+...++.+|+.+||.+||++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~ 828 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKD 828 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHH
Confidence 68889999999999999999864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=280.53 Aligned_cols=179 Identities=25% Similarity=0.320 Sum_probs=148.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+|...+.||+|+||.||+++.. +++.||||.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999954 68999999986432 1234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC------
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE------ 276 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~------ 276 (388)
|+++|+|.+++.+. ..++.|+| |+||+|+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 99999999987542 23566777 56788999999999999999999975321000
Q ss_pred ------------------------------------cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC
Q 035768 277 ------------------------------------SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK 320 (388)
Q Consensus 277 ------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~ 320 (388)
........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~ 241 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCC
Confidence 00011346999999999999889999999999999999999999
Q ss_pred CCCCC
Q 035768 321 QPTGP 325 (388)
Q Consensus 321 ~P~~~ 325 (388)
.||..
T Consensus 242 ~Pf~~ 246 (376)
T cd05598 242 PPFLA 246 (376)
T ss_pred CCCCC
Confidence 99854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=269.83 Aligned_cols=222 Identities=21% Similarity=0.306 Sum_probs=169.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 221 (388)
+|...+.||+|+||+||+|... +++.||+|++++.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3666789999999999999864 68899999987532 223356778999998885 577888999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.++| |+||+|+|||++.++.+||+|||+++...... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTR 159 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cccc
Confidence 999999999887542 23567777 45788999999999999999999997643222 1223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||++....++.++|||||||++|||+||+.||... +...+.+.+... .. . .| .
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~----~~~~~~~~i~~~----~~-~--~p---~--- 222 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE----DEDELFQSIMEH----NV-S--YP---K--- 222 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhC----CC-C--CC---c---
Confidence 456899999999998888999999999999999999999998532 223333322211 10 0 01 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.....+.+++.+||+.+|.+|++..
T Consensus 223 -~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 223 -SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1123578899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=262.38 Aligned_cols=225 Identities=28% Similarity=0.450 Sum_probs=166.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCC----EEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGK----TVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35777889999999999999863 344 478888754322 22356788888999999999999999875 456789
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||+++|+|.+++.... .++.|+| |.+|+|+|||+++++.+||+|||+++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 999999999999986432 2445556 4578899999999999999999999876433221
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......++..|+|||......++.++|||||||++|||+| |+.||... ....+.+.+.. .. ....+..
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~~~~~~~~~~~----~~--~~~~~~~ 235 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM----RPHEVPDLLEK----GE--RLAQPQI 235 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHC----CC--cCCCCCC
Confidence 2233456789999999988899999999999999999998 99997532 22233333221 11 1111111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||..+|++|||+.|
T Consensus 236 -------~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 236 -------CTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred -------CCHHHHHHHHHHcCCCcccCcCHHH
Confidence 1225678899999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=268.89 Aligned_cols=176 Identities=27% Similarity=0.357 Sum_probs=148.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999864 578899998865432 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.++++.. ..++.|+|. .+|+|+|||+++++.+||+|||++....... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 9999999998542 235666663 4788999999999999999999987653321 223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
..|+..|+|||...+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 468899999999888889999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=270.61 Aligned_cols=218 Identities=25% Similarity=0.336 Sum_probs=164.2
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHH-HHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEM-ETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||+|+.. +++.||+|.+.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999986532 12223444444 456889999999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++... ..+|.++| |+||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCC
Confidence 9999887532 23566777 45788999999999999999999997643222 122345699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||++.+..++.++|||||||++|||++|+.||... +.....+.+.. . .. ...+ ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~---~-~~--~~~~--------~~~~ 221 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----NTAEMYDNILN---K-PL--QLKP--------NITN 221 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC----CHHHHHHHHHh---C-Cc--CCCC--------CCCH
Confidence 9999999999889999999999999999999999998532 22223222221 1 00 0111 1122
Q ss_pred HHHHHHHhcccCCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+++.+|++.||.+||++.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCC
Confidence 5788999999999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.67 Aligned_cols=227 Identities=32% Similarity=0.505 Sum_probs=174.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
..++|...+.||+|+||.||+|..++++.||||.+.... ....++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788889999999999999998888899999987543 3456799999999999999999999999988999999999
Q ss_pred cCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++++|.+++.+.. .++.++| |.+|+|+||++++++.+||+|||+++...........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 99999999986532 2344555 4568899999999999999999999876532222222
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...++..|+|||...+..++.++||||||+++||++| |+.||... +.....+.+....... .+
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~~~~~~~~~~~~~~------~~------ 226 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVERGYRMP------RP------ 226 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCC------CC------
Confidence 2234568999999988889999999999999999999 99997432 2223333322211100 00
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++||+++|
T Consensus 227 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 253 (261)
T cd05034 227 -PNCPEELYDLMLQCWDKDPEERPTFEY 253 (261)
T ss_pred -CCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 011236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.38 Aligned_cols=227 Identities=28% Similarity=0.469 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC------CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
.++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567788999999999999998642 46899999865432 2345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc-------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ-------------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFG 267 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~-------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG 267 (388)
++||||+++|+|.+++... ..++.|+| |.+|+|+||+++.++.+||+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999988532 12345555 45788999999999999999999
Q ss_pred cceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcc
Q 035768 268 LARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKN 345 (388)
Q Consensus 268 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 345 (388)
+++....... .......++..|+|||......++.++|||||||++||++| |..||.. .+..+..+.+. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~----~~~~~~~~~~~----~ 236 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG----LSNEEVLKFVI----D 236 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc----CCHHHHHHHHh----c
Confidence 9986643322 12223446789999999888889999999999999999998 8888743 23333433332 1
Q ss_pred ccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 EQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... . .....+.+++.+||+.+|++|||+.|
T Consensus 237 ~~~~~~~-----~----~~~~~~~~li~~~l~~~p~~Rpt~~~ 270 (277)
T cd05032 237 GGHLDLP-----E----NCPDKLLELMRMCWQYNPKMRPTFLE 270 (277)
T ss_pred CCCCCCC-----C----CCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 1111110 1 11346889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=283.00 Aligned_cols=234 Identities=18% Similarity=0.277 Sum_probs=164.1
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC--------
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD-------- 214 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 214 (388)
...+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457999999999999999999964 68899999885432 2345799999999999999999887432
Q ss_pred CeeEEEEeccCCCCHHHHHh-------------------ccCCCCCHHh-----hhccccCCeeecCCC-CEEEcccccc
Q 035768 215 EEKLLVYEYMVKGSLDDWLR-------------------NQAASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLA 269 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~-------------------~~~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a 269 (388)
...++||||++ ++|.+++. +...+|.|+| |+||+|+|||++.++ .+||+|||+|
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 24679999997 46766553 2234677777 567889999999664 7999999999
Q ss_pred eeccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc-
Q 035768 270 RLISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ- 347 (388)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 347 (388)
+.+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||.+||... ...+....+........
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~----~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ----SSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCCH
Confidence 87643222 223468999999998755 46899999999999999999999998542 22222222222111100
Q ss_pred ---------ccccCCcc-----ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ---------ADEVLDPA-----VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ---------~~~~~~~~-----~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.-+. +....+.....++.+++.+||..||.+|||+.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00000000 000001112346889999999999999999754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=264.71 Aligned_cols=224 Identities=26% Similarity=0.317 Sum_probs=169.0
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55668899999999999986 4688999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..++.++| |.+|+|+||++++++.+||+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 159 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIR 159 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--ccc
Confidence 9999999887532 22455666 45778999999999999999999997654322 122
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|+..|+|||.+.+..++.++|||||||++|||++|..||... ......+.+........ ....
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~----~~~~~~~~~~~~~~~~~--~~~~-------- 225 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR----KEKVKREEVDRRVLETE--EVYS-------- 225 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhhhccc--cccC--------
Confidence 346899999999998889999999999999999999999998532 11111111111111111 0010
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
......+.+++..||+.||++|||+.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11123578899999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=263.51 Aligned_cols=223 Identities=26% Similarity=0.395 Sum_probs=160.6
Q ss_pred eeeccCCceEEEEEcCC---CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 153 VIGGGGFGTVFKGTMPD---GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.||+|+||.||+|...+ +..+|+|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 45799999875432 233568899999999999999999999999899999999999999
Q ss_pred HHHHHhcc--------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eeec
Q 035768 229 LDDWLRNQ--------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTV 282 (388)
Q Consensus 229 L~~~l~~~--------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 282 (388)
|.++++.. ..++.|+| |.+|+|+||+++.++.+||+|||+++........ ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ 161 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCC
Confidence 99988632 11344555 4578899999999999999999999765332221 1223
Q ss_pred cccccCccCccccCCC-------CCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 283 VAGTIGYVPPEYGGTG-------KATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
..++..|+|||++... .++.++||||||+++|||++ |+.||... ...+....... .......++
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~----~~~~~~~~~~~----~~~~~~~~~ 233 (269)
T cd05087 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL----SDEQVLTYTVR----EQQLKLPKP 233 (269)
T ss_pred cCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHHhh----cccCCCCCC
Confidence 4577889999987532 35789999999999999997 99998532 11222111111 111122222
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... ....+.+++.+|| .+|++|||++|
T Consensus 234 ~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~ 262 (269)
T cd05087 234 RLKLP----LSDRWYEVMQFCW-LQPEQRPSAEE 262 (269)
T ss_pred ccCCC----CChHHHHHHHHHh-cCcccCCCHHH
Confidence 22111 1224677889999 58999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=261.04 Aligned_cols=224 Identities=31% Similarity=0.450 Sum_probs=170.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|.....||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3467778999999999999998777789999886543 33467899999999999999999999875 566899999999
Q ss_pred CCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+|+|.+++++.. .++.|+| |.||+|+||++++++.+||+|||+++.............
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 999999986421 2345566 457789999999999999999999987644322222223
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.++..|+|||......++.++||||||+++|||+| |+.||... ...+..+++..... .. ...
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~~~~~----~~---------~~~ 226 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----VNREVLEQVERGYR----MP---------CPQ 226 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCC----CC---------CCc
Confidence 45678999999988889999999999999999999 88897532 22223332221110 00 011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++||++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEY 252 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 22346889999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=259.92 Aligned_cols=227 Identities=28% Similarity=0.485 Sum_probs=170.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CC---CEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DG---KTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
+++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999864 23 379999987543 2334578999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.++++... .++.++| |.+|+|+||+++.++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 999999999999986432 2344555 4578899999999999999999999876433222
Q ss_pred eee--ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 279 VST--VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 279 ~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
... ....+..|+|||+.....++.++|||||||++|||++ |+.||... ...++...+... .....
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~----~~~~~~~~i~~~---~~~~~----- 231 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM----SNHEVMKAINDG---FRLPA----- 231 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC----CHHHHHHHHhcC---CCCCC-----
Confidence 111 1223457999999888889999999999999999998 99997432 222333322211 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++||+|.+
T Consensus 232 -----~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 259 (268)
T cd05063 232 -----PMDCPSAVYQLMLQCWQQDRARRPRFVD 259 (268)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 1112346889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=269.85 Aligned_cols=217 Identities=25% Similarity=0.336 Sum_probs=163.8
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEME-TLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
++||+|+||.||+|+.. +++.||+|.+.+.. ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986432 122334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++.. ...+|.|+| |.||+|+||+++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCC
Confidence 999887743 233566777 45788999999999999999999987543222 122345689
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||.+....++.++|||||||++|||++|+.||... +...+.+.+. .. .. .+ . . ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~---~~-~~-~~-~----~----~~~~ 221 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR----DVSQMYDNIL---HK-PL-QL-P----G----GKTV 221 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC----CHHHHHHHHh---cC-CC-CC-C----C----CCCH
Confidence 9999999998889999999999999999999999998532 2222222221 11 10 00 0 1 1123
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+|++.||.+||+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=257.66 Aligned_cols=225 Identities=26% Similarity=0.476 Sum_probs=171.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
.+|...+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567778999999999999998778899999986543 234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+|+|.+++.... .++.++| |.+|+|+||+++.++.+||+|||+++..............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence 999999886432 1334455 4578899999999999999999999866433222222233
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
++..|+|||......++.++||||||+++|||++ |..||... ....+.+.+.. . .....+..
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~----~--~~~~~~~~------- 225 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR----SNSEVVETINA----G--FRLYKPRL------- 225 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC----CHHHHHHHHhC----C--CCCCCCCC-------
Confidence 5678999999988889999999999999999998 89997532 22222222211 1 01111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.+|++|||+.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHH
Confidence 1236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=260.47 Aligned_cols=228 Identities=23% Similarity=0.359 Sum_probs=173.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999976 78999999886422 223457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 222 EYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||+++|+|.+++.+. ..++.++| |.+|+|+||+++.++.++|+|||+++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999988531 12345555 356789999999999999999999986643222
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
. .....++..|+|||...+..++.++|||||||++|||++|+.||.... .+..+..... .........
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-~~~~~~~~~----- 229 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKI-EKCDYPPLP----- 229 (267)
T ss_pred c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhhh-hcCCCCCCC-----
Confidence 1 223458889999999888889999999999999999999999974321 1222221111 111111100
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||..+|++|||+.|
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 1123346889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.52 Aligned_cols=217 Identities=28% Similarity=0.338 Sum_probs=164.1
Q ss_pred CeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEME-TLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999986532 122344556654 56789999999999999999999999999999
Q ss_pred CCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++.. ...++.|+| |+||+|+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCC
Confidence 999887753 234567777 45788999999999999999999987542211 122345699
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
+.|+|||.+.+..++.++|||||||++|||++|+.||... +..++.+.+. .. . ....+ . ...
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~~~~~~~~~~---~~-~--~~~~~----~----~~~ 221 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR----DVAEMYDNIL---HK-P--LVLRP----G----ASL 221 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC----CHHHHHHHHH---cC-C--ccCCC----C----CCH
Confidence 9999999999899999999999999999999999998532 2222222221 11 0 01111 1 122
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+|++.+|.+||++.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCC
Confidence 577899999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=265.43 Aligned_cols=227 Identities=25% Similarity=0.382 Sum_probs=174.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.+|...+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3577888999999999999985 578999999987655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.+++.+. ..++.++| |.+|+|+||+++.++.+||+|||++......... .....|
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 177 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcCC
Confidence 999999987643 22455555 4578899999999999999999998866443221 223458
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+..|+|||.+....++.++|||||||++|||++|+.||... +.......+.. . .......+ ....
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~----~~~~~~~~~~~---~-~~~~~~~~-------~~~~ 242 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLIAT---N-GTPELQNP-------EKLS 242 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh---c-CCcccCCc-------ccCC
Confidence 88999999998888999999999999999999999998532 11111111111 1 00011011 1122
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||..||++|||+.|
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHH
Confidence 35778999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=291.19 Aligned_cols=226 Identities=24% Similarity=0.345 Sum_probs=171.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|... +++.||+|+++..... ..+.|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999964 5899999999754322 2456899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc--------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccce
Q 035768 222 EYMVKGSLDDWLRNQ--------------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 222 e~~~~g~L~~~l~~~--------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
||+++|+|.+++.+. ..++.++| |+||+|+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999987531 12455666 56888999999999999999999998
Q ss_pred eccCCCc-----------------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcc
Q 035768 271 LISDCES-----------------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGE 333 (388)
Q Consensus 271 ~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~ 333 (388)
....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||... +..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~----~~~ 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK----KGR 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc----chh
Confidence 7621110 0111246999999999999889999999999999999999999998532 111
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.+... ... .++.... ........+.+++.+|++.||++||+.
T Consensus 238 ki~~~--~~i--------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 238 KISYR--DVI--------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred hhhhh--hhc--------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCH
Confidence 11110 000 0110000 011222357889999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=258.92 Aligned_cols=227 Identities=25% Similarity=0.412 Sum_probs=170.5
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+|...+.||+|+||.||+|...+++.+|+|.++..... ....+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36677899999999999999888999999998643221 124588999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC----
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE---- 276 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~---- 276 (388)
+||+++|+|.+++.+. ..++.++| |.+|+|+||++++++.+||+|||+++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 9999999999998642 12445555 45778999999999999999999987653211
Q ss_pred -cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 277 -SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 277 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
........|+..|+|||+..+..++.++|||||||++|||++|+.||... +.......+.. .... .+.
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~~~~~~~~~--~~~~-----~~~ 229 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM----DRLAAMFYIGA--HRGL-----MPR 229 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC----ChHHHHHHhhh--ccCC-----CCC
Confidence 11122345889999999998888999999999999999999999998532 11111111100 0001 111
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... .....+.+++.+||+.+|++|||+.|
T Consensus 230 ~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 230 LPD----SFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCC----CCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 111 12235788999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=271.18 Aligned_cols=179 Identities=26% Similarity=0.335 Sum_probs=148.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+++.. +++.||+|.+.+.. ....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999964 58899999986421 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+++|+|.+++.+. ..++.++| |+||+|+|||++.++.+||+|||++..+........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999999998642 22456666 457889999999999999999999987654333333
Q ss_pred eccccccCccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 34569999999998752 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=266.54 Aligned_cols=233 Identities=22% Similarity=0.381 Sum_probs=169.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-----------------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccce
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-----------------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 207 (388)
++|+..+.||+|+||.||++... ++..||+|.++.... .....|.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 244689999875432 334679999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhccC--------------------------CCCCHHh-----hhccccCCeeec
Q 035768 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA--------------------------ASLDWGK-----RCKIVASNILLN 256 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------~~l~~~~-----~~~i~~~NiLl~ 256 (388)
++++..++..++||||+++|+|.+++.... .++.++| |.+|+|+|||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 999999999999999999999999986421 2345556 457889999999
Q ss_pred CCCCEEEcccccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCCCCcc
Q 035768 257 DDFEAKISDFGLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT--GKQPTGPEFEDKDGE 333 (388)
Q Consensus 257 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t--g~~P~~~~~~~~~~~ 333 (388)
.++.++|+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++ |..||... ...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~----~~~ 240 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL----SDE 240 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc----ChH
Confidence 99999999999998654322111 112234678999998888889999999999999999998 67787432 222
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+................. .+. .......+.+++.+||+.||.+||||.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 241 QVIENTGEFFRDQGRQVY-LPK-----PALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred HHHHHHHHHHhhcccccc-CCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 222222111111110000 010 1112246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=265.78 Aligned_cols=224 Identities=27% Similarity=0.432 Sum_probs=166.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CC--EEEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GK--TVAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|...+ +. .+++|.++... ....+.|.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467788999999999999998653 33 47888887432 23345789999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 221 YEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
+||+++|+|.++++... .++.++| |.||+|+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999986421 1345555 45788999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhh
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
|||++...... ........+..|+|||+.....++.++|||||||++|||++ |..||... ...++...+....
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~----~~~~~~~~~~~~~ 235 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM----TCAELYEKLPQGY 235 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHhcCC
Confidence 99998643211 11111223567999999988889999999999999999998 99997532 2222222211110
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. +.. .......+.+++.+||+.+|.+|||+.|
T Consensus 236 ~---------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 236 R---------MEK----PRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred C---------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0 000 0112236789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=287.93 Aligned_cols=232 Identities=28% Similarity=0.435 Sum_probs=178.6
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcC----C----CCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeE
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMP----D----GKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGY 210 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~ 210 (388)
++...+++...+.||+|.||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444455566679999999999999742 1 45799999986543 4456799999999998 69999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhccC---------------CCCC----------------HH-----hhhccccCCee
Q 035768 211 CSVDEEKLLVYEYMVKGSLDDWLRNQA---------------ASLD----------------WG-----KRCKIVASNIL 254 (388)
Q Consensus 211 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~----------------~~-----~~~~i~~~NiL 254 (388)
|..++..++|+||+..|+|.+||+... ..|. |+ .|+|++++|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 999999999999999999999998765 1122 22 26789999999
Q ss_pred ecCCCCEEEcccccceeccCCCcceeecccc--ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCC
Q 035768 255 LNDDFEAKISDFGLARLISDCESHVSTVVAG--TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKD 331 (388)
Q Consensus 255 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~ 331 (388)
+.++..+||+|||+|+..............| ...|||||.+....|+.|||||||||+|||++| |..||... ..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~---~~ 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI---PP 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC---Cc
Confidence 9999999999999999776554443332233 346999999999999999999999999999999 88887531 11
Q ss_pred cccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 332 GENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++.+++..+.+.... ..+..++.++|..||+.+|++||++.|
T Consensus 528 ~~~l~~~l~~G~r~~~P-------------~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 528 TEELLEFLKEGNRMEQP-------------EHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred HHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 33444444443332221 122347889999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=264.32 Aligned_cols=223 Identities=25% Similarity=0.330 Sum_probs=168.1
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|+..+.||+|+||.||++... +++.||+|.+...... ....+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999864 6889999998653222 234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..++.|+|. .+|+|+||+++.++.++|+|||++........ ..
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IK 159 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--cc
Confidence 9999999887432 234566664 56889999999999999999999976543221 12
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|+..|+|||.+.+..++.++|||||||++|||++|+.||........ .... ....... .. ....
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~---~~~~~~~--~~----~~~~--- 226 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV---ERLVKEV--QE----EYSE--- 226 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH---Hhhhhhh--hh----hcCc---
Confidence 34689999999999888999999999999999999999999864321100 0111 1111000 00 0001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.....+.+++.+||+.||++|||+
T Consensus 227 -~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 227 -KFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred -cCCHHHHHHHHHHhhcCHHHccCC
Confidence 112357899999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=267.21 Aligned_cols=228 Identities=30% Similarity=0.470 Sum_probs=171.2
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
..++|...+.||+|+||.||++... ....+|+|.+..... .....+.+|++++.++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4456788899999999999999863 236799999875422 2335688999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDDF 259 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~ 259 (388)
..+++|||+++|+|.++++.. ..++.|+| |.+|+|+||++++++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 999999999999999998532 22455666 457889999999999
Q ss_pred CEEEcccccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHH
Q 035768 260 EAKISDFGLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 337 (388)
.+||+|||+++.+....... .....++..|+|||......++.++|||||||++|||++ |..||... ....+.+
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~ 245 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----PVEELFK 245 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC----CHHHHHH
Confidence 99999999998765432211 122235678999999888899999999999999999998 88887432 2222222
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. ..... ........+.+++.+||..+|++||||.|
T Consensus 246 ~~~~----~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 246 LLKE----GYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred HHHc----CCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 2211 11000 01112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=265.18 Aligned_cols=228 Identities=26% Similarity=0.409 Sum_probs=171.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEE 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 216 (388)
.++|...+.||+|+||.||++.. ..+..||+|.++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688899999999999999974 1355799999875432 2345689999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
.++||||+++|+|.+++++.. .++.|+| |.+|+|+|||++.++.+||+|||+++....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999986421 2345566 457889999999999999999999986643
Q ss_pred CCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 275 CESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 275 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
.... ......++..|+|||.+....++.++|||||||++|||++ |..||.... ....+.+.+.. .....
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~---~~~~~~~~~~~----~~~~~-- 264 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP---VDSKFYKLIKE----GYRMA-- 264 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC---chHHHHHHHHc----CCcCC--
Confidence 3221 1122345678999999988889999999999999999998 999975422 11122222111 10000
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+ ......+.+++.+||+.+|++|||+.|
T Consensus 265 ~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~e 293 (302)
T cd05055 265 QP-------EHAPAEIYDIMKTCWDADPLKRPTFKQ 293 (302)
T ss_pred CC-------CCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 00 011236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=266.82 Aligned_cols=227 Identities=25% Similarity=0.357 Sum_probs=174.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4688889999999999999995 578999999997655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++++|.+++.+. ..++.++| |.+++|+||+++.++.++|+|||++......... .....+
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 177 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCcccC
Confidence 999999987542 23456666 4577899999999999999999999876443221 223458
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
++.|+|||...+..++.++|||||||++|||++|+.||..... ... ....... ....... .....
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~----~~~---~~~~~~~-~~~~~~~-------~~~~~ 242 (297)
T cd06656 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRA---LYLIATN-GTPELQN-------PERLS 242 (297)
T ss_pred CccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----chh---eeeeccC-CCCCCCC-------ccccC
Confidence 8899999999888899999999999999999999999853211 100 0000000 0001001 11122
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.+|++|||++|
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHH
Confidence 35778999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=265.79 Aligned_cols=233 Identities=24% Similarity=0.407 Sum_probs=173.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-----------------CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccce
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-----------------GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 207 (388)
.+|+..+.||+|+||.||++...+ +..||+|.+..... .....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467888999999999999987532 24589999875432 334678999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhccC--------------------------CCCCHHh-----hhccccCCeeec
Q 035768 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA--------------------------ASLDWGK-----RCKIVASNILLN 256 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------~~l~~~~-----~~~i~~~NiLl~ 256 (388)
++++..++..+++|||+++++|.+++.+.. .++.++| |.+|+|+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence 999999999999999999999999886432 1344555 457889999999
Q ss_pred CCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCCCCcc
Q 035768 257 DDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT--GKQPTGPEFEDKDGE 333 (388)
Q Consensus 257 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t--g~~P~~~~~~~~~~~ 333 (388)
.++.++|+|||+++........ ......++..|+|||......++.++|||||||++|||++ |..||... ...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~----~~~ 240 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL----TDQ 240 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc----ChH
Confidence 9999999999999876433221 2223446778999999888889999999999999999998 66776432 223
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.............. .......++.+++.+||+.||++|||+.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 289 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFRE 289 (296)
T ss_pred HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence 33333332222211111111 01112246899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=259.08 Aligned_cols=217 Identities=28% Similarity=0.430 Sum_probs=163.3
Q ss_pred eeeccCCceEEEEEc---CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 153 VIGGGGFGTVFKGTM---PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 3578899999865432 23457899999999999999999999885 45678999999999
Q ss_pred CHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce--eecccc
Q 035768 228 SLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV--STVVAG 285 (388)
Q Consensus 228 ~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~g 285 (388)
+|.+++... ..++.++| |.+|+|+||++++++.+||+|||+++......... .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 999988542 23455666 45788999999999999999999998765433221 112234
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|+|||......++.++|||||||++|||++ |+.||... ....+.+.+.. ...... | . ..
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~i~~----~~~~~~--~---~----~~ 223 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM----KGNEVTQMIES----GERMEC--P---Q----RC 223 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHC----CCCCCC--C---C----CC
Confidence 578999999888889999999999999999998 99997532 22333333322 111110 0 1 12
Q ss_pred HHHHHHHHHhcccCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
..++.+++.+||+.||++||+|+
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHH
Confidence 23678999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.08 Aligned_cols=231 Identities=24% Similarity=0.348 Sum_probs=175.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35666788999999999999964 68899999876543 23356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++... ..++.|+| |.+|+|+||++++++.++|+|||++....... ...
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~ 161 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADT 161 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCc
Confidence 9999999887542 22455665 35788999999999999999999987653221 123
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC----CcccHHHHHHHhhccccccccCCccccC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK----DGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
..|+..|+|||++....++.++|||||||++|||+||+.||....... ....+.+++........ .. ..
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~- 234 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PR-----LP- 234 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-CC-----CC-
Confidence 468999999999888889999999999999999999999987543211 11223333333222111 00 00
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||++|
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 235 --SSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred --chhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 1113346889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=261.14 Aligned_cols=223 Identities=22% Similarity=0.429 Sum_probs=164.0
Q ss_pred CcCCeeeccCCceEEEEEcCC-CC--EEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC------Cee
Q 035768 149 CEENVIGGGGFGTVFKGTMPD-GK--TVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD------EEK 217 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 217 (388)
...+.||+|+||.||+|...+ +. .||+|.++... ....+.|.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999754 33 58999887542 23345788999999999999999999987532 246
Q ss_pred EEEEeccCCCCHHHHHhc---------------------cCCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 218 LLVYEYMVKGSLDDWLRN---------------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~---------------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+++|||+++|+|.+++.. ...++.|+| |.||+|+|||+++++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999987631 123456666 457889999999999999999999987
Q ss_pred ccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 272 ISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 272 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
........ .....+++.|+|||......++.++|||||||++|||++ |+.||... ....+.+.+. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~~----~~~~~ 233 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV----ENSEIYDYLR----QGNRL 233 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHH----cCCCC
Confidence 64432211 122345678999999988899999999999999999999 78887432 2222322222 11110
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .+ ......+.+++.+||+.+|++|||+.|
T Consensus 234 ~--~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ 263 (272)
T cd05075 234 K--QP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263 (272)
T ss_pred C--CC-------CCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 0 00 112235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=266.63 Aligned_cols=227 Identities=28% Similarity=0.449 Sum_probs=170.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC--------CCCEEEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
.++|...+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356777899999999999999741 24579999987543 23346789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
...++||||+++|+|.+++.+. ..++.++| |.||+|+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 9999999999999999998642 22345555 45788999999999
Q ss_pred CCEEEcccccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++......... .....+++.|+|||...+..++.++||||||+++|||++ |..||... ...++.
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~ 249 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVEELF 249 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----CHHHHH
Confidence 999999999998764432221 222345678999999988889999999999999999999 77886421 222333
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+.. ..... . .......+.+++.+||+.+|++||||.|
T Consensus 250 ~~~~~----~~~~~--~-------~~~~~~~~~~li~~cl~~~p~~Rps~~e 288 (304)
T cd05101 250 KLLKE----GHRMD--K-------PANCTNELYMMMRDCWHAIPSHRPTFKQ 288 (304)
T ss_pred HHHHc----CCcCC--C-------CCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 22211 11000 0 0112346888999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=267.65 Aligned_cols=224 Identities=29% Similarity=0.456 Sum_probs=166.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCC--EEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGK--TVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|.+. ++. .+|+|.++.... .....+.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999964 444 468887764332 2345788999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 221 YEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
|||+++|+|.++++.. ..++.++| |.+|+|+|||+++++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 9999999999998632 12345666 45788999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhh
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
|||+++..... .......++..|+|||+.....++.++|||||||++|||+| |..||... +..+..+.+..
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~-- 238 (303)
T cd05088 167 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEKLPQ-- 238 (303)
T ss_pred ccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC----ChHHHHHHHhc--
Confidence 99998643211 11112234668999999888889999999999999999998 99997532 22222222111
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... . .......+.+++.+||+.+|++||++.+
T Consensus 239 --~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 239 --GYRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred --CCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 10000 0 0011235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.11 Aligned_cols=229 Identities=23% Similarity=0.311 Sum_probs=170.5
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566677899999999999985 468899999987654444556889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
++++|.+++... ..++.++| |.+|+|+||+++.++.+||+|||++....... .......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 167 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFI 167 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccccccc
Confidence 999999987532 23566666 45678999999999999999999997664322 1223346
Q ss_pred cccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 285 GTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 285 gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
|+..|+|||.+. ...++.++|||||||++|||++|+.||.... ....+.. .... .. ..+.....
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~---~~~~~~~----~~~~-~~---~~~~~~~~-- 234 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH---PMRALFL----MTKS-NF---QPPKLKDK-- 234 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc---chhhHHh----hhcc-CC---CCCccccc--
Confidence 899999999864 4568899999999999999999999974321 1111111 1100 00 00000000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 011235788999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=261.83 Aligned_cols=227 Identities=22% Similarity=0.365 Sum_probs=168.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeC------C
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVD------E 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~ 215 (388)
+++.|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566778889999999999999864 58899999986543 3456788999999998 799999999998753 4
Q ss_pred eeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceecc
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
..+++|||+++|+|.+++... ..++.|+|. .+++|+||++++++.+||+|||+++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 578999999999999988642 123455664 4677999999999999999999998764
Q ss_pred CCCcceeeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
... .......|+..|+|||++. ...++.++|||||||++|||++|+.||.... . ..... .... ...
T Consensus 163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~----~--~~~~~-~~~~-~~~ 233 (272)
T cd06637 163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----P--MRALF-LIPR-NPA 233 (272)
T ss_pred ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC----H--HHHHH-HHhc-CCC
Confidence 322 1223456899999999875 3467889999999999999999999985321 1 11111 1111 111
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+ ......+.+++.+||..+|.+|||+.|
T Consensus 234 ~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 234 PRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred CCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 11111 112236789999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=263.64 Aligned_cols=227 Identities=23% Similarity=0.376 Sum_probs=172.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC-----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEe-CCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD-----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 217 (388)
.++|...+.||+|+||.||+|.+.+ +..|++|++..... .....+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999755 68899999875432 334568899999999999999999999876 4678
Q ss_pred EEEEeccCCCCHHHHHhcc-----------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ-----------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~-----------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
++++||+++|+|.+++... ..++.|+| |.+|+|+||++++++.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999999998542 11344555 4577899999999999999999999
Q ss_pred eeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 270 RLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 270 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
+.+....... .....++..|+|||++....++.++|||||||++||+++ |+.||... +..++..++.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~~--- 237 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI----DPFEMAAYLKDGYR--- 237 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC----CHHHHHHHHHcCCC---
Confidence 8764433221 122345778999999988889999999999999999999 99997532 33334433332111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. .+ ......+.+++.+||+.+|++|||+.|
T Consensus 238 ~~---~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ 268 (280)
T cd05043 238 LA---QP-------INCPDELFAVMACCWALDPEERPSFSQ 268 (280)
T ss_pred CC---CC-------CcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00 00 011236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=257.98 Aligned_cols=226 Identities=28% Similarity=0.470 Sum_probs=170.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.+|...+.||+|+||.||+|... .+..+|+|.++.... .....|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999853 234799999875432 2345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+++|+|.+++.... .++.++| |.+|+|+|||++.++.+||+|||+++.........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 99999999999986532 2344555 45788999999999999999999998765433222
Q ss_pred ee--ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 280 ST--VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 280 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.. ...++..|+|||+.....++.++||||||+++||+++ |..||... ...+....+..... . +.
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~----~~~~~~~~~~~~~~---~-----~~- 230 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM----SNQDVIKAIEEGYR---L-----PA- 230 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC----CHHHHHHHHhCCCc---C-----CC-
Confidence 11 1223568999999988889999999999999999887 99997532 22233333322111 0 00
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|.+||||.|
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (267)
T cd05066 231 ----PMDCPAALHQLMLDCWQKDRNERPKFEQ 258 (267)
T ss_pred ----CCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence 0112235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=264.59 Aligned_cols=236 Identities=24% Similarity=0.350 Sum_probs=173.6
Q ss_pred ccHHHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEE-
Q 035768 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCS- 212 (388)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 212 (388)
+.++.+..+.++|...+.||+|+||.||++... +++.+|+|.++... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666677889999999999999999999864 58899999886532 2345688999999999 6999999999884
Q ss_pred ----eCCeeEEEEeccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 213 ----VDEEKLLVYEYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 213 ----~~~~~~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
.++..++||||+++|+|.++++.. ..++.++| |.+++|+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999876421 22445566 45788999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHH
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 339 (388)
|||+++....... ......|++.|+|||++. ...++.++|||||||++|||++|+.||.... ....+.
T Consensus 167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~---~~~~~~--- 239 (286)
T cd06638 167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH---PMRALF--- 239 (286)
T ss_pred cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc---hhHHHh---
Confidence 9999987643222 222345899999999864 3457889999999999999999999985321 111111
Q ss_pred HHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 340 LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ........++. .....+.+++.+||+.||++|||+.|
T Consensus 240 -~~~-~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e 279 (286)
T cd06638 240 -KIP-RNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSD 279 (286)
T ss_pred -hcc-ccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHH
Confidence 110 01101111111 11235889999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=259.28 Aligned_cols=220 Identities=31% Similarity=0.488 Sum_probs=160.7
Q ss_pred CeeeccCCceEEEEEcC----CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeccC
Q 035768 152 NVIGGGGFGTVFKGTMP----DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEKLLVYEYMV 225 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~ 225 (388)
+.||+|+||.||+|... +...||+|.+.... ......+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 24579999986432 2334678899999999999999999998764 556889999999
Q ss_pred CCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc---eee
Q 035768 226 KGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH---VST 281 (388)
Q Consensus 226 ~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~---~~~ 281 (388)
+|+|.+++.+. ..++.|+| |.+|+|+|||+++++.+||+|||+++........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999998642 22455666 4578899999999999999999999865432211 111
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK-QPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...++..|+|||......++.++|||||||++|||++|. +||.. .+..++...+.. .... ..+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~----~~~~~~~~~~~~---~~~~---~~~------ 224 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VDSFDITVYLLQ---GRRL---LQP------ 224 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC----CCHHHHHHHHhc---CCCC---CCC------
Confidence 234577899999988888999999999999999999965 45432 222333332221 1100 000
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++||++.|
T Consensus 225 -~~~~~~~~~li~~cl~~~p~~Rp~~~~ 251 (262)
T cd05058 225 -EYCPDPLYEVMLSCWHPKPEMRPTFSE 251 (262)
T ss_pred -CcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 011236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=259.02 Aligned_cols=224 Identities=29% Similarity=0.450 Sum_probs=171.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|...+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35678889999999999999998778889999886532 234678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++|+|.+++... ..++.++| |.+|+|+||+++.++.+||+|||.+.............
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 999999988642 12344555 45788999999999999999999998764433222223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..++..|+|||++....++.++|||||||++||++| |+.||... +...+..++..... ... .
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~----~~~~~~~~~~~~~~----~~~---------~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYR----MPR---------P 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHhCCCC----CCC---------c
Confidence 345678999999988889999999999999999999 89897532 22233333221110 000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
......+.+++.+||+.+|++||++.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHH
Confidence 11223688999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=259.25 Aligned_cols=227 Identities=21% Similarity=0.330 Sum_probs=170.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+.|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46778899999999999999964 58899999997665555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++++|..++.+. ..++.++| |.+++|+||+++.++.+||+|||++....... ......
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 170 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSF 170 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccccee
Confidence 999998876432 23445555 45788999999999999999999987643321 112234
Q ss_pred ccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 284 AGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 284 ~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.++..|+|||++. ...++.++|||||||++|||++|+.||... +.. ..+....... ......
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~---~~~~~~~~~~-~~~~~~----- 237 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL----NPM---RVLLKIAKSE-PPTLSQ----- 237 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc----cHH---HHHHHHhcCC-CccCCC-----
Confidence 5788999999874 345788999999999999999999997432 111 1111111111 111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++||++.|
T Consensus 238 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 238 --PSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred --CcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 1112236788999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=270.76 Aligned_cols=228 Identities=28% Similarity=0.424 Sum_probs=166.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC-C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD-E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 215 (388)
.++|...+.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35688899999999999999973 3477899999975432 2345688999999999 689999999988654 4
Q ss_pred eeEEEEeccCCCCHHHHHhccC----------------------------------------------------------
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQA---------------------------------------------------------- 237 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 237 (388)
..+++|||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred ------------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eeecccccc
Q 035768 238 ------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTI 287 (388)
Q Consensus 238 ------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~ 287 (388)
.++.|+| |+||+|+|||++.++.+||+|||+++........ ......++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 1234455 4578899999999999999999999865332211 112233567
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
.|+|||......++.++||||||+++|||++ |..||..... ...+... ........ .+. . ...
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~--~~~---~----~~~ 309 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRR----LKEGTRMR--APD---Y----TTP 309 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---cHHHHHH----HhccCCCC--CCC---C----CCH
Confidence 8999999888889999999999999999997 8889753211 1112111 11111100 010 0 112
Q ss_pred HHHHHHHhcccCCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+++..||+.+|++|||+.|
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHH
Confidence 5789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=263.09 Aligned_cols=227 Identities=28% Similarity=0.420 Sum_probs=169.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
+++|...+.||+|+||.||+|.+. .+..||+|.+..... .....|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888899999999999999874 356799998865432 2345699999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC----------------------CCCCHHh-----hhccccCCeeecCCC---CEEEcccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQA----------------------ASLDWGK-----RCKIVASNILLNDDF---EAKISDFG 267 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~-----~~~i~~~NiLl~~~~---~~kl~DfG 267 (388)
++||||+++|+|.+++.+.. .++.|+| |.+|+|+||+++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999886431 1344555 457889999998754 69999999
Q ss_pred cceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcc
Q 035768 268 LARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKN 345 (388)
Q Consensus 268 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 345 (388)
+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||... ....+.+.+.. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~----~~~~~~~~~~~---~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR----TNQEVMEFVTG---G 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHc---C
Confidence 998763322111 111223568999999988889999999999999999997 99997532 22233322211 1
Q ss_pred ccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 EQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... . . .......+.+++.+||+.+|++|||+.|
T Consensus 238 ~~~-~--~-------~~~~~~~~~~~i~~cl~~~p~~Rps~~~ 270 (277)
T cd05036 238 GRL-D--P-------PKGCPGPVYRIMTDCWQHTPEDRPNFAT 270 (277)
T ss_pred CcC-C--C-------CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 110 0 0 0111236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=255.14 Aligned_cols=220 Identities=25% Similarity=0.412 Sum_probs=164.5
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
+.||+|+||.||+|+.. +++.||+|.+..... .....|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 35899999999999964 688999998865432 2345699999999999999999999999999999999999999999
Q ss_pred HHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee-ecccccc
Q 035768 230 DDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS-TVVAGTI 287 (388)
Q Consensus 230 ~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~gt~ 287 (388)
.++++... .++.++| |.+|+|+||+++.++.+||+|||+++.......... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 99986432 2344555 457889999999999999999999976543211111 1112345
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
.|+|||.+....++.++|||||||++|||++ |..||... ........+..... .. .......
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~----~~~~~~~~~~~~~~----~~---------~~~~~~~ 223 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL----SNQQTREAIEQGVR----LP---------CPELCPD 223 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc----CHHHHHHHHHcCCC----CC---------CcccCCH
Confidence 7999999988889999999999999999998 88887432 22222221111000 00 0111233
Q ss_pred HHHHHHHhcccCCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+++.+||+.+|++|||+.|
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~ 245 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFST 245 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHH
Confidence 6889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=256.80 Aligned_cols=220 Identities=31% Similarity=0.489 Sum_probs=171.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||.||+|... ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777899999999999999874 78999999976543 45679999999999999999999999998999999999999
Q ss_pred CCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+++|.+++.... .++.++| |.+|+|+||+++.++.+||+|||.++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~ 159 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SG 159 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc----cC
Confidence 999999986432 2345555 457889999999999999999999987633211 22
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.++..|+|||......++.++||||||+++||+++ |..||... ...++...+..... ... ..
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~~~----~~~---------~~ 222 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPHVEKGYR----MEA---------PE 222 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHhcCCC----CCC---------cc
Confidence 34668999999888889999999999999999998 99997532 22233322221110 000 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||..+|++|||++|
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHH
Confidence 12246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=260.50 Aligned_cols=225 Identities=22% Similarity=0.348 Sum_probs=172.5
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|...+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5677788999999999999964 68899999987543 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++++|.+++... ..++.++| |.+|.|+||++++++.++|+|||+++.+..... ......+
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 160 (274)
T cd06609 82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFVG 160 (274)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccccC
Confidence 999999988653 12444555 456789999999999999999999988754321 2233457
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+..|+|||...+..++.++|||||||++|||+||+.||... +.......+.. ....... .. ...
T Consensus 161 ~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~----~~~~~~~-----~~---~~~ 224 (274)
T cd06609 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL----HPMRVLFLIPK----NNPPSLE-----GN---KFS 224 (274)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC----chHHHHHHhhh----cCCCCCc-----cc---ccC
Confidence 88999999998888999999999999999999999998532 11111111111 1111110 00 022
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||..+|++|||++|
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHH
Confidence 35788999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=270.51 Aligned_cols=178 Identities=29% Similarity=0.301 Sum_probs=144.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE------ 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 215 (388)
.++|...+.||+|+||.||++... +++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 367888999999999999999864 58899999986532 233456889999999999999999999986543
Q ss_pred eeEEEEeccCCCCHHHHH-------------hccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 216 EKLLVYEYMVKGSLDDWL-------------RNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l-------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
..++||||+++ +|.+++ .+...+|.|+| |+||+|+|||++.++.+||+|||+++.....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 176 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-- 176 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--
Confidence 46899999965 555543 23445677777 4578899999999999999999999765332
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 122334689999999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=263.32 Aligned_cols=227 Identities=30% Similarity=0.479 Sum_probs=171.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
.++|+..+.||+|+||.||++... ++..||+|.+..... .....|.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999853 467899999875432 2345689999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC-------------------------------------CCCCHHh-----hhccccCCeee
Q 035768 218 LLVYEYMVKGSLDDWLRNQA-------------------------------------ASLDWGK-----RCKIVASNILL 255 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~-------------------------------------~~l~~~~-----~~~i~~~NiLl 255 (388)
+++|||+++|+|.+++.... .++.++| |.+|+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 99999999999999986321 1344555 45788999999
Q ss_pred cCCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 035768 256 NDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGE 333 (388)
Q Consensus 256 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~ 333 (388)
+.++.+||+|||+++........ .......+..|+|||......++.++|||||||++|||++ |..||... ...
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~----~~~ 239 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM----AHE 239 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----CHH
Confidence 99999999999999865432211 1122234678999999888889999999999999999998 88887432 222
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
++...+. ....... ......++.+++.+||+.+|++|||+.|
T Consensus 240 ~~~~~~~----~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 240 EVIYYVR----DGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHh----cCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 2222221 1111110 0112246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=270.53 Aligned_cols=180 Identities=26% Similarity=0.302 Sum_probs=149.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+++.. +++.||+|.+.+.. ......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 58899999986522 122345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+++|+|.+++... ..+|.++| |+||+|+|||++.++.+||+|||+++..........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999998642 22455666 457889999999999999999999987654433333
Q ss_pred eccccccCccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 34569999999998764 4678999999999999999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=255.61 Aligned_cols=229 Identities=23% Similarity=0.354 Sum_probs=174.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999864 57889999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++++|.+++... ..++.++| |.+++|+||++++++.+||+|||++........ .....
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 161 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSF 161 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccc
Confidence 999999987543 22455655 346789999999999999999999976643221 22234
Q ss_pred ccccCccCccccCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 284 AGTIGYVPPEYGGTG---KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
.++..|+|||..... .++.++||||||+++|||+||+.||..... ...... .... .. ..+.. ..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~----~~~~-~~---~~~~~--~~ 228 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFL----ISKS-NF---PPPKL--KD 228 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhc-cC---CCccc--cc
Confidence 578899999998766 889999999999999999999999853211 111111 1100 00 00000 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||..+|.+|||+.|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 1223446889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=256.36 Aligned_cols=225 Identities=24% Similarity=0.392 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|+..+.||+|+||.||+|...+ ++.+++|.++.... ..++.+|++++++++||||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888999999999999999764 78999999865432 568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++++|.+++.... .++.++| |.++.|+||++++++.+||+|||++........ .....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 159 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTV 159 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccc
Confidence 9999999885422 2344555 456779999999999999999999987654321 22234
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
.|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..... . .......... ....
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~----~~~~~---~-~~~~~~~~~~-------~~~~ 224 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP----MRAIF---M-IPNKPPPTLS-------DPEK 224 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch----hhhhh---h-hccCCCCCCC-------chhh
Confidence 578899999999888899999999999999999999999853211 11110 0 0000000000 0112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.+|++|||+.|
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHH
Confidence 2346889999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=257.76 Aligned_cols=224 Identities=24% Similarity=0.336 Sum_probs=171.6
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|...+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.+++.++||||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667789999999999999864 68899999986432 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++|+|.+++... ..++.++| |.+|+|+||++++++.++++|||+++....... ....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cccc
Confidence 999999887532 22345555 457889999999999999999999987644322 2223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..|++.|+|||+.....++.++||||||+++|+|++|+.||... +...... ... ....... . .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~----~~~~~~~---~~~-~~~~~~~-~--------~ 222 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----SWKNLIL---KVC-QGSYKPL-P--------S 222 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC----CHHHHHH---HHh-cCCCCCC-C--------c
Confidence 45889999999998888999999999999999999999998532 2222221 111 1111111 0 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 11235788999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=254.11 Aligned_cols=220 Identities=29% Similarity=0.445 Sum_probs=167.4
Q ss_pred CeeeccCCceEEEEEcCC--C--CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMPD--G--KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.|.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3699999987655 455679999999999999999999999988 889999999999
Q ss_pred CCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc--eeec
Q 035768 227 GSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH--VSTV 282 (388)
Q Consensus 227 g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~--~~~~ 282 (388)
|+|.+++.+.. .++.++| |.+|+|+||+++.++.+||+|||+++........ ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999986543 1334444 4578899999999999999999999876442221 1123
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..++..|+|||......++.++|||||||++|||++ |+.||... ...++.+.+.. ... ....+
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~~---~~~--~~~~~------- 223 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL----SGSQILKKIDK---EGE--RLERP------- 223 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHh---cCC--cCCCC-------
Confidence 456789999999988889999999999999999999 99997432 22233332221 110 00011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+.|
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~ 250 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAA 250 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 112246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=266.71 Aligned_cols=227 Identities=27% Similarity=0.450 Sum_probs=168.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC--------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
.++|...+.||+|+||.||++... ....+|+|.++.... .....+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 245799999875432 2345688999999999 699999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
+..+++|||+++|+|.+++... ..++.++| |.+|+|+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999999998542 12344555 45788999999999
Q ss_pred CCEEEcccccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||... ...++.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~----~~~~~~ 246 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI----PVEELF 246 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC----CHHHHH
Confidence 999999999998764322111 112224567999999888889999999999999999999 88887432 223333
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+.. ...... ......++.+++.+||+.+|++|||+.|
T Consensus 247 ~~~~~----~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 247 KLLRE----GHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred HHHHc----CCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 32221 111110 0111236779999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=254.63 Aligned_cols=218 Identities=24% Similarity=0.402 Sum_probs=162.5
Q ss_pred eeeccCCceEEEEEcC---CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 153 VIGGGGFGTVFKGTMP---DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.||+|+||.||+|.+. ++..||+|.+..... ...+.|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999876533 23456999999999999999999999885 457899999999999
Q ss_pred HHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee--ecccc
Q 035768 229 LDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS--TVVAG 285 (388)
Q Consensus 229 L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~--~~~~g 285 (388)
|.+++.... .++.++| |.||+|+|||++.++.+||+|||+++.......... ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 999986432 2455666 457889999999999999999999986543322211 11223
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|+|||......++.++|||||||++||+++ |..||... ...++...+..... .. .+ ...
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~~----~~-~~--------~~~ 223 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM----KGPEVMSFIEQGKR----LD-CP--------AEC 223 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC----CHHHHHHHHHCCCC----CC-CC--------CCC
Confidence 578999999888889999999999999999997 99997532 22233332222111 00 11 112
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++.+++.+||+.+|++||++.+
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHH
Confidence 236888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=257.87 Aligned_cols=225 Identities=21% Similarity=0.333 Sum_probs=168.5
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
|+..+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999965 4778899998765444556789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 227 GSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 227 g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
|+|..++.+. ..+|.++| |.+|+|+||+++.++.+||+|||++....... .......+
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 165 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIG 165 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccccccc
Confidence 9999877532 22455666 45688999999999999999999997654322 12233458
Q ss_pred ccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 286 TIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 286 t~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
+..|+|||++. ...++.++|||||||++|||++|+.||... +.... +........ .....+
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~---~~~~~~~~~-~~~~~~------ 231 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL----NPMRV---LLKIAKSEP-PTLAQP------ 231 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc----CHHHH---HHHHhhcCC-CCCCCc------
Confidence 89999999873 445788999999999999999999997532 11111 111111111 011111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|.+|||+.|
T Consensus 232 -~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 232 -SRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred -cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 111236889999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=260.73 Aligned_cols=224 Identities=24% Similarity=0.382 Sum_probs=172.8
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.|...+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3556788999999999999964 58899999987543 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.+++... ..++.++| |.+|.|+||+++.++.++|+|||++........ ......+
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 163 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVG 163 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccC
Confidence 999999988642 22455666 346779999999999999999999987654322 2223457
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+..|+|||...+..++.++|||||||++|||+||+.||.... .......+ .... .........
T Consensus 164 ~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~----~~~~---------~~~~~~~~~ 226 (277)
T cd06640 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH----PMRVLFLI----PKNN---------PPTLTGEFS 226 (277)
T ss_pred cccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC----hHhHhhhh----hcCC---------CCCCchhhh
Confidence 889999999888889999999999999999999999975422 11111111 0000 011122345
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.+|++||++.|
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHH
Confidence 57889999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=264.45 Aligned_cols=226 Identities=28% Similarity=0.436 Sum_probs=168.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC--------CCCEEEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
++|...+.||+|+||.||++... +...+|+|.++... ......+.+|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888899999999999999752 23579999997542 23345688899999999 7999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDDF 259 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~~ 259 (388)
..++||||+++|+|.+++.... .++.++| |.+|+|+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999999999999986421 1344555 457889999999999
Q ss_pred CEEEcccccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHH
Q 035768 260 EAKISDFGLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 337 (388)
.+||+|||+++......... .....+++.|+|||...+..++.++|||||||++|||++ |..||.. ....++.+
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~----~~~~~~~~ 253 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFK 253 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc----CCHHHHHH
Confidence 99999999997654322111 111224568999999888889999999999999999998 8888642 12222322
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. ...... .......+.+++.+||+.+|++||||.|
T Consensus 254 ~~~~----~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e 291 (307)
T cd05098 254 LLKE----GHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQ 291 (307)
T ss_pred HHHc----CCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHH
Confidence 2211 111010 1112236788999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=272.78 Aligned_cols=180 Identities=25% Similarity=0.328 Sum_probs=149.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778899999999999999864 68899999986432 223456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc----
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES---- 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~---- 277 (388)
||+++|+|.+++.+. ..++.++| |+||+|+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999988542 23566777 467889999999999999999999875432110
Q ss_pred ------------------------------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 ------------------------------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134699999999999989999999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=256.50 Aligned_cols=219 Identities=29% Similarity=0.471 Sum_probs=164.8
Q ss_pred CeeeccCCceEEEEEcCC----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 36899999876543 23457899999999999999999999876 4567999999999
Q ss_pred CCHHHHHhccC---------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee--eccc
Q 035768 227 GSLDDWLRNQA---------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS--TVVA 284 (388)
Q Consensus 227 g~L~~~l~~~~---------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~--~~~~ 284 (388)
|+|.+++.+.. .++.++| |.+|+|+||+++.++.+||+|||+++.......... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 99999986432 2455555 457889999999999999999999987644332211 1122
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
++..|+|||......++.++|||||||++|||++ |..||... +..++..++..... .. .+ ..
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~----~~~~~~~~~~~~~~----~~--~~-------~~ 222 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM----KGAEVIAMLESGER----LP--RP-------EE 222 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHHcCCc----CC--CC-------CC
Confidence 3568999999988889999999999999999998 99997532 33344443322111 00 01 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||..+|++|||+.|
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~ 247 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSE 247 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHH
Confidence 2236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=260.65 Aligned_cols=234 Identities=29% Similarity=0.449 Sum_probs=167.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 218 (388)
.+|...+.||+|+||.||++.. .++..||+|.+........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3577788999999999999974 2578999999876655556679999999999999999999998754 34678
Q ss_pred EEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++.+.. .+|.++| |.+|+|+||++++++.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 9999999999999986432 2455566 457889999999999999999999987644322
Q ss_pred ce--eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC--------CCcccHHHHHHHhhcccc
Q 035768 278 HV--STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED--------KDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 278 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~--------~~~~~~~~~~~~~~~~~~ 347 (388)
.. .....++..|+|||...+..++.++|||||||++|||++|..|+...... .........+........
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 11 11122345699999998888999999999999999999987775321100 000000011111111100
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ..........+.+++.+||+.+|++||||.|
T Consensus 244 ~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 275 (284)
T cd05081 244 R---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSE 275 (284)
T ss_pred c---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0 0001112346889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=266.05 Aligned_cols=179 Identities=27% Similarity=0.326 Sum_probs=147.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||++... +++.+|+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999965 47889999986421 122345888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+++|+|.+++++.. .++.++| |+||+|+|||++.++.+||+|||+++..........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 9999999999986521 2455566 457889999999999999999999987644333333
Q ss_pred eccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 4457999999999875 3468899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.48 Aligned_cols=235 Identities=22% Similarity=0.315 Sum_probs=186.0
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceee
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLG 209 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g 209 (388)
...++....+++....++-+|.||.||+|.|. +.+.|-||.++....+ ....++.|...+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34567777788888899999999999999654 3456788888764332 3456889999999999999999999
Q ss_pred EEEeC-CeeEEEEeccCCCCHHHHHhcc-----------------------CCCCCHHh-----hhccccCCeeecCCCC
Q 035768 210 YCSVD-EEKLLVYEYMVKGSLDDWLRNQ-----------------------AASLDWGK-----RCKIVASNILLNDDFE 260 (388)
Q Consensus 210 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~l~~~~-----~~~i~~~NiLl~~~~~ 260 (388)
++..+ ..++.++.++.-|+|..||... +.+++++| |.||+++|++||+..+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 98764 5678999999999999999721 22456666 4578899999999999
Q ss_pred EEEcccccceeccCCCcceeec-cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHH
Q 035768 261 AKISDFGLARLISDCESHVSTV-VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDW 338 (388)
Q Consensus 261 ~kl~DfG~a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~ 338 (388)
+||+|=.+++.+...+++.... ...+..||+||.+....|+.++|||||||+||||+| |+.|+.+ -+..++..+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae----IDPfEm~~y 510 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE----IDPFEMEHY 510 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc----cCHHHHHHH
Confidence 9999999999887766554322 234679999999999999999999999999999999 9999643 356666666
Q ss_pred HHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
++...+-.+... ++.++..+|.-||+.+|++||+++|
T Consensus 511 lkdGyRlaQP~N-------------CPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 511 LKDGYRLAQPFN-------------CPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred HhccceecCCCC-------------CcHHHHHHHHHHHhcCcccCCCHHH
Confidence 655444333222 3347999999999999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=255.88 Aligned_cols=225 Identities=24% Similarity=0.369 Sum_probs=168.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 356778899999999999998643 3468999887554 2345579999999999999999999999875 567899
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+++|+|.+++.... .++.++| |.+|+|+||+++.++.+||+|||+++.........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 99999999999986432 2344555 45788999999999999999999998765433222
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....++..|+|||.+....++.++||||||+++||+++ |..||... ...+...++.... .. . .+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~----~~~~~~~~~~~~~---~~-~--~~---- 230 (270)
T cd05056 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV----KNNDVIGRIENGE---RL-P--MP---- 230 (270)
T ss_pred cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCC---cC-C--CC----
Confidence 223334568999999888889999999999999999996 99998543 2222322222111 00 0 00
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||..+|++|||+.|
T Consensus 231 ---~~~~~~~~~li~~~l~~~P~~Rpt~~~ 257 (270)
T cd05056 231 ---PNCPPTLYSLMTKCWAYDPSKRPRFTE 257 (270)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 111236888999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=257.09 Aligned_cols=225 Identities=27% Similarity=0.478 Sum_probs=168.8
Q ss_pred CCCcCCeeeccCCceEEEEEcCC-C---CEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPD-G---KTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.|...+.||+|+||.||+|.... + ..||||.++... .....+|..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46677899999999999998643 3 369999987542 233467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+++|+|.+++.... .++.++| |.+|+|+||+++.++.+||+|||+++..........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccc
Confidence 9999999999886432 2345555 457889999999999999999999986643222111
Q ss_pred --eccc--cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 281 --TVVA--GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 281 --~~~~--gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.... .+..|+|||.+....++.++|||||||++||+++ |..||... +..+..+++..... .. .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~----~~~~~~~~i~~~~~---~~---~-- 232 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----SNQDVINAIEQDYR---LP---P-- 232 (269)
T ss_pred cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC----CHHHHHHHHHcCCc---CC---C--
Confidence 1111 2457999999988899999999999999999887 99997532 23334444321110 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+....+.+++.+||+.+|++||+|.+
T Consensus 233 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (269)
T cd05065 233 -----PMDCPTALHQLMLDCWQKDRNARPKFGQ 260 (269)
T ss_pred -----cccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0112235788999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=256.32 Aligned_cols=238 Identities=26% Similarity=0.364 Sum_probs=173.5
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEe-----CCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSV-----DEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 217 (388)
..|...+.||+|+||.|+.+.. .+|+.||||++... .....++..+|+++|+.++|+||+.+++.+.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455578899999999999985 46899999999743 23345678899999999999999999999865 3468
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC-C
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC-E 276 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~-~ 276 (388)
|+|+|+| .-||...+++. ..+|.|+| |+|++|+|+|++.+..+||+|||+|+..... .
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 9999999 67888777543 45788888 5688999999999999999999999987542 1
Q ss_pred cceeeccccccCccCcccc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc---cccC
Q 035768 277 SHVSTVVAGTIGYVPPEYG-GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA---DEVL 352 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 352 (388)
....+....|.+|.|||.+ ....||.+.||||.|||+.||++|++-|.+ .+..+..+.+......+.. ..+-
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG----~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG----KDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC----CchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 1223456689999999975 456899999999999999999999988643 3333333333322221110 0000
Q ss_pred --------C--ccccCC----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 --------D--PAVLNA----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 --------~--~~~~~~----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. |..... .........++++.+++..||.+|+|++|
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 0 000000 00111235788999999999999999864
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=254.69 Aligned_cols=224 Identities=25% Similarity=0.444 Sum_probs=170.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-----cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-----QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+|...+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|+++++.++||||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3566789999999999999975 789999999864321 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC---------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQA---------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~---------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+||+++++|.+++.... .++.++| |.+|.|+||+++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--cc
Confidence 99999999999886432 2445555 45778999999999999999999998764432 22
Q ss_pred eccccccCccCccccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGK-ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....|+..|+|||...... ++.++|+|||||++|||++|+.||.... . .+.............+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~---~~~~~~~~~~~~~~~~-------- 223 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----G---VAAVFKIGRSKELPPI-------- 223 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----H---HHHHHHHHhcccCCCc--------
Confidence 3355889999999887665 8999999999999999999999985421 1 1111111110111110
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|.+|||+.|
T Consensus 224 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 224 -PDHLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred -CCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 0111235788999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=266.60 Aligned_cols=227 Identities=25% Similarity=0.309 Sum_probs=179.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCc---ChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQ---GDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 220 (388)
+.|...+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.+++++.+....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 457778899999999999999764 999999999765443 3357999999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCC----CCEEEcccccceeccCCCc
Q 035768 221 YEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDD----FEAKISDFGLARLISDCES 277 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~----~~~kl~DfG~a~~~~~~~~ 277 (388)
||++.||.|++.+... ..++.|+| |+|++|+|+|+... +.+|++|||+|..... .
T Consensus 115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--G 192 (382)
T ss_pred EEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--C
Confidence 9999999999987653 23456666 45788999999643 5799999999998866 3
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......+||+.|+|||++....|+..+||||.||++|.|++|.+||.... .......+.. ... ++.+
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~~~~~i~~----~~~-~f~~---- 259 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFEIFLAILR----GDF-DFTS---- 259 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhHHHHHHHc----CCC-CCCC----
Confidence 34556789999999999999999999999999999999999999986432 2222221211 111 1111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+.+++..|+..||.+|+|+.+
T Consensus 260 -~~w~~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 260 -EPWDDISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred -CCccccCHHHHHHHHHhcccCcccCCCHHH
Confidence 112223346788999999999999999753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=255.83 Aligned_cols=224 Identities=24% Similarity=0.397 Sum_probs=169.2
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcC---------hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQG---------DREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
|.....||+|+||.||+|... +++.+|+|.+....... .+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999864 58899999886432211 24588999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+++|||+++++|.+++... ..++.++| |.+|+|+||++++++.+||+|||+++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 9999999999999988542 22455666 456889999999999999999999987653211
Q ss_pred c-----eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 278 H-----VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 278 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
. ......|+..|+|||.+....++.++|||||||++|||++|+.||... +.... +..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~---~~~~~~------~~ 228 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC----TQLQA---IFKIGE------NA 228 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc----cHHHH---HHHHhc------cC
Confidence 1 111245788999999998888999999999999999999999998532 11111 111111 01
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+... ......+.+++.+||+.||.+||++.|
T Consensus 229 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 229 SPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CCcCC----cccCHHHHHHHHHHccCCchhCcCHHH
Confidence 11111 112336788999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=271.32 Aligned_cols=173 Identities=23% Similarity=0.252 Sum_probs=143.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
...|...+.||+|+||.||++.+. .++.||||... ...+.+|++++++++|||||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888999999999999999975 47889999642 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eee
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~ 281 (388)
+ .|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++........ ...
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 9 57898887543 23455666 4578899999999999999999999876432221 222
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
...||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 4569999999999998899999999999999999999887653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=253.37 Aligned_cols=224 Identities=24% Similarity=0.344 Sum_probs=173.2
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|+..+.||.|+||.||.++. .+++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 467789999999999999884 468899999986432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..++.++| |.+++|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-ccc
Confidence 9999999998653 12345555 457889999999999999999999987654332 223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|++.|+|||...+..++.++||||||+++|||++|+.||... +..+....+ .. ...... .
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~~~~---~~-~~~~~~---------~ 222 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----NPLNLVVKI---VQ-GNYTPV---------V 222 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHH---Hc-CCCCCC---------c
Confidence 345899999999988888899999999999999999999997532 222222221 11 111110 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+.|
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 112336889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=269.45 Aligned_cols=178 Identities=26% Similarity=0.285 Sum_probs=145.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD------E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 215 (388)
.++|...+.||+|+||.||++... .++.||||++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 467888999999999999999854 588999999875422 2345688999999999999999999988643 3
Q ss_pred eeEEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 216 EKLLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
..++||||+++ +|.+++. +...+|.++| |+||+|+|||++.++.+||+|||+++......
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 173 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc-
Confidence 46899999964 6665442 3445677777 45788999999999999999999998654321
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred -ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22335689999999999888999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=249.14 Aligned_cols=238 Identities=22% Similarity=0.228 Sum_probs=173.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 219 (388)
.++|+..+.|++|+||.||+|+.+ +++.||+|+++..... -.-.-++|+.+|.+++|||||.+-.+... -+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356778899999999999999964 6899999999754322 12246799999999999999999988764 357899
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|||||+ -||..++.... .++.|+| |+|++++|+|+.+.|.+||+|||+|+.++....
T Consensus 155 VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred eHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 999995 48888776432 2445555 779999999999999999999999999876533
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccCCc
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVLDP 354 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 354 (388)
..+..+-|..|.|||.+.+ ..|+++.|+||+|||+.||+++++-|.. ....+..+.+...+.... ...+...
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G----~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG----KSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC----CchHHHHHHHHHHhCCCccccCCCcccc
Confidence 3344567999999997655 5799999999999999999999988643 344444444444433211 1111111
Q ss_pred ccc--------------CCCCHH-HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVL--------------NANSKP-TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~--------------~~~~~~-~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ..+... ....-.+++...+..||.+|-|+.|
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 000 001000 2245678888999999999999865
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=261.82 Aligned_cols=223 Identities=23% Similarity=0.392 Sum_probs=169.8
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 444567999999999999864 57889999987443 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 226 KGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 226 ~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
+++|.+++... ..++.++| |.+|.|+||++++++.++|+|||++..+..... ......|+
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 164 (277)
T cd06642 86 GGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGT 164 (277)
T ss_pred CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccCc
Confidence 99999887532 23455666 456789999999999999999999987654221 12234578
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
..|+|||++....++.++|||||||++|||+||+.|+.... ......++ .... .+.. ......
T Consensus 165 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~----~~~~-----~~~~----~~~~~~ 227 (277)
T cd06642 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH----PMRVLFLI----PKNS-----PPTL----EGQYSK 227 (277)
T ss_pred ccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc----hhhHHhhh----hcCC-----CCCC----CcccCH
Confidence 89999999988889999999999999999999999975321 11111111 1110 1111 112234
Q ss_pred HHHHHHHhcccCCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+++.+||+.+|++||||.|
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHH
Confidence 6889999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=258.20 Aligned_cols=228 Identities=23% Similarity=0.362 Sum_probs=172.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.++|...+.||+|+||.||++... ++..+|+|.++.......+.|.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456778889999999999999964 6889999998765544556799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++... ..++.++| |.+|+|+||+++.++.++|+|||++........ ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 162 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDT 162 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccce
Confidence 9999999987542 22455666 456789999999999999999999876543222 1223
Q ss_pred cccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 283 VAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 283 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
..|++.|+|||.+. ...++.++||||||+++|||++|+.||... +.... +..... ........+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~----~~~~~---~~~~~~-~~~~~~~~~--- 231 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL----NPMRV---LLKILK-SEPPTLDQP--- 231 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC----CHHHH---HHHHhc-CCCCCcCCc---
Confidence 45889999999864 345788999999999999999999997532 11111 111111 110111011
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++||++.|
T Consensus 232 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 232 ----SKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred ----ccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 112235788999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=259.83 Aligned_cols=237 Identities=21% Similarity=0.301 Sum_probs=170.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999864 678899999875432 2334678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ ++|.+++... ..++.++| |+||+|+||+++.++.+||+|||+++....... ....
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 163 (309)
T cd07872 86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSN 163 (309)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cccc
Confidence 96 4888776432 23556666 457889999999999999999999976533221 1223
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc---cccC------
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA---DEVL------ 352 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------ 352 (388)
..+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||... +..+....+......... ..+.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS----TVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 457899999998754 56899999999999999999999998542 222222222221111000 0000
Q ss_pred ---CccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 ---DPAVLN----ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ---~~~~~~----~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.... .........+.+++.+|++.||.+|||++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 000000 000112335789999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=256.55 Aligned_cols=224 Identities=21% Similarity=0.360 Sum_probs=167.3
Q ss_pred CCCcCCeeeccCCceEEEEEcCC--CCEEEEEEcccCC----------CcChHHHHHHHHHHhc-CCCCCccceeeEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPD--GKTVAVKKLSQAT----------GQGDREFAAEMETLGM-VKHQNLVELLGYCSV 213 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 213 (388)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677889999999999999754 6789999875321 1123457788888865 799999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhcc-------------------CCCCCHHh------hhccccCCeeecCCCCEEEccccc
Q 035768 214 DEEKLLVYEYMVKGSLDDWLRNQ-------------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGL 268 (388)
Q Consensus 214 ~~~~~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~ 268 (388)
++..+++|||+++++|.+++... ..++.++| |.+|+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999877321 12344444 447889999999999999999999
Q ss_pred ceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 269 ARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
+....... ......|+..|+|||......++.++||||||+++|||++|+.||... +.......+.. ...
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~----~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----NMLSLATKIVE----AVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc----CHHHHHHHHhh----ccC
Confidence 98765432 223456889999999998888999999999999999999999997432 22222221111 111
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... .......+.+++.+||+.||++||++.|
T Consensus 231 ~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 231 EPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred CcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 1100 0011236889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.95 Aligned_cols=218 Identities=29% Similarity=0.455 Sum_probs=161.4
Q ss_pred CeeeccCCceEEEEEcCC-CC--EEEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMPD-GK--TVAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
++||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 47888887533 23345788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccce
Q 035768 227 GSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 227 g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
|+|.++++... .++.++| |.||+|+||++++++.+||+|||+++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986421 1344555 45788999999999999999999986
Q ss_pred eccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 271 LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
..... ........+..|+|||+.....++.++|||||||++|||++ |..||... +..+..+.+.. ....
T Consensus 161 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~----~~~~~~~~~~~----~~~~ 230 (270)
T cd05047 161 GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEKLPQ----GYRL 230 (270)
T ss_pred ccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc----CHHHHHHHHhC----CCCC
Confidence 43211 11111224567999999988889999999999999999997 99997432 22222222111 1000
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ . .......+.+++.+||+.+|.+|||+.|
T Consensus 231 ~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (270)
T cd05047 231 E-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQ 260 (270)
T ss_pred C-----C----CCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence 0 0 0112236789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=261.55 Aligned_cols=235 Identities=23% Similarity=0.300 Sum_probs=165.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcC---CCCCccceeeEEEe-----CC
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMV---KHQNLVELLGYCSV-----DE 215 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 215 (388)
+|...+.||+|+||+||+|... +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3677889999999999999865 688999999875322 2234566787777665 79999999998864 24
Q ss_pred eeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceecc
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
..+++|||++ ++|.+++... ..++.++| |.||+|+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5789999997 5888877542 23456666 45788999999999999999999998764
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc----
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD---- 349 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 349 (388)
... ......||..|+|||++.+..++.++|||||||++|||++|++||.... ..+....+..........
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 160 CQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred Ccc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC----HHHHHHHHHHHhCCCChhhCcc
Confidence 322 1223458899999999988889999999999999999999999985321 111111121111100000
Q ss_pred ------ccCCcccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 ------EVLDPAVL---NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ------~~~~~~~~---~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+... ..........+.+++.+|++.||++|||+.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 281 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence 00000000 0001122346789999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=289.57 Aligned_cols=226 Identities=21% Similarity=0.332 Sum_probs=167.5
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKL 218 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 218 (388)
..++|.+.+.||+|+||+||++... ++..||+|.+.... ......|..|+.++++++|||||++++++.. ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467889999999999999999964 57789999886432 2234568999999999999999999998854 35689
Q ss_pred EEEeccCCCCHHHHHhc-------------------cCCCCCHHhh------------hccccCCeeecC----------
Q 035768 219 LVYEYMVKGSLDDWLRN-------------------QAASLDWGKR------------CKIVASNILLND---------- 257 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~-------------------~~~~l~~~~~------------~~i~~~NiLl~~---------- 257 (388)
+||||+++|+|.++|.. .+.+|.|+|. .||+|+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999988753 1235666664 578899999964
Q ss_pred -------CCCEEEcccccceeccCCCcceeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCC
Q 035768 258 -------DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFE 328 (388)
Q Consensus 258 -------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~ 328 (388)
...+||+|||+++.+.... ......||+.|+|||++.. ..++.++|||||||+||||+||+.||...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~-- 246 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-- 246 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC--
Confidence 3458999999998764322 2234568999999998753 45899999999999999999999998532
Q ss_pred CCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 329 DKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.. +.... ... . . .....+.+|+..||+.+|.+|||+.|
T Consensus 247 ----~~~~qli~~-lk~~p--~lp---i-~----~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 247 ----NNFSQLISE-LKRGP--DLP---I-K----GKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred ----CcHHHHHHH-HhcCC--CCC---c-C----CCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 112222211 11111 000 0 0 01236889999999999999999753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=268.79 Aligned_cols=178 Identities=25% Similarity=0.287 Sum_probs=145.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD------E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 215 (388)
.++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999854 58899999997532 23345688999999999999999999987543 3
Q ss_pred eeEEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 216 EKLLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
..++||||+++ +|.+++. +...+|.++| |+||+|+|||++.++.+||+|||+++......
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~- 180 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 180 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-
Confidence 57999999964 6666543 3345677777 46788999999999999999999998654322
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 181 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred -cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 22334689999999999888999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=254.20 Aligned_cols=219 Identities=30% Similarity=0.464 Sum_probs=166.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS-VDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~ 224 (388)
.+|...+.||+|+||.||++.. .+..||+|.++... ..+.|.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3577789999999999999987 47789999986432 3457899999999999999999999765 456789999999
Q ss_pred CCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++|+|.+++++.. .++.++| |.+|+|+||++++++.+||+|||+++...... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 9999999986532 2344555 45788999999999999999999998654321 12
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..++..|+|||+.....++.++|||||||++|||++ |+.||... +..++...+..... ... .
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~~----~~~---------~ 221 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYK----MDA---------P 221 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCC----CCC---------C
Confidence 335678999999988889999999999999999998 99997421 22233332221110 110 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+.|
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ 248 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQ 248 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=252.13 Aligned_cols=213 Identities=23% Similarity=0.367 Sum_probs=158.7
Q ss_pred CeeeccCCceEEEEEcCC-------------CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 152 NVIGGGGFGTVFKGTMPD-------------GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
+.||+|+||.||+|.+.+ ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358999887655445567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCC-------EEEcccccce
Q 035768 219 LVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFE-------AKISDFGLAR 270 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~-------~kl~DfG~a~ 270 (388)
+||||+++|+|..+++.. +.++.|+| |.+|+|+|||++.++. +|++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999999887642 22455666 4578899999987664 8999999987
Q ss_pred eccCCCcceeeccccccCccCccccC-CCCCCcccchHhHHHHHHHHH-hCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 271 LISDCESHVSTVVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELV-TGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~-tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
..... ....++..|+|||.+. ...++.++|||||||++|||+ +|..|+... ...+... . .. ..
T Consensus 161 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~----~~~~~~~-~---~~-~~- 225 (262)
T cd05077 161 TVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK----TLAEKER-F---YE-GQ- 225 (262)
T ss_pred cccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc----chhHHHH-H---Hh-cC-
Confidence 65321 2234788999999876 467899999999999999998 488886431 1111111 1 00 00
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... +....+.+++.+||+.||.+||++.|
T Consensus 226 ~~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~ 256 (262)
T cd05077 226 CMLVT---------PSCKELADLMTHCMNYDPNQRPFFRA 256 (262)
T ss_pred ccCCC---------CChHHHHHHHHHHcCCChhhCcCHHH
Confidence 00111 11235789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=275.81 Aligned_cols=225 Identities=22% Similarity=0.369 Sum_probs=175.0
Q ss_pred CCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 148 FCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
|.+.-.||.|+||.||++..++ +-..|.|.+........++|.-|++||...+||+||++++.|..++.+||+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445679999999999999765 445677888776667778899999999999999999999999999999999999999
Q ss_pred CCHHHHHh----------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 227 GSLDDWLR----------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 227 g~L~~~l~----------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
|-....+- +...+|.|+| |+|+++.|||++-+|.++|+|||.+....... .....+.|
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsFIG 192 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSFIG 192 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH-hhhccccC
Confidence 98877653 2345789998 45777899999999999999999987643322 22345779
Q ss_pred ccCccCcccc-----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 286 TIGYVPPEYG-----GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 286 t~~y~aPE~~-----~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
|++|||||+. ...+|+.++||||||++|.||..+.+|... .+.+..+....... .+..+.|.
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-------lnpMRVllKiaKSe-PPTLlqPS----- 259 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-------LNPMRVLLKIAKSE-PPTLLQPS----- 259 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-------cchHHHHHHHhhcC-CCcccCcc-----
Confidence 9999999964 467899999999999999999999999532 23333333332222 23333332
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.++..+|+..||..||++.|
T Consensus 260 --~Ws~~F~DfLk~cL~Knp~~Rp~aaq 285 (1187)
T KOG0579|consen 260 --HWSRSFSDFLKRCLVKNPRNRPPAAQ 285 (1187)
T ss_pred --hhhhHHHHHHHHHHhcCCccCCCHHH
Confidence 23346889999999999999999754
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=256.01 Aligned_cols=227 Identities=25% Similarity=0.413 Sum_probs=170.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||.||+|+.. +.+.|++|.+...... ....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778889999999999999853 2467999988654433 3467999999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHhccC------------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 219 LVYEYMVKGSLDDWLRNQA------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
+||||+++|+|.+++.... .++.|+| |.||+|+||+++.++.++++|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999986432 1234555 4578899999999999999999998
Q ss_pred eeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 270 RLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
+..............++..|+|||......++.++||||||+++|||++ |..||... ....+..... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~----~~~~~~~~~~----~~~~ 236 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL----SDEEVLNRLQ----AGKL 236 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc----chHHHHHHHH----cCCc
Confidence 7654322222233446778999999888888999999999999999999 78887432 1222222221 1111
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...+ ......+.+++.+||+.+|++|||+.|
T Consensus 237 ~-~~~~-------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 268 (275)
T cd05046 237 E-LPVP-------EGCPSRLYKLMTRCWAVNPKDRPSFSE 268 (275)
T ss_pred C-CCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 1 0000 112236889999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=269.37 Aligned_cols=176 Identities=19% Similarity=0.240 Sum_probs=145.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC---CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP---DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..+|...+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 346889999999999999999743 3578999988643 24568999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-ee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~ 280 (388)
||+. ++|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+++........ ..
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 9994 788887742 223566777 4578899999999999999999999876443221 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2456999999999999889999999999999999999999998543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=261.12 Aligned_cols=172 Identities=23% Similarity=0.303 Sum_probs=136.2
Q ss_pred CCeeeccCCceEEEEEcC---CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccC
Q 035768 151 ENVIGGGGFGTVFKGTMP---DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLLVYEYMV 225 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 225 (388)
.+.||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 46789999986542 23467899999999999999999998854 456789999995
Q ss_pred CCCHHHHHh------------------------ccCCCCCHHh-----hhccccCCeee----cCCCCEEEcccccceec
Q 035768 226 KGSLDDWLR------------------------NQAASLDWGK-----RCKIVASNILL----NDDFEAKISDFGLARLI 272 (388)
Q Consensus 226 ~g~L~~~l~------------------------~~~~~l~~~~-----~~~i~~~NiLl----~~~~~~kl~DfG~a~~~ 272 (388)
++|.+++. +...++.|+| |+||+|+|||+ +.++.+||+|||+++..
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 57776653 2234567777 56788999999 45678999999999876
Q ss_pred cCCCc--ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 273 SDCES--HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 273 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 43221 12234568999999998766 4689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=254.73 Aligned_cols=225 Identities=28% Similarity=0.424 Sum_probs=168.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCC----EEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGK----TVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||+||+|.+ .+++ .||+|.++.... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4677889999999999999985 3444 489999875432 334578899999999999999999999975 45789
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||+++|+|.+++++.. .++.++| |.||+|+|||+++++.+||+|||+++........
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 999999999999986532 2445666 4578899999999999999999999876532221
Q ss_pred e-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 V-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
. .....++..|+|||......++.++|||||||++|||++ |..||... ....+..++...... ..
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~~~~~~----~~----- 232 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI----PAREIPDLLEKGERL----PQ----- 232 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHCCCcC----CC-----
Confidence 1 112234678999999988889999999999999999998 88887532 223333333221110 00
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 233 ----~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 233 ----PPICTIDVYMIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred ----CccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0112236789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=254.88 Aligned_cols=226 Identities=21% Similarity=0.343 Sum_probs=165.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-----cChHHHHHHHHHHhcCCCCCccceeeEEEe--CCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-----QGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 217 (388)
.+|...+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999864 588999999864321 123458889999999999999999998875 3567
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++++||+++++|.+++... ..++.++|. .+++|+||+++.++.+||+|||+++.+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999999987542 234556663 46779999999999999999999986532111
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||... + ....+........ .+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~----~---~~~~~~~~~~~~~-----~~~ 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY----E---AMAAIFKIATQPT-----NPQ 229 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc----c---hHHHHHHHhcCCC-----CCC
Confidence 1112345788999999998888999999999999999999999998532 1 1111111111110 111
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .......+.+++ +||..+|++||||+|
T Consensus 230 ~----~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 230 L----PSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred C----chhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 1 111122345555 788899999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=261.41 Aligned_cols=238 Identities=23% Similarity=0.303 Sum_probs=173.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999965 58899999987532 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 224 MVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 224 ~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++++.+..+..+ ...++.++| |.+++|+||++++++.+||+|||++..............
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCc
Confidence 998777665542 223556666 456779999999999999999999987755433233345
Q ss_pred ccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc------------cc---
Q 035768 284 AGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN------------EQ--- 347 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------------~~--- 347 (388)
.++..|+|||++... .++.++||||||+++|||++|+.||... ...+........... ..
T Consensus 162 ~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD----SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 678899999998877 8899999999999999999999998532 111111111111100 00
Q ss_pred --ccccCCcccc-CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 --ADEVLDPAVL-NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 --~~~~~~~~~~-~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....++... .........++.+++.+||+.+|++|||++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 0000000000 0001112457899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=259.02 Aligned_cols=227 Identities=19% Similarity=0.268 Sum_probs=169.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999965 578999999875432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-----
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE----- 276 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~----- 276 (388)
||+++|+|.+++... ..++.++| |.+++|+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999998542 23455666 45678999999999999999999987421100
Q ss_pred ---------cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 277 ---------SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 277 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
........|+..|+|||.+....++.++|||||||++|||++|..||... +..++...... . .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~----~~~~~~~~~~~---~-~ 232 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD----TPEELFGQVIS---D-D 232 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh---c-c
Confidence 00111235788999999988888999999999999999999999997532 22222221111 1 1
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
...+... ......+.+++.+||+.+|++||++.
T Consensus 233 ---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 233 ---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred ---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCcc
Confidence 0011100 01223578999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=249.80 Aligned_cols=220 Identities=28% Similarity=0.432 Sum_probs=167.2
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHH
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLD 230 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 230 (388)
+.||+|+||.||++...+++.||+|+++..... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877999999998765433 4457999999999999999999999999999999999999999999
Q ss_pred HHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee-eccccccC
Q 035768 231 DWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS-TVVAGTIG 288 (388)
Q Consensus 231 ~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~gt~~ 288 (388)
+++.+.. .++.++| |.+|+|+||+++.++.+||+|||+++.......... ....++..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 9985432 2345555 457889999999999999999999986542221111 11223567
Q ss_pred ccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 289 YVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 289 y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
|+|||.+.+..++.++|||||||++|||+| |..||... ........+.... .... .......
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~----~~~~~~~~~~~~~------~~~~-------~~~~~~~ 223 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM----SNQQTRERIESGY------RMPA-------PQLCPEE 223 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC----CHHHHHHHHhcCC------CCCC-------CccCCHH
Confidence 999999888889999999999999999999 78887432 2222222221110 0000 1112336
Q ss_pred HHHHHHhcccCCCCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+++.+||..+|.+|||+.|
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~e 244 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSE 244 (251)
T ss_pred HHHHHHHHhccChhhCcCHHH
Confidence 889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=259.95 Aligned_cols=236 Identities=25% Similarity=0.364 Sum_probs=174.0
Q ss_pred ccHHHHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 035768 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSV 213 (388)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 213 (388)
++.+++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34456666788999999999999999999996 468899999986532 2345678899999998 89999999999875
Q ss_pred C-----CeeEEEEeccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 214 D-----EEKLLVYEYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 214 ~-----~~~~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
. +..++||||+++|+|.++++.. ..++.++| |.+|+|+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 4 3579999999999999987531 12445566 45688999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCC-----CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHH
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG-----KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 339 (388)
|||+++........ .....|+..|+|||.+... .++.++|||||||++|||++|+.||.... ....+.
T Consensus 171 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~---~~~~~~--- 243 (291)
T cd06639 171 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH---PVKTLF--- 243 (291)
T ss_pred ecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc---HHHHHH---
Confidence 99999876432211 2234588999999986543 36899999999999999999999985321 111111
Q ss_pred HHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 340 LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... .......++ ......+.+++.+||+.+|++||++.|
T Consensus 244 -~~~~-~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 244 -KIPR-NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred -HHhc-CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 1111 111111111 112235889999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=260.09 Aligned_cols=227 Identities=25% Similarity=0.360 Sum_probs=173.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4678889999999999999985 468899999987554445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRNQ--------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~~--------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.+++.+. ..++.++|. .+++|+||+++.++.+||+|||++......... .....|
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~ 177 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-cccccC
Confidence 999999987642 224566664 467799999999999999999998765443221 223458
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
++.|+|||......++.++|||||||++||+++|+.||..... ..... .....+. ... .......
T Consensus 178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~----~~~~~---~~~~~~~-~~~-------~~~~~~~ 242 (293)
T cd06647 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALY---LIATNGT-PEL-------QNPEKLS 242 (293)
T ss_pred ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hhhee---ehhcCCC-CCC-------CCccccC
Confidence 8899999998888899999999999999999999999854211 11100 0000000 000 0011223
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.+|++||++.|
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHH
Confidence 36788999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=261.80 Aligned_cols=223 Identities=24% Similarity=0.318 Sum_probs=169.8
Q ss_pred cCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 150 EENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 346699999999999986 4688999999876544445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCc
Q 035768 229 LDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289 (388)
Q Consensus 229 L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y 289 (388)
|.+++... ..++.++| |.+|+|+||++++++.+||+|||++........ ......|+..|
T Consensus 106 L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y 184 (292)
T cd06658 106 LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYW 184 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccc
Confidence 99987532 23556666 457789999999999999999999876543222 12234588999
Q ss_pred cCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHH
Q 035768 290 VPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKML 369 (388)
Q Consensus 290 ~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 369 (388)
+|||......++.++||||||+++|||++|+.||... +.......+.... .+.... .......+.
T Consensus 185 ~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~~~~~~~~---------~~~~~~--~~~~~~~~~ 249 (292)
T cd06658 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE----PPLQAMRRIRDNL---------PPRVKD--SHKVSSVLR 249 (292)
T ss_pred cCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcC---------CCcccc--ccccCHHHH
Confidence 9999998888999999999999999999999997532 2222222111111 110000 011223577
Q ss_pred HHHHhcccCCCCCCCCCCC
Q 035768 370 QIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 370 ~l~~~C~~~~P~~RPt~~e 388 (388)
+++.+||..||++|||+.|
T Consensus 250 ~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 250 GFLDLMLVREPSQRATAQE 268 (292)
T ss_pred HHHHHHccCChhHCcCHHH
Confidence 8899999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=258.86 Aligned_cols=229 Identities=29% Similarity=0.473 Sum_probs=170.8
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChH--HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDR--EFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
|+..+.||+|+||+||++... +++.+|+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 445688999999999999965 4668999999766433222 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
++++|.+++... ..+|.++| |.||+|+||++++++.++|+|||.+..... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999988621 23556666 457889999999999999999999986522 223334566
Q ss_pred cccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
++..|+|||... ...++.++||||+|+++|+|++|..||... ...+....+.............. ...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 228 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES----NSDDQLEIIEKILKRPLPSSSQQ-------SRE 228 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS----SHHHHHHHHHHHHHTHHHHHTTS-------HTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc----cchhhhhhhhhcccccccccccc-------cch
Confidence 899999999988 788999999999999999999999998643 11111111111111100000000 000
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred hHHHHHHHHHHHccCChhHCcCHHH
Confidence 1147899999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=255.36 Aligned_cols=223 Identities=26% Similarity=0.396 Sum_probs=158.1
Q ss_pred eeeccCCceEEEEEcCC---CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 153 VIGGGGFGTVFKGTMPD---GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 45688888764432 234568899999999999999999999999999999999999999
Q ss_pred HHHHHhccC--------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-eeec
Q 035768 229 LDDWLRNQA--------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VSTV 282 (388)
Q Consensus 229 L~~~l~~~~--------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 282 (388)
|.+++.... .++.|+| |.||+|+|||+++++.+||+|||+++........ ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence 999885421 2345566 4578899999999999999999998754332211 1122
Q ss_pred cccccCccCccccC-------CCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 283 VAGTIGYVPPEYGG-------TGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 283 ~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
..++..|+|||+.. ...++.++|||||||++|||++ |..||... ...+..... .... .....++
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~----~~~~~~~~~---~~~~-~~~~~~~ 233 (269)
T cd05042 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL----SDEQVLKQV---VREQ-DIKLPKP 233 (269)
T ss_pred CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC----CHHHHHHHH---hhcc-CccCCCC
Confidence 34567899999753 3456889999999999999999 77786432 222222211 1111 1112222
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... .....+.+++..|| .||++|||++|
T Consensus 234 ~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 234 QLDL----KYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred cccc----cCCHHHHHHHHHHh-cCcccccCHHH
Confidence 1111 12235667888899 59999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=254.98 Aligned_cols=223 Identities=24% Similarity=0.407 Sum_probs=158.8
Q ss_pred eeeccCCceEEEEEcCCC---CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 153 VIGGGGFGTVFKGTMPDG---KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.||+|+||.||+|...++ ..+++|.++.... ...+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 3466777654332 345679999999999999999999999999999999999999999
Q ss_pred HHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-cceeecc
Q 035768 229 LDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE-SHVSTVV 283 (388)
Q Consensus 229 L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 283 (388)
|.+++++. +.++.|+| |.||+|+|||++.++.+||+|||++....... .......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 99988642 12455666 45788999999999999999999986432211 1122234
Q ss_pred ccccCccCccccCC-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 284 AGTIGYVPPEYGGT-------GKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 284 ~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.++..|+|||+... ..++.++|||||||++|||++ |..||... +..+.... .... ......++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~----~~~~~~~~---~~~~-~~~~~~~~~ 233 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL----SDREVLNH---VIKD-QQVKLFKPQ 233 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHH---HHhh-cccccCCCc
Confidence 57889999998642 245789999999999999998 46676421 22222222 1211 112233333
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+..... ..+.+++..|| .+|++||||+|
T Consensus 234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 234 LELPYS----ERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred cCCCCc----HHHHHHHHHHh-hCcccCCCHHH
Confidence 322222 35677888999 57999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.43 Aligned_cols=222 Identities=23% Similarity=0.303 Sum_probs=169.4
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 456999999999999864 6899999998755444556788999999999999999999999999999999999999999
Q ss_pred HHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCcc
Q 035768 230 DDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290 (388)
Q Consensus 230 ~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~ 290 (388)
.+++... ..++.++| |.+|+|+||+++.++.+||+|||++....... .......|+..|+
T Consensus 106 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~ 184 (297)
T cd06659 106 TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWM 184 (297)
T ss_pred HHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCcccc
Confidence 9877532 23455566 45788999999999999999999987654322 1223356899999
Q ss_pred CccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHH
Q 035768 291 PPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQ 370 (388)
Q Consensus 291 aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 370 (388)
|||++....++.++|||||||++|||++|+.||... +..+....+.. ........ .......+.+
T Consensus 185 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~~~----~~~~~~~~-------~~~~~~~l~~ 249 (297)
T cd06659 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKRLRD----SPPPKLKN-------AHKISPVLRD 249 (297)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhc----cCCCCccc-------cCCCCHHHHH
Confidence 999998888999999999999999999999998532 22222222111 11000000 0111235788
Q ss_pred HHHhcccCCCCCCCCCCC
Q 035768 371 IATGCISNDPTVRPTMLH 388 (388)
Q Consensus 371 l~~~C~~~~P~~RPt~~e 388 (388)
++.+||+.+|++||++.|
T Consensus 250 ~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 250 FLERMLTREPQERATAQE 267 (297)
T ss_pred HHHHHhcCCcccCcCHHH
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.90 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=170.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999975 5899999998654322 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++++|.++... ...++.++|. .++.|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 9999988877642 2335566664 4577999999999999999999998764432 22223
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc--ccc----------c
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN--EQA----------D 349 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~----------~ 349 (388)
..++..|+|||+..+ ..++.++|||||||++|||++|+.||... ...+....+...... ... .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD----SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC----chHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 457889999998764 45788999999999999999999887532 111111111111000 000 0
Q ss_pred ccCCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNA-----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+..... ........+.+++.+||+.+|++|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 0000000000 01122346889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.32 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=170.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778889999999999999975 58999999986432 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++++|..++.. ...++.++| |.+|+|+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 9999888877643 123455666 457789999999999999999999987754322 1223
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc-----------ccc-c
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN-----------EQA-D 349 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~ 349 (388)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+...... ... .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS----DVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 457889999998765 567899999999999999999999985422 11111111111100 000 0
Q ss_pred ccCCccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+....... ......+.+++.+||+.+|++|||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 000000000000 111346789999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=253.82 Aligned_cols=212 Identities=23% Similarity=0.346 Sum_probs=156.7
Q ss_pred eeeccCCceEEEEEcCC-------------------------CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccce
Q 035768 153 VIGGGGFGTVFKGTMPD-------------------------GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 207 (388)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13589999875544444678899999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCC-------
Q 035768 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDF------- 259 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~------- 259 (388)
+++|..+...++||||+++|+|..+++.. +.++.|+| |.||+|+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 99999999999999999999999988542 22455666 457889999997643
Q ss_pred CEEEcccccceeccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHH-hCCCCCCCCCCCCCcccHHH
Q 035768 260 EAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELV-TGKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~-tg~~P~~~~~~~~~~~~~~~ 337 (388)
.+|++|||++...... ....++..|+|||.+.. ..++.++|||||||++|||+ +|+.||... .......
T Consensus 162 ~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~~~ 232 (274)
T cd05076 162 FIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER----TPSEKER 232 (274)
T ss_pred eeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc----ChHHHHH
Confidence 3899999998654321 12347788999998765 56899999999999999995 689887532 1122211
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... ..... .. ....+.+++.+||+.+|++||||.|
T Consensus 233 ~~~~---~~~~~--------~~----~~~~~~~li~~cl~~~p~~Rps~~~ 268 (274)
T cd05076 233 FYEK---KHRLP--------EP----SCKELATLISQCLTYEPTQRPSFRT 268 (274)
T ss_pred HHHh---ccCCC--------CC----CChHHHHHHHHHcccChhhCcCHHH
Confidence 1111 00000 00 1125789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=258.53 Aligned_cols=177 Identities=25% Similarity=0.341 Sum_probs=143.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4667789999999999999964 688999999864322 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc------------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQ------------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~------------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
++ ++|.+++... ..+|.++|. .+|+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccc
Confidence 96 6888877432 234566664 5678999999999999999999997654321 112
Q ss_pred eccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22346889999998754 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=264.34 Aligned_cols=226 Identities=29% Similarity=0.444 Sum_probs=168.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC--------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
.+|...+.||+|+||.||++... .+..||+|.++.... ...+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778899999999999999742 123689998875432 2346789999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDDF 259 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~ 259 (388)
..+++|||+++|+|.+++.+. ..++.++| |.+|+|+|||++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 999999999999999998642 11344555 457889999999999
Q ss_pred CEEEcccccceeccCCCcce-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHH
Q 035768 260 EAKISDFGLARLISDCESHV-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 337 (388)
.+||+|||+++......... .....++..|+|||......++.++|||||||++|||++ |..||... +..++..
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~ 247 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----PVEELFK 247 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Confidence 99999999998764322111 112234567999999988899999999999999999999 88887432 2222322
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. ...... .......+.+++.+||+.+|++||||.|
T Consensus 248 ~~~~----~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 248 LLKE----GHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred HHHc----CCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 2211 111110 0112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=259.09 Aligned_cols=232 Identities=25% Similarity=0.389 Sum_probs=168.2
Q ss_pred CCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 218 (388)
.|...+.||+|+||.||++.+ .++..||+|.++... ......+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356788999999999999974 357889999987543 23345789999999999999999999999775 5678
Q ss_pred EEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++++|.+++.... .++.++| |.+|+|+||+++.++.+||+|||+++.+.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 9999999999999985432 2345555 457889999999999999999999987643222
Q ss_pred c--eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-------CCcc-cHHHHHHHhhcccc
Q 035768 278 H--VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED-------KDGE-NLVDWVLHMMKNEQ 347 (388)
Q Consensus 278 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~-------~~~~-~~~~~~~~~~~~~~ 347 (388)
. ......++..|+|||...+..++.++|||||||++|||+|++.|....... .... ....++ .......
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 243 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEEGK 243 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHHcCc
Confidence 1 112345677899999988888999999999999999999987764321110 0000 111111 1111111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ........+.+++.+||+.+|++|||++|
T Consensus 244 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 275 (284)
T cd05079 244 RLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQN 275 (284)
T ss_pred cCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 000 01112347889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=261.54 Aligned_cols=171 Identities=20% Similarity=0.259 Sum_probs=141.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
...+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4457999999999999999999965 5778999975432 23569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|+ .|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++..... ....
T Consensus 138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 214 (357)
T PHA03209 138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL 214 (357)
T ss_pred cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence 99 57888887532 23556666 4578899999999999999999999754321 1223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPT 323 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~ 323 (388)
...||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 356899999999998889999999999999999999966554
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=248.74 Aligned_cols=223 Identities=31% Similarity=0.523 Sum_probs=171.3
Q ss_pred CcCCeeeccCCceEEEEEcCC-----CCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 149 CEENVIGGGGFGTVFKGTMPD-----GKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
...+.||.|+||.||++...+ +..||+|.+...... ....+..|++++..++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999753 388999999765433 45679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+++++|.+++.... .++.++| |.+|+|+||++++++.++|+|||+++..........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK 161 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc
Confidence 999999999886432 2344555 457889999999999999999999987755422222
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+++.|+|||......++.++||||+|+++|||++ |..||.. .+...+.+.+..... .. .+
T Consensus 162 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~----~~~~~~~~~~~~~~~----~~--~~----- 226 (258)
T smart00219 162 KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG----MSNEEVLEYLKKGYR----LP--KP----- 226 (258)
T ss_pred ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHhcCCC----CC--CC-----
Confidence 22336789999999888889999999999999999999 7788643 233333333322111 00 00
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||..+|++|||+.|
T Consensus 227 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 227 --ENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred --CcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 112336888999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=255.87 Aligned_cols=233 Identities=26% Similarity=0.348 Sum_probs=172.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 221 (388)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999974 588999999875432 3345689999999999999999999998653 4689999
Q ss_pred eccCCCCHHHHHhc-------------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 222 EYMVKGSLDDWLRN-------------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~-------------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||+++++|.+++.. ...++.|+| |.++.|+||++++++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999887642 123456666 446779999999999999999999876543211
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CCcccHHHHHHHhhccccccccCCccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED-KDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
....++..|+|||......++.++|||||||++|||++|+.||...... ....+...++..... ....+. .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~ 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN----PELKDE-P 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc----hhhccC-C
Confidence 2345788999999998889999999999999999999999998643210 112233333222110 010000 0
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+.+++.+||+.+|++|||+.|
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 262 (287)
T cd06621 233 --GNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262 (287)
T ss_pred --CCCCchHHHHHHHHHHHcCCCcccCCCHHH
Confidence 001122346889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=249.19 Aligned_cols=220 Identities=32% Similarity=0.530 Sum_probs=170.6
Q ss_pred CeeeccCCceEEEEEcCC----CCEEEEEEcccCCCcC-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATGQG-DREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7889999997654333 56789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcc--------CC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 227 GSLDDWLRNQ--------AA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 227 g~L~~~l~~~--------~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
|+|.+++... .. ++.++| |.+|+|+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999998764 12 344555 457889999999999999999999987754321
Q ss_pred -ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 -HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.......++..|+|||......++.++||||+|+++|||++ |..||... +...+.+.+.. .. ....+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~----~~--~~~~~- 229 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL----SNEEVLEYLRK----GY--RLPKP- 229 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHc----CC--CCCCC-
Confidence 12233457889999999888889999999999999999999 68897543 23333333322 11 00011
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||..+|++|||+.|
T Consensus 230 ------~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (262)
T cd00192 230 ------EYCPDELYELMLSCWQLDPEDRPTFSE 256 (262)
T ss_pred ------ccCChHHHHHHHHHccCCcccCcCHHH
Confidence 111336889999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=249.98 Aligned_cols=228 Identities=28% Similarity=0.433 Sum_probs=171.7
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3667789999999999999864 6889999998765432 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceee--
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVST-- 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~-- 281 (388)
+++++|.+++... ..++.++|. .++.|+||++++++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999999988643 224455553 467899999999999999999999876543322111
Q ss_pred -ccccccCccCccccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 282 -VVAGTIGYVPPEYGGTGK---ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 282 -~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
...++..|+|||++.... ++.++||||||+++||+++|+.||.... ........+. . ..... +.
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~---~~~~~~~~~~---~-~~~~~-~~---- 228 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD---NEFQIMFHVG---A-GHKPP-IP---- 228 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc---chHHHHHHHh---c-CCCCC-CC----
Confidence 345788999999987666 8899999999999999999999985321 1111111111 1 11000 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .......+.+++.+||+.+|.+|||+.|
T Consensus 229 ~--~~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 229 D--SLQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred c--ccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 0 0111235778999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=245.14 Aligned_cols=231 Identities=24% Similarity=0.301 Sum_probs=173.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----ee
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EK 217 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 217 (388)
..++|.+.+.||+|||+.||.++ ..+++.+|+|++.....++.+...+|++..++++|||++++++++..+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 44678899999999999999998 5678999999998776677788999999999999999999999886543 48
Q ss_pred EEEEeccCCCCHHHHHhcc-------------------CCCCCHHh-------hhccccCCeeecCCCCEEEccccccee
Q 035768 218 LLVYEYMVKGSLDDWLRNQ-------------------AASLDWGK-------RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~-------~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
|++++|...|+|.+.+... ..+|.++| |+||+|.|||+.+.+.+++.|||.+..
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999987532 12333333 679999999999999999999999876
Q ss_pred ccCCCc--------ceeeccccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHH
Q 035768 272 ISDCES--------HVSTVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340 (388)
Q Consensus 272 ~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 340 (388)
..-.-. ........|..|.|||.+. +...++++|||||||+||+|+.|..||+..+. .+.++.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgSla---- 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGSLA---- 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCeEE----
Confidence 421100 0011234688999999764 44578999999999999999999999976554 222211
Q ss_pred HhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+..+.+.-+........+.+++..|++.||.+||++.|
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ 292 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE 292 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence 1111111111111124457899999999999999999753
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=252.98 Aligned_cols=224 Identities=24% Similarity=0.381 Sum_probs=171.4
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|+..+.||+|+||.||++.. .+++.||+|.+.... .....++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 467788999999999999985 468899999986432 23345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++++|.+++.... .++.++| |.++.|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-AR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-hh
Confidence 99999999885421 2344555 3467799999999999999999999876442221 22
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|++.|+|||+..+..++.++|||||||++|||++|+.||... +..+.. ...... ..... .
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~---~~~~~~-~~~~~---------~ 222 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----NMKNLV---LKIIRG-SYPPV---------S 222 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC----CHHHHH---HHHhcC-CCCCC---------c
Confidence 345788999999998888999999999999999999999997532 222222 221111 11100 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++||+|+|
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 112336889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=252.20 Aligned_cols=235 Identities=20% Similarity=0.274 Sum_probs=171.1
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCC-ccceeeEEEeCC------e
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQN-LVELLGYCSVDE------E 216 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 216 (388)
.|...+.||+|+||+||+|+. .+|+.||+|+++..... ......+|+.++++++|+| ||++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 355566799999999999995 47899999999765432 2345689999999999999 999999999877 7
Q ss_pred eEEEEeccCCCCHHHHHh-------------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceec
Q 035768 217 KLLVYEYMVKGSLDDWLR-------------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~-------------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
.++|+||+ .-+|.+|+. |...+++|+| |+|++|.|||++++|.+||+|||+|+..
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 88999998 446666654 3344677888 5688899999999999999999999976
Q ss_pred cCCCcceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
.-.. ...+...+|..|.|||++.+. .|++..||||+||++.||++++.-|.... ..+....+...+.......+
T Consensus 171 ~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s----e~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 171 SIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS----EIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred cCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHHHcCCCCccCC
Confidence 5322 223445689999999987665 79999999999999999999988875433 23333333333332211111
Q ss_pred ---C-Ccc----ccC---CC--C---HHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 352 ---L-DPA----VLN---AN--S---KPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 352 ---~-~~~----~~~---~~--~---~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
. -|. ... .. . ........+++.+|++.+|.+|.|++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~ 297 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK 297 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence 0 000 000 00 0 11113678999999999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=256.73 Aligned_cols=235 Identities=24% Similarity=0.397 Sum_probs=172.8
Q ss_pred ccHHHHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 035768 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSV 213 (388)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 213 (388)
.++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34556666778899999999999999999996 468899999886543 2345688899999998 79999999999853
Q ss_pred ------CCeeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcc
Q 035768 214 ------DEEKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISD 265 (388)
Q Consensus 214 ------~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~D 265 (388)
.+..+++|||+++|+|.+++... ..++.|+| |.+++|+||++++++.++|+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 45789999999999999987542 22455666 346779999999999999999
Q ss_pred cccceeccCCCcceeeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHH
Q 035768 266 FGLARLISDCESHVSTVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340 (388)
Q Consensus 266 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 340 (388)
||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..... ...+.
T Consensus 165 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~---- 236 (282)
T cd06636 165 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALF---- 236 (282)
T ss_pred Ccchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---Hhhhh----
Confidence 999876532211 122345889999999865 34678899999999999999999999853211 11111
Q ss_pred HhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... . .+... .......+.+++.+||+.||.+|||+.|
T Consensus 237 ~~~~~-~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 237 LIPRN-P-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred hHhhC-C-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 00000 0 00000 0112236889999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=261.46 Aligned_cols=175 Identities=22% Similarity=0.303 Sum_probs=139.3
Q ss_pred CCeeecc--CCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 151 ENVIGGG--GFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 151 ~~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
.++||+| +|++||++.. .+|+.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999986 4689999999975432 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-----
Q 035768 226 KGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH----- 278 (388)
Q Consensus 226 ~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~----- 278 (388)
+|+|.+++... ..+|.|+| |.||+|+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 162 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccc
Confidence 99999988532 23456666 4578899999999999999999876543221110
Q ss_pred -eeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 279 -VSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0112346778999998865 4689999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=252.49 Aligned_cols=229 Identities=21% Similarity=0.367 Sum_probs=171.1
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
+|+..+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999985 5689999999864331 123568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~ 278 (388)
|+||+++++|.+++.+. ..++.++| |.+|+|+||+++.++ .+||+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 99999999999988542 23455666 457789999998775 5999999999876432111
Q ss_pred ---eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 279 ---VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 279 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
......|+..|+|||......++.++||||+|+++|||++|+.||.... .......+......... +
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~-----~- 230 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK----HSNHLALIFKIASATTA-----P- 230 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----CcchHHHHHHHhccCCC-----C-
Confidence 1123457889999999888889999999999999999999999985321 11111211111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+.+++.+||..+|++|||+.|
T Consensus 231 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 231 ---SIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 111223346889999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=277.17 Aligned_cols=224 Identities=21% Similarity=0.285 Sum_probs=169.1
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCC-CEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeE-EEe------C
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDG-KTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGY-CSV------D 214 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~ 214 (388)
+..++++.+.|.+|||+.||.+....+ ..+|+|++-.......+...+|+++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 344567789999999999999997655 999999987666667788999999999997 9999999993 221 1
Q ss_pred CeeEEEEeccCCCCHHHHHhccC-----------------CCCCHHh-------hhccccCCeeecCCCCEEEcccccce
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-------RCKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-------~~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
-+.+|.||||++|.|-|++.+.. .++..+| |+|||.+||||+.++..||||||-|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 35689999999999999986432 2344444 77999999999999999999999986
Q ss_pred eccCCCcce--------eeccccccCccCccc---cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHH
Q 035768 271 LISDCESHV--------STVVAGTIGYVPPEY---GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 271 ~~~~~~~~~--------~~~~~gt~~y~aPE~---~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 339 (388)
......... .-....|+.|+|||+ ..+...++|+|||++||+||-|+....||+..- .
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----K------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----c-------
Confidence 432211000 011346899999996 456789999999999999999999999986421 1
Q ss_pred HHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 340 LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
..+++-...-+........+.+||..||+.||.+||++-
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~ 302 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIY 302 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHH
Confidence 111111111111234555799999999999999999863
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.03 Aligned_cols=237 Identities=21% Similarity=0.297 Sum_probs=170.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999864 588999999864432 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ ++|.+++... ..++.++| |.||+|+||++++++.+||+|||+++....... ....
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~ 163 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSN 163 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccc
Confidence 96 6888877532 23456666 457889999999999999999999976543221 1222
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccCC-----
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVLD----- 353 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 353 (388)
..+++.|+|||.+.+ ..++.++|||||||++|||+||+.||... +..+....+........ .....+
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS----TVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 346889999998754 45788999999999999999999998532 22222222222211100 000000
Q ss_pred ----ccccCC----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 ----PAVLNA----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ----~~~~~~----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+..... ........+.+++.+|++.||.+|||++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e 282 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 000000 00112335789999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=254.07 Aligned_cols=231 Identities=26% Similarity=0.397 Sum_probs=173.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|+..+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788899999999999999954 68899999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc--
Q 035768 224 MVKGSLDDWLRNQ------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-- 278 (388)
Q Consensus 224 ~~~g~L~~~l~~~------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-- 278 (388)
+++++|.++++.. ..++.++| |.+++|+||++++++.+||+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999998642 12344555 3467799999999999999999999876543222
Q ss_pred -eeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......|+..|+|||.+... .++.++|||||||++|||++|+.||..... .....+.. .... .. ....
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~----~~~~-~~-~~~~- 230 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP---MKVLMLTL----QNDP-PS-LETG- 230 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh---hhhHHHHh----cCCC-CC-cCCc-
Confidence 12334588999999988766 789999999999999999999999854311 11111111 1110 00 0000
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+.+++.+||+.||++|||+.|
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 231 --ADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred --cccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 001122346789999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=265.88 Aligned_cols=216 Identities=23% Similarity=0.260 Sum_probs=159.3
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV---KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 589999999864321 1223455677777655 699999999999999999999999999
Q ss_pred CCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
|+|.+++.+ ...++.|+| |+||+|+|||++.++.+||+|||+++...... ......+||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGT 159 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCccCC
Confidence 999887753 234567777 45788999999999999999999997643222 122345699
Q ss_pred cCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 287 IGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 287 ~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+.|+|||.+.+. .++.++|||||||++|||+||+.||... +...+.+.+. .... .... . ...
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~----~~~~~~~~i~----~~~~-~~~~-----~---~~~ 222 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE----DTQQMYRNIA----FGKV-RFPK-----N---VLS 222 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC----CHHHHHHHHH----cCCC-CCCC-----c---cCC
Confidence 999999987654 5899999999999999999999998532 2222222111 1110 0000 0 012
Q ss_pred HHHHHHHHhcccCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
..+.+++.+||+.||.+||++.
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCC
Confidence 2577899999999999999653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.11 Aligned_cols=225 Identities=27% Similarity=0.372 Sum_probs=167.7
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLG-MVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+....||.|+||+|+|-.++ .|+..|||+++.... .+..+++.|.+... .-+.||||++||.+..++..|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 34567999999999999864 699999999986544 45567888887654 457899999999999999999999999
Q ss_pred CCCHHHHHhc--------------------cCCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 226 KGSLDDWLRN--------------------QAASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 226 ~g~L~~~l~~--------------------~~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
.-+|..+-.. ...+|+|+. |+||+|+|||+|..|.+||||||++-.+.+ +..
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 5566554321 012455553 679999999999999999999999987754 234
Q ss_pred eeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 280 STVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
.+..+|...|||||.+.. ..|+-+|||||+|++|||+.||+.|+.. -.++.+.+........ ..+..+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~------w~svfeql~~Vv~gdp-p~l~~~--- 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK------WDSVFEQLCQVVIGDP-PILLFD--- 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch------HHHHHHHHHHHHcCCC-CeecCc---
Confidence 455678999999997653 3589999999999999999999999753 1234444444333221 111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
....+....+.+++..|+..|-++||..+
T Consensus 294 -~~~~~~s~~~~~fintCl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 294 -KECVHYSFSMVRFINTCLIKDRSDRPKYD 322 (361)
T ss_pred -ccccccCHHHHHHHHHHhhcccccCcchh
Confidence 11123344688899999999999999865
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=253.48 Aligned_cols=225 Identities=23% Similarity=0.373 Sum_probs=169.5
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|+..+.||+|+||.||++... +++.||+|.++... ......+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999975 68999999886532 223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc------------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 225 VKGSLDDWLRNQ------------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 225 ~~g~L~~~l~~~------------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
++++|..++... ..++.++| |.+|+|+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---A 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---c
Confidence 999999988652 11345555 35788999999999999999999997653321 2
Q ss_pred eccccccCccCccccCCC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 281 TVVAGTIGYVPPEYGGTG------KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
....++..|+|||.+... .++.++|||||||++|||++|+.||... ........+..... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~-~~~~~---- 229 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE----TYANIFAQLSAIVD-GDPPT---- 229 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc----chhhHHHHHHHHhh-cCCCC----
Confidence 234578899999987543 3588999999999999999999998542 11122221111111 11011
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .......+.+++.+||+.+|++||++.|
T Consensus 230 -~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 230 -L----PSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred -C----CcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 0 1123346789999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=250.41 Aligned_cols=224 Identities=23% Similarity=0.357 Sum_probs=169.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 222 (388)
+|+..+.||+|++|.||++... +++.||+|++..... ...+.+.+|++++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3677889999999999999964 578899999865322 334568899999999999999999998764 446789999
Q ss_pred ccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+++++|.+++.... .++.++| |.+|+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-cc
Confidence 999999999886421 1344555 456889999999999999999999987643322 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....|++.|+|||......++.++||||||+++|||++|+.||... +.... ...... ..... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~----~~~~~---~~~~~~-~~~~~-----~---- 222 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----DMNSL---VYRIIE-GKLPP-----M---- 222 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----CHHHH---HHHHHh-cCCCC-----C----
Confidence 3345889999999998888999999999999999999999997532 21111 111111 11101 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++|||+.|
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHH
Confidence 1122346889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=251.84 Aligned_cols=224 Identities=23% Similarity=0.283 Sum_probs=172.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
+.|+..+.||+|.-|+||+++..+ +..+|+|++.+... ....+...|-+||+.++||.++.||+.++.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667889999999999999764 68899999976532 23345777999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-----------------CCCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccC-----
Q 035768 222 EYMVKGSLDDWLRNQ-----------------AASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISD----- 274 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-----------------~~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~----- 274 (388)
|||+||+|....+.+ ..+|+|+|-+ |+||+|||+.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999999988653 2368899976 5669999999999999999998743210
Q ss_pred ----------------------------CCc----------------------ceeeccccccCccCccccCCCCCCccc
Q 035768 275 ----------------------------CES----------------------HVSTVVAGTIGYVPPEYGGTGKATERG 304 (388)
Q Consensus 275 ----------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 304 (388)
... ..+..++||-.|+|||++.+...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 000 111236799999999999999999999
Q ss_pred chHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 035768 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 305 Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
|+|+|||++|||+.|..||.... ....+...+.+-.. . +........+.+|+.+.|.+||++|-
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~---~~~Tl~NIv~~~l~------F-------p~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSN---NKETLRNIVGQPLK------F-------PEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCC---chhhHHHHhcCCCc------C-------CCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999986432 22223222211110 0 01113344688999999999999996
Q ss_pred C
Q 035768 385 T 385 (388)
Q Consensus 385 t 385 (388)
.
T Consensus 381 g 381 (459)
T KOG0610|consen 381 G 381 (459)
T ss_pred c
Confidence 5
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=252.33 Aligned_cols=213 Identities=24% Similarity=0.465 Sum_probs=158.1
Q ss_pred CeeeccCCceEEEEEcCC--------CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 152 NVIGGGGFGTVFKGTMPD--------GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 358999999999998532 234888888655444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCC--------EEEcccccceeccC
Q 035768 224 MVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFE--------AKISDFGLARLISD 274 (388)
Q Consensus 224 ~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~--------~kl~DfG~a~~~~~ 274 (388)
+++|+|.++++.... ++.++| |++|+|+||+++.++. ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 999999999864322 344555 4578899999987765 69999999875532
Q ss_pred CCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGK-QPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
.....++..|+|||++.. ..++.++|||||||++|||++|. .|+.. .+......... ... ...
T Consensus 161 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~----~~~~~~~~~~~---~~~---~~~ 225 (258)
T cd05078 161 -----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA----LDSQKKLQFYE---DRH---QLP 225 (258)
T ss_pred -----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh----ccHHHHHHHHH---ccc---cCC
Confidence 123457889999998876 45799999999999999999985 55432 11111111110 000 110
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ....++.+++.+||+.+|++|||++|
T Consensus 226 -----~----~~~~~~~~li~~~l~~~p~~Rps~~~ 252 (258)
T cd05078 226 -----A----PKWTELANLINQCMDYEPDFRPSFRA 252 (258)
T ss_pred -----C----CCcHHHHHHHHHHhccChhhCCCHHH
Confidence 0 11136889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=249.01 Aligned_cols=223 Identities=24% Similarity=0.401 Sum_probs=169.9
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999986 468899999986542 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCC-CCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+++++|.+++.+.. .++.++| |.+|+|+||+++++ +.+||+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--A 158 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--c
Confidence 99999999986421 2344555 45688999999855 4689999999987654321 2
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....|+..|+|||......++.++||||||+++|||++|+.||... +.......+.. . ......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~----~~~~~~~~~~~---~-~~~~~~~------- 223 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA----NLPALVLKIMS---G-TFAPISD------- 223 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC----chHHHHHHHHh---c-CCCCCCC-------
Confidence 2345889999999998888999999999999999999999997532 22222222211 1 1111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.+|++|||+.|
T Consensus 224 --~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 224 --RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred --CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 12236889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=255.05 Aligned_cols=220 Identities=32% Similarity=0.507 Sum_probs=164.2
Q ss_pred CeeeccCCceEEEEEcCC-------CCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 152 NVIGGGGFGTVFKGTMPD-------GKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998642 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------------CCCCCHHh-----hhccccCCeeecCCC-----CEEEccccccee
Q 035768 224 MVKGSLDDWLRNQ----------------------AASLDWGK-----RCKIVASNILLNDDF-----EAKISDFGLARL 271 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------------~~~l~~~~-----~~~i~~~NiLl~~~~-----~~kl~DfG~a~~ 271 (388)
+++|+|.++++.. ..++.|+| |.+++|+||+++.+. .+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 11234555 457889999999877 899999999976
Q ss_pred ccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 272 ISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 272 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
....... ......++..|+|||.+....++.++|||||||++|||+| |+.||... ...+....+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~----~~-- 230 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL----NNQEVLQHVTA----GG-- 230 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc----CHHHHHHHHhc----CC--
Confidence 5432211 1122335678999999988899999999999999999998 99997532 22222222211 10
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... .......+.+++.+||+.+|.+||+++|
T Consensus 231 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 231 RLQK-------PENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred ccCC-------cccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 0000 1112346789999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=252.29 Aligned_cols=223 Identities=24% Similarity=0.401 Sum_probs=169.7
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
|...+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 56678899999999999985 4688999999864432 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 226 KGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 226 ~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
+|+|.+++... ..++.++| |.+|+|+||+++.++.++|+|||++..+..... ......++
T Consensus 86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 164 (277)
T cd06641 86 GGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGT 164 (277)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccCC
Confidence 99999988642 12344555 456789999999999999999999987644221 12234578
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
..|+|||......++.++|||||||++|||++|..||... ........+ ...... .. ......
T Consensus 165 ~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~~~~~~----~~~~~~-----~~----~~~~~~ 227 (277)
T cd06641 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL----HPMKVLFLI----PKNNPP-----TL----EGNYSK 227 (277)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc----chHHHHHHH----hcCCCC-----CC----CcccCH
Confidence 8999999988888899999999999999999999997532 111111111 111110 01 111223
Q ss_pred HHHHHHHhcccCCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+++.+||+.+|.+||++.|
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 228 PLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred HHHHHHHHHccCChhhCcCHHH
Confidence 5788999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=253.12 Aligned_cols=230 Identities=25% Similarity=0.440 Sum_probs=168.0
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---c-------ChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---Q-------GDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
+|...+.||.|+||.||+|.. .+++.||+|.++.... . ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356678999999999999985 4688999998853211 0 1235788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
..++||||+++|+|.+++++. ..++.++|. .+|.|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999999988653 223455553 468899999999999999999999765432
Q ss_pred Ccc-eeeccccccCccCccccCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 276 ESH-VSTVVAGTIGYVPPEYGGTGK--ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 276 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
... ......|+..|+|||...... ++.++||||||+++||+++|..||... +. . .......... ....+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~--~-~~~~~~~~~~-~~~~~ 233 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EA--I-AAMFKLGNKR-SAPPI 233 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----ch--H-HHHHHhhccc-cCCcC
Confidence 211 123345889999999876544 789999999999999999999997421 11 1 1111111111 01111
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. .......+.+++.+||+.+|++|||++|
T Consensus 234 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 234 PPDV----SMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred Cccc----cccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 1111 1122346888999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=256.44 Aligned_cols=233 Identities=27% Similarity=0.424 Sum_probs=170.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-----CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-----DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 218 (388)
.|...+.||+|+||.||++++. +++.+|||.++..... ....|.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566788999999999999853 3678999999765433 35679999999999999999999999877 55789
Q ss_pred EEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++|||+++|+|.+++.... .+|.++| |.+|+|+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 9999999999999986432 2345555 457889999999999999999999987753222
Q ss_pred ce--eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCc-------ccHHHHHHHhhccccc
Q 035768 278 HV--STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDG-------ENLVDWVLHMMKNEQA 348 (388)
Q Consensus 278 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 348 (388)
.. .....++..|+|||......++.++||||||+++|||+||+.|+......... ......+.........
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc
Confidence 11 11223456799999988888999999999999999999999997542211000 0001111111111100
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ........++.+++.+||+.+|++||||.|
T Consensus 245 --~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 275 (284)
T cd05038 245 --L-------PRPPSCPDEVYDLMKLCWEAEPQDRPSFAD 275 (284)
T ss_pred --C-------CCCccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 0 001112246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=260.03 Aligned_cols=172 Identities=24% Similarity=0.301 Sum_probs=135.4
Q ss_pred CCeeeccCCceEEEEEcC---CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccC
Q 035768 151 ENVIGGGGFGTVFKGTMP---DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLLVYEYMV 225 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 225 (388)
...||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 35789999986542 23467899999999999999999999854 557789999986
Q ss_pred CCCHHHHHh------------------------ccCCCCCHHh-----hhccccCCeee----cCCCCEEEcccccceec
Q 035768 226 KGSLDDWLR------------------------NQAASLDWGK-----RCKIVASNILL----NDDFEAKISDFGLARLI 272 (388)
Q Consensus 226 ~g~L~~~l~------------------------~~~~~l~~~~-----~~~i~~~NiLl----~~~~~~kl~DfG~a~~~ 272 (388)
++|.+++. +...++.++| |+||+|+|||+ +.++.+||+|||+++..
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 57766653 2233556666 45788999999 56679999999999876
Q ss_pred cCCCcc--eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 273 SDCESH--VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 273 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
...... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 443221 1233568999999998765 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=251.26 Aligned_cols=226 Identities=19% Similarity=0.283 Sum_probs=166.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-----cChHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-----QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 217 (388)
.+|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999864 588999998853221 1234688899999999999999999988763 467
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+++|||+++|+|.+++.+. ..++.++| |.+|+|+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999988542 22455565 457889999999999999999999986532111
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.......|+..|+|||...+..++.++|||||||++|||++|+.||... +.. ..+........ .+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~---~~~~~~~~~~~-----~~- 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF----EAM---AAIFKIATQPT-----NP- 228 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc----chH---HHHHHHhcCCC-----CC-
Confidence 1122345888999999988888999999999999999999999998532 111 11111111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+.+++.+||. +|++|||++|
T Consensus 229 ---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 229 ---VLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred ---CCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 0112233467788889985 8999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=254.62 Aligned_cols=218 Identities=25% Similarity=0.326 Sum_probs=170.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35778899999999999999964 68999999986532 123456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.++| |.+|.|+||+++.++.+||+|||+++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 999999999987542 23556666 4567799999999999999999999876543 22
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|++.|+|||.......+.++||||||+++|||++|+.||... +.....+.+. .... . +...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~----~~~~-~-----~~~~-- 220 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD----NPIQIYEKIL----EGKV-R-----FPSF-- 220 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHh----cCCc-c-----CCcc--
Confidence 346889999999988888899999999999999999999997532 2222222111 1110 0 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
....+.+++.+||+.+|.+||+
T Consensus 221 --~~~~l~~li~~~l~~~p~~R~~ 242 (290)
T cd05580 221 --FSPDAKDLIRNLLQVDLTKRLG 242 (290)
T ss_pred --CCHHHHHHHHHHccCCHHHccC
Confidence 1236788999999999999994
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=263.40 Aligned_cols=176 Identities=29% Similarity=0.366 Sum_probs=144.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD------E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 215 (388)
.++|...+.||+|+||+||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46788899999999999999985 4688999999875322 2335678999999999999999999988543 3
Q ss_pred eeEEEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
..++++|++ +++|.+++.. ...+|.|+| |+||+|+|||+++++.+||+|||+++.....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred cEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 568999998 8889877642 344677777 5578899999999999999999999876432
Q ss_pred cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 277 SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 223468999999998766 5789999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=252.32 Aligned_cols=225 Identities=24% Similarity=0.311 Sum_probs=171.4
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44467899999999999985 46889999998654444456688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccccc
Q 035768 227 GSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 227 g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
++|.+++.+. ..++.++| |.+|.|+||+++.++.++|+|||++........ ......|+.
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ 179 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTP 179 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCc
Confidence 9999987542 22455555 457789999999999999999999876543221 222345889
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
.|+|||......++.++|||||||++|||++|+.||... +.......+... .......+ ......
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~----~~~~~~~~~~~~----~~~~~~~~-------~~~~~~ 244 (285)
T cd06648 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE----PPLQAMKRIRDN----LPPKLKNL-------HKVSPR 244 (285)
T ss_pred cccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC----CHHHHHHHHHhc----CCCCCccc-------ccCCHH
Confidence 999999998888999999999999999999999997532 222222211111 11111000 112236
Q ss_pred HHHHHHhcccCCCCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+++.+||+.+|++|||+.|
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred HHHHHHHHcccChhhCcCHHH
Confidence 889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=250.70 Aligned_cols=218 Identities=29% Similarity=0.471 Sum_probs=165.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++||||+++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577789999999999999975 67889999986532 345789999999999999999999998654 5799999999
Q ss_pred CCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+|+|.+++.... .++.++| |.||+|+||+++.++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 157 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS 157 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence 999999986432 2344555 45788999999999999999999997643211 112
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..+..|+|||.+....++.++|||||||++|||++ |+.||... +..+..+.+.... .. ++ ..
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~----~~---~~------~~ 220 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM----SLKEVKECVEKGY----RM---EP------PE 220 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC----CHHHHHHHHhCCC----CC---CC------CC
Confidence 24568999999988889999999999999999998 89997532 2222222221111 00 00 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.+|++||++++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 12246789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=252.36 Aligned_cols=225 Identities=21% Similarity=0.391 Sum_probs=169.8
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVK---HQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 221 (388)
.|+..+.||+|+||.||+|.. .+++.||+|.++... .....++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366678899999999999996 568999999986542 234467889999999987 999999999999999999999
Q ss_pred eccCCCCHHHHHhcc--------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 222 EYMVKGSLDDWLRNQ--------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 222 e~~~~g~L~~~l~~~--------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
||+++++|.++++.. ..++.++|. .+|.|+||+++.++.++|+|||++......... ...
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RST 160 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-ccc
Confidence 999999999988643 224455664 467799999999999999999999877543322 233
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..|+..|+|||.... ..++.++|||||||++|||++|+.||.... ....+... ... ..+.+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-------~~~~~~~~-~~~-----~~~~~~~~-- 225 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-------AFRAMMLI-PKS-----KPPRLEDN-- 225 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-------hhhhhhcc-ccC-----CCCCCCcc--
Confidence 458899999998764 457899999999999999999999985321 11111110 000 01111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~R~~~~~ 251 (277)
T cd06917 226 -GYSKLLREFVAACLDEEPKERLSAEE 251 (277)
T ss_pred -cCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 12346889999999999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=250.46 Aligned_cols=225 Identities=28% Similarity=0.434 Sum_probs=169.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CC----EEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GK----TVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.+|...+.||+|+||.||+|...+ +. .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457778899999999999998642 33 589998876543 234578899999999999999999999987 78899
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++.+.. .++.++| |.+|+|+||+++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 999999999999986532 2455666 4578899999999999999999999876533222
Q ss_pred ee-eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 VS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.. ....++..|+|||......++.++||||||+++||+++ |+.||... ...++.+.+... .. ...+
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~----~~--~~~~-- 233 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI----PAVEIPDLLEKG----ER--LPQP-- 233 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHHhCC----CC--CCCC--
Confidence 11 11223568999999888889999999999999999999 99997532 223333333211 10 0011
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||..+|.+|||+.+
T Consensus 234 -----~~~~~~~~~~~~~~l~~~p~~Rp~~~~ 260 (279)
T cd05057 234 -----PICTIDVYMVLVKCWMIDAESRPTFKE 260 (279)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 011235788999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=253.98 Aligned_cols=178 Identities=25% Similarity=0.362 Sum_probs=144.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999965 688999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ ++|.+++... ..++.++| |.+|+|+||+++.++.+||+|||+++...... .....
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSN 162 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccc
Confidence 97 5999887542 23456666 45678999999999999999999987643211 11122
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..++..|+|||...+ ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 346789999998754 4688999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=250.99 Aligned_cols=228 Identities=24% Similarity=0.366 Sum_probs=174.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|+..+.||+|+||.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666788999999999999975 688999999876532 33456899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++++|.+++... ..++.++|. .+|+|+||++++++.+||+|||.+......... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---~ 158 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---T 158 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---c
Confidence 999999988643 124555664 467799999999999999999998765432211 1
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..++..|+|||...+..++.++||||||+++|||++|+.||..... ......+.+........ .. .. ..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~-~~-----~~---~~ 227 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQYIVNEPP-PR-----LP---SG 227 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHHHhcCCC-CC-----CC---hh
Confidence 5688899999999888999999999999999999999999864321 11223333322221111 00 00 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||..+|++|||+.|
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 12336889999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=251.08 Aligned_cols=237 Identities=26% Similarity=0.356 Sum_probs=172.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667789999999999999964 68999999987543 23346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+ +++|.+++... ..++.++| |.+|+|+||+++.++.++|+|||++.............
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 99999987542 23455566 45678999999999999999999998765433222334
Q ss_pred cccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc------------c
Q 035768 283 VAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA------------D 349 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------------~ 349 (388)
..|+..|+|||.+... .++.++||||+|+++|||+||.+||... .......++......... .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE----NDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC----CHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 4688999999987544 5689999999999999999997776432 222222222222111100 0
Q ss_pred ccCCccc----cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAV----LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~----~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+..+.. ......+....+.+++.+|++.+|++|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 0000000 00000112357889999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=246.79 Aligned_cols=211 Identities=25% Similarity=0.433 Sum_probs=159.0
Q ss_pred CeeeccCCceEEEEEcCCCC-----------EEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 152 NVIGGGGFGTVFKGTMPDGK-----------TVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999975432 5788877654333 6789999999999999999999999988 778999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCC-------CEEEcccccceec
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDF-------EAKISDFGLARLI 272 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~-------~~kl~DfG~a~~~ 272 (388)
|||+++|+|.+++.... .++.|+| |.||+|+||+++.++ .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 99999999999886432 2455666 457889999999888 7999999999875
Q ss_pred cCCCcceeeccccccCccCccccCCC--CCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTG--KATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
.. .....++..|+|||++... .++.++|||||||++|||++ |..|+... .......+.. ...
T Consensus 159 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~----~~~~~~~~~~----~~~-- 223 (259)
T cd05037 159 LS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL----SSSEKERFYQ----DQH-- 223 (259)
T ss_pred cc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC----CchhHHHHHh----cCC--
Confidence 43 1223467789999998766 78999999999999999999 56776432 1111111111 000
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+ ....+.+++.+||..+|.+|||+.|
T Consensus 224 ~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 224 RLPMP---------DCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred CCCCC---------CchHHHHHHHHHhccChhhCCCHHH
Confidence 00000 0146889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=253.02 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=168.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||+|+.. +|+.||+|.++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667788999999999999964 689999999864322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ ++|.+++... ..++.++| |.+|+|+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSA 158 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCC
Confidence 96 5788776532 23556666 456789999999999999999999986543221 1223
Q ss_pred cccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc------cccCCcc
Q 035768 283 VAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA------DEVLDPA 355 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 355 (388)
..++..|+|||.+.+. .++.++|||||||++|||+||+.|+.... +.....+.+......... ....+..
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC---CHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 4578899999987654 57899999999999999999999864322 222222222211111000 0000000
Q ss_pred ----cc-----CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 ----VL-----NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ----~~-----~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ..........+.+++.+||+.||.+|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 00 0001112346789999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=247.92 Aligned_cols=228 Identities=27% Similarity=0.398 Sum_probs=175.7
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|...+.||+|++|.||+++.. +++.||+|++..... .....+.+|++.+.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999976 589999999876543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++++|.+++.+. ..++.++|. .++.|+||+++.++.++|+|||++.......... ...
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~ 160 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTF 160 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-cce
Confidence 999999998642 224555664 4677999999999999999999998765433221 234
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
.++..|+|||......++.++||||||+++|||+||+.||..... ....+...++. .. .... .+. . .
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~---~~-~~~~-~~~----~---~ 227 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAIC---DG-PPPS-LPA----E---E 227 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHh---cC-CCCC-CCc----c---c
Confidence 578899999999888899999999999999999999999854321 11122222222 11 1110 110 0 0
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.+|++|||+.|
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHH
Confidence 2346889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=256.12 Aligned_cols=236 Identities=22% Similarity=0.282 Sum_probs=166.9
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|+..+.||.|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999864 688999999864332 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+. ++|.+++... ..++.|+| |.+|+|+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT 158 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccc
Confidence 95 6888877532 23456666 456779999999999999999999876543221 122
Q ss_pred ccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc--------------
Q 035768 282 VVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE-------------- 346 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------------- 346 (388)
...++..|+|||...+. .++.++|||||||++|||+||+.||.... ....+.+.+.......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 33468899999987654 46889999999999999999999985321 1111222111110000
Q ss_pred -cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 -QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......... ..........+.+++.+||+.||++|||+.|
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 236 PSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred hhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 0000000000 0000111235778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=252.10 Aligned_cols=228 Identities=25% Similarity=0.355 Sum_probs=169.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCC------
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDE------ 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 215 (388)
++++|+..+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999974 578999999875432 346789999999999 7999999999997644
Q ss_pred eeEEEEeccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
..++||||+++++|.+++... ..++.++| |.+|.|+||+++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 489999999999999887532 22445555 446779999999999999999999986
Q ss_pred ccCCCcceeeccccccCccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
...... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.... ....+. .... .
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~----~~~~-~ 233 (275)
T cd06608 163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH---PMRALF----KIPR-N 233 (275)
T ss_pred cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc---hHHHHH----Hhhc-c
Confidence 543222 2233458899999997643 346889999999999999999999985321 111111 1111 1
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... .......+.+++.+||..||++|||+.|
T Consensus 234 ~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 234 PPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred CCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 1111111 1123346889999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=268.46 Aligned_cols=218 Identities=24% Similarity=0.384 Sum_probs=177.0
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcc--cC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe--eEEEEec
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLS--QA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE--KLLVYEY 223 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~ 223 (388)
..+||+|+|-+||||... +|..||--.++ +. .....+.|..|+.+|+.|+|||||++|.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999964 57778754332 21 22344789999999999999999999999987665 6789999
Q ss_pred cCCCCHHHHHhc---------------cCCCCCHHh-------hhccccCCeeecC-CCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRN---------------QAASLDWGK-------RCKIVASNILLND-DFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~---------------~~~~l~~~~-------~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|..|+|+.|+++ ...+|.|+| |+|++..||+|+. .|.+||+|+|+|..+.... .
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---a 201 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---A 201 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc---c
Confidence 999999998753 345788888 6789999999985 5899999999999875422 2
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..+.|||.|||||++. ..|++..||||||++++||+|+..||... .....+.+.|....++..+..+-||
T Consensus 202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC---~n~AQIYKKV~SGiKP~sl~kV~dP------ 271 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC---TNPAQIYKKVTSGIKPAALSKVKDP------ 271 (632)
T ss_pred ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh---CCHHHHHHHHHcCCCHHHhhccCCH------
Confidence 3377999999999886 78999999999999999999999998543 3455666666666666666666666
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
++.+++.+|+.. .++|||+.|
T Consensus 272 ------evr~fIekCl~~-~~~R~sa~e 292 (632)
T KOG0584|consen 272 ------EVREFIEKCLAT-KSERLSAKE 292 (632)
T ss_pred ------HHHHHHHHHhcC-chhccCHHH
Confidence 688999999999 999999764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=256.61 Aligned_cols=223 Identities=24% Similarity=0.336 Sum_probs=170.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+..|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999965 4899999998754322 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc--
Q 035768 223 YMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-- 278 (388)
Q Consensus 223 ~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-- 278 (388)
|+.+++|.+++.+. ..++.|+| |.+|+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999999988642 22455666 4578899999999999999999998765321110
Q ss_pred --------------------------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCc
Q 035768 279 --------------------------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDG 332 (388)
Q Consensus 279 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~ 332 (388)
......||..|+|||+..+..++.++||||||+++|||++|+.||... +.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~----~~ 237 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS----NR 237 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC----ch
Confidence 111235788999999998888999999999999999999999998532 11
Q ss_pred ccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 333 ENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
..... ...... . .. + ........+.+++.+||+.+|++|||
T Consensus 238 ~~~~~---~~~~~~-~-~~--~-----~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 238 DETFS---NILKKE-V-TF--P-----GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred HHHHH---HHhcCC-c-cC--C-----CccccCHHHHHHHHHHccCCHhHCCC
Confidence 11111 111110 0 00 0 01113347889999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=253.44 Aligned_cols=225 Identities=29% Similarity=0.460 Sum_probs=166.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCC----EEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGK----TVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|+..+.||+|+||.||+|.+. ++. .||+|.+...... ...++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999853 343 5789988654322 234688999999999999999999998754 5679
Q ss_pred EEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||+++|+|.+++... ..++.|+| |.+|+|+||++++++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999999987643 22455666 4578899999999999999999999876432221
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||... ...+..+++.. ... ...+
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~----~~~~~~~~~~~----~~~--~~~~-- 233 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLLEK----GER--LPQP-- 233 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHC----CCC--CCCC--
Confidence 1122335678999999988889999999999999999998 88997532 22223333221 110 0001
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++..||..+|++||+|+|
T Consensus 234 -----~~~~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 234 -----PICTIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 011236789999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.14 Aligned_cols=224 Identities=23% Similarity=0.343 Sum_probs=170.8
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 221 (388)
+|+..+.||.|+||.||++.. .+++.||+|.+.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999985 468899999986532 2234568899999999999999999998764 45678999
Q ss_pred eccCCCCHHHHHhcc-------------------CCCCCHHh----------hhccccCCeeecCCCCEEEcccccceec
Q 035768 222 EYMVKGSLDDWLRNQ-------------------AASLDWGK----------RCKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-------------------~~~l~~~~----------~~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
||+++++|.+++... ..++.++| |.+|+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999887532 22455666 3478899999999999999999999877
Q ss_pred cCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
...... .....++..|+|||.+....++.++||||||+++|+|++|+.||... +...+.+.+.. .....
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~----~~~~~-- 229 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR----NQLQLASKIKE----GKFRR-- 229 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc----CHHHHHHHHhc----CCCCC--
Confidence 543321 22345899999999998888999999999999999999999997532 22222222221 11110
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........+.+++.+||+.+|++|||++|
T Consensus 230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 11122346889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=272.78 Aligned_cols=181 Identities=23% Similarity=0.294 Sum_probs=141.9
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC------CCccceeeEE
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKH------QNLVELLGYC 211 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~ 211 (388)
+++...+++|...+.||+|+||+||+|... +++.||||+++... ....++..|++++..++| ++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456788999999999999999999864 57889999996532 223456667777776654 4588888888
Q ss_pred EeC-CeeEEEEeccCCCCHHHHHhc---------------cCCCCCHHhh------hccccCCeeecCCC----------
Q 035768 212 SVD-EEKLLVYEYMVKGSLDDWLRN---------------QAASLDWGKR------CKIVASNILLNDDF---------- 259 (388)
Q Consensus 212 ~~~-~~~~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~~------~~i~~~NiLl~~~~---------- 259 (388)
... ...++|||++ +++|.+++.+ ...+|.|+|. +||+|+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 764 5788999998 7888887643 2346777773 47889999998765
Q ss_pred ------CEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 260 ------EAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 260 ------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998864322 23346799999999999999999999999999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=252.03 Aligned_cols=225 Identities=21% Similarity=0.347 Sum_probs=163.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMET-LGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||++... +|+.||+|+++.... .....+..|..+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36778899999999999999964 689999999875432 233456667665 666799999999999999999999999
Q ss_pred ccCCCCHHHHHhcc-------------------CCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 223 YMVKGSLDDWLRNQ-------------------AASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 223 ~~~~g~L~~~l~~~-------------------~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
|++ |+|.+++... ..++.++|. .+|+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 995 7887776431 224556663 4788999999999999999999998764321
Q ss_pred ceeeccccccCccCccccCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGT----GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
......|+..|+|||.+.. ..++.++|+|||||++|||++|+.||..... ....+ ...... .......
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~----~~~~~~-~~~~~~~ 230 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQL----KQVVEE-PSPQLPA 230 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHH----HHHHhc-CCCCCCc
Confidence 1223457889999998754 4568899999999999999999999853211 11111 111111 0011100
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||++|
T Consensus 231 --------~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 231 --------EKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred --------cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 012236889999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=247.31 Aligned_cols=217 Identities=24% Similarity=0.313 Sum_probs=166.3
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||.|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 488999999875432 2345689999999999999999999999999999999999999999
Q ss_pred HHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCc
Q 035768 230 DDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289 (388)
Q Consensus 230 ~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y 289 (388)
.+++.+. ..++.++| |.+|.|+||+++.++.+||+|||+++...... ......|+..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCc
Confidence 9988643 22455566 34677999999999999999999998775432 22234688999
Q ss_pred cCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHH
Q 035768 290 VPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKML 369 (388)
Q Consensus 290 ~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 369 (388)
+|||......++.++|+||||+++|||++|..||..... +. .+.............. +......+.
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~~~~~~~~~~~~---------~~~~~~~~~ 224 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DP---MEIYNDILKGNGKLEF---------PNYIDKAAK 224 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CH---HHHHHHHhccCCCCCC---------CcccCHHHH
Confidence 999998888899999999999999999999999864321 11 2222222110100000 011133688
Q ss_pred HHHHhcccCCCCCCCCC
Q 035768 370 QIATGCISNDPTVRPTM 386 (388)
Q Consensus 370 ~l~~~C~~~~P~~RPt~ 386 (388)
+++.+||+.+|++|||+
T Consensus 225 ~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 225 DLIKQLLRRNPEERLGN 241 (262)
T ss_pred HHHHHHccCChhhCcCC
Confidence 99999999999999994
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=276.02 Aligned_cols=178 Identities=19% Similarity=0.284 Sum_probs=139.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC--CCEEEEEEc--------------cc---CCCcChHHHHHHHHHHhcCCCCCcc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD--GKTVAVKKL--------------SQ---ATGQGDREFAAEMETLGMVKHQNLV 205 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~H~niv 205 (388)
.++|...+.||+|+||+||++..+. +...+.|.+ .+ ........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 222222211 00 1112234688999999999999999
Q ss_pred ceeeEEEeCCeeEEEEeccCCCCHHHHHh--------------------ccCCCCCHHh-----hhccccCCeeecCCCC
Q 035768 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR--------------------NQAASLDWGK-----RCKIVASNILLNDDFE 260 (388)
Q Consensus 206 ~l~g~~~~~~~~~lv~e~~~~g~L~~~l~--------------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~ 260 (388)
++++++...+..++|+|++ .++|.+++. +...+|.|+| |+||+|+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999998 456666542 2334677777 5678899999999999
Q ss_pred EEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCC
Q 035768 261 AKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPT 323 (388)
Q Consensus 261 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~ 323 (388)
+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999877544333333457999999999999889999999999999999999988654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=249.01 Aligned_cols=180 Identities=26% Similarity=0.335 Sum_probs=144.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++++|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 456788899999999999999985 4688999999865432 22346789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||++ ++|.+++... ..+|.++| |.+|+|+||+++.++.+||+|||+++....... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 160 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TY 160 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CC
Confidence 9995 7777765432 22455666 457889999999999999999999976533221 12
Q ss_pred eccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
....+++.|+|||...+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 23347889999998765 4578899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=250.77 Aligned_cols=224 Identities=22% Similarity=0.414 Sum_probs=164.7
Q ss_pred CCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 035768 148 FCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE------ 215 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 215 (388)
|...+.||+|+||.||+|.+. +++.||||.+.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999853 36789999986542 223456889999999999999999999886532
Q ss_pred eeEEEEeccCCCCHHHHHhcc---------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ---------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~---------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
..++++||+++|+|.+++... ..++.++| |.+|+|+||++++++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999998876321 12455666 4578899999999999999999999
Q ss_pred eeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 270 RLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 270 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
+........ ......+++.|++||......++.++|||||||++|||++ |+.||... +..++..++... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~----~~~~~~~~~~~~---~~ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV----ENSEIYNYLIKG---NR 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC----CHHHHHHHHHcC---Cc
Confidence 876432211 1222345678999999988889999999999999999999 88887432 223333332211 10
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. . .......+.+++.+||+.+|++|||+.|
T Consensus 234 ~~---~-------~~~~~~~~~~l~~~~l~~~p~~Rps~~~ 264 (273)
T cd05074 234 LK---Q-------PPDCLEDVYELMCQCWSPEPKCRPSFQH 264 (273)
T ss_pred CC---C-------CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 0 0112236889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=242.83 Aligned_cols=228 Identities=25% Similarity=0.363 Sum_probs=174.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC----cC----hHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG----QG----DREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
.++|...++||.|..++|.++.+ ++|+..|+|++..... .. .+.-.+|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677888999999999999886 4688999999863211 11 23456799999998 699999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
...++|+|.|+.|.|+|||... ..++.|+| |+|++|+|||+|++.++||+|||+|..+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999999998532 23566777 557789999999999999999999998876
Q ss_pred CCcceeeccccccCccCccccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGG------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
+. .....||||+|+|||.+. ...|+...|+||.||++|.|+.|.+||... ..+. +.++..++..
T Consensus 176 Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR------kQml--MLR~ImeGky 245 (411)
T KOG0599|consen 176 GE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR------KQML--MLRMIMEGKY 245 (411)
T ss_pred ch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH------HHHH--HHHHHHhccc
Confidence 43 345689999999999754 345788999999999999999999998421 1111 1222233321
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.-.|. ..+......+++.+|++.||.+|.|++|
T Consensus 246 -qF~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake 279 (411)
T KOG0599|consen 246 -QFRSPE-----WADISATVKDLISRLLQVDPTKRITAKE 279 (411)
T ss_pred -ccCCcc-----hhhccccHHHHHHHHHeeCchhcccHHH
Confidence 222222 2233346889999999999999999764
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=257.16 Aligned_cols=226 Identities=26% Similarity=0.352 Sum_probs=168.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccC--CCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 222 (388)
..|++.+.||+||.+.||++...+.+.+|+|++... +.+....|.+|+..|.+|+ |.+||++++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 457888999999999999999888899999987543 3344567999999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHhccCCCCC----------------HHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-ee
Q 035768 223 YMVKGSLDDWLRNQAASLD----------------WGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~~~l~----------------~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~ 280 (388)
|= .-||..+|++....+. ..| |.|++|.|.|+-. |.+||+|||+|..+..+... ..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceee
Confidence 87 6789888876544332 233 4578899998864 68999999999988654332 33
Q ss_pred eccccccCccCccccCCC-----------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 281 TVVAGTIGYVPPEYGGTG-----------KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
...+||+.||+||.+... +.+.++||||+|||||+|+.|++||.. -.+....+.
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~------~~n~~aKl~--------- 583 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ------IINQIAKLH--------- 583 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH------HHHHHHHHH---------
Confidence 457899999999975432 256899999999999999999999852 112222221
Q ss_pred ccCCccccCCC-CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNAN-SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~-~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+|...-++ ......++.++|..||+.||.+|||+.|
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence 22222110000 0011123889999999999999999754
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=251.50 Aligned_cols=221 Identities=28% Similarity=0.398 Sum_probs=165.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..|...+.||+|+||.||+|... +++.||+|.+..... ....++.+|+++++.++||||++++++|..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777889999999999999864 689999999864332 22346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc----------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRN----------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~----------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||++ |+|.+++.. ...++.++|. .+|.|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence 9996 677666542 2234556664 467799999999999999999999765432
Q ss_pred eccccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 281 TVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
....++..|+|||.+. ...++.++||||||+++|||+||+.||... +.... +....... . +..
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~----~~~~~---~~~~~~~~-~-----~~~- 234 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSA---LYHIAQND-S-----PTL- 234 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc----cHHHH---HHHHhcCC-C-----CCC-
Confidence 2345788999999863 456889999999999999999999997432 11111 11111110 0 000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........+.+++.+||+.+|++||+|.+
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 263 (307)
T cd06607 235 --SSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263 (307)
T ss_pred --CchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence 01123346889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=245.81 Aligned_cols=221 Identities=25% Similarity=0.343 Sum_probs=175.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcCh---HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|+..++||+|.||.|.+++. .+++.+|+|++++.-.-.. ..-+.|-++|+..+||.+..+...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35788899999999999999985 4699999999987643333 3356788999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHhhhc-----cccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGKRCK-----IVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~-----i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+.||.|+-+|... ..+|.|+|+.+ ++.+|.|+|.+|++||+|||+++.--. .....
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~ 325 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDTT 325 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-cccee
Confidence 9999999999887532 34789999865 558999999999999999999986422 23445
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..+|||+.|+|||++....|+.+.|+|.+||++|||++|+.||+. ++...+.+.+.. .+-..+.-+.|
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn----~dh~kLFeLIl~--ed~kFPr~ls~------ 393 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN----KDHEKLFELILM--EDLKFPRTLSP------ 393 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc----cchhHHHHHHHh--hhccCCccCCH------
Confidence 678999999999999999999999999999999999999999853 345555554432 11111121111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
+...+....+..||.+|-
T Consensus 394 ------eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 394 ------EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------HHHHHHHHHhhcChHhhc
Confidence 455666777888998885
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=248.80 Aligned_cols=228 Identities=25% Similarity=0.365 Sum_probs=173.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.++.|...+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+++++.++|+||+++++++...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3456777889999999999999976 688999999976543 45678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhccC----------------CCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRNQA----------------ASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~----------------~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|+++++|.+++.... .++.++|. .++.|+||+++.++.++|+|||++........ ...
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 174 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN 174 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence 999999999987643 13445553 45779999999999999999999876543221 112
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...++..|+|||.+.+..++.++|||||||++|||++|+.||... ........+. . .......+ .
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~----~~~~~~~~~~---~-~~~~~~~~-------~ 239 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE----PPLRALFLIT---T-KGIPPLKN-------P 239 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHH---h-cCCCCCcc-------h
Confidence 334788999999988888999999999999999999999997432 1111111111 1 11111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|.+|||+.|
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 112346889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=249.19 Aligned_cols=219 Identities=24% Similarity=0.300 Sum_probs=163.3
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||+|+||+||++... +++.||+|.+.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999986432 12344578899999999999999999999999999999999999999
Q ss_pred HHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccccc
Q 035768 230 DDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287 (388)
Q Consensus 230 ~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 287 (388)
.+++.... .++.++| |.+|.|+||++++++.+||+|||++....... ......++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCC
Confidence 99886432 2344555 44678999999999999999999987654321 122345788
Q ss_pred CccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHH
Q 035768 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367 (388)
Q Consensus 288 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (388)
.|+|||...+..++.++|||||||++|||++|+.||........... +........ ... .......
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~------~~~----~~~~~~~ 224 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE----LKRRTLEMA------VEY----PDKFSPE 224 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH----HHhcccccc------ccC----CccCCHH
Confidence 99999998888899999999999999999999999854321111111 111111100 000 0111236
Q ss_pred HHHHHHhcccCCCCCCCCCCC
Q 035768 368 MLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 368 l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+++.+||+.+|++||++.|
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHccCChhHccCCCc
Confidence 789999999999999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=247.79 Aligned_cols=223 Identities=24% Similarity=0.298 Sum_probs=172.6
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+|...+.||.|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999975 589999999975432 335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++++|.+++.+. ..++.++|. .+++|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccc
Confidence 99999999988643 224566664 4677999999999999999999998764432 2233
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..|+..|+|||......++.++|+||||+++|+|++|+.||..... . ...++....... .... +.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~~~~~~~--~~~~--------~~ 223 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR----T-IRDQIRAKQETA--DVLY--------PA 223 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc----c-HHHHHHHHhccc--cccC--------cc
Confidence 4588899999998888899999999999999999999999864321 1 122222211110 0000 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.....+.+++.+||+.||.+||++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCc
Confidence 122468899999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=249.81 Aligned_cols=225 Identities=26% Similarity=0.337 Sum_probs=167.2
Q ss_pred CCCcCCeeeccCCceEEEEEc----CCCCEEEEEEcccCCC----cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 035768 147 KFCEENVIGGGGFGTVFKGTM----PDGKTVAVKKLSQATG----QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 217 (388)
+|+..+.||+|+||.||++.. .+|+.||+|.++.... ...+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999985 3688999999875321 2345688999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++||||+++++|.+++... ..++.++| |.+|+|+|||++.++.+||+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999987532 23455666 457889999999999999999999987644332
Q ss_pred ceeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 HVSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.......|+..|+|||.... ..++.++||||||+++|||++|+.||..... ................ .
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~--~----- 230 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSEP--P----- 230 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhccCC--C-----
Confidence 22334568899999998764 3468899999999999999999999853211 1112222211111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
. +......+.+++.+||+.+|++||+
T Consensus 231 ~----~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 231 Y----PQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred C----CccCCHHHHHHHHHHhcCCHHHhcC
Confidence 0 0111235789999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=240.11 Aligned_cols=224 Identities=28% Similarity=0.443 Sum_probs=173.0
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
|...+.||+|++|.||++... +++.+++|++..........+.+|++.+++++|||++++++++..++..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 666788999999999999975 6889999999766544567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 227 GSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 227 g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|.+++..... ++.++| |.+|.|+||++++++.++|+|||.+........ .....+
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 159 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVG 159 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceec
Confidence 999998865422 334444 457779999999999999999999987654332 234558
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
+..|+|||......++.++||||||+++|||++|+.||... +...... .... ........+ ....
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~---~~~~-~~~~~~~~~-------~~~~ 224 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL----PPMKALF---KIAT-NGPPGLRNP-------EKWS 224 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----chHHHHH---HHHh-cCCCCcCcc-------cccC
Confidence 89999999988888999999999999999999999997532 1111111 1111 111111111 0012
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.||++|||+.|
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHH
Confidence 36889999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=253.12 Aligned_cols=227 Identities=25% Similarity=0.376 Sum_probs=165.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999964 589999999875432 33456889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHh--------------------ccCCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 224 MVKGSLDDWLR--------------------NQAASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 224 ~~~g~L~~~l~--------------------~~~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+. +++.++.. +...++.|+| |.||+|+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 85 45444321 1123455665 357889999999999999999999976543221
Q ss_pred ceeeccccccCccCccccCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTG---KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.....|+..|+|||.+... .++.++|||||||++|||++|+.||.... ...+.+........ +
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~------~ 229 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDP------P 229 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCC------C
Confidence 1233588999999988765 68999999999999999999999985321 22222222211110 1
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+...........+.+++.+||+.+|++|||++|
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 263 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111111223446889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=246.70 Aligned_cols=224 Identities=24% Similarity=0.369 Sum_probs=170.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4667789999999999999965 58899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+++++|.+++... ..++.++| |.+++|+||++++++ .+||+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cc
Confidence 9999999988542 12345555 346789999999885 569999999987654322 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....|++.|+|||+.....++.++||||||+++|||++|+.||... ...+++...... ..... .
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~-~~~~~-~------- 223 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-------NLHQLVLKICQG-YFAPI-S------- 223 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcc-cCCCC-C-------
Confidence 2345889999999988888999999999999999999999997432 122223222211 11110 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|++|||+.|
T Consensus 224 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 224 -PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred -CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 111236889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=249.99 Aligned_cols=226 Identities=27% Similarity=0.355 Sum_probs=167.2
Q ss_pred CCcCCeeeccCCceEEEEEc----CCCCEEEEEEcccCC----CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 035768 148 FCEENVIGGGGFGTVFKGTM----PDGKTVAVKKLSQAT----GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 218 (388)
|...+.||+|+||.||+++. .+++.||||.++... ......+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999999999974 357889999987432 12335688999999999 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||||+++|+|.+++... ..++.++| |.+|+|+||+++.++.++|+|||+++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence 999999999999887532 23455666 4567899999999999999999999876443332
Q ss_pred eeeccccccCccCccccCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGK--ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......|+..|+|||...+.. .+.++||||||+++|||++|..||..........++.+ ...... +..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-------~~~ 231 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RILKSK-------PPF 231 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HHHccC-------CCC
Confidence 233345889999999876654 78899999999999999999999853211111111111 111110 000
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.......+.+++.+||+.+|++|||+.
T Consensus 232 ----~~~~~~~l~~li~~~l~~~p~~R~t~~ 258 (288)
T cd05583 232 ----PKTMSAEARDFIQKLLEKDPKKRLGAN 258 (288)
T ss_pred ----CcccCHHHHHHHHHHhcCCHhhccCcc
Confidence 011123578899999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=260.30 Aligned_cols=225 Identities=23% Similarity=0.341 Sum_probs=177.3
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
....|.....||+|.|+.|..|++. ++..||||.+++.... ..+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567888999999999999999964 6899999999876433 234588999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+.+|.+++|+..+ ..+++|+| |+|++++||||+.++++||+|||++..+.. ....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--cccc
Confidence 9999999999999643 33677888 457779999999999999999999988763 3344
Q ss_pred eccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
...+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+... -.++.+.+... .-.+.. .
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~g--k~rIp~-----~--- 277 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLRG--KYRIPF-----Y--- 277 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----cccccchheee--eecccc-----e---
Confidence 56789999999999888766 688999999999999999999986431 11221111110 000111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++.+++++.+-.+|.+|+++++
T Consensus 278 ----ms~dce~lLrk~lvl~Pskr~~~dq 302 (596)
T KOG0586|consen 278 ----MSCDCEDLLRKFLVLNPSKRGPCDQ 302 (596)
T ss_pred ----eechhHHHHHHhhccCccccCCHHH
Confidence 1114667888888999999999764
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=248.00 Aligned_cols=236 Identities=20% Similarity=0.270 Sum_probs=168.8
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc-----ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ-----GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+|...+.||+|+||.||+|... +++.||||+++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999999999964 6899999999754322 234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+ +|+|.+++.... .+|.++| |.+|+|+||+++.++.+||+|||+++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 999999986532 2344555 4577899999999999999999999876543221
Q ss_pred eeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---------cc
Q 035768 280 STVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---------AD 349 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 349 (388)
.....++..|+|||.+.+ ..++.++|||||||++|||++|.+||... +..+....+........ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD----SDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC----ccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 122346788999998754 46789999999999999999997776432 22222222211111000 00
Q ss_pred ccCCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNA-----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......... ........+.+++.+||+.+|++|||++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000000000 01122356889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=256.54 Aligned_cols=178 Identities=26% Similarity=0.305 Sum_probs=144.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD------E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 215 (388)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36788899999999999999995 468999999986532 22345677899999999999999999988643 3
Q ss_pred eeEEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 216 EKLLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
..++||||+. ++|.+++. +...++.++| |.||+|+||+++.++.+||+|||+++.......
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 173 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC
Confidence 5699999995 57877653 2334566777 457889999999999999999999987644221
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 174 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred --CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 2234578899999999888999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=250.43 Aligned_cols=235 Identities=20% Similarity=0.280 Sum_probs=166.2
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
|+..+.||.|++|.||+|... +|..||+|++.... ......+.+|++++++++|||++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999864 69999999986543 223356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|.+++.... .++.++| |.+|.|+||+++.++.++|+|||+++....... ....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~ 158 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTH 158 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCc
Confidence 478998875432 2345555 346779999999999999999999976543221 1122
Q ss_pred cccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc--------------
Q 035768 283 VAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ-------------- 347 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 347 (388)
..++..|+|||++.+. .++.++||||||+++|||++|+.||.... ....+.+..........
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS---EIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 3468899999987554 57899999999999999999999985321 11112221111000000
Q ss_pred -ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 -ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 -~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.. ..........+.+++.+||+.+|++|||++|
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 000000000 0001112246789999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=249.19 Aligned_cols=221 Identities=24% Similarity=0.317 Sum_probs=168.1
Q ss_pred CeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHH
Q 035768 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLD 230 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 230 (388)
..||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 468999999986544444567899999999999999999999999999999999999999999
Q ss_pred HHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccC
Q 035768 231 DWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP 291 (388)
Q Consensus 231 ~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~a 291 (388)
+++.+. ..++.++| |.+|+|+||+++.++.++|+|||++....... .......|+..|+|
T Consensus 106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~ 184 (292)
T cd06657 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMA 184 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccCccccC
Confidence 887432 22455666 35678999999999999999999987664322 12233458899999
Q ss_pred ccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHH
Q 035768 292 PEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQI 371 (388)
Q Consensus 292 PE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 371 (388)
||......++.++||||||+++|||++|..||... ........+...... .... .......+.++
T Consensus 185 pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~----~~~~~~~~~~~~~~~-~~~~----------~~~~~~~l~~l 249 (292)
T cd06657 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKMIRDNLPP-KLKN----------LHKVSPSLKGF 249 (292)
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhhCCc-ccCC----------cccCCHHHHHH
Confidence 99988888899999999999999999999997532 222222222111110 0000 00112257789
Q ss_pred HHhcccCCCCCCCCCCC
Q 035768 372 ATGCISNDPTVRPTMLH 388 (388)
Q Consensus 372 ~~~C~~~~P~~RPt~~e 388 (388)
+.+||+.+|.+||++.|
T Consensus 250 i~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 250 LDRLLVRDPAQRATAAE 266 (292)
T ss_pred HHHHHhCCcccCcCHHH
Confidence 99999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=253.84 Aligned_cols=179 Identities=27% Similarity=0.318 Sum_probs=142.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC---CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP---DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 218 (388)
+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667788999999999999964 47899999997633 33346688999999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHhc--------------------cCCCCCHHh-----hhccccCCeeecC----CCCEEEcccccc
Q 035768 219 LVYEYMVKGSLDDWLRN--------------------QAASLDWGK-----RCKIVASNILLND----DFEAKISDFGLA 269 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~--------------------~~~~l~~~~-----~~~i~~~NiLl~~----~~~~kl~DfG~a 269 (388)
+||||++ ++|.+++.. ...++.++| |.+|+|+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 466665531 223455666 4578899999999 999999999999
Q ss_pred eeccCCCc--ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 270 RLISDCES--HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 270 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
+....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 87643322 11223457889999997655 46789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=247.84 Aligned_cols=219 Identities=28% Similarity=0.392 Sum_probs=163.4
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||+|+||.||+++. .++..||+|.+..... .....+.+|++++++++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999995 4688999999864322 2234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ |+|.+++... ..++.++| |.++.|+||+++.++.+||+|||++...... ..
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~ 180 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NS 180 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----cc
Confidence 96 5777766432 22445555 4577899999999999999999998764331 23
Q ss_pred cccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 283 VAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 283 ~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
..|+..|+|||++. ...++.++|||||||++|||++|+.||... +...... ........ ..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~~---~~~~~~~~-~~-------- 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALY---HIAQNESP-TL-------- 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc----cHHHHHH---HHHhccCC-CC--------
Confidence 45888999999863 456899999999999999999999997532 1111111 11111110 00
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........+.+++.+||+.+|.+|||+.|
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHH
Confidence 01112235789999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=246.61 Aligned_cols=236 Identities=25% Similarity=0.298 Sum_probs=169.4
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEe
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLLVYE 222 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 222 (388)
|...+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999965 58899999997653 23345688999999999999999999999988 88999999
Q ss_pred ccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|++ ++|.+++.+. ..++.++| |.+|+|+||++++++.+||+|||++............
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 997 5888877543 22445555 3467899999999999999999999877554322223
Q ss_pred ccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc---CC----
Q 035768 282 VVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV---LD---- 353 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---- 353 (388)
...++..|+|||.+.+ ..++.++||||||+++|||+||+.||... +.......+............ .+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS----TELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 3456889999997654 46789999999999999999999997542 222222222221111100000 00
Q ss_pred ----c------cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 ----P------AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ----~------~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ .+...........+.+++.+||+.+|++|||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0 0000000012457889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-33 Score=254.08 Aligned_cols=229 Identities=27% Similarity=0.346 Sum_probs=177.6
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
.....+.|..-++||+|+||.||-++.+ +|+.+|.|++.+... ......++|-++|.+++.+.||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 3445567888999999999999999854 699999999865432 334557899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhccC-----------------CCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQA-----------------ASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
+++|+..|.||||.-+|.+.. .+|.++|+. |++|+|||+|++|+++|+|.|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998886543 356677764 6779999999999999999999998876
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.... ...+||.+|||||++....|+...|+||+||++|||+.|+.||...-......++. +...+. +
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd----rr~~~~-------~ 406 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD----RRTLED-------P 406 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH----HHHhcc-------h
Confidence 5433 34479999999999999999999999999999999999999985321111111221 211111 1
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
. ..+.....+...|...-++.||++|--
T Consensus 407 ~---ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 407 E---EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred h---hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 0 112233346677778889999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=253.42 Aligned_cols=239 Identities=24% Similarity=0.306 Sum_probs=168.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----ee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 217 (388)
+++|...+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35788899999999999999985 468999999986432 223456889999999999999999999876543 57
Q ss_pred EEEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 218 LLVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++++||++ ++|.+++.. ...+|.++| |.+|+|+||+++.++.+||+|||+++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 99999996 588776653 234566777 4567899999999999999999999876432211
Q ss_pred --eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccC
Q 035768 279 --VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVL 352 (388)
Q Consensus 279 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 352 (388)
......||..|+|||.+.. ..++.++|||||||++|||++|+.||... +.......+........ ...+.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK----DYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 1123468899999997644 56899999999999999999999998532 21122222211111100 00000
Q ss_pred Ccc-------c--cCCC-----CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPA-------V--LNAN-----SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~-------~--~~~~-----~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.. . .... .......+.+++.+||+.+|++|||+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 000 0 0000 0012346889999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=253.85 Aligned_cols=221 Identities=21% Similarity=0.318 Sum_probs=174.5
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
-|...+.||+|.|..|-++++ -+|..||||++.+..-. ....+.+|++.|+-++|||||++|.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 466778899999999999985 48999999999865432 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeee-cCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILL-NDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl-~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
-.+|+|+|||-.+. .++.|+| |+|++|+|+.+ ..-|-+||+|||++..+.... ..+
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--kL~ 176 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--KLT 176 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--hhh
Confidence 99999999985443 3456666 56899999876 566899999999998775533 345
Q ss_pred ccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..||+..|-|||.+.+..| .++.||||+|||||.|++|+.||..... .+. ... ++|.. ...
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SET-LTm------------ImDCK--Ytv 238 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SET-LTM------------IMDCK--YTV 238 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhh-hhh------------hhccc--ccC
Confidence 6789999999999888877 4679999999999999999999864322 111 111 11111 112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+.....++.+|+..|+..||.+|.+.+
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslE 265 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLE 265 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHH
Confidence 334555789999999999999998864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=260.48 Aligned_cols=172 Identities=28% Similarity=0.379 Sum_probs=142.9
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-C-----CCccceeeEEEeCCeeEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-H-----QNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 219 (388)
+|.+.++||+|+||.|.+|.. .+++.||||++++.. ...++-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 678899999999999999994 579999999998654 23455667999999986 4 489999999999999999
Q ss_pred EEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCC--CCEEEcccccceeccCC
Q 035768 220 VYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDD--FEAKISDFGLARLISDC 275 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~--~~~kl~DfG~a~~~~~~ 275 (388)
|+|.+ .-||+++|++.. .+|.++| |+|+||+||||.+. ..+||+|||.|......
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 99999 679999997532 2344444 67899999999753 47999999999876542
Q ss_pred CcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
-. ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus 345 vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 345 VY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 22 4456889999999999999999999999999999999976654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=236.14 Aligned_cols=222 Identities=24% Similarity=0.389 Sum_probs=163.9
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccC
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+....||+|+.|+|+++++. +|..+|||.+.+... .+.++++..++++.+- +.|.||+.+|+|..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999975 589999999976543 3445677777776655 48999999999999999999999983
Q ss_pred CCCHHHHHhcc----------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 226 KGSLDDWLRNQ----------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 226 ~g~L~~~l~~~----------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
--+..+++.. ..+|.|+. |+|++|+|||+|+.|++|+||||++-.+.+.. ..+..
T Consensus 175 -~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ahtrs 251 (391)
T KOG0983|consen 175 -TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRS 251 (391)
T ss_pred -HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--ccccc
Confidence 3344444322 12455553 67999999999999999999999998876543 34455
Q ss_pred ccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 284 AGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 284 ~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
+|.+.|||||.+. ..+|+.++|||||||+|+||.||+.||... +...+....+.. ++ ...+++..
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c---~tdFe~ltkvln---~e--PP~L~~~~---- 319 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC---KTDFEVLTKVLN---EE--PPLLPGHM---- 319 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC---CccHHHHHHHHh---cC--CCCCCccc----
Confidence 7999999999765 347899999999999999999999998542 223333333322 11 12222211
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.....+.+++..|+..|+.+||...
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~ 344 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYN 344 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchH
Confidence 1334688999999999999999743
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=243.08 Aligned_cols=217 Identities=23% Similarity=0.337 Sum_probs=165.7
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||+|+||.||+++.. +++.+|+|.+..... .....+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 3345688999999999999999999999999999999999999999
Q ss_pred HHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-------ceeec
Q 035768 230 DDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-------HVSTV 282 (388)
Q Consensus 230 ~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-------~~~~~ 282 (388)
.+++... ..+|.++| |.+|.|+||++++++.+||+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9887642 23456666 456789999999999999999999876533211 12233
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..++..|+|||.......+.++||||||+++|||++|+.||... ........+.. .... . +. ..
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~~~~~~~~~----~~~~-~--~~-----~~ 224 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE----TPEEIFQNILN----GKIE-W--PE-----DV 224 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhc----CCcC-C--Cc-----cc
Confidence 45788999999988888899999999999999999999998532 22222222211 1100 0 00 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.....+.+++.+||+.+|++|||+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCC
Confidence 013467899999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=245.29 Aligned_cols=237 Identities=21% Similarity=0.227 Sum_probs=168.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 220 (388)
++|...+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999975 5889999999754322 234577899999999999999999999877 889999
Q ss_pred EeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||++ ++|.+++... ..+|.++| |.+|+|+||+++.++.+||+|||+++....... .
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 162 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-P 162 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-c
Confidence 99996 5898877542 23455666 456789999999999999999999987654321 1
Q ss_pred eeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc-------------
Q 035768 280 STVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN------------- 345 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------------- 345 (388)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+......
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS----EIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 2234478899999987654 46899999999999999999999985321 11111111111100
Q ss_pred ----ccccccCCccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 ----EQADEVLDPAVLNANSKP-TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ----~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..........+....... ....+.+++.+||+.+|++|||+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e 286 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence 000000000000111111 2446789999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=242.90 Aligned_cols=233 Identities=21% Similarity=0.216 Sum_probs=164.8
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEEe
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVK-HQNLVELLGYCSVD--EEKLLVYE 222 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 222 (388)
|...+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45567899999999999985 4688999999875432 22334567999999885 99999999999987 88999999
Q ss_pred ccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|++ |+|.+++.... .+|.++| |.+|+|+||+++. +.+||+|||+++........ .
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--~ 156 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--T 156 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc--C
Confidence 996 68888776432 2445555 4467899999999 99999999999876433221 2
Q ss_pred ccccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc-----------ccc
Q 035768 282 VVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE-----------QAD 349 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 349 (388)
...++..|+|||... ...++.++|||||||++|||++|..||... +..+...+........ ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT----NELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC----CHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 345788999999754 456789999999999999999999997532 2223333332211110 000
Q ss_pred ccCCccccCC----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNA----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+..... ........+.+++.+||+.+|++|||+.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 275 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence 0000100000 01123457899999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.24 Aligned_cols=236 Identities=21% Similarity=0.286 Sum_probs=165.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|++|+||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999965 688999999865432 233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-----------------cCCCCCHHh-----hhccccCCeeecC-CCCEEEcccccceeccCCCcce
Q 035768 223 YMVKGSLDDWLRN-----------------QAASLDWGK-----RCKIVASNILLND-DFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 223 ~~~~g~L~~~l~~-----------------~~~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|++ ++|.+++.. ...++.++| |.+|+|+||+++. ++.+||+|||++....... ..
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RT 159 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cc
Confidence 995 577776532 233455666 4577899999985 5679999999997653321 11
Q ss_pred eeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC------
Q 035768 280 STVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL------ 352 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 352 (388)
.....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.... ....+.+ +........ ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~---~~~~~~~-~~~~~~~~~-~~~~~~~~~~ 234 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS---EIDELFK-IFRILGTPN-EETWPGVTSL 234 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH-HHHHhCCCC-hhhccccccc
Confidence 223357889999998755 457899999999999999999999985321 1111111 111111000 0000
Q ss_pred -C-----ccccCC----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 -D-----PAVLNA----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 -~-----~~~~~~----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ +..... ........+.+++.+|++.+|++||++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 280 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence 0 000000 00112235788999999999999999864
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=240.78 Aligned_cols=225 Identities=20% Similarity=0.294 Sum_probs=166.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-----CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-----GQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 217 (388)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688889999999999999986 458999999875321 12235688999999999999999999998764 457
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++++||+++++|.+++... ..++.++| |.+++|+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999999999887532 22455665 457889999999999999999999986532111
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.......|+..|+|||...+..++.++|||||||++|||++|+.||... ... ..+........ ...+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~---~~~~~~~~~~~-~~~~--- 230 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----EAM---AAIFKIATQPT-KPML--- 230 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----CHH---HHHHHHHcCCC-CCCC---
Confidence 1112345889999999998888999999999999999999999998532 111 11111111110 1111
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+......+.+++.+||. +|..|||..
T Consensus 231 -----p~~~~~~~~~~i~~~l~-~~~~r~~~~ 256 (264)
T cd06653 231 -----PDGVSDACRDFLKQIFV-EEKRRPTAE 256 (264)
T ss_pred -----CcccCHHHHHHHHHHhc-CcccCccHH
Confidence 11222368899999999 579999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=247.40 Aligned_cols=237 Identities=22% Similarity=0.260 Sum_probs=165.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCC-CCCccceeeEEEeCCe-----
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVK-HQNLVELLGYCSVDEE----- 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 216 (388)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999964 689999998865422 23457889999999995 6999999999987665
Q ss_pred eEEEEeccCCCCHHHHHhcc--------------------CCCCCHHh-----hhccccCCeeecC-CCCEEEcccccce
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ--------------------AASLDWGK-----RCKIVASNILLND-DFEAKISDFGLAR 270 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~--------------------~~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~ 270 (388)
.++||||+++ +|.+++... ..+|.++| |.+|+|+||+++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999975 888876432 22455666 4467899999998 8999999999998
Q ss_pred eccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc-
Q 035768 271 LISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA- 348 (388)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 348 (388)
....... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.... +.....+.. ........
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~---~~~~~~~~~-~~~~~~~~~ 234 (295)
T cd07837 160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS---ELQQLLHIF-KLLGTPTEQ 234 (295)
T ss_pred ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHH-HHhCCCChh
Confidence 6543211 1122346788999998754 467999999999999999999999985321 111111111 11100000
Q ss_pred --ccc---C--------CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 --DEV---L--------DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 --~~~---~--------~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... . .+............++.+++.+||+.||++|||++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 000 0 000000001123346889999999999999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=261.67 Aligned_cols=180 Identities=32% Similarity=0.453 Sum_probs=147.7
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEE
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE------EKLL 219 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 219 (388)
+...+.||+|+||.||+|+. .+|+.||||.+++.. ....+...+|+++|++++|||||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457799999999999995 579999999998744 334566889999999999999999999765533 5689
Q ss_pred EEeccCCCCHHHHHhcc------------------CCCCCHHh-----hhccccCCeeec--CCC--CEEEcccccceec
Q 035768 220 VYEYMVKGSLDDWLRNQ------------------AASLDWGK-----RCKIVASNILLN--DDF--EAKISDFGLARLI 272 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~------------------~~~l~~~~-----~~~i~~~NiLl~--~~~--~~kl~DfG~a~~~ 272 (388)
|||||.+|||+..|.+. ..++.++| |+||||.||++- .+| .-||+|||.|+.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999998653 23455655 678999999984 223 4799999999998
Q ss_pred cCCCcceeeccccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFED 329 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~ 329 (388)
.+.. ....++||..|++||.+. ...|+..+|.|||||++||.+||..||.+....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 7654 455678999999999988 488999999999999999999999999775433
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=236.66 Aligned_cols=227 Identities=24% Similarity=0.371 Sum_probs=173.7
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 221 (388)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999975 688999999875542 3456789999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHHhccC---------------CCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcc-ee
Q 035768 222 EYMVKGSLDDWLRNQA---------------ASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESH-VS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~---------------~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~ 280 (388)
||+++++|.+++.+.. .++.++|. .++.|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999886532 24455553 467799999999999999999999877553321 12
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....++..|+|||.......+.++||||||+++|||++|..||.... +....+........... .
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---------~ 225 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPE---------I 225 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcC---------C
Confidence 33458889999999988889999999999999999999999985422 11111111111111111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+|++.+|++||++.|
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 1112346889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=244.33 Aligned_cols=240 Identities=28% Similarity=0.328 Sum_probs=168.9
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE----- 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 215 (388)
..++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3467888999999999999999975 58899999986542 223356788999999999999999999987654
Q ss_pred -----eeEEEEeccCCCCHHHHHhcc----------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccc
Q 035768 216 -----EKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 216 -----~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
..++|+||+++ ++.+++... ..++.++|. .+++|+||++++++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999975 666665432 234566663 467799999999999999999999
Q ss_pred eeccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 270 RLISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
...............++..|+|||.+.. ..++.++|||||||++|||++|+.||... +..+....+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN----QELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCCh
Confidence 8765433222223346788999997754 45789999999999999999999998532 222222222222111100
Q ss_pred ---cccC--------Cccc-----cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 ---DEVL--------DPAV-----LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ---~~~~--------~~~~-----~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+. ++.. ...........+.+++.+||+.+|++|||+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0000 0000 00000112346889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=239.54 Aligned_cols=218 Identities=20% Similarity=0.223 Sum_probs=158.8
Q ss_pred hhcCCCcCCee--eccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 035768 144 GTNKFCEENVI--GGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 144 ~~~~~~~~~~l--G~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 219 (388)
-.++|...+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34456665655 9999999999995 4688899999865432211 22222222 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++... ..++.++| |.+|+|+||+++.++ .++|+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 99999999999988653 22455555 457889999999998 9999999999876432
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
....|+..|+|||++....++.++||||||+++|||++|+.||..... .......+...........
T Consensus 164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~--------- 230 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQQKKLPFI--------- 230 (267)
T ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhhcccCCcc---------
Confidence 123588999999999888899999999999999999999999863321 1112222222211000000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
......+.+++.+||+.+|.+||+
T Consensus 231 ---~~~~~~~~~li~~~l~~~p~~R~~ 254 (267)
T PHA03390 231 ---KNVSKNANDFVQSMLKYNINYRLT 254 (267)
T ss_pred ---cccCHHHHHHHHHHhccChhhCCc
Confidence 112236889999999999999996
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=243.95 Aligned_cols=215 Identities=24% Similarity=0.316 Sum_probs=156.5
Q ss_pred eeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 153 VIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETL---GMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+||+|+||.||++... +++.+|+|.+.+.... ....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 5889999998654321 123344554443 34579999999999999999999999999
Q ss_pred CCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 226 KGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 226 ~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
+|+|.+++... ..++.++| |.||+|+|||+++++.++|+|||++....... .....|
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcCC
Confidence 99999887532 23566676 55788999999999999999999997654322 123458
Q ss_pred ccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|+|||... +..++.++|||||||++|||++|..||..... ..... +....... ...+ ....
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~----~~~~~~~~------~~~~----~~~~ 222 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHE----IDRMTLTV------NVEL----PDSF 222 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC-cCHHH----HHHHhhcC------CcCC----cccc
Confidence 99999999876 45689999999999999999999999864321 11111 11111100 0011 1112
Q ss_pred HHHHHHHHHhcccCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt 385 (388)
...+.+++.+||..||++||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 236788999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=284.16 Aligned_cols=226 Identities=27% Similarity=0.358 Sum_probs=173.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
-++....+||.|.||.||-|.. .+|...|+|-++-.. ........+|+.++..++|||+|++||+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3566678899999999999984 569999999886433 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce---
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV--- 279 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~--- 279 (388)
||.+|+|.+.+.. ...++.|+| |+||+|+||+|+.+|.+|++|||.|..+.......
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 9999999998753 234677777 56888999999999999999999999886543111
Q ss_pred eeccccccCccCccccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 280 STVVAGTIGYVPPEYGGTGK---ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.....||+.|||||++.+.. -..+.||||+|||++||+||+.||.... ....++-.|.. +..+++
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---ne~aIMy~V~~----gh~Pq~----- 1462 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---NEWAIMYHVAA----GHKPQI----- 1462 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---chhHHHhHHhc----cCCCCC-----
Confidence 12357999999999886543 4568999999999999999999996421 22222222221 221111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+.....+-.+++.+|++.||++|.++.
T Consensus 1463 ----P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1463 ----PERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred ----chhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 111333567889999999999998763
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=241.51 Aligned_cols=222 Identities=20% Similarity=0.288 Sum_probs=171.7
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 366788999999999999985 468899999987532 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 224 MVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 224 ~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
+++++|.+++.+. ..++.++| |.+|.|+||++++++.+||+|||+++..... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 9999999987541 12344555 4467899999999999999999999877543 1
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....++..|+|||......++.++|+||||+++|||++|+.||... +...+...+. ......
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~----~~~~~~~~~~----~~~~~~--------- 220 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR----SMQDLRYKVQ----RGKYPP--------- 220 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHh----cCCCCC---------
Confidence 22245788999999998888999999999999999999999997532 2222222211 111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........+.+++.+||+.+|++|||+.|
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 11123346899999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=237.17 Aligned_cols=224 Identities=26% Similarity=0.448 Sum_probs=171.4
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999865 578999999976543 3446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+++++|.+++... ..++.++| |.+|+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASV 159 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cccc
Confidence 9999999987542 22344555 4467899999999999999999999877543322 2234
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
.++..|+|||......++.++||||+|+++|||++|+.||... +..... ..... ..... +. ..
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~----~~~~~~---~~~~~-~~~~~-~~--------~~ 222 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL----NPMAAL---FRIVQ-DDHPP-LP--------EG 222 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc----cHHHHH---HHHhc-cCCCC-CC--------CC
Confidence 5788999999987777899999999999999999999997532 111111 11111 11110 11 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||..+|++|||+.|
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHH
Confidence 1236789999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=244.18 Aligned_cols=238 Identities=26% Similarity=0.270 Sum_probs=167.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 219 (388)
.++|...+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999964 689999999864332 2233567899999999999999999998765 46899
Q ss_pred EEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+. ++|.+++... ..++.++| |.+|+|+||++++++.+||+|||+++.......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 999996 5788776532 23455666 456789999999999999999999987654321
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc--------
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD-------- 349 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 349 (388)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+....+..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK----SEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 1122335788999998754 56789999999999999999999997532 2333333222221110000
Q ss_pred ----cc-CCccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 ----EV-LDPAVLNA---NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ----~~-~~~~~~~~---~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ........ ........+.+++.+|++.||++|||+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~ 286 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 00 00000000 00112346788999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=251.71 Aligned_cols=173 Identities=20% Similarity=0.284 Sum_probs=136.2
Q ss_pred eeecc--CCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 153 VIGGG--GFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 153 ~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
.||+| +||+||++.+ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999996 4799999999865332 22356889999999999999999999999999999999999999
Q ss_pred CHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce------
Q 035768 228 SLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV------ 279 (388)
Q Consensus 228 ~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~------ 279 (388)
+|.+++.+. ..+|.|+| |+||+|+||+++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccc
Confidence 999988642 23556666 56888999999999999999998654332111100
Q ss_pred eeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 280 STVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 011234567999999865 3478999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=242.65 Aligned_cols=226 Identities=24% Similarity=0.391 Sum_probs=163.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCC-cChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATG-QGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||+|.+.+ ++.||||.++.... ....++..|+.++.+.. ||||+++++++..+...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567778999999999999999764 88999999975432 23345777887776664 9999999999999999999999
Q ss_pred ccCCCCHHHHHhc----------------cCCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRN----------------QAASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~----------------~~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|++ ++|.+++.. ...++.|+|. .+|.|+||++++++.+||+|||++..+......
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~-- 171 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-- 171 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--
Confidence 985 466655432 2234566663 467799999999999999999999766432221
Q ss_pred eccccccCccCccccCCCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 281 TVVAGTIGYVPPEYGGTGK----ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
....++..|+|||.+.... ++.++||||||+++|||++|+.||.... ...+... ...... ......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~---~~~~~~-~~~~~~--- 241 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK---TEFEVLT---KILQEE-PPSLPP--- 241 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch---hHHHHHH---HHhcCC-CCCCCC---
Confidence 2234788999999876543 7899999999999999999999985321 1111111 111111 011100
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......++.+++.+||+.||++|||+.|
T Consensus 242 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 242 ----NEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0012236889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=238.23 Aligned_cols=217 Identities=20% Similarity=0.267 Sum_probs=159.8
Q ss_pred CeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMET-LGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+|... +++.||+|.++..... ....+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 5889999998654321 12234455544 4456899999999999999999999999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeeccccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 286 (388)
++|.+++... ..+|.++|. .++.|+||++++++.+||+|||+++.... .....|+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCC
Confidence 9999988542 235566664 46779999999999999999999876533 2234578
Q ss_pred cCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHH
Q 035768 287 IGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366 (388)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (388)
..|+|||...+..++.++||||||+++|||++|..||... +.......+.. .... ..+.. ......
T Consensus 157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~----~~~~--~~~~~----~~~~~~ 222 (260)
T cd05611 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE----TPDAVFDNILS----RRIN--WPEEV----KEFCSP 222 (260)
T ss_pred cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHh----cccC--CCCcc----cccCCH
Confidence 8999999988888899999999999999999999998532 22222221111 1100 00000 011223
Q ss_pred HHHHHHHhcccCCCCCCCCCC
Q 035768 367 KMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 367 ~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.+.+++.+||+.+|++|||+.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred HHHHHHHHHccCCHHHccCCC
Confidence 688999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=243.75 Aligned_cols=219 Identities=26% Similarity=0.381 Sum_probs=162.4
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||+|+||.||+|+.. +++.+|+|.+..... ....++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555678999999999999964 578899999864321 2234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+. |+|.+++... ..++.++| |.+|+|+||+++.++.+||+|||++...... ..
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~ 170 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NX 170 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----cc
Confidence 96 6887766432 22345555 4578899999999999999999998765432 23
Q ss_pred cccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 283 VAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 283 ~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
..|+..|+|||.+. ...++.++|||||||++|||++|..||... +..+. ........ .....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~---~~~~~~~~-~~~~~------- 235 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSA---LYHIAQNE-SPALQ------- 235 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc----cHHHH---HHHHhhcC-CCCcC-------
Confidence 45788999999863 356788999999999999999999997432 11111 11111111 00000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.+|++||++.+
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 1112235789999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=271.52 Aligned_cols=187 Identities=26% Similarity=0.303 Sum_probs=160.1
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVD 214 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 214 (388)
.++....++|.+.++||+|+||.|..++++ +++.+|+|++++. ......-|..|-.+|..-+.+-|+.++..|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 456666788999999999999999999975 5889999999873 233455688999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhccC---------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA---------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
.++|+|||||+||||-.++.... .+|+-+| |+||+|.|||||..|++||+|||.+-.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999999999886543 1333344 569999999999999999999999988876
Q ss_pred CCcceeeccccccCccCccccC----C-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGG----T-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
++.......+|||.|++||++. + +.|++.+|+||+||++|||+.|..||+.
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 6666677788999999999753 3 6799999999999999999999999863
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=241.48 Aligned_cols=219 Identities=28% Similarity=0.371 Sum_probs=162.1
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||+|+||+||+|+.. +++.||+|.+...... ....+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445677999999999999864 6889999998654322 234688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ |+|.+++.... .++.|+| |.+++|+||+++.++.+||+|||++..... ...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 95 67777764322 2345555 346779999999999999999999865322 123
Q ss_pred cccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 283 VAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 283 ~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
..|+..|+|||++. ...++.++|||||||++|||++|..||... +........ .... ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~----~~~~~~~~~---~~~~-~~~~~~------ 242 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHI---AQND-SPTLQS------ 242 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHH---HhcC-CCCCCc------
Confidence 45889999999873 456889999999999999999999997432 212222211 1111 111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.+|.+||++.|
T Consensus 243 --~~~~~~l~~li~~~l~~~P~~Rp~~~~ 269 (313)
T cd06633 243 --NEWTDSFRGFVDYCLQKIPQERPASAE 269 (313)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 111235788999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=245.50 Aligned_cols=232 Identities=21% Similarity=0.248 Sum_probs=161.3
Q ss_pred eeeccCCceEEEEEcCCCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHH
Q 035768 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLD 230 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 230 (388)
.+|.|+++.||++.. +++.||||+++.. .......+.+|+++++.++||||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 345555555555554 6899999998754 2334467999999999999999999999999999999999999999999
Q ss_pred HHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc------eeec
Q 035768 231 DWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH------VSTV 282 (388)
Q Consensus 231 ~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~------~~~~ 282 (388)
+++.+. ..++.|+| |.||+|+||+++.++.+||+|||.+......... ....
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 988642 23566777 4578899999999999999999998765322111 1122
Q ss_pred cccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc----c-------ccc
Q 035768 283 VAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN----E-------QAD 349 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----~-------~~~ 349 (388)
..++..|+|||.+.. ..++.++|||||||++|||++|+.||.... ......+.+...... . ...
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP---ATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 346788999998765 358899999999999999999999986421 111111111110000 0 000
Q ss_pred c----cCCccc----cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 E----VLDPAV----LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~----~~~~~~----~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ..++.. ...........+.+++.+||+.||++|||++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 0 000000 00112233456889999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=234.13 Aligned_cols=224 Identities=24% Similarity=0.375 Sum_probs=173.0
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|+||.||++... +++.+|+|++..... .....+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4667789999999999999965 588999999875433 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC-------------------CCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 224 MVKGSLDDWLRNQA-------------------ASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 224 ~~~g~L~~~l~~~~-------------------~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
+++++|.+++.+.. .++.++|. .++.|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 99999999886531 23455563 4677999999999999999999998765432 12
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....|++.|+|||......++.++||||+|+++|+|++|+.||... +...+... ... ...... ..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~~~~~~---~~~-~~~~~~-----~~- 225 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE----NLLELALK---ILK-GQYPPI-----PS- 225 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC----cHHHHHHH---Hhc-CCCCCC-----CC-
Confidence 23346889999999988888999999999999999999999997432 22222221 111 111111 00
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||..+|++|||+.|
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 12236889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=241.30 Aligned_cols=234 Identities=24% Similarity=0.305 Sum_probs=165.1
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcC---CCCCccceeeEEEeCCe-----
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMV---KHQNLVELLGYCSVDEE----- 216 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 216 (388)
|+..+.||+|+||.||+|+.. +++.||+|.++..... ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999976 4899999999743322 234566788777655 69999999999988776
Q ss_pred eEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
.+++|||++ ++|.+++... ..++.++| |.++.|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 899999996 5888877542 12445555 346779999999999999999999987644
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc-----
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD----- 349 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 349 (388)
... .....++..|+|||...+..++.++|||||||++|||++|+.||... ...+....+..........
T Consensus 160 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 160 EMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT----SEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred Ccc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC----ChHHHHHHHHHHcCCCChHhcCCC
Confidence 322 12234788999999998888999999999999999999999887532 1122222121111100000
Q ss_pred -----ccCCccc---cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 -----EVLDPAV---LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 -----~~~~~~~---~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... ...........+.+++.+||+.||++||+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 280 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence 0000000 00011223456789999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=250.18 Aligned_cols=175 Identities=27% Similarity=0.361 Sum_probs=140.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE------E 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 216 (388)
++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6788889999999999999995 468999999986532 222356889999999999999999999987543 4
Q ss_pred eEEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 217 KLLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
.++|+||+. ++|.+++. +...++.++| |.+|+|+||+++.++.+||+|||+++.....
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--- 170 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 170 (342)
T ss_pred EEEEecccc-cCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---
Confidence 589999995 47776543 2234566666 4577899999999999999999999765321
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 171 -MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred -CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 123457889999998765 4688999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=250.91 Aligned_cols=238 Identities=28% Similarity=0.341 Sum_probs=166.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC--CCcChHHHHHHHHHHhcC-CCCCccceeeEEEeC--CeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA--TGQGDREFAAEMETLGMV-KHQNLVELLGYCSVD--EEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~l 219 (388)
++|...+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 46777889999999999999965 5889999998543 222345677899999999 999999999998653 36799
Q ss_pred EEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc---
Q 035768 220 VYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES--- 277 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~--- 277 (388)
||||++ ++|.+++... ..++.++| |.+|+|+||+++.++.+||+|||+++.......
T Consensus 87 v~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 87 VFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred Eecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence 999996 6998877542 23455666 456789999999999999999999987643321
Q ss_pred -ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc----------
Q 035768 278 -HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN---------- 345 (388)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---------- 345 (388)
.......|+..|+|||.+.. ..++.++||||||+++|||+||+.||.... ..+....+......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS----TLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCHHHHHHHH
Confidence 12223458899999997654 567899999999999999999999985321 11111111111000
Q ss_pred -ccccccCC----ccc--cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 -EQADEVLD----PAV--LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 -~~~~~~~~----~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......++ ... ...........+.+++.+||+.+|++|||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~ 291 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHH
Confidence 00000000 000 00000112346889999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=243.28 Aligned_cols=228 Identities=17% Similarity=0.208 Sum_probs=154.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCCcCh-----------HHHHHHHHHHhcCCCCCccceeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATGQGD-----------REFAAEMETLGMVKHQNLVELLGY 210 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g~ 210 (388)
++|...+.||+|+||+||+|...+ +..+|+|.......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 468889999999999999999654 34566665432221110 112233445667899999999997
Q ss_pred EEeCC----eeEEEEeccCCCCHHHHH---------------hccCCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 211 CSVDE----EKLLVYEYMVKGSLDDWL---------------RNQAASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 211 ~~~~~----~~~lv~e~~~~g~L~~~l---------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
+.... ..++++|++. .++.+.+ .+.+.++.|+| |+||+|+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 76543 3467888773 3444433 23344667777 5688999999999999999999
Q ss_pred ccceeccCCCc------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHH
Q 035768 267 GLARLISDCES------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340 (388)
Q Consensus 267 G~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 340 (388)
|+|+....... .......||+.|+|||...+..++.++|||||||++|||++|+.||..... ..++.....
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~---~~~~~~~~~ 247 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH---NGNLIHAAK 247 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc---chHHHHHhH
Confidence 99987643221 111234699999999999889999999999999999999999999864311 112211111
Q ss_pred ----HhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 ----HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........ . . ......+.+++..||..+|++||++.+
T Consensus 248 ~~~~~~~~~~~~----~----~---~~~~~~~~~~~~~~~~~~~~~rp~~~~ 288 (294)
T PHA02882 248 CDFIKRLHEGKI----K----I---KNANKFIYDFIECVTKLSYEEKPDYDA 288 (294)
T ss_pred HHHHHHhhhhhh----c----c---CCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence 11111110 0 0 011246889999999999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=248.86 Aligned_cols=233 Identities=23% Similarity=0.255 Sum_probs=164.5
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcC--------------hHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQG--------------DREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
.+.||+|+||+||+|... +++.||||+++...... ...+.+|++++++++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999954 68999999986432211 125779999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
..++||||++ |+|.+++... ..++.++| |.+|+|+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~ 172 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccc
Confidence 9999999996 6898887532 23556666 4567899999999999999999999866411
Q ss_pred C-------------cceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHH
Q 035768 276 E-------------SHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341 (388)
Q Consensus 276 ~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 341 (388)
. ........++..|+|||.+.+. .++.++|||||||++|||+||+.||... +..+....+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~----~~~~~~~~i~~ 248 (335)
T PTZ00024 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE----NEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHH
Confidence 1 0111223467889999987654 4789999999999999999999997532 22222222222
Q ss_pred hhccccccccC-----------C---ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 342 MMKNEQADEVL-----------D---PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 342 ~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+. . +.............+.+++.+||+.+|++|||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 22111100000 0 00000000112346889999999999999999864
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=250.55 Aligned_cols=238 Identities=22% Similarity=0.293 Sum_probs=168.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 218 (388)
++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999854 689999999875422 334567889999999999999999998753 34679
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||||+. |+|.+++... ..++.++|. .+|+|+||++++++.+||+|||+++........
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999995 6898887432 235566664 467799999999999999999999876432211
Q ss_pred ---eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc-------
Q 035768 279 ---VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ------- 347 (388)
Q Consensus 279 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 347 (388)
......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.... .......+........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~----~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN----YVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC----hHHHHHHHHHHhCCChhHhhhhh
Confidence 1123468899999998755 468999999999999999999999985431 1111111111111000
Q ss_pred ----ccccC---Cccc---cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ----ADEVL---DPAV---LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ----~~~~~---~~~~---~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... .... ...........+.+++.+||+.+|++|||++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 290 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 00000 0000 00000112457889999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=250.90 Aligned_cols=236 Identities=23% Similarity=0.285 Sum_probs=166.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD-----EEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 217 (388)
++|...+.||+|+||+||+++. .+++.||||.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4688889999999999999985 468999999987532 22345677899999999999999999988654 347
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++|+||+. ++|.+++... ..++.++| |.+|+|+||+++.++.+||+|||+++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 99999995 7888877432 23456666 34678999999999999999999998764332
Q ss_pred ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc---ccc----
Q 035768 278 HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE---QAD---- 349 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 349 (388)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||... +.......+....... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK----DYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 12223457889999997654 46899999999999999999999998532 1111111111111000 000
Q ss_pred -----------ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 -----------EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 -----------~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++... .........+.+++.+||+.+|++|||++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~e 287 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEE 287 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 00000000 000122346789999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=240.31 Aligned_cols=236 Identities=21% Similarity=0.298 Sum_probs=168.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|+..+.||.|++|.||+|+.. +++.||||.++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777889999999999999975 688999999875433 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 225 VKGSLDDWLRNQA------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~~------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+ |+|.+++.... .++.++| |.+|+|+||++++++.+||+|||+++....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFS 158 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccc
Confidence 7 58888775422 2345555 446789999999999999999999976543221 122
Q ss_pred ccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---cc-----ccC
Q 035768 282 VVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---AD-----EVL 352 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~ 352 (388)
...++..|++||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+........ .. ...
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN----NEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 3347889999998754 457889999999999999999999985432 2222222211111000 00 000
Q ss_pred Ccccc-------CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVL-------NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... ..........+.+++.+|++.||.+|||+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 00000 0000112346789999999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=241.95 Aligned_cols=223 Identities=25% Similarity=0.357 Sum_probs=170.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|.+++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999964 68999999986532 223456889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc---
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES--- 277 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~--- 277 (388)
|||+++++|.+++.+. ..++.++| |.+|+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999988643 22445555 346779999999999999999999987643221
Q ss_pred ----------------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHH
Q 035768 278 ----------------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341 (388)
Q Consensus 278 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 341 (388)
.......++..|+|||......++.++||||||++++|+++|+.||... +.....+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~- 235 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS----NEYLTFQKIL- 235 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHH-
Confidence 1122345788999999988888999999999999999999999997532 1111111111
Q ss_pred hhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 342 MMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
... ..+ +......+.+++.+||+.+|++|||+
T Consensus 236 --~~~---~~~--------~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 236 --KLE---YSF--------PPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred --hcC---CCC--------CCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 100 000 01112368899999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=248.14 Aligned_cols=237 Identities=24% Similarity=0.309 Sum_probs=171.4
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 218 (388)
+|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677889999999999999965 48999999987643 334467899999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES- 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~- 277 (388)
++|||++ ++|.+++.+. ..++.++| |.+|+|.||+++.++.++|+|||++........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999997 5888877542 23455666 456889999999999999999999987754321
Q ss_pred -ceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc------
Q 035768 278 -HVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD------ 349 (388)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 349 (388)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||... +..+....+..........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR----DYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHhcCCCChhHhhhcc
Confidence 112234578899999998777 8899999999999999999999998543 2222222222211110000
Q ss_pred -----ccCC---cc---ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 -----EVLD---PA---VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 -----~~~~---~~---~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+. .. ............+.+++.+||+.+|++|||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0000 00 000000112346789999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=241.25 Aligned_cols=179 Identities=29% Similarity=0.355 Sum_probs=140.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC-------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE------- 215 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 215 (388)
++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999964 688999999864322 22345678999999999999999999987654
Q ss_pred -eeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceecc
Q 035768 216 -EKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 216 -~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
..++||||+. ++|.+++.+. ..++.++| |.+|+|+||+++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 3499999995 5787776543 23455666 45788999999999999999999998664
Q ss_pred CCCcc---eeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 274 DCESH---VSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 274 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..... ......++..|+|||...+. .++.++||||||+++|||+||..||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 32211 11234577899999987554 478899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=249.46 Aligned_cols=180 Identities=28% Similarity=0.364 Sum_probs=145.2
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe-CCe
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV-DEE 216 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 216 (388)
+...+++|...+.||.|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999854 78999999886432 2234678899999999999999999999875 557
Q ss_pred eEEEEeccCCCCHHHHHhcc--------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ--------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
.++++||+ +++|.+++++. ..++.++|. .+|+|+||++++++.+||+|||++......
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 88999999 67888877532 234566664 467799999999999999999999765321
Q ss_pred ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 122357889999998755 5689999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=241.36 Aligned_cols=235 Identities=22% Similarity=0.279 Sum_probs=169.5
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
|...+.||+|++|.||+|... +++.+++|.++..... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 445678999999999999964 6889999998754322 3457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+ ++|.+++... ..++.++| |.+++|+||+++.++.+||+|||.+....... ......
T Consensus 81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~ 158 (283)
T cd05118 81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHY 158 (283)
T ss_pred C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCc
Confidence 6 4888877542 22445555 45677999999999999999999998775433 112234
Q ss_pred ccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccCC------
Q 035768 284 AGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVLD------ 353 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------ 353 (388)
.++..|+|||..... .++.++||||||+++|+|+||+.||... +..+....+........ .....+
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK----SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 578899999987766 7899999999999999999999997432 22222221211111100 000000
Q ss_pred ---ccc----cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 ---PAV----LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ---~~~----~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.. ..........++.+++.+||+.||.+||++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 000 00011223457899999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=238.89 Aligned_cols=234 Identities=22% Similarity=0.285 Sum_probs=165.7
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEecc
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
|...+.||+|+||+||+|+.. +++.||||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999975 478899999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+|+|.+++.... .++.++| |.+|.|+||++++++.++|+|||+++....... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCC
Confidence 889998876432 2344555 446779999999999999999999987643222 123
Q ss_pred cccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc-------------cc
Q 035768 283 VAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE-------------QA 348 (388)
Q Consensus 283 ~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 348 (388)
..++..|+|||.+. ...++.++||||||+++|||++|+.||.... ..+....+....... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS----EIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC----hHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 45788999999764 4467899999999999999999999975321 111111111111000 00
Q ss_pred cccCCc---cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDP---AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~---~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.. .............+.+++.+||+.+|++|||++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 000000 0000000011346889999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=238.39 Aligned_cols=214 Identities=23% Similarity=0.315 Sum_probs=155.7
Q ss_pred eeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHH---HHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 153 VIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEME---TLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+||+|+||.||++... +++.||+|.+...... ....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5889999998654221 1223444443 4455689999999999999999999999999
Q ss_pred CCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 226 KGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 226 ~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
+|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++...... .....|
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcCC
Confidence 99999887532 23456666 56788999999999999999999997654322 123468
Q ss_pred ccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
+..|+|||.+..+ .++.++|||||||++|||++|+.||...... ..... ....... ++.+... .
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~------~~~~~~~----~ 222 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEI----DRMTLTM------AVELPDS----F 222 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-chHHH----HHHhhcc------CCCCCCc----C
Confidence 9999999998644 6899999999999999999999998643211 11111 1111100 1111111 1
Q ss_pred HHHHHHHHHhcccCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RP 384 (388)
...+.+++.+|+..+|++||
T Consensus 223 s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CHHHHHHHHHHhhcCHHhcc
Confidence 23688999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=241.57 Aligned_cols=238 Identities=23% Similarity=0.261 Sum_probs=164.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDE------ 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 215 (388)
.++|...+.||+|+||.||+|... +++.+|+|++...... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999964 6889999998643322 2346789999999999999999999875433
Q ss_pred --eeEEEEeccCCCCHHHHHhc----------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceec
Q 035768 216 --EKLLVYEYMVKGSLDDWLRN----------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 216 --~~~lv~e~~~~g~L~~~l~~----------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
..++|+||+. ++|..++.. ...++.++|. .+++|+||++++++.+||+|||+++..
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 4689999995 466665542 2345667764 467799999999999999999999865
Q ss_pred cCCCcc----------eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHH
Q 035768 273 SDCESH----------VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341 (388)
Q Consensus 273 ~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 341 (388)
...... ..+...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||... +.....+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~----~~~~~~~~~~~ 241 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK----SDIDQLHLIFK 241 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHH
Confidence 432211 1123356888999997654 45889999999999999999999997532 21222221111
Q ss_pred hhcccc---------ccccC--------CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 342 MMKNEQ---------ADEVL--------DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 342 ~~~~~~---------~~~~~--------~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... ..... .+.+.. ........+.+++.+|++.||++|||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 111000 00000 000000 00111246789999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=248.27 Aligned_cols=179 Identities=26% Similarity=0.357 Sum_probs=141.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC----------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD---------- 214 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 214 (388)
.+|...+.||.|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 4688889999999999999986 46889999998766555567789999999999999999999876543
Q ss_pred ----CeeEEEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeec-CCCCEEEcccccce
Q 035768 215 ----EEKLLVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLN-DDFEAKISDFGLAR 270 (388)
Q Consensus 215 ----~~~~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~-~~~~~kl~DfG~a~ 270 (388)
...++||||++ ++|.+++.+ ...++.++| |.+|+|+||+++ +++.+||+|||+++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~ 163 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccce
Confidence 35789999996 688877643 234566776 456779999997 45678999999998
Q ss_pred eccCCCcc--eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 271 LISDCESH--VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 271 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.+...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 65332111 1122357889999997543 5688899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=232.70 Aligned_cols=215 Identities=28% Similarity=0.350 Sum_probs=165.8
Q ss_pred eeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
||.|+||.||++... +++.+|+|.++..... ....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 5889999998754322 345788999999999999999999999999999999999999999
Q ss_pred HHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCc
Q 035768 230 DDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289 (388)
Q Consensus 230 ~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y 289 (388)
.+++.+. ..++.++| |.+|.|+||+++.++.++|+|||++....... .......++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccc
Confidence 9988643 22445555 45677999999999999999999998764432 122334578899
Q ss_pred cCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHH
Q 035768 290 VPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKML 369 (388)
Q Consensus 290 ~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 369 (388)
+|||.......+.++|+||||+++||+++|+.||... +.....+.+.. ........ ....+.
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~----~~~~~~~~~~~--~~~~~~~~------------~~~~l~ 221 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE----DRKEIYEKILK--DPLRFPEF------------LSPEAR 221 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHhc--CCCCCCCC------------CCHHHH
Confidence 9999988888899999999999999999999998432 22222222211 00001111 123678
Q ss_pred HHHHhcccCCCCCCCCCC
Q 035768 370 QIATGCISNDPTVRPTML 387 (388)
Q Consensus 370 ~l~~~C~~~~P~~RPt~~ 387 (388)
+++.+||..||++|||+.
T Consensus 222 ~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 222 DLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHhcCCHhhCCCcc
Confidence 999999999999999983
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=251.90 Aligned_cols=235 Identities=23% Similarity=0.360 Sum_probs=180.0
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEe-
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSV- 213 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 213 (388)
.++.+...++.|++.++||+|.+|.||+++. ++++.+|||++.... ...++...|.++++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4455566778899999999999999999995 568889999886543 4456788899999887 69999999999964
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccc
Q 035768 214 ----DEEKLLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFG 267 (388)
Q Consensus 214 ----~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG 267 (388)
++++|||||||.+|+..|++++.. .++.++| |+||+-.|||++.++.+||.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 678999999999999999876532 1233333 56889999999999999999999
Q ss_pred cceeccCCCcceeeccccccCccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHh
Q 035768 268 LARLISDCESHVSTVVAGTIGYVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 268 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
++..+...... ..+..||+.|||||++.. ..|+..+|+||+|++..||.-|.+|+.++.. ++.+
T Consensus 169 vSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----------mraL 237 (953)
T KOG0587|consen 169 VSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----------MRAL 237 (953)
T ss_pred eeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------hhhh
Confidence 99988654333 334679999999998753 3467899999999999999999999865432 1111
Q ss_pred hccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. +..-..|.+. .+.....++.+++..|+..|-++||++.+
T Consensus 238 F~---IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ 278 (953)
T KOG0587|consen 238 FL---IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEE 278 (953)
T ss_pred cc---CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhh
Confidence 11 1111112221 13455668999999999999999999854
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=235.01 Aligned_cols=235 Identities=23% Similarity=0.304 Sum_probs=169.0
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345678999999999999975 58999999987653 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+ ++|.+++.+. ..++.++| |.+|.|+||++++++.+||+|||+++....... .....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHE 158 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCcc
Confidence 7 6899988654 12455565 446779999999999999999999987644322 12223
Q ss_pred ccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc------cc--CC-
Q 035768 284 AGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD------EV--LD- 353 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~--~~- 353 (388)
.++..|+|||.+... .++.++|||||||++|||++|+.||... ...+....+.......... .. .+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD----SEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 457789999987666 7899999999999999999999997532 2222222222211110000 00 00
Q ss_pred --ccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 --PAVLN----ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 --~~~~~----~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.... .........+.+++.+||+.+|++||++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 00000 000111346899999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=235.59 Aligned_cols=223 Identities=22% Similarity=0.326 Sum_probs=163.1
Q ss_pred CCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCC-----CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQAT-----GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+|...+.||+|+||.||++.... +..+++|.++... ......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36777899999999999998643 4445566554321 22334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc-------------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 221 YEYMVKGSLDDWLRN-------------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~-------------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
|||+++++|.+++.+ ...++.++|. .+++|+||++++ +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 1224556653 467899999976 569999999998764332
Q ss_pred cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
. ......|+..|+|||......++.++|+||||+++|+|++|..||... .. ......... .. .+..
T Consensus 160 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~---~~~~~~~~~-~~-----~~~~ 225 (260)
T cd08222 160 D-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NF---LSVVLRIVE-GP-----TPSL 225 (260)
T ss_pred c-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cH---HHHHHHHHc-CC-----CCCC
Confidence 2 222345788999999988888899999999999999999999997421 11 111111111 11 0101
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||..+|++||++.|
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 226 ----PETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred ----cchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 1122346889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=236.54 Aligned_cols=220 Identities=23% Similarity=0.313 Sum_probs=169.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
.+|....+||+|+||.|.++..+ +.+.+|||++++... .+.+--..|-++|..- +-|.++++..+++.-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999854 577899999987532 2222344677777665 578999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHhhhc-----cccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGKRCK-----IVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~-----i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+.||+|--+++|. +.+|-++|..+ ++..|||+|.+|++||+|||+++.--- ....+
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~~TT 507 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DGVTT 507 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-CCcce
Confidence 9999999999988763 23566777655 458999999999999999999986432 23445
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..++||+.|+|||.+...+|+..+|+|||||+||||+.|++||+. ++..++.+.+.... +.-
T Consensus 508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG----eDE~elF~aI~ehn-------vsy------- 569 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG----EDEDELFQAIMEHN-------VSY------- 569 (683)
T ss_pred eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHHHcc-------CcC-------
Confidence 568999999999999999999999999999999999999999754 35555555443311 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
+.....+...+...-+...|.+|-
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cccccHHHHHHHHHHhhcCCcccc
Confidence 122233566677777888888885
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=242.59 Aligned_cols=183 Identities=28% Similarity=0.351 Sum_probs=146.7
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV 213 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 213 (388)
...++...+++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456666788999999999999999999985 568899999987532 2234568889999999999999999998864
Q ss_pred C------CeeEEEEeccCCCCHHHHHhc--------------cCCCCCHHhh-----hccccCCeeecCCCCEEEccccc
Q 035768 214 D------EEKLLVYEYMVKGSLDDWLRN--------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGL 268 (388)
Q Consensus 214 ~------~~~~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~ 268 (388)
. ...+++++++ +++|.+++.. ...++.++|. .+|+|+||++++++.+||+|||+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3 3467888887 7899876643 2345677774 46779999999999999999999
Q ss_pred ceeccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 269 ARLISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
++..... .....++..|+|||...+ ..++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 167 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred ccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9865321 223457889999998755 568899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=242.70 Aligned_cols=177 Identities=28% Similarity=0.361 Sum_probs=142.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE----- 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 215 (388)
..++|...+.||+|+||.||++.. .++..||||++..... .....+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 356788899999999999999985 4689999999864322 22346889999999999999999999987654
Q ss_pred -eeEEEEeccCCCCHHHHHhc--------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCC
Q 035768 216 -EKLLVYEYMVKGSLDDWLRN--------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 216 -~~~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
..++||||+ +++|.+++.+ ...++.++|. .+|+|+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 358999999 7889887643 2335666774 567899999999999999999999865432
Q ss_pred CcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.....+++.|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 123357889999998765 4588999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=240.77 Aligned_cols=237 Identities=25% Similarity=0.284 Sum_probs=163.2
Q ss_pred CCCcCCeeeccCCceEEEEEcC-C--CCEEEEEEcccCCC--cChHHHHHHHHHHhcC-CCCCccceeeEEEeC----Ce
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-D--GKTVAVKKLSQATG--QGDREFAAEMETLGMV-KHQNLVELLGYCSVD----EE 216 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 216 (388)
+|...+.||+|+||.||+++.. + +..||+|++..... .....+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667788999999999999964 3 77899999875322 2245688999999999 599999999876432 45
Q ss_pred eEEEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 KLLVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
.++++||+. ++|.+++.. ...+|.++| |.+|+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 688999985 688887743 233566666 45788999999999999999999998764322
Q ss_pred cc---eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---cc
Q 035768 277 SH---VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---AD 349 (388)
Q Consensus 277 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 349 (388)
.. ......||..|+|||...+ ..++.++|||||||++|||++|+.||... +..+....+........ ..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK----DYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC----CHHHHHHHHHHHhCCCCHHHHH
Confidence 11 1123468899999997654 56899999999999999999999997532 21222222111111000 00
Q ss_pred ccCCc-------------cc-cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDP-------------AV-LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~-------------~~-~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.++ .. ...........+.+++.+|++.||++|||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 00000 00 00000011346889999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=244.70 Aligned_cols=234 Identities=24% Similarity=0.318 Sum_probs=167.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE----- 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 216 (388)
.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 467888899999999999999965 58899999986532 2233567789999999999999999998876554
Q ss_pred -eEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 -KLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 -~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
.++|+||+ +++|.+++... ..++.++| |.+|+|+||++++++.+||+|||++......
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 89999999 67998887542 23556666 4467899999999999999999999876432
Q ss_pred cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccC
Q 035768 277 SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVL 352 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 352 (388)
.....++..|+|||.... ..++.++|||||||++|||++|+.||... ........+........ ...+.
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS----DHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 223457889999998754 46789999999999999999999998532 22222222211111000 00000
Q ss_pred --------C-------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 --------D-------PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 --------~-------~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. +... .........+.+++.+||+.+|++|||+.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred chhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 0 0000 000012346889999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=258.66 Aligned_cols=125 Identities=27% Similarity=0.409 Sum_probs=107.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|... +++.||||+++..... ....+..|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999975 6889999999754322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccce
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
||+++|+|.++++. ...+|.|+| |+||+|+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998753 233577777 45788999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=242.86 Aligned_cols=217 Identities=23% Similarity=0.287 Sum_probs=168.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++.|.....+|.|+|+.|-++.+ .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56777778899999999999985 468899999997652 2234566555544 79999999999999999999999
Q ss_pred ccCCCCHHHHHh--------------ccCCCCCHHhh-----hccccCCeee-cCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLR--------------NQAASLDWGKR-----CKIVASNILL-NDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~--------------~~~~~l~~~~~-----~~i~~~NiLl-~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++.+|-|.+-+. +...++.++|. +|++|+|||+ ++.++++|+|||.++..... ...
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t 472 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT 472 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence 999987766443 34456777774 5778999999 58999999999999887543 222
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.+-|..|.|||+.....|++++||||||++||||++|+.||.... .+.++ ...+..+...+.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P---~~~ei----~~~i~~~~~s~~----------- 534 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP---AGIEI----HTRIQMPKFSEC----------- 534 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC---chHHH----HHhhcCCccccc-----------
Confidence 346889999999999999999999999999999999999986432 22223 233333322222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+|+.+|++.||.+||+|+|
T Consensus 535 -vS~~AKdLl~~LL~~dP~~Rl~~~~ 559 (612)
T KOG0603|consen 535 -VSDEAKDLLQQLLQVDPALRLGADE 559 (612)
T ss_pred -cCHHHHHHHHHhccCChhhCcChhh
Confidence 2236789999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=261.17 Aligned_cols=228 Identities=27% Similarity=0.380 Sum_probs=163.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--------
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVD-------- 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 214 (388)
..+|++.++||+||||.|||++.+ ||+.+|||+|.-.. ........+|+.++++|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356888899999999999999965 89999999997543 22334588999999999999999998754210
Q ss_pred --------------------------------------------------------------------------------
Q 035768 215 -------------------------------------------------------------------------------- 214 (388)
Q Consensus 215 -------------------------------------------------------------------------------- 214 (388)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh---
Q 035768 215 -------------------------------EEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK--- 244 (388)
Q Consensus 215 -------------------------------~~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~--- 244 (388)
..+||-||||+.-.|.+++++. ..+|.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1136778888777777766432 33567777
Q ss_pred --hhccccCCeeecCCCCEEEcccccceecc-----------------CCCcceeeccccccCccCccccCCC---CCCc
Q 035768 245 --RCKIVASNILLNDDFEAKISDFGLARLIS-----------------DCESHVSTVVAGTIGYVPPEYGGTG---KATE 302 (388)
Q Consensus 245 --~~~i~~~NiLl~~~~~~kl~DfG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ 302 (388)
|+|++|.||++|++..+||+|||+|.... .......+...||.-|+|||.+.+. +|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 67899999999999999999999998721 0111234456799999999987654 4999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCC
Q 035768 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTV 382 (388)
Q Consensus 303 ~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~ 382 (388)
|+|+||+|||++||+. ||.. ..+=+. +...++.+.++.. + ....+....-..++.++++.||.+
T Consensus 798 KiDmYSLGIVlFEM~y---PF~T------sMERa~-iL~~LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGT------SMERAS-ILTNLRKGSIPEP--A----DFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCc------hHHHHH-HHHhcccCCCCCC--c----ccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999986 4432 122111 2222333333222 1 112223334567889999999999
Q ss_pred CCCCCC
Q 035768 383 RPTMLH 388 (388)
Q Consensus 383 RPt~~e 388 (388)
|||+.|
T Consensus 862 RPtA~e 867 (1351)
T KOG1035|consen 862 RPTATE 867 (1351)
T ss_pred CCCHHH
Confidence 999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=224.02 Aligned_cols=200 Identities=24% Similarity=0.228 Sum_probs=151.4
Q ss_pred cCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhc
Q 035768 157 GGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN 235 (388)
Q Consensus 157 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~ 235 (388)
|.||.||++... +++.+|+|.++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999997542 334555566666799999999999999999999999999999988753
Q ss_pred c---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCcccc
Q 035768 236 Q---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295 (388)
Q Consensus 236 ~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 295 (388)
. ..++.|+| |.||+|+||+++.++.++++|||.+...... .....++..|+|||..
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVG 154 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCccc
Confidence 2 23556666 4578899999999999999999988765432 1223457789999999
Q ss_pred CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhc
Q 035768 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGC 375 (388)
Q Consensus 296 ~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 375 (388)
....++.++||||+|+++|||++|+.|+..... .. ... .....| ......+.+++.+|
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-----~~--------~~~--~~~~~~-------~~~~~~~~~li~~~ 212 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPS-----GI--------NTH--TTLNIP-------EWVSEEARSLLQQL 212 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-----hc--------ccc--cccCCc-------ccCCHHHHHHHHHH
Confidence 888899999999999999999999988642110 00 000 000000 11123678899999
Q ss_pred ccCCCCCCCCCC
Q 035768 376 ISNDPTVRPTML 387 (388)
Q Consensus 376 ~~~~P~~RPt~~ 387 (388)
++.||++|||+.
T Consensus 213 l~~dp~~R~~~~ 224 (237)
T cd05576 213 LQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHhcCCC
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=241.30 Aligned_cols=194 Identities=24% Similarity=0.334 Sum_probs=154.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcC---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQG---DREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.-|...+.||-|+||+|.+++. ++...+|+|.+++.+.-. ......|-.||...+.+-||+||..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3477788999999999999984 456789999998765332 234678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceecc--------
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLIS-------- 273 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~-------- 273 (388)
||++|||+-.+|-+. ..++++.| |+||+|.|||||.+|++||+|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999999998877442 12333444 56999999999999999999999985321
Q ss_pred -CCC--------------------------------cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC
Q 035768 274 -DCE--------------------------------SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK 320 (388)
Q Consensus 274 -~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~ 320 (388)
..+ .......+||+.|+|||++....|+..+|+||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 000 00011257999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHH
Q 035768 321 QPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 321 ~P~~~~~~~~~~~~~~~~~ 339 (388)
.||-..........+..|-
T Consensus 869 ~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWR 887 (1034)
T ss_pred CCccCCCCCcceeeeeehh
Confidence 9997766655556666663
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=221.19 Aligned_cols=180 Identities=26% Similarity=0.312 Sum_probs=144.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC---C--CCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe-CCe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP---D--GKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV-DEE 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 216 (388)
...|+....||+|.||.||+|.-. + .+.+|+|+++.... .-.....+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888899999999999999632 2 34799999976532 234568899999999999999999999977 778
Q ss_pred eEEEEeccCCCCHHHHHhc--------------------cCCCCCHHh-----hhccccCCeeecCC----CCEEEcccc
Q 035768 217 KLLVYEYMVKGSLDDWLRN--------------------QAASLDWGK-----RCKIVASNILLNDD----FEAKISDFG 267 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~--------------------~~~~l~~~~-----~~~i~~~NiLl~~~----~~~kl~DfG 267 (388)
.++++||++. ||.+.++- ...++.|+| |+|++|.|||+..+ |.+||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999954 78776642 234555555 78999999999877 999999999
Q ss_pred cceeccCCCcce--eeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 268 LARLISDCESHV--STVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 268 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
+++.+.+.-... ...++-|..|.|||.+.+ ..||.+.||||.|||+.||+|-++-|..
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999876543222 234567999999997655 5799999999999999999999887754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=239.17 Aligned_cols=171 Identities=27% Similarity=0.483 Sum_probs=144.8
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
.++||+|.||+||-|.++ +|+.||||.+.+.. .....++.+|+.||.+++||.||.+.-.|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999964 79999999997643 344567899999999999999999999999999999999999 56
Q ss_pred CHHHHH-h----------------ccCCCCCHHh-----hhccccCCeeecCC---CCEEEcccccceeccCCCcceeec
Q 035768 228 SLDDWL-R----------------NQAASLDWGK-----RCKIVASNILLNDD---FEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 228 ~L~~~l-~----------------~~~~~l~~~~-----~~~i~~~NiLl~~~---~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|..+.+ . |...+|.|+| |+|++|+|||+... -.+||||||+|+.+.+.. ....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRrs 725 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRRS 725 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--hhhh
Confidence 655433 2 2334677777 56788999999643 479999999999987633 3445
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
++||+.|+|||++....|+..-|+||.||++|--++|..||.
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 789999999999999999999999999999999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=247.69 Aligned_cols=176 Identities=20% Similarity=0.268 Sum_probs=124.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-C----CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeE------EE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-D----GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY------CS 212 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 212 (388)
..++|...+.||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.+++.+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999964 4 68999999864321 1112221 1222223333332222 24
Q ss_pred eCCeeEEEEeccCCCCHHHHHhcc-----------------------------------CCCCCHHh-----hhccccCC
Q 035768 213 VDEEKLLVYEYMVKGSLDDWLRNQ-----------------------------------AASLDWGK-----RCKIVASN 252 (388)
Q Consensus 213 ~~~~~~lv~e~~~~g~L~~~l~~~-----------------------------------~~~l~~~~-----~~~i~~~N 252 (388)
.+...++||||+++++|.+++... ..+|.|+| |+||+|+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 566789999999999998887532 12456666 56889999
Q ss_pred eeecC-CCCEEEcccccceeccCCCcceeeccccccCccCccccCCC----------------------CCCcccchHhH
Q 035768 253 ILLND-DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG----------------------KATERGDVYSF 309 (388)
Q Consensus 253 iLl~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~S~ 309 (388)
||++. ++.+||+|||+|+.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 58999999999987654333334456789999999954321 23456799999
Q ss_pred HHHHHHHHhCCCCC
Q 035768 310 GVILLELVTGKQPT 323 (388)
Q Consensus 310 Gv~l~el~tg~~P~ 323 (388)
||+||||+++..|+
T Consensus 366 GviL~el~~~~~~~ 379 (566)
T PLN03225 366 GLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHhCcCCC
Confidence 99999999987764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=237.42 Aligned_cols=222 Identities=21% Similarity=0.277 Sum_probs=175.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCC-EEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGK-TVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++.....||-|+||.|-++...... .+|+|++++... ...+....|-.+|...+.|.||++|--|.++.+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999998865433 489999876532 33456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhccC---------------CCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQA---------------ASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~---------------~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|-|-||.|...|+... .+++|+|+. |++|+|+++|.+|-+||.|||+|+.+.... .+.
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTw 577 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTW 577 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC--cee
Confidence 9999999999997642 367899986 556999999999999999999999987643 455
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
++|||+.|.|||.+.....+.++|.||+|+++|||+||.+||.. .+.......+.+.+..-..+
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~----~dpmktYn~ILkGid~i~~P------------ 641 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG----VDPMKTYNLILKGIDKIEFP------------ 641 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC----CchHHHHHHHHhhhhhhhcc------------
Confidence 68999999999999999999999999999999999999999743 34444444444433221111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
........+++.+.+..+|.+|--
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 111224567777778889999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=239.10 Aligned_cols=235 Identities=21% Similarity=0.290 Sum_probs=153.1
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc-----------------CCCCEEEEEEcccCCCcChHH--------------HHHH
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM-----------------PDGKTVAVKKLSQATGQGDRE--------------FAAE 192 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 192 (388)
..++|...++||+|+||+||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999986543222223 3346
Q ss_pred HHHHhcCCCCCc-----cceeeEEEe--------CCeeEEEEeccCCCCHHHHHhccC----------------------
Q 035768 193 METLGMVKHQNL-----VELLGYCSV--------DEEKLLVYEYMVKGSLDDWLRNQA---------------------- 237 (388)
Q Consensus 193 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 237 (388)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 678888753 356899999999999999886321
Q ss_pred -----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCcccc
Q 035768 238 -----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295 (388)
Q Consensus 238 -----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 295 (388)
.++.|+| |+||+|+|||++.++.+||+|||+++..............+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1233444 457889999999999999999999976543222222223357899999976
Q ss_pred CCCCC----------------------CcccchHhHHHHHHHHHhCCC-CCCCCCCCCC-----cccHHHHHHHhhcccc
Q 035768 296 GTGKA----------------------TERGDVYSFGVILLELVTGKQ-PTGPEFEDKD-----GENLVDWVLHMMKNEQ 347 (388)
Q Consensus 296 ~~~~~----------------------~~~~Dv~S~Gv~l~el~tg~~-P~~~~~~~~~-----~~~~~~~~~~~~~~~~ 347 (388)
..... ..+.||||+||++|||++|.. |+........ ..++..|.. .....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC
Confidence 43221 234799999999999999885 6532110000 111112211 11111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCC---CCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDP---TVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P---~~RPt~~e 388 (388)
.+-..... ......+++.+++..+| .+|+|++|
T Consensus 461 ----~~~~~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 461 ----YDFSLLDR----NKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred ----CCcccccc----cChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 01111111 12357788888998766 68999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=214.82 Aligned_cols=215 Identities=28% Similarity=0.374 Sum_probs=164.3
Q ss_pred CCceEEEEEcC-CCCEEEEEEcccCCCcC-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhc
Q 035768 158 GFGTVFKGTMP-DGKTVAVKKLSQATGQG-DREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN 235 (388)
Q Consensus 158 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~ 235 (388)
+||.||+|... +++.+|+|.+....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997655444 67899999999999999999999999999999999999999999998754
Q ss_pred cC---------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCcccc
Q 035768 236 QA---------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295 (388)
Q Consensus 236 ~~---------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 295 (388)
.. .++.++| |.+|.|+||++++++.++|+|||.+....... ......++..|++||..
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHH
Confidence 32 2334444 34677999999999999999999998775432 22334578899999998
Q ss_pred CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhc
Q 035768 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGC 375 (388)
Q Consensus 296 ~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 375 (388)
....++.++||||||+++|||++|..||... .+...+.++... ..... ... .......+.+++.+|
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~---~~~~~~~~~~~~----~~~~~-~~~------~~~~~~~~~~~i~~~ 224 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGD---DQLLELFKKIGK----PKPPF-PPP------EWKISPEAKDLIRKL 224 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhc----cCCCC-ccc------cccCCHHHHHHHHHH
Confidence 8888899999999999999999999997532 122233332221 11000 000 000223688999999
Q ss_pred ccCCCCCCCCCCC
Q 035768 376 ISNDPTVRPTMLH 388 (388)
Q Consensus 376 ~~~~P~~RPt~~e 388 (388)
|..+|++||++.|
T Consensus 225 l~~~p~~Rp~~~~ 237 (244)
T smart00220 225 LVKDPEKRLTAEE 237 (244)
T ss_pred ccCCchhccCHHH
Confidence 9999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-30 Score=232.66 Aligned_cols=181 Identities=29% Similarity=0.460 Sum_probs=141.3
Q ss_pred cCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcc--cCCC-----cChHHHHHHHHHHhcCCCCCccceeeEEEe-CCe
Q 035768 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLS--QATG-----QGDREFAAEMETLGMVKHQNLVELLGYCSV-DEE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 216 (388)
++|-...+||+|+|+.||++. +...+.||||+-. +.-. ...+...+|.+|.+.|+||.||++|+++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 345566789999999999998 4567789999743 2111 112346689999999999999999999965 556
Q ss_pred eEEEEeccCCCCHHHHHhccC---------------CCCCHHh-------hhccccCCeeecC---CCCEEEccccccee
Q 035768 217 KLLVYEYMVKGSLDDWLRNQA---------------ASLDWGK-------RCKIVASNILLND---DFEAKISDFGLARL 271 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~-------~~~i~~~NiLl~~---~~~~kl~DfG~a~~ 271 (388)
.|-|+|||+|.||.-||++.. .+|.|+. |.|++|.|||+.+ .|.+||+|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 789999999999999997642 2344432 6689999999954 58899999999999
Q ss_pred ccCCCcc------eeeccccccCccCccccCC----CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 272 ISDCESH------VSTVVAGTIGYVPPEYGGT----GKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 272 ~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
+.+.... .+...+||.+|++||.+.- .+.+.|.||||.||++|..+.|+.||+..
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 8654322 2345789999999996543 35789999999999999999999998643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=198.80 Aligned_cols=192 Identities=26% Similarity=0.373 Sum_probs=147.7
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+|...+.||+|.||+||+|+. .+++.||+|.++-... .-.....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 344567899999999999995 4688999999875432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHh----------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLR----------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~----------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
| ..+|..|.. |...+|.++| |+|++|.|.|++.+|++|++|||+++..+-.-.. .+.
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc-ysa 160 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YSA 160 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-eec
Confidence 9 456665543 3345667766 5689999999999999999999999987643322 223
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhh
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
..-|..|.+|.++-+ .-|++..|+||-||++.|+.....|. |.+.+..+....+...+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl---fpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL---FPGNDVDDQLKRIFRLL 219 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC---CCCCcHHHHHHHHHHHh
Confidence 346899999997655 46899999999999999999855553 33345555555444443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=214.93 Aligned_cols=239 Identities=22% Similarity=0.310 Sum_probs=173.3
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
+++|+..-|+ +.||+|+|+.|--+. +.+|..+|||++.+...+......+|++++.+. .|+||++++.+|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3556655553 579999999999887 678999999999988777788899999999998 599999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCC---CEEEccccccee
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDF---EAKISDFGLARL 271 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~---~~kl~DfG~a~~ 271 (388)
...|||||-|.||.|..+|++. +.+|+++|. +|++|+|||-.... -+|||||.+...
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999999999988643 457889884 56679999986543 489999988754
Q ss_pred ccCCC------cceeeccccccCccCcccc-----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCc---c----
Q 035768 272 ISDCE------SHVSTVVAGTIGYVPPEYG-----GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDG---E---- 333 (388)
Q Consensus 272 ~~~~~------~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~---~---- 333 (388)
+.... .......+|+..|||||+. ....|+.++|.||+|||||-|++|-+||...-..+-+ .
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 42211 1122345788999999953 3457899999999999999999999999764432211 1
Q ss_pred cHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
...+.+...++++. .+..|.. ......+..+++...+..||.+|-++
T Consensus 309 ~CQ~~LFesIQEGk-YeFPdkd-----WahIS~eakdlisnLlvrda~~rlsa 355 (463)
T KOG0607|consen 309 VCQNKLFESIQEGK-YEFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSA 355 (463)
T ss_pred HHHHHHHHHHhccC-CcCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhh
Confidence 11122222223322 2222221 12233345666667777888888664
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=217.35 Aligned_cols=227 Identities=21% Similarity=0.257 Sum_probs=168.9
Q ss_pred hcCCCcC-CeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEe----CCee
Q 035768 145 TNKFCEE-NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSV----DEEK 217 (388)
Q Consensus 145 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 217 (388)
+++|.+. ++||-|-.|.|..+.++ +++.+|+|.+... ....+|+++.-.. .|||||+++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455443 57999999999999865 6889999998643 3456788775444 69999999999864 3456
Q ss_pred EEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecC---CCCEEEcccccceec
Q 035768 218 LLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLI 272 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~ 272 (388)
.+|||+|+||+|+..+.+. ..++.|+| |+|++|+|+|... +-.+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 7999999999999877543 33567777 4577799999964 567999999999976
Q ss_pred cCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
... ......+-|+.|.|||++...+|+..+|+||+||++|-|++|-+||+.... ..+..-++...+.+.. ++.
T Consensus 215 ~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy-~FP 287 (400)
T KOG0604|consen 215 QEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQY-EFP 287 (400)
T ss_pred CCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCc-cCC
Confidence 432 223345679999999999999999999999999999999999999975432 2222223333333221 222
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ +...+..+...+++...+..+|++|-|+.|
T Consensus 288 ~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 288 E-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred C-----hhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 2 223455567888999999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=218.45 Aligned_cols=230 Identities=21% Similarity=0.309 Sum_probs=174.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 218 (388)
...+|....+||+|+|..|..+++. +.+.+|+|++++.-. ++..-...|-.+..+. +||.+|.+..+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467899999999999999999964 578899999986532 2233356677777665 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHhhhcc-----ccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKI-----VASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i-----~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+|.||+++|+|--++++. ..+|.|+|.++| +..|+|+|.+|++||+|+|+++.--.. ..
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~-gd 406 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GD 406 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC-Cc
Confidence 999999999997666432 226778887654 588999999999999999999864332 23
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.++.++||+.|+|||.+.+..|....|+|++||+++||+.|+.||+-.-.+....+..+++.+..-+.++. -|+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---ipr--- 480 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---IPR--- 480 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---ccc---
Confidence 45568999999999999999999999999999999999999999975333333344444444443332221 111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
....+...+...-++.||.+|-
T Consensus 481 ----slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 ----SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----eeehhhHHHHHHhhcCCcHHhc
Confidence 1122445666777889998885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=203.92 Aligned_cols=176 Identities=25% Similarity=0.396 Sum_probs=140.6
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLG-MVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.......||+|++|.|-+-++ .+|+..|+|.++..- .+.....++|+.+.. ....|.+|.+||........|+.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 344456799999999999885 579999999997543 344556788888754 45799999999999999999999999
Q ss_pred cCCCCHHHHHhcc-------------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 224 MVKGSLDDWLRNQ-------------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 224 ~~~g~L~~~l~~~-------------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
| .-+|..|-++. ..+|.++| |+|++|+|||++.+|++|+||||++-.+.+. -
T Consensus 127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--i 203 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--I 203 (282)
T ss_pred h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh--h
Confidence 9 55777654321 12445555 6799999999999999999999999887653 2
Q ss_pred eeeccccccCccCccccC----CCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 279 VSTVVAGTIGYVPPEYGG----TGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..+...|...|||||.+. ...|+-||||||+|+++.||.+++.||+.
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 334456889999999753 34789999999999999999999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=224.34 Aligned_cols=237 Identities=21% Similarity=0.287 Sum_probs=171.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-C-CC----ccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVK-H-QN----LVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~~ 217 (388)
+++|.+...+|+|.||.|.++... .+..||||+++... ...+...-|++++.++. + |+ +|.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678899999999999999999853 47899999997643 33455677999999993 2 33 77888899999999
Q ss_pred EEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecC------------------
Q 035768 218 LLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLND------------------ 257 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~------------------ 257 (388)
++|+|.+ |-+++++|... ..++.++| |.|++|+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999999 77999998752 12344444 4578899999832
Q ss_pred --CCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccH
Q 035768 258 --DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335 (388)
Q Consensus 258 --~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~ 335 (388)
+..+||+|||-|..-... .+..+.|..|.|||++.+-.++.++||||+||||.|+.||...|.... +.+...+
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n~EHLaM 320 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-NLEHLAM 320 (415)
T ss_pred CCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-cHHHHHH
Confidence 235899999999875432 244668999999999999999999999999999999999999875421 2222223
Q ss_pred HHHHHHhhccccc-------------------------cccCCccc----cCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 336 VDWVLHMMKNEQA-------------------------DEVLDPAV----LNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 336 ~~~~~~~~~~~~~-------------------------~~~~~~~~----~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
++.+..-.+...+ ..+.++.. .-.....+..++.+|+.+++..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 3333211110000 00111100 011234566789999999999999999998
Q ss_pred CC
Q 035768 387 LH 388 (388)
Q Consensus 387 ~e 388 (388)
.|
T Consensus 401 ~E 402 (415)
T KOG0671|consen 401 RE 402 (415)
T ss_pred HH
Confidence 75
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-29 Score=210.68 Aligned_cols=236 Identities=25% Similarity=0.312 Sum_probs=162.4
Q ss_pred CCcCCeeeccCCceEEEEEcC-CCCEEEEEEccc--CCCcChHHHHHHHHHHhcCCCCCccceeeEEEe--------CCe
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQ--ATGQGDREFAAEMETLGMVKHQNLVELLGYCSV--------DEE 216 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~ 216 (388)
|.....||+|.||.||+|+.+ +|+.||+|++-- ..........+|+++|..++|+|++.++..|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444567999999999999965 578899987532 222233457899999999999999999998854 234
Q ss_pred eEEEEeccCCCCHHHHHhcc----------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ----------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
.|+|+++|+. ||.-+|.+. ..+|.|+|+ +|++++|+||+.++.+||+|||+++.+...
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 7999999954 666665432 346777774 578899999999999999999999877543
Q ss_pred Ccc---eeeccccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc---cc
Q 035768 276 ESH---VSTVVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE---QA 348 (388)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~ 348 (388)
... ..+..+-|..|.+||.+. ...|+++.|||.-||++.||+||.+-+.. .........+....... ..
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg----nteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG----NTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC----ChHHHHHHHHHHHhccCCcccC
Confidence 221 123344589999999654 56899999999999999999999887543 23333333332222111 11
Q ss_pred cccCCcc---------ccCC-C--CHHHH------HHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPA---------VLNA-N--SKPTM------LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~---------~~~~-~--~~~~~------~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+..-. +... . -.+.+ ...++++.+.+..||.+||+++|
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 1110000 0000 0 01111 25678889999999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=237.20 Aligned_cols=221 Identities=25% Similarity=0.381 Sum_probs=165.4
Q ss_pred cCCCcCCeeeccCCce-EEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGT-VFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.-|...+++|.|+.|+ ||+|.+ +|+.||||++-... ..-..+|+..|+.- +|||||++++.-.+++..||..|.
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 3456677899999985 799998 67899999985322 23456899999877 699999999999999999999999
Q ss_pred cCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecC-----CCCEEEcccccceeccC
Q 035768 224 MVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLND-----DFEAKISDFGLARLISD 274 (388)
Q Consensus 224 ~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~-----~~~~kl~DfG~a~~~~~ 274 (388)
| ..+|.+++... ..++.++| |+|++|.||||+. ..+++|+|||+++.+..
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 67888887652 23566666 5577899999975 35799999999999865
Q ss_pred CCcc--eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 275 CESH--VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTG-KQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 275 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
+... ......||.+|+|||++....-+.++||||+||++|..++| .+||++....+ .++. ........
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl-------~~~~~L~~ 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANIL-------TGNYTLVH 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhh-------cCccceee
Confidence 4433 23456799999999999988888899999999999999995 89987543211 1111 11000000
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ .+. .++ ...+|+.++++++|..||++.+
T Consensus 735 L-----~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 735 L-----EPL-PDC--EAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred e-----ccC-chH--HHHHHHHHhcCCCcccCCCHHH
Confidence 0 111 111 5779999999999999999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=227.40 Aligned_cols=229 Identities=23% Similarity=0.337 Sum_probs=176.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
..++|.....+|.|.||.|||++. ..++..|+|.++-.......-..+|+-+++..+|||||.++|.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345788889999999999999995 4689999999987766666677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
||.+|+|.+.-+ +...++.|+| |+||+-.|||+.+.+.+|++|||.+..+...-. ....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krks 171 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKS 171 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh-hhhc
Confidence 999999988532 3345788888 678999999999999999999999987654322 2334
Q ss_pred cccccCccCcccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc-ccccccCCccccC
Q 035768 283 VAGTIGYVPPEYG---GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN-EQADEVLDPAVLN 358 (388)
Q Consensus 283 ~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 358 (388)
+.||+.|||||+. ..+.|..++|||+.|++..|+-.-++|-... .-.+...-+... .+....-|+.
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-------hpmr~l~LmTkS~~qpp~lkDk~--- 241 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-------HPMRALFLMTKSGFQPPTLKDKT--- 241 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-------chHHHHHHhhccCCCCCcccCCc---
Confidence 6799999999964 4678999999999999999998888773211 111111111111 1111222221
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
....-+-+++..|+..+|++|||+.
T Consensus 242 ----kws~~fh~fvK~altknpKkRptae 266 (829)
T KOG0576|consen 242 ----KWSEFFHNFVKGALTKNPKKRPTAE 266 (829)
T ss_pred ----cchHHHHHHHHHHhcCCCccCCChh
Confidence 1223577888999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-27 Score=202.97 Aligned_cols=175 Identities=29% Similarity=0.360 Sum_probs=142.4
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEE
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE-----EKLLV 220 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv 220 (388)
+..+.||-|+||.||..+.+ +|+.||.|++..... ...+.+.+|+++|..++|.|++..++...... ++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34577999999999999975 699999999865432 23467889999999999999999998876542 45788
Q ss_pred EeccCCCCHHH---------------HHhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDD---------------WLRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~---------------~l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+|.| ..||.. |+.+...+|.|+| |+||+|.|.|++.+..+||||||+|+.....+....
T Consensus 136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 8888 456655 3445566888888 678999999999999999999999998766555555
Q ss_pred eccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 281 TVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
+...-|..|.|||.+.+ ..|+.+.||||.||++.||+..+.-|.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 55567899999998765 579999999999999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=191.01 Aligned_cols=177 Identities=36% Similarity=0.504 Sum_probs=146.2
Q ss_pred CCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 148 FCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
|...+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3456789999999999999764 889999999765544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+++|.+++..... ++.++| |.++.+.||+++.++.++|+|||.+...............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999865322 233333 3467799999999999999999999887543211223345
Q ss_pred cccCccCcccc-CCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 285 GTIGYVPPEYG-GTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 285 gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 78899999988 66778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-26 Score=189.71 Aligned_cols=236 Identities=17% Similarity=0.302 Sum_probs=169.7
Q ss_pred hcCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCC--eeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDE--EKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv 220 (388)
.++|++.+.+|+|.|++||.|. ..+.+.++||.++... .+.+.+|+.+|..++ ||||+++++...+.. .+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4577888899999999999998 4678899999997643 456889999999997 999999999987654 46799
Q ss_pred EeccCCCCHHH------------HHhccCCCCCHHhh-----hccccCCeeecCC-CCEEEcccccceeccCCCcceeec
Q 035768 221 YEYMVKGSLDD------------WLRNQAASLDWGKR-----CKIVASNILLNDD-FEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 221 ~e~~~~g~L~~------------~l~~~~~~l~~~~~-----~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+||+.+-+... |+.+...+|+|+|. +|++|.|+++|.. -.++|+|+|+|...-.... ...
T Consensus 114 FE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--YnV 191 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNV 191 (338)
T ss_pred hhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce--eee
Confidence 99998876554 44566678999995 4677999999964 5799999999988754322 223
Q ss_pred cccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc-------ccccCCc
Q 035768 283 VAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ-------ADEVLDP 354 (388)
Q Consensus 283 ~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 354 (388)
...+..|.-||.+. ...|+..-|+|||||+|.+|+..+.||- .+.+..+..-.+...+.... ..-.+||
T Consensus 192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF---hG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF---HGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc---CCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 45678899999764 4568889999999999999999999984 33332222211211111110 0111222
Q ss_pred ccc---------------CCCCHH-HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVL---------------NANSKP-TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~---------------~~~~~~-~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ...... ...+.++++...+..|..+|||++|
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE 318 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence 210 011111 1246788889999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=208.73 Aligned_cols=177 Identities=21% Similarity=0.319 Sum_probs=145.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCc--------ChHHHHHHHHHHhcCC---CCCccceeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQ--------GDREFAAEMETLGMVK---HQNLVELLGYCS 212 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~g~~~ 212 (388)
..+|...+.+|.|+||.|+.|.++. ...|+||.+.+.+.- ..-....|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468888999999999999999764 668999998765321 1123567999999997 999999999999
Q ss_pred eCCeeEEEEecc-CCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 213 VDEEKLLVYEYM-VKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 213 ~~~~~~lv~e~~-~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+++..||+||-- ++-||++++. |...+..++| |+||+-+|+.+|.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999976 4558999874 3344566666 567888999999999999999999977
Q ss_pred ccCCCcceeeccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCC
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
.... ....+.||..|.|||++.+.+| +..-|||++|++||.++....||+
T Consensus 720 ~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6442 3345789999999999999887 556899999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=182.79 Aligned_cols=185 Identities=32% Similarity=0.537 Sum_probs=152.4
Q ss_pred eeccCCceEEEEEcCC-CCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHH
Q 035768 154 IGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~ 231 (388)
||+|++|.||++...+ ++.+++|++...... ....+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998765432 34679999999999999999999999999999999999999999999
Q ss_pred HHhccC----------------CCCCHHh-----hhccccCCeeecC-CCCEEEcccccceeccCCCcceeeccccccCc
Q 035768 232 WLRNQA----------------ASLDWGK-----RCKIVASNILLND-DFEAKISDFGLARLISDCESHVSTVVAGTIGY 289 (388)
Q Consensus 232 ~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y 289 (388)
++.... .++.++| |.++.|.||+++. ++.++|+|||.+........ ......+...|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ 159 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAY 159 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCc
Confidence 986531 1334444 3467799999999 89999999999987654321 12224478899
Q ss_pred cCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHH
Q 035768 290 VPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368 (388)
Q Consensus 290 ~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 368 (388)
++||..... .++.++|+|++|+++++| ..+
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------~~~ 190 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------PEL 190 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------HHH
Confidence 999988776 888999999999999999 257
Q ss_pred HHHHHhcccCCCCCCCCCCC
Q 035768 369 LQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 369 ~~l~~~C~~~~P~~RPt~~e 388 (388)
.+++..|++.+|++||++.|
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHHhhCCcccCcCHHH
Confidence 88999999999999999753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-25 Score=202.47 Aligned_cols=175 Identities=26% Similarity=0.258 Sum_probs=140.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCC------CCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVK------HQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~ 218 (388)
..|......|+|-|++|.+|... .|+.||||+|+... ...+.=+.|+++|++|+ --|+++++-.|...+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 46777788999999999999964 48899999997642 22334568999999994 458999999999999999
Q ss_pred EEEeccCCCCHHHHHhccCC------------------CCCHHh-----hhccccCCeeecCC-CCEEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQAA------------------SLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~~------------------~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~ 274 (388)
||+|-+ .-+|.+.|+.... +|..+. |+||+|.|||+++. ..+||||||.|.....
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 999988 6789998865322 222222 56899999999865 5689999999987765
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
... +...-+..|.|||++.+-+|+..-|+||.||+||||.||+..|..
T Consensus 590 nei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 590 NEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 432 223346789999999999999999999999999999999988754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-23 Score=174.99 Aligned_cols=139 Identities=21% Similarity=0.198 Sum_probs=98.5
Q ss_pred HHHhccCCCCCHHhhhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHH
Q 035768 231 DWLRNQAASLDWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFG 310 (388)
Q Consensus 231 ~~l~~~~~~l~~~~~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~G 310 (388)
.++.+...+|.|+|..+ +|+|||++.++.+|+ ||+++...... ..||+.|||||++.+..++.++||||||
T Consensus 21 ~i~~qi~~~L~~lH~~~-kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG 91 (176)
T smart00750 21 AVCLQCLRALRELHRQA-KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPEVIQGQSYTEKADIYSLG 91 (176)
T ss_pred HHHHHHHHHHHHHHhcC-CcccEeEcCccceee--ccceEeecccc------CCCcccccChHHhcCCCCcchhhHHHHH
Confidence 34445556788888888 999999999999999 99998764322 2589999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH--HHHHHHHHhcccCCCCCCCCCCC
Q 035768 311 VILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM--LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 311 v~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
|++|||+||+.||.... ........+........... ........ ..+.+++.+||+.+|.+|||+.|
T Consensus 92 ~il~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 161 (176)
T smart00750 92 ITLYEALDYELPYNEER---ELSAILEILLNGMPADDPRD-------RSNLESVSAARSFADFMRVCASRLPQRREAANH 161 (176)
T ss_pred HHHHHHHhCCCCccccc---hhcHHHHHHHHHhccCCccc-------cccHHHHHhhhhHHHHHHHHHhcccccccCHHH
Confidence 99999999999985321 11122222222111110000 00111112 25899999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-23 Score=183.74 Aligned_cols=174 Identities=28% Similarity=0.318 Sum_probs=137.0
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC------Cee
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD------EEK 217 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 217 (388)
+|...+.+|.|.- .|..+.. -.++.||+|++.... ....+...+|..++..+.|+||++++.++... ...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555677888877 5555543 258899999986432 23446678999999999999999999999754 356
Q ss_pred EEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 218 LLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+||||| .++|...+. +...+..++| |+|++|+||++..+..+||.|||+|+..... ..
T Consensus 97 y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred HHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 8999999 678877654 2334555666 4578899999999999999999999865432 34
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
.+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 556778999999999988889999999999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=183.30 Aligned_cols=237 Identities=21% Similarity=0.271 Sum_probs=164.6
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-----C---CCccceeeEEEe---
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-----H---QNLVELLGYCSV--- 213 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 213 (388)
.+|...+.||-|.|++||++.. .+.+.||+|+.+... ...+..+.|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788889999999999999985 457789999987543 44566788999999883 3 369999999975
Q ss_pred -CCeeEEEEeccCCCCHHHHHh-----------------ccCCCCCHHhhh------ccccCCeee--------------
Q 035768 214 -DEEKLLVYEYMVKGSLDDWLR-----------------NQAASLDWGKRC------KIVASNILL-------------- 255 (388)
Q Consensus 214 -~~~~~lv~e~~~~g~L~~~l~-----------------~~~~~l~~~~~~------~i~~~NiLl-------------- 255 (388)
+.+.+||+|++ |-+|..+|. +...+|+|+|+. ||+|+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a 235 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA 235 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence 45889999999 778887764 234477787742 333111111
Q ss_pred --------------------------------------------------------------------------------
Q 035768 256 -------------------------------------------------------------------------------- 255 (388)
Q Consensus 256 -------------------------------------------------------------------------------- 255 (388)
T Consensus 236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~ 315 (590)
T KOG1290|consen 236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST 315 (590)
T ss_pred ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence
Q ss_pred ------------------------------------------------------------------------cCCCCEEE
Q 035768 256 ------------------------------------------------------------------------NDDFEAKI 263 (388)
Q Consensus 256 ------------------------------------------------------------------------~~~~~~kl 263 (388)
..+.++||
T Consensus 316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI 395 (590)
T KOG1290|consen 316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI 395 (590)
T ss_pred hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence 11235778
Q ss_pred cccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC---CCcccHHHHHH
Q 035768 264 SDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED---KDGENLVDWVL 340 (388)
Q Consensus 264 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~---~~~~~~~~~~~ 340 (388)
+|||-|..... ..+...-|..|.|||++.+..|++.+|||||+|+++||+||...|++.... .+...+...+.
T Consensus 396 aDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E 471 (590)
T KOG1290|consen 396 ADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME 471 (590)
T ss_pred eeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence 88887765421 122334688999999999999999999999999999999999988764332 23333332221
Q ss_pred H-------hhcccc-ccccCCcc-----------------c--cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 H-------MMKNEQ-ADEVLDPA-----------------V--LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ~-------~~~~~~-~~~~~~~~-----------------~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
- ....+. ..++++.. + .-..+.+...++.+++.-+++.+|++|||+.+
T Consensus 472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1 111111 11222211 0 12356788889999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=174.33 Aligned_cols=175 Identities=21% Similarity=0.391 Sum_probs=134.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeE-EEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGY-CSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lv~e 222 (388)
+.|.+.+.+|+|.||.+.+++++ +.+.+++|.+.... ...++|.+|..---.| .|.||+..|++ |+..+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45778899999999999999986 46788999886543 3467899998765555 58999988764 677788889999
Q ss_pred ccCCCCHHHHHh--------------ccCCCCCHHh-----hhccccCCeeec--CCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLR--------------NQAASLDWGK-----RCKIVASNILLN--DDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~--------------~~~~~l~~~~-----~~~i~~~NiLl~--~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|+|.|||..-+. +...+++|+| |+||+.+|||+- +..++||||||+++..+..- .
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV----~ 178 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV----K 178 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee----h
Confidence 999999987542 3455788888 567889999983 34589999999997654311 1
Q ss_pred ccccccCccCccccCC---C--CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 282 VVAGTIGYVPPEYGGT---G--KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~---~--~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
...-+..|.+||.... + ...+.+|||.||++++.++||.+||..
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 1234567899996432 2 347889999999999999999999974
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=171.94 Aligned_cols=214 Identities=21% Similarity=0.355 Sum_probs=150.2
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcc--cCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLS--QATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
...|.+...|+.|+|+++. ..+++|+++ .......++|..|.-.|+-+.||||..++|.|.......++..|||.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3457888899999999954 455667664 3344456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcc-----------------CCCCCHHhhhc-------cccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 229 LDDWLRNQ-----------------AASLDWGKRCK-------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 229 L~~~l~~~-----------------~~~l~~~~~~~-------i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
|+..|++. +.++.|+|..+ +-+..+++|++.+++|+= +-++.- .......
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~gr~ 347 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEVGRA 347 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceee-----eeccccc
Confidence 99999864 22445666443 336789999999988761 111111 1111123
Q ss_pred cccCccCccccCCCCC---CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 285 GTIGYVPPEYGGTGKA---TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~---~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
-.+.||+||.+...+- -.++|+|||.+++|||.|...||.+...-+-+. +.....+ ...+.|.
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---kialegl-----rv~ippg------ 413 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---KIALEGL-----RVHIPPG------ 413 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---hhhhccc-----cccCCCC------
Confidence 4688999998876554 347999999999999999999986532211111 1111111 1111221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
....+.+++.-|...||.+||.++
T Consensus 414 --is~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 414 --ISRHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred --ccHHHHHHHHHHhcCCCCcCCCcc
Confidence 122567788889999999999886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-22 Score=211.56 Aligned_cols=171 Identities=22% Similarity=0.290 Sum_probs=113.5
Q ss_pred cCCC-CCccceeeEE-------EeCCeeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhcc
Q 035768 198 MVKH-QNLVELLGYC-------SVDEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKI 248 (388)
Q Consensus 198 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i 248 (388)
.++| +||++++++| ......+.++||+ +++|.++|... ..+|.|+| |+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3456 6888888887 2334567888988 67999998542 33566777 5578
Q ss_pred ccCCeeecC-------------------CCCEEEcccccceeccCCC---------------cceeeccccccCccCccc
Q 035768 249 VASNILLND-------------------DFEAKISDFGLARLISDCE---------------SHVSTVVAGTIGYVPPEY 294 (388)
Q Consensus 249 ~~~NiLl~~-------------------~~~~kl~DfG~a~~~~~~~---------------~~~~~~~~gt~~y~aPE~ 294 (388)
+|+|||++. ++.+|++|||+++...... ........||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 899999954 4567777777776432100 000112357889999999
Q ss_pred cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHh
Q 035768 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATG 374 (388)
Q Consensus 295 ~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 374 (388)
+.+..++.++|||||||+||||++|..|+... ......+... ...+... ....+...++.+
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~~~~--------~~~~~~~-----~~~~~~~~~~~~ 247 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSLRHR--------VLPPQIL-----LNWPKEASFCLW 247 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHHHHh--------hcChhhh-----hcCHHHHHHHHH
Confidence 98899999999999999999999998885321 1111111110 1111110 112245678889
Q ss_pred cccCCCCCCCCCCC
Q 035768 375 CISNDPTVRPTMLH 388 (388)
Q Consensus 375 C~~~~P~~RPt~~e 388 (388)
||+.+|.+||||.|
T Consensus 248 ~L~~~P~~Rps~~e 261 (793)
T PLN00181 248 LLHPEPSCRPSMSE 261 (793)
T ss_pred hCCCChhhCcChHH
Confidence 99999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-22 Score=179.99 Aligned_cols=183 Identities=28% Similarity=0.350 Sum_probs=143.2
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCC
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDE 215 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 215 (388)
+....+.|...+.||.|.|++||++... ..+.||+|.+.... ......+|+++|..+. |.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344567888999999999999999853 46789999997543 3356889999999984 999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHh------------ccCCCCCHHh-----hhccccCCeeecC-CCCEEEcccccceecc----
Q 035768 216 EKLLVYEYMVKGSLDDWLR------------NQAASLDWGK-----RCKIVASNILLND-DFEAKISDFGLARLIS---- 273 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~------------~~~~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~---- 273 (388)
...+|+||++.-+..++.+ +...+|.+.| |+||+|+|+|.+. .+.-.|.|||+|....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999999887776554 3344666666 5678899999985 4678999999996210
Q ss_pred -------------C-CC-------------------------cceeeccccccCccCccccCC-CCCCcccchHhHHHHH
Q 035768 274 -------------D-CE-------------------------SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVIL 313 (388)
Q Consensus 274 -------------~-~~-------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l 313 (388)
. .. .......+||++|.|||++.. ..-+++.||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 00 001113579999999998654 4668999999999999
Q ss_pred HHHHhCCCCCCC
Q 035768 314 LELVTGKQPTGP 325 (388)
Q Consensus 314 ~el~tg~~P~~~ 325 (388)
+-+++++.||..
T Consensus 269 Lslls~~~PFf~ 280 (418)
T KOG1167|consen 269 LSLLSRRYPFFK 280 (418)
T ss_pred ehhhcccccccc
Confidence 999999999854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=181.50 Aligned_cols=151 Identities=21% Similarity=0.193 Sum_probs=113.8
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC--CCCEEEEEEcccCC-----CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP--DGKTVAVKKLSQAT-----GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
..++|...+.||+|+||+||+|.+. +++.||||++.... ......|.+|+++|++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467889999999999999999864 57778999875321 1124568999999999999999963322 246
Q ss_pred eEEEEeccCCCCHHH--------HHhccCCCCCHHh-----hhcc-ccCCeeecCCCCEEEcccccceeccCCCcce---
Q 035768 217 KLLVYEYMVKGSLDD--------WLRNQAASLDWGK-----RCKI-VASNILLNDDFEAKISDFGLARLISDCESHV--- 279 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~--------~l~~~~~~l~~~~-----~~~i-~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~--- 279 (388)
.++||||+++++|.. ++.+...+|.++| |+|| +|+|||++.++.+||+|||+|+.+.......
T Consensus 93 ~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~ 172 (365)
T PRK09188 93 DGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIA 172 (365)
T ss_pred cEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhh
Confidence 799999999999863 2223345677777 5688 8999999999999999999999765432111
Q ss_pred ----eeccccccCccCccccCC
Q 035768 280 ----STVVAGTIGYVPPEYGGT 297 (388)
Q Consensus 280 ----~~~~~gt~~y~aPE~~~~ 297 (388)
.+...+++.|+|||.+..
T Consensus 173 ~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 173 AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhccCccCCcccCCh
Confidence 124568889999998653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=173.47 Aligned_cols=186 Identities=25% Similarity=0.434 Sum_probs=135.9
Q ss_pred HhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhccCC----------------CCCHHhhh------ccccCCe
Q 035768 196 LGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA----------------SLDWGKRC------KIVASNI 253 (388)
Q Consensus 196 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~l~~~~~~------~i~~~Ni 253 (388)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+..... ++.|+|.. .++++|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999998876433 44555533 3458999
Q ss_pred eecCCCCEEEcccccceeccCC-CcceeeccccccCccCccccCCC-------CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 254 LLNDDFEAKISDFGLARLISDC-ESHVSTVVAGTIGYVPPEYGGTG-------KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 254 Ll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
++|..+.+||+|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999999876421 11111222244679999987653 146789999999999999999999987
Q ss_pred CCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 326 EFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+..+++.++.. .....+.|.+.... +....+..++..||..+|.+||++++
T Consensus 161 ~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHH
Confidence 6554444556655544 11223333332221 22336889999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-18 Score=158.02 Aligned_cols=233 Identities=28% Similarity=0.425 Sum_probs=168.0
Q ss_pred CCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEEec
Q 035768 148 FCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQ-NLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~ 223 (388)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 78999998765433 356799999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhccC------------------CCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCcc-
Q 035768 224 MVKGSLDDWLRNQA------------------ASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESH- 278 (388)
Q Consensus 224 ~~~g~L~~~l~~~~------------------~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~- 278 (388)
+.++++.+++.... .++.++| |++++|+||+++... .++++|||.++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 99999997776432 1234556 568889999999988 7999999999866543322
Q ss_pred ----eeeccccccCccCccccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 279 ----VSTVVAGTIGYVPPEYGGT---GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 279 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
......||..|+|||.... ..++...|+||+|++++++++|..||.............+.+...... .....
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 238 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASP 238 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccccc
Confidence 2355679999999998877 578899999999999999999999964322100012222222221111 00000
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
..+ .........+.+++..|+..+|..|.++.
T Consensus 239 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 270 (384)
T COG0515 239 LSP----SNPELISKAASDLLKKLLAKDPKNRLSSS 270 (384)
T ss_pred cCc----cccchhhHHHHHHHHHHHhcCchhcCCHH
Confidence 000 00012224577888999999999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-19 Score=154.34 Aligned_cols=158 Identities=13% Similarity=0.103 Sum_probs=118.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHH---------HHHHHHHHhcCCCCCccceeeEEEeC-
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE---------FAAEMETLGMVKHQNLVELLGYCSVD- 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~- 214 (388)
.++|...+++|.|+||.||.... ++..+|+|.++......... |.+|++.+.+++||+|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46899999999999999999765 57789999997554333222 67999999999999999999886643
Q ss_pred -------CeeEEEEeccCCCCHHHHH-------hccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 215 -------EEKLLVYEYMVKGSLDDWL-------RNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 215 -------~~~~lv~e~~~~g~L~~~l-------~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
...+++|||++|.+|.++. .+....+..+| |.|+.|+||+++.++ ++|+|||..+.....
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccch
Confidence 3578999999999997763 22333455555 458889999999988 999999988655321
Q ss_pred CcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHH
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELV 317 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~ 317 (388)
... ..+.....+..++|+||||+++.-..
T Consensus 188 ~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 188 KAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 111 01334455677999999999877543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-19 Score=177.24 Aligned_cols=230 Identities=21% Similarity=0.220 Sum_probs=157.5
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC--CCcCh----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA--TGQGD----REFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
....++|.|++|.|+..... .....+.|..+.. ..... ..+..|..+-..++|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988777643 3344444433210 11111 12556788888899999998888877766666669
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCc---c
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCES---H 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~---~ 278 (388)
|||++ ||+.++.. ...++.|+|. +|++++|+++..++.+||+|||.+....-... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 99987643 3346778874 56779999999999999999999976643222 4
Q ss_pred eeeccccccCccCccccCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATER-GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
.....+|+-.|+|||.+....|.+. .||||.|+++..|++|+.||......++.. .......+......+
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~~~~--- 550 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIFEGP--- 550 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccccCh---
Confidence 4556789999999999999888764 899999999999999999996543222111 000000110000001
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.............++.++++.+|.+|-||++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence 0012233445678899999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=150.97 Aligned_cols=179 Identities=23% Similarity=0.286 Sum_probs=139.1
Q ss_pred CCCcCCeeeccCCceEEEEEcCCC--CEEEEEEcccCCCcChHHHHHHHHHHhcCCC----CCccceeeEE-EeCCeeEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDG--KTVAVKKLSQATGQGDREFAAEMETLGMVKH----QNLVELLGYC-SVDEEKLL 219 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 219 (388)
+|...+.||+|+||.||++..... ..+|+|.-..........+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999996543 4788888765433333367889999888863 5888888888 47778999
Q ss_pred EEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCC-----CCEEEcccccce--
Q 035768 220 VYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDD-----FEAKISDFGLAR-- 270 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~-----~~~kl~DfG~a~-- 270 (388)
||+.+ |.+|.++..... .+|.++| |+||+|.|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99998 889999774322 2344555 56999999999765 469999999998
Q ss_pred eccCCCcc------e-eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 271 LISDCESH------V-STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 271 ~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
........ . .....||..|.++....+...+.+.|+||++-++.|+..|..||...
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 43221110 1 22355999999999999999999999999999999999999998543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-18 Score=165.68 Aligned_cols=166 Identities=30% Similarity=0.394 Sum_probs=133.0
Q ss_pred eeeccCCceEEEEE----cCCCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccC
Q 035768 153 VIGGGGFGTVFKGT----MPDGKTVAVKKLSQATGQ--GDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|+|+||.|+.++ ...|..+|+|.+++.... .......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 234778999988765322 1124556788888887 9999999999999999999999999
Q ss_pred CCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 226 KGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 226 ~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
+|+|...+.+. +-+++..|. ++++++||+++.+|++++.|||+++..-.... .||
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----ccc
Confidence 99998766432 223444443 46779999999999999999999987644322 289
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
|..|||||+.. .....+|.||||++++||+||..||..
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99999999987 567789999999999999999999853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.7e-16 Score=132.66 Aligned_cols=171 Identities=15% Similarity=0.064 Sum_probs=122.9
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc----ChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEecc
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ----GDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
....|++|+||+||.+.- .+..++.+.+.....- ....|.+|+++|+++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356799999999997766 6778887777654321 1225889999999995 5889999886 4469999999
Q ss_pred CCCCHHHHH--------hccCCCCCHHh-----hhcc-ccCCeeecCCCCEEEcccccceeccCCCcc----e-------
Q 035768 225 VKGSLDDWL--------RNQAASLDWGK-----RCKI-VASNILLNDDFEAKISDFGLARLISDCESH----V------- 279 (388)
Q Consensus 225 ~~g~L~~~l--------~~~~~~l~~~~-----~~~i-~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~----~------- 279 (388)
.|.+|.+.+ .+....+.++| |.|| +|+|||++.++.++|+|||+|........- .
T Consensus 81 ~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l 160 (218)
T PRK12274 81 AGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL 160 (218)
T ss_pred cCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence 999997543 22233556666 4577 689999999999999999999855432210 0
Q ss_pred -eeccccccCccCccccC--CCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 280 -STVVAGTIGYVPPEYGG--TGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 280 -~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......++.|++|+... ..+--...++++-|.-+|.++|++.|...
T Consensus 161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 01123577888887422 22222567889999999999999988643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-16 Score=134.44 Aligned_cols=178 Identities=21% Similarity=0.321 Sum_probs=140.2
Q ss_pred cCCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKH-QNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+|...+.||+|+||.+|.|. ..+|..||||.=+... ...++..|..+.+.++| ..|..+..+..+.....+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 578889999999999999998 5789999999865432 23457789999998876 6677777788888889999999
Q ss_pred cCCCCHHHHHh----------------ccCCCCCHHh-----hhccccCCeeecC---CCCEEEcccccceeccCCCcc-
Q 035768 224 MVKGSLDDWLR----------------NQAASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 224 ~~~g~L~~~l~----------------~~~~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~~~~~~- 278 (388)
. |.+|.+++. |....+.|.| |+||+|+|.|..- ...+.++|||+|+...+....
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 9 889988753 2222345555 5799999999853 346899999999987553322
Q ss_pred -----eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 279 -----VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 279 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
......||.+|.+-....+...+.+-|+=|+|-+|...--|..||...
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 223467999999887776667788899999999999999999999764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.1e-16 Score=132.83 Aligned_cols=120 Identities=16% Similarity=0.122 Sum_probs=85.9
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc--C-------hHH-----------------HHHHHHHHhcCCCCCc
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ--G-------DRE-----------------FAAEMETLGMVKHQNL 204 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 204 (388)
...||+|+||.||+|..++|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 112 2349999999988887
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHH-H--------------hccCCCCCHH-h-----hhccccCCeeecCCCCEEE
Q 035768 205 VELLGYCSVDEEKLLVYEYMVKGSLDDW-L--------------RNQAASLDWG-K-----RCKIVASNILLNDDFEAKI 263 (388)
Q Consensus 205 v~l~g~~~~~~~~~lv~e~~~~g~L~~~-l--------------~~~~~~l~~~-~-----~~~i~~~NiLl~~~~~~kl 263 (388)
.....+.. ...++||||++++++... + .+...++.++ | |.||+|+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 54433322 234899999998776543 2 2223455666 3 458889999998 478999
Q ss_pred cccccceecc
Q 035768 264 SDFGLARLIS 273 (388)
Q Consensus 264 ~DfG~a~~~~ 273 (388)
+|||+|....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05147 159 IDVSQSVEHD 168 (190)
T ss_pred EEccccccCC
Confidence 9999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.8e-15 Score=131.71 Aligned_cols=177 Identities=19% Similarity=0.324 Sum_probs=138.9
Q ss_pred CCCcCCeeeccCCceEEEEE-cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEecc
Q 035768 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+|...+.||+|+||+.+.|+ +-+++.||||.=... ....++..|.+..+.|. .++|..+|.+-..+-+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 58889999999999999998 558999999975332 22345667777777774 689999988888888889999999
Q ss_pred CCCCHHHHHhc----------------cCCCCCHHhh-----hccccCCeeecCC-----CCEEEcccccceeccCCCcc
Q 035768 225 VKGSLDDWLRN----------------QAASLDWGKR-----CKIVASNILLNDD-----FEAKISDFGLARLISDCESH 278 (388)
Q Consensus 225 ~~g~L~~~l~~----------------~~~~l~~~~~-----~~i~~~NiLl~~~-----~~~kl~DfG~a~~~~~~~~~ 278 (388)
|.+|.|+..= ...-+.+.|. +||+|+|.||... ..+.++|||+|+...+....
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 8888876531 1112334443 4899999999754 35899999999988665432
Q ss_pred ------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 279 ------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 279 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
......||.+||+-....+..-+.+-|.=|+|-++...+-|..||...
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 223467999999999888888999999999999999999999999754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.2e-15 Score=129.35 Aligned_cols=119 Identities=14% Similarity=0.225 Sum_probs=90.1
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-----CCCCccceeeEEEeCC---eeE-E
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMV-----KHQNLVELLGYCSVDE---EKL-L 219 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~-l 219 (388)
...+.||+|+||.||. +++....+||++........+.+.+|+++++.+ +||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 544343479988765444567799999999999 6799999999998863 433 7
Q ss_pred EEec--cCCCCHHHHHhccC------------CCC-CHHh-----hhccccCCeeecC----CCCEEEcccccc
Q 035768 220 VYEY--MVKGSLDDWLRNQA------------ASL-DWGK-----RCKIVASNILLND----DFEAKISDFGLA 269 (388)
Q Consensus 220 v~e~--~~~g~L~~~l~~~~------------~~l-~~~~-----~~~i~~~NiLl~~----~~~~kl~DfG~a 269 (388)
|+|| +++|+|.+++.+.. .++ .|+| ++||+|+|||++. +..++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 66899999986431 123 5666 4578899999974 348999995444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.4e-15 Score=126.80 Aligned_cols=121 Identities=18% Similarity=0.146 Sum_probs=88.1
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc--C------------------------hHHHHHHHHHHhcCCCCCc
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ--G------------------------DREFAAEMETLGMVKHQNL 204 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 204 (388)
...||+|+||.||+|...+|+.||||.++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998754211 0 1124578999999999998
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHH-HHhc--------------cCCCCCHHhh------hccccCCeeecCCCCEEE
Q 035768 205 VELLGYCSVDEEKLLVYEYMVKGSLDD-WLRN--------------QAASLDWGKR------CKIVASNILLNDDFEAKI 263 (388)
Q Consensus 205 v~l~g~~~~~~~~~lv~e~~~~g~L~~-~l~~--------------~~~~l~~~~~------~~i~~~NiLl~~~~~~kl 263 (388)
.....+... ..++||||++++++.. .+.+ ...++.++|+ .||+|+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 655544433 3489999998875432 2321 2223445554 57889999999 889999
Q ss_pred cccccceeccC
Q 035768 264 SDFGLARLISD 274 (388)
Q Consensus 264 ~DfG~a~~~~~ 274 (388)
+|||+++.+..
T Consensus 159 iDFG~a~~~~~ 169 (190)
T cd05145 159 IDVSQAVELDH 169 (190)
T ss_pred EEcccceecCC
Confidence 99999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-15 Score=152.09 Aligned_cols=195 Identities=19% Similarity=0.265 Sum_probs=130.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|..+++|..|+||.||..+++. .+.+|+ ++++.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee-------------------
Confidence 578889999999999999999864 567788 444322 11111 33333444444
Q ss_pred CCCCHHHHHhcc-------CCCCCHHhhh-----ccccCCeeecCCCCEEEcccccceeccCCC--------------cc
Q 035768 225 VKGSLDDWLRNQ-------AASLDWGKRC-----KIVASNILLNDDFEAKISDFGLARLISDCE--------------SH 278 (388)
Q Consensus 225 ~~g~L~~~l~~~-------~~~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~--------------~~ 278 (388)
||-.+.++.. ..++.|+|+. +.+|.|.+|..-|++|++|||+++...... ..
T Consensus 136 --gDc~tllk~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef 213 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEF 213 (1205)
T ss_pred --chhhhhcccCCCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHh
Confidence 3333333321 2357788754 567999999999999999999987542110 11
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
....++||+.|+|||++....|+..+|+|++|+++||.+.|..||.. +..+++...+...... +.
T Consensus 214 ~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG----dtpeelfg~visd~i~-----------wp 278 (1205)
T KOG0606|consen 214 QDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG----DTPEELFGQVISDDIE-----------WP 278 (1205)
T ss_pred hhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC----CCHHHHHhhhhhhhcc-----------cc
Confidence 22346899999999999999999999999999999999999999754 3445555544332111 01
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
+.+.....+..+++.+.++.+|..|-
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11112223566777788888888773
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.7e-16 Score=157.28 Aligned_cols=221 Identities=20% Similarity=0.211 Sum_probs=146.3
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCC-CcChHHHHHHHHH--HhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT-GQGDREFAAEMET--LGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++...+.||++.|=+|.+|+++.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-..+...|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556788999999999999998887 8899875543 3344556554433 4556899999998887777778888888
Q ss_pred cCCCCHHHHHhc---------------cCCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccC--CCcceee
Q 035768 224 MVKGSLDDWLRN---------------QAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISD--CESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~---------------~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~--~~~~~~~ 281 (388)
. .-+|+|.|.- ...++.-+|. -|||.+|||++.-.-+.|+||.--+...- ++....+
T Consensus 103 v-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred H-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 8 4578875532 2234455553 47889999999988899999987665422 1111111
Q ss_pred ccc----cccCccCccccCC----------CC-CCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHh--h
Q 035768 282 VVA----GTIGYVPPEYGGT----------GK-ATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM--M 343 (388)
Q Consensus 282 ~~~----gt~~y~aPE~~~~----------~~-~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~--~ 343 (388)
.+. .-..|+|||.+.. .. .+++-||||+||++.||++ |++||.- ..+..+-... .
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGNADD 254 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccCccC
Confidence 111 2246999995432 22 5788999999999999999 6777631 1111110000 0
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.....+-|+ .+.+++..|++.||++|-++++
T Consensus 255 ~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 255 PEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred HHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHH
Confidence 00001111111 4778899999999999988753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.2e-14 Score=126.81 Aligned_cols=207 Identities=20% Similarity=0.266 Sum_probs=121.9
Q ss_pred cCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCC----------CCccceeeEEE---
Q 035768 150 EENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKH----------QNLVELLGYCS--- 212 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~--- 212 (388)
....||.|+++.||.+++. +++.+|||...... ....+++.+|.-....+.+ -.++--++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4578999999999999975 58999999875322 2234567777655555432 12222222221
Q ss_pred ------eCC--------eeEEEEeccCCCCHHHHHhc---cCC-------------------CCCHHhh-----hccccC
Q 035768 213 ------VDE--------EKLLVYEYMVKGSLDDWLRN---QAA-------------------SLDWGKR-----CKIVAS 251 (388)
Q Consensus 213 ------~~~--------~~~lv~e~~~~g~L~~~l~~---~~~-------------------~l~~~~~-----~~i~~~ 251 (388)
... ..+++|+-+ .+||.+++.- ... .+.++|+ .+|+++
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~ 174 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE 174 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence 111 225677777 6788877531 111 1223443 367799
Q ss_pred CeeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccCC--------CCCCcccchHhHHHHHHHHHhCCCCC
Q 035768 252 NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT--------GKATERGDVYSFGVILLELVTGKQPT 323 (388)
Q Consensus 252 NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gv~l~el~tg~~P~ 323 (388)
|++++.+|.+.|+||+.....+.. ... ...+..|.+||.... -.++.+.|.|++|+++|.|++|+.||
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred eEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 999999999999999887654321 111 234578999996532 35789999999999999999999998
Q ss_pred CCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 035768 324 GPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVR 383 (388)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R 383 (388)
+.......... ...... +..+.+..|+...++.+|.+|
T Consensus 251 ~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 64322111100 111122 455578899999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.2e-15 Score=139.88 Aligned_cols=152 Identities=26% Similarity=0.404 Sum_probs=108.2
Q ss_pred eeEEEEeccCCCCHHHHHhcc------------------CCCC--CHHhhhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ------------------AASL--DWGKRCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~------------------~~~l--~~~~~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
..|+.|++|...+|.+||... ..++ .|.-+.+.+|.||....+..+||.|||+.......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 578999999999999999532 2233 45557899999999999999999999998876554
Q ss_pred C-----cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 276 E-----SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 276 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
. ....+...||..||+||.+.+..|+.|+||||+|++|+|+++ -..++.. .. ...-.+.+
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~-t~~d~r~g--- 475 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IA-TLTDIRDG--- 475 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HH-hhhhhhcC---
Confidence 4 223445679999999999999999999999999999999998 3333210 00 01111112
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.++|......+ .-..+..+.+.+.|.+||++.
T Consensus 476 -~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 476 -IIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred -CCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 22222221111 234677889999999999653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=5e-14 Score=140.76 Aligned_cols=125 Identities=21% Similarity=0.259 Sum_probs=96.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEE-cccCCC-------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKK-LSQATG-------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
..|...+.||+|+||+||+|.+.+.. +++|+ +.+... ...+.+.+|++++..++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44566789999999999999875544 34443 222111 1124588999999999999999888888877888
Q ss_pred EEEEeccCCCCHHHHHh-------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceec
Q 035768 218 LLVYEYMVKGSLDDWLR-------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~-------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
++||||+++++|.+++. +...++.++| |.|++|+|||+ +++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999873 3445666777 56888999999 6789999999999764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.2e-15 Score=146.72 Aligned_cols=229 Identities=21% Similarity=0.257 Sum_probs=162.6
Q ss_pred CCCcCCeeeccCCceEEEEEcCC--CCEEEEEEcccCC--CcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPD--GKTVAVKKLSQAT--GQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 221 (388)
.|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556779999999998887533 4567777765443 112233445777777776 999999999999999999999
Q ss_pred eccCCCCHHHHH-h----------------ccCCCCCHHh------hhccccCCeeecCCC-CEEEcccccceeccC--C
Q 035768 222 EYMVKGSLDDWL-R----------------NQAASLDWGK------RCKIVASNILLNDDF-EAKISDFGLARLISD--C 275 (388)
Q Consensus 222 e~~~~g~L~~~l-~----------------~~~~~l~~~~------~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~--~ 275 (388)
||..+|++++.+ . +...++.|.| +.+|+|+|.+++..+ ..|++|||+|..... .
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999999988766 2 3344677777 568999999999999 999999999988755 3
Q ss_pred Ccceeecccc-ccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 276 ESHVSTVVAG-TIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 276 ~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+..... .......|...... ..
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~-------~~ 251 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR--KDGRYSSWKSNKGR-------FT 251 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc--ccccceeecccccc-------cc
Confidence 3334445678 9999999988774 557789999999999999999999864332 11222222222100 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+. .......++..+++..+|..|.+.++
T Consensus 252 ~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 252 QLPWN----SISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred cCccc----cCChhhhhcccccccCCchhcccccc
Confidence 00011 11124567777888899999988764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.5e-13 Score=120.60 Aligned_cols=118 Identities=18% Similarity=0.233 Sum_probs=94.0
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCc--------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ--------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+.||+|++|.||+|.+ +|..|++|........ ....+.+|++++..++|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 6778999986533211 123577899999999999998888888778888999999
Q ss_pred cCCCCHHHHHhcc-----------CCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 224 MVKGSLDDWLRNQ-----------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+++++|.+++... ...+.++| |.|+.|.|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887532 22344555 457889999999 78999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.8e-13 Score=118.97 Aligned_cols=129 Identities=19% Similarity=0.134 Sum_probs=92.5
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc----------------------ChHHHHHHHHHHhc
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ----------------------GDREFAAEMETLGM 198 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~ 198 (388)
+...-..|...+.||+|+||.||++..++|+.||||+++..... ....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333346677899999999999999888999999987542210 01236678889999
Q ss_pred CCCCC--ccceeeEEEeCCeeEEEEeccCCCCHHHHHh---------ccCCCCCHHh-----hhccccCCeeecCCCCEE
Q 035768 199 VKHQN--LVELLGYCSVDEEKLLVYEYMVKGSLDDWLR---------NQAASLDWGK-----RCKIVASNILLNDDFEAK 262 (388)
Q Consensus 199 l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~---------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~k 262 (388)
+.|++ +.+.++ ....++||||+++++|.+... +...++..+| |.||+|+||++++++.++
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 98874 444443 345689999999999876543 1112233333 458889999999999999
Q ss_pred Ecccccceecc
Q 035768 263 ISDFGLARLIS 273 (388)
Q Consensus 263 l~DfG~a~~~~ 273 (388)
|+|||++....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.8e-13 Score=119.07 Aligned_cols=117 Identities=19% Similarity=0.261 Sum_probs=91.0
Q ss_pred eeeccCCceEEEEEcCCCCEEEEEEcccCCC-c-------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQATG-Q-------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+||+|+||.||+|.+ ++..|++|....... . ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 568899998643221 1 1245778999999999988776666666777789999999
Q ss_pred CCCCHHHHHhc--------cCCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 225 VKGSLDDWLRN--------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 225 ~~g~L~~~l~~--------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
++++|.+++.. ....+.++| |.|+.|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999977643 233455566 457789999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.8e-13 Score=117.52 Aligned_cols=122 Identities=17% Similarity=0.117 Sum_probs=87.3
Q ss_pred CCCcCCeeeccCCceEEEEE--cCCCCEEEEEEcccCCCc------------------------ChHHHHHHHHHHhcCC
Q 035768 147 KFCEENVIGGGGFGTVFKGT--MPDGKTVAVKKLSQATGQ------------------------GDREFAAEMETLGMVK 200 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 200 (388)
-|...+.||+|+||.||+|. ..+|+.||+|.++..... ....+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999999998 568999999998743210 0123568999999997
Q ss_pred CCC--ccceeeEEEeCCeeEEEEeccCCCCHHHHH---------------hccCCCCCHHh------hhccccCCeeecC
Q 035768 201 HQN--LVELLGYCSVDEEKLLVYEYMVKGSLDDWL---------------RNQAASLDWGK------RCKIVASNILLND 257 (388)
Q Consensus 201 H~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l---------------~~~~~~l~~~~------~~~i~~~NiLl~~ 257 (388)
|.+ +.+++++ ...++||||+++++|..+. .+...++.++| |.||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3344432 2358999999998775543 22223444455 456789999999
Q ss_pred CCCEEEcccccceecc
Q 035768 258 DFEAKISDFGLARLIS 273 (388)
Q Consensus 258 ~~~~kl~DfG~a~~~~ 273 (388)
++.++|+|||.+....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.5e-13 Score=135.17 Aligned_cols=180 Identities=22% Similarity=0.255 Sum_probs=134.0
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC---CCCccceeeEEEeCCe
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK---HQNLVELLGYCSVDEE 216 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~ 216 (388)
+.....+.|.+.+.||+|+||.||+|...+|+.||+|.=+.... -+|.--.+++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 44455678899999999999999999988899999998654332 12333334445554 2445566666666788
Q ss_pred eEEEEeccCCCCHHHHHhccC---------------CCCCHHh-----hhccccCCeeecC-------CCCEEEcccccc
Q 035768 217 KLLVYEYMVKGSLDDWLRNQA---------------ASLDWGK-----RCKIVASNILLND-------DFEAKISDFGLA 269 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~-----~~~i~~~NiLl~~-------~~~~kl~DfG~a 269 (388)
.++|+||.+.|+|.+++.... .-++.+| |-||+|+|.||.. ...++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 899999999999999986321 1123334 4578899999943 356899999999
Q ss_pred eeccCC-CcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCC
Q 035768 270 RLISDC-ESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQP 322 (388)
Q Consensus 270 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P 322 (388)
-.+.-- +.......++|-.+-.+|+..+..++...|-|.+..+++-|+.|+.-
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 655321 12344556788999999999999999999999999999999999753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.9e-12 Score=116.74 Aligned_cols=171 Identities=19% Similarity=0.225 Sum_probs=108.5
Q ss_pred CCCCccceeeEEEeC---------------------------CeeEEEEeccCCCCHHHHHhc--------------cCC
Q 035768 200 KHQNLVELLGYCSVD---------------------------EEKLLVYEYMVKGSLDDWLRN--------------QAA 238 (388)
Q Consensus 200 ~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~--------------~~~ 238 (388)
+|||||+++++|.++ ...|+||.-. ..+|++|+.. ...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 699999999988541 3467888766 4578887642 234
Q ss_pred CCCHHh-----hhccccCCeee--cCCC--CEEEcccccceeccCC-----CcceeeccccccCccCccccCCCC-----
Q 035768 239 SLDWGK-----RCKIVASNILL--NDDF--EAKISDFGLARLISDC-----ESHVSTVVAGTIGYVPPEYGGTGK----- 299 (388)
Q Consensus 239 ~l~~~~-----~~~i~~~NiLl--~~~~--~~kl~DfG~a~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~----- 299 (388)
+.+++| |+|+|+.|||+ |+|. .+.|+|||.+-.-... .....-...|.-.-||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 566666 45777999998 3443 4688999987432211 111112234677899999764332
Q ss_pred -CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccC
Q 035768 300 -ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISN 378 (388)
Q Consensus 300 -~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~ 378 (388)
--.|+|.|+.|.+.||+++...||+.. ++-..+... .++.+. |.+.. .....+.+++...++.
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~r~-----Yqe~qL-----Palp~----~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDTRT-----YQESQL-----PALPS----RVPPVARQLVFDLLKR 496 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCccccc--chheechhh-----hhhhhC-----CCCcc----cCChHHHHHHHHHhcC
Confidence 135899999999999999999998641 111111111 111111 11111 1222467888889999
Q ss_pred CCCCCCCCC
Q 035768 379 DPTVRPTML 387 (388)
Q Consensus 379 ~P~~RPt~~ 387 (388)
||++||+..
T Consensus 497 ~pskRvsp~ 505 (598)
T KOG4158|consen 497 DPSKRVSPN 505 (598)
T ss_pred CccccCCcc
Confidence 999999863
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.1e-11 Score=104.85 Aligned_cols=118 Identities=21% Similarity=0.200 Sum_probs=78.3
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc--ChHH----------------------HHHHHHHHhcCCCCC--c
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ--GDRE----------------------FAAEMETLGMVKHQN--L 204 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 204 (388)
.+.||+|+||+||+|...+++.||||.++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999888999999988653211 1111 134556666664433 3
Q ss_pred cceeeEEEeCCeeEEEEeccCCC-----CHHHHH---------hccCCCCCHHh------hhccccCCeeecCCCCEEEc
Q 035768 205 VELLGYCSVDEEKLLVYEYMVKG-----SLDDWL---------RNQAASLDWGK------RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 205 v~l~g~~~~~~~~~lv~e~~~~g-----~L~~~l---------~~~~~~l~~~~------~~~i~~~NiLl~~~~~~kl~ 264 (388)
.+.++. ...++||||++++ .|.+.. .+...++.++| |.|++|+||+++ ++.++|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 444432 3468999999984 343322 11122333333 458889999999 8999999
Q ss_pred ccccceecc
Q 035768 265 DFGLARLIS 273 (388)
Q Consensus 265 DfG~a~~~~ 273 (388)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.8e-11 Score=99.69 Aligned_cols=118 Identities=19% Similarity=0.184 Sum_probs=92.6
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKH--QNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999854 7899999865433 4578999999999977 589999998888888999999999887
Q ss_pred HHH--------HHhccCCCCCHHh--------hhccccCCeeecCCCCEEEccccccee
Q 035768 229 LDD--------WLRNQAASLDWGK--------RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 229 L~~--------~l~~~~~~l~~~~--------~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+.. ...+....+..+| |.|+.|+||+++..+.+++.|||.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 752 1112222233333 458899999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.5e-11 Score=115.94 Aligned_cols=124 Identities=22% Similarity=0.256 Sum_probs=84.8
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcC----------------------------------------hHHHH
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG----------------------------------------DREFA 190 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 190 (388)
.+.||.|++|.||+|++.+|+.||||+.+...... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999985431000 01245
Q ss_pred HHHHHHhcC----CCCCccceeeEEE-eCCeeEEEEeccCCCCHHHHHhccCCCC--------------CHHh-----hh
Q 035768 191 AEMETLGMV----KHQNLVELLGYCS-VDEEKLLVYEYMVKGSLDDWLRNQAASL--------------DWGK-----RC 246 (388)
Q Consensus 191 ~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l--------------~~~~-----~~ 246 (388)
+|++.+.++ +|.+-+.+-.++. .....+|||||++|++|.++........ ...+ |.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~ 281 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA 281 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence 566655554 2333333333332 2445799999999999988764221111 1111 45
Q ss_pred ccccCCeeecCCCCEEEcccccceeccC
Q 035768 247 KIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 247 ~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
|+.|.||+++.++.++++|||++..+..
T Consensus 282 D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 282 DLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8889999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.7e-10 Score=103.03 Aligned_cols=121 Identities=21% Similarity=0.225 Sum_probs=89.6
Q ss_pred CCeee-ccCCceEEEEEcCCCCEEEEEEcccCC-------------CcChHHHHHHHHHHhcCCCCCc--cceeeEEEeC
Q 035768 151 ENVIG-GGGFGTVFKGTMPDGKTVAVKKLSQAT-------------GQGDREFAAEMETLGMVKHQNL--VELLGYCSVD 214 (388)
Q Consensus 151 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 214 (388)
...|| .|+.|+||++... +..++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999874 6788998875311 0122457889999999998885 6777765432
Q ss_pred C----eeEEEEeccCC-CCHHHHHhcc----------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceec
Q 035768 215 E----EKLLVYEYMVK-GSLDDWLRNQ----------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 215 ~----~~~lv~e~~~~-g~L~~~l~~~----------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
. ..++||||+++ .+|.+++.+. ...+..+| |.|++|.|||++.++.++|+|||.+...
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 2 23599999997 6898887542 22445555 4578899999999999999999998653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-10 Score=113.39 Aligned_cols=128 Identities=18% Similarity=0.202 Sum_probs=86.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCc--------------------------C--------h----
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQ--------------------------G--------D---- 186 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~---- 186 (388)
..|+. +.||+|++|+||+|++++ |+.||||+++..-.. . .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999877 999999998643100 0 0
Q ss_pred --HHHHHHHHHHhcC----CCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHHhccCCCCC-----------H------
Q 035768 187 --REFAAEMETLGMV----KHQNLVELLGYCSV-DEEKLLVYEYMVKGSLDDWLRNQAASLD-----------W------ 242 (388)
Q Consensus 187 --~~~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~l~-----------~------ 242 (388)
-+|.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++-.-...+.+ |
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~ 278 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR 278 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh
Confidence 1244455544444 24444444444433 4567899999999999875221111110 0
Q ss_pred --HhhhccccCCeeecCCC----CEEEcccccceeccC
Q 035768 243 --GKRCKIVASNILLNDDF----EAKISDFGLARLISD 274 (388)
Q Consensus 243 --~~~~~i~~~NiLl~~~~----~~kl~DfG~a~~~~~ 274 (388)
.-|.|+.|.||+++.++ .+++.|||+...+..
T Consensus 279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 12568999999999888 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-10 Score=110.07 Aligned_cols=175 Identities=25% Similarity=0.290 Sum_probs=131.6
Q ss_pred CCcCCeeec--cCCceEEEEEc---CCCCEEEEEEccc--CCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEE
Q 035768 148 FCEENVIGG--GGFGTVFKGTM---PDGKTVAVKKLSQ--ATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 148 ~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 219 (388)
|...+.+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+....+++ |+|.++.+..+...+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 455677999 99999999986 3578899998432 22233333446776667774 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc--------------------CCCCCHHhh-----hccccCCeeecCC-CCEEEcccccceecc
Q 035768 220 VYEYMVKGSLDDWLRNQ--------------------AASLDWGKR-----CKIVASNILLNDD-FEAKISDFGLARLIS 273 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~--------------------~~~l~~~~~-----~~i~~~NiLl~~~-~~~kl~DfG~a~~~~ 273 (388)
-+|++ +.+|.++.+.. ..++.|.|. .+++|.||++..+ ...+++|||+...+.
T Consensus 196 qtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred eeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence 99998 47777665421 226777774 4667999999998 889999999998886
Q ss_pred CCCcc----eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 274 DCESH----VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 274 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
+.... ......|...|++||... +.++..+|+||+|.+..|..++..+..
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 54421 111225778899999874 567889999999999999999887643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.3e-09 Score=95.95 Aligned_cols=128 Identities=24% Similarity=0.411 Sum_probs=88.4
Q ss_pred HHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHHhcc-------------------CCCCCHHhhhc---
Q 035768 195 TLGMVKHQNLVELLGYCSVDE-----EKLLVYEYMVKGSLDDWLRNQ-------------------AASLDWGKRCK--- 247 (388)
Q Consensus 195 ~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~g~L~~~l~~~-------------------~~~l~~~~~~~--- 247 (388)
-+-++.|.|||+++.|+.+.. ...++.|||..|+|..+|++. ..+|.|+|.++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 345567999999999986543 467899999999999988642 34677777654
Q ss_pred ----cccCCeeecCCCCEEEcccccceecc---CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC
Q 035768 248 ----IVASNILLNDDFEAKISDFGLARLIS---DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK 320 (388)
Q Consensus 248 ----i~~~NiLl~~~~~~kl~DfG~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~ 320 (388)
+..+-|++..++-+|+.----..... ...........+-++|.|||+......+.++|||+||...+||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 22455777777777765321111000 00011112234678999999988888889999999999999999987
Q ss_pred CC
Q 035768 321 QP 322 (388)
Q Consensus 321 ~P 322 (388)
.-
T Consensus 280 iq 281 (458)
T KOG1266|consen 280 IQ 281 (458)
T ss_pred ec
Confidence 53
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.5e-08 Score=85.52 Aligned_cols=115 Identities=18% Similarity=0.168 Sum_probs=80.6
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEeccCCCCHH
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV-ELLGYCSVDEEKLLVYEYMVKGSLD 230 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g~L~ 230 (388)
+.|+.|.++.||+++.. +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56889999999999874 77899998765432 223567899999988766655 444433 33458999999998876
Q ss_pred HH-------HhccCCCCCH----------HhhhccccCCeeecCCCCEEEccccccee
Q 035768 231 DW-------LRNQAASLDW----------GKRCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 231 ~~-------l~~~~~~l~~----------~~~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+. +.+....+.. .-|.|+.+.||+++ ++.++++|||.+..
T Consensus 80 ~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 31 1111111222 24568899999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=6.9e-08 Score=93.22 Aligned_cols=174 Identities=21% Similarity=0.176 Sum_probs=124.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC--CCCEEEEEEcccCCCcChHH--HHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP--DGKTVAVKKLSQATGQGDRE--FAAEMETLGMV-KHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 219 (388)
+.+|.....||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++.+..+...+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 456888889999999999998743 57889999886543332222 23455555544 58999998888888888889
Q ss_pred EEeccCCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCC-CCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~~~~~ 278 (388)
-.|||.++++...+. +...++.++| |.|++|+||++.++ +..++.|||.+..+.-
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---- 419 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---- 419 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce----
Confidence 999999998765431 2233455554 56899999999886 8889999999864321
Q ss_pred eeeccccccCcc--CccccCCCCCCcccchHhHHHHHHHHHhCCCC
Q 035768 279 VSTVVAGTIGYV--PPEYGGTGKATERGDVYSFGVILLELVTGKQP 322 (388)
Q Consensus 279 ~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P 322 (388)
........-++. +|+......+..+.|++|||..+.|.+++..-
T Consensus 420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 111112233334 55566677889999999999999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.9e-08 Score=101.12 Aligned_cols=182 Identities=23% Similarity=0.250 Sum_probs=123.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.+.|.+.+-+-+|+++.++.+.-. .|...++|...... ....+...++-.++-..+||-+++...-+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345666677889999999887632 34444444433221 11222333343343344567777665555566788999
Q ss_pred EeccCCCCHHHHHhccC---------------CCCCHH-----hhhccccCCeeecCCCCEEEcccccceeccCC-----
Q 035768 221 YEYMVKGSLDDWLRNQA---------------ASLDWG-----KRCKIVASNILLNDDFEAKISDFGLARLISDC----- 275 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~---------------~~l~~~-----~~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~----- 275 (388)
++|..+|+|...|+... ..++++ .+.+.+|.|+|...++..+++|||+.......
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 99999999999887532 122333 35577799999999999999999854322100
Q ss_pred -------------------------CcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 276 -------------------------ESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 276 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
.........||+.|.+||...+......+|+|++|++++|.++|.+||...
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 001122356899999999999999999999999999999999999997543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-07 Score=91.73 Aligned_cols=151 Identities=21% Similarity=0.262 Sum_probs=105.0
Q ss_pred cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHH------------h
Q 035768 167 MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL------------R 234 (388)
Q Consensus 167 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l------------~ 234 (388)
..++..|.|...+...........+-++.|+.+|||||++++..+..++..|+|+|-+. .|..++ +
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~~Gl~ 111 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVCLGLF 111 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHHHHHH
Confidence 44688899998876655334456778899999999999999999999999999999874 344433 3
Q ss_pred ccCCCCCHHh-hhccccCC-----eeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHh
Q 035768 235 NQAASLDWGK-RCKIVASN-----ILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308 (388)
Q Consensus 235 ~~~~~l~~~~-~~~i~~~N-----iLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 308 (388)
+...+|.++| .+++.+.| |+++..|+-||++|-++........ ......--..|..|+.+.... -..|.|-
T Consensus 112 qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 112 QILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhh
Confidence 4455777775 45555555 6778999999999988755432211 011111122456666543322 2459999
Q ss_pred HHHHHHHHHhCCCC
Q 035768 309 FGVILLELVTGKQP 322 (388)
Q Consensus 309 ~Gv~l~el~tg~~P 322 (388)
|||+++|++.|..+
T Consensus 189 Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 189 LGCLIEELFNGSLL 202 (690)
T ss_pred HHHHHHHHhCcccC
Confidence 99999999999443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-06 Score=89.34 Aligned_cols=44 Identities=27% Similarity=0.390 Sum_probs=29.2
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
++|++|+.|||++|+|+|.|| ..+. .+|+.|++++|+++|.+|.
T Consensus 463 ~~l~~L~~LdLs~N~lsg~iP-~~l~~L~~L~~L~Ls~N~l~g~iP~ 508 (623)
T PLN03150 463 GSITSLEVLDLSYNSFNGSIP-ESLGQLTSLRILNLNGNSLSGRVPA 508 (623)
T ss_pred hCCCCCCEEECCCCCCCCCCc-hHHhcCCCCCEEECcCCcccccCCh
Confidence 566777777777777777777 3232 3677777777776666553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.6e-06 Score=76.35 Aligned_cols=80 Identities=16% Similarity=0.236 Sum_probs=61.2
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCC--CCccceeeEEEeC---CeeEEEEeccC
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKH--QNLVELLGYCSVD---EEKLLVYEYMV 225 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~---~~~~lv~e~~~ 225 (388)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765432 134578899999999976 4456777776653 25689999998
Q ss_pred CCCHHH
Q 035768 226 KGSLDD 231 (388)
Q Consensus 226 ~g~L~~ 231 (388)
+.++.+
T Consensus 84 G~~l~~ 89 (223)
T cd05154 84 GRVLRD 89 (223)
T ss_pred CEecCC
Confidence 886644
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.4e-06 Score=79.71 Aligned_cols=145 Identities=23% Similarity=0.307 Sum_probs=103.6
Q ss_pred CCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCC-CCHHH
Q 035768 158 GFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKLLVYEYMVK-GSLDD 231 (388)
Q Consensus 158 ~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-g~L~~ 231 (388)
--.+.||+.. .||..|+.|++..........-..-++.++++.|+|+|++..++.. +..+++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899984 5899999999954333333233456788999999999999998863 5578899999986 46665
Q ss_pred HH------------------------------hccCCCCCHHhhhccc-----cCCeeecCCCCEEEcccccceeccCCC
Q 035768 232 WL------------------------------RNQAASLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 232 ~l------------------------------~~~~~~l~~~~~~~i~-----~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
+- .|...+|..+|+.+++ +++||++.+.+++|+..|....+..+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 32 2333456667777766 789999999999999988877664422
Q ss_pred cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK 320 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~ 320 (388)
. |.+. --.+-|.=.||.+++-|.||.
T Consensus 448 ~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 448 T---------------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred C---------------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 0 1111 123568889999999999994
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.3e-06 Score=85.19 Aligned_cols=164 Identities=20% Similarity=0.171 Sum_probs=119.3
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEeccCCC-CH
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN-LVELLGYCSVDEEKLLVYEYMVKG-SL 229 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~~~~g-~L 229 (388)
+..++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++..| +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 447899999999987533344445555332 34556889999999999 778788788888899999999887 21
Q ss_pred H-----------HH-----HhccCCCCCHHhhhc-cccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCc
Q 035768 230 D-----------DW-----LRNQAASLDWGKRCK-IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPP 292 (388)
Q Consensus 230 ~-----------~~-----l~~~~~~l~~~~~~~-i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aP 292 (388)
. ++ ++.....+++++... .-+.||+..+ ...|..||+....+.... ......+|+.|+||
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~p 399 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAP 399 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhcccccccccccccCcccccccc-cccccccccCCcccCccc--ccccCCCCCCCCCc
Confidence 1 11 122234556665542 3344777765 678999999998776533 33456689999999
Q ss_pred cccCCCCCCcccchHhHHHHHHHHHhCCCCC
Q 035768 293 EYGGTGKATERGDVYSFGVILLELVTGKQPT 323 (388)
Q Consensus 293 E~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~ 323 (388)
|+...+.+..+.|+|+.|+--.++.-|.+|-
T Consensus 400 ev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 400 EVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred hhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 9999999999999999998877887777763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=67.02 Aligned_cols=118 Identities=19% Similarity=0.258 Sum_probs=81.1
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEc-ccCCCc-C------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKL-SQATGQ-G------DREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~-~~~~~~-~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
..+++|+=+.+|.+.+. |..+++|.- ++.... . .....+|++++.+++--.|....=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999763 334666643 222111 1 13466899999988755555445556677888999999
Q ss_pred cCCCCHHHHHhccCC--------CCCHHhhh-----ccccCCeeecCCCCEEEccccccee
Q 035768 224 MVKGSLDDWLRNQAA--------SLDWGKRC-----KIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 224 ~~~g~L~~~l~~~~~--------~l~~~~~~-----~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
++|-.|.+++..... .+.-+|+. |+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999988865411 12233444 4558999998765 99999999974
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.9e-05 Score=65.27 Aligned_cols=117 Identities=15% Similarity=0.141 Sum_probs=75.8
Q ss_pred CeeeccCCceEEEEEcCC-------CCEEEEEEcccCCC---------------------cC-hHHHH----HHHHHHhc
Q 035768 152 NVIGGGGFGTVFKGTMPD-------GKTVAVKKLSQATG---------------------QG-DREFA----AEMETLGM 198 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~-~~~~~----~E~~~l~~ 198 (388)
..||.|.=+.||.|.-.+ +..+|||..+.... .. ...+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998543 47899998652110 00 11233 79999998
Q ss_pred CCC--CCccceeeEEEeCCeeEEEEeccCCCCH-----HHH----------HhccCCCCCHH-h-----hhccccCCeee
Q 035768 199 VKH--QNLVELLGYCSVDEEKLLVYEYMVKGSL-----DDW----------LRNQAASLDWG-K-----RCKIVASNILL 255 (388)
Q Consensus 199 l~H--~niv~l~g~~~~~~~~~lv~e~~~~g~L-----~~~----------l~~~~~~l~~~-~-----~~~i~~~NiLl 255 (388)
+.. -++.+.+++ ...++||||+.++.+ .+. +.+....+..+ | |.|+.+.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 456666654 567899999976422 111 11222233333 3 34677899999
Q ss_pred cCCCCEEEcccccceecc
Q 035768 256 NDDFEAKISDFGLARLIS 273 (388)
Q Consensus 256 ~~~~~~kl~DfG~a~~~~ 273 (388)
+ ++.+.|+|||.+....
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 7 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=6.6e-05 Score=62.67 Aligned_cols=121 Identities=17% Similarity=0.205 Sum_probs=81.8
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEc-ccCCC-------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKL-SQATG-------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
...++-+|+=+.|+++.+ .|+...||.- .+... -......+|++.+.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456789999999999998 5677777753 22211 12245778999999886555554444666777778999
Q ss_pred eccCC-CCHHHHHhccCC-----------------CCCHHhhh-----ccccCCeeecCCC---CEEEccccccee
Q 035768 222 EYMVK-GSLDDWLRNQAA-----------------SLDWGKRC-----KIVASNILLNDDF---EAKISDFGLARL 271 (388)
Q Consensus 222 e~~~~-g~L~~~l~~~~~-----------------~l~~~~~~-----~i~~~NiLl~~~~---~~kl~DfG~a~~ 271 (388)
||+++ .++.+++..... .+.-+|.. |+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 477887754211 12223433 4558999996554 468999999854
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=4.5e-05 Score=75.04 Aligned_cols=123 Identities=18% Similarity=0.182 Sum_probs=83.0
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCC----------------------c----Ch--------------HHHHH
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG----------------------Q----GD--------------REFAA 191 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~----~~--------------~~~~~ 191 (388)
+-|+.++-|.||+|++++|+.||||+.+..-. . .. -+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998753110 0 00 12445
Q ss_pred HHHHHhcC----CCCCccceeeEEE-eCCeeEEEEeccCCCCHHHHHhccCCCCC--HH-----------------hhhc
Q 035768 192 EMETLGMV----KHQNLVELLGYCS-VDEEKLLVYEYMVKGSLDDWLRNQAASLD--WG-----------------KRCK 247 (388)
Q Consensus 192 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~--~~-----------------~~~~ 247 (388)
|+.-+.++ ++.-=+++-.+|+ -.....|+|||++|-.+.+...-...+.+ .+ -|.|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaD 290 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHAD 290 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccC
Confidence 55555544 2222233333443 35677899999999888877432223333 11 1446
Q ss_pred cccCCeeecCCCCEEEcccccceeccC
Q 035768 248 IVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 248 i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
--|.||+++.++++-+.|||+...+.+
T Consensus 291 pHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 291 PHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CCccceEEecCCcEEEEcCcceecCCH
Confidence 669999999999999999999877654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.71 E-value=7.5e-05 Score=63.94 Aligned_cols=123 Identities=20% Similarity=0.285 Sum_probs=87.8
Q ss_pred cCCCcCCeeeccCC-ceEEEEEcCCCCEEEEEEccc---CC--------C----------cChHHHHHHHHHHhcCC---
Q 035768 146 NKFCEENVIGGGGF-GTVFKGTMPDGKTVAVKKLSQ---AT--------G----------QGDREFAAEMETLGMVK--- 200 (388)
Q Consensus 146 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~--- 200 (388)
.+++..+.||.|.- |.||++.+ +|+.+|+|..+. .. . .....|..|++...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67788899999999 99999998 677999999321 00 0 11235889999888774
Q ss_pred CCCc--cceeeEEEeC------------------CeeEEEEeccCCCC--HHHHHhccCCCCCHHhhhccccCCeeecCC
Q 035768 201 HQNL--VELLGYCSVD------------------EEKLLVYEYMVKGS--LDDWLRNQAASLDWGKRCKIVASNILLNDD 258 (388)
Q Consensus 201 H~ni--v~l~g~~~~~------------------~~~~lv~e~~~~g~--L~~~l~~~~~~l~~~~~~~i~~~NiLl~~~ 258 (388)
+.++ |+.+||..-. ....||.||++... -...+.+....+..+|+.+|.+..+-..+-
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny 195 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRNY 195 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCccccc
Confidence 4566 8999998432 12358999998765 222333334455667888888888777777
Q ss_pred CCEEEcccccc
Q 035768 259 FEAKISDFGLA 269 (388)
Q Consensus 259 ~~~kl~DfG~a 269 (388)
..-||+|||.+
T Consensus 196 ~~G~lvDfs~~ 206 (207)
T PF13095_consen 196 RGGKLVDFSSS 206 (207)
T ss_pred cCCEEEecccC
Confidence 78899999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=3.9e-05 Score=78.19 Aligned_cols=50 Identities=32% Similarity=0.496 Sum_probs=33.8
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccC---CCCeeEecCCCCCCCCCCCCCCc
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQ---NLSIMSLTGNKDLCGKIMGSDCK 51 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~---~l~~~~~s~N~~~~~~~~~~~~~ 51 (388)
+++|++|++|||++|+|+|.|| ..+.. ++..+++++|...|+.|....|.
T Consensus 486 l~~L~~L~~L~Ls~N~l~g~iP-~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 486 LGQLTSLRILNLNGNSLSGRVP-AALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred HhcCCCCCEEECcCCcccccCC-hHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 3567778888888888888887 32322 45567777887777766555554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00036 Score=58.07 Aligned_cols=116 Identities=21% Similarity=0.261 Sum_probs=74.3
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
..+.|++|.+|.||+|.+. |..+|+|.-+.. .....+..|+++|..+.-.++.+=+-.+ +..++.|||+.|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 3567999999999999984 458888876543 3356799999999998877766433222 223455999988788
Q ss_pred HHHHhcc--C---CCC--CHH-hhhccc------cCCeeecCCCCEEEccccccee
Q 035768 230 DDWLRNQ--A---ASL--DWG-KRCKIV------ASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 230 ~~~l~~~--~---~~l--~~~-~~~~i~------~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
.++-... . ..+ .|. ...+|- |...++-++..+.|+||--|+.
T Consensus 100 ~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7764321 0 000 010 111222 3334444445899999988863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00053 Score=58.64 Aligned_cols=108 Identities=23% Similarity=0.258 Sum_probs=62.8
Q ss_pred eEEEEEcCCCCEEEEEEcccCCC-------------c--------C-----hHHHHHHHHHHhcCCCC--CccceeeEEE
Q 035768 161 TVFKGTMPDGKTVAVKKLSQATG-------------Q--------G-----DREFAAEMETLGMVKHQ--NLVELLGYCS 212 (388)
Q Consensus 161 ~Vy~~~~~~~~~vavK~~~~~~~-------------~--------~-----~~~~~~E~~~l~~l~H~--niv~l~g~~~ 212 (388)
.||.|..++|..+|||..+.... . . .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998652110 0 0 12356899999999765 455665442
Q ss_pred eCCeeEEEEeccC--CCCHHHHHhcc-------------CCCCC-HHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 213 VDEEKLLVYEYMV--KGSLDDWLRNQ-------------AASLD-WGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 213 ~~~~~~lv~e~~~--~g~L~~~l~~~-------------~~~l~-~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
...+||||++ +..+..+.... ...+. ..| |-|+.+.|||++++ .+.|+|||.+..
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 3479999998 43343322111 00001 112 33555789999988 999999998876
Q ss_pred cc
Q 035768 272 IS 273 (388)
Q Consensus 272 ~~ 273 (388)
..
T Consensus 156 ~~ 157 (188)
T PF01163_consen 156 SS 157 (188)
T ss_dssp TT
T ss_pred cC
Confidence 53
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=3.9e-05 Score=75.80 Aligned_cols=137 Identities=17% Similarity=0.248 Sum_probs=83.2
Q ss_pred CCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcc--------eeeccccccCccCccccCCCCCCcc
Q 035768 238 ASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESH--------VSTVVAGTIGYVPPEYGGTGKATER 303 (388)
Q Consensus 238 ~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~ 303 (388)
.++.+.| |..|.|++|.++..+..||+.|+.+......... ......-...|.|||++.....+.+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~ 189 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA 189 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc
Confidence 4455555 3478899999999999999999987655431110 0011123457999999988888999
Q ss_pred cchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 035768 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVR 383 (388)
Q Consensus 304 ~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~R 383 (388)
+|+||+||++|-+..|..+.-... ............. +.. ....+.....++.+=+.+.+..++.-|
T Consensus 190 sd~fSlG~li~~i~~~gk~i~~a~---~~~~~~~~~~~~~---------~~~-~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 190 SDVFSLGVLIYTIYNGGKSIIAAN---GGLLSYSFSRNLL---------NAG-AFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred ccceeeeeEEEEEecCCcchhhcc---CCcchhhhhhccc---------ccc-cccccccCcHHHHHHHHHHhcCCcccC
Confidence 999999999999996554432111 1111111100000 000 000112223356666777888899999
Q ss_pred CCCC
Q 035768 384 PTML 387 (388)
Q Consensus 384 Pt~~ 387 (388)
|++.
T Consensus 257 p~~~ 260 (700)
T KOG2137|consen 257 PTLD 260 (700)
T ss_pred cchh
Confidence 9764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00033 Score=68.93 Aligned_cols=124 Identities=23% Similarity=0.276 Sum_probs=77.7
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc-------------------------------------ChHHHHHHH
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ-------------------------------------GDREFAAEM 193 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~ 193 (388)
.+.||.-+.|.||+|++++|+.||||+-+..-.. .+-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3679999999999999999999999975422110 001255566
Q ss_pred HHHhc----CCCCCc---cceeeEEEe-CCeeEEEEeccCCCCHHHHH--hccCCCC-C--------H--------Hhhh
Q 035768 194 ETLGM----VKHQNL---VELLGYCSV-DEEKLLVYEYMVKGSLDDWL--RNQAASL-D--------W--------GKRC 246 (388)
Q Consensus 194 ~~l~~----l~H~ni---v~l~g~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~l-~--------~--------~~~~ 246 (388)
+-..+ ++|-+. |.+-.++++ .....|+||||+|..+.|.- ....... + | .-|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffHa 325 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFHA 325 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCccC
Confidence 54333 345551 112223322 35678999999998766542 2211100 0 0 0144
Q ss_pred ccccCCeeec----CCCCEEEcccccceeccC
Q 035768 247 KIVASNILLN----DDFEAKISDFGLARLISD 274 (388)
Q Consensus 247 ~i~~~NiLl~----~~~~~kl~DfG~a~~~~~ 274 (388)
|=-|.||+++ .++.+.+-|||+...+..
T Consensus 326 DPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 326 DPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 5558999998 367899999999887654
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.00045 Score=43.81 Aligned_cols=36 Identities=28% Similarity=0.395 Sum_probs=27.6
Q ss_pred CCCCeeeccCCcCccccCc-ccccCCCCeeEecCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPR-SGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~-~~~~~~l~~~~~s~N~~~ 41 (388)
++|++|+|++|+++ .||. -.-+.+|+.+++++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 58999999999999 6873 233449999999999875
|
... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00066 Score=65.44 Aligned_cols=163 Identities=21% Similarity=0.280 Sum_probs=89.7
Q ss_pred hHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHHhccCCCCCHHhhhccccCCeeecCCCCEEEc
Q 035768 186 DREFAAEMETLGMVKHQNLVELLGYCSVDE-EKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 186 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~NiLl~~~~~~kl~ 264 (388)
...+....+.++.+.|+|....+.+..... ...+|+|++ +-+|.+++......-.-....++.+-|++ +.+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~~~~~~~~~~~-------~~t 97 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLLAHGVLHLNII-------YIT 97 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhcccccceehhh-------hcc
Confidence 345667788899999999999988876533 467899999 78999988654210000001122222222 222
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
| .+.. .| |- ...+|+||||+|.++.|+.-|..-+... ...+....+.....
T Consensus 98 d-----~~~t-------------~~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~~----~~s~~l~~i~k~~~ 148 (725)
T KOG1093|consen 98 D-----HFLT-------------KY--PS-----PIGPKSDVWSLGFIILELYLGISLEAEL----TESEYLEILLKYYT 148 (725)
T ss_pred c-----cccc-------------cC--CC-----CCCcchhhhhHHHHHHHHHHhhHHHHHH----HHHHHHHHHHHhcc
Confidence 2 0000 00 11 1125999999999999999987654211 11122222222211
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.......... -.....+....++++...|.-..|..||...
T Consensus 149 ~d~~~~~~a~--e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 149 DDQELLSTAM--EHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred CchhHHHHHH--HHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 1110000000 0011223445688899999999999999653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0057 Score=52.74 Aligned_cols=114 Identities=17% Similarity=0.266 Sum_probs=78.6
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEcccCC----------------CcChHHHHHHHHHHhcCC------CCCccce
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT----------------GQGDREFAAEMETLGMVK------HQNLVEL 207 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 207 (388)
....||+|+.-.||. +++.....||+..... ....+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999986 6667778899886554 123456777776655555 8899999
Q ss_pred eeEEEeCCeeEEEEeccCC------CCHHHHHhccCCCC----------CHHh-----hhccccCCeeecCC--C--CEE
Q 035768 208 LGYCSVDEEKLLVYEYMVK------GSLDDWLRNQAASL----------DWGK-----RCKIVASNILLNDD--F--EAK 262 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~l----------~~~~-----~~~i~~~NiLl~~~--~--~~k 262 (388)
+|+..++.-.-+|+|.+.+ -+|.+++.+..... .|+. ..++.|.||++... + .+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lv 162 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLV 162 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEE
Confidence 9999999999999998743 35888885432211 1111 13667999999643 2 466
Q ss_pred Ecc
Q 035768 263 ISD 265 (388)
Q Consensus 263 l~D 265 (388)
|+|
T Consensus 163 lID 165 (199)
T PF10707_consen 163 LID 165 (199)
T ss_pred EEe
Confidence 666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00079 Score=46.06 Aligned_cols=36 Identities=36% Similarity=0.609 Sum_probs=22.8
Q ss_pred CCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDL 41 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~ 41 (388)
|+|++|+|++|+|+ .||...+. .+|+.+++++|++.
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~ 38 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLT 38 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSES
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccC
Confidence 56777777777777 55533222 27777777777665
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0033 Score=55.63 Aligned_cols=72 Identities=15% Similarity=0.159 Sum_probs=53.5
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEeccCCCC
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN--LVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 24467788876432 3345788999998886443 4677777777777889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0056 Score=55.55 Aligned_cols=119 Identities=13% Similarity=0.090 Sum_probs=75.1
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCC-----------cChHHHHHHHHHHhcCCCCCc--cceeeEEEe-----
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG-----------QGDREFAAEMETLGMVKHQNL--VELLGYCSV----- 213 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~----- 213 (388)
+.+-.-....|++..+ +|+.+.||....... .....+.+|...+.++..-+| .+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 677899997643221 011247789988888743333 344555543
Q ss_pred CCeeEEEEeccCCC-CHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecC-------CCCEEE
Q 035768 214 DEEKLLVYEYMVKG-SLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLND-------DFEAKI 263 (388)
Q Consensus 214 ~~~~~lv~e~~~~g-~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~-------~~~~kl 263 (388)
....++|+|++++- +|.+++.+.. ..+.-+| |.|+.++|||++. ++.+.+
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999876 8988875311 0111223 3466799999985 578999
Q ss_pred ccccccee
Q 035768 264 SDFGLARL 271 (388)
Q Consensus 264 ~DfG~a~~ 271 (388)
+||+.++.
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0037 Score=55.79 Aligned_cols=119 Identities=20% Similarity=0.203 Sum_probs=79.6
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccC----------C--------Cc----ChHHHHHHHHHHhcCCCC--Cc
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQA----------T--------GQ----GDREFAAEMETLGMVKHQ--NL 204 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----------~--------~~----~~~~~~~E~~~l~~l~H~--ni 204 (388)
.....||-|.=+.||.|..+.|.++|||.=+.. . .. ......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 346789999999999999999999999953210 0 00 112456899999998644 56
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHH----------hccCCCCCH-----HhhhccccCCeeecCCCCEEEcccccc
Q 035768 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWL----------RNQAASLDW-----GKRCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 205 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l----------~~~~~~l~~-----~~~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
.+.+++ +...+||||+++-.|...- ......+.- ..|.|+.+=||+++++|.+.++||--+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccc
Confidence 666553 5668999999876554321 110000001 113455577999999999999999655
Q ss_pred ee
Q 035768 270 RL 271 (388)
Q Consensus 270 ~~ 271 (388)
..
T Consensus 250 v~ 251 (304)
T COG0478 250 VP 251 (304)
T ss_pred cc
Confidence 43
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.00067 Score=35.95 Aligned_cols=17 Identities=47% Similarity=0.841 Sum_probs=15.3
Q ss_pred CCCeeeccCCcCccccCc
Q 035768 6 NLLYLNLADNRLEGEVPR 23 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~ 23 (388)
+|++||||+|+|+ .||.
T Consensus 1 ~L~~Ldls~n~l~-~ip~ 17 (22)
T PF00560_consen 1 NLEYLDLSGNNLT-SIPS 17 (22)
T ss_dssp TESEEEETSSEES-EEGT
T ss_pred CccEEECCCCcCE-eCCh
Confidence 5899999999999 9993
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.01 Score=56.06 Aligned_cols=79 Identities=18% Similarity=0.319 Sum_probs=56.7
Q ss_pred ccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhC-C
Q 035768 247 KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTG-K 320 (388)
Q Consensus 247 ~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg-~ 320 (388)
|+-++|+|+.+++.+.|.|-.--....+ .......+|...|.+||... +-.-+...|-|.+||++++++.| +
T Consensus 142 DVn~~~~lVsd~~~V~LVdsDsfqi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggr 219 (637)
T COG4248 142 DVNQNSFLVSDDSKVVLVDSDSFQINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGR 219 (637)
T ss_pred ccCccceeeecCceEEEEcccceeeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCC
Confidence 5668999999999999987432222111 12222345888999999643 34457789999999999999885 9
Q ss_pred CCCCCCC
Q 035768 321 QPTGPEF 327 (388)
Q Consensus 321 ~P~~~~~ 327 (388)
+||....
T Consensus 220 HPysGI~ 226 (637)
T COG4248 220 HPYSGIP 226 (637)
T ss_pred CCCCccc
Confidence 9986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.016 Score=51.72 Aligned_cols=74 Identities=18% Similarity=0.157 Sum_probs=52.0
Q ss_pred eeccCC-ceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHH
Q 035768 154 IGGGGF-GTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYMVKGSLDD 231 (388)
Q Consensus 154 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~ 231 (388)
|-.|.. ..||+.... +..+.||...... .....+|+++++.+. +--+.+++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344544 789999864 4678888875432 335678998888774 3345577777776667899999999877663
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0089 Score=52.63 Aligned_cols=77 Identities=19% Similarity=0.284 Sum_probs=55.8
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCC--CccceeeEEEe---CCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ--NLVELLGYCSV---DEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lv~e~~~~ 226 (388)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999866 68999987543 3345677888888887533 34566665433 3356899999998
Q ss_pred CCHHH
Q 035768 227 GSLDD 231 (388)
Q Consensus 227 g~L~~ 231 (388)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.0041 Score=30.58 Aligned_cols=17 Identities=53% Similarity=0.917 Sum_probs=10.4
Q ss_pred CCCCeeeccCCcCccccC
Q 035768 5 PNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP 22 (388)
++|+.||||+|+|+ ++|
T Consensus 1 ~~L~~L~l~~n~L~-~lP 17 (17)
T PF13504_consen 1 PNLRTLDLSNNRLT-SLP 17 (17)
T ss_dssp TT-SEEEETSS--S-SE-
T ss_pred CccCEEECCCCCCC-CCc
Confidence 57899999999986 443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.0063 Score=41.53 Aligned_cols=39 Identities=33% Similarity=0.521 Sum_probs=31.1
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKD 40 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~ 40 (388)
+.++++|++|||++|+++.--| ..+. .+|+.+++++|++
T Consensus 21 f~~l~~L~~L~l~~N~l~~i~~-~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 21 FSNLPNLETLDLSNNNLTSIPP-DAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTTGTTESEEEETSSSESEEET-TTTTTSTTESEEEETSSSB
T ss_pred HcCCCCCCEeEccCCccCccCH-HHHcCCCCCCEEeCcCCcC
Confidence 4678999999999999985555 4333 3899999999964
|
... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.00081 Score=72.38 Aligned_cols=134 Identities=14% Similarity=0.023 Sum_probs=95.7
Q ss_pred HHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHHhccCCCCCHH--------h--------------
Q 035768 189 FAAEMETLGMVKHQNLVELLGYCSV--DEEKLLVYEYMVKGSLDDWLRNQAASLDWG--------K-------------- 244 (388)
Q Consensus 189 ~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~--------~-------------- 244 (388)
...|...++...|+++...+.-... +.+.+..++|+..|++++.|-+......+. |
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4455556667789998876654432 345689999999999999875432211110 0
Q ss_pred -------hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHH
Q 035768 245 -------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELV 317 (388)
Q Consensus 245 -------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~ 317 (388)
+..+++-|.+|+.+..+|+.++|+.+...+. ........+++.|+.|+....-.++.++|+|..|+-+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 1234467888999999999999999943332 22223345778899999988888999999999999999998
Q ss_pred hCCCCC
Q 035768 318 TGKQPT 323 (388)
Q Consensus 318 tg~~P~ 323 (388)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.034 Score=48.46 Aligned_cols=125 Identities=15% Similarity=0.160 Sum_probs=74.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHH---------HHHHHHHhcCCC---CCccceeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREF---------AAEMETLGMVKH---QNLVELLGYCS 212 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~~~ 212 (388)
..+|...+++-......|.+-.. +|+.+.+|..+......++.| .+++..+.+++. -..+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35677777777777777777666 568899998865443322222 233443444432 23333333332
Q ss_pred e-----CCeeEEEEeccCCCCHHHHH-------hccCCCCCHHhh-----hccccCCeeecCCCCEEEccccccee
Q 035768 213 V-----DEEKLLVYEYMVKGSLDDWL-------RNQAASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 213 ~-----~~~~~lv~e~~~~g~L~~~l-------~~~~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
. ....+++|||++|-.|.++. ......+.-+|. -|.-|.|+++++++ +++.||+..+.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 2 23456899999998776532 111123334443 36669999998655 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.012 Score=63.62 Aligned_cols=45 Identities=24% Similarity=0.375 Sum_probs=35.1
Q ss_pred CCCCCCCeeeccCCcCccccCcccccC--CCCeeEecCCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQ--NLSIMSLTGNKDLCGKIMG 47 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~--~l~~~~~s~N~~~~~~~~~ 47 (388)
++|++|++|||++|+|+|.+| ..+.. +|+.+++++|++.|.+|..
T Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~l~ls~N~l~~~~p~~ 590 (968)
T PLN00113 544 SEMPVLSQLDLSQNQLSGEIP-KNLGNVESLVQVNISHNHLHGSLPST 590 (968)
T ss_pred hCcccCCEEECCCCcccccCC-hhHhcCcccCEEeccCCcceeeCCCc
Confidence 567788888888888888888 43333 7888899999988888764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.044 Score=49.42 Aligned_cols=71 Identities=13% Similarity=0.127 Sum_probs=45.5
Q ss_pred eeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV-ELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
+..|-.+.+|+... +++.+++|..........-...+|.++++.+....++ ++++.+ . .++||||++|..+
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 45677788998874 5667888876443222112357788888888644343 444432 2 3799999988654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.063 Score=46.55 Aligned_cols=116 Identities=19% Similarity=0.235 Sum_probs=75.6
Q ss_pred eeccCCceEEEEEcCCCCEEEEEEcccCC------CcChHHHHHHHHHHhcCCCCC--ccceeeEEE-e----CCeeEEE
Q 035768 154 IGGGGFGTVFKGTMPDGKTVAVKKLSQAT------GQGDREFAAEMETLGMVKHQN--LVELLGYCS-V----DEEKLLV 220 (388)
Q Consensus 154 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~----~~~~~lv 220 (388)
-|+||.+-|++-.+. |+.+-+|+-.... +.....|.+|...+.++..-+ +.+.. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477899999998774 4478888765211 335568999999999885332 44444 332 1 1245799
Q ss_pred EeccCC-CCHHHHHhccCC-----------------CCCHHhh-----hccccCCeeecCCCC--EEEccccccee
Q 035768 221 YEYMVK-GSLDDWLRNQAA-----------------SLDWGKR-----CKIVASNILLNDDFE--AKISDFGLARL 271 (388)
Q Consensus 221 ~e~~~~-g~L~~~l~~~~~-----------------~l~~~~~-----~~i~~~NiLl~~~~~--~kl~DfG~a~~ 271 (388)
+|-+++ -+|.+++.+... .+.-+|. .+..+.||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 588888754211 1222333 345589999986666 99999976654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.13 Score=47.57 Aligned_cols=76 Identities=12% Similarity=0.070 Sum_probs=56.6
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC---CCccceeeEEEe---CCeeEEEEecc
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKH---QNLVELLGYCSV---DEEKLLVYEYM 224 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lv~e~~ 224 (388)
.+.||.|..+.||+....+++ +.+|..+.. .....|..|.+.|+.+.- -.+.+++++|.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 467999999999999876664 566664321 123578999999988853 357788888754 36689999999
Q ss_pred CCCCH
Q 035768 225 VKGSL 229 (388)
Q Consensus 225 ~~g~L 229 (388)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98766
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.17 Score=44.86 Aligned_cols=132 Identities=22% Similarity=0.229 Sum_probs=75.0
Q ss_pred cHHHHHHhhcCCCcCCe---eeccCCceEEEEEcCCCCEEEEEEcccCCCcC-------------------hHH-----H
Q 035768 137 TYDQIVAGTNKFCEENV---IGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG-------------------DRE-----F 189 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~---lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~-----~ 189 (388)
++..+..-.+...+... |.+|.-+.||+|.-.++..+|||+.+...... .++ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34444444444444444 55677778999998889999999986432111 111 2
Q ss_pred HHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeccCCC-----CHHHHHhcc-------CCCCCH---------Hhhh
Q 035768 190 AAEMETLGMVK--HQNLVELLGYCSVDEEKLLVYEYMVKG-----SLDDWLRNQ-------AASLDW---------GKRC 246 (388)
Q Consensus 190 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~g-----~L~~~l~~~-------~~~l~~---------~~~~ 246 (388)
.+|..-|.++. +-.+.+-+++. ...|||||+... .|.+.-... ...+++ +.|-
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHg 191 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHG 191 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccc
Confidence 35666666663 33444444433 347999998543 122110000 000011 1233
Q ss_pred ccccCCeeecCCCCEEEcccccceecc
Q 035768 247 KIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 247 ~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
|+..=|||+. ++.+.|+|||-|....
T Consensus 192 DLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 192 DLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cchhhheEEE-CCeEEEEECccccccC
Confidence 5556699999 8899999999887654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.14 Score=44.54 Aligned_cols=86 Identities=19% Similarity=0.173 Sum_probs=59.0
Q ss_pred HHHHHHHHHHhcCCC--CCccceeeEEEeCC----eeEEEEeccCCC-CHHHHHhccCC---------------CCCHHh
Q 035768 187 REFAAEMETLGMVKH--QNLVELLGYCSVDE----EKLLVYEYMVKG-SLDDWLRNQAA---------------SLDWGK 244 (388)
Q Consensus 187 ~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~---------------~l~~~~ 244 (388)
....+|...+..+.. -.+.+.+++..... ..++|+|++++- +|.+++.+... .+.-+|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 457788888777743 34556667665532 458999999874 79998875110 112223
Q ss_pred -----hhccccCCeeecCCC---CEEEcccccceec
Q 035768 245 -----RCKIVASNILLNDDF---EAKISDFGLARLI 272 (388)
Q Consensus 245 -----~~~i~~~NiLl~~~~---~~kl~DfG~a~~~ 272 (388)
|.|+.+.|||++.+. .+.++||+-++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 346779999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.099 Score=55.63 Aligned_cols=132 Identities=20% Similarity=0.198 Sum_probs=84.9
Q ss_pred HHHHHHHHhcCCCCCccceeeEEEeCCee----EEEEeccCCCCHHHHHhc---------------cCCCCCHHhhhccc
Q 035768 189 FAAEMETLGMVKHQNLVELLGYCSVDEEK----LLVYEYMVKGSLDDWLRN---------------QAASLDWGKRCKIV 249 (388)
Q Consensus 189 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~~~~i~ 249 (388)
..-|...+.++.|+|++.++.|-...... .+..|++..-++...+.. ...++.+.|...+-
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 34567778899999999999887654332 244577877777766543 22355566654221
Q ss_pred --------cCCeeecCCCCEEEc--ccccceeccCCCcceeeccccccCccCccccCCCCCCc--ccchHhHHHHHHHHH
Q 035768 250 --------ASNILLNDDFEAKIS--DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE--RGDVYSFGVILLELV 317 (388)
Q Consensus 250 --------~~NiLl~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~S~Gv~l~el~ 317 (388)
..+--.+.++...++ ||+.++.+.+...... ..-+..|.+||......+.. ..|+|.+|..+..+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 112233455666666 8888877655332221 22345678888776655544 479999999999999
Q ss_pred hCCCC
Q 035768 318 TGKQP 322 (388)
Q Consensus 318 tg~~P 322 (388)
.|..+
T Consensus 387 ~~~~i 391 (1351)
T KOG1035|consen 387 QGEDI 391 (1351)
T ss_pred hcCcc
Confidence 88765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.044 Score=46.95 Aligned_cols=77 Identities=27% Similarity=0.419 Sum_probs=55.9
Q ss_pred HHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeccCCCCHH-------HHHhcc-------------------CCCCCHH
Q 035768 191 AEMETLGMVKH-QNLVELLGYCSVDEEKLLVYEYMVKGSLD-------DWLRNQ-------------------AASLDWG 243 (388)
Q Consensus 191 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~g~L~-------~~l~~~-------------------~~~l~~~ 243 (388)
.|.-+++.+.+ +++.+++|+|- .++|.||.+.+++. ++.... .....+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57788888876 69999999994 37799999876543 332110 1123344
Q ss_pred hhhccccCCeeecCCCCEEEccccccee
Q 035768 244 KRCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 244 ~~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+-+|+.++|+-+++++++|+.|......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 5568889999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.044 Score=30.09 Aligned_cols=18 Identities=50% Similarity=0.872 Sum_probs=15.9
Q ss_pred CCCCCeeeccCCcCccccC
Q 035768 4 LPNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP 22 (388)
|++|++|+|++|+++ .||
T Consensus 1 L~~L~~L~L~~N~l~-~lp 18 (26)
T smart00369 1 LPNLRELDLSNNQLS-SLP 18 (26)
T ss_pred CCCCCEEECCCCcCC-cCC
Confidence 678999999999998 667
|
|
| >smart00370 LRR Leucine-rich repeats, outliers | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.044 Score=30.09 Aligned_cols=18 Identities=50% Similarity=0.872 Sum_probs=15.9
Q ss_pred CCCCCeeeccCCcCccccC
Q 035768 4 LPNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP 22 (388)
|++|++|+|++|+++ .||
T Consensus 1 L~~L~~L~L~~N~l~-~lp 18 (26)
T smart00370 1 LPNLRELDLSNNQLS-SLP 18 (26)
T ss_pred CCCCCEEECCCCcCC-cCC
Confidence 678999999999998 667
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.021 Score=44.99 Aligned_cols=44 Identities=20% Similarity=0.385 Sum_probs=33.6
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHh
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLG 197 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~ 197 (388)
.+.||.|+.|.||+|++++|+.||||..+..- .+.+...+.+|+
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i---~~~i~~Dl~~l~ 59 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGI---EEQIEADLRILR 59 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHH---HHHHHHHHHHHH
Confidence 36799999999999999999999999986532 334555555554
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.16 Score=46.83 Aligned_cols=75 Identities=11% Similarity=0.080 Sum_probs=49.0
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC--ccceeeE------EEeCCeeEEEEe
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN--LVELLGY------CSVDEEKLLVYE 222 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 222 (388)
.+.|..|....+|+....+ ..+++|.... ........|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567788888999987644 4688888754 22345667887777774332 3444331 123456689999
Q ss_pred ccCCCCH
Q 035768 223 YMVKGSL 229 (388)
Q Consensus 223 ~~~~g~L 229 (388)
|++|..+
T Consensus 95 ~i~G~~~ 101 (296)
T cd05153 95 FLAGEHL 101 (296)
T ss_pred eCCCCCC
Confidence 9988664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.18 Score=53.50 Aligned_cols=78 Identities=17% Similarity=0.267 Sum_probs=57.3
Q ss_pred CCeeeccCCceEEEEEcCCC---CEEEEEEcccCC-CcChHHHHHHHHHHhcCC-CCCc--cceeeEEEeC---CeeEEE
Q 035768 151 ENVIGGGGFGTVFKGTMPDG---KTVAVKKLSQAT-GQGDREFAAEMETLGMVK-HQNL--VELLGYCSVD---EEKLLV 220 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv 220 (388)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |+++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45689999999999886553 367777764322 123456889999999995 6765 7888888664 467899
Q ss_pred EeccCCCC
Q 035768 221 YEYMVKGS 228 (388)
Q Consensus 221 ~e~~~~g~ 228 (388)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.03 Score=30.11 Aligned_cols=19 Identities=37% Similarity=0.525 Sum_probs=13.4
Q ss_pred CCCCCeeeccCCcCccccC
Q 035768 4 LPNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP 22 (388)
+++|++|||++|++++.-+
T Consensus 1 ~~~L~~L~l~~n~i~~~g~ 19 (24)
T PF13516_consen 1 NPNLETLDLSNNQITDEGA 19 (24)
T ss_dssp -TT-SEEE-TSSBEHHHHH
T ss_pred CCCCCEEEccCCcCCHHHH
Confidence 5789999999999987643
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=93.27 E-value=0.056 Score=34.11 Aligned_cols=21 Identities=38% Similarity=0.725 Sum_probs=18.3
Q ss_pred CCCCCCCCeeeccCCcCccccC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP 22 (388)
|++|++|++|||++|+++ .||
T Consensus 20 l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 20 LSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp GTTCTTSSEEEETSSCCS-BEG
T ss_pred HhCCCCCCEEEecCCCCC-CCc
Confidence 578999999999999998 554
|
... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.025 Score=54.73 Aligned_cols=70 Identities=23% Similarity=0.384 Sum_probs=56.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSV 213 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 213 (388)
-.++|+....+|.|+||+|+.+... ++..+|||+|..... .......+|+..+.++.|+++++++..+..
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence 3467888999999999999999865 455899999865433 334567889999999999999998877754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.73 E-value=0.31 Score=43.25 Aligned_cols=73 Identities=19% Similarity=0.203 Sum_probs=44.3
Q ss_pred CeeeccCCc-eEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCC---CccceeeEEEeC---CeeEEEEecc
Q 035768 152 NVIGGGGFG-TVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ---NLVELLGYCSVD---EEKLLVYEYM 224 (388)
Q Consensus 152 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lv~e~~ 224 (388)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456767666 48875 234667765432 2345788999999877532 233444433322 2358899999
Q ss_pred CCCCHH
Q 035768 225 VKGSLD 230 (388)
Q Consensus 225 ~~g~L~ 230 (388)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 887653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.55 E-value=0.66 Score=44.62 Aligned_cols=75 Identities=23% Similarity=0.242 Sum_probs=53.5
Q ss_pred CeeeccCCceEEEEEcCCC-CEEEEEEcccC----C---CcChHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEE
Q 035768 152 NVIGGGGFGTVFKGTMPDG-KTVAVKKLSQA----T---GQGDREFAAEMETLGMVK---HQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv 220 (388)
+.||.|.+..||++...+| +.|.||.-... . ....+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 48999984311 0 123456777888887762 3456677666 34567899
Q ss_pred EeccCCCC
Q 035768 221 YEYMVKGS 228 (388)
Q Consensus 221 ~e~~~~g~ 228 (388)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.12 Score=40.37 Aligned_cols=32 Identities=22% Similarity=0.454 Sum_probs=17.1
Q ss_pred ceeeehHHHHHHHHHHHHHHHHHHHHhhccCC
Q 035768 57 KLALVGIVVGSVLVIAIIVSVLWWWIQRSNRQ 88 (388)
Q Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~~~~~~r~~~~ 88 (388)
.-++++|++|+++.+++++++++|+++|++++
T Consensus 63 ~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 63 EPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp -TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred ccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 34566777777666655555555555544443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.93 E-value=1.2 Score=41.38 Aligned_cols=75 Identities=7% Similarity=0.025 Sum_probs=43.7
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC--ccceee------EEEeCCeeEEEEe
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN--LVELLG------YCSVDEEKLLVYE 222 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lv~e 222 (388)
.+.|+.|....+|+....+| .+++|+.... .......|..++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34577788889999886555 6888887521 2233334555554442111 223332 1223566789999
Q ss_pred ccCCCCH
Q 035768 223 YMVKGSL 229 (388)
Q Consensus 223 ~~~~g~L 229 (388)
|++|..+
T Consensus 103 ~l~G~~~ 109 (319)
T PRK05231 103 FLEGKWP 109 (319)
T ss_pred ecCCCCC
Confidence 9988643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.58 E-value=1.3 Score=41.02 Aligned_cols=75 Identities=9% Similarity=0.021 Sum_probs=45.3
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC--ccceeeE------EEeCCeeEEEEe
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN--LVELLGY------CSVDEEKLLVYE 222 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 222 (388)
.+.++.|....+|+....++ .+++|...... .......|.+++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999876444 57788765422 2334556666666663222 3343331 122456789999
Q ss_pred ccCCCC
Q 035768 223 YMVKGS 228 (388)
Q Consensus 223 ~~~~g~ 228 (388)
|++|..
T Consensus 104 ~i~G~~ 109 (307)
T TIGR00938 104 FLQGLS 109 (307)
T ss_pred eCCCCC
Confidence 998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >smart00364 LRR_BAC Leucine-rich repeats, bacterial type | Back alignment and domain information |
|---|
Probab=89.55 E-value=0.19 Score=27.54 Aligned_cols=17 Identities=41% Similarity=0.772 Sum_probs=14.5
Q ss_pred CCCCeeeccCCcCccccC
Q 035768 5 PNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP 22 (388)
++|+.|++|+|+|+ ++|
T Consensus 2 ~~L~~L~vs~N~Lt-~LP 18 (26)
T smart00364 2 PSLKELNVSNNQLT-SLP 18 (26)
T ss_pred cccceeecCCCccc-cCc
Confidence 57899999999998 666
|
|
| >smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type | Back alignment and domain information |
|---|
Probab=89.06 E-value=0.29 Score=27.43 Aligned_cols=14 Identities=43% Similarity=0.733 Sum_probs=12.0
Q ss_pred CCCCeeeccCCcCc
Q 035768 5 PNLLYLNLADNRLE 18 (388)
Q Consensus 5 ~~L~~L~ls~N~l~ 18 (388)
++|++|||++|.|.
T Consensus 2 ~~L~~LdL~~N~i~ 15 (28)
T smart00368 2 PSLRELDLSNNKLG 15 (28)
T ss_pred CccCEEECCCCCCC
Confidence 57899999999885
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=88.26 E-value=0.16 Score=49.87 Aligned_cols=44 Identities=30% Similarity=0.625 Sum_probs=37.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccC-CCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQ-NLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~-~l~~~~~s~N~~~~~~~~ 46 (388)
+++|..|++||||.|+|+ ..| ..+|. -|+.+-+++|++.+....
T Consensus 117 i~~L~~lt~l~ls~NqlS-~lp-~~lC~lpLkvli~sNNkl~~lp~~ 161 (722)
T KOG0532|consen 117 ICNLEALTFLDLSSNQLS-HLP-DGLCDLPLKVLIVSNNKLTSLPEE 161 (722)
T ss_pred hhhhhHHHHhhhccchhh-cCC-hhhhcCcceeEEEecCccccCCcc
Confidence 467889999999999999 566 57887 899999999999876544
|
|
| >smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily | Back alignment and domain information |
|---|
Probab=88.19 E-value=0.39 Score=26.44 Aligned_cols=15 Identities=40% Similarity=0.647 Sum_probs=13.0
Q ss_pred CCCCCeeeccCCcCc
Q 035768 4 LPNLLYLNLADNRLE 18 (388)
Q Consensus 4 l~~L~~L~ls~N~l~ 18 (388)
|++|+.|+|++|+++
T Consensus 1 L~~L~~L~L~~NkI~ 15 (26)
T smart00365 1 LTNLEELDLSQNKIK 15 (26)
T ss_pred CCccCEEECCCCccc
Confidence 578999999999885
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=87.97 E-value=0.41 Score=40.37 Aligned_cols=37 Identities=22% Similarity=0.280 Sum_probs=9.6
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
|.+|+.||||+|.++ .|+.-....+|..|++++|...
T Consensus 41 l~~L~~L~Ls~N~I~-~l~~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 41 LDKLEVLDLSNNQIT-KLEGLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp -TT--EEE-TTS--S---TT----TT--EEE--SS---
T ss_pred hcCCCEEECCCCCCc-cccCccChhhhhhcccCCCCCC
Confidence 455566666666655 2321111235556666666543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=87.40 E-value=2.1 Score=39.25 Aligned_cols=73 Identities=22% Similarity=0.412 Sum_probs=48.7
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCCC
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK---HQNLVELLGYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~g 227 (388)
.+.++-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999988 5778899998752 23457888998888773 445778888888888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=86.94 E-value=0.18 Score=40.71 Aligned_cols=18 Identities=33% Similarity=0.335 Sum_probs=10.4
Q ss_pred ceeeehHHHHHHHHHHHH
Q 035768 57 KLALVGIVVGSVLVIAII 74 (388)
Q Consensus 57 ~~~~i~~~~~~~~~~~~~ 74 (388)
+.++||++||+.+.++++
T Consensus 48 knIVIGvVVGVGg~ill~ 65 (154)
T PF04478_consen 48 KNIVIGVVVGVGGPILLG 65 (154)
T ss_pred ccEEEEEEecccHHHHHH
Confidence 456777777654444433
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=86.76 E-value=0.23 Score=37.23 Aligned_cols=28 Identities=39% Similarity=0.789 Sum_probs=14.7
Q ss_pred ceeeehHHHHHHHHHHHHHHHH-HHHHhh
Q 035768 57 KLALVGIVVGSVLVIAIIVSVL-WWWIQR 84 (388)
Q Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~-~~~~~r 84 (388)
.-+++++++++++++.+++.++ ||+++|
T Consensus 65 ~gaiagi~vg~~~~v~~lv~~l~w~f~~r 93 (96)
T PTZ00382 65 TGAIAGISVAVVAVVGGLVGFLCWWFVCR 93 (96)
T ss_pred cccEEEEEeehhhHHHHHHHHHhheeEEe
Confidence 3456676676665554444444 444333
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 388 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-117
Identities = 101/284 (35%), Positives = 163/284 (57%), Gaps = 29/284 (10%)
Query: 132 SLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG-DREFA 190
L++ + ++ ++ F +N++G GGFG V+KG + DG VAVK+L + QG + +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 191 AEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAAS---LDWGKRCK 247
E+E + M H+NL+ L G+C E+LLVY YM GS+ LR + S LDW KR +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 248 IV------------------------ASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283
I A+NILL+++FEA + DFGLA+L+ ++HV+T V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP-EFEDKDGENLVDWVLHM 342
GTIG++ PEY TGK++E+ DV+ +GV+LLEL+TG++ + D L+DWV +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+K ++ + ++D + + +++Q+A C + P RP M
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-111
Identities = 91/309 (29%), Positives = 153/309 (49%), Gaps = 33/309 (10%)
Query: 103 SDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTV 162
S ++ + S + + + + TN F + +IG G FG V
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRV-------PLVDLEEATNNFDHKFLIGHGVFGKV 55
Query: 163 FKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222
+KG + DG VA+K+ + + QG EF E+ETL +H +LV L+G+C E +L+Y+
Sbjct: 56 YKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 223 YMVKGSLDDWL---RNQAASLDWGKRCKIV---------------------ASNILLNDD 258
YM G+L L S+ W +R +I + NILL+++
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 259 FEAKISDFGLARLISDC-ESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELV 317
F KI+DFG+++ ++ ++H+STVV GT+GY+ PEY G+ TE+ DVYSFGV+L E++
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 318 TGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCIS 377
+ + NL +W + N Q ++++DP + + ++ K A C++
Sbjct: 236 CARSAIVQSLPREM-VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 378 NDPTVRPTM 386
RP+M
Sbjct: 295 LSSEDRPSM 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-106
Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 41/296 (13%)
Query: 126 LAMFEPSLQKLTYDQIVAGTNKFCEE------NVIGGGGFGTVFKGTMPDGKTVAVKKLS 179
L + + ++ ++ TN F E N +G GGFG V+KG + + TVAVKKL+
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63
Query: 180 ----QATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL-- 233
T + ++F E++ + +H+NLVELLG+ S ++ LVY YM GSL D L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 234 RNQAASLDWGKRCKIV---------------------ASNILLNDDFEAKISDFGLARLI 272
+ L W RCKI ++NILL++ F AKISDFGLAR
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 273 -SDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
++ +++ + GT Y+ PE G+ T + D+YSFGV+LLE++TG ++
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE---HRE 239
Query: 332 GENLVDWVLHMMKNEQA-DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ L+D + E+ ++ +D +N ++ M +A+ C+ RP +
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDI 294
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-67
Identities = 62/299 (20%), Positives = 109/299 (36%), Gaps = 52/299 (17%)
Query: 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMET 195
L + + + V G FG V+K + + VAVK Q + E+ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 196 LGMVKHQNLVELLGYC----SVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV-- 249
L +KH+N+++ +G SVD + L+ + KGSL D+L+ + W + C I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 250 -----------------------------ASNILLNDDFEAKISDFGLARLISDCESHV- 279
+ N+LL ++ A I+DFGLA +S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 280 STVVAGTIGYVPPEY-----GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
+ GT Y+ PE A R D+Y+ G++L EL + ++
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE-YMLP 248
Query: 335 LVDWV-----LHMMKNEQADEVLDPAVLNA-NSKPTMLKMLQIATGCISNDPTVRPTML 387
+ + L M+ + P + + M + + C +D R +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-49
Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 68/279 (24%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD-------REFAAEMETLGMVKHQ 202
E IG GGFG V KG + D VA+K L +G+ +EF E+ + + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VA--------- 250
N+V+L G +V E++ G L L ++A + W + ++ +A
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 251 -----------SNILL-----NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
NI L N AK++DFGL++ H + + G ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPET 197
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352
TE+ D YSF +IL ++TG+ P F++ + +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGP----FDE-------------YSYGKIKFIN 240
Query: 353 DPAVLNANSKPTM-----LKMLQIATGCISNDPTVRPTM 386
+ +PT+ ++ + C S DP RP
Sbjct: 241 --MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-49
Identities = 64/314 (20%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEME- 194
+ + +IG G +G V+KG++ D + VAVK S + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNI 58
Query: 195 -TLGMVKHQNLVELLGYC-----SVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI 248
+ +++H N+ + E LLV EY GSL +L + DW C++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 249 VAS------------------------------NILLNDDFEAKISDFGLARLISDC--- 275
S N+L+ +D ISDFGL+ ++
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 276 ----ESHVSTVVAGTIGYVPPEY-------GGTGKATERGDVYSFGVILLELVTGKQPTG 324
E + + GTI Y+ PE A ++ D+Y+ G+I E+
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 325 PE---------FEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA--NSKPTMLKMLQIAT 373
P F+ + G M+ + E P A + + + +
Sbjct: 237 PGESVPEYQMAFQTEVGN---HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 374 GCISNDPTVRPTML 387
C D R T
Sbjct: 294 DCWDQDAEARLTAQ 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-48
Identities = 73/268 (27%), Positives = 110/268 (41%), Gaps = 55/268 (20%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELL 208
+ IG G FGTV + G VAVK L + EF E+ + ++H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAA--SLDWGKRCKI---VA------------- 250
G + +V EY+ +GSL L A LD +R + VA
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 251 -------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATER 303
N+L++ + K+ DFGL+RL + S AGT ++ PE + E+
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363
DVYSFGVIL EL T +QP + + + Q AV +
Sbjct: 220 SDVYSFGVILWELATLQQP----WGN-------------LNPAQVVA----AVGFKCKRL 258
Query: 364 TM-----LKMLQIATGCISNDPTVRPTM 386
+ ++ I GC +N+P RP+
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 60/272 (22%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQNLVELL 208
IG G FGTV+KG VAVK L+ + F E+ L +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 209 GYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR----------------CKIV-- 249
GY + +L +V ++ SL L + K I+
Sbjct: 87 GYST--APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 250 ---ASNILLNDDFEAKISDFGLARLISDCE-SHVSTVVAGTIGYVPPE---YGGTGKATE 302
++NI L++D KI DFGLA S SH ++G+I ++ PE + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
+ DVY+FG++L EL+TG+ P + + + N +++ V +
Sbjct: 205 QSDVYAFGIVLYELMTGQLP----YSN-------------INNRDQ--IIE-MVGRGSLS 244
Query: 363 PTMLK--------MLQIATGCISNDPTVRPTM 386
P + K M ++ C+ RP+
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSF 276
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-45
Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 54/285 (18%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEME--TLGMVKHQNLVELL 208
+G G +G V++G+ G+ VAVK S + ++ + E E M++H+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 209 GYCSVDEEK----LLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVAS------------- 251
L+ Y GSL D+L+ +LD +IV S
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 252 ----------------NILLNDDFEAKISDFGLARLISDCESHV---STVVAGTIGYVPP 292
NIL+ + + I+D GLA + S + + + GT Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 293 E------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK---DGENLVDWVLHMM 343
E + +R D+++FG++L E+ G + K D M
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 344 KNEQADEVLDPAVLNA-NSKPTMLKMLQIATGCISNDPTVRPTML 387
+ + P + N S PT+ + ++ C +P+ R T L
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-44
Identities = 75/340 (22%), Positives = 119/340 (35%), Gaps = 74/340 (21%)
Query: 97 SKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLT-YDQIVAGTNKFCEENVIG 155
S+ D +S S S S L P L + T QI IG
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGL------------PLLVQRTIAKQIQMV-------KQIG 46
Query: 156 GGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEME--TLGMVKHQNLVELLGYCSV 213
G +G V+ G G+ VAVK + + E E +++H+N++ +
Sbjct: 47 KGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 214 DEEK----LLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVAS------------------ 251
L+ +Y GSL D+L++ +LD K+ S
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 252 -----------NILLNDDFEAKISDFGLARLISDCESHV---STVVAGTIGYVPPE---- 293
NIL+ + I+D GLA + V GT Y+PPE
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 294 --YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK---DGENLVDWVLHMMKNEQA 348
++ D+YSFG+IL E+ G E + D M+
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC 280
Query: 349 DEVLDPAV-LNANSKPTMLKMLQIATGCISNDPTVRPTML 387
+ L P+ +S + +M ++ T C +++P R T L
Sbjct: 281 IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 55/272 (20%), Positives = 99/272 (36%), Gaps = 52/272 (19%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
V+G G FG K T G+ + +K+L + + R F E++ + ++H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR----------------CKIV---- 249
D+ + EY+ G+L +++ + W +R I+
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESH-------------VSTVVAGTIGYVPPEYG 295
+ N L+ ++ ++DFGLARL+ D ++ V G ++ PE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPT-GPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
E+ DV+SFG++L E++ D V L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSF-- 252
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
I C DP RP+
Sbjct: 253 --------------FPITVRCCDLDPEKRPSF 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 63/277 (22%), Positives = 94/277 (33%), Gaps = 68/277 (24%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKL----SQATGQGDREFAAEMETLGMVKHQNLVE 206
E +IG GGFG V++ G VAVK + Q E + M+KH N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV----------------- 249
L G C + LV E+ G L+ L + +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 250 -------ASNILLNDDFE--------AKISDFGLARLISDCESHVSTVVAGTIGYVPPEY 294
+SNIL+ E KI+DFGLAR AG ++ PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEV 185
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
++ DV+S+GV+L EL+TG+ P F +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAVAY---- 224
Query: 355 AVLNANSKPTM-----LKMLQIATGCISNDPTVRPTM 386
V + ++ C + DP RP+
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF 261
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 66/273 (24%), Positives = 102/273 (37%), Gaps = 61/273 (22%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+ E V+G G FG V K K VA+K++ + F E+ L V H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIV 64
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ--AASLDWGKRCKI---VA---------- 250
+L G C LV EY GSL + L +
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 251 -----------SNILLNDDFE-AKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG 298
N+LL KI DFG A I T G+ ++ PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGS 178
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358
+E+ DV+S+G+IL E++T ++P F++ G ++
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKP----FDEIGGP----------------AFRIMWAVH 218
Query: 359 ANSKPTMLK-----MLQIATGCISNDPTVRPTM 386
++P ++K + + T C S DP+ RP+M
Sbjct: 219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSM 251
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 54/272 (19%), Positives = 93/272 (34%), Gaps = 64/272 (23%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELL 208
+ G ++KG G + VK L + + R+F E L + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 209 GYCSVDEEKLL--VYEYMVKGSLDDWLRNQAA-SLDWGKRCKI---VA------------ 250
G C + +M GSL + L +D + K +A
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 251 --------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGK 299
++++++D A+IS + S S +V PE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
D++SF V+L ELVT + P F D + N + V
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGM----KVALE 226
Query: 360 NSKPTM-----LKMLQIATGCISNDPTVRPTM 386
+PT+ + ++ C++ DP RP
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKF 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-42
Identities = 49/272 (18%), Positives = 92/272 (33%), Gaps = 55/272 (20%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQNLVELL 208
+IG G FG V+ G VA++ + D + F E+ +H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VA--------------- 250
G C ++ +L +R+ LD K +I +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 251 ---SNILLNDDFEAKISDFGLARLISDCE----SHVSTVVAGTIGYVPPE---------Y 294
N+ D+ + I+DFGL + + + G + ++ PE
Sbjct: 156 LKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
++ DV++ G I EL + P F+ + E ++ + MK + +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWP----FKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ I C + + RPT
Sbjct: 271 E------------ISDILLFCWAFEQEERPTF 290
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-42
Identities = 61/285 (21%), Positives = 103/285 (36%), Gaps = 54/285 (18%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEME--TLGMVKHQNLVELL 208
+ IG G FG V++G G+ VAVK S + +R + E E M++H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 209 GYCSVDEEK----LLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVAS------------- 251
+ D LV +Y GSL D+L ++ K+ S
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 252 ----------------NILLNDDFEAKISDFGLARLISDCESHV---STVVAGTIGYVPP 292
NIL+ + I+D GLA + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 293 E------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK---DGENLVDWVLHMM 343
E ++ +R D+Y+ G++ E+ G + + D + M
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 344 KNEQADEVLDPAVLNA-NSKPTMLKMLQIATGCISNDPTVRPTML 387
+ ++ L P + N S + M +I C + R T L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 56/201 (27%), Positives = 81/201 (40%), Gaps = 33/201 (16%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKT-VAVKKL-SQATGQGDREFAAEMETLGMVKHQNLVELL 208
IG G FG VF G + T VAVK +F E L H N+V L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS-------------- 251
G C+ + +V E + G +LR + A L ++ A+
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 252 ----NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGKATE 302
N L+ + KISDFG++R +D S G + VP PE G+ +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAAS----GGLRQVPVKWTAPEALNYGRYSS 294
Query: 303 RGDVYSFGVILLELVT-GKQP 322
DV+SFG++L E + G P
Sbjct: 295 ESDVWSFGILLWETFSLGASP 315
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 75/270 (27%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 87 RQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTN 146
R S + S + +K+ S+ + I+L+ P L + ++ ++
Sbjct: 29 RGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS 88
Query: 147 KFCE-ENVIGGGGFGTVFKGTMPDGK----TVAVKKLSQATGQGDR-EFAAEMETLGMVK 200
VIG G FG V+ GT+ D AVK L++ T G+ +F E +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 201 HQNLVELLGYCSVDEEKLL-VYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS----- 251
H N++ LLG C E L V YM G L +++RN+ + VA
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 252 -------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PE 293
N +L++ F K++DFGLAR + D E +V T +P E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKTGAKLPVKWMALE 266
Query: 294 YGGTGKATERGDVYSFGVILLELVT-GKQP 322
T K T + DV+SFGV+L EL+T G P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 38/205 (18%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGK----TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
V+G G FGTV+KG +P+G+ VA+K+L +AT E E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS---------- 251
LLG C L+ + M G L D++R ++ +A
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTG 298
N+L+ KI+DFGLA+L+ E G VP E
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALESILHR 194
Query: 299 KATERGDVYSFGVILLELVT-GKQP 322
T + DV+S+GV + EL+T G +P
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 62/237 (26%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 151 ENVIGGGGFGTVFKGT---MPDGKT--VAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+G G FG+V + D VAVKKL +T + R+F E+E L ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 206 ELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS--------- 251
+ G C + L+ EY+ GSL D+L+ +D K + +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 252 ---------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGT 297
NIL+ ++ KI DFGL +++ + + G P PE
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY---YKVKEPGESPIFWYAPESLTE 222
Query: 298 GKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
K + DV+SFGV+L EL T ++ P E M E+L
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLIELLK 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 40/237 (16%)
Query: 151 ENVIGGGGFGTVFKGT---MPDGKT--VAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+ +G G FG+V + D VAVK+L + R+F E++ L + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 206 ELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS--------- 251
+ G + LV EY+ G L D+L+ A LD + +
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 252 ---------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGT 297
NIL+ + KI+DFGLA+L+ + + V G P PE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIFWYAPESLSD 204
Query: 298 GKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
+ + DV+SFGV+L EL T + P E ++ + + E+L+
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR---MMGCERDVPALSRLLELLE 258
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 69/274 (25%), Positives = 107/274 (39%), Gaps = 49/274 (17%)
Query: 151 ENVIGGGGFGTVFKGT---MPDGKT--VAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+G G FG+V + D VAVKKL +T + R+F E+E L ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 206 ELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS--------- 251
+ G C + L+ EY+ GSL D+L+ +D K + +
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 252 ---------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGT 297
NIL+ ++ KI DFGL +++ + G P PE
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF---FKVKEPGESPIFWYAPESLTE 191
Query: 298 GKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD--- 353
K + DV+SFGV+L EL T ++ P E M E+L
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLIELLKNNG 249
Query: 354 --PAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
P + M+ M + C +N+ RP+
Sbjct: 250 RLPRPDGCPDEIYMI-MTE----CWNNNVNQRPS 278
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 35/205 (17%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK----TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLV 205
VIG G FG V+ GT+ D AVK L++ T G+ +F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 206 ELLGYCSVDEEKLL-VYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS---------- 251
LLG C E L V YM G L +++RN+ + VA
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTG 298
N +L++ F K++DFGLAR + D E + +V T +P E T
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQTQ 207
Query: 299 KATERGDVYSFGVILLELVT-GKQP 322
K T + DV+SFGV+L EL+T G P
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 29/197 (14%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
+G G FG V G VA+K + + + D EF E + + + H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS---------------- 251
C+ ++ EYM G L ++LR + ++ V
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 252 --NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGKATERGDV 306
N L+ND K+SDFGL+R + D E T G+ + + PPE K + + D+
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 307 YSFGVILLELVT-GKQP 322
++FGV++ E+ + GK P
Sbjct: 205 WAFGVLMWEIYSLGKMP 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGKT--VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLV 205
E +IG G G V G +P + VA+K L + R +F +E +G H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS----------- 251
L G + ++V EYM GSLD +LR + + V +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 252 -------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKATE 302
N+L++ + K+SDFGL+R++ D T G I + PE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 303 RGDVYSFGVILLELVT-GKQP 322
DV+SFGV++ E++ G++P
Sbjct: 234 ASDVWSFGVVMWEVLAYGERP 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 25/196 (12%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKT-VAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
++ +GGG +G V++G VAVK L + T + + EF E + +KH NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 283
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAAS-------LDWGK----------RCKIV--- 249
C+ + ++ E+M G+L D+LR L + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
A N L+ ++ K++DFGL+RL++ I + PE K + + DV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 308 SFGVILLELVT-GKQP 322
+FGV+L E+ T G P
Sbjct: 404 AFGVLLWEIATYGMSP 419
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 31/204 (15%)
Query: 150 EENVIGGGGFGTVFKGTMPDGK----TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+ VIG G FG V+ G D A+K LS+ T F E + + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 205 VELLGYCSVDEE-KLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS--------- 251
+ L+G E ++ YM G L ++R+ + VA
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 252 ---------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGK 299
N +L++ F K++DFGLAR I D E + + + E T +
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 300 ATERGDVYSFGVILLELVT-GKQP 322
T + DV+SFGV+L EL+T G P
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 61/277 (22%), Positives = 96/277 (34%), Gaps = 55/277 (19%)
Query: 151 ENVIGGGGFGTVFKGTMP-----DGKTVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+G G FG V G+ VAVK L +G + E+E L + H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 205 VELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS-------- 251
V+ G C+ D L+ E++ GSL ++L ++ ++ K +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 252 ----------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGG 296
N+L+ + + KI DFGL + I E+ P PE
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 297 TGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD-- 353
K DV+SFGV L EL+T + P M + L
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ---MTVTRLVNTLKEG 259
Query: 354 ---PAVLNANSKPTM--LKMLQIATGCISNDPTVRPT 385
P P ++ Q+ C P+ R +
Sbjct: 260 KRLP-------CPPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGK---TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+ VIG G FG V+KG GK VA+K L + R +F E +G H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR---CKIVAS---------- 251
+ L G S + +++ EYM G+LD +LR + + + +A+
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKAT 301
NIL+N + K+SDFGL+R++ D T G I + PE K T
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 302 ERGDVYSFGVILLELVT-GKQP 322
DV+SFG+++ E++T G++P
Sbjct: 229 SASDVWSFGIVMWEVMTYGERP 250
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 29/197 (14%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G FG V G + VA+K + + + +F E E + + H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR---CKIVAS---------------- 251
C LV E+M G L D+LR Q C V
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 252 --NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGKATERGDV 306
N L+ ++ K+SDFG+ R + D + T GT + + PE + + + DV
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 307 YSFGVILLELVT-GKQP 322
+SFGV++ E+ + GK P
Sbjct: 189 WSFGVLMWEVFSEGKIP 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 29/201 (14%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGKT--VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLV 205
+ V+G G FG V G +P K VA+K L + R +F E +G H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS----------- 251
L G + + ++V EYM GSLD +LR A + + +AS
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 252 -------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKATE 302
NIL+N + K+SDFGL R++ D T G I + PE K T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 303 RGDVYSFGVILLELVT-GKQP 322
DV+S+G++L E+++ G++P
Sbjct: 230 ASDVWSYGIVLWEVMSYGERP 250
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 29/197 (14%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
+G G FG V G VAVK + + + D EF E +T+ + H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR---CKIVAS---------------- 251
CS + +V EY+ G L ++LR+ L+ + C V
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 252 --NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGKATERGDV 306
N L++ D K+SDFG+ R + D + GT + + PE K + + DV
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 307 YSFGVILLELVT-GKQP 322
++FG+++ E+ + GK P
Sbjct: 189 WAFGILMWEVFSLGKMP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGK----TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
V+G G FGTV KG +P+G+ V +K + +G+ M +G + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL------DWG------------KRC 246
V LLG C LV +Y+ GSL D +R +L +WG
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 247 ---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTG 298
+ A N+LL + +++DFG+A L+ + + + P E G
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----SEAKTPIKWMALESIHFG 192
Query: 299 KATERGDVYSFGVILLELVT-GKQP 322
K T + DV+S+GV + EL+T G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 36/211 (17%)
Query: 151 ENVIGGGGFGTVFKGT---MPDGK--TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+G G FG V DG VAVK L G R + E++ L + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 205 VELLGYCSVDEEK--LLVYEYMVKGSLDDWLRNQAAS----LDWG------------KRC 246
++ G C LV EY+ GSL D+L + L + +
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 247 ---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTG 298
+ A N+LL++D KI DFGLA+ + + + G P PE
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAPECLKEY 212
Query: 299 KATERGDVYSFGVILLELVT-GKQPTGPEFE 328
K DV+SFGV L EL+T P +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 52/220 (23%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDREFAAEMETLGMVKHQNL 204
+ +G G FG VF + VAVK L T ++F E E L ++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---------------- 248
V+ G C + ++V+EYM G L+ +LR +
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 249 --VAS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288
+AS N L+ + KI DFG++R + + + G
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 289 YVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P PE K T DV+SFGVIL E+ T GKQP
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 64/195 (32%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
E +G G FG V+ GT VA+K L T + F E + + ++H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 330
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLR-NQAASLDWGKRCKI---VAS--------------- 251
S +E +V EYM KGSL D+L+ L + + +AS
Sbjct: 331 VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 252 ---NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
NIL+ ++ K++DFGLARLI D E I + PE G+ T + DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 309 FGVILLELVT-GKQP 322
FG++L EL T G+ P
Sbjct: 450 FGILLTELTTKGRVP 464
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 64/195 (32%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
E +G G FG V+ GT VA+K L T + F E + + ++H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 247
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLR-NQAASLDWGKRCKI---VAS--------------- 251
S +E +V EYM KGSL D+L+ L + + +AS
Sbjct: 248 VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 252 ---NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
NIL+ ++ K++DFGLARLI D E I + PE G+ T + DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 309 FGVILLELVT-GKQP 322
FG++L EL T G+ P
Sbjct: 367 FGILLTELTTKGRVP 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 29/202 (14%)
Query: 149 CEENVIGGGGFGTVFKGT--MPDGKT-VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+ +G G FG+V +G M + VA+K L Q T + D E E + + + + +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS---------- 251
V L+G C E +LV E G L +L + + ++ V+
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKAT 301
N+LL + AKISDFGL++ + +S+ + AG + + PE K +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 302 ERGDVYSFGVILLELVT-GKQP 322
R DV+S+GV + E ++ G++P
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 38/205 (18%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGK----TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
V+G G FGTV+KG +P+G+ VA+K+L +AT E E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS---------- 251
LLG C L+ + M G L D++R ++ +A
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTG 298
N+L+ KI+DFGLA+L+ E G VP E
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALESILHR 194
Query: 299 KATERGDVYSFGVILLELVT-GKQP 322
T + DV+S+GV + EL+T G +P
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/274 (21%), Positives = 101/274 (36%), Gaps = 42/274 (15%)
Query: 81 WIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQ 140
I+ + N+ ++ + + S + E + +
Sbjct: 329 IIRPQKEGERALPSIPKLANN----EKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRD 384
Query: 141 IVAGTNKFCEENVIGGGGFGTVFKGT--MPDGKT--VAVKKLSQATGQGDR-EFAAEMET 195
+ IG G FG V +G P+ VA+K T R +F E T
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT 444
Query: 196 LGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWG------------ 243
+ H ++V+L+G + + ++ E G L +L+ + SLD
Sbjct: 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 244 ------KRC---KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP--- 291
KR I A N+L++ + K+ DFGL+R + D ST + G +P
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKASKGKLPIKW 558
Query: 292 --PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
PE + T DV+ FGV + E++ G +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 61/219 (27%), Positives = 88/219 (40%), Gaps = 51/219 (23%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDREFAAEMETLGMVKHQNL 204
+ +G G FG VF + VAVK L +A+ ++F E E L M++HQ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---------------- 248
V G C+ L+V+EYM G L+ +LR+ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 249 -VAS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289
VA+ N L+ KI DFG++R I + G
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRTM 221
Query: 290 VP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P PE K T DV+SFGV+L E+ T GKQP
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 29/202 (14%)
Query: 149 CEENVIGGGGFGTVFKGT--MPDGKT-VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+ +G G FG+V +G M + VA+K L Q T + D E E + + + + +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS---------- 251
V L+G C E +LV E G L +L + + ++ V+
Sbjct: 399 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 252 --------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGT--IGYVPPEYGGTGKAT 301
N+LL + AKISDFGL++ + +S+ + AG + + PE K +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 302 ERGDVYSFGVILLELVT-GKQP 322
R DV+S+GV + E ++ G++P
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 53/221 (23%), Positives = 83/221 (37%), Gaps = 53/221 (23%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQ-ATGQGDREFAAEMETLGMVKHQN 203
+G FG V+KG + VA+K L A G EF E ++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI--------------- 248
+V LLG + D+ +++ Y G L ++L ++ D G
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 249 ---VAS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287
+A+ N+L+ D KISD GL R + +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YYKLLGN 189
Query: 288 GYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P PE GK + D++S+GV+L E+ + G QP
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 37/199 (18%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G FG V G G VAVK + + F AE + ++H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 211 CSVDEEKL-LVYEYMVKGSLDDWLRNQAAS-------LDWGK----------RCKIV--- 249
++ L +V EYM KGSL D+LR++ S L + V
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGKATERG 304
A N+L+++D AK+SDFGL + S+ + + PE K + +
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 305 DVYSFGVILLELVT-GKQP 322
DV+SFG++L E+ + G+ P
Sbjct: 368 DVWSFGILLWEIYSFGRVP 386
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 38/204 (18%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGKT--VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLV 205
IG G FG V +G P+ VA+K T R +F E T+ H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS----------- 251
+L+G + + ++ E G L +L+ + SLD +++
Sbjct: 80 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 138
Query: 252 -------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGK 299
N+L++ + K+ DFGL+R + D ST + G +P PE +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKASKGKLPIKWMAPESINFRR 193
Query: 300 ATERGDVYSFGVILLELVT-GKQP 322
T DV+ FGV + E++ G +P
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKP 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 41/204 (20%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKT-VAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
++ +GGG +G V++G VAVK L + T + + EF E + +KH NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRN----------------QAASLDWG------KRC- 246
C+ + ++ E+M G+L D+LR Q +S K
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS---AMEYLEKKNFI 133
Query: 247 --KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGK 299
+ A N L+ ++ K++DFGL+RL++ T A P PE K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 300 ATERGDVYSFGVILLELVT-GKQP 322
+ + DV++FGV+L E+ T G P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 65/195 (33%), Positives = 88/195 (45%), Gaps = 25/195 (12%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
+G G FG V+ G VAVK L Q + D F AE + ++HQ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLR-NQAASLDWGK----------------RCKIV---- 249
+ E ++ EYM GSL D+L+ L K +
Sbjct: 77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
A+NIL++D KI+DFGLARLI D E I + PE G T + DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 309 FGVILLELVT-GKQP 322
FG++L E+VT G+ P
Sbjct: 196 FGILLTEIVTHGRIP 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 59/206 (28%), Positives = 79/206 (38%), Gaps = 38/206 (18%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGKT--VAVKKL---SQATGQGDREFAAEMETLGMVKHQN 203
+G G FG V +G P GKT VAVK L + + +F E+ + + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS--------- 251
L+ L G +V E GSL D LR G + VA
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 252 ---------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGT 297
N+LL KI DFGL R + + H V VP PE T
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---YVMQEHRKVPFAWCAPESLKT 198
Query: 298 GKATERGDVYSFGVILLELVT-GKQP 322
+ D + FGV L E+ T G++P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 48/204 (23%), Positives = 82/204 (40%), Gaps = 38/204 (18%)
Query: 151 ENVIGGGGFGTVFKGT--MPDGKT--VAVKKLSQATGQGDR-EFAAEMETLGMVKHQNLV 205
++G G FG V++G G+ VAVK + ++ +F +E + + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS----------- 251
+L+G +E ++ E G L +L SL +
Sbjct: 77 KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 252 -------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGK 299
NIL+ K+ DFGL+R I D + ++ +P PE +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDED-----YYKASVTRLPIKWMSPESINFRR 190
Query: 300 ATERGDVYSFGVILLELVT-GKQP 322
T DV+ F V + E+++ GKQP
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
E +G G FG V+ T VAVK + + + F AE + ++H LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 251
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAAS-------LDWGK----------RCKIV---- 249
+ E ++ E+M KGSL D+L++ S +D+ + +
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
A+NIL++ KI+DFGLAR+I D E I + PE G T + DV+S
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370
Query: 309 FGVILLELVT-GKQP 322
FG++L+E+VT G+ P
Sbjct: 371 FGILLMEIVTYGRIP 385
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 47/214 (21%)
Query: 152 NVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQNL 204
+G G FG V++G VA+K +++A +R EF E + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC------------------ 246
V LLG S + L++ E M +G L +LR+ ++
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 247 -------KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP--- 291
K V A N ++ +DF KI DFG+ R I + + + G G +P
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRW 206
Query: 292 --PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
PE G T DV+SFGV+L E+ T +QP
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 60/219 (27%), Positives = 87/219 (39%), Gaps = 54/219 (24%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK---TVAVKKL-SQATGQGDREFAAEMETLGMV-KHQNLV 205
++VIG G FG V K + A+K++ A+ R+FA E+E L + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI----------------- 248
LLG C L EY G+L D+LR
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 249 -VAS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGY 289
VA NIL+ +++ AKI+DFGL+R V T+G
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 202
Query: 290 VP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P E T DV+S+GV+L E+V+ G P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 43/202 (21%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G FG V G G VAVK + + F AE + ++H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 211 CSVDEEKL-LVYEYMVKGSLDDWLRN----------------QAASLDWG------KRC- 246
++ L +V EYM KGSL D+LR+
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE---AMEYLEGNNFV 139
Query: 247 --KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT---IGYVPPEYGGTGKAT 301
+ A N+L+++D AK+SDFGL + S + + + PE K +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKFS 192
Query: 302 ERGDVYSFGVILLELVT-GKQP 322
+ DV+SFG++L E+ + G+ P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 47/215 (21%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK----TVAVK--KLSQATGQGDREFAAEMETLGMVKHQNL 204
++G G FG+V +G + VAVK KL ++ + EF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 205 VELLGYCSVDE-----EKLLVYEYMVKGSLDDWLR-----NQAASLDWGKRCKI---VAS 251
+ LLG C + +++ +M G L +L + K +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 252 ------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-- 291
N +L DD ++DFGL++ I + + G I +P
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 292 ---PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
E T + DV++FGV + E+ T G P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 44/211 (20%)
Query: 151 ENVIGGGGFGTVFKGT--------MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ 202
+G G F +FKG V +K L +A F + + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI---VAS-------- 251
+LV G C +E +LV E++ GSLD +L+ ++ + ++ +A+
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 252 ----------NILLNDDFE--------AKISDFGLARLISDCESHVSTVVAGTIGYVPPE 293
NILL + + K+SD G++ + + I +VPPE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWVPPE 187
Query: 294 YGGTGKA-TERGDVYSFGVILLELVT-GKQP 322
K D +SFG L E+ + G +P
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 150 EENVIGGGGFGTVFKGTMPDGK---TVAVKKLSQATGQGDR--EFAAEMETLGMVKHQNL 204
E+ +G G FGTV KG K TVAVK L E AE + + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRN-----QAASLDWGKRCKIVAS-------- 251
V ++G C E +LV E G L+ +L+ ++ V+
Sbjct: 81 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEES 136
Query: 252 ----------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGG 296
N+LL AKISDFGL++ + E++ A T G P PE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECIN 193
Query: 297 TGKATERGDVYSFGVILLELVT-GKQP 322
K + + DV+SFGV++ E + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 64/229 (27%), Positives = 94/229 (41%), Gaps = 61/229 (26%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQN 203
+G G FG V K T K TVAVK L + + + +E L V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN---------------QAASLDWGKRCKI 248
+++L G CS D LL+ EY GSL +LR ++SLD +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 249 -----------VAS------------------NILLNDDFEAKISDFGLARLISDCESHV 279
++ NIL+ + + KISDFGL+R + + +S+
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 280 STVVAGTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
V + G +P E T + DV+SFGV+L E+VT G P
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 46/216 (21%), Positives = 79/216 (36%), Gaps = 48/216 (22%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK----TVAVKKL-SQATGQGDRE-FAAEMETLGMVKHQNL 204
++G G FG+V + + VAVK L + D E F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 205 VELLGYCSVDEEK------LLVYEYMVKGSLDDWLR-----NQAASLDWGKRCKI---VA 250
+L+G K +++ +M G L +L +L + +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 251 S------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP- 291
N +L +D ++DFGL+R I + + G +P
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPV 203
Query: 292 ----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
E T DV++FGV + E++T G+ P
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 59/224 (26%), Positives = 84/224 (37%), Gaps = 56/224 (25%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDR-EFAAEMETLGMV-KHQ 202
+G G FG V + T TVAVK L + +R +E++ L + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC---------------- 246
N+V LLG C++ L++ EY G L ++LR + S K
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 247 -----------------KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
+ A NILL KI DFGLAR I + ++ V
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----VV 203
Query: 285 GTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P PE T DV+S+G+ L EL + G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 53/215 (24%), Positives = 76/215 (35%), Gaps = 47/215 (21%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDR-EFAAEMETLGMVKHQN 203
+G G FG V++G + VAVK L + + D +F E + HQN
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR---------CKIVAS--- 251
+V +G + ++ E M G L +LR + +A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 252 ---------------NILLN---DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-- 291
N LL AKI DFG+AR I G +P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPVK 210
Query: 292 ---PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
PE G T + D +SFGV+L E+ + G P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 56/224 (25%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK--------TVAVKKLSQATGQGDR-EFAAEMETLGMV-K 200
+G G FG V TVAVK L + D + +EME + M+ K
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC-------------- 246
H+N++ LLG C+ D ++ EY KG+L ++LR +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 247 -----------------KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
K + A N+L+ ++ KI+DFGLAR I++ + +
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 215
Query: 285 GTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
T G +P PE T + DV+SFGV++ E+ T G P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 60/224 (26%), Positives = 88/224 (39%), Gaps = 56/224 (25%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK--------TVAVKKLSQATGQGDR-EFAAEMETLGMV-K 200
+G G FG V VAVK L + D + +EME + M+ K
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC-------------- 246
H+N++ LLG C+ D ++ EY KG+L ++L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 247 -----------------KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
K + A N+L+ +D KI+DFGLAR I +
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYKK 249
Query: 285 GTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
T G +P PE T + DV+SFGV+L E+ T G P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 52/220 (23%)
Query: 151 ENVIGGGGFGTVFKGTMPD------GKTVAVKKL-SQATGQGDREFAAEMETLGMV-KHQ 202
+G G FG V + T VAVK L S A +E++ + + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI-------------- 248
N+V LLG C+ L++ EY G L ++LR ++ L+ I
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 249 --VAS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288
VA N+LL + AKI DFGLAR I + ++ +
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNA 226
Query: 289 YVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P PE T + DV+S+G++L E+ + G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 56/224 (25%)
Query: 151 ENVIGGGGFGTVFKGT--------MPDGKTVAVKKL-SQATGQGDREFAAEMETLGMV-K 200
+G G FG V + TVAVK L AT + + +EME + M+ K
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRN-------QAASLDWGKRCKI----- 248
H+N++ LLG C+ D ++ EY KG+L ++LR + ++ ++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 249 ------VAS------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
+A N+L+ ++ KI+DFGLAR I++ + +
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 261
Query: 285 GTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
T G +P PE T + DV+SFGV++ E+ T G P
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 60/293 (20%), Positives = 98/293 (33%), Gaps = 55/293 (18%)
Query: 78 LWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLT 137
+ ++ + D T +S + S S + + P+
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKL---RTSTIMTDYNPNYCFAG 57
Query: 138 YDQIVAGTNKFCEENV-----IGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGD 186
++ + +N+ +G G FG V++G + VAVK L + + D
Sbjct: 58 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 187 R-EFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR 245
+F E + HQN+V +G + ++ E M G L +LR
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 246 ---------CKIVAS------------------NILLN---DDFEAKISDFGLARLISDC 275
+ +A N LL AKI DFG+AR I
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 276 ESHVSTVVAGTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+ G +P PE G T + D +SFGV+L E+ + G P
Sbjct: 238 GYYRK----GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 61/229 (26%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKL-SQATGQGDREFAAEMETLGMVKHQN 203
IG G FG VF+ P VAVK L +A+ +F E + + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKI--------------- 248
+V+LLG C+V + L++EYM G L+++LR+ +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 249 -----------VAS------------------NILLNDDFEAKISDFGLARLISDCESHV 279
VA+ N L+ ++ KI+DFGL+R I + +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 280 STVVAGTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
A +P PE + T DV+++GV+L E+ + G QP
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 55/229 (24%), Positives = 86/229 (37%), Gaps = 61/229 (26%)
Query: 151 ENVIGGGGFGTVFKGTMPDGK------TVAVKKLSQATGQGDR-EFAAEMETLGMV-KHQ 202
V+G G FG V T VAVK L + +R +E++ + + H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRC---------------- 246
N+V LLG C++ L++EY G L ++LR++ +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 247 ----------------------KIV-----ASNILLNDDFEAKISDFGLARLISDCESHV 279
V A N+L+ KI DFGLAR I ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 280 STVVAGTIGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
V +P PE G T + DV+S+G++L E+ + G P
Sbjct: 229 ---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 61/222 (27%), Positives = 86/222 (38%), Gaps = 55/222 (24%)
Query: 152 NVIGGGGFGTVFKGT------MPDGKTVAVKKL-SQATGQGDREFAAEMETLGMV-KHQN 203
+G G FG V + +TVAVK L AT R +E++ L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 204 LVELLGYCSVDEEKLLV-YEYMVKGSLDDWLRNQAASLDWGKRC---------------- 246
+V LLG C+ L+V E+ G+L +LR++ K
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 247 ---------------KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286
K + A NILL++ KI DFGLAR I + V
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKG 208
Query: 287 IGYVP-----PEYGGTGKATERGDVYSFGVILLELVT-GKQP 322
+P PE T + DV+SFGV+L E+ + G P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 55/305 (18%)
Query: 119 MEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVK-- 176
M H + + + + L + + + IG GG VF+ + A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 177 KLSQATGQGDREFAAEMETLGMVKHQNL--VELLGYCSVDEEKLLVYEYMVKGSLDDWLR 234
L +A Q + E+ L ++ + + L Y D+ +V E L+ WL+
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119
Query: 235 NQAA-SLDWGKR--------------CKIV-----ASNILLNDDFEAKISDFGLARLISD 274
+ + K IV +N L+ D K+ DFG+A +
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 275 CE-SHVSTVVAGTIGYVPPE-----------YGGTGKATERGDVYSFGVILLELVTGKQP 322
S V GT+ Y+PPE K + + DV+S G IL + GK P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 323 TGPEFEDKDGENLVDWVLHMMKNEQADEVLD-PAVLNANSKPTMLKMLQIATGCISNDPT 381
F+ + + + + ++ P + + + + L+ DP
Sbjct: 239 ----FQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR-------DPK 282
Query: 382 VRPTM 386
R ++
Sbjct: 283 QRISI 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 63/340 (18%), Positives = 117/340 (34%), Gaps = 74/340 (21%)
Query: 84 RSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVA 143
R + + + +++ S D++SS+ E +S+ ++
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYS------------- 59
Query: 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVK--KLSQATGQGDREFAAEMETLGMVKH 201
IG GG VF+ + A+K L +A Q + E+ L ++
Sbjct: 60 ------ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 202 QNL--VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA-SLDWGKR------------- 245
+ + L Y D+ +V E L+ WL+ + + K
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 246 -CKIV-----ASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPE----- 293
IV +N L+ D K+ DFG+A + D S V G + Y+PPE
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 294 ------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347
K + + DV+S G IL + GK P F+ + + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQ-----ISKLHAIID 282
Query: 348 ADEVLD-PAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ ++ P + + + + L+ DP R ++
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKR-------DPKQRISI 315
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 56/272 (20%), Positives = 97/272 (35%), Gaps = 55/272 (20%)
Query: 152 NVIGGGGFGTVFKGTMPDGKTVAVK--KLSQATGQGDREFAAEMETLGMVKHQNL--VEL 207
IG GG VF+ + A+K L +A Q + E+ L ++ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA-SLDWGKR--------------CKIV--- 249
Y D+ +V E L+ WL+ + + K IV
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCE-SHVSTVVAGTIGYVPPE-----------YG 295
+N L+ D K+ DFG+A + S V GT+ Y+PPE
Sbjct: 134 LKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD-P 354
K + + DV+S G IL + GK P F+ + + + + ++ P
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQ-----ISKLHAIIDPNHEIEFP 243
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + + + L+ DP R ++
Sbjct: 244 DIPEKDLQDVLKCCLKR-------DPKQRISI 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 68/291 (23%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
+ F E V+G G FG V K D + A+KK+ + +E+ L + HQ
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 204 LVELLG----------YCSVDEEKLLVY---EYMVKGSLDDWLRNQAASLDWGKRCKIV- 249
+V + ++K ++ EY G+L D + ++ + + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 250 --------------------ASNILLNDDFEAKISDFGLARLISDCESHV---------- 279
NI +++ KI DFGLA+ + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 280 ----STVVAGTIGYVPPE-YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
++ + GT YV E GTG E+ D+YS G+I E++ P +
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY------PFSTGME--- 233
Query: 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
++++K ++ + P + N K+++ I +DP RP
Sbjct: 234 ----RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPG 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 40/200 (20%), Positives = 68/200 (34%), Gaps = 41/200 (20%)
Query: 153 VIGGGGFGTVFKG--TMPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLG 209
I GG G ++ +G+ V +K L + + AE + L V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 210 YCSVDEEKL-----LVYEYMVKG-SLDDWLRNQAASLDWGKRCKIVA------------- 250
+ + +V EY V G SL + L + +
Sbjct: 147 FVEHTDRHGDPVGYIVMEY-VGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIG 202
Query: 251 --------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
NI+L ++ + K+ D G I+ + GT G+ PE T
Sbjct: 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIV-RTGPTV 255
Query: 303 RGDVYSFGVILLELVTGKQP 322
D+Y+ G L L
Sbjct: 256 ATDIYTVGRTLAALTLDLPT 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 154 IGGGGFGTVFKGTMPD---GKTVAVKKLSQATGQGDREFAA----EMETLGMVKHQNLVE 206
+GGGG TV+ D VA+K + + E E+ + HQN+V
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 207 LLGYCSVDEEKLLVYEYMVKG-SLDDWLRNQAASLDWGKRCKIVA--------------- 250
++ D+ LV EY ++G +L +++ + L
Sbjct: 76 MIDVDEEDDCYYLVMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 251 ------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
NIL++ + KI DFG+A+ +S+ + V GT+ Y PE E
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 305 DVYSFGVILLELVTGKQP 322
D+YS G++L E++ G+ P
Sbjct: 194 DIYSIGIVLYEMLVGEPP 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 58/266 (21%), Positives = 102/266 (38%), Gaps = 45/266 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT-GQGDREFA-AEMETLGMVKHQ 202
K+ IG G FG DG+ +K+++ + +RE + E+ L +KH
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 203 NLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAAS-------LDWGK---------- 244
N+V+ + L +V +Y G L + Q LDW
Sbjct: 84 NIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 245 RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
KI+ + NI L D ++ DFG+AR+++ + GT Y+ PE
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKP 201
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
+ D+++ G +L EL T K FE +NLV + + V +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLV----LKIISGSFPPV--SLHYSY 251
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPT 385
+ + + ++ + +P RP+
Sbjct: 252 DLRSLVSQLFKR-------NPRDRPS 270
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 38/202 (18%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
V+G G +G V+ G + + +A+K++ + + + E+ +KH+N+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 212 SVDEEKLLVY-EYMVKGSLDDWLRNQAASLDWGK------------------RCKIV--- 249
+ + ++ E + GSL LR++ L + +IV
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 250 --ASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTGKA 300
N+L+N KISDFG ++ ++ T GT+ Y+ PE G A
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGKAA 206
Query: 301 TERGDVYSFGVILLELVTGKQP 322
D++S G ++E+ TGK P
Sbjct: 207 ----DIWSLGCTIIEMATGKPP 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 34/201 (16%)
Query: 151 ENVIGGGGFGTVFKGTMPD---GKTVAVKKLSQATGQGDREFAA----EMETLGMVKHQN 203
++G GG G V++ D + VA+K +S+ D F E T G ++ +
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEPH 95
Query: 204 LVELLGYCSVDEEKLLVYEYMVKG-SLDDWLRNQAASLDWGKRCKIVA------------ 250
+V + + +D + + + G L LR Q L + IV
Sbjct: 96 VVPIHDFGEIDGQLYVDMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAA 153
Query: 251 ---------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKAT 301
NIL++ D A + DFG+A +D + GT+ Y+ PE AT
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 302 ERGDVYSFGVILLELVTGKQP 322
R D+Y+ +L E +TG P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 57/294 (19%), Positives = 108/294 (36%), Gaps = 58/294 (19%)
Query: 131 PSLQKLTYDQ----IVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGD 186
PSL++ D+ ++ G FC ++V+G G GT+ M D + VAVK++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE----C 60
Query: 187 REFAA-EMETLGMV-KHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWG 243
FA E++ L +H N++ D + + E +L +++ + +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYFCTEK-DRQFQYIAIEL-CAATLQEYVEQKDFAHLGL 118
Query: 244 KRCKIV---------------------ASNILLNDDFE-----AKISDFGLARLISDCES 277
+ ++ NIL++ A ISDFGL + ++
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 278 HVSTV--VAGTIGYVPPEY---GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDG 332
S V GT G++ PE T D++S G + +++ P F
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P-FGKSLQ 235
Query: 333 ENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
++ D + + ++ + KM+ + DP RP+
Sbjct: 236 RQA----NILLGACSLDCLHPEKHEDVIARELIEKMIAM-------DPQKRPSA 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 58/263 (22%), Positives = 97/263 (36%), Gaps = 49/263 (18%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK--KLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
IG G F TV+KG VA + + T + F E E L ++H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 210 YCSV---DEEKLLVY-EYMVKGSLDDWLR-----NQAASLDW------------GKRCKI 248
++ +++ E M G+L +L+ W + I
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 249 V-----ASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
+ NI + KI D GLA L S V+ GT ++ PE K E
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVI-GTPEFMAPEMY-EEKYDE 208
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
DVY+FG+ +LE+ T + P + +N + + PA + +
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVK------PASFDKVAI 256
Query: 363 PTMLKMLQIATGCISNDPTVRPT 385
P + ++++ CI + R +
Sbjct: 257 PEVKEIIEG---CIRQNKDERYS 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 66/323 (20%), Positives = 103/323 (31%), Gaps = 60/323 (18%)
Query: 91 PEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCE 150
N + R S ++ ++PS + + Q F
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ------SFQR 61
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT-GQGDREFA-AEMETL-GMVKHQNLVE 206
+ +G G +G VFK DG+ AVK+ G DR AE+ + + +H V
Sbjct: 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--------------- 250
L + L L E SL ASL + +
Sbjct: 122 LEQ-AWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 251 ------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY--GGTGKATE 302
+NI L K+ DFGL + G Y+ PE G G A
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQE-GDPRYMAPELLQGSYGTAA- 236
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
DV+S G+ +LE+ + P GE ++ A L++ +
Sbjct: 237 --DVFSLGLTILEVACNMEL--P----HGGEG-----WQQLRQGYLPPEF-TAGLSSELR 282
Query: 363 PTMLKMLQIATGCISNDPTVRPT 385
++ ML+ DP +R T
Sbjct: 283 SVLVMMLEP-------DPKLRAT 298
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 55/269 (20%), Positives = 99/269 (36%), Gaps = 45/269 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKK--LSQATGQGDREFA-AEMETLGMVKH 201
F E IG G F V++ + DG VA+KK + R E++ L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 202 QNLVELLGYCSVDEEKLLVY-EYMVKGSLDDWLRNQAAS---------LDWGK------- 244
N+++ +++ +L + E G L +++ +
Sbjct: 92 PNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 245 ---RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGG 296
+++ +N+ + K+ D GL R S + ++V GT Y+ PE
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 209
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356
+ D++S G +L E+ + P F D NL + + D
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSP----FYG-DKMNLYSLCKKIEQC-------DYPP 257
Query: 357 LNANSKPTMLKMLQIATGCISNDPTVRPT 385
L ++ L+ Q+ CI+ DP RP
Sbjct: 258 LPSDHYSEELR--QLVNMCINPDPEKRPD 284
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 51/204 (25%), Positives = 81/204 (39%), Gaps = 40/204 (19%)
Query: 154 IGGGGFGTVFKGTMPD---GKTVAVKKLSQATGQGDREFAA----EMETLGMVKHQNLVE 206
+G GG V D + VAVK L D F E + + H +V
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 207 LLGYCSVDEEKL----LVYEYMVKG-SLDDWLRNQAASLDWGKRCKIVA----------- 250
+ + +V EY V G +L D + + + + +++A
Sbjct: 77 VYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ 134
Query: 251 ----------SNILLNDDFEAKISDFGLARLISDCESHV--STVVAGTIGYVPPEYGGTG 298
+NI+++ K+ DFG+AR I+D + V + V GT Y+ PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 299 KATERGDVYSFGVILLELVTGKQP 322
R DVYS G +L E++TG+ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 57/222 (25%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNL 204
F E +IG GGFG VFK DGKT +K++ + + E++ L + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 205 VELLGY-------------CSVDEEKLLVY---EYMVKGSLDDWLRNQAAS-------LD 241
V G S + ++ E+ KG+L+ W+ + L+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 242 WGK----------RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286
+ K++ SNI L D + KI DFGL + + + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GT 184
Query: 287 IGYVPPE------YGGTGKATERGDVYSFGVILLELVTGKQP 322
+ Y+ PE YG + D+Y+ G+IL EL+
Sbjct: 185 LRYMSPEQISSQDYG------KEVDLYALGLILAELLHVCDT 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-22
Identities = 53/292 (18%), Positives = 94/292 (32%), Gaps = 65/292 (22%)
Query: 140 QIVAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGM 198
++ + +G GGF V + DG A+K++ Q E E + +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 199 VKHQNLVELLGYCSVDEEK----LLVYEYMVKGSLDDWLRNQAAS---------LDWG-- 243
H N++ L+ YC + L+ + +G+L + + L
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 244 -----KRC---KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA------ 284
+ +NILL D+ + + D G +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 285 --GTIGYVPPE----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338
TI Y PE ER DV+S G +L ++ G+ P ++
Sbjct: 203 QRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP----YDMVF------- 250
Query: 339 VLHMMKNEQADEVLDPAVLNANSKPTMLK----MLQIATGCISNDPTVRPTM 386
Q + + AV N S P + + Q+ ++ DP RP +
Sbjct: 251 --------QKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-22
Identities = 56/294 (19%), Positives = 93/294 (31%), Gaps = 79/294 (26%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQN 203
F +G GGFG VF+ D A+K++ + RE E++ L ++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 204 LVELLGY---------CSVDEEKLLVY---EYMVKGSLDDWLRNQ--------AASLDWG 243
+V K+ +Y + K +L DW+ + + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 244 K----------RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA---- 284
++ SNI D K+ DFGL + E + +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 285 -------GTIGYVPPE------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
GT Y+ PE Y + D++S G+IL EL+ P F
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYS------HKVDIFSLGLILFELLY---P----FS--- 228
Query: 332 GENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
+ L ++N + P + + +S P RP
Sbjct: 229 TQMERVRTLTDVRNLKF-----PPLFTQKYP----CEYVMVQDMLSPSPMERPE 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 28/293 (9%), Positives = 61/293 (20%), Gaps = 75/293 (25%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK---KLSQATGQGDREFAAEMETLGMVKHQNLVELL 208
+ G VF + + A+K ++ + + ++ E
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 209 GYCSV--------------------------DEEKLLVYEYMV-----KGSLDDWLRNQA 237
+ LL+ S D++
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 238 ASLDWGKRCKIVA---------------------SNILLNDDFEAKISDFGLARLISDCE 276
+ A N+ + D + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-- 246
Query: 277 SHVSTVVAGTIGYVPPEY--GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
+ + Y P E+ T T + + G+ + + P F
Sbjct: 247 --RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGI 300
Query: 335 LVDWVLHMMKNEQADEVLDPAVLN--ANSKPTMLKMLQIATGCISNDPTVRPT 385
W ++ D + + K + + L D R
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF-------DRRRRLL 346
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 56/281 (19%), Positives = 96/281 (34%), Gaps = 66/281 (23%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT-GQGDREFA-AEMETLGMVKHQ 202
+ IG G +G K DGK + K+L + + +++ +E+ L +KH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 203 NLVELLGYCSVDEEKLLVY---EYMVKGSLDDWLRNQAAS---------LDW-------- 242
N+V +D +Y EY G L + L
Sbjct: 66 NIVRYYD-RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 243 -------GKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290
++ +N+ L+ K+ DFGLAR+++ S T V GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 291 PPE------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
PE Y E+ D++S G +L EL P F + L ++
Sbjct: 184 SPEQMNRMSYN------EKSDIWSLGCLLYELCALMPP----FTAFSQKELA----GKIR 229
Query: 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
+ + P + + +ML + RP+
Sbjct: 230 EGKFRRI--PYRYSDELNEIITRMLNL-------KDYHRPS 261
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 47/239 (19%), Positives = 83/239 (34%), Gaps = 45/239 (18%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGY 210
++G G VF+G G A+K + + + E E L + H+N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 211 CSVDEEKL--LVYEYMVKGSLDDWLRNQ------------------AASLDWGKRCKIV- 249
+ L+ E+ GSL L ++ + IV
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 250 ----ASNILLNDDFEA----KISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKA 300
NI+ + K++DFG AR + D + ++ GT Y+ P+ Y
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTEEYLHPDMYERAVLR 193
Query: 301 TERG-------DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352
+ D++S GV TG P F +G V++ + + +
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITGKPSGAI 248
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 47/239 (19%), Positives = 83/239 (34%), Gaps = 45/239 (18%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGY 210
++G G VF+G G A+K + + + E E L + H+N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 211 CSVDEEKL--LVYEYMVKGSLDDWLRNQ------------------AASLDWGKRCKIV- 249
+ L+ E+ GSL L ++ + IV
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 250 ----ASNILLNDDFEA----KISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKA 300
NI+ + K++DFG AR + D + ++ GT Y+ P+ Y
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTEEYLHPDMYERAVLR 193
Query: 301 TERG-------DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352
+ D++S GV TG P F +G V++ + + +
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITGKPSGAI 248
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 62/264 (23%), Positives = 101/264 (38%), Gaps = 57/264 (21%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDRE-FAAEMETLGMVKHQNLVELLG 209
+G GGF F+ + + A K + S RE + E+ + HQ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV---- 249
+ D + + +V E + SL + + + + R +++
Sbjct: 109 FFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTGKATE 302
N+ LN+D E KI DFGLA + + GT Y+ PE + +
Sbjct: 168 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS--FEV-- 222
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
DV+S G I+ L+ GK P FE + + +E P +N +
Sbjct: 223 --DVWSIGCIMYTLLVGKPP----FETSC-------LKETYLRIKKNEYSIPKHINPVAA 269
Query: 363 PTMLKMLQIATGCISNDPTVRPTM 386
+ KMLQ DPT RPT+
Sbjct: 270 SLIQKMLQT-------DPTARPTI 286
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-21
Identities = 62/264 (23%), Positives = 101/264 (38%), Gaps = 57/264 (21%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDRE-FAAEMETLGMVKHQNLVELLG 209
+G GGF F+ + + A K + S RE + E+ + HQ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV---- 249
+ D + + +V E + SL + + + + R +++
Sbjct: 83 FFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTGKATE 302
N+ LN+D E KI DFGLA + + GT Y+ PE + +
Sbjct: 142 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS--FEV-- 196
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
DV+S G I+ L+ GK P FE + + +E P +N +
Sbjct: 197 --DVWSIGCIMYTLLVGKPP----FETSC-------LKETYLRIKKNEYSIPKHINPVAA 243
Query: 363 PTMLKMLQIATGCISNDPTVRPTM 386
+ KMLQ DPT RPT+
Sbjct: 244 SLIQKMLQT-------DPTARPTI 260
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 7e-21
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 56/281 (19%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELL-- 208
+G GGFG V + G+ VA+K+ Q +RE + E++ + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 209 ----GYCSVDEEKLLVYEYMVKGSLDDWLR-----------------NQAAS-LDWGKRC 246
+ ++ LL EY G L +L + +S L +
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 247 KIV-----ASNILLNDDFEA---KISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG 298
+I+ NI+L + KI D G A+ + + V GT+ Y+ PE
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV-GTLQYLAPELLEQK 198
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEF---------EDKDGENLVDWVLHMMKNEQAD 349
K T D +SFG + E +TG +P P + +K E++V + + +
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSS 258
Query: 350 EVLDPAVLN----ANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ P L+ + + ML R T
Sbjct: 259 VLPTPNHLSGILAGKLERWLQCMLMW-------HQRQRGTD 292
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 52/293 (17%), Positives = 95/293 (32%), Gaps = 69/293 (23%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLS-QATGQGDREFAAEMETLGMVKHQNL 204
N E ++G G GTV G+ VAVK++ E E+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNV 71
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWL-RNQAASLDWGKRCKIVAS------------ 251
+ + D + E +L D + + + + +
Sbjct: 72 IRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 252 --------------NILL-------------NDDFEAKISDFGLARLISDCESHVSTV-- 282
NIL+ ++ ISDFGL + + +S T
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 283 -VAGTIGYVPPE-------YGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGE 333
+GT G+ PE + T D++S G + +++ GK P G ++ +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN- 249
Query: 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+++ + + + + L I + I +DP RPT
Sbjct: 250 --------IIRGIFSLDEMKCLHDRSLIAEA--TDL-I-SQMIDHDPLKRPTA 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 38/352 (10%), Positives = 79/352 (22%), Gaps = 90/352 (25%)
Query: 100 NSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAG-TNKFCEENVIGGGG 158
N I N ++ S+ SA +S + Q + + V+G
Sbjct: 34 NRIPQANVRTTSEYMQSAADSLVS---TSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 159 FGTVFKGTMP-DGKTVAVKKLSQATGQGD------REFAAEMETLGMVKHQ--------- 202
+ T G++ V +E + L +K+Q
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 203 ----NLVELLGYCSVDEEK-----------LLVYEYM------VKGSLDDWLRNQAASLD 241
+LV+ + + +Y M L SL
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK-SLV 209
Query: 242 WGKRCKIVA---------------------SNILLNDDFEAKISDFGLARLISDCESHVS 280
R ++ +I+L+ ++ F
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 281 TVVAGTIGYVPPE-----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
T D ++ G+ + + P D
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGG 325
Query: 336 VDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387
+W+ ++ + + V + + L+ R L
Sbjct: 326 SEWIF------RSCKNIPQPV-----RALLEGFLRY-------PKEDRLLPL 359
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 3e-20
Identities = 58/274 (21%), Positives = 104/274 (37%), Gaps = 60/274 (21%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLS----QATGQGDREFAAEMETLGMVK 200
F N++G G F V++ + G VA+K + G R E++ +K
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 201 HQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--------- 250
H +++EL Y D + LV E G ++ +L+N+ + +
Sbjct: 70 HPSILELYNYFE-DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 251 ------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE----- 293
SN+LL + KI+DFGLA + T + GT Y+ PE
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRS 187
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352
+G DV+S G + L+ G+ P F+ V + + +
Sbjct: 188 AHG------LESDVWSLGCMFYTLLIGRPP----FDTDT-------VKNTLNKVVLADYE 230
Query: 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
P+ L+ +K + ++L+ +P R ++
Sbjct: 231 MPSFLSIEAKDLIHQLLRR-------NPADRLSL 257
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 50/270 (18%), Positives = 90/270 (33%), Gaps = 54/270 (20%)
Query: 85 SNRQSDPEETRESKRNSISDQNRK-SISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVA 143
S + S Q D L E L + + +T
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT------ 61
Query: 144 GTNKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ 202
+ +G G FG V + G AVKK+ + + E+ +
Sbjct: 62 ------HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSP 110
Query: 203 NLVELLGYCSVDEEKLLVY-EYMVKGSLDDWLR-------NQAAS--------LDWGKRC 246
+V L G + + ++ E + GSL ++ ++A L++
Sbjct: 111 RIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 247 KIV-----ASNILLNDD-FEAKISDFGLARLISDCESHVSTV----VAGTIGYVPPE--- 293
+I+ A N+LL+ D A + DFG A + S + + GT ++ PE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQP 322
K D++S ++L ++ G P
Sbjct: 230 GKPCDAKV----DIWSSCCMMLHMLNGCHP 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 26/262 (9%), Positives = 56/262 (21%), Gaps = 79/262 (30%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE----------------------- 188
V+G + T G++ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 189 -----FAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM--------VKGSLDDWLRN 235
F + + + + ++ + + Y L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 236 QAASLDWGKRCKIVA---------------------SNILLNDDFEAKISDFGLARLISD 274
SL R ++ +I+L+ ++ F
Sbjct: 200 HK-SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 275 CESHVSTVVAGTIGYVPPEY-----------GGTGKATERGDVYSFGVILLELVTGKQPT 323
V + + G+ PPE T D ++ G+++ + P
Sbjct: 259 -----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 324 GPEFEDKDGENLVDWVLHMMKN 345
+W+ KN
Sbjct: 313 ---ITKDAALGGSEWIFRSCKN 331
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 59/267 (22%), Positives = 103/267 (38%), Gaps = 61/267 (22%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLS----QATGQGDREFAAEMETLGMVKHQNLVE 206
+G G FG V+ +A+K L + G + E+E ++H N++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV- 249
L GY D ++ L+ EY G++ L+ A +L + +++
Sbjct: 74 LYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTGK 299
N+LL E KI+DFG + S T + GT+ Y+PPE +
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMHD---- 185
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
E+ D++S GV+ E + GK P FE K E P +
Sbjct: 186 --EKVDLWSLGVLCYEFLVGKPP----FEANT-------YQETYKRISRVEFTFPDFVTE 232
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386
++ + ++L+ +P+ RP +
Sbjct: 233 GARDLISRLLKH-------NPSQRPML 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 60/276 (21%), Positives = 95/276 (34%), Gaps = 71/276 (25%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVK--KLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G +G V A+K + + + + + E+ L ++ H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 208 LGYCSVDEEKL-LVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS-------- 251
+ D+ LV E G L D + AA + K V S
Sbjct: 102 YDFFE-DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSGVTYLHKH 155
Query: 252 ----------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE----- 293
N+LL D KI DFGL+ + GT Y+ PE
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRKK 213
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM---MKNEQADE 350
Y E+ DV+S GVIL L+ G P F + + ++ V + +
Sbjct: 214 YD------EKCDVWSIGVILFILLAGYPP----FGGQTDQEILRKVEKGKYTFDSPEWKN 263
Query: 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
V + A K + +MLQ D R +
Sbjct: 264 VSEGA------KDLIKQMLQF-------DSQRRISA 286
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 68/276 (24%), Positives = 99/276 (35%), Gaps = 71/276 (25%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVK--KLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
++G G FG V K + AVK + A + E+E L + H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 208 LGYCSVDEEKL-LVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS-------- 251
D +V E G L D + + AA + K V S
Sbjct: 87 FEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSGITYMHKH 140
Query: 252 ----------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE----- 293
NILL D + KI DFGL+ ++ GT Y+ PE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVLRGT 198
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM---MKNEQADE 350
Y E+ DV+S GVIL L++G P F K+ +++ V Q
Sbjct: 199 YD------EKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ D A K + KML P++R T
Sbjct: 249 ISDDA------KDLIRKMLTF-------HPSLRITA 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 33/204 (16%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
K+ IG G GTV+ + G+ VA+++++ E+ + K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDW-GKRCK--------------- 247
+V L V +E +V EY+ GSL D + C+
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTG 298
I + NILL D K++DFG I+ +S ST+V GT ++ PE YG
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG--P 195
Query: 299 KATERGDVYSFGVILLELVTGKQP 322
K D++S G++ +E++ G+ P
Sbjct: 196 KV----DIWSLGIMAIEMIEGEPP 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 30/226 (13%)
Query: 119 MEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKK 177
M H + + P +Q L D F + IG G FG VFKG K VA+K
Sbjct: 1 MAHSPVQSGL--PGMQNLKADP----EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI 54
Query: 178 LSQATGQGDRE-FAAEMETLGMVKHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRN 235
+ + + E E+ L + + G + + KL ++ EY+ GS D L
Sbjct: 55 IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEP 113
Query: 236 QAASLDW-GKRCK------------------IVASNILLNDDFEAKISDFGLARLISDCE 276
+ I A+N+LL++ E K++DFG+A ++D +
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQP 322
+T V GT ++ PE + D++S G+ +EL G+ P
Sbjct: 174 IKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 67/277 (24%), Positives = 105/277 (37%), Gaps = 72/277 (25%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVKKL--SQATGQGDRE-FAAEMETLGMVKHQNLVE 206
+ V+G G FG V G+ AVK + Q + D+E E++ L + H N+++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSLDDWLRN-------QAASLDWGKRCKIVAS------- 251
L + D+ LV E G L D + + AA + + V S
Sbjct: 91 LYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSGITYMHK 144
Query: 252 -----------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---- 293
N+LL + D +I DFGL+ S GT Y+ PE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLHG 202
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM---MKNEQAD 349
Y E+ DV+S GVIL L++G P F + +++ V + Q
Sbjct: 203 TYD------EKCDVWSTGVILYILLSGCPP----FNGANEYDILKKVEKGKYTFELPQWK 252
Query: 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+V + A K + KML P++R +
Sbjct: 253 KVSESA------KDLIRKMLTY-------VPSMRISA 276
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 58/262 (22%), Positives = 100/262 (38%), Gaps = 28/262 (10%)
Query: 148 FCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLV 205
F + + +G G G VFK + P G +A K + R E++ L +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-----------AASLDWG-----KRCKIV 249
G D E + E+M GSLD L+ + ++ G ++ KI+
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
SNIL+N E K+ DFG++ + D S ++ V GT Y+ PE + +
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQS 211
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN--EQADEVLDPAVLNANSK 362
D++S G+ L+E+ G+ P P + V + P
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 363 PTMLKMLQIATGCISNDPTVRP 384
+ + ++ ++ P P
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLP 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 53/218 (24%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLS----QATGQGDREFAAEMETLGMVKHQNL 204
+G G FG V+ K +A+K L + G + E+E ++H N+
Sbjct: 21 PLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNI 76
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKI 248
+ + Y D +++ L+ E+ +G L L+ A +L + K+
Sbjct: 77 LRMYNYFH-DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGT 297
+ N+L+ E KI+DFG + GT+ Y+PPE +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPEMIEGKTHD-- 190
Query: 298 GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
E+ D++ GV+ E + G P F+
Sbjct: 191 ----EKVDLWCAGVLCYEFLVGMPP----FDSPSHTET 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 37/288 (12%), Positives = 78/288 (27%), Gaps = 69/288 (23%)
Query: 96 ESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIG 155
+ + K +S S L +P + G+ +++G
Sbjct: 24 DKLIFKLLSGLSKPVS---SYPNTFEWQCKLPAIKPKTE------FQLGSKLVYVHHLLG 74
Query: 156 GGGFGTVFKGT------MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
G F V++ T + + +K A ME L ++
Sbjct: 75 EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYS 134
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK---------------------RCKI 248
+LV E G+L + + N + C+I
Sbjct: 135 AHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193
Query: 249 V-----ASNILLNDDFEA-----------KISDFGLARLISDC-ESHVSTVVAGTIGYVP 291
+ N +L + F + D G + + + + T T G+
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 292 PE------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGE 333
E + + D + + ++ G + +++ GE
Sbjct: 254 VEMLSNKPW------NYQIDYFGVAATVYCMLFGTY---MKVKNEGGE 292
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 40/228 (17%), Positives = 78/228 (34%), Gaps = 58/228 (25%)
Query: 153 VIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAA-----------------EMET 195
+ G F + D K A+KK ++ + R+F E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 196 LGMVKHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR--------- 245
+ +K++ + G + + +++ ++YEYM S+ +
Sbjct: 97 ITDIKNEYCLTCEGIIT-NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 246 -----------C----KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285
I SNIL++ + K+SDFG + + D + G
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKG-SRG 212
Query: 286 TIGYVPPE--YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
T ++PPE + + D++S G+ L + P F K
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKI 256
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 49/235 (20%), Positives = 88/235 (37%), Gaps = 54/235 (22%)
Query: 144 GTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETL-GMVKH 201
G + V+ GGF V++ + G+ A+K+L + +R E+ + + H
Sbjct: 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 202 QNLVELLGYCSVDEEKLL--VYEYMV-----KGSLDDWLRNQAAS--------LDW---- 242
N+V+ S+ +E+ E+++ KG L ++L+ + L
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 243 --------GKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA----- 284
++ I+ N+LL++ K+ DFG A IS + +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 285 ------GTIGYVPPE----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED 329
T Y PE Y E+ D+++ G IL L + P FED
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FED 255
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 60/273 (21%), Positives = 97/273 (35%), Gaps = 71/273 (26%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLS----QATGQGDREFAAEMETLGM------VKH 201
++G GGFGTVF G + D VA+K + +E + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGS-LDDWLRN--------------QAAS-LDWGKR 245
++ LL + E +LV E + L D++ Q + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 246 CKIV-----ASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------ 293
+V NIL++ AK+ DFG L+ D GT Y PPE
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPEWISRHQ 214
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
Y A V+S G++L ++V G P FE +++ LH
Sbjct: 215 YHAL-PA----TVWSLGILLYDMVCGDIP----FERDQ--EILEAELHF----------- 252
Query: 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
PA ++ + + + L P+ RP++
Sbjct: 253 PAHVSPDCCALIRRCLAP-------KPSSRPSL 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 21/198 (10%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
IG G G V G+ VAVK + Q E+ + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDW-GKRCK--------------- 247
+VE+ V EE ++ E++ G+L D + + + C+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163
Query: 248 ---IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
I + +ILL D K+SDFG IS ++V GT ++ PE
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEV 222
Query: 305 DVYSFGVILLELVTGKQP 322
D++S G++++E+V G+ P
Sbjct: 223 DIWSLGIMVIEMVDGEPP 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 48/233 (20%)
Query: 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQN 203
+ VIG G FG VF+ + + VA+KK+ Q D+ F E++ + +VKH N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 204 LVELLGY-----CSVDEEKL-LVYEYM---VKGSLDDWLR-NQAASLDWGKR-----CKI 248
+V+L + DE L LV EY+ V + + + Q + K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 249 VA--------------SNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE 293
+A N+LL+ K+ DFG A+++ E +VS + + Y PE
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPE 211
Query: 294 --YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
+G T T D++S G ++ EL+ G+ P F GE+ +D ++ ++K
Sbjct: 212 LIFGAT-NYTTNIDIWSTGCVMAELMQGQ----PLFP---GESGIDQLVEIIK 256
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 51/261 (19%), Positives = 99/261 (37%), Gaps = 37/261 (14%)
Query: 91 PEETRESKRNSISDQNRKSISDRSSSAL--MEHLSINLAMFEPSLQKLTYDQIVAGTNKF 148
P + R+ +R D+ K + + + + ++ + P ++ +D + + +
Sbjct: 103 PGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV---LDHY 159
Query: 149 CEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G FG V + T G A K + E++T+ +++H LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASL---DWGKRCKIVAS------------- 251
D E +++YE+M G L + + ++ + + + + V
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 252 -----NILLNDDFEA--KISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKAT 301
NI+ K+ DFGL + + V GT + PE G T
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 302 ERGDVYSFGVILLELVTGKQP 322
D++S GV+ L++G P
Sbjct: 338 ---DMWSVGVLSYILLSGLSP 355
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 61/287 (21%), Positives = 95/287 (33%), Gaps = 82/287 (28%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVKKLS------------QATGQGDRE-FAAEMETL 196
+G G +G V A+K + + E E+ L
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 197 GMVKHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRN-------QAASLDWGKRCKI 248
+ H N+++L D++ LV E+ G L + + N AA++ K
Sbjct: 101 KSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQ 154
Query: 249 VAS------------------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTI 287
+ S NILL N KI DFGL+ S + + GT
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTA 212
Query: 288 GYVPPE-----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM 342
Y+ PE Y E+ DV+S GVI+ L+ G P F ++ ++++ V
Sbjct: 213 YYIAPEVLKKKYN------EKCDVWSCGVIMYILLCGYPP----FGGQNDQDIIKKVEKG 262
Query: 343 ---MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ D A K + ML D R T
Sbjct: 263 KYYFDFNDWKNISDEA------KELIKLMLTY-------DYNKRCTA 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 45/231 (19%), Positives = 77/231 (33%), Gaps = 63/231 (27%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT-GQGDREFA-AEMETL-GMVK 200
T +F E IG G FG+VFK DG A+K+ + G D + A E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 201 HQNLVELLGYCSVDEEKLLVY-EYMVKGSLDDWLRNQAASLDWGK--------------- 244
H ++V +++ +L+ EY GSL D + + + K
Sbjct: 70 HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 245 ----RCKIV-----ASNILLNDD-------------------FEAKISDFGLARLISDCE 276
+V SNI ++ KI D G IS +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 277 SHVSTVVAGTIGYVPPE-----YGGTGKATERGDVYSFGVILLELVTGKQP 322
G ++ E Y KA D+++ + ++ +
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAEPL 230
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 56/272 (20%), Positives = 100/272 (36%), Gaps = 71/272 (26%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAA----EMETLGMVKHQ--N 203
++G GGFG+V+ G + D VA+K + + + G+ E+ L V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLD--DWLRN--------------QAAS-LDWGKRC 246
++ LL + + +L+ E + D D++ Q + C
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 247 KIV-----ASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------Y 294
++ NIL++ + E K+ DFG L+ D GT Y PPE Y
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIRYHRY 225
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
G A V+S G++L ++V G P FE + ++ +
Sbjct: 226 HGR-SA----AVWSLGILLYDMVCGDIP----FEHDE--EIIRGQVFF-----------R 263
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+++ + + L + P+ RPT
Sbjct: 264 QRVSSECQHLIRWCLAL-------RPSDRPTF 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 39/205 (19%), Positives = 80/205 (39%), Gaps = 28/205 (13%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
+ +G G FG V+K G A K + + + ++ E+E L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK---RCK------------- 247
+V+LLG D + ++ E+ G++D + L + C+
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 248 -----IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
+ A N+L+ + + +++DFG++ + + GT ++ PE +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 303 RG-----DVYSFGVILLELVTGKQP 322
D++S G+ L+E+ + P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 60/258 (23%), Positives = 98/258 (37%), Gaps = 33/258 (12%)
Query: 92 EETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEE 151
+ ++ R + + +SAL + A F+ + + + +
Sbjct: 36 HNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-VSKT 94
Query: 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
++GGG FG V K G +A K + + E E+ + + H NL++L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASL---DWGKRCKIVAS---------------- 251
+ +LV EY+ G L D + +++ +L D K +
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 252 --NILL--NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKATERG 304
NIL D + KI DFGLAR E V GT ++ PE Y T
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPT--- 269
Query: 305 DVYSFGVILLELVTGKQP 322
D++S GVI L++G P
Sbjct: 270 DMWSVGVIAYMLLSGLSP 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-17
Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 47/223 (21%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
V+G G F VF GK A+K + ++ D E+ L +KH+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS----------- 251
LV + + G L D + + A+ + + V S
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSAVKYLHENGIV 128
Query: 252 -------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTG 298
N+L ++ + I+DFGL+++ + + + GT GYV PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVLAQKPYS 185
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
KA D +S GVI L+ G P F ++ L + +
Sbjct: 186 KAV---DCWSIGVITYILLCGYPP----FYEETESKLFEKIKE 221
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQ 202
+ + VIG G FG V++ G+ VA+KK+ Q D+ F E++ + + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 203 NLVELLGY-----CSVDEEKL-LVYEYM---VKGSLDD-WLRNQAASLDWGKR-----CK 247
N+V L + DE L LV +Y+ V Q + + K +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 248 IVA--------------SNILLNDD-FEAKISDFGLARLISDCESHVSTVVAGTIGYVPP 292
+A N+LL+ D K+ DFG A+ + E +VS + + Y P
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAP 225
Query: 293 E--YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
E +G T T DV+S G +L EL+ G+ P F G++ VD ++ ++K
Sbjct: 226 ELIFGAT-DYTSSIDVWSAGCVLAELLLGQ----PIFP---GDSGVDQLVEIIK 271
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 55/240 (22%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFA----AEMETLGMV 199
++F E + G G FGTV G G +VA+KK+ Q D F M+ L ++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 200 KHQNLVELL------GYCSVDEEKL-LVYEYM---VKGSLDDWLR-NQAASLDWGKR--- 245
H N+V+L G + L +V EY+ + ++ R A K
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 246 --CKIVA----------------SNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGT 286
+ + N+L+N D K+ DFG A+ +S E +V+ + +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--S 194
Query: 287 IGYVPPE--YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
Y PE +G T D++S G I E++ G+ P F G+N + +++
Sbjct: 195 RYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE----PIFR---GDNSAGQLHEIVR 246
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 51/209 (24%), Positives = 72/209 (34%), Gaps = 49/209 (23%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
+G G F V K G A K + + RE E+ L V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS------- 251
L + +L+ E + G L D+L +A S K +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILDGVNYLHT 133
Query: 252 -----------NILL----NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--- 293
NI+L K+ DFGLA I D + GT +V PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVN 191
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQP 322
Y G D++S GVI L++G P
Sbjct: 192 YEPLGLEA---DMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 50/209 (23%), Positives = 76/209 (36%), Gaps = 49/209 (23%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
+G G F V K GK A K +LS + RE E+ L ++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS------- 251
L + +L+ E + G L D+L ++A K +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILDGVHYLHS 126
Query: 252 -----------NILL----NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--- 293
NI+L + K+ DFG+A I + GT +V PE
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVN 184
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQP 322
Y G D++S GVI L++G P
Sbjct: 185 YEPLGLEA---DMWSIGVITYILLSGASP 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 42/224 (18%), Positives = 70/224 (31%), Gaps = 57/224 (25%)
Query: 145 TNKFCEENVIGGG--GFGTVFKGT-MPDGKTVAVKK--LSQATGQGDREFAAEMETLGMV 199
+ VIG G TV P G+ V V++ L + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 200 KHQNLVELLGYCS-VDEEKL-LVYEYMVKGSLDDWLRN---------QAASLDWGKRCK- 247
H N+V + + + +L +V +M GS D + A + +
Sbjct: 84 NHPNIVPY--RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI-----LQG 136
Query: 248 -----------------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290
+ AS+IL++ D + +S + V V
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 291 --P----PE------YGGTGKATERGDVYSFGVILLELVTGKQP 322
PE G K+ D+YS G+ EL G P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVP 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 51/209 (24%), Positives = 72/209 (34%), Gaps = 49/209 (23%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
+G G F V K G A K + + RE E+ L V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS------- 251
L + +L+ E + G L D+L +A S K +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILDGVNYLHT 133
Query: 252 -----------NILL----NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--- 293
NI+L K+ DFGLA I D + GT +V PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVN 191
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQP 322
Y G D++S GVI L++G P
Sbjct: 192 YEPLGLEA---DMWSIGVITYILLSGASP 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 52/229 (22%), Positives = 79/229 (34%), Gaps = 58/229 (25%)
Query: 153 VIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGY 210
+G G FG V G +K +++ Q E AE+E L + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 211 CSVDEEKL-LVYEYMVKGSLDDWLR-----------NQAASLDWGKRCKIVAS------- 251
D + +V E G L + + A L K + +
Sbjct: 89 FE-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-----MKQMMNALAYFHS 142
Query: 252 -----------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---- 293
NIL + KI DFGLA L ST AGT Y+ PE
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTALYMAPEVFKR 200
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
+ D++S GV++ L+TG P F E + +
Sbjct: 201 DVT------FKCDIWSAGVVMYFLLTGCLP----FTGTSLEEVQQKATY 239
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 25/200 (12%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
F +G G +G+V+K G+ VA+K++ +E E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK---RCK------------- 247
+V+ G + + +V EY GS+ D +R + +L + +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 248 -----IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
I A NILLN + AK++DFG+A ++D + +TV+ GT ++ PE
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 303 RGDVYSFGVILLELVTGKQP 322
D++S G+ +E+ GK P
Sbjct: 205 VADIWSLGITAIEMAEGKPP 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 53/214 (24%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLGY 210
VIG G V P + VA+K+++ Q + E++ + H N+V Y
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--Y 79
Query: 211 CS-VDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGKR----------CK----------- 247
S V +++L LV + + GS+ D +++ A + +
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 248 -------IVASNILLNDDFEAKISDFGLARLISDCESHVS-----TVVAGTIGYVPPE-- 293
+ A NILL +D +I+DFG++ ++ T V GT ++ PE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEVM 198
Query: 294 -----YGGTGKATERGDVYSFGVILLELVTGKQP 322
Y KA D++SFG+ +EL TG P
Sbjct: 199 EQVRGYD--FKA----DIWSFGITAIELATGAAP 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 57/224 (25%), Positives = 85/224 (37%), Gaps = 53/224 (23%)
Query: 153 VIGGGGFGTVFKGTM-PDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
++G G FG V K + AVK + + A + E+E L + H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS----------- 251
+V E G L D + + AA + K V S
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSGITYMHKHNIV 143
Query: 252 -------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-----YGG 296
NILL D + KI DFGL+ ++ GT Y+ PE Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVLRGTYD- 200
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
E+ DV+S GVIL L++G P F K+ +++ V
Sbjct: 201 -----EKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVE 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 39/197 (19%), Positives = 69/197 (35%), Gaps = 32/197 (16%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
+G G FG V + G+ K ++ E+ + + H L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQAASL---DWGKRCKIVAS----------------- 251
E +L+ E++ G L D + + + + +
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177
Query: 252 -NILLNDDFEA--KISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKATERGD 305
NI+ + KI DFGLA ++ E + V T + PE G T D
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYT---D 232
Query: 306 VYSFGVILLELVTGKQP 322
+++ GV+ L++G P
Sbjct: 233 MWAIGVLGYVLLSGLSP 249
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 49/224 (21%), Positives = 74/224 (33%), Gaps = 53/224 (23%)
Query: 153 VIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
IG G +G V A KK+ + + F E+E + + H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 212 SVDEEKL-LVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS------------ 251
D + LV E G L + + + AA + K V S
Sbjct: 76 E-DNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSAVAYCHKLNVAH 129
Query: 252 ------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-----YGGT 297
N L + D K+ DFGLA + GT YV P+ YG
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQVLEGLYG-- 185
Query: 298 GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
D +S GV++ L+ G P F ++ +
Sbjct: 186 ----PECDEWSAGVMMYVLLCGYPP----FSAPTDSEVMLKIRE 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 49/211 (23%), Positives = 72/211 (34%), Gaps = 49/211 (23%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDRE-FAAEMETLGMVKHQN 203
+G G F V K G A K + + RE E+ L ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS----- 251
++ L + +L+ E + G L D+L +A K + +
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNGVYYL 130
Query: 252 -------------NILL----NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
NI+L KI DFGLA I + GT +V PE
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 294 --YGGTGKATERGDVYSFGVILLELVTGKQP 322
Y G D++S GVI L++G P
Sbjct: 189 VNYEPLGLEA---DMWSIGVITYILLSGASP 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 46/202 (22%), Positives = 71/202 (35%), Gaps = 50/202 (24%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAAEMETLGMVKHQNLVE 206
VIG G F V + G+ AVK K + + G + E M+KH ++VE
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-----------AASLDWGKRCKIVAS---- 251
LL S D +V+E+M L + + A+ + +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQILEALRY 145
Query: 252 --------------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
+LL + K+ FG+A + + V GT ++ PE
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 294 --YGGTGKATERGDVYSFGVIL 313
GK DV+ GVIL
Sbjct: 205 VKREPYGKPV---DVWGCGVIL 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 47/223 (21%), Positives = 79/223 (35%), Gaps = 54/223 (24%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAA---EMETLGMVKHQN 203
+G G G V K VA++ K + + + E+E L + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 204 LVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS---- 251
++++ + D E +V E M G L D + +
Sbjct: 202 IIKIKNF--FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLLAVQY 254
Query: 252 --------------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
N+LL +D KI+DFG ++++ + S + T+ GT Y+ PE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC-GTPTYLAPEV 312
Query: 294 --YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
GT D +S GVIL ++G P F + +
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEHRTQV 351
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 57/319 (17%)
Query: 91 PEETRESKRNSISDQNRKSISDRSSSALMEHLS-------INLAMFEPSLQKLTYDQIVA 143
P + + + K + + E+LS ++ F LQ ++
Sbjct: 122 PRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPV 181
Query: 144 GTNKFCEENVIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETL 196
N F + V+G GGFG V + T GK A KKL + + + A E + L
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 197 GMVKHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-------------AA---- 238
V + +V L Y ++ L LV M G L + + AA
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 239 SLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE 293
L+ R +IV NILL+D +ISD GLA + + ++ + V GT+GY+ PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE 355
Query: 294 ---YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350
+ D ++ G +L E++ G+ P F+ + + + V ++K
Sbjct: 356 VVKNERYTFSP---DWWALGCLLYEMIAGQSP----FQQRKKKIKREEVERLVKE---VP 405
Query: 351 VLDPAVLNANSKPTMLKML 369
+ ++ ++ L
Sbjct: 406 EEYSERFSPQAR-SLCSQL 423
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 35/256 (13%), Positives = 76/256 (29%), Gaps = 65/256 (25%)
Query: 153 VIGGGGFGTVFKGTMPD---GKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVE 206
GG ++ D + VA+ + D +E + L + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------------AASLDWGKRCKIV---- 249
+L L+V E++ GSL + AA+ D R +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 250 -ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
S + ++ D + ++ +P A + D+
Sbjct: 156 HPSRVRVSIDGDVVLAYPA---------------------TMPD-------ANPQDDIRG 187
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368
G L L+ + P + + L + + A + ++PA ++ + +
Sbjct: 188 IGASLYALLVNRWP----LPEAGVRS----GLAPAERDTAGQPIEPADIDRDIPFQ---I 236
Query: 369 LQIATGCISNDPTVRP 384
+A + D +R
Sbjct: 237 SAVAARSVQGDGGIRS 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 37/213 (17%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLG-MVKHQ 202
F ++G G +G V+KG + G+ A+K + TG + E E+ L H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 203 NLVELLG-----YCSVDEEKL-LVYEYMVKGSLDDWLRN-QAASLD-------------- 241
N+ G +++L LV E+ GS+ D ++N + +L
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 242 ---WGKRCKI----VASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY 294
+ I N+LL ++ E K+ DFG++ + +T + GT ++ PE
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEV 200
Query: 295 GGTGKATERG-----DVYSFGVILLELVTGKQP 322
+ + D++S G+ +E+ G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 40/206 (19%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMVK 200
K+ + +G G +G V+K G+ VA+K++ + E A E+ L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIREISLLKELH 77
Query: 201 HQNLVELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA-- 250
H N+V L+ + LV+E+M +K LD+ K + VA
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 251 ------------SNILLNDDFEAKISDFGLARLISDCESHVST--VVAGTIGYVPPE--Y 294
N+L+N D K++DFGLAR T VV T+ Y P+
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV--TLWYRAPDVLM 192
Query: 295 GGTGKATERGDVYSFGVILLELVTGK 320
G +T D++S G I E++TGK
Sbjct: 193 GSKKYSTSV-DIWSIGCIFAEMITGK 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 53/229 (23%), Positives = 87/229 (37%), Gaps = 52/229 (22%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-------KLSQATGQGDRE-FAAEMETLGMVK-HQ 202
VIG G V + G AVK +LS + RE E L V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS---- 251
+++ L+ LV++ M KG L D+L + S+ + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEAVSF 215
Query: 252 --------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGG 296
NILL+D+ + ++SDFG + + + + GT GY+ PE
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC-GTPGYLAPEILKC 273
Query: 297 TGKATERG-----DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
+ T G D+++ GVIL L+ G P F + ++ ++
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPP----FWHRRQILMLRMIM 318
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 52/230 (22%), Positives = 85/230 (36%), Gaps = 53/230 (23%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK--------KLSQATGQGDRE-FAAEMETLGMVK-H 201
++G G V + P K AVK S Q RE E++ L V H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS--- 251
N+++L + LV++ M KG L D+L + + + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLEVIC 138
Query: 252 ---------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YG 295
NILL+DD K++DFG + + + V GT Y+ PE
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC-GTPSYLAPEIIE 196
Query: 296 GTGKATERG-----DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
+ G D++S GVI+ L+ G P F + ++ ++
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLRMIM 242
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 38/203 (18%), Positives = 73/203 (35%), Gaps = 45/203 (22%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQNLVELLGY 210
+G G FG V + KT K + D+ E+ L + +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 211 CSVDEEKLLVYEYMVKGSLDDWL--RN------QAASLDWGKRCKIVAS----------- 251
EE ++++E++ + + + + S V
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCEALQFLHSHNIG 124
Query: 252 -------NILLNDDFEA--KISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGK 299
NI+ + KI +FG AR + ++ ++ Y PE +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVST 182
Query: 300 ATERGDVYSFGVILLELVTGKQP 322
AT D++S G ++ L++G P
Sbjct: 183 AT---DMWSLGTLVYVLLSGINP 202
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 57/265 (21%), Positives = 103/265 (38%), Gaps = 58/265 (21%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLV 205
IG G FG V T K A+K +++ E E++ + ++H LV
Sbjct: 22 AIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV 249
L Y DEE + +V + ++ G L L+ +LD+ + +I+
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTG 298
NILL++ I+DF +A ++ + +AGT Y+ PE G
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGAGYS 195
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358
A D +S GV EL+ G++P + + + + ++ + V P+ +
Sbjct: 196 FAV---DWWSLGVTAYELLRGRRP----YHIRSSTSSKE----IVHTFETTVVTYPSAWS 244
Query: 359 ANSKPTMLKMLQIATGCISNDPTVR 383
+ K+L+ +P R
Sbjct: 245 QEMVSLLKKLLEP-------NPDQR 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 62/293 (21%), Positives = 108/293 (36%), Gaps = 86/293 (29%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAA---------------- 191
IG G +G V D A+K KL + G R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 192 -----EMETLGMVKHQNLVELLGYCSVD---EEKL-LVYEYMVKGSLDDWLRNQAASLDW 242
E+ L + H N+V+L +D E+ L +V+E + +G + + + S D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 243 GKR-----------C---KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283
+ KI+ SN+L+ +D KI+DFG++ ++ +S
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-T 197
Query: 284 AGTIGYVPPE--------YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
GT ++ PE + +GKA DV++ GV L V G+ P F D E +
Sbjct: 198 VGTPAFMAPESLSETRKIF--SGKAL---DVWAMGVTLYCFVFGQCP----FMD---ERI 245
Query: 336 VDWVLHMMKNEQADEVLDPA--VLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + ++ + P + + K + +ML +P R +
Sbjct: 246 MC----LHSKIKSQALEFPDQPDIAEDLKDLITRMLDK-------NPESRIVV 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 55/230 (23%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELL 208
+ +G G F K + AVK +S+ ++ E+ L + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS---------- 251
LV E + G L + ++ + A+ + + + S
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSAVSHMHDVGV 127
Query: 252 --------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------Y 294
N+L ND+ E KI DFG ARL + T T+ Y PE Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGY 186
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
E D++S GVIL +++G+ P F+ D + +MK
Sbjct: 187 D------ESCDLWSLGVILYTMLSGQVP----FQSHDRSLTCTSAVEIMK 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 47/225 (20%), Positives = 81/225 (36%), Gaps = 54/225 (24%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
+G G F V + G A K + + + + ++ E ++H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS----------- 251
+ LV++ + G L + + A+ + +
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILESIAYCHSNGIV 150
Query: 252 -------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YG 295
N+LL K++DFGLA ++ +S AGT GY+ PE Y
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
+ D+++ GVIL L+ G P F D+D L +
Sbjct: 209 ------KPVDIWACGVILYILLVGYPP----FWDEDQHRLYAQIK 243
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 45/205 (21%), Positives = 73/205 (35%), Gaps = 56/205 (27%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAA---EMETLGMVKHQN 203
+G G G V K VA+K K + + + E+E L + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 204 LVELLGYCSVDEEKL-LVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS---- 251
++++ + D E +V E M G L D + +
Sbjct: 77 IIKIKNF--FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLLAVQY 129
Query: 252 --------------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
N+LL +D KI+DFG ++++ + S + T+ GT Y+ PE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC-GTPTYLAPEV 187
Query: 294 -----YGGTGKATERGDVYSFGVIL 313
G +A D +S GVIL
Sbjct: 188 LVSVGTAGYNRAV---DCWSLGVIL 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 47/225 (20%), Positives = 81/225 (36%), Gaps = 54/225 (24%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELLG 209
+G G F V + G A K + + + + ++ E ++H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLR-------NQAASLDWGKRCKIVAS----------- 251
+ LV++ + G L + + A+ + +
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILESIAYCHSNGIV 127
Query: 252 -------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YG 295
N+LL K++DFGLA ++ +S AGT GY+ PE Y
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
+ D+++ GVIL L+ G P F D+D L +
Sbjct: 186 ------KPVDIWACGVILYILLVGYPP----FWDEDQHRLYAQIK 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 60/257 (23%), Positives = 106/257 (41%), Gaps = 44/257 (17%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G F V + G+ VA+K + +Q ++ E+ + ++ H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRN--------------QAAS-LDWGKRCKIV-----A 250
++ L+ EY G + D+L Q S + + + +IV A
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 251 SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYSF 309
N+LL+ D KI+DFG + + + G Y PE + G DV+S
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 310 GVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKML 369
GVIL LV+G P F+ ++ + L + VL + P ++ + + + + L
Sbjct: 201 GVILYTLVSGSLP----FDGQNLKELRERVL-------RGKYRIPFYMSTDCENLLKRFL 249
Query: 370 QIATGCISNDPTVRPTM 386
+ +P R T+
Sbjct: 250 VL-------NPIKRGTL 259
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 71/279 (25%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQN 203
+ EE +G G F V + + G+ A + + + + ++ E ++KH N
Sbjct: 14 QLFEE--LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS----- 251
+V L S + L+++ + G L + + + A+ + +
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEAVLHC 126
Query: 252 -------------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-- 293
N+LL K++DFGLA + + GT GY+ PE
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 294 ----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM---MKNE 346
YG + D+++ GVIL L+ G P F D+D L + +
Sbjct: 186 RKDPYG------KPVDLWACGVILYILLVGYPP----FWDEDQHRLYQQIKAGAYDFPSP 235
Query: 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
+ D V A K + KML I +P+ R T
Sbjct: 236 EWDTVTPEA------KDLINKMLTI-------NPSKRIT 261
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 37/208 (17%)
Query: 148 FCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEME---TLGMVKHQN 203
+G G +G V K +P G+ +AVK++ +AT + M+ ++ V
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDW------GKRCKIV-------- 249
V G + + + E M SLD + + GK +
Sbjct: 68 TVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 250 -----------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE----Y 294
SN+L+N + K+ DFG++ + D + AG Y+ PE
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERINPE 184
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQP 322
+ + D++S G+ ++EL + P
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 38/209 (18%)
Query: 148 FCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEME---TLGMVKHQN 203
+ IG G +G+V K P G+ +AVK++ ++T + M+ +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWG-------------------- 243
+V+ G + + + E M S D + + + LD
Sbjct: 83 IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 244 -KRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---- 293
+ KI+ SNILL+ K+ DFG++ + D S T AG Y+ PE
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDP 199
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQP 322
R DV+S G+ L EL TG+ P
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 43/211 (20%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLV 205
++G G F TV T + A+K L + + + E + + + H V
Sbjct: 37 ILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKIV 249
+L + D+EKL Y G L ++R A +L++ I+
Sbjct: 94 KLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII 152
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTV-VAGTIGYVPPE---YGGTGKA 300
NILLN+D +I+DFG A+++S GT YV PE K+
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 212
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
+ D+++ G I+ +LV G P F +
Sbjct: 213 S---DLWALGCIIYQLVAGLPP----FRAGN 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 67/311 (21%), Positives = 110/311 (35%), Gaps = 58/311 (18%)
Query: 101 SISDQNRKSISDRSSSALMEHLS-------INLAMFEPSLQKLTYDQIVAGTNKFCEENV 153
+ A++ HL ++ F LQ + G + F + V
Sbjct: 133 RARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRV 192
Query: 154 IGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLVE 206
+G GGFG VF K T GK A KKL++ + + + E + L V + +V
Sbjct: 193 LGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AA----SLDWGKRC 246
L Y + L LV M G + + N A L+ +
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 247 KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTG 298
I+ N+LL+DD +ISD GLA + ++ GT G++ PE
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYD 367
Query: 299 KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358
+ D ++ GV L E++ + P F + + + + V P +
Sbjct: 368 FSV---DYFALGVTLYEMIAARGP----FRARGEKVENKELKQRVLE---QAVTYPDKFS 417
Query: 359 ANSKPTMLKML 369
SK + L
Sbjct: 418 PASK-DFCEAL 427
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 57/204 (27%), Positives = 81/204 (39%), Gaps = 35/204 (17%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQAT-GQGDREFAA-EMETLGMVKHQ 202
K+ + IG G +G VFK G+ VA+KK ++ ++ A E+ L +KH
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 203 NLVELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA---- 250
NLV LL LV+EY V LD + K + V
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 251 ----------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--YGGT- 297
NIL+ K+ DFG ARL++ + VA T Y PE G T
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179
Query: 298 -GKATERGDVYSFGVILLELVTGK 320
G DV++ G + EL++G
Sbjct: 180 YGPPV---DVWAIGCVFAELLSGV 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 42/207 (20%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMVK 200
K+ IG G +G V+K G+T A+KK+ + + E E+ L +K
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---EKEDEGIPSTTIREISILKELK 58
Query: 201 HQNLVELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA-- 250
H N+V+L + +LV+E++ +K LD K +A
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYC 116
Query: 251 ------------SNILLNDDFEAKISDFGLARLISD---CESHVSTVVAGTIGYVPPE-- 293
N+L+N + E KI+DFGLAR +H +V T+ Y P+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWYRAPDVL 172
Query: 294 YGGTGKATERGDVYSFGVILLELVTGK 320
G +T D++S G I E+V G
Sbjct: 173 MGSKKYSTTI-DIWSVGCIFAEMVNGT 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 42/219 (19%), Positives = 71/219 (32%), Gaps = 55/219 (25%)
Query: 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
IG G + + AVK + ++ E + +H N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-LLRY--GQHPNIITLKDV 84
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS------------ 251
+ +V E M G L D + Q A+++ +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKTVEYLHAQGVVH 139
Query: 252 ------NILLNDDFEA----KISDFGLARLISDCESHVSTVVAGTIGYVPPE------YG 295
NIL D+ +I DFG A+ + + T T +V PE Y
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYD 198
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
D++S GV+L ++TG P F + +
Sbjct: 199 ------AACDIWSLGVLLYTMLTGYTP----FANGPDDT 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 45/215 (20%)
Query: 142 VAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE----FAA--EME 194
++ +++F + +G G + TV+KG G VA+K++ D E A E+
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-----DSEEGTPSTAIREIS 55
Query: 195 TLGMVKHQNLVELLGYCSVDEEKLLVYEYM---VKGSLDD-WLRNQAASLDWGKRCKIV- 249
+ +KH+N+V L + + LV+E+M +K +D + N L+
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 250 --------------------ASNILLNDDFEAKISDFGLARLISDCESHVST--VVAGTI 287
N+L+N + K+ DFGLAR + + VV T+
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV--TL 172
Query: 288 GYVPPE--YGGTGKATERGDVYSFGVILLELVTGK 320
Y P+ G +T D++S G IL E++TGK
Sbjct: 173 WYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 41/209 (19%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMV 199
K+ + IG G +GTVFK + VA+K++ D E +A E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKEL 58
Query: 200 KHQNLVELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA- 250
KH+N+V L D++ LV+E+ +K D N + K K +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGF 116
Query: 251 -------------SNILLNDDFEAKISDFGLARLISDCESHVST--VVAGTIGYVPPE-- 293
N+L+N + E K+++FGLAR + VV T+ Y PP+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV--TLWYRPPDVL 173
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQP 322
+G +T D++S G I EL +P
Sbjct: 174 FGAKLYSTSI-DMWSAGCIFAELANAGRP 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 49/214 (22%), Positives = 78/214 (36%), Gaps = 48/214 (22%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
+G G V++ K A+K L + + E+ L + H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS------------- 251
E LV E + G L D + + AA K +
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEAVAYLHENGIVHR 172
Query: 252 -----NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
N+L D KI+DFGL++++ + V GT GY PE G
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
D++S G+I L+ G +P F D+ G+
Sbjct: 231 V---DMWSVGIITYILLCGFEP----FYDERGDQ 257
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 48/207 (23%), Positives = 70/207 (33%), Gaps = 47/207 (22%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLS-QATGQGDRE-FAAEMETLGMVKHQ-NLVELL 208
+G G F V + G+ A K L + GQ R E+ L + K ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLR---------NQAASLDWGKRCKIVAS-------- 251
E +L+ EY G + N L K +
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILEGVYYLHQN 150
Query: 252 ----------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YG 295
NILL + KI DFG++R I + GT Y+ PE Y
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYD 208
Query: 296 GTGKATERGDVYSFGVILLELVTGKQP 322
AT D+++ G+I L+T P
Sbjct: 209 PITTAT---DMWNIGIIAYMLLTHTSP 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 70/337 (20%), Positives = 114/337 (33%), Gaps = 68/337 (20%)
Query: 90 DPEETRESKRNSISDQNRKSISDRSSSALMEHLS-------INLAMFEPSLQ-KLTYDQI 141
+ + + Q + + ++L I F Q K I
Sbjct: 125 SKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNI 184
Query: 142 VAGTNKFCEENVIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEME 194
N F +IG GGFG V+ T GK A+K L + + + E
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 195 TLGMVKHQN---LVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA- 238
L +V + +V + Y +KL + + M G L L AA
Sbjct: 242 MLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 239 ---SLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290
L+ +V +NILL++ +ISD GLA S + H S GT GY+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 291 PPE----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346
PE + D +S G +L +L+ G P F ++ + + +
Sbjct: 358 APEVLQKGVAYDSSA---DWFSLGCMLFKLLRGHSP----FRQHKTKDKHE----IDRMT 406
Query: 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVR 383
V P + + ++L+ L + D R
Sbjct: 407 LTMAVELPDSFSPELR-SLLEGL------LQRDVNRR 436
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 46/204 (22%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELL 208
E+V+G G V + + AVK + + G E+E L + H+N++EL+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQ-------AASLDWGKRCKIVAS---------- 251
+ ++ LV+E M GS+ + + A+ + + VAS
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQDVASALDFLHNKGI 132
Query: 252 --------NILL---NDDFEAKISDFGLARLI------SDCESHVSTVVAGTIGYVPPE- 293
NIL N KI DF L I S + G+ Y+ PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 294 ----YGGTGKATERGDVYSFGVIL 313
+R D++S GVIL
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 37/205 (18%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKK--LSQATGQGDREFAA-EMETLGMVKH 201
K+ ++G G +G V K G+ VA+KK S + ++ A E++ L ++H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRH 83
Query: 202 QNLVELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA--- 250
+NLV LL C + LV+E++ + L+ ++ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 251 -----------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--YGGT 297
NIL++ K+ DFG AR ++ VA T Y PE G
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDV 200
Query: 298 --GKATERGDVYSFGVILLELVTGK 320
GKA DV++ G ++ E+ G+
Sbjct: 201 KYGKAV---DVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 42/207 (20%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD-----REFAAEMETLGMV 199
+ + + +G G + TV+KG VA+K++ +G RE + L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 200 KHQNLVELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA- 250
KH N+V L ++ LV+EY+ +K LDD ++ K + +A
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAY 115
Query: 251 -------------SNILLNDDFEAKISDFGLARLISDCESHVST--VVAGTIGYVPPE-- 293
N+L+N+ E K++DFGLAR S + VV T+ Y PP+
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV--TLWYRPPDIL 172
Query: 294 YGGTGKATERGDVYSFGVILLELVTGK 320
G T +T+ D++ G I E+ TG+
Sbjct: 173 LGSTDYSTQI-DMWGVGCIFYEMATGR 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 51/227 (22%), Positives = 78/227 (34%), Gaps = 60/227 (26%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
++ IG G G V + VA+KKLS+ ++ A E+ + V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCV 81
Query: 200 KHQNLVELL------GYCSVDEEKLLVYEYM-------VKGSLDDWLRNQAASLDWGKRC 246
H+N++ LL ++ +V E M ++ LD +R
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH------------ERM 129
Query: 247 KIVA----------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
+ SNI++ D KI DFGLAR S + T
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 187
Query: 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
T Y PE E D++S G I+ E++ G F D
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTD 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 58/260 (22%), Positives = 92/260 (35%), Gaps = 54/260 (20%)
Query: 111 SDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVF----KGT 166
+ S +++ L +P K+ ++ F VIG G FG V K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRL--HREDFEILKVIGRGAFGEVAVVKLKNA 98
Query: 167 MPDGKTVAVKKLSQATGQGDRE---FAAEMETLGMVKHQNLVELLGYCSVDEEKL-LVYE 222
K A+K L++ E F E + L + + L Y D+ L LV +
Sbjct: 99 ---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMD 154
Query: 223 YMVKGSLDDWLRNQAASLDWGKRCKIVAS----------------------NILLNDDFE 260
Y V G L L L + + + NIL++ +
Sbjct: 155 YYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH 213
Query: 261 AKISDFGLA-RLISDCESHVSTVVAGTIGYVPPE--------YGGTGKATERGDVYSFGV 311
+++DFG +L+ D S V GT Y+ PE G G D +S GV
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPEC---DWWSLGV 269
Query: 312 ILLELVTGKQPTGPEFEDKD 331
+ E++ G+ P F +
Sbjct: 270 CMYEMLYGETP----FYAES 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 36/216 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETL-GMVKHQ 202
N +G G G V+K G +AVK++ ++ + + + +++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLD---WGKRCK------------ 247
+V+ G + + + E M + + + GK
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 248 -------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-----YG 295
+ SNILL++ + K+ DFG++ + D AG Y+ PE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDP 201
Query: 296 GTGKATERGDVYSFGVILLELVTGKQP---TGPEFE 328
R DV+S G+ L+EL TG+ P +FE
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 46/226 (20%), Positives = 74/226 (32%), Gaps = 47/226 (20%)
Query: 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG-------DREFAA----EM 193
+ + + I G +G V G +G VA+K++ G D E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 194 ETLGMVKHQNLVELLG-YCSVDEEKL----LVYEYMVKGSLDDWLRNQAASLDWGKRCKI 248
L H N++ L + +E + LV E M + L + +Q + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVIS-PQHIQY 138
Query: 249 VA----------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286
NILL D+ + I DF LAR D T
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH 196
Query: 287 IGYVPPEY-GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
Y PE T+ D++S G ++ E+ K F
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRGST 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 57/267 (21%), Positives = 89/267 (33%), Gaps = 51/267 (19%)
Query: 103 SDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTN-----KFCEENVIGGG 157
D + +++ + M + + Y V + ++ IG G
Sbjct: 14 LDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSG 73
Query: 158 GFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMVKHQNLVELL---- 208
G V + VA+KKLS+ ++ A E+ + V H+N++ LL
Sbjct: 74 AQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 209 --GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA---------------- 250
++ LV E M D L +R +
Sbjct: 132 PQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 186
Query: 251 ------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
SNI++ D KI DFGLAR S + T T Y PE E
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKD 331
D++S G I+ E+V K F +D
Sbjct: 245 DIWSVGCIMGEMVRHK----ILFPGRD 267
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 67/269 (24%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAA---EMETLGMVKHQNL 204
+G G FG V+ K V VK K+ + D + E+ L V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 205 VELLGYCSVDEEKLLVYEYMVKGS-LDDWLRN--------------QAAS-LDWGKRCKI 248
+++L LV E G L ++ Q S + + + I
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGT 297
+ NI++ +DF K+ DFG A + T GTI Y PE Y G
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC-GTIEYCAPEVLMGNPYRG- 208
Query: 298 GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357
+++S GV L LV + P F + + V+ +H P ++
Sbjct: 209 ----PELEMWSLGVTLYTLVFEENP----FCELE--ETVEAAIHP-----------PYLV 247
Query: 358 NANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + +LQ P R T+
Sbjct: 248 SKELMSLVSGLLQP-------VPERRTTL 269
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 48/213 (22%), Positives = 82/213 (38%), Gaps = 54/213 (25%)
Query: 154 IGGGGFGTVFKGTMPDGKT---VAVKKLSQATGQGDREFAA--EMETLGMVKHQNLVELL 208
+G G +G V+K DGK A+K++ +A E+ L +KH N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACREIALLRELKHPNVISLQ 84
Query: 209 G-YCSVDEEKL-LVYEYM---VKGSLDDWLRNQAASLDWGKRCKIV-------------- 249
+ S + K+ L+++Y + + ++A +V
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 250 -----------ASNILLNDDFEA----KISDFGLARLISD---CESHVSTVVAGTIGYVP 291
+NIL+ + KI+D G ARL + + + VV T Y
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRA 203
Query: 292 PE--YGGT--GKATERGDVYSFGVILLELVTGK 320
PE G KA D+++ G I EL+T +
Sbjct: 204 PELLLGARHYTKAI---DIWAIGCIFAELLTSE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 53/275 (19%), Positives = 94/275 (34%), Gaps = 69/275 (25%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLS----QATGQGDREFAAEMETLGMVKHQNLVEL 207
++G G +G V + AVK L + G+ E++ L ++H+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 208 ---------------LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA--------ASLDWGK 244
+ YC +++L + + + QA L++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML--DSVPEKRFPVC---QAHGYFCQLIDGLEYLH 126
Query: 245 RCKIV-----ASNILLNDDFEAKISDFGLARLISDC-ESHVSTVVAGTIGYVPPE----- 293
IV N+LL KIS G+A + G+ + PPE
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 294 --YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351
+ G K D++S GV L + TG P FE +N+ + +N
Sbjct: 187 DTFSGF-KV----DIWSAGVTLYNITTGLYP----FEG---DNIYK----LFENIGKGSY 230
Query: 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
P + ML+ +P R ++
Sbjct: 231 AIPGDCGPPLSDLLKGMLEY-------EPAKRFSI 258
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 45/267 (16%)
Query: 99 RNSISDQNRKSISDRSSSALM--EHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGG 156
+ + D + D AL +++ L+ ++ ++ K+ ++ + VIG
Sbjct: 22 SDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRM--KAEDYEVVKVIGR 79
Query: 157 GGFGTVF----KGTMPDGKTVAVKKLSQATGQGDRE---FAAEMETLGMVKHQNLVELLG 209
G FG V K T K A+K LS+ + F E + + +V+L
Sbjct: 80 GAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 210 YCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGK--RCKIVAS--------------- 251
Y D+ L +V EYM G L + + N W + ++V +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 252 --NILLNDDFEAKISDFGLA-RLISDCESHVSTVVAGTIGYVPPE----YGGTGKATERG 304
N+LL+ K++DFG ++ + T V GT Y+ PE GG G
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 254
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKD 331
D +S GV L E++ G P F
Sbjct: 255 DWWSVGVFLYEMLVGDTP----FYADS 277
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 38/201 (18%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMVKHQNLV 205
+ +G G F TV+K + VA+KK+ ++ A E++ L + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 206 ELLGYCSVDEEKL-LVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA------ 250
LL + + LV+++M ++ + D + + K + +
Sbjct: 76 GLLD-AFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 251 --------SNILLNDDFEAKISDFGLARLISD-CESHVSTVVAGTIGYVPPE--YGGTGK 299
+N+LL+++ K++DFGLA+ ++ VV T Y PE +G
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELLFGARMY 190
Query: 300 ATERGDVYSFGVILLELVTGK 320
D+++ G IL EL+
Sbjct: 191 GVGV-DMWAVGCILAELLLRV 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 53/211 (25%), Positives = 80/211 (37%), Gaps = 53/211 (25%)
Query: 152 NVIGGGGFGTVFKG--TMPDGKTVAVKKL----------SQATGQGDREFAAEMETLGMV 199
IG G +G VFK G+ VA+K++ RE A L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH-LETF 71
Query: 200 KHQNLVELL----GYCSVDEEKL-LVYEYM---VKGSLDDWLRNQAASLDWGKR------ 245
+H N+V L + E KL LV+E++ + LD + + K
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLL 130
Query: 246 -----C---KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPP 292
++V NIL+ + K++DFGLAR+ S + S VV T+ Y P
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 188
Query: 293 E--YGGT-GKATERGDVYSFGVILLELVTGK 320
E + D++S G I E+ K
Sbjct: 189 EVLLQSSYATPV---DLWSVGCIFAEMFRRK 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 46/212 (21%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLS---QATGQGDREFAAEMETLGMVK 200
F + IG G FG V+ + + + VA+KK+S + + + ++ E+ L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGK---RCK---------- 247
H N ++ G + LV EY GS D L L +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 248 --------IVASNILLNDDFEAKISDFGLARLISDCESHVST-------VVAGT--IGYV 290
+ A NILL++ K+ DFG A +++ S V T V+ Y
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY- 230
Query: 291 PPEYGGTGKATERGDVYSFGVILLELVTGKQP 322
GK DV+S G+ +EL K P
Sbjct: 231 ------DGKV----DVWSLGITCIELAERKPP 252
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 54/212 (25%), Positives = 81/212 (38%), Gaps = 53/212 (25%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKL---SQATGQGD------REFAAEMETLGMVKH 201
IG G +GTV+K G VA+K + + G G RE A L +H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR-LEAFEH 73
Query: 202 QNLVELL----GYCSVDEEKL-LVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKI 248
N+V L+ + E K+ LV+E++ ++ LD + K +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMRQFLRG 132
Query: 249 VA--------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
+ NIL+ K++DFGLAR+ S + VV T+ Y PE
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAPEV 190
Query: 294 -----YGGTGKATERGDVYSFGVILLELVTGK 320
Y T D++S G I E+ K
Sbjct: 191 LLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 47/220 (21%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
+ +G G +G+V G+ VA+KKLS+ FA E+ L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHM 80
Query: 200 KHQNLVELL------GYCSVDEEKLLVYEYM-------VKGSLDD---------WLRNQA 237
+H+N++ LL + LV +M + + L+
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK--- 137
Query: 238 ASLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPP 292
L + +V N+ +N+D E KI DFGLAR ++ V T Y P
Sbjct: 138 -GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVV-TRWYRAP 192
Query: 293 E-YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
E + D++S G I+ E++TGK F+ KD
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKD 228
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 60/268 (22%), Positives = 96/268 (35%), Gaps = 50/268 (18%)
Query: 112 DRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVF----KGTM 167
S A ++++ L EP + +L ++ + F VIG G F V K T
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRL--QRDDFEILKVIGRGAFSEVAVVKMKQT- 85
Query: 168 PDGKTVAVKKLSQATGQGDRE---FAAEMETLGMVKHQNLVELLGYCSVDEEKL-LVYEY 223
G+ A+K +++ E F E + L + + +L + DE L LV EY
Sbjct: 86 --GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142
Query: 224 MVKGSLDDWLRNQAASLDWGKRCKIVAS----------------------NILLNDDFEA 261
V G L L + + + + NILL+
Sbjct: 143 YVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201
Query: 262 KISDFGLA-RLISDCESHVSTVVAGTIGYVPPE----YGGTGKATERG---DVYSFGVIL 313
+++DFG +L +D V GT Y+ PE GG G D ++ GV
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 314 LELVTGKQPTGPEFEDKDGENLVDWVLH 341
E+ G+ P F ++H
Sbjct: 261 YEMFYGQTP----FYADSTAETYGKIVH 284
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 55/214 (25%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMVKHQNLV 205
IG G FG VFK G+ VA+KK+ + ++E A E++ L ++KH+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHENVV 79
Query: 206 ELLGYCSVDEEKL--------LVYEYM---VKGSLDDWLRNQAASLDWGKRCKIV----- 249
L+ C LV+++ + G L N + +++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLN 135
Query: 250 ----------------ASNILLNDDFEAKISDFGLARLISDCESHVST-----VVAGTIG 288
A+N+L+ D K++DFGLAR S ++ VV T+
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--TLW 193
Query: 289 YVPPE--YGGTGKATERGDVYSFGVILLELVTGK 320
Y PPE G D++ G I+ E+ T
Sbjct: 194 YRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRS 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 48/221 (21%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
+ + +G G +G V G VA+KKL + FA E+ L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHM 81
Query: 200 KHQNLVELLGYCSVDEEKL------LVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--- 250
+H+N++ LL + DE LV +M L ++++ D R + +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGED---RIQFLVYQM 137
Query: 251 -------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP 291
N+ +N+D E KI DFGLAR ++ V T Y
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVV-TRWYRA 193
Query: 292 PEY-GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
PE + T+ D++S G I+ E++TGK F+ D
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSD 230
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 47/230 (20%), Positives = 84/230 (36%), Gaps = 51/230 (22%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
+ V+G G G V + G+ A+K L + +E + G ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASG---GPHIVCILD 89
Query: 210 -YCSVDEEKLLVY---EYMVKGSLDDWLRNQ---------AASLDWGKRCKIVAS----- 251
Y ++ K + E M G L ++ + AA + + + +
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI-----MRDIGTAIQFL 144
Query: 252 -------------NILL---NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295
N+L D K++DFG A+ + + T T YV PE
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVL 201
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN 345
G K + D++S GVI+ L+ G P F G+ + + ++
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPP----FYSNTGQAISPGMKRRIRL 247
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 151 ENVIGGGGFGTVFKGT------MPDGKTVAVKKL-SQATGQGDREFAAEMETLGMV-KHQ 202
+G G FG V + +TVAVK L AT R +E++ L + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 203 NLVELLGYCSVDEEKLLV-YEYMVKGSLDDWLRN 235
N+V LLG C+ L+V E+ G+L +LR+
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 29/79 (36%), Positives = 37/79 (46%), Gaps = 10/79 (12%)
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP-----PEYGGTGKATERG 304
A NILL++ KI DFGLAR I V +P PE T +
Sbjct: 221 ARNILLSEKNVVKICDFGLARDIYK----DPDYVRKGDARLPLKWMAPETIFDRVYTIQS 276
Query: 305 DVYSFGVILLELVT-GKQP 322
DV+SFGV+L E+ + G P
Sbjct: 277 DVWSFGVLLWEIFSLGASP 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 47/206 (22%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAA--EMETLGMVKHQNLV 205
+G G +G V+K +TVA+K++ + + E A E+ L ++H+N++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRL---EHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 206 ELLGYCSVDEEKLLVYEYM---VKGSLDDWLRNQAASLDWGKR-----CKIVA------- 250
EL + L++EY +K +D +N S+ K V
Sbjct: 97 ELKSVIHHNHRLHLIFEYAENDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 251 -------SNILLNDDFEA-----KISDFGLARLISDCESHVST--VVAGTIGYVPPE--Y 294
N+LL+ + KI DFGLAR T ++ T+ Y PPE
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII--TLWYRPPEILL 210
Query: 295 GGTGKATERGDVYSFGVILLELVTGK 320
G +T D++S I E++
Sbjct: 211 GSRHYSTSV-DIWSIACIWAEMLMKT 235
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 6e-12
Identities = 16/48 (33%), Positives = 25/48 (52%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIMGS 48
+ L L LN++ N L GE+P+ G Q + + NK LCG + +
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 13/44 (29%), Positives = 22/44 (50%), Gaps = 2/44 (4%)
Query: 3 SLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ L+ L+ + N L G +P S NL ++ GN+ + G I
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR-ISGAI 165
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 12/41 (29%), Positives = 20/41 (48%), Gaps = 2/41 (4%)
Query: 6 NLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
NL +++L+ N LEG+ G +N + L N L +
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS-LAFDL 237
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 3e-04
Identities = 10/44 (22%), Positives = 17/44 (38%), Gaps = 2/44 (4%)
Query: 3 SLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
L L YL + + G +P + L + + N L G +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA-LSGTL 141
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 12/43 (27%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45
S N ++LA N L ++ + G+ +NL+ + L N+ + G +
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR-IYGTL 260
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 6e-04
Identities = 12/46 (26%), Positives = 20/46 (43%), Gaps = 3/46 (6%)
Query: 2 CSLPNLLYLNLAD-NRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+LP L +L + N L G +P + L + +T + G I
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-VSGAI 117
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 48/223 (21%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
++ + IG G +G V + VA+KK+S + + E++ L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRF 82
Query: 200 KHQNLVELL-----GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA---- 250
+H+N++ + ++ +V + M + L L+ Q S D
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSND---HICYFLYQIL 138
Query: 251 ------------------SNILLNDDFEAKISDFGLARLISDCESHVSTV---VAGTIGY 289
SN+LLN + KI DFGLAR+ H + VA T Y
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWY 197
Query: 290 VPPEY-GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
PE + T+ D++S G IL E+++ + P F K
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKH 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 70/258 (27%), Positives = 109/258 (42%), Gaps = 45/258 (17%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDRE-FAAEMETLGMVKHQNLVELLG 209
+G G FG V G G VAVK L + E++ L + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRN--------------QAAS-LDWGKRCKIV----- 249
S + +V EY+ G L D++ Q S +D+ R +V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYS 308
N+LL+ AKI+DFGL+ ++SD + T G+ Y PE G A D++S
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSD-GEFLRT-SCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368
GVIL L+ G P F+D E++ + K + P LN + ++ M
Sbjct: 197 CGVILYALLCGTLP----FDD---EHVPT----LFKKIRGGVFYIPEYLNRSVATLLMHM 245
Query: 369 LQIATGCISNDPTVRPTM 386
LQ+ DP R T+
Sbjct: 246 LQV-------DPLKRATI 256
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 53/229 (23%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
++ F ++++G G +G V T P G+ VA+KK+ FA E++ L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHF 66
Query: 200 KHQNLVELL-----GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA---- 250
KH+N++ + E ++ E M + L + Q S D +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDD---HIQYFIYQTL 122
Query: 251 ------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI---GY 289
SN+L+N + + K+ DFGLAR+I + + S +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 290 V------PPEY-GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
V PE + K + DV+S G IL EL + P F +D
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIFPGRD 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 48/221 (21%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
++ + +G G +G+V G VAVKKLS+ A E+ L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHM 85
Query: 200 KHQNLVELL------GYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--- 250
KH+N++ LL + LV M L++ ++ Q + D + +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDD---HVQFLIYQI 141
Query: 251 -------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP 291
SN+ +N+D E KI DFGLAR +D ++ VA T Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVA-TRWYRA 197
Query: 292 PE-YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
PE + D++S G I+ EL+TG+ F D
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTD 234
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 49/287 (17%), Positives = 86/287 (29%), Gaps = 59/287 (20%)
Query: 133 LQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAE 192
L KL + IV N + E + ++ + +
Sbjct: 58 LAKLEHPGIVRYFNAWLETP------PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVK 111
Query: 193 METLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA--------SLDWGK 244
+ + +N V L S + + K +L DW+ + + L
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 245 ----------RCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA----- 284
++ SNI D K+ DFGL + E + +
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 285 ------GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338
GT Y+ PE + + D++S G+IL EL+ T E
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-STQMERVR--------- 281
Query: 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
++ ++N + + P M+Q +S PT RP
Sbjct: 282 IITDVRNLKFPLLFT------QKYPQEHMMVQ---DMLSPSPTERPE 319
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 18/132 (13%), Positives = 36/132 (27%), Gaps = 4/132 (3%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQN 203
F +G GGFG VF+ D A+K++ + RE E++ L ++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVASNILLNDDFEAKI 263
+V + + E ++ + ++
Sbjct: 66 IVR--YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 264 SDFGLARLISDC 275
Sbjct: 124 VGQLQPSSPKVY 135
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G +G V + VAVK + +E + M+ H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA---------------ASLDWGKRCKIV--- 249
G+ + L EY G L D + A + + I
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 250 --ASNILLNDDFEAKISDFGLARLISDC--ESHVSTVVAGTIGYVPPE-YGGTGKATERG 304
N+LL++ KISDFGLA + E ++ + GT+ YV PE E
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHAEPV 189
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKD 331
DV+S G++L ++ G+ P ++
Sbjct: 190 DVWSCGIVLTAMLAGELP----WDQPS 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 46/258 (17%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDRE-FAAEMETLGMVKHQNLVELLG 209
+G G FG V T + VA+K + E+ L +++H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRN--------------QAAS-LDWGKRCKIV----- 249
+ + ++V EY G L D++ Q +++ R KIV
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYS 308
N+LL+D+ KI+DFGL+ +++D + + T G+ Y PE G A DV+S
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTD-GNFLKT-SCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368
G++L ++ G+ P F+D E + + + K + + P L+ ++ + +M
Sbjct: 194 CGIVLYVMLVGRLP----FDD---EFIPN----LFKKVNSCVYVMPDFLSPGAQSLIRRM 242
Query: 369 LQIATGCISNDPTVRPTM 386
+ DP R T+
Sbjct: 243 IVA-------DPMQRITI 253
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 54/221 (24%)
Query: 151 ENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAA-EMETLGMV-KHQNLVEL 207
V+G G G V + + A+K L D A E+E + ++V +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRI 120
Query: 208 LGYC----SVDEEKLLVYEYMVKGSLDDWLRNQ---------AASLDWGKRCKIVAS--- 251
+ + + L+V E + G L ++++ A+ + K +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIGEAIQ 175
Query: 252 ---------------NILLNDDFEA---KISDFGLARLISDCESHVSTVVAGTIGYVPPE 293
N+L K++DFG A+ + S ++T T YV PE
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPE 233
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334
G K + D++S GVI+ L+ G P F G
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLA 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 31/207 (14%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAA-EMETLGMVKHQNLVELLG 209
+G G FG V G G VAVK L + E++ L + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWL-----------RN---QAAS-LDWGKRCKIV----- 249
S + +V EY+ G L D++ R Q S +D+ R +V
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 250 ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERGDVYS 308
N+LL+ AKI+DFGL+ ++SD + T G+ Y PE G A D++S
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENL 335
GVIL L+ G P F+D L
Sbjct: 202 SGVILYALLCGTLP----FDDDHVPTL 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 8e-11
Identities = 55/273 (20%), Positives = 97/273 (35%), Gaps = 82/273 (30%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLV 205
+G G FG V + G+ A+K L + ++ E L +V H ++
Sbjct: 13 TLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGK----RCKIVAS--------- 251
+ D +++ ++ +Y+ G L LR + K A+
Sbjct: 70 RMW-GTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYL 122
Query: 252 -------------NILLNDDFEAKISDFGLARLISD-----CESHVSTVVAGTIGYVPPE 293
NILL+ + KI+DFG A+ + D C GT Y+ PE
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---------GTPDYIAPE 173
Query: 294 ---YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350
K+ D +SFG+++ E++ G P F D + + + E
Sbjct: 174 VVSTKPYNKSI---DWWSFGILIYEMLAGYTP----FYDSN-------TMKTYEKILNAE 219
Query: 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVR 383
+ P N + K + + I+ D + R
Sbjct: 220 LRFPPFFNEDVK-------DLLSRLITRDLSQR 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 53/288 (18%), Positives = 90/288 (31%), Gaps = 89/288 (30%)
Query: 86 NRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGT 145
N + + + + + ++ + + PS DQ
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWET--------------PSQNTAQLDQ----- 42
Query: 146 NKFCEENVIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGM 198
F +G G FG V K + G A+K L + ++ E L
Sbjct: 43 --FDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 199 VKHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGK----RCKIVAS-- 251
V LV+L + D L +V EY+ G + LR G+ + A+
Sbjct: 98 VNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQI 150
Query: 252 --------------------NILLNDDFEAKISDFGLARLISD-----CESHVSTVVAGT 286
N+L++ +++DFG A+ + C GT
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---------GT 201
Query: 287 IGYVPPE---YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
+ PE G KA D ++ GV++ E+ G P F
Sbjct: 202 PEALAPEIILSKGYNKAV---DWWALGVLIYEMAAGYPP----FFADQ 242
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 48/212 (22%), Positives = 80/212 (37%), Gaps = 48/212 (22%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAAEMETLGMVKHQNLVEL 207
+G G +G V + VAVK + +E + M+ H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQA---------------ASLDWGKRCKIV--- 249
G+ + L EY G L D + A + + I
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 250 --ASNILLNDDFEAKISDFGLARLISDC--ESHVSTVVAGTIGYVPPE------YGGTGK 299
N+LL++ KISDFGLA + E ++ + GT+ YV PE +
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA--- 186
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
E DV+S G++L ++ G+ P ++
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELP----WDQPS 212
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 48/233 (20%), Positives = 84/233 (36%), Gaps = 59/233 (25%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
+++ + +G GG G VF K VA+KK+ D + E++ + +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL----TDPQSVKHALREIKIIRRL 65
Query: 200 KHQNLVELL----------GYCSVDEEKL----LVYEYMVKGSLDDWLRNQAASLDWGKR 245
H N+V++ +L +V EYM + L + L +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEE---H 121
Query: 246 CKIVA----------------------SNILLN-DDFEAKISDFGLARLISDCESHVSTV 282
++ +N+ +N +D KI DFGLAR++ SH +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 283 ---VAGTIGYVPPE-YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD 331
+ T Y P T+ D+++ G I E++TGK F
Sbjct: 182 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAH 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 11/96 (11%)
Query: 252 NILLNDDFEA--KISDFGLARLISDC---ESHVSTVVAGTIGYVPPE--YGGTGKATERG 304
N L + + K+ DFGL++ E + T AGT +V PE +
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
D +S GV+L L+ G P F + + + VL
Sbjct: 258 DAWSAGVLLHLLLMGAVP----FPGVNDADTISQVL 289
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 19/85 (22%), Positives = 29/85 (34%), Gaps = 6/85 (7%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVK-----KLSQATGQGDREFAAEMETLGMVKHQNLVE 206
IG G +G V A+K K+ Q + E+ + + H N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDD 231
L ++ LV E G L D
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLD 117
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 61/250 (24%), Positives = 97/250 (38%), Gaps = 51/250 (20%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLV 205
++G G FG V K T G+ A+K L + E A E L +H L
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AASLDWG-----KRCKI 248
L Y ++L V EY G L L + A + +
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
V N++L+ D KI+DFGL + + + T GT Y+ PE G+A
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 329
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
D + GV++ E++ G+ P F ++D E L + +L +E+ P L
Sbjct: 330 V---DWWGLGVVMYEMMCGRLP----FYNQDHEKLFELILM-------EEIRFPRTLGPE 375
Query: 361 SKPTMLKMLQ 370
+K + +L+
Sbjct: 376 AKSLLSGLLK 385
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 8e-10
Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 65/267 (24%)
Query: 153 VIGGGGFGTVF---KGTMPD-GKTVAVKKLSQATGQGDREFAAEME--TLGMVKHQNLVE 206
V+G G FG VF K + D + A+K L +AT + +ME L V H +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 207 LLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGK----RCKIVAS---------- 251
L Y E KL L+ +++ G L L + K +
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLH 143
Query: 252 ------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGG 296
NILL+++ K++DFGL++ D E + GT+ Y+ PE G
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 202
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356
++ D +SFGV++ E++TG P F+ KD + + +L ++ P
Sbjct: 203 HTQSA---DWWSFGVLMFEMLTGTLP----FQGKDRKETMTMILK-------AKLGMPQF 248
Query: 357 LNANSKPTMLKMLQIATGCISNDPTVR 383
L+ ++ + + + +P R
Sbjct: 249 LSPEAQSLLRMLFK-------RNPANR 268
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 50/211 (23%), Positives = 74/211 (35%), Gaps = 41/211 (19%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS 212
IG G FG + VAVK + + + E+ ++H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86
Query: 213 VDEEKLLVYEYMVKGSLDDWLRN--------------QAAS-LDWGKRCKIV-----ASN 252
++ EY G L + + N Q S + + +I N
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLEN 146
Query: 253 ILLNDDFEA--KISDFGLARLISDCESHVSTVVAGTIGYVPPE------YGGTGKATERG 304
LL+ KI DFG ++ S + V GT Y+ PE Y G A
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVLLRQEYDGK-IA---- 199
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
DV+S GV L ++ G P FED +
Sbjct: 200 DVWSCGVTLYVMLVGAYP----FEDPEEPRD 226
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 65/293 (22%), Positives = 103/293 (35%), Gaps = 58/293 (19%)
Query: 90 DPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTNKFC 149
E + + D L + A +K+ + F
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-------FE 57
Query: 150 EENVIGGGGFGTVF---KGTMPD-GKTVAVKKLSQAT-GQGDREFA---AEMETLGMVKH 201
V+G G +G VF K + D GK A+K L +AT Q + E + L ++
Sbjct: 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 202 QN-LVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAASLDWGK----RCKIVAS---- 251
LV L Y E KL L+ +Y+ G L L + + +I
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVL 170
Query: 252 ------------------NILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE 293
NILL+ + ++DFGL++ E+ + GTI Y+ P+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 294 -----YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
G KA D +S GV++ EL+TG P + E + +L
Sbjct: 231 IVRGGDSGHDKAV---DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 53/239 (22%), Positives = 82/239 (34%), Gaps = 63/239 (26%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLG-M 198
K+ +G G +G V+K G+ VAVKK+ A + A E+ L +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--NSTDAQRTFREIMILTEL 65
Query: 199 VKHQNLVELLG--YCSVDEEKLLVYEYMVKGS-LDDWLRNQAASLDWGKRCKIVA----- 250
H+N+V LL D + LV++YM + L +R + V
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV---HKQYVVYQLIK 120
Query: 251 -----------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE 293
SNILLN + K++DFGL+R + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 294 YGGTGKATE-------RG--------------DVYSFGVILLELVTGKQPTGPEFEDKD 331
T+ R D++S G IL E++ GK P F
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK----PIFPGSS 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 68/263 (25%), Positives = 111/263 (42%), Gaps = 55/263 (20%)
Query: 153 VIGGGGFGTVF---KGTMPD-GKTVAVKKLSQAT-GQGDREFA---AEMETLGMVKHQNL 204
V+G GG+G VF K T + GK A+K L +A + ++ A AE L VKH +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKI 248
V+L+ Y KL L+ EY+ G L L + A +L + I
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
+ NI+LN K++DFGL + + T GTI Y+ PE G +A
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRSGHNRA 201
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
D +S G ++ +++TG P F ++ + +D +L ++ P L
Sbjct: 202 V---DWWSLGALMYDMLTGAPP----FTGENRKKTIDKILK-------CKLNLPPYLTQE 247
Query: 361 SKPTMLKMLQIATGCISNDPTVR 383
++ + K+L+ + R
Sbjct: 248 ARDLLKKLLK-------RNAASR 263
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 13/43 (30%), Positives = 20/43 (46%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43
M +L L ++L++N L G +P G + N LCG
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 15/46 (32%), Positives = 22/46 (47%), Gaps = 2/46 (4%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ L NL L L++N G +P G C++L + L N G I
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL-FNGTI 554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 17/46 (36%), Positives = 25/46 (54%), Gaps = 2/46 (4%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ + L L L N L GE+P C NL+ +SL+ N+ L G+I
Sbjct: 462 LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR-LTGEI 506
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 17/46 (36%), Positives = 23/46 (50%), Gaps = 2/46 (4%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ SL L L L N LEGE+P+ + L + L N L G+I
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND-LTGEI 482
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 15/46 (32%), Positives = 23/46 (50%), Gaps = 2/46 (4%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ + L+ L+L+ N L G +P S G L + L N L G+I
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM-LEGEI 458
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 17/46 (36%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ + NL +++L++NRL GE+P+ G +NL+I+ L+ N G I
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS-FSGNI 530
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 13/43 (30%), Positives = 22/43 (51%), Gaps = 2/43 (4%)
Query: 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45
+ L LN++ N+ G +P ++L +SL NK G+I
Sbjct: 245 TCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENK-FTGEI 285
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 13/44 (29%), Positives = 21/44 (47%), Gaps = 2/44 (4%)
Query: 3 SLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ L L+L+ N G VP G C L ++L+ N G++
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN-FSGEL 334
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 13/45 (28%), Positives = 22/45 (48%), Gaps = 1/45 (2%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45
+ NL +L+++ N +P G C L + ++GNK L G
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNK-LSGDF 239
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 17/46 (36%), Positives = 26/46 (56%), Gaps = 3/46 (6%)
Query: 2 CSLPNLLYLNLADNRLEGEVPRS--GICQNLSIMSLTGNKDLCGKI 45
L +L YL+LA+N+ GE+P G C L+ + L+GN G +
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH-FYGAV 310
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 11/44 (25%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 3 SLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
L +L+++ N+L G+ R+ C L +++++ N+ G I
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ-FVGPI 263
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 7/46 (15%), Positives = 15/46 (32%), Gaps = 2/46 (4%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45
+ L N+ G + ++ + ++ N L G I
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNM-LSGYI 648
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 50/249 (20%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMVKHQNLV 205
++G G FG V K T G+ A+K L + E A E L +H L
Sbjct: 12 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKIV 249
L Y ++L V EY G L L + A +L++ +V
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKAT 301
N++L+ D KI+DFGL + + + T GT Y+ PE G+A
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
D + GV++ E++ G+ P F ++D E L + +L +E+ P L+ +
Sbjct: 187 ---DWWGLGVVMYEMMCGRLP----FYNQDHERLFELILM-------EEIRFPRTLSPEA 232
Query: 362 KPTMLKMLQ 370
K + +L+
Sbjct: 233 KSLLAGLLK 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 65/327 (19%), Positives = 114/327 (34%), Gaps = 56/327 (17%)
Query: 81 WIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQ 140
+ + EE + + + R + A E + ++
Sbjct: 271 GVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330
Query: 141 IVAGTNKFCEEN-----VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA- 190
++ + V+G G FG V KGT + AVK L + D +
Sbjct: 331 NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVEC 387
Query: 191 --AEMETLGMV-KHQNLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------- 236
E L + K L +L C ++L V EY+ G L ++
Sbjct: 388 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 446
Query: 237 -AASLDWGKRC----KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGT 286
AA + G I+ N++L+ + KI+DFG+ + T GT
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGT 505
Query: 287 IGYVPPE---YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM 343
Y+ PE Y GK+ D ++FGV+L E++ G+ P FE +D + L ++
Sbjct: 506 PDYIAPEIIAYQPYGKSV---DWWAFGVLLYEMLAGQAP----FEGEDEDELFQSIME-- 556
Query: 344 KNEQADEVLDPAVLNANSKPTMLKMLQ 370
V P ++ + ++
Sbjct: 557 -----HNVAYPKSMSKEAVAICKGLMT 578
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 64/263 (24%), Positives = 100/263 (38%), Gaps = 58/263 (22%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMV-KHQNL 204
++G G FG VF K T + A+K L + D + E L + +H L
Sbjct: 24 MLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKI 248
+ +E L V EY+ G L +++ AA L + I
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
V NILL+ D KI+DFG+ + ++ +T GT Y+ PE +
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHS 198
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
D +SFGV+L E++ G+ P F +D E L + D P L
Sbjct: 199 V---DWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRM-------DNPFYPRWLEKE 244
Query: 361 SKPTMLKMLQIATGCISNDPTVR 383
+K ++K+ +P R
Sbjct: 245 AKDLLVKLFV-------REPEKR 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 58/221 (26%), Positives = 85/221 (38%), Gaps = 44/221 (19%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGM-VKHQNL 204
VIG G FG V K AVK L + +E +E L VKH L
Sbjct: 45 VIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKI 248
V L + +KL V +Y+ G L L+ + AA +L + I
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
V NILL+ ++DFGL + + S ST GT Y+ PE +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQPYDRT 219
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
D + G +L E++ G P F ++ + D +L+
Sbjct: 220 V---DWWCLGAVLYEMLYGLPP----FYSRNTAEMYDNILN 253
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 47/245 (19%), Positives = 81/245 (33%), Gaps = 69/245 (28%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLGMV 199
+ + +++IG G +G V+ K VA+KK+++ D E+ L +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRL 82
Query: 200 KHQNLVELL-----GYCSVDEEKLLVYEYMVKGSLDDWLR-----NQAASLDWGKRCK-- 247
K ++ L +E +V E D L+ + + K
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEE---HIKTI 134
Query: 248 ----------IVASNI----------LLNDDFEAKISDFGLARLI-SDCESHVSTVVAGT 286
I S I LLN D K+ DFGLAR I S+ ++++ +
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 287 IGYVPPEYGGTGKATE-------RG--------------DVYSFGVILLELVTGKQPTGP 325
P + T R D++S G I EL+ Q
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 326 EFEDK 330
+ ++
Sbjct: 255 DPTNR 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 35/208 (16%), Positives = 77/208 (37%), Gaps = 60/208 (28%)
Query: 154 IGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-------HQNLV 205
+G G + VF+ + + + V VK L + + + +K N++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKK-KIKREIKILENLRGGPNII 94
Query: 206 ELLGYCSVDEEK--LLVYEYM-------VKGSLDDW---------LRNQAASLDWGKRCK 247
L + LV+E++ + +L D+ L+ +LD+
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK----ALDYCHSMG 150
Query: 248 IV-----ASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-------Y 294
I+ N++++ + + ++ D+GLA + + V + + PE Y
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQMY 208
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQP 322
D++S G +L ++ K+P
Sbjct: 209 ------DYSLDMWSLGCMLASMIFRKEP 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 62/263 (23%), Positives = 100/263 (38%), Gaps = 58/263 (22%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMV-KHQNL 204
V+G G FG V KGT + AVK L + D + E L + K L
Sbjct: 27 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AA----SLDWGKRCKI 248
+L C ++L V EY+ G L ++ AA L + + I
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
+ N++L+ + KI+DFG+ + T GT Y+ PE Y GK+
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQPYGKS 201
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
D ++FGV+L E++ G+ P FE +D + L ++ V P ++
Sbjct: 202 V---DWWAFGVLLYEMLAGQAP----FEGEDEDELFQSIME-------HNVAYPKSMSKE 247
Query: 361 SKPTMLKMLQIATGCISNDPTVR 383
+ ++ P R
Sbjct: 248 AVAICKGLMT-------KHPGKR 263
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 13/97 (13%)
Query: 251 SNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE--YGGTGKATERGDVY 307
N+L+N D K+ DFG A+ + E V+ + + Y PE G T + T D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGAT-EYTPSIDLW 226
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
S G + EL+ GK P F GE +D ++ +++
Sbjct: 227 SIGCVFGELILGK----PLFS---GETSIDQLVRIIQ 256
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 18/68 (26%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA-EMETLGMVKHQ 202
+ K+ +G G FG V + + GK A+KK+ Q D + E++ + ++ H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 203 NLVELLGY 210
N+++L+ Y
Sbjct: 61 NIIKLVDY 68
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 62/263 (23%), Positives = 104/263 (39%), Gaps = 58/263 (22%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMV-KHQNL 204
V+G G FG V K T G AVK L + D + E L + H L
Sbjct: 30 VLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AASLDWGKRC----KI 248
+L C ++L V E++ G L ++ AA + I
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
+ N+LL+ + K++DFG+ + +T GT Y+ PE G A
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEMLYGPA 204
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
D ++ GV+L E++ G P FE ++ ++L + +L+ DEV+ P L+ +
Sbjct: 205 V---DWWAMGVLLYEMLCGHAP----FEAENEDDLFEAILN-------DEVVYPTWLHED 250
Query: 361 SKPTMLKMLQIATGCISNDPTVR 383
+ + + +PT+R
Sbjct: 251 ATGILKSFMT-------KNPTMR 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 54/268 (20%), Positives = 93/268 (34%), Gaps = 59/268 (22%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMV-KHQNL 204
VIG G + V K T + A+K + + D + E H L
Sbjct: 16 VIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AASLDWGKRC----KI 248
V L C E +L V EY+ G L ++ Q +A + I
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
+ N+LL+ + K++D+G+ + ST GT Y+ PE G +
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFS 190
Query: 301 TERGDVYSFGVILLELVTGKQP-----TGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355
D ++ GV++ E++ G+ P + + + L +L ++ P
Sbjct: 191 V---DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQIRIPR 240
Query: 356 VLNANSKPTMLKMLQIATGCISNDPTVR 383
L+ + + L DP R
Sbjct: 241 SLSVKAASVLKSFLN-------KDPKER 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 48/309 (15%), Positives = 92/309 (29%), Gaps = 83/309 (26%)
Query: 85 SNRQSDPEETRESKR--NSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIV 142
S+ + ++ + S S Q + SS + + ++
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI----------- 51
Query: 143 AGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAA----EMETLG 197
+++ ++IG G +G V + + + VA+KK+ + D E+ L
Sbjct: 52 --PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILN 107
Query: 198 MVKHQNLVELL-----GYCSVDEEKLLVYEYMVKGS-LDDWLR-NQAASLDWGKRCK--- 247
+ H ++V++L +E +V E S R + K
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTEL---HIKTLL 162
Query: 248 ---------IVASNIL----------LNDDFEAKISDFGLARLISDCESHVSTVVAGTIG 288
+ ++ IL +N D K+ DFGLAR + E+ S +
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 289 YVPPEYGGTGKATERG---------------------------DVYSFGVILLELVTGKQ 321
+ DV+S G I EL+ +
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 322 PTGPEFEDK 330
D+
Sbjct: 283 ENVAYHADR 291
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 53/268 (19%), Positives = 93/268 (34%), Gaps = 59/268 (22%)
Query: 153 VIGGGGFGTVF----KGTMPDGKTVAVKKLSQATGQGDREFA---AEMETLGMV-KHQNL 204
VIG G + V K T + A++ + + D + E H L
Sbjct: 59 VIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 205 VELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ-----------AASLDWGKRC----KI 248
V L C E +L V EY+ G L ++ Q +A + I
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE---YGGTGKA 300
+ N+LL+ + K++D+G+ + ST GT Y+ PE G +
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFS 233
Query: 301 TERGDVYSFGVILLELVTGKQP-----TGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355
D ++ GV++ E++ G+ P + + + L +L ++ P
Sbjct: 234 V---DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQIRIPR 283
Query: 356 VLNANSKPTMLKMLQIATGCISNDPTVR 383
L+ + + L DP R
Sbjct: 284 SLSVKAASVLKSFLN-------KDPKER 304
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 37/202 (18%), Positives = 63/202 (31%), Gaps = 67/202 (33%)
Query: 153 VIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDRE-FAAEMETLG-MVKHQNLVELLG 209
V+G G G V + + A+K L D E+E + ++V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 210 YC----SVDEEKLLVYEYMVKGSLDDWLRNQ---------AASLDWGKRCKIVAS----- 251
+ + L+V E + G L ++++ A+ + K +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIGEAIQYL 133
Query: 252 -------------NILL---NDDFEAKISDFGLARLI--------SDCESHVSTVVAGTI 287
N+L + K++DFG A+ D S G I
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWS------LGVI 187
Query: 288 GY-----VPPEYGGTGKATERG 304
Y PP Y G A G
Sbjct: 188 MYILLCGYPPFYSNHGLAISPG 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 43/339 (12%), Positives = 89/339 (26%), Gaps = 125/339 (36%)
Query: 11 NLADNRLEGEVPRSGICQNLSIMSLTG--NKDLCGKIMGSDCKILTFGKLALVGIVVGSV 68
+ D L + I + M+LT K L K + + L ++ +
Sbjct: 276 QVTD-FLSAAT-TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ-----DLPRE-VLTTNP 327
Query: 69 LVIAIIVSVLWWWIQRSNRQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAM 128
++II E R+ + D + D+ L + +L +
Sbjct: 328 RRLSII----------------AESIRD--GLATWDNWKHVNCDK----LTTIIESSLNV 365
Query: 129 FEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLS----QATGQ 184
EP+ + +D++ VF P + LS
Sbjct: 366 LEPAEYRKMFDRLS-------------------VF----PPSAHIPTILLSLIWFDVIKS 402
Query: 185 GDREFAAEMETLGMVK---------------------------HQNLVE----LLGYCSV 213
++ +V+ H+++V+ + S
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 214 DEEKLLV----YEY----MVKGS------------LD-DWLRNQ--AASLDWGKRCKIVA 250
D + Y + + LD +L + S W I+
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 251 ---------SNILLND-DFEAKISDFGLARLISDCESHV 279
I ND +E ++ + + E ++
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENL 559
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 23/144 (15%), Positives = 43/144 (29%), Gaps = 8/144 (5%)
Query: 199 VKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVASNILLNDD 258
+K +N++ + + E+ G+ + + + +
Sbjct: 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232
Query: 259 FEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT 318
+ KI+D G A + + T Y E D++S + EL T
Sbjct: 233 LKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
Query: 319 GKQPTGPEFEDKDGENLVDWVLHM 342
G FE GE H+
Sbjct: 289 GDYL----FEPHSGEEYTRDEDHI 308
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 57/214 (26%), Positives = 79/214 (36%), Gaps = 67/214 (31%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKL-------SQATGQGDREFAAEMETLGMVKHQ-- 202
VIG G FG V K + VA+K + QA A E+ L ++ Q
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEIRILEHLRKQDK 155
Query: 203 ----NLVELLGY-------CSVDEEKLL---VYEYMVKG-----SLDDWLRNQA----AS 239
N++ +L C E LL +YE + K SL +R A
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 240 LDWGKRCKIVAS-----NILLND--DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPP 292
LD + +I+ NILL K+ DFG + V T + + Y P
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFYRAP 268
Query: 293 E------YGGTGKATERGDVYSFGVILLELVTGK 320
E YG D++S G IL EL+TG
Sbjct: 269 EVILGARYG------MPIDMWSLGCILAELLTGY 296
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 388 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.73 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.6 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 97.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.61 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.52 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 97.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.05 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.92 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 96.84 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 96.81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 96.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 96.62 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 96.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 96.53 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 96.52 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 96.51 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 96.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 96.42 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 96.35 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 96.23 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 96.21 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 96.17 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 96.13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 96.09 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 96.07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 96.05 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.03 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 95.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.99 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 95.98 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 95.94 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.94 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 95.91 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 95.9 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 95.86 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 95.85 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 95.82 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 95.8 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 95.78 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 95.76 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 95.72 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 95.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 95.64 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 95.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 95.57 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 95.55 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 95.52 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 95.5 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 95.46 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 95.42 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 95.34 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 95.26 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 95.2 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 95.19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 95.13 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 95.07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 95.06 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 95.03 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 94.94 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 94.93 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 94.92 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 94.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 94.91 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.87 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 94.75 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 94.74 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 94.7 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 94.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 94.66 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 94.64 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 94.63 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 94.62 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 94.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 94.59 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 94.59 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 94.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 94.49 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 94.41 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 94.34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 94.28 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 94.25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 94.24 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 94.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 94.19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 94.09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 93.98 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 93.98 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 93.94 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 93.91 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 93.9 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 93.86 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 93.83 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 93.8 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 93.72 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 93.64 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 93.64 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 93.62 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 93.57 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 93.56 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 93.55 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 93.49 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 93.42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 93.39 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 93.38 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 93.35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 93.33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 93.26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 93.25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 93.13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 93.09 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 93.07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 93.06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 93.04 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 92.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 92.92 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 92.87 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 92.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 92.76 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 92.72 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 92.66 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 92.58 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 92.55 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 92.45 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.34 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 92.29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 92.18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 92.16 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 92.08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 92.0 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 91.79 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 91.74 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 91.72 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 91.64 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 91.62 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 91.59 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 91.27 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 90.95 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.86 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 90.76 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 90.56 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 90.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 90.18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 90.08 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 90.06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 90.02 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 89.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 89.3 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 88.65 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 88.64 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 87.92 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 86.85 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 86.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 85.66 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 82.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 81.15 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 80.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 80.77 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 80.46 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=387.76 Aligned_cols=226 Identities=28% Similarity=0.482 Sum_probs=179.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677889999999999999863 477899999987665566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc----------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 220 VYEYMVKGSLDDWLRNQ----------------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~----------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
|||||++|+|.++|++. +.++.|+| |+||+|+|||+++++.+||+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCc
Confidence 99999999999999642 22455666 5688999999999999999999
Q ss_pred ccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 267 GLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 267 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
|+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||... +..++...+.....
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~----~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL----SNNEVIECITQGRV 248 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHHTCC
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHcCCC
Confidence 999876543322 2233569999999999999999999999999999999999 89998542 33444444433211
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .. | .....++.+++.+||+.||++||||+|
T Consensus 249 ~----~~--p-------~~~~~~~~~li~~cl~~dP~~RPs~~~ 279 (299)
T 4asz_A 249 L----QR--P-------RTCPQEVYELMLGCWQREPHMRKNIKG 279 (299)
T ss_dssp C----CC--C-------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C----CC--C-------ccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 1 10 1 112236889999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=388.60 Aligned_cols=226 Identities=31% Similarity=0.500 Sum_probs=173.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667788999999999999864 477899999987665566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc------------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 220 VYEYMVKGSLDDWLRNQ------------------------------AASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
|||||++|+|.++|++. +.++.|+| |+||+|+|||+++++.+||+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEc
Confidence 99999999999998642 12445566 56889999999999999999
Q ss_pred ccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHh
Q 035768 265 DFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 265 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||... +..++...+...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~----~~~~~~~~i~~g 276 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL----SNTEAIDCITQG 276 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS----CHHHHHHHHHHT
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC----CHHHHHHHHHcC
Confidence 9999997654332 23345679999999999999999999999999999999999 89998532 334444444332
Q ss_pred hccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. .| . ....++.+|+.+||+.||++||||+|
T Consensus 277 ~~~~------~p---~----~~~~~~~~li~~cl~~dP~~RPs~~e 309 (329)
T 4aoj_A 277 RELE------RP---R----ACPPEVYAIMRGCWQREPQQRHSIKD 309 (329)
T ss_dssp CCCC------CC---T----TCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCCC------Cc---c----cccHHHHHHHHHHcCcChhHCcCHHH
Confidence 1111 01 1 12236889999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=385.68 Aligned_cols=225 Identities=25% Similarity=0.388 Sum_probs=177.1
Q ss_pred CCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++...+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999863 467899999975433 345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCCCCEEE
Q 035768 220 VYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDDFEAKI 263 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl 263 (388)
|||||++|||.++|+.. +.++.|+| |+||+|+|||+++++.+||
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEE
Confidence 99999999999999532 22455666 5688999999999999999
Q ss_pred cccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHH
Q 035768 264 SDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLH 341 (388)
Q Consensus 264 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 341 (388)
+|||+|+.+..... .......||+.|||||++.++.|+.++|||||||+||||+| |+.||... +..++.+.+..
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~----~~~~~~~~i~~ 262 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDVVEMIRN 262 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC----CHHHHHHHHHT
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHc
Confidence 99999987644322 22344679999999999999999999999999999999999 89997542 34445444432
Q ss_pred hhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 342 MMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ..... +..+...+.+|+.+||+.||++||||+|
T Consensus 263 ~----~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~e 296 (308)
T 4gt4_A 263 R----QVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKD 296 (308)
T ss_dssp T----CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C----CCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 1 11111 1112346889999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=374.32 Aligned_cols=230 Identities=26% Similarity=0.404 Sum_probs=169.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..+++...+.||+|+||+||+|++.+ .||||+++.... ...+.|.+|+++|++++|||||+++|+|. ++..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEE
Confidence 34567778899999999999999754 599999975432 33467999999999999999999999886 45689999
Q ss_pred eccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-cce
Q 035768 222 EYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE-SHV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~-~~~ 279 (388)
|||++|+|.++|+... .+|.|+| |+||||+|||+++++.+||+|||+|+...... ...
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 9999999999996532 3556666 56889999999999999999999998765322 223
Q ss_pred eeccccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 280 STVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
....+||+.|||||++. ..+|+.++|||||||+||||+||+.||.... ....+...+........... .
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~---~~~~~~~~~~~~~~~p~~~~-----~ 262 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN---NRDQIIFMVGRGYASPDLSK-----L 262 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CHHHHHHHHHTTCCCCCSTT-----S
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC---hHHHHHHHHhcCCCCCCccc-----c
Confidence 34567999999999874 4469999999999999999999999985321 11222222222111111110 1
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++||||.|
T Consensus 263 ----~~~~~~~l~~li~~cl~~dP~~RPs~~e 290 (307)
T 3omv_A 263 ----YKNCPKAMKRLVADCVKKVKEERPLFPQ 290 (307)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred ----cccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 1122346889999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=375.46 Aligned_cols=227 Identities=23% Similarity=0.296 Sum_probs=184.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+.|+..+.||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999964 69999999997665556677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.+++.+ ...+|.|+| |+||||+|||++.++.+||+|||+|+.+..... .....+|
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~G 232 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 232 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCS
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccccc
Confidence 99999998854 234677888 568899999999999999999999998754332 3345689
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|||||++....|+.++|||||||++|||++|+.||.. .+..++...+..... .....+ ....
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~~~i~~~~~----~~~~~~-------~~~s 297 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPLKAMKMIRDNLP----PRLKNL-------HKVS 297 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHHHHHHHSSC----CCCSCG-------GGSC
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHHHHHHcCCC----CCCCcc-------ccCC
Confidence 9999999999999999999999999999999999999853 233344433332111 111110 1112
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.||++|||++|
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHH
Confidence 36789999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=378.11 Aligned_cols=225 Identities=23% Similarity=0.340 Sum_probs=174.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5789999999999999999996 4699999999975432 234679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||++|+|.++|... ..+|.|+| |+||||+|||++.++.+||+|||+|+.+.... ...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccc
Confidence 99999999998532 23566777 56899999999999999999999998764321 223
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+||+.|||||++.+..|+.++|||||||++|||+||+.||... +..++...+... .... ....
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~----~~~~-----~~~~- 248 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----SMKNLVLKIISG----SFPP-----VSLH- 248 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHT----CCCC-----CCTT-
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHcC----CCCC-----CCcc-
Confidence 4567999999999999999999999999999999999999998532 333333333221 1111 1111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++.+++.+||+.||++|||++|
T Consensus 249 ---~s~~~~~li~~~L~~dP~~R~s~~e 273 (350)
T 4b9d_A 249 ---YSYDLRSLVSQLFKRNPRDRPSVNS 273 (350)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHH
Confidence 1236889999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=366.34 Aligned_cols=225 Identities=22% Similarity=0.318 Sum_probs=183.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+. .+++.||||++++. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999996 46999999999753 2234567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-ccee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE-SHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~-~~~~ 280 (388)
|||++|+|.+++++. ..+|.|+| |+||||+|||++.++.+||+|||+|+.+.... ....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 999999999988642 34677888 56889999999999999999999999875432 2234
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+||+.|||||++.+..|+.++||||+||++|||+||+.||.. .+..++.+.+.... .... ...
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~~~i~~~~--~~~p--------~~~ 257 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEGLIFAKIIKLE--YDFP--------EKF 257 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHTC--CCCC--------TTC
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHcCC--CCCC--------ccc
Confidence 457899999999999999999999999999999999999999853 23344444333211 0111 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ .++.+++.+||+.||++|||++|
T Consensus 258 s----~~~~dli~~lL~~dp~~R~t~~e 281 (311)
T 4aw0_A 258 F----PKARDLVEKLLVLDATKRLGCEE 281 (311)
T ss_dssp C----HHHHHHHHHHSCSSGGGSTTSGG
T ss_pred C----HHHHHHHHHHccCCHhHCcChHH
Confidence 2 25789999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=362.91 Aligned_cols=221 Identities=26% Similarity=0.367 Sum_probs=168.6
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEE
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKLLVY 221 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 221 (388)
...+.||+|+||+||+|.+. +++.||||++.... ....+.|.+|+++|++++|||||+++++|.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999964 68899999996542 2334579999999999999999999999865 34579999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-------hhccccCCeeecC-CCCEEEcccccceeccCCCcc
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-------RCKIVASNILLND-DFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-------~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|||++|+|.+++++. +.+|.|+| |+||||+|||++. ++.+||+|||+|+.... .
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---S 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---T
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---C
Confidence 999999999988642 34677777 4578999999985 79999999999986533 2
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....+||+.|||||++. ++|+.++|||||||++|||+||+.||... .....+...+....... ....
T Consensus 186 ~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~---~~~~~~~~~i~~~~~~~--------~~~~ 253 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGVKPA--------SFDK 253 (290)
T ss_dssp SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC---SSHHHHHHHHTTTCCCG--------GGGG
T ss_pred ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CcHHHHHHHHHcCCCCC--------CCCc
Confidence 234568999999999886 46999999999999999999999998532 12222222222111111 1111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+ .++.+++.+||+.||++|||++|
T Consensus 254 ~~~----~~~~~li~~~L~~dP~~R~s~~e 279 (290)
T 3fpq_A 254 VAI----PEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp CCC----HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHH
Confidence 111 25788999999999999999854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=376.42 Aligned_cols=228 Identities=24% Similarity=0.305 Sum_probs=184.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+.|+..+.||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356889999999999999999964 6999999999876656667799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 224 MVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 224 ~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
|++|+|.++++. ...+|.|+| |+||||+|||++.++.+||+|||+|+.+..... .....+
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 308 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 308 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCE
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccc
Confidence 999999998853 244678888 568899999999999999999999998754332 334568
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
||+.|||||++.+..|+.++|||||||++|||++|+.||.. .+..++...+..... ..... ... .
T Consensus 309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~~~i~~~~~----~~~~~---~~~----~ 373 (423)
T 4fie_A 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPLKAMKMIRDNLP----PRLKN---LHK----V 373 (423)
T ss_dssp ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHHHHHHHSCC----CCCSC---TTS----S
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHHHHHHcCCC----CCCcc---ccc----C
Confidence 99999999999999999999999999999999999999853 233334433332111 11100 011 1
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+|+.+||+.||++|||+.|
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHH
Confidence 236789999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=366.50 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=169.2
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE----EKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e 222 (388)
+|...+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|..++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 355678899999999999998 68999999996532 11122345666677899999999999998754 5799999
Q ss_pred ccCCCCHHHHHhcc--------------CCCCCHHh-------------hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 223 YMVKGSLDDWLRNQ--------------AASLDWGK-------------RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 223 ~~~~g~L~~~l~~~--------------~~~l~~~~-------------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
||++|+|.++|++. +.+|.|+| |+||||+|||++.++++||+|||+|+.....
T Consensus 82 y~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 99999999998643 33567777 6799999999999999999999999987544
Q ss_pred Ccce---eeccccccCccCccccCCC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCC-------cccHHHHH
Q 035768 276 ESHV---STVVAGTIGYVPPEYGGTG------KATERGDVYSFGVILLELVTGKQPTGPEFEDKD-------GENLVDWV 339 (388)
Q Consensus 276 ~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~-------~~~~~~~~ 339 (388)
.... ....+||+.|||||++.+. .++.++|||||||+||||+||+.|+........ .....+.+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 3221 2345799999999988654 478899999999999999999887643211100 00111122
Q ss_pred HHhhccccccccCCccccCC-CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 340 LHMMKNEQADEVLDPAVLNA-NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........ .+|.+... ...+....+.+|+.+||+.||++||||.|
T Consensus 242 ~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 287 (303)
T 3hmm_A 242 RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 22222211 12222111 12355667899999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=365.64 Aligned_cols=223 Identities=20% Similarity=0.231 Sum_probs=173.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+.|...+.||+|+||+||+|++. +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777788999999999999964 699999999975432 247999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCcc----e
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESH----V 279 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~----~ 279 (388)
++|+|.++|++. ..+|.|+| |+||||+|||++.++ .+||+|||+|+.+...... .
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999999998642 34677887 568899999999987 6999999999987543221 2
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ...+...+..... ...+ +...
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~~~--~~~~-----~~~~ 281 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKIASEPP--PIRE-----IPPS 281 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHHHHSCC--GGGG-----SCTT
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHcCCC--Cchh-----cCcc
Confidence 234679999999999999999999999999999999999999986432 2233333322110 0011 1111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 282 ----~s~~~~~li~~~L~~dP~~R~sa~e 306 (336)
T 4g3f_A 282 ----CAPLTAQAIQEGLRKEPVHRASAME 306 (336)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHH
Confidence 1236788999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=371.81 Aligned_cols=236 Identities=27% Similarity=0.384 Sum_probs=182.7
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEcCC------CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCC-CCcccee
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATG-QGDREFAAEMETLGMVKH-QNLVELL 208 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~ 208 (388)
..+++....++|...+.||+|+||+||+|.+.. ++.||||+++.... ...++|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345566677889999999999999999998532 45799999976543 334679999999999965 9999999
Q ss_pred eEEEeC-CeeEEEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccC
Q 035768 209 GYCSVD-EEKLLVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVAS 251 (388)
Q Consensus 209 g~~~~~-~~~~lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~ 251 (388)
|+|... +..++|||||++|+|.++|+.. +.++.|+| |+||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999764 5689999999999999999642 22455666 5688999
Q ss_pred CeeecCCCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCC
Q 035768 252 NILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFED 329 (388)
Q Consensus 252 NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~ 329 (388)
|||+++++.+||+|||+|+.+..... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~-- 292 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-- 292 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC--
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999998754433 33445679999999999999999999999999999999998 899985421
Q ss_pred CCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 330 KDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+...+....+. .. | .. ...++.+++.+||+.||++||||.|
T Consensus 293 -~~~~~~~~i~~g~~~----~~--p---~~----~~~~~~~li~~c~~~dP~~RPt~~e 337 (353)
T 4ase_A 293 -IDEEFCRRLKEGTRM----RA--P---DY----TTPEMYQTMLDCWHGEPSQRPTFSE 337 (353)
T ss_dssp -CSHHHHHHHHHTCCC----CC--C---TT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -HHHHHHHHHHcCCCC----CC--C---cc----CCHHHHHHHHHHcCcChhHCcCHHH
Confidence 122333333322111 11 1 11 1236889999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=359.84 Aligned_cols=223 Identities=26% Similarity=0.331 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|+..+.||+|+||+||+|+.. +++.||||++++.. ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999852 47899999997542 2233468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||||++|+|.+++.+. ..+|.|+| |+||||+|||++.++.+||+|||+|+....... .
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 182 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 182 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-c
Confidence 99999999999988642 34677888 568889999999999999999999987644322 2
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..++...+.... ..... .
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~----~~~~~~~~~i~~~~--~~~p~--------~ 248 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAK--LGMPQ--------F 248 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCC--CCCCT--------T
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC----cCHHHHHHHHHcCC--CCCCC--------c
Confidence 3456799999999999999999999999999999999999999853 23344443333211 11111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
...++.+++.+||+.||++|||+.
T Consensus 249 ----~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 249 ----LSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCC
Confidence 122678999999999999999963
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=349.66 Aligned_cols=222 Identities=20% Similarity=0.333 Sum_probs=164.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+. .+|+.||||++++.. ......+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999996 469999999997542 233467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||| +|+|.+++.+. ..+|.|+| |+||||+|||++.++.+||+|||+|+...... ...
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~ 169 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLK 169 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccC
Confidence 999 78999988542 34677777 56889999999999999999999998765432 233
Q ss_pred ccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..+||+.|||||++.+..+ +.++||||+||++|||+||+.||.. .+...+.+.+.... ...... .
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~----~~~~~~~~~i~~~~--~~~p~~--------~ 235 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----ESIPVLFKNISNGV--YTLPKF--------L 235 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHTC--CCCCTT--------S
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHcCC--CCCCCC--------C
Confidence 4679999999999988776 5799999999999999999999853 23333333332211 011111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.||++|||++|
T Consensus 236 ----s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 236 ----SPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHH
Confidence 125789999999999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=350.12 Aligned_cols=223 Identities=23% Similarity=0.367 Sum_probs=161.3
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCC---------
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDE--------- 215 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------- 215 (388)
+|+..+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 588889999999999999996 46899999999754432 3457899999999999999999999987644
Q ss_pred ---eeEEEEeccCCCCHHHHHhcc------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 216 ---EKLLVYEYMVKGSLDDWLRNQ------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 216 ---~~~lv~e~~~~g~L~~~l~~~------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
..|+|||||++|+|.+++.+. ..+|.|+| |+||||+|||++.++.+||+|||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 368999999999999988642 23567777 5688999999999999999999999
Q ss_pred eeccCCCcc-----------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHH
Q 035768 270 RLISDCESH-----------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338 (388)
Q Consensus 270 ~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 338 (388)
+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.. ..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~------~~~~~~~ 236 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST------QMERVRT 236 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS------HHHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC------ccHHHHH
Confidence 887543211 1234579999999999999999999999999999999996 7632 1111111
Q ss_pred HHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.. ....... + . .......+.+++.+||+.||++|||+.|
T Consensus 237 ~~~-~~~~~~p----~-~----~~~~~~~~~~li~~~L~~dP~~Rps~~e 276 (299)
T 4g31_A 237 LTD-VRNLKFP----P-L----FTQKYPCEYVMVQDMLSPSPMERPEAIN 276 (299)
T ss_dssp HHH-HHTTCCC----H-H----HHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHH-HhcCCCC----C-C----CcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 111 1111111 1 0 1122234678999999999999999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=340.65 Aligned_cols=238 Identities=20% Similarity=0.274 Sum_probs=174.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe------CCe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV------DEE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 216 (388)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788999999999999999996 4799999999975432 234568899999999999999999998764 357
Q ss_pred eEEEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 KLLVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
.|||||||+ |+|.+++.+ ...+|.|+| |+||||+|||++.++.+||+|||+|+.+....
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 899999995 789988753 234677887 56888999999999999999999998764321
Q ss_pred ---cceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 277 ---SHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 277 ---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
.......+||+.|||||++.+. .++.++||||+||++|||++|++||.. .+..+....+............-
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g----~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC----SSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC----CCHHHHHHHHHHhcCCCChHHhh
Confidence 1233457899999999987664 579999999999999999999999853 23344444443332221110000
Q ss_pred C--c--------ccc--CCCCH-----HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 D--P--------AVL--NANSK-----PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~--~--------~~~--~~~~~-----~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. . .+. ..... .....+.+|+.+||..||++|||+.|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 0 0 000 00000 11236789999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=337.90 Aligned_cols=181 Identities=27% Similarity=0.340 Sum_probs=149.9
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 217 (388)
.-.+.|+..+.||+|+||+||+|+.+ +++.||||++.... ....+.+|+++|+.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999752 46789999986543 345788999999998 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhc------------cCCCCCHHh-----hhccccCCeeecCC-CCEEEcccccceeccCCCc--
Q 035768 218 LLVYEYMVKGSLDDWLRN------------QAASLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLISDCES-- 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~------------~~~~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~~~~~-- 277 (388)
|+|||||++|+|.++++. ...+|.|+| |+||||+|||++.+ +.+||+|||+|+...+...
T Consensus 96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 999999999999998753 345778888 56889999999877 7999999999986543211
Q ss_pred -------------------------ceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 -------------------------HVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 -------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......+||+.|||||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 112335799999999988765 589999999999999999999999853
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=328.92 Aligned_cols=256 Identities=37% Similarity=0.709 Sum_probs=213.6
Q ss_pred cccccHHHHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEE
Q 035768 133 LQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYC 211 (388)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 211 (388)
...+++.++....++|...+.||+|+||.||+|...+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356788999999999999999999999999999988899999999976432 2334799999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhccC-------------------CCCCHHhhh--------ccccCCeeecCCCCEEEc
Q 035768 212 SVDEEKLLVYEYMVKGSLDDWLRNQA-------------------ASLDWGKRC--------KIVASNILLNDDFEAKIS 264 (388)
Q Consensus 212 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~l~~~~~~--------~i~~~NiLl~~~~~~kl~ 264 (388)
...+..++||||+++|+|.++++... .+|.++|.. ||+|+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999987532 235566654 678999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-CCCCcccHHHHHHHhh
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEF-EDKDGENLVDWVLHMM 343 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~-~~~~~~~~~~~~~~~~ 343 (388)
|||+++..............||+.|+|||.+....++.++|||||||++|||+||+.||.... .........+|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999999876555555555679999999999888889999999999999999999999985211 1224456777777766
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.........+..............+.+++.+||+.||++|||+.|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 301 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence 666667777777666777888899999999999999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=350.41 Aligned_cols=227 Identities=23% Similarity=0.344 Sum_probs=181.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57899999999999999999964 69999999997765555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCC--CCEEEcccccceeccCCCcceee
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDD--FEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~--~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
++|+|.++|... ..+|.|+| |+||+|+|||++.+ +.+||+|||+|+.+.... ...
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~ 314 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVK 314 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--cee
Confidence 999999988532 33677777 56888999999854 899999999999876533 334
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+....+..... .+.+......+
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~----~~~~~~~~i~~~~~------~~~~~~~~~~s 384 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDW------NMDDSAFSGIS 384 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHTTCC------CCCSGGGTTSC
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHhCCC------CCCcccccCCC
Confidence 567999999999999999999999999999999999999998532 33333333322111 01111111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+|+.+||+.||++|||+.|
T Consensus 385 ----~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 385 ----EDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ----HHHHHHHHHHccCChhHCcCHHH
Confidence 25789999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.61 Aligned_cols=252 Identities=34% Similarity=0.638 Sum_probs=207.2
Q ss_pred ccHHHHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 136 LTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
+++.++...+++|...+.||+|+||.||+|++.+++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566788999999999999999999998889999999988766556678999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhccC-------------------CCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQA-------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
..++||||+++|+|.+++.... .++.++| |.||+|+||+++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999998875431 2455566 457889999999999999999999987
Q ss_pred ccCCC-cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccc
Q 035768 272 ISDCE-SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350 (388)
Q Consensus 272 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (388)
..... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .+......|............
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHHHTHHHHTTTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHHHhhhccccccHHH
Confidence 54322 2223345689999999998888899999999999999999999999875433 234556666655555566666
Q ss_pred cCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+++.............+.+++.+||+.||++|||+.|
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 305 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 77776666667788889999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=343.72 Aligned_cols=224 Identities=23% Similarity=0.313 Sum_probs=172.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHH---HHHHHhcCCCCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAA---EMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
.++|...++||+|+||+||+|+.. +|+.||||++++.. ......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999964 69999999996532 122233333 46777888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
|+|||||+||+|.++|.+. ..+|.|+| |+||+|+|||++.+|.+||+|||+|+.+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 9999999999999988642 34677888 56888999999999999999999999875432
Q ss_pred ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..... .+...+...+.. .......
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-~~~~~i~~~i~~--~~~~~p~------ 415 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLT--MAVELPD------ 415 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-CCHHHHHHHHHH--CCCCCCT------
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcC--CCCCCCc------
Confidence 334689999999999864 5799999999999999999999999853211 111122222111 0111111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.. ..++.+|+.+||+.||++|++.
T Consensus 416 --~~----S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 416 --SF----SPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp --TS----CHHHHHHHHHHTCSCGGGCTTC
T ss_pred --cC----CHHHHHHHHHHccCCHhHCCCC
Confidence 11 2267899999999999999984
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=310.48 Aligned_cols=228 Identities=24% Similarity=0.362 Sum_probs=180.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.++|...+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788999999999999999995 57899999999766556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 224 MVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 224 ~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+++|+|.+++.+. ..++.|+| |.||+|+|||++.++.+||+|||+++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 177 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCcc
Confidence 9999999988643 23566777 457889999999999999999999987754332 233457
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
||+.|+|||.+.+..++.++|||||||++|||+||+.||... +.......+.. ... .....+ ...
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~~~---~~~-~~~~~~-------~~~ 242 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----NPLRALYLIAT---NGT-PELQNP-------EKL 242 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHH---HCS-CCCSCG-------GGS
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh---CCC-CCCCCc-------ccc
Confidence 999999999998899999999999999999999999998532 22222111111 111 111111 111
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.||++|||++|
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHH
Confidence 235789999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.02 Aligned_cols=239 Identities=23% Similarity=0.280 Sum_probs=186.2
Q ss_pred ccccHHHHHHhhcC----------CCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCC
Q 035768 134 QKLTYDQIVAGTNK----------FCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ 202 (388)
Q Consensus 134 ~~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 202 (388)
..++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34667777766654 566678999999999999975 7999999999876666677899999999999999
Q ss_pred CccceeeEEEeCCeeEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEE
Q 035768 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKI 263 (388)
Q Consensus 203 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl 263 (388)
||+++++++...+..++||||+++|+|.+++.+. ..+|.|+| |.||+|+|||++.++.+||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEE
Confidence 9999999999999999999999999999988642 23466666 4578899999999999999
Q ss_pred cccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhh
Q 035768 264 SDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 264 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
+|||+++....... ......||+.|+|||.+....++.++|||||||++|||++|+.||... ........+....
T Consensus 183 ~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~~ 257 (321)
T 2c30_A 183 SDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKRLRDSP 257 (321)
T ss_dssp CCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSS
T ss_pred eeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCC
Confidence 99999987654322 233456999999999999899999999999999999999999998532 2222332222211
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+ ......+.+++.+||+.||++|||+.|
T Consensus 258 ----~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 258 ----PPKLKNS-------HKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp ----CCCCTTG-------GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----CCCcCcc-------ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111110 111235789999999999999999853
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=308.55 Aligned_cols=224 Identities=23% Similarity=0.338 Sum_probs=176.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999996 5799999999975432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.|+| |+||+|+|||++.++.+||+|||+++...... ...
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccc
Confidence 999999999988532 33566777 45788999999999999999999998765432 234
Q ss_pred ccccccCccCccccCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKAT-ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..+||+.|+|||.+.+..++ .++|||||||++|||++|+.||... +...+.+.+.... ......
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~--~~~p~~--------- 236 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGK--YRIPFY--------- 236 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC--CCCCTT---------
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCC--CCCCCC---------
Confidence 46799999999998877764 7999999999999999999998532 3333333322211 011111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||.+|||+.|
T Consensus 237 ---~s~~~~~li~~~L~~dP~~R~t~~e 261 (328)
T 3fe3_A 237 ---MSTDCENLLKRFLVLNPIKRGTLEQ 261 (328)
T ss_dssp ---SCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred ---CCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1225788999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=304.01 Aligned_cols=226 Identities=23% Similarity=0.420 Sum_probs=176.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||+||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46778899999999999999964 68999999987655556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce----
Q 035768 225 VKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV---- 279 (388)
Q Consensus 225 ~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~---- 279 (388)
++|+|.+++..... +|.|+| |.||+|+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 99999999875322 455566 45788999999999999999999998764432211
Q ss_pred ---------eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCC--cccHHHHHHHhhccccc
Q 035768 280 ---------STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD--GENLVDWVLHMMKNEQA 348 (388)
Q Consensus 280 ---------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~ 348 (388)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+........ ............
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~----- 244 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC----- 244 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC-----
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC-----
Confidence 1145699999999999999999999999999999999999999765332111 111211111100
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+. ....+.+++.+||+.||++|||+.|
T Consensus 245 ----~~~--------~~~~l~~li~~~l~~dP~~Rps~~~ 272 (310)
T 3s95_A 245 ----PPN--------CPPSFFPITVRCCDLDPEKRPSFVK 272 (310)
T ss_dssp ----CTT--------CCTTHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCC--------CCHHHHHHHHHHccCChhhCcCHHH
Confidence 000 1115789999999999999999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.63 Aligned_cols=251 Identities=33% Similarity=0.559 Sum_probs=192.5
Q ss_pred cccccHHHHHHhhcCCCcC------CeeeccCCceEEEEEcCCCCEEEEEEcccCC----CcChHHHHHHHHHHhcCCCC
Q 035768 133 LQKLTYDQIVAGTNKFCEE------NVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT----GQGDREFAAEMETLGMVKHQ 202 (388)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~ 202 (388)
...+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3567899999999999887 8999999999999997 68899999986532 22346799999999999999
Q ss_pred CccceeeEEEeCCeeEEEEeccCCCCHHHHHhcc------------------CCCCCHHh-----hhccccCCeeecCCC
Q 035768 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ------------------AASLDWGK-----RCKIVASNILLNDDF 259 (388)
Q Consensus 203 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------~~~l~~~~-----~~~i~~~NiLl~~~~ 259 (388)
||+++++++...+..++||||+++|+|.+++... ..+|.++| |.||+|+||+++.++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 9999999999999999999999999999998632 12345556 457889999999999
Q ss_pred CEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHH
Q 035768 260 EAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 338 (388)
.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+.+.
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH
Confidence 9999999999876543222 2234568999999998754 5899999999999999999999998654322212222221
Q ss_pred HHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.. ........+++.+ ..........+.+++.+||+.||.+|||++|
T Consensus 250 ~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 296 (307)
T 2nru_A 250 IED--EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296 (307)
T ss_dssp HHT--TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhh--hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 111 1111223333322 2335667778999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=305.97 Aligned_cols=230 Identities=30% Similarity=0.437 Sum_probs=169.1
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
+....++|...+.||+|+||+||+|+. +++.||||++..... ...+.|.+|++++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334456788899999999999999987 678899999875432 22357899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc------------------CCCCCHHhh-------hccccCCeeecCCCCEEEcccccceecc
Q 035768 219 LVYEYMVKGSLDDWLRNQ------------------AASLDWGKR-------CKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~------------------~~~l~~~~~-------~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
+||||+++|+|.+++... ..+|.|+|. .||+|+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999988642 224556654 4678999999999999999999998654
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||... +.......+...........
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~----~~~~~~~~~~~~~~~~~~~~--- 262 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL----NPAQVVAAVGFKCKRLEIPR--- 262 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS----CHHHHHHHHHHSCCCCCCCT---
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCc---
Confidence 322 2233456999999999999999999999999999999999999998532 22233222211111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 263 ---------~~~~~l~~li~~~l~~dP~~Rps~~~ 288 (309)
T 3p86_A 263 ---------NLNPQVAAIIEGCWTNEPWKRPSFAT 288 (309)
T ss_dssp ---------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11226889999999999999999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=323.73 Aligned_cols=229 Identities=29% Similarity=0.445 Sum_probs=180.3
Q ss_pred HHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 141 IVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 141 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
+....++|...+.||+|+||+||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344566788889999999999999999888899999997643 45678999999999999999999999986 6678999
Q ss_pred EeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 221 YEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|||+++|+|.++++.. +.+|.|+| |+||+|+|||++.++.+||+|||+++........
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999998632 23556666 4578899999999999999999999876543222
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......+|+.|+|||.+....++.++|||||||++|||+| |+.||... +..++...+....... .|
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i~~~~~~~------~~--- 407 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMP------RP--- 407 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHHTCCCC------CC---
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCC------CC---
Confidence 2233446789999999988899999999999999999999 99997532 3334444333221111 01
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++||||.|
T Consensus 408 ----~~~~~~l~~li~~cl~~dp~~RPt~~~ 434 (454)
T 1qcf_A 408 ----ENCPEELYNIMMRCWKNRPEERPTFEY 434 (454)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 112236889999999999999999853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=313.60 Aligned_cols=227 Identities=28% Similarity=0.446 Sum_probs=176.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEc--------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM--------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
.++|...+.||+|+||.||+|++ .++..||||+++.... ...+.+.+|+++++++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 45788889999999999999985 2355799999976532 2345799999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
+..++||||+++|+|.+++.... .+|.|+| |+||+|+|||++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999986532 2345566 45788999999999
Q ss_pred CCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...++.
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~----~~~~~~ 315 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVEELF 315 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHH
Confidence 99999999999876543322 2233457889999999988899999999999999999999 99997542 334444
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+....... . .......+.+++.+||+.||++|||+.|
T Consensus 316 ~~~~~~~~~~---------~----~~~~~~~l~~li~~~l~~dP~~Rpt~~e 354 (370)
T 2psq_A 316 KLLKEGHRMD---------K----PANCTNELYMMMRDCWHAVPSQRPTFKQ 354 (370)
T ss_dssp HHHHTTCCCC---------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHhcCCCCC---------C----CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 4332221110 0 0112236889999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=302.93 Aligned_cols=220 Identities=24% Similarity=0.304 Sum_probs=175.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+|+.. +++.||+|.+++. .......+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999964 6899999999753 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ....
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~ 163 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cccc
Confidence 999999999887532 33567777 45788999999999999999999998643322 2234
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+.+.+... ...... .
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~--~~~~p~--------~-- 227 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELILME--EIRFPR--------T-- 227 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHC--CCCCCT--------T--
T ss_pred ccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC----CHHHHHHHHHcC--CCCCCC--------C--
Confidence 567999999999999999999999999999999999999998532 333333322211 111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
....+.+++.+||+.||++||
T Consensus 228 --~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 228 --LSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp --SCHHHHHHHHHHTCSSTTTST
T ss_pred --CCHHHHHHHHHHhhcCHHHhc
Confidence 122678999999999999999
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=312.68 Aligned_cols=238 Identities=21% Similarity=0.228 Sum_probs=183.2
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEE
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCS 212 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 212 (388)
.+.++...+++|...+.||+|+||+||+|+.. +++.||+|++++.. ......+.+|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566667789999999999999999999975 47899999996521 122334889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 213 VDEEKLLVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 213 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+++..++|||||++|+|.+++.+.. .+|.|+| |+||+|+|||++.++.+||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 9999999999999999999997532 2455666 458889999999999999999999988
Q ss_pred ccCCCcceeeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
............+||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+....+.......
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERF 300 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHC
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC----ChhHHHHhhhhccccc
Confidence 7655544455578999999999875 567899999999999999999999998532 3333333332211111
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTV--RPTML 387 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPt~~ 387 (388)
.... ..... ...+.+++.+|+..+|++ ||+++
T Consensus 301 ~~p~-----~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~ 334 (437)
T 4aw2_A 301 QFPT-----QVTDV----SENAKDLIRRLICSREHRLGQNGIE 334 (437)
T ss_dssp CCCS-----SCCCS----CHHHHHHHHTTSSCGGGCTTTTTTH
T ss_pred cCCc-----ccccC----CHHHHHHHHHHhcccccccCCCCHH
Confidence 1111 10111 125788999999888887 99875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=303.19 Aligned_cols=227 Identities=22% Similarity=0.280 Sum_probs=178.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
+.|...+.||+|+||.||+|+.. +|+.||+|.++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 56888899999999999999965 6899999999754322 3467999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC----CEEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF----EAKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~----~~kl~DfG~a~~~~~ 274 (388)
+||||+++|+|.+++.+. ..++.|+| |+||+|+|||++.++ .+||+|||+++....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 999999999999988542 23566777 457889999998877 799999999988754
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.. .....+||+.|+|||++....++.++|||||||++|||++|..||... +..++...+.... ..+++
T Consensus 172 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~------~~~~~ 239 (361)
T 2yab_A 172 GV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANITAVS------YDFDE 239 (361)
T ss_dssp TC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHTTC------CCCCH
T ss_pred CC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcC------CCCCc
Confidence 32 223456999999999999889999999999999999999999998532 2233333222211 01111
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+ ..+.+++.+||..||++|||+.|
T Consensus 240 ~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e 269 (361)
T 2yab_A 240 EFFSQTS----ELAKDFIRKLLVKETRKRLTIQE 269 (361)
T ss_dssp HHHTTSC----HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhccCCC----HHHHHHHHHHCCCChhHCcCHHH
Confidence 1111112 35789999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=294.41 Aligned_cols=225 Identities=27% Similarity=0.472 Sum_probs=177.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5677889999999999999998888899999997643 345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+|+|.+++..... ++.++| |.||+|+||+++.++.+||+|||+++..............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 168 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence 9999999865332 345556 4578899999999999999999999876543322333445
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
+|+.|+|||.+....++.++||||||+++|||++ |+.||... ...++...+..... ...+. .
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~----~~~~~~~~~~~~~~------~~~~~-------~ 231 (269)
T 4hcu_A 169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFR------LYKPR-------L 231 (269)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCC------CCCCT-------T
T ss_pred cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHHhcCcc------CCCCC-------c
Confidence 6788999999988899999999999999999999 99997532 23333332222111 11111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||++|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ 256 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSR 256 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHH
Confidence 1235889999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=314.16 Aligned_cols=235 Identities=20% Similarity=0.238 Sum_probs=181.8
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVD 214 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 214 (388)
.++....++|...+.||+|+||+||+|+.. +++.||+|++++.. ......+.+|+.+++.++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 455556788999999999999999999965 58899999986521 22334588999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
+..++||||+++|+|.+++++. ..+|.|+| |+||+|+|||++.++.+||+|||+++.....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999988643 23566777 4578899999999999999999999887654
Q ss_pred CcceeeccccccCccCccccCCCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGTGK----ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
........+||+.|+|||++.... ++.++|||||||++|||++|+.||... +.......+...........
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~p~- 296 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLTFPD- 296 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHCCCCT-
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC----ChhhHHHHHHhccccccCCC-
Confidence 443444678999999999886654 889999999999999999999998532 33333333322111111110
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTV--RPTML 387 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~--RPt~~ 387 (388)
. .. ....+.+++.+||..+|.+ ||+++
T Consensus 297 --~---~~----~s~~~~~li~~lL~~~~~rlgR~~~~ 325 (410)
T 3v8s_A 297 --D---ND----ISKEAKNLICAFLTDREVRLGRNGVE 325 (410)
T ss_dssp --T---CC----CCHHHHHHHHHHSSCGGGCTTSSCHH
T ss_pred --c---cc----ccHHHHHHHHHHccChhhhCCCCCHH
Confidence 0 01 1126789999999999988 99875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=306.39 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=173.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE----EKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv 220 (388)
.++|...+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457888999999999999999975 7899999996542 23345677999999999999999999998754 36999
Q ss_pred EeccCCCCHHHHHhcc--------------CCCCCHHhh---------------hccccCCeeecCCCCEEEccccccee
Q 035768 221 YEYMVKGSLDDWLRNQ--------------AASLDWGKR---------------CKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~--------------~~~l~~~~~---------------~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
|||+++|+|.++++.. ..++.|+|. +||+|+|||++.++.+||+|||+++.
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 9999999999998642 234556653 47889999999999999999999987
Q ss_pred ccCCCcc-eeeccccccCccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCc---------ccHH
Q 035768 272 ISDCESH-VSTVVAGTIGYVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDG---------ENLV 336 (388)
Q Consensus 272 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~---------~~~~ 336 (388)
....... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||......... ....
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 7543322 2233569999999998876 35677899999999999999999998653221110 0111
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+... .........+.... ........+.+++.+||+.||++|||+.|
T Consensus 261 ~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 261 DMQEV-VVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGC 308 (322)
T ss_dssp HHHHH-HTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhhhh-hhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHH
Confidence 11111 11111111111111 12244567899999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=298.79 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=181.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE--EKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~ 221 (388)
++|...+.||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46788899999999999999965 58999999997543 234567889999999999999999999998765 779999
Q ss_pred eccCCCCHHHHHhccC------------------CCCCHHh-----hhccccCCeee----cCCCCEEEcccccceeccC
Q 035768 222 EYMVKGSLDDWLRNQA------------------ASLDWGK-----RCKIVASNILL----NDDFEAKISDFGLARLISD 274 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~------------------~~l~~~~-----~~~i~~~NiLl----~~~~~~kl~DfG~a~~~~~ 274 (388)
||+++|+|.+++.... .+|.|+| |.||+|+|||+ +.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 9999999999986532 2455666 45788999999 8888899999999988754
Q ss_pred CCcceeeccccccCccCccccC--------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGG--------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
... .....||+.|+|||.+. ...++.++|||||||++|||+||+.||..........++...+.......
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 169 DEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 332 23356999999999865 57889999999999999999999999865433233333333333322211
Q ss_pred cccccCC---------cc--ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLD---------PA--VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~---------~~--~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.. +. ............+.+++.+||+.||++|||++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 1111000 00 011234667778899999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=320.90 Aligned_cols=227 Identities=31% Similarity=0.454 Sum_probs=171.8
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
...++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.. +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4456788889999999999999999888889999997643 345789999999999999999999999875 67899999
Q ss_pred ccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+++|+|.++++.. +.+|.|+| |+||+|+|||++.++.+||+|||+++..........
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99999999998632 22456666 457889999999999999999999987654333333
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+|+.|+|||.+....++.++|||||||++|||+| |+.||... ...++...+....+.. .
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i~~~~~~~------~------ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGYRMP------C------ 402 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTTCCCC------C------
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCC------C------
Confidence 34457889999999988899999999999999999999 99997532 2333333332211100 0
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+......+.+++.+||+.||++|||++|
T Consensus 403 -~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 430 (452)
T 1fmk_A 403 -PPECPESLHDLMCQCWRKEPEERPTFEY 430 (452)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0112236889999999999999999853
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=322.79 Aligned_cols=228 Identities=28% Similarity=0.466 Sum_probs=180.5
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcCC-CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
...++|...+.||+|+||.||+|.+.. +..||||.++... ...+.|.+|+++|++++||||++++++|...+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345668888999999999999999764 8899999997643 34678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 222 EYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||+++|+|.++++.. +.+|.|+| |+||+|+|||++.++.+||+|||+++.........
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999998642 22455666 45788999999999999999999999875443333
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....+++.|+|||.+....++.++|||||||++|||+| |+.||... +...+.+.+....+.. .
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~----~~~~~~~~~~~~~~~~------~----- 440 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKDYRME------R----- 440 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHHHTTCCCC------C-----
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCC------C-----
Confidence 334456789999999988889999999999999999999 99997542 3334444333211110 0
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++||||.|
T Consensus 441 --~~~~~~~l~~li~~cl~~dP~~RPs~~e 468 (495)
T 1opk_A 441 --PEGCPEKVYELMRACWQWNPSDRPSFAE 468 (495)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CCCCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 1112236889999999999999999853
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.68 Aligned_cols=234 Identities=24% Similarity=0.393 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhc--CCCCCccceeeEEEeC----CeeE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGM--VKHQNLVELLGYCSVD----EEKL 218 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 218 (388)
.++|...+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35688899999999999999998 6889999998643 34556677777666 8999999999997653 4578
Q ss_pred EEEeccCCCCHHHHHhcc--------------CCCCCHHh-------------hhccccCCeeecCCCCEEEccccccee
Q 035768 219 LVYEYMVKGSLDDWLRNQ--------------AASLDWGK-------------RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-------------~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+||||+++|+|.++++.. +.++.|+| |+||+|+|||++.++.+||+|||+++.
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 999999999999988532 34677888 568899999999999999999999987
Q ss_pred ccCCCcce---eeccccccCccCccccCCC------CCCcccchHhHHHHHHHHHhC----------CCCCCCCCCCCCc
Q 035768 272 ISDCESHV---STVVAGTIGYVPPEYGGTG------KATERGDVYSFGVILLELVTG----------KQPTGPEFEDKDG 332 (388)
Q Consensus 272 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~el~tg----------~~P~~~~~~~~~~ 332 (388)
........ .....||+.|+|||.+... .++.++|||||||++|||+|| +.||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 65443322 2234699999999988766 456799999999999999999 8887654332222
Q ss_pred ccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 333 ENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. . +..............+. .........+.+++.+||+.||++|||+.|
T Consensus 243 ~~--~-~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 243 FE--D-MRKVVCVDQQRPNIPNR---WFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp HH--H-HHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hh--h-hhHHHhccCCCCCCChh---hccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 11 1 11211111111111110 012345667999999999999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.40 Aligned_cols=229 Identities=26% Similarity=0.413 Sum_probs=176.4
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
...++|...+.||+|+||.||+|.+. +++.||||.++.... ...+.|.+|++++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567888899999999999999975 689999999975432 2234688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+++|+|.++++.. +.++.|+| |+||+|+|||++.++.+||+|||+++.........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999998643 23456666 45788999999999999999999998754322111
Q ss_pred e-eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 280 S-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 280 ~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
. ....+++.|+|||.+....++.++|||||||++|||+| |+.||... ......+.+..... .. .|
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~----~~~~~~~~~~~~~~----~~--~~--- 337 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL----SNQQTREFVEKGGR----LP--CP--- 337 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS----CHHHHHHHHHTTCC----CC--CC---
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCC----CC--CC---
Confidence 1 12235778999999988889999999999999999999 99997532 23333333322111 00 01
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||+.|
T Consensus 338 ----~~~~~~l~~li~~cl~~dP~~Rps~~~ 364 (377)
T 3cbl_A 338 ----ELCPDAVFRLMEQCWAYEPGQRPSFST 364 (377)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 111236889999999999999999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.19 Aligned_cols=227 Identities=27% Similarity=0.465 Sum_probs=164.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||.||+|++. ++..||||.++.... ...+.|.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888999999999999999864 577899999976432 334579999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++++... +|.|+| |+||+|+|||++.++.+||+|||+++........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 9999999999999875432 445566 4578899999999999999999999876543221
Q ss_pred e--eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 279 V--STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 279 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
. .....+|+.|+|||.+....++.++|||||||++|||++ |+.||... ...++.+.+........
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~----~~~~~~~~i~~~~~~~~-------- 271 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM----SNQDVIKAVDEGYRLPP-------- 271 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC----CHHHHHHHHHTTEECCC--------
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCCC--------
Confidence 1 122335778999999988899999999999999999998 99998532 23333333322111100
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++||||.|
T Consensus 272 -----~~~~~~~l~~li~~cl~~dp~~RPs~~~ 299 (373)
T 2qol_A 272 -----PMDCPAALYQLMLDCWQKDRNNRPKFEQ 299 (373)
T ss_dssp -----CTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----CccccHHHHHHHHHHhCcChhhCcCHHH
Confidence 1112236889999999999999999853
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=301.00 Aligned_cols=225 Identities=23% Similarity=0.312 Sum_probs=177.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 218 (388)
..++|...+.||+|+||.||+|+.. +++.||||++++.. ......+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4568899999999999999999975 68899999997532 23456688899999876 9999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... .
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 173 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 173 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-C
Confidence 999999999999988642 23567777 45788999999999999999999998653322 2
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+.+.+... .......
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~--~~~~p~~------- 240 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DEEELFHSIRMD--NPFYPRW------- 240 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHC--CCCCCTT-------
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHhC--CCCCCcc-------
Confidence 234567999999999999999999999999999999999999998532 333333333221 0111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
....+.+++.+||+.||++||++.
T Consensus 241 -----~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 241 -----LEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred -----cCHHHHHHHHHHhcCCHhHcCCCh
Confidence 123678999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=300.99 Aligned_cols=226 Identities=27% Similarity=0.436 Sum_probs=172.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|.+. .+..||||.++.... ...+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999974 344699999976432 3345799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~- 278 (388)
|||+++|+|.++++... .+|.|+| |.||+|+|||++.++.+||+|||+++........
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 99999999999986432 2455666 4578899999999999999999999887543222
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......+|+.|+|||.+....++.++|||||||++|||++ |+.||... ...++...+....... .
T Consensus 209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~~~~~~~~------~--- 275 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM----TNRDVISSVEEGYRLP------A--- 275 (325)
T ss_dssp EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS----CHHHHHHHHHTTCCCC------C---
T ss_pred eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHHcCCCCC------C---
Confidence 2223346778999999988899999999999999999999 99997532 3333333332211110 0
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 276 ----~~~~~~~l~~li~~~l~~dp~~Rps~~e 303 (325)
T 3kul_A 276 ----PMGCPHALHQLMLDCWHKDRAQRPRFSQ 303 (325)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence 0112236889999999999999999853
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=295.55 Aligned_cols=226 Identities=21% Similarity=0.303 Sum_probs=168.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--------------------------cChHHHHHHHHHHhc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--------------------------QGDREFAAEMETLGM 198 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 198 (388)
++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5688889999999999999986 4688999999865321 113468899999999
Q ss_pred CCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHH--------------hccCCCCCHHh-----hhccccCCeeecC
Q 035768 199 VKHQNLVELLGYCSV--DEEKLLVYEYMVKGSLDDWL--------------RNQAASLDWGK-----RCKIVASNILLND 257 (388)
Q Consensus 199 l~H~niv~l~g~~~~--~~~~~lv~e~~~~g~L~~~l--------------~~~~~~l~~~~-----~~~i~~~NiLl~~ 257 (388)
++||||+++++++.. .+..++||||+++|+|.+++ .+...+|.|+| |.||+|+|||++.
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 172 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC
Confidence 999999999999987 56889999999999887643 33445677777 4578899999999
Q ss_pred CCCEEEcccccceeccCCCcceeeccccccCccCccccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCccc
Q 035768 258 DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK---ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334 (388)
Q Consensus 258 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~ 334 (388)
++.+||+|||+++....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||... ....
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~ 247 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE----RIMC 247 (298)
T ss_dssp TSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS----SHHH
T ss_pred CCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc----cHHH
Confidence 99999999999988754332 233456999999999987654 478899999999999999999998532 2222
Q ss_pred HHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+...+.. .... ..+ ... ....+.+++.+||+.||++|||+.|
T Consensus 248 ~~~~~~~----~~~~-~~~---~~~----~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 248 LHSKIKS----QALE-FPD---QPD----IAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp HHHHHHH----CCCC-CCS---SSC----CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHHhc----ccCC-CCC---ccc----cCHHHHHHHHHHhhcChhhCCCHHH
Confidence 2222211 1110 000 011 1236889999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=291.11 Aligned_cols=226 Identities=27% Similarity=0.422 Sum_probs=178.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|...+.||+|+||.||+|...++..||+|+++... ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35678889999999999999998888899999997643 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++|+|.+++.... .++.++| |.||+|+||+++.++.+||+|||+++.............
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 9999999886532 2455666 457889999999999999999999987765444334445
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.+|+.|+|||.+....++.++||||||+++|||+| |+.||... ........+.. .. ....+..
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~---~~---~~~~~~~------ 229 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY----TNSEVVLKVSQ---GH---RLYRPHL------ 229 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHT---TC---CCCCCTT------
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc----ChHHHHHHHHc---CC---CCCCCCc------
Confidence 56778999999988889999999999999999999 99997532 22222222211 11 1111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 230 -~~~~l~~li~~~l~~~p~~Rps~~~ 254 (268)
T 3sxs_A 230 -ASDTIYQIMYSCWHELPEKRPTFQQ 254 (268)
T ss_dssp -SCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred -ChHHHHHHHHHHcCCChhhCcCHHH
Confidence 1125889999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.96 Aligned_cols=231 Identities=19% Similarity=0.299 Sum_probs=174.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||+||+|+.. +++.||+|++++... ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457888999999999999999965 578999999975432 2334688999999876 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ..
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~ 209 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 209 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-Cc
Confidence 99999999999887642 33567777 45788999999999999999999998643222 23
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCC-cccHHHHHHHhhccccccccCCccccC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD-GENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.+.......... -| .
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p---~ 283 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IP---R 283 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC---CC---T
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC---CC---C
Confidence 3456799999999999999999999999999999999999999864221111 111111122211111110 01 1
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
. ....+.+++.+||+.||++||++
T Consensus 284 ~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 284 S----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp T----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred c----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 12267899999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=295.27 Aligned_cols=227 Identities=23% Similarity=0.381 Sum_probs=168.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|+. .+++.||+|.+...... ..+.|.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4688889999999999999995 46899999998654322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.++| |.||+|+|||++.++.+||+|||+++...........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence 999999999988643 23556666 4578899999999999999999999876544333344
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||.+.+..++.++||||||+++|||+||+.||... ... ........... ... .+....
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~---~~~~~~~~~~~-~~~-~~~~~~--- 238 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE----TAV---SIAIKHIQDSV-PNV-TTDVRK--- 238 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS----CHH---HHHHHHHSSCC-CCH-HHHSCT---
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChH---HHHHHHhhccC-CCc-chhccc---
Confidence 567999999999998889999999999999999999999998532 111 11111111111 000 000111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
.....+.+++.+||+.||++||+
T Consensus 239 -~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 239 -DIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp -TSCHHHHHHHHHHSCSSGGGSCS
T ss_pred -CCCHHHHHHHHHHhcCCHhHccc
Confidence 11236889999999999999994
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=303.54 Aligned_cols=223 Identities=22% Similarity=0.299 Sum_probs=172.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC---CCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA---TGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467889999999999999999964 6899999999753 223445688999999988 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ..
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 180 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VT 180 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-cc
Confidence 99999999999988542 33567777 45788999999999999999999998643322 23
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..++.+.+.... ......
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i~~~~--~~~p~~-------- 246 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE----NEDDLFEAILNDE--VVYPTW-------- 246 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC--CCCCTT--------
T ss_pred ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC----CHHHHHHHHHcCC--CCCCCC--------
Confidence 34567999999999998888999999999999999999999998532 3333333332210 011111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
....+.+++.+||+.||++||++
T Consensus 247 ----~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 247 ----LHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ----CCHHHHHHHHHHhhhCHHHccCC
Confidence 11257889999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.19 Aligned_cols=218 Identities=22% Similarity=0.340 Sum_probs=174.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+++.. +|+.||+|++++.. ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999964 68999999997532 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..+|.++| |+||+|+|||++.++.+||+|||+++..... ..
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~ 161 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TY 161 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BC
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc----cc
Confidence 999999999998642 23566777 4578899999999999999999999876432 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+||+.|+|||.+.+..++.++|||||||++|||++|+.||... +.......+... ...... .
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~--~~~~p~--------~-- 225 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNA--ELRFPP--------F-- 225 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHC--CCCCCT--------T--
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhC--CCCCCC--------C--
Confidence 457999999999999999999999999999999999999998532 222232222211 001111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
....+.+++.+||+.||++||+
T Consensus 226 --~~~~~~~li~~lL~~dp~~R~~ 247 (318)
T 1fot_A 226 --FNEDVKDLLSRLITRDLSQRLG 247 (318)
T ss_dssp --SCHHHHHHHHHHTCSCTTTCTT
T ss_pred --CCHHHHHHHHHHhccCHHHcCC
Confidence 1126789999999999999993
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=312.84 Aligned_cols=221 Identities=30% Similarity=0.480 Sum_probs=173.3
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE-EKLLVYE 222 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e 222 (388)
..++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888899999999999999984 7799999997643 4578999999999999999999999987765 7899999
Q ss_pred ccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+++|+|.++++... .++.|+| |+||+|+|||++.++.+||+|||+++..... .
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----c
Confidence 999999999987532 2345566 4588899999999999999999999865322 1
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+++.|+|||.+....++.++|||||||++|||+| |+.||... ...++...+....+.. .|
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i~~~~~~~------~p----- 408 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYKMD------AP----- 408 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS----CTTTHHHHHHTTCCCC------CC-----
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCC------CC-----
Confidence 22357889999999988999999999999999999999 99998543 2334444333221110 01
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||+.|
T Consensus 409 --~~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 409 --DGCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 112236889999999999999999853
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=299.69 Aligned_cols=228 Identities=25% Similarity=0.361 Sum_probs=172.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999965 789999999865432 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-cceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE-SHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 282 (388)
+++|+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++...... ......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence 9999998876532 34566777 45788999999999999999999998764322 122234
Q ss_pred cccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..||+.|+|||++....+ +.++|||||||++|||++|+.||..... .......+... . ....+ .
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~----~---~~~~~------~ 231 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEK----K---TYLNP------W 231 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT--TSHHHHHHHTT----C---TTSTT------G
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhcc----c---ccCCc------c
Confidence 679999999999877665 7899999999999999999999864321 11222222111 0 00010 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||+.|
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~e 258 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPD 258 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 111235788999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=302.73 Aligned_cols=229 Identities=20% Similarity=0.261 Sum_probs=166.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.++|...+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357888999999999999999965 78999999997543 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCC--EEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFE--AKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~--~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..+|.|+| |+||+|+|||++.++. +||+|||+++...... ...
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 175 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPK 175 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCC
Confidence 9999999987532 33567777 4578899999987765 9999999998543221 223
Q ss_pred ccccccCccCccccCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATER-GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...||+.|+|||.+.+..++.+ +|||||||++|||++|+.||..... .......+........ ...+. ..
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~~~--~~~~~---~~- 246 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PRDYRKTIQRILSVKY--SIPDD---IR- 246 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-------CCCHHHHHHHHHTTCC--CCCTT---SC-
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhcCCC--CCCCc---CC-
Confidence 4569999999999877777655 8999999999999999999864322 2223332222221110 00000 00
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 247 ---~s~~~~~li~~~L~~dP~~Rps~~e 271 (361)
T 3uc3_A 247 ---ISPECCHLISRIFVADPATRISIPE 271 (361)
T ss_dssp ---CCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHH
Confidence 1136789999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=294.49 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=173.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|+..+++.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 56888899999999999999988899999999975432 2245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++....... ....
T Consensus 101 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 178 (311)
T 3niz_A 101 ME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTH 178 (311)
T ss_dssp CS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----C
T ss_pred CC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccC
Confidence 97 5888776543 23456666 457889999999999999999999987653322 2234
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc---CCc----
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV---LDP---- 354 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 354 (388)
..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+...........+ .+.
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT----DDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----TTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 568999999998765 568999999999999999999999986432 22333333332222111100 000
Q ss_pred ----cccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 ----AVLNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ----~~~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... .....++.+++.+||+.||++|||++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 0000000 011236789999999999999999854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=299.47 Aligned_cols=227 Identities=24% Similarity=0.296 Sum_probs=175.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC-----CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA-----TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
+.|...+.||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++..++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888899999999999999864 6899999998632 12245779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc-------------------cCCCCCHHh-----hhccccCCeeecCCCC---EEEcccccceec
Q 035768 220 VYEYMVKGSLDDWLRN-------------------QAASLDWGK-----RCKIVASNILLNDDFE---AKISDFGLARLI 272 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~-------------------~~~~l~~~~-----~~~i~~~NiLl~~~~~---~kl~DfG~a~~~ 272 (388)
||||+++|+|.+++.+ ...+|.|+| |+||+|+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999887643 223566677 4578899999986654 999999999887
Q ss_pred cCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||... ...+...+... .. ..
T Consensus 184 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~i~~~----~~--~~ 251 (351)
T 3c0i_A 184 GESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KERLFEGIIKG----KY--KM 251 (351)
T ss_dssp CTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-----HHHHHHHHHHT----CC--CC
T ss_pred cCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-----HHHHHHHHHcC----CC--CC
Confidence 54322 233456999999999999889999999999999999999999998532 22222222211 10 01
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+...... ...+.+++.+||+.||++|||+.|
T Consensus 252 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e 283 (351)
T 3c0i_A 252 NPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283 (351)
T ss_dssp CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CccccccC----CHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111111 236789999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.67 Aligned_cols=229 Identities=21% Similarity=0.279 Sum_probs=176.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 35688889999999999999985 4689999999875432 23456899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeec---CCCCEEEcccccceeccCCCcc
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLN---DDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~---~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||+++|+|.+++... ..++.|+| |+||+|+|||++ .++.+||+|||+++.......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 999999999877532 34567777 457889999998 467899999999987654322
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
......||+.|+|||++....++.++|||||||++|||++|..||... +...+...+...... ...+ ...
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~-----~~~~-~~~ 238 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE----DQHRLYQQIKAGAYD-----FPSP-EWD 238 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCCC-----CCTT-TTT
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHhCCCC-----CCcc-ccc
Confidence 223467999999999999889999999999999999999999998532 333333333321111 1111 011
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ....+.+++.+||+.||++|||+.|
T Consensus 239 ~----~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 239 T----VTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp T----SCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred c----CCHHHHHHHHHHcCCChhHCCCHHH
Confidence 1 1236889999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=300.40 Aligned_cols=232 Identities=21% Similarity=0.247 Sum_probs=172.6
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC-----CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA-----TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
...++|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3456788999999999999999996 46889999998643 23345679999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHh-------------------------------------------------------ccCCCCC
Q 035768 217 KLLVYEYMVKGSLDDWLR-------------------------------------------------------NQAASLD 241 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~-------------------------------------------------------~~~~~l~ 241 (388)
.++||||+++|+|.+++. +...++.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999998874 2223566
Q ss_pred HHh-----hhccccCCeeecCCC--CEEEcccccceeccCCC---cceeeccccccCccCccccCC--CCCCcccchHhH
Q 035768 242 WGK-----RCKIVASNILLNDDF--EAKISDFGLARLISDCE---SHVSTVVAGTIGYVPPEYGGT--GKATERGDVYSF 309 (388)
Q Consensus 242 ~~~-----~~~i~~~NiLl~~~~--~~kl~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~ 309 (388)
|+| |.||+|+|||++.++ .+||+|||+++...... ........||+.|+|||.+.. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 666 457889999998766 89999999998764322 112344569999999998764 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 310 GVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 310 Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
||++|||++|+.||... ...+....+.. ... ....+.. ......+.+++.+||+.||.+|||+.|
T Consensus 263 G~il~el~~g~~pf~~~----~~~~~~~~~~~---~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGV----NDADTISQVLN---KKL--CFENPNY-----NVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHSSCSSCCS----SHHHHHHHHHH---CCC--CTTSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHCCCCCCCC----ChHHHHHHHHh---ccc--ccCCccc-----ccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 99999999999998532 22222222221 111 0011110 011236889999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=295.38 Aligned_cols=238 Identities=22% Similarity=0.358 Sum_probs=163.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.++|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999964 689999999975432 334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 223 YMVKGSLDDWLRNQ---------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
|++ |+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 997 6999887532 22455666 45788999999999999999999998764322
Q ss_pred cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc---c--
Q 035768 277 SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD---E-- 350 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 350 (388)
. ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||... +..+....+.......... .
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT----NDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCChhHhhhhh
Confidence 2 2234568999999998865 46899999999999999999999998542 2333333333322111000 0
Q ss_pred ---cCCcccc---C---------CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 ---VLDPAVL---N---------ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ---~~~~~~~---~---------~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+... . .........+.+++.+||+.||++|||++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 290 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 0000000 0 000012236889999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.11 Aligned_cols=227 Identities=22% Similarity=0.279 Sum_probs=176.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
+.|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45788899999999999999964 689999999875432 13567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC----CEEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF----EAKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~----~~kl~DfG~a~~~~~ 274 (388)
+||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++ .+||+|||+++....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 999999999999998542 23566777 457889999999887 899999999988754
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.. ......||+.|+|||++....++.++|||||||++|||++|+.||... ...+....+..... ...+
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~~------~~~~ 238 (326)
T 2y0a_A 171 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANVSAVNY------EFED 238 (326)
T ss_dssp TS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHHTCC------CCCH
T ss_pred CC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC----CHHHHHHHHHhcCC------CcCc
Confidence 32 223456999999999998889999999999999999999999998532 22222222221110 0111
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... ...+.+++.+||+.||++|||+.|
T Consensus 239 ~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e 268 (326)
T 2y0a_A 239 EYFSNT----SALAKDFIRRLLVKDPKKRMTIQD 268 (326)
T ss_dssp HHHTTS----CHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccccC----CHHHHHHHHHHccCChhhCCCHHH
Confidence 111111 235789999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=294.29 Aligned_cols=227 Identities=18% Similarity=0.298 Sum_probs=177.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.++|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888899999999999999965 58899999987542 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecC--CCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLND--DFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~--~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+++|+|.+++.... .++.|+| |+||+|+|||++. ++.+||+|||+++...... ..
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 160 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF 160 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--cc
Confidence 99999999986532 2455666 4578899999987 7899999999998875432 23
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||.+.+..++.++|||||||++|||++|..||... ....+...+...... .++......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~------~~~~~~~~~ 230 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE----TNQQIIENIMNAEYT------FDEEAFKEI 230 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCCC------CCHHHHTTS
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC----CHHHHHHHHHcCCCC------CChhhhccC
Confidence 3456999999999998888999999999999999999999998542 233333333221110 111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.||++|||+.|
T Consensus 231 ----s~~~~~li~~~L~~dp~~Rpt~~e 254 (321)
T 1tki_A 231 ----SIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHH
Confidence 236889999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.46 Aligned_cols=228 Identities=22% Similarity=0.302 Sum_probs=176.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888999999999999999964 689999999975432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCC---CCEEEcccccceeccCCCcc
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDD---FEAKISDFGLARLISDCESH 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~---~~~kl~DfG~a~~~~~~~~~ 278 (388)
||+++|+|.+++... ..+|.|+| |+||+|+|||++.+ +.+||+|||+++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 999999999887532 33566777 45788999999865 459999999998765432
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+...... ...+. .
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~-----~~~~~-~- 254 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYD-----YPSPE-W- 254 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC-----CCTTG-G-
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCCC-----CCccc-c-
Confidence 223457999999999999889999999999999999999999998532 333333333221111 00010 0
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||+.|
T Consensus 255 ---~~~~~~~~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 255 ---DTVTPEAKSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp ---GGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ---cCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 111236789999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=292.13 Aligned_cols=226 Identities=26% Similarity=0.434 Sum_probs=174.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|...+.||+|+||.||+|.+.++..||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45788889999999999999999888899999997643 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++|+|.+++.... .++.++| |.||+|+||+++.++.+||+|||+++.............
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 9999999986532 2455666 457889999999999999999999987644322223334
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.+|+.|+|||.+....++.++||||||+++|||+| |+.||... +..+....+...... ..+. .
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~----~~~~~~~~~~~~~~~------~~~~---~--- 245 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQGLRL------YRPH---L--- 245 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHTTCCC------CCCT---T---
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc----ChhHHHHHHhcccCC------CCCC---c---
Confidence 56788999999988889999999999999999999 99997532 222333322221110 0110 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||++|
T Consensus 246 -~~~~l~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 246 -ASEKVYTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp -CCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHH
Confidence 1136889999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=297.60 Aligned_cols=223 Identities=22% Similarity=0.290 Sum_probs=176.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467888999999999999999975 48899999997532 23456788999999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 177 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cc
Confidence 99999999999988642 23566777 45788999999999999999999998643322 22
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..++.+.+.... .... .
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i~~~~--~~~p--------~- 242 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEHN--VAYP--------K- 242 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC--CCCC--------T-
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC----CHHHHHHHHHhCC--CCCC--------C-
Confidence 34567999999999999999999999999999999999999998532 3333333332210 0011 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.....+.+++.+||+.||++||++
T Consensus 243 ---~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 243 ---SMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ---CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112368899999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=307.02 Aligned_cols=236 Identities=27% Similarity=0.381 Sum_probs=178.4
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCcccee
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELL 208 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~ 208 (388)
...++....++|...+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4455666778899999999999999999973 3467899999976433 2345699999999999 799999999
Q ss_pred eEEEeCCe-eEEEEeccCCCCHHHHHhccC--------------------------------------------------
Q 035768 209 GYCSVDEE-KLLVYEYMVKGSLDDWLRNQA-------------------------------------------------- 237 (388)
Q Consensus 209 g~~~~~~~-~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------- 237 (388)
+++...+. .++||||+++|+|.++++...
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987554 899999999999999986532
Q ss_pred -------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-cee
Q 035768 238 -------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-HVS 280 (388)
Q Consensus 238 -------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~ 280 (388)
.+|.|+| |.||+|+|||++.++.+||+|||+++....... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 1344555 457889999999999999999999987643322 233
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ....+...+..... ..... .
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~~~~-~~~~~--------~ 320 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRLKEGTR-MRAPD--------Y 320 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC---CSHHHHHHHHHTCC-CCCCT--------T
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc---hhHHHHHHHHcCCC-CCCCC--------C
Confidence 44568999999999988899999999999999999999 999985432 11222222221111 01111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 321 ----~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 321 ----TTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCHHHHHHHHHHccCChhhCCCHHH
Confidence 1226889999999999999999854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.59 Aligned_cols=234 Identities=22% Similarity=0.246 Sum_probs=179.3
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEE
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCS 212 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 212 (388)
.++++....++|...+.||+|+||+||+++.. +++.||||++++.. ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44556667789999999999999999999974 69999999996532 122345889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 213 VDEEKLLVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 213 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+.+..|+||||+++|+|.+++.+.. .+|.|+| |+||+|+|||++.++.+||+|||+++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 9999999999999999999986532 2455666 457889999999999999999999998
Q ss_pred ccCCCcceeeccccccCccCccccC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGG-------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
............+||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAETYGKIVHYKE 287 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHH
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC----CHHHHHHHHHhccc
Confidence 7654443444568999999999876 457899999999999999999999998542 23333332222111
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
.... |..... ....+.+++.+||. +|.+|+
T Consensus 288 ~~~~-----p~~~~~----~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 288 HLSL-----PLVDEG----VPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp HCCC-----C----C----CCHHHHHHHHTTSS-CGGGCT
T ss_pred CcCC-----CccccC----CCHHHHHHHHHHcC-ChhhcC
Confidence 1111 100011 12368899999999 999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=295.96 Aligned_cols=230 Identities=20% Similarity=0.309 Sum_probs=174.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc---ChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ---GDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|+.. +++.||+|++++.... ..+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999965 5889999999764322 234578899999987 899999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~ 167 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 167 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-Ccc
Confidence 9999999999988542 23566777 45788999999999999999999998643322 223
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCc-ccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDG-ENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+.......... + | ..
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~-p---~~ 241 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I-P---RS 241 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--C-C---TT
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--C-C---CC
Confidence 4567999999999999999999999999999999999999998642111100 01111111211111110 0 1 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
....+.+++.+||+.||++||++
T Consensus 242 ----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 242 ----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 12367899999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.75 Aligned_cols=223 Identities=25% Similarity=0.327 Sum_probs=166.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc----CCCCEEEEEEcccCC----CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM----PDGKTVAVKKLSQAT----GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
++|...+.||+|+||.||+++. .+++.||+|++++.. ......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688899999999999999986 478999999997642 12345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 175 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG- 175 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC-
Confidence 9999999999999988542 23566777 45788999999999999999999998653322
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
.......||+.|+|||.+....++.++|||||||++|||++|+.||... +.......+.... .....
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~--~~~p~------- 242 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCK--LNLPP------- 242 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTC--CCCCT-------
T ss_pred ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCC--CCCCC-------
Confidence 2233457999999999998889999999999999999999999998532 2233333222211 01111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
. ....+.+++.+||+.||++||++.
T Consensus 243 -~----~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 243 -Y----LTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp -T----SCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred -C----CCHHHHHHHHHHHhcCHhhccCCC
Confidence 1 123678999999999999999653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=297.30 Aligned_cols=218 Identities=19% Similarity=0.253 Sum_probs=175.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999965 68999999986532 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++..... ..
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~ 196 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----cc
Confidence 999999999988642 23566777 4578899999999999999999999876442 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+.+.+... .. . -| ..
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~----~~-~--~p---~~-- 260 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKIVSG----KV-R--FP---SH-- 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHC----CC-C--CC---TT--
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC----CHHHHHHHHHcC----CC-C--CC---CC--
Confidence 457999999999999999999999999999999999999998532 233333322221 11 0 01 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
....+.+++.+||+.||++||+
T Consensus 261 --~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTT
T ss_pred --CCHHHHHHHHHHhhcCHHhccC
Confidence 1236889999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.69 Aligned_cols=222 Identities=23% Similarity=0.368 Sum_probs=172.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688899999999999999996 578999999986431 223457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+ +|+|.+++.+ ...++.|+| |+||+|+|||++.++.+||+|||+++...... ...
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~ 165 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLK 165 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TTC
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--ccc
Confidence 999 7899988743 233566777 45788999999999999999999998765432 223
Q ss_pred ccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..+||+.|+|||.+.+..+ ++++|||||||++|||++|+.||.......... .... .....|
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~~---~~~~~p------ 228 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------KVNS---CVYVMP------ 228 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------CCCS---SCCCCC------
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHc---CCCCCc------
Confidence 4569999999999887776 789999999999999999999986432111000 0000 000001
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||.+|||++|
T Consensus 229 -~~~s~~~~~li~~~L~~dP~~Rpt~~e 255 (336)
T 3h4j_B 229 -DFLSPGAQSLIRRMIVADPMQRITIQE 255 (336)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 111235789999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=288.37 Aligned_cols=237 Identities=23% Similarity=0.287 Sum_probs=171.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|+..+++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999988899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 159 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTH 159 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccccc
Confidence 97 4888887543 23456666 45788999999999999999999998764322 12233
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccc--------cCC
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE--------VLD 353 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 353 (388)
..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+....+........... ..+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV----SEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 468999999998865 46899999999999999999999998542 22222222222221111000 001
Q ss_pred cccc-------CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVL-------NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+... ..........+.+++.+||+.||++|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 277 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 1000 0000112346789999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=311.61 Aligned_cols=228 Identities=25% Similarity=0.327 Sum_probs=178.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|...+.||+|+||.||+|+.. +|+.||+|++.+.. ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999974 69999999996532 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 221 YEYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
|||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999999988643 12455666 45788999999999999999999998875433
Q ss_pred cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
. .....+||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.+.+.... .....
T Consensus 344 ~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~------ 414 (543)
T 3c4z_A 344 T-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPD------ 414 (543)
T ss_dssp C-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCT------
T ss_pred c-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCc------
Confidence 2 22345799999999999999999999999999999999999999865422222223333222110 00111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.....+.+++.+||+.||++||++.
T Consensus 415 ------~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 415 ------KFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------TSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ------ccCHHHHHHHHHhccCCHhHCCCCc
Confidence 1123678899999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=300.34 Aligned_cols=224 Identities=22% Similarity=0.338 Sum_probs=169.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCC--------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDE-------- 215 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 215 (388)
++|...+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46788899999999999999975 799999999975433 34567999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEeccCCCCHHHHHhcc----------
Q 035768 216 -------------------------------------------------EKLLVYEYMVKGSLDDWLRNQ---------- 236 (388)
Q Consensus 216 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~---------- 236 (388)
..++||||+++|+|.+++...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 379999999999999988642
Q ss_pred --------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-----------ceeeccccccCccCc
Q 035768 237 --------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-----------HVSTVVAGTIGYVPP 292 (388)
Q Consensus 237 --------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~gt~~y~aP 292 (388)
..+|.|+| |.||+|+|||++.++.+||+|||+++....... .......||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 23556666 457889999999999999999999988754321 122335699999999
Q ss_pred cccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHH
Q 035768 293 EYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIA 372 (388)
Q Consensus 293 E~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 372 (388)
|.+.+..++.++|||||||++|||++|..|+. +....... ........ . .......+.+++
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~~----~~~~~~~~-----~----~~~~~~~~~~li 306 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRIITD----VRNLKFPL-----L----FTQKYPQEHMMV 306 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHHH----HHTTCCCH-----H----HHHHCHHHHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHHH----hhccCCCc-----c----cccCChhHHHHH
Confidence 99988899999999999999999999877631 11111111 11111100 0 112234578899
Q ss_pred HhcccCCCCCCCCCCC
Q 035768 373 TGCISNDPTVRPTMLH 388 (388)
Q Consensus 373 ~~C~~~~P~~RPt~~e 388 (388)
.+||+.||++|||+.|
T Consensus 307 ~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 307 QDMLSPSPTERPEATD 322 (332)
T ss_dssp HHHHCSSGGGSCCHHH
T ss_pred HHHccCCCCcCCCHHH
Confidence 9999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=298.25 Aligned_cols=224 Identities=22% Similarity=0.306 Sum_probs=174.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999964 58899999986432 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ...
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~ 172 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QIT 172 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBC
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--cee
Confidence 999999999988643 23566777 45788999999999999999999998765432 234
Q ss_pred ccccccCccCccccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 282 VVAGTIGYVPPEYGGT---GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
..+||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .....+...+.... .....
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~--~~~p~-------- 241 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTV--VTYPS-------- 241 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-SCHHHHHHHHHHCC--CCCCT--------
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhhcc--cCCCC--------
Confidence 5679999999998863 4589999999999999999999999864321 11222222221100 00011
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.....+.+++.+||+.||.+||+.
T Consensus 242 ----~~s~~~~~li~~lL~~dP~~R~s~ 265 (384)
T 4fr4_A 242 ----AWSQEMVSLLKKLLEPNPDQRFSQ 265 (384)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCCS
T ss_pred ----cCCHHHHHHHHHHhcCCHhHhccc
Confidence 112368899999999999999983
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=293.25 Aligned_cols=227 Identities=23% Similarity=0.331 Sum_probs=153.7
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6899999999643 3467889999999997 9999999999999999999999999999
Q ss_pred HHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC---CEEEcccccceeccCCCcceeecccc
Q 035768 229 LDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF---EAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 229 L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
|.+++... ..+|.|+| |.||+|+|||++.++ .+||+|||+++...... .......|
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~ 171 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCF 171 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCC
Confidence 99988643 23566777 457889999997765 89999999998765432 22334568
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|+|||.+....++.++|||||||++|||++|+.||.............+..... ..+... ..+... ....
T Consensus 172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~--~~~~~~----~~~s 244 (325)
T 3kn6_A 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS--FEGEAW----KNVS 244 (325)
T ss_dssp ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC--CCSHHH----HTSC
T ss_pred CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC--CCcccc----cCCC
Confidence 999999999999999999999999999999999999986533221222222222221 111110 010000 1122
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.||++|||+.|
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~e 267 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSG 267 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHH
Confidence 36889999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=287.04 Aligned_cols=238 Identities=22% Similarity=0.312 Sum_probs=174.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||+||+|... +++.||||+++..... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999964 6899999999754322 23678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRN----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|+++ +|.+++.. ...++.|+| |.||+|+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 159 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS 159 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cccc
Confidence 9975 55555432 233566777 45788999999999999999999998765332 2233
Q ss_pred ccccccCccCccccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC-------
Q 035768 282 VVAGTIGYVPPEYGGTGK-ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD------- 353 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 353 (388)
...||+.|+|||.+.+.. ++.++|||||||++|||++|..|+.. ..+..+....+...........+..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~---~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC---CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC---CCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 456899999999887665 89999999999999999999988632 2233344443333322211110000
Q ss_pred ------c--cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 ------P--AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ------~--~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ .............+.+++.+||+.||++|||++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence 0 0000011122346789999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=306.98 Aligned_cols=226 Identities=27% Similarity=0.412 Sum_probs=173.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||+||+|++. +++.||||+++.... .....+.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999843 466899999975432 33456899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhccC----------------------CCCCHHh-----hhccccCCeeecCCC---CEEEccccc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------------ASLDWGK-----RCKIVASNILLNDDF---EAKISDFGL 268 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~-----~~~i~~~NiLl~~~~---~~kl~DfG~ 268 (388)
+||||+++|+|.++++... .+|.|+| |+||+|+|||++.++ .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999999999999986532 2345566 457889999999554 599999999
Q ss_pred ceeccCCC-cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 269 ARLISDCE-SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 269 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |..||... +..++.+.+.......
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~----~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFVTSGGRMD 306 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHTTCCCC
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCC
Confidence 98653211 122234557899999999988899999999999999999998 99997532 3333443332211110
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .......+.+++.+||+.||++|||+.|
T Consensus 307 ~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 307 P-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 335 (367)
T ss_dssp C-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C-------------CccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 0 0111235889999999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=297.95 Aligned_cols=228 Identities=20% Similarity=0.276 Sum_probs=178.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+.|...+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357888999999999999999964 6889999999765544556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecC--CCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLND--DFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~--~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+++|+|.+++... ..+|.|+| |+||+|+|||++. ++.+||+|||+++....... .
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~ 207 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V 207 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--e
Confidence 9999999988643 22456666 4578899999974 57899999999998754332 2
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||++....++.++|||||||++|||++|+.||... +..+....+..... ..++.....
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~----~~~~~~~~i~~~~~------~~~~~~~~~- 276 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETLQNVKRCDW------EFDEDAFSS- 276 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHHCCC------CCCSSTTTT-
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCC------CCCcccccc-
Confidence 3346999999999999999999999999999999999999998532 22233332222110 011111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 277 ---~s~~~~~li~~~L~~dP~~Rpt~~e 301 (387)
T 1kob_A 277 ---VSPEAKDFIKNLLQKEPRKRLTVHD 301 (387)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ---CCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1236889999999999999999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=293.94 Aligned_cols=234 Identities=29% Similarity=0.440 Sum_probs=170.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 218 (388)
++|+..+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4677889999999999999984 35889999999866555567899999999999999999999998653 5589
Q ss_pred EEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++.... .++.|+| |.||+|+|||++.++.+||+|||+++.......
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc
Confidence 9999999999999986532 2455666 457889999999999999999999987644322
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC--------CCCcccHHHHHHHhhcccc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFE--------DKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~--------~~~~~~~~~~~~~~~~~~~ 347 (388)
.......++..|+|||.+.+..++.++||||||+++|||+||..|+..... ..........+........
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccC
Confidence 122234577889999999888999999999999999999999999753210 0000111111111111111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ........+.+++.+||+.||++|||+.|
T Consensus 250 ~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 281 (295)
T 3ugc_A 250 RLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRD 281 (295)
T ss_dssp CCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 000 01112246889999999999999999854
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=299.46 Aligned_cols=224 Identities=24% Similarity=0.315 Sum_probs=168.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMET-LGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||.||+|+.. +++.||||++++... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999965 588999999975432 223456677776 577899999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 220 VYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++...... ..
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~ 195 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-ST 195 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-Cc
Confidence 99999999999988542 23567777 45788999999999999999999998643322 22
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..++.+.+... .... .+ .
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i~~~--~~~~----~~----~ 261 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----NTAEMYDNILNK--PLQL----KP----N 261 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----BHHHHHHHHHHS--CCCC----CS----S
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhc--ccCC----CC----C
Confidence 34567999999999999999999999999999999999999998532 333333332221 0001 11 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
....+.+++.+||+.||.+||++.
T Consensus 262 ----~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 ----ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ----CCHHHHHHHHHHcccCHHhCCCCC
Confidence 112578999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.55 Aligned_cols=228 Identities=28% Similarity=0.447 Sum_probs=176.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC--------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSV 213 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 213 (388)
..++|...+.||+|+||.||+|+.. ++..||||+++.... .....+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888899999999999999852 235799999976533 2346789999999999 99999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecC
Q 035768 214 DEEKLLVYEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLND 257 (388)
Q Consensus 214 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~ 257 (388)
++..++||||+++|+|.+++.... .+|.++| |+||+|+|||++.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 999999999999999999986532 1344555 4578899999999
Q ss_pred CCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccH
Q 035768 258 DFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENL 335 (388)
Q Consensus 258 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 335 (388)
++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||... ...++
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~----~~~~~ 302 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----PVEEL 302 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHHH
Confidence 99999999999987654322 22233457889999999988999999999999999999999 99997532 33333
Q ss_pred HHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 336 VDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.+........ + .. ....+.+++.+||+.||++|||++|
T Consensus 303 ~~~~~~~~~~~~------~---~~----~~~~l~~li~~~l~~dP~~Rps~~e 342 (382)
T 3tt0_A 303 FKLLKEGHRMDK------P---SN----CTNELYMMMRDCWHAVPSQRPTFKQ 342 (382)
T ss_dssp HHHHHTTCCCCC------C---SS----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHcCCCCCC------C---cc----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence 333322111110 0 11 1236889999999999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.77 Aligned_cols=230 Identities=30% Similarity=0.443 Sum_probs=178.4
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.+....++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.. +..++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3344556788889999999999999999888889999997644 345789999999999999999999999875 67899
Q ss_pred EEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 220 VYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||||+++|+|.++++.. +.+|.|+| |+||+|+|||++.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999998632 22456666 457889999999999999999999987643222
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.......++..|+|||.+....++.++|||||||++|||+| |+.||... ...++.+.+....+. . .
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~----~~~~~~~~i~~~~~~----~--~--- 485 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGYRM----P--C--- 485 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC----CHHHHHHHHHTTCCC----C--C---
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCC----C--C---
Confidence 22223446789999999888899999999999999999999 89997532 233333333221110 0 0
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 486 ----~~~~~~~l~~li~~cl~~dP~~RPt~~~ 513 (535)
T 2h8h_A 486 ----PPECPESLHDLMCQCWRKEPEERPTFEY 513 (535)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 0112236889999999999999999853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=296.87 Aligned_cols=228 Identities=22% Similarity=0.390 Sum_probs=165.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcC---hHHHHHHHHHHhcCCCCCccceeeEEEeCCe----e
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQG---DREFAAEMETLGMVKHQNLVELLGYCSVDEE----K 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 217 (388)
++|...+.||+|+||.||+|+. .+++.||||+++...... ...+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5688889999999999999995 578899999997653322 3468899999999999999999999876543 4
Q ss_pred EEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
++||||+++|+|.++++.. ..+|.|+| |.||+|+|||++.++.+||+|||+++.......
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 9999999999999988642 23566777 457889999999999999999999987644322
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||... ...... ......... .+.
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~~~~---~~~~~~~~~----~~~ 240 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVA---YQHVREDPI----PPS 240 (311)
T ss_dssp ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHH---HHHHHCCCC----CHH
T ss_pred ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHH---HHHhcCCCC----Ccc
Confidence 1223456899999999998889999999999999999999999998532 222221 111111111 111
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.... .....+.+++.+||+.||++||++.
T Consensus 241 ~~~~---~~~~~l~~li~~~l~~dP~~R~~~~ 269 (311)
T 3ork_A 241 ARHE---GLSADLDAVVLKALAKNPENRYQTA 269 (311)
T ss_dssp HHST---TCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred cccC---CCCHHHHHHHHHHHhcCHhhChhhH
Confidence 0000 1123678999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=300.59 Aligned_cols=230 Identities=29% Similarity=0.458 Sum_probs=176.3
Q ss_pred HHhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 035768 142 VAGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVD 214 (388)
Q Consensus 142 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 214 (388)
....++|...+.||+|+||.||+|+.. +++.||||.++.... ...+.|.+|++++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999964 347899999976533 2345799999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhccC---------------------------------------CCCCHHh-----hhcccc
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA---------------------------------------ASLDWGK-----RCKIVA 250 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------~~l~~~~-----~~~i~~ 250 (388)
+..++||||+++|+|.+++.+.. .+|.|+| |.||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 99999999999999999986521 1345555 457889
Q ss_pred CCeeecCCCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCC
Q 035768 251 SNILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFE 328 (388)
Q Consensus 251 ~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~ 328 (388)
+|||++.++.+||+|||+++....... .......||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-- 280 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-- 280 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC--
Confidence 999999999999999999987643221 12234567899999999888889999999999999999999 99997532
Q ss_pred CCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 329 DKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++...+.. ...... + . .....+.+++.+||+.||++|||+.|
T Consensus 281 --~~~~~~~~~~~----~~~~~~--~---~----~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 281 --AHEEVIYYVRD----GNILAC--P---E----NCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp --CHHHHHHHHHT----TCCCCC--C---T----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --ChHHHHHHHhC----CCcCCC--C---C----CCCHHHHHHHHHHcccCcccCCCHHH
Confidence 22333332222 111110 0 1 11236889999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=298.02 Aligned_cols=227 Identities=23% Similarity=0.323 Sum_probs=160.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+.|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999975 58899999997543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecC---CCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
+++|+|.+++... ..+|.|+| |.||+|+|||++. ++.+||+|||+++...... ..
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 207 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LM 207 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--cc
Confidence 9999999988542 23566666 4578899999975 8899999999998764322 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+...+.. ... ....+ ...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~i~~----~~~-~~~~~-~~~-- 276 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER---GDQFMFRRILN----CEY-YFISP-WWD-- 276 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT---CHHHHHHHHHT----TCC-CCCTT-TTT--
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc---ccHHHHHHHHh----CCC-ccCCc-hhh--
Confidence 34569999999999998899999999999999999999999985421 11112222211 110 01111 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 277 --~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (349)
T 2w4o_A 277 --EVSLNAKDLVRKLIVLDPKKRLTTFQ 302 (349)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred --hCCHHHHHHHHHHccCChhhCcCHHH
Confidence 12236889999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=288.29 Aligned_cols=223 Identities=30% Similarity=0.449 Sum_probs=162.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC----cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG----QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56788899999999999999974 88999999875432 23467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc--------------CCCCCHHh--------hhccccCCeeecC--------CCCEEEccccccee
Q 035768 222 EYMVKGSLDDWLRNQ--------------AASLDWGK--------RCKIVASNILLND--------DFEAKISDFGLARL 271 (388)
Q Consensus 222 e~~~~g~L~~~l~~~--------------~~~l~~~~--------~~~i~~~NiLl~~--------~~~~kl~DfG~a~~ 271 (388)
||+++|+|.+++.+. ..++.++| |.||+|+|||++. ++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 86 EFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp ECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred EcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 999999999987532 23556666 5578899999986 77899999999987
Q ss_pred ccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||... +.......+ ........
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~---~~~~~~~~- 234 (271)
T 3dtc_A 166 WHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI----DGLAVAYGV---AMNKLALP- 234 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS----CHHHHHHHH---HTSCCCCC-
T ss_pred ccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHhh---hcCCCCCC-
Confidence 64322 22346899999999998888999999999999999999999998532 222221111 11111000
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... .....+.+++.+||+.||++|||+.|
T Consensus 235 ----~~~----~~~~~~~~li~~~l~~~p~~Rps~~e 263 (271)
T 3dtc_A 235 ----IPS----TCPEPFAKLMEDCWNPDPHSRPSFTN 263 (271)
T ss_dssp ----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----CCc----ccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 011 11236889999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=296.95 Aligned_cols=223 Identities=23% Similarity=0.328 Sum_probs=168.6
Q ss_pred cCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 150 EENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
..+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356799999999999986 4689999999987654556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcc----------------CCCCCHHh-----hhccccCCeee--cCCCCEEEcccccceeccCCCcceeecccc
Q 035768 229 LDDWLRNQ----------------AASLDWGK-----RCKIVASNILL--NDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 229 L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl--~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
|.+++... ..+|.|+| |+||+|+|||+ +.++.+||+|||+++....... .....|
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~g 250 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFG 250 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCS
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccccC
Confidence 99887532 23556666 45788999999 5678999999999998754322 233469
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|+|||++....++.++|||||||++|||++|+.||... +..+....+...... ..+...... .
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~~------~~~~~~~~~----~ 316 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD----NDAETLNNILACRWD------LEDEEFQDI----S 316 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCCC------SCSGGGTTS----C
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCC------CChhhhccC----C
Confidence 99999999998889999999999999999999999998532 222222222221100 011111111 2
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.||.+|||+.|
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e 339 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASE 339 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHH
Confidence 36889999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.31 Aligned_cols=221 Identities=24% Similarity=0.297 Sum_probs=165.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|...+.||+|+||.||+|.. .+++.||||+++.. .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 45788899999999999999995 46899999999753 223345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc---------------cCCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRN---------------QAASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~---------------~~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+++|+|.+++.. ...+|.|+|. +||+|+|||++.++.+||+|||+++...... ..
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 305 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 305 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-cc
Confidence 999999999988753 2346777874 4788999999999999999999998643322 22
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+... .......
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~--~~~~p~~-------- 371 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFELILME--EIRFPRT-------- 371 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHC--CCCCCTT--------
T ss_pred cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC----CHHHHHHHHHhC--CCCCCcc--------
Confidence 34467999999999998899999999999999999999999998532 333333332221 1111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
....+.+++.+||+.||.+||
T Consensus 372 ----~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 372 ----LGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTST
T ss_pred ----CCHHHHHHHHHHcccCHHHhC
Confidence 113688999999999999999
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.94 Aligned_cols=229 Identities=23% Similarity=0.400 Sum_probs=161.1
Q ss_pred HHhhcCCCcCCeeeccCCceEEEEEcCCC----CEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 142 VAGTNKFCEENVIGGGGFGTVFKGTMPDG----KTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 142 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
....++|...+.||+|+||.||+|..... ..||||.++... ....+.+.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34456899999999999999999997543 279999997542 334567999999999999999999999998776
Q ss_pred ee------EEEEeccCCCCHHHHHhcc---------------------CCCCCHHh-----hhccccCCeeecCCCCEEE
Q 035768 216 EK------LLVYEYMVKGSLDDWLRNQ---------------------AASLDWGK-----RCKIVASNILLNDDFEAKI 263 (388)
Q Consensus 216 ~~------~lv~e~~~~g~L~~~l~~~---------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl 263 (388)
.. ++||||+++|+|.+++... ..+|.|+| |.||+|+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 9999999999999988532 22455666 4578899999999999999
Q ss_pred cccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHH
Q 035768 264 SDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLH 341 (388)
Q Consensus 264 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 341 (388)
+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||... +..++...+..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~~~ 254 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI----ENAEIYNYLIG 254 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHT
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc----ChHHHHHHHhc
Confidence 99999987644322 12223456789999999988899999999999999999999 89997542 33344433322
Q ss_pred hhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 342 MMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
...... .......+.+++.+||+.||++|||+.
T Consensus 255 ~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 287 (323)
T 3qup_A 255 GNRLKQ-------------PPECMEEVYDLMYQCWSADPKQRPSFT 287 (323)
T ss_dssp TCCCCC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCCCC-------------CCccCHHHHHHHHHHccCChhhCcCHH
Confidence 111100 011123688999999999999999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=285.67 Aligned_cols=226 Identities=27% Similarity=0.460 Sum_probs=176.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++|...+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35677889999999999999998888899999997643 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++|+|.+++..... ++.++| |.||+|+||+++.++.+||+|||+++.............
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 99999999865322 345555 457889999999999999999999987643222222334
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
.+|..|+|||.+....++.++||||||+++|||++ |+.||... ........+..... ...+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~i~~~~~------~~~~~------- 228 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFR------LYKPR------- 228 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCC------CCCCT-------
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC----CHHHHHHHHhcCCc------CCCCc-------
Confidence 57788999999988889999999999999999999 89997532 22333332222111 00111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSR 254 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHH
Confidence 11236889999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=287.22 Aligned_cols=226 Identities=23% Similarity=0.374 Sum_probs=162.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||.||+|.+.. +..||+|.++.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3567888999999999999998643 45799999876433 23456899999999999999999999984 567899
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++.... .+|.++| |.||+|+|||++.++.+||+|||+++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 999999999999986432 2445556 4578899999999999999999999877544333
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......+|+.|+|||.+....++.++||||||+++|||++ |..||... ...+....+...... . ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~----~~~~~~~~i~~~~~~----~-----~~ 239 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIENGERL----P-----MP 239 (281)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHTTCCC----C-----CC
T ss_pred ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC----CHHHHHHHHHcCCCC----C-----CC
Confidence 3334457889999999988889999999999999999997 99998543 233444333221110 0 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .....+.+++.+||+.||++|||+.|
T Consensus 240 ~----~~~~~l~~li~~~l~~~p~~Rps~~~ 266 (281)
T 1mp8_A 240 P----NCPPTLYSLMTKCWAYDPSRRPRFTE 266 (281)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C----CCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1 11236889999999999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.84 Aligned_cols=226 Identities=31% Similarity=0.460 Sum_probs=176.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
..++|...+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 345788889999999999999998888899999997543 34578999999999999999999999986 5568999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..++.++| |.||+|+||++++++.+||+|||+++...........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9999999988532 22456666 4578899999999999999999999887654333333
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...++..|+|||.+....++.++||||||+++|||++ |+.||... ...++...+...... ..+ .
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~~~~~~~------~~~---~-- 233 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNLERGYRM------VRP---D-- 233 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTTCCC------CCC---T--
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc----CHHHHHHHHhcccCC------CCc---c--
Confidence 4457789999999888889999999999999999999 89997532 223333322221110 001 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||++|
T Consensus 234 --~~~~~l~~li~~~l~~~p~~Rps~~~ 259 (279)
T 1qpc_A 234 --NCPEELYQLMRLCWKERPEDRPTFDY 259 (279)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --cccHHHHHHHHHHhccChhhCCCHHH
Confidence 11236889999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=294.32 Aligned_cols=221 Identities=26% Similarity=0.382 Sum_probs=169.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
+.|...+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999995 57899999999754322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||++ |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9996 7888877432 23455666 4578899999999999999999999876432
Q ss_pred eccccccCccCcccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 281 TVVAGTIGYVPPEYG---GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
....||+.|+|||.+ ....++.++|||||||++|||++|+.||... +.... +........ .....
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~----~~~~~---~~~~~~~~~-~~~~~---- 275 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSA---LYHIAQNES-PALQS---- 275 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHH---HHHHHHSCC-CCCCC----
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHH---HHHHHhcCC-CCCCC----
Confidence 235699999999987 3567899999999999999999999998532 21121 222211111 11100
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ....+.+++.+||+.||++|||+.|
T Consensus 276 ~~----~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 276 GH----WSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CC----CCHHHHHHHHHHcccChhhCcCHHH
Confidence 11 1235788999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=309.65 Aligned_cols=227 Identities=26% Similarity=0.339 Sum_probs=178.4
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
..++|...+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+|+++|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999964 69999999996532 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 220 VYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 99999999999988643 22456666 45788999999999999999999998875432
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+... ......
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~------- 410 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSE------- 410 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCT-------
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCc-------
Confidence 2234579999999999998899999999999999999999999986533222222233222211 001111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
. ....+.+++.+||+.||++||++
T Consensus 411 -~----~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 411 -R----FSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp -T----SCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -c----CCHHHHHHHHHhccCCHHHcCCC
Confidence 1 12368899999999999999954
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=305.91 Aligned_cols=223 Identities=25% Similarity=0.403 Sum_probs=176.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|++. +|+.||||+++... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999965 79999999996532 223457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++.+. ..++.|+| |+||+|+|||++.++.+||+|||+++...... ...
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~ 173 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLR 173 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CBC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--ccc
Confidence 999999999988542 23566777 56788999999999999999999998875432 233
Q ss_pred ccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
..+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||... ....+...+.... . ..| ..
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~----~---~~p---~~- 238 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD----HVPTLFKKICDGI----F---YTP---QY- 238 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS----SSHHHHHHHHTTC----C---CCC---TT-
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCC----c---CCC---cc-
Confidence 4579999999999887765 78999999999999999999998542 2233333222211 0 001 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 239 ---~s~~~~~Li~~~L~~dP~~Rpt~~e 263 (476)
T 2y94_A 239 ---LNPSVISLLKHMLQVDPMKRATIKD 263 (476)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ---CCHHHHHHHHHHcCCCchhCcCHHH
Confidence 1125789999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.27 Aligned_cols=226 Identities=20% Similarity=0.250 Sum_probs=175.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45788899999999999999965 57799999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCCcceee
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
++++|.+++... ..++.++| |.||+|+||++ +.++.+||+|||++....... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~ 166 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMR 166 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--chh
Confidence 999999887532 23566677 45788999999 788999999999998765433 223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||.+.+ .++.++||||||+++|||++|+.||... ...+....+...... ........
T Consensus 167 ~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~------~~~~~~~~-- 233 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP----TDSEVMLKIREGTFT------FPEKDWLN-- 233 (277)
T ss_dssp CCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCC------CCHHHHTT--
T ss_pred ccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCCC------CCchhhhc--
Confidence 4569999999998765 4899999999999999999999998542 222222222221100 00000001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 234 --~~~~~~~li~~~l~~dp~~R~s~~~ 258 (277)
T 3f3z_A 234 --VSPQAESLIRRLLTKSPKQRITSLQ 258 (277)
T ss_dssp --SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHH
Confidence 1236889999999999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=282.35 Aligned_cols=223 Identities=27% Similarity=0.423 Sum_probs=167.0
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcC-------hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQG-------DREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
++|...+.||+|+||+||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5688889999999999999996 478999999986543221 167899999999999999999999986554
Q ss_pred EEEEeccCCCCHHHHHhccCC----------------CCCHHhh-------hccccCCeeecCCCC-----EEEcccccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQAA----------------SLDWGKR-------CKIVASNILLNDDFE-----AKISDFGLA 269 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~~----------------~l~~~~~-------~~i~~~NiLl~~~~~-----~kl~DfG~a 269 (388)
++||||+++|+|.+++.+... ++.++|. .||+|+|||++.++. +||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 799999999999988754322 3445554 467799999988776 999999999
Q ss_pred eeccCCCcceeeccccccCccCcccc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 270 RLISDCESHVSTVVAGTIGYVPPEYG--GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
+.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||..... ........+.. ..
T Consensus 177 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~---~~- 246 (287)
T 4f0f_A 177 QQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY--GKIKFINMIRE---EG- 246 (287)
T ss_dssp BCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC--CHHHHHHHHHH---SC-
T ss_pred ccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc--cHHHHHHHHhc---cC-
Confidence 85433 23345699999999988 455678999999999999999999999864321 11111221111 11
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... .... .....+.+++.+||+.||++|||++|
T Consensus 247 ~~~----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ 279 (287)
T 4f0f_A 247 LRP----TIPE----DCPPRLRNVIELCWSGDPKKRPHFSY 279 (287)
T ss_dssp CCC----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCC----CCCc----ccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 111 1111 11236889999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=293.40 Aligned_cols=227 Identities=28% Similarity=0.476 Sum_probs=179.9
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
..++|...+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567888899999999999999975 48889999997543 345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++..........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 99999999998642 22455666 457889999999999999999999987765444444
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....+|+.|+|||.+....++.++||||||+++|||++ |..||... +...+.+.+........ + .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~----~~~~~~~~~~~~~~~~~------~---~- 235 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKDYRMER------P---E- 235 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHHHTTCCCCC------C---T-
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhccCCCCC------C---C-
Confidence 45567889999999988899999999999999999999 99997542 33344433322211110 0 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||.+|||+.|
T Consensus 236 ---~~~~~l~~li~~~l~~dp~~Rps~~~ 261 (288)
T 3kfa_A 236 ---GCPEKVYELMRACWQWNPSDRPSFAE 261 (288)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCHHHHHHHHHHhCCChhhCcCHHH
Confidence 11236889999999999999999853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.90 Aligned_cols=227 Identities=22% Similarity=0.317 Sum_probs=163.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcC---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQG---DREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|...+.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367889999999999999999964 68899999997543322 35688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+++++|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++..........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 9999999999988642 23456666 457789999999999999999999987654433333
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc-ccccCCccccCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ-ADEVLDPAVLNA 359 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 359 (388)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||... ....+. ....... ......+ .
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~----~~~~~~~~~~~~~~~----~ 260 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD----QLSVMG----AHINQAIPRPSTVRP----G 260 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC----HHHHHH----HHHHSCCCCGGGTST----T
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc----hHHHHH----HHhccCCCCccccCC----C
Confidence 4456899999999998889999999999999999999999998532 111111 1111111 0001111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-CCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRP-TML 387 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RP-t~~ 387 (388)
....+.+++.+||+.||++|| |++
T Consensus 261 ----~~~~l~~li~~~l~~dP~~Rp~s~~ 285 (309)
T 2h34_A 261 ----IPVAFDAVIARGMAKNPEDRYVTCG 285 (309)
T ss_dssp ----CCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred ----CCHHHHHHHHHhccCCHHHHHHhHH
Confidence 112588999999999999999 553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.86 Aligned_cols=227 Identities=25% Similarity=0.337 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEc----CCCCEEEEEEcccCC----CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM----PDGKTVAVKKLSQAT----GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
.++|...+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999986 368999999987532 12345677899999999 6999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
..++||||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++.....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 999999999999999988642 33566777 4578899999999999999999999876543
Q ss_pred CcceeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
.........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+...+ ....
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~------- 282 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKSE------- 282 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHCC-------
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---hccC-------
Confidence 3333445679999999999875 357899999999999999999999986432222222222222 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 385 (388)
+.... .....+.+++.+||+.||.+||+
T Consensus 283 ~~~~~----~~~~~~~~li~~~L~~dP~~R~~ 310 (355)
T 1vzo_A 283 PPYPQ----EMSALAKDLIQRLLMKDPKKRLG 310 (355)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSTT
T ss_pred CCCCc----ccCHHHHHHHHHHhhhCHHHhcC
Confidence 00001 11235788999999999999993
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=291.64 Aligned_cols=227 Identities=30% Similarity=0.420 Sum_probs=176.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
.++|...+.||+|+||.||+|.. .+++.||||.++.... ...+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45688889999999999999985 2457899999975432 3346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC---------------------------------------CCCCHHh-----hhccccCCe
Q 035768 218 LLVYEYMVKGSLDDWLRNQA---------------------------------------ASLDWGK-----RCKIVASNI 253 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~---------------------------------------~~l~~~~-----~~~i~~~Ni 253 (388)
++||||+++|+|.+++.+.. .+|.|+| |.||+|+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 99999999999999986431 2345556 457889999
Q ss_pred eecCCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCC
Q 035768 254 LLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKD 331 (388)
Q Consensus 254 Ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~ 331 (388)
+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||... .
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~ 257 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI----P 257 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----C
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC----C
Confidence 9999999999999999877543322 2223457889999999888889999999999999999999 99997542 3
Q ss_pred cccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 332 GENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+...+...... . ... .....+.+++.+||+.||++|||+.|
T Consensus 258 ~~~~~~~~~~~~~~----~-----~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 258 PERLFNLLKTGHRM----E-----RPD----NCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp GGGHHHHHHTTCCC----C-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhhcCCcC----C-----CCc----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 33444333221111 0 001 11236889999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=296.79 Aligned_cols=226 Identities=23% Similarity=0.372 Sum_probs=166.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKH--QNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~ 221 (388)
+.|...+.||+|+||.||++...+++.||||++..... ...+.+.+|++++++++| |||+++++++..++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 45888899999999999999998899999999875432 233678999999999986 99999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-ee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~ 280 (388)
|| .+|+|.+++... ..+|.|+| |+||+|+|||++ ++.+||+|||+++........ ..
T Consensus 89 e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp CC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---------
T ss_pred eC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccC
Confidence 95 588999988643 23566676 457889999997 578999999999876543222 23
Q ss_pred eccccccCccCccccCC-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 281 TVVAGTIGYVPPEYGGT-----------GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... +....+..........
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHCTTSCC
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHHhcCCccc
Confidence 34579999999998743 678999999999999999999999985422 1111122222111110
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. + ... ...+.+++.+||+.||.+|||+.|
T Consensus 241 ~~--~---~~~----~~~l~~li~~~L~~dp~~Rpt~~e 270 (343)
T 3dbq_A 241 EF--P---DIP----EKDLQDVLKCCLKRDPKQRISIPE 270 (343)
T ss_dssp CC--C---CCS----CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CC--c---ccC----CHHHHHHHHHHcCCChhHCCCHHH
Confidence 00 0 111 125789999999999999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=299.92 Aligned_cols=181 Identities=21% Similarity=0.267 Sum_probs=150.5
Q ss_pred hcCCCcCCeeecc--CCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGG--GFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+| +||+||+|+.. +++.||||+++.... ...+.+.+|++++++++|||||++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568889999999 99999999965 699999999975432 233568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 220 VYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||.+........
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999999988643 23556666 457889999999999999999999876532211
Q ss_pred ------ceeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 278 ------HVSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 278 ------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.......||+.|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 11122468999999999877 6799999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.75 Aligned_cols=228 Identities=17% Similarity=0.175 Sum_probs=174.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|.. .+++.||||.+.... ..+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5688889999999999999995 578999999986543 234688999999999 999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCC-----EEEcccccceeccCCCc
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFE-----AKISDFGLARLISDCES 277 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~-----~kl~DfG~a~~~~~~~~ 277 (388)
+ +|+|.+++... ..+|.|+| |+||+|+|||++.++. +||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9 99999998743 22455666 4578899999998887 99999999997654332
Q ss_pred c------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 278 H------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 278 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+..+....+.........
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~--- 241 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKERYQKIGDTKRATPI--- 241 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-SSHHHHHHHHHHHHHHSCH---
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-ccHHHHHHHHHhhhccCCH---
Confidence 1 12356799999999999999999999999999999999999999865321 1222222222211111110
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
....... . .+.+++..||+.||.+||+++
T Consensus 242 ---~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~ 270 (330)
T 2izr_A 242 ---EVLCENF---P-EMATYLRYVRRLDFFEKPDYD 270 (330)
T ss_dssp ---HHHTTTC---H-HHHHHHHHHHHCCTTCCCCHH
T ss_pred ---HHHhccC---h-HHHHHHHHHHhCCCCCCCCHH
Confidence 0001111 1 688999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=285.33 Aligned_cols=226 Identities=23% Similarity=0.371 Sum_probs=168.6
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
+|....+||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455567999999999999995 5688999999987655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccC------------------CCCCHHh-----hhccccCCeeecC-CCCEEEcccccceeccCCCcceee
Q 035768 226 KGSLDDWLRNQA------------------ASLDWGK-----RCKIVASNILLND-DFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 226 ~g~L~~~l~~~~------------------~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+|+|.+++.... .++.++| |.||+|+||+++. ++.+||+|||+++....... ...
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 181 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTE 181 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------C
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccc
Confidence 999999986532 2345555 4577899999987 89999999999987654222 223
Q ss_pred ccccccCccCccccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 282 VVAGTIGYVPPEYGGTG--KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
...||+.|+|||.+... .++.++||||||+++|||++|+.||.... ...... ....... ..+.....
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~--~~~~~~~------~~~~~~~~ 250 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG---EPQAAM--FKVGMFK------VHPEIPES 250 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS---SHHHHH--HHHHHHC------CCCCCCTT
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC---chhHHH--Hhhcccc------cccccccc
Confidence 45689999999987654 37899999999999999999999985311 111111 1110000 01111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 251 ----~~~~~~~li~~~l~~dp~~Rps~~~ 275 (295)
T 2clq_A 251 ----MSAEAKAFILKCFEPDPDKRACAND 275 (295)
T ss_dssp ----SCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred ----CCHHHHHHHHHHccCChhhCCCHHH
Confidence 1236788999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=296.98 Aligned_cols=229 Identities=26% Similarity=0.419 Sum_probs=174.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
..++|...+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456788899999999999999985 245689999997543 23456799999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhccCC--------------------------------------CCCHHh-----hhccccCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQAA--------------------------------------SLDWGK-----RCKIVASN 252 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------~l~~~~-----~~~i~~~N 252 (388)
..++||||+++|+|.+++..... +|.++| |.||+|+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 99999999999999999865321 344555 45888999
Q ss_pred eeecCCCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCC
Q 035768 253 ILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDK 330 (388)
Q Consensus 253 iLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~ 330 (388)
||++.++.+||+|||+++....... .......||+.|+|||.+....++.++|||||||++|||+| |..||....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--- 279 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--- 279 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC---
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 9999999999999999987644332 22334557889999999888899999999999999999998 999985432
Q ss_pred CcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 331 DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+...+....... .+ . .....+.+++.+||+.||.+|||+.|
T Consensus 280 ~~~~~~~~~~~~~~~~------~~---~----~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMD------QP---F----YATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp CSHHHHHHHHTTCCCC------CC---T----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cHHHHHHHHhcCCCCC------CC---C----CCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 1122222222111100 00 1 11236889999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=292.81 Aligned_cols=225 Identities=27% Similarity=0.429 Sum_probs=167.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCC----EEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGK----TVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||+||+|++. +++ .||+|.++... ....+.|.+|+.++++++||||++++++|..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46788899999999999999954 444 36888886443 345578999999999999999999999998654 789
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|+||+++|+|.+++.... .+|.|+| |+||+|+|||++.++.+||+|||+++........
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 999999999999986532 2455666 4578899999999999999999999876543322
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||... ....+...+....... .+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~~~~~~------~~-- 241 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERLP------QP-- 241 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHTTCCCC------CC--
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC----CHHHHHHHHHcCCCCC------CC--
Confidence 2233456889999999988999999999999999999999 99998542 3334443333211111 00
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++||||.|
T Consensus 242 -----~~~~~~~~~li~~~l~~~p~~Rps~~e 268 (327)
T 3poz_A 242 -----PICTIDVYMIMVKCWMIDADSRPKFRE 268 (327)
T ss_dssp -----TTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred -----ccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 112236889999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=296.88 Aligned_cols=226 Identities=20% Similarity=0.241 Sum_probs=164.1
Q ss_pred cCCCcC-CeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHH-hcCCCCCccceeeEEEe----CCeeE
Q 035768 146 NKFCEE-NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETL-GMVKHQNLVELLGYCSV----DEEKL 218 (388)
Q Consensus 146 ~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 218 (388)
++|... +.||+|+||+||++... +++.||||+++. ...+.+|++++ +..+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 68999999999999964 688999999863 24677888887 45689999999999876 56789
Q ss_pred EEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecC---CCCEEEcccccceecc
Q 035768 219 LVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLIS 273 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~ 273 (388)
+||||+++|+|.+++.... .+|.|+| |+||+|+|||++. ++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999999999986532 2456677 4578899999997 7899999999998764
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
... .....+||+.|+|||++....++.++|||||||++|||++|+.||...............+..... ....
T Consensus 216 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-----~~~~ 288 (400)
T 1nxk_A 216 SHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-----EFPN 288 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-----CCCT
T ss_pred CCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-----cCCC
Confidence 322 233467899999999999999999999999999999999999998654322222223333222110 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ ... .....+.+++.+||+.||++|||+.|
T Consensus 289 ~-~~~----~~s~~~~~li~~~L~~dP~~Rpt~~e 318 (400)
T 1nxk_A 289 P-EWS----EVSEEVKMLIRNLLKTEPTQRMTITE 318 (400)
T ss_dssp T-TTT----TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred c-ccc----cCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 001 12236889999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=297.03 Aligned_cols=177 Identities=27% Similarity=0.402 Sum_probs=149.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999965 689999999876532 2345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++... ..++.|+|. .||+|+|||++.++.+||+|||+++..... ....
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 189 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 189 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C---
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccC
Confidence 9999999988642 235566663 477899999999999999999999765321 2233
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5689999999999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.47 Aligned_cols=220 Identities=23% Similarity=0.265 Sum_probs=163.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+|... +++.||||++...... ....+..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46888999999999999999975 7999999998654322 233455666655554 9999999999999999999999
Q ss_pred eccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+ +|+|.+++.... .+|.|+| |.||+|+|||++.++.+||+|||+++...... ..
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CC
Confidence 999 789988876432 3455666 45788999999999999999999998765432 23
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+.. ... ...+ ... ...+......
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~------~~~-~~~~----~~~----~~~~~~~~~~ 277 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG------GEG-WQQL----RQG----YLPPEFTAGL 277 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS------HHH-HHHH----TTT----CCCHHHHTTS
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC------ccH-HHHH----hcc----CCCcccccCC
Confidence 34569999999998865 799999999999999999999776531 111 1111 111 1111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.||++|||++|
T Consensus 278 ----~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 278 ----SSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp ----CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHH
Confidence 236889999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=299.58 Aligned_cols=226 Identities=22% Similarity=0.366 Sum_probs=167.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVK--HQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~ 221 (388)
..|...+.||+|+||.||++...+++.||||++..... ...+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 35888899999999999999988899999999865432 23467899999999996 599999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-ee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-VS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-~~ 280 (388)
| +.+|+|.+++.+. ..+|.|+| |+||+|+|||++ ++.+||+|||+++........ ..
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 9 5689999988643 23456666 457889999996 589999999999876543221 23
Q ss_pred eccccccCccCccccCC-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 281 TVVAGTIGYVPPEYGGT-----------GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
...+||+.|+|||++.. ..++.++|||||||++|||++|+.||.... +....+..........
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDPNHEI 287 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHCTTSCC
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHhCccccC
Confidence 34579999999998754 468999999999999999999999985421 1111222222111100
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. + ... ...+.+++.+||+.||++|||+.|
T Consensus 288 ~~--~---~~~----~~~~~~li~~~L~~dP~~Rps~~e 317 (390)
T 2zmd_A 288 EF--P---DIP----EKDLQDVLKCCLKRDPKQRISIPE 317 (390)
T ss_dssp CC--C---CCS----CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CC--C---ccc----hHHHHHHHHHHcccChhhCCCHHH
Confidence 00 0 111 235789999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=287.79 Aligned_cols=227 Identities=22% Similarity=0.287 Sum_probs=176.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||.||+|+.. +++.||||.++..... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45788899999999999999965 6899999998754321 3567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC----CEEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF----EAKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~----~~kl~DfG~a~~~~~ 274 (388)
+||||+++|+|.+++... ..+|.++| |.||+|+||+++.++ .+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 999999999999998642 23566777 457889999999888 799999999987754
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
... .....||+.|+|||.+....++.++|||||||++|||++|+.||... ...+....+.... ...++
T Consensus 172 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~------~~~~~ 239 (321)
T 2a2a_A 172 GVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANITSVS------YDFDE 239 (321)
T ss_dssp TCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHTTC------CCCCH
T ss_pred ccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhcc------cccCh
Confidence 322 23456899999999998889999999999999999999999998532 2222222221110 01111
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+ ..+.+++.+||+.||++|||+.|
T Consensus 240 ~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e 269 (321)
T 2a2a_A 240 EFFSHTS----ELAKDFIRKLLVKETRKRLTIQE 269 (321)
T ss_dssp HHHTTCC----HHHHHHHHTTSCSSTTTSCCHHH
T ss_pred hhhcccC----HHHHHHHHHHcCCChhhCcCHHH
Confidence 1111112 35789999999999999999753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.49 Aligned_cols=241 Identities=21% Similarity=0.267 Sum_probs=180.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDE--EKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~ 221 (388)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46788899999999999999965 58999999997543 234567889999999999999999999998765 679999
Q ss_pred eccCCCCHHHHHhccC------------------CCCCHHh-----hhccccCCeee----cCCCCEEEcccccceeccC
Q 035768 222 EYMVKGSLDDWLRNQA------------------ASLDWGK-----RCKIVASNILL----NDDFEAKISDFGLARLISD 274 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~------------------~~l~~~~-----~~~i~~~NiLl----~~~~~~kl~DfG~a~~~~~ 274 (388)
||+++|+|.+++.... .+|.|+| |.||+|+|||+ +.++.+||+|||+++....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 9999999999986432 2455666 45788999999 7888899999999987654
Q ss_pred CCcceeeccccccCccCccccCC--------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGT--------GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
.. ......||+.|+|||.+.. ..++.++|||||||++|||+||+.||..........++...+.......
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 169 DE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp GG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred CC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 32 2234569999999998654 5678899999999999999999999865433233333333332222111
Q ss_pred cccccC---C--------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVL---D--------PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~---~--------~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+. . ..............+.+++.+||+.||++|||++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 111000 0 00011234667778899999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=282.71 Aligned_cols=224 Identities=23% Similarity=0.347 Sum_probs=174.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46788899999999999999975 588999999865432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++++|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++....... ...
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 173 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccc
Confidence 999999999987542 23566666 457889999999999999999999987653222 223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||.+....++.++||||||+++|||++|+.||... ...+... ..... .. . .+ ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~---~~~~~-~~-~--~~---~~-- 237 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS----CLKETYL---RIKKN-EY-S--IP---KH-- 237 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHH---HHHTT-CC-C--CC---TT--
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHH---HHhhc-cC-C--Cc---cc--
Confidence 456899999999998888999999999999999999999998532 1122211 11111 10 0 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||++|
T Consensus 238 --~~~~~~~li~~~l~~~p~~Rps~~~ 262 (294)
T 2rku_A 238 --INPVAASLIQKMLQTDPTARPTINE 262 (294)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred --cCHHHHHHHHHHcccChhhCcCHHH
Confidence 1125788999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.79 Aligned_cols=228 Identities=22% Similarity=0.326 Sum_probs=162.5
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999995 5789999999975332 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 222 EYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++.......
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 999999999988531 22455666 457889999999999999999999987644222
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......|++.|+|||.+....++.++||||||+++|||++|+.||..... ....+...+. .........
T Consensus 192 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~----~~~~~~~~~---- 260 (310)
T 2wqm_A 192 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIE----QCDYPPLPS---- 260 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHHHHHH----TTCSCCCCT----
T ss_pred -cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHHHHhh----cccCCCCcc----
Confidence 22334689999999999888999999999999999999999999853211 1112222211 111111100
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .....+.+++.+||+.||++|||+.|
T Consensus 261 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ 287 (310)
T 2wqm_A 261 D----HYSEELRQLVNMCINPDPEKRPDVTY 287 (310)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred c----ccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 1 11236889999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.59 Aligned_cols=218 Identities=26% Similarity=0.414 Sum_probs=165.6
Q ss_pred eeeccCCceEEEEEcC---CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035768 153 VIGGGGFGTVFKGTMP---DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGS 228 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 228 (388)
.||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 456799999986533 356789999999999999999999999975 56899999999999
Q ss_pred HHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce--eecccc
Q 035768 229 LDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV--STVVAG 285 (388)
Q Consensus 229 L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~g 285 (388)
|.+++.... .+|.|+| |+||+|+|||++.++.+||+|||+++.+....... .....+
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 501 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCC
Confidence 999986432 2455666 45788999999999999999999998764332211 122345
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
|+.|+|||++....++.++|||||||++|||+| |+.||... +..++.+.+..... ... +...
T Consensus 502 ~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----~~~~~~~~i~~~~~----~~~---------p~~~ 564 (613)
T 2ozo_A 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKR----MEC---------PPEC 564 (613)
T ss_dssp CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CSHHHHHHHHTTCC----CCC---------CTTC
T ss_pred ccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHcCCC----CCC---------CCcC
Confidence 689999999988899999999999999999998 99998543 33344443332211 110 0112
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.||++||||.|
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~ 588 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLT 588 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHH
Confidence 236889999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.87 Aligned_cols=237 Identities=23% Similarity=0.243 Sum_probs=169.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVD------E 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 215 (388)
.++|...+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788899999999999999985 468899999997542 23345688999999999999999999999654 3
Q ss_pred eeEEEEeccCCCCHHHHH-------------hccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 216 EKLLVYEYMVKGSLDDWL-------------RNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l-------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
..++||||++++ |.+.+ .+...+|.|+| |+||+|+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 217 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 217 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C--
T ss_pred eEEEEEeCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--
Confidence 569999999654 55544 33445677887 4578899999999999999999999876542
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc----------
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---------- 347 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------- 347 (388)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....+........
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~----~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR----DYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 2234467999999999999999999999999999999999999998542 22222222222111100
Q ss_pred ---------------ccccCCccccCCCC---HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ---------------ADEVLDPAVLNANS---KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ---------------~~~~~~~~~~~~~~---~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+......... ......+.+++.+||+.||++|||++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00000000111111 112456899999999999999999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=294.21 Aligned_cols=227 Identities=28% Similarity=0.444 Sum_probs=174.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC--------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
.++|...+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888899999999999999852 467899999975432 2345689999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
+..++||||+++|+|.+++.... .+|.++| |.||+|+|||++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 99999999999999999987532 1344555 45788999999999
Q ss_pred CCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||... ...++.
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~ 269 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVEELF 269 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC----CHHHHH
Confidence 99999999999877543322 2223457889999999888889999999999999999999 99997532 333333
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+....... ... .....+.+++.+||+.||.+|||+.|
T Consensus 270 ~~~~~~~~~~---------~~~----~~~~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 270 KLLKEGHRMD---------KPA----NCTNELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp HHHHHTCCCC---------CCT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHhcCCCCC---------CCc----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 3332211110 001 11236889999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=281.20 Aligned_cols=228 Identities=22% Similarity=0.301 Sum_probs=175.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357888999999999999999964 689999999865432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCC---EEEcccccceeccCCCcc
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFE---AKISDFGLARLISDCESH 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~---~kl~DfG~a~~~~~~~~~ 278 (388)
||+++|+|.+++.. ...++.++| |.||+|+||+++.++. +||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-- 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--
Confidence 99999999887643 233566777 4578899999986655 9999999998765432
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||... +.......+...... ...+. ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~-----~~~~~-~~ 232 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYD-----YPSPE-WD 232 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC-----CCTTT-TT
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC----chhHHHHHHHhcccc-----CCchh-hc
Confidence 223456899999999999999999999999999999999999998532 223333322221111 00010 01
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 233 ----~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (284)
T 3kk8_A 233 ----TVTPEAKSLIDSMLTVNPKKRITADQ 258 (284)
T ss_dssp ----TSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----ccCHHHHHHHHHHcccChhhCCCHHH
Confidence 11235789999999999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=283.23 Aligned_cols=225 Identities=24% Similarity=0.303 Sum_probs=167.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||++.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4577889999999999999996 468899999987643 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCC
Q 035768 224 MVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 224 ~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~ 276 (388)
+++|+|.+++... ..+|.++| |.||+|+||++ +.++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 9999999987431 23456666 45788999999 456889999999998764422
Q ss_pred cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......||+.|+|||.+. ..++.++||||||+++|||++|+.||... ...++........ ..... .
T Consensus 182 --~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~--~~~~~--~--- 247 (285)
T 3is5_A 182 --HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT----SLEEVQQKATYKE--PNYAV--E--- 247 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC--CCCCC------
T ss_pred --cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC----CHHHHHhhhccCC--ccccc--c---
Confidence 223456899999999875 56899999999999999999999998532 2222222221111 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ....+.+++.+||+.||++|||+.|
T Consensus 248 ~~~----~~~~~~~li~~~L~~dP~~Rps~~e 275 (285)
T 3is5_A 248 CRP----LTPQAVDLLKQMLTKDPERRPSAAQ 275 (285)
T ss_dssp -CC----CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCc----CCHHHHHHHHHHccCChhhCcCHHH
Confidence 001 1236789999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=288.95 Aligned_cols=225 Identities=22% Similarity=0.320 Sum_probs=175.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999965 588999999865422 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+++++|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++....... ..
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 198 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cc
Confidence 9999999999987542 23566777 457889999999999999999999987653322 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||... ...+....+... ...... .
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~--~~~~~~--------~- 263 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKN--EYSIPK--------H- 263 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHT--CCCCCT--------T-
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC----CHHHHHHHHhcC--CCCCCc--------c-
Confidence 3456899999999998888999999999999999999999998532 222222211110 011111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 264 ---~~~~~~~li~~~l~~dp~~Rps~~e 288 (335)
T 2owb_A 264 ---INPVAASLIQKMLQTDPTARPTINE 288 (335)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHH
Confidence 1125788999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.31 Aligned_cols=228 Identities=29% Similarity=0.440 Sum_probs=175.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEE 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 216 (388)
.++|...+.||+|+||.||+|++ .+++.||||.++.... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45688889999999999999984 3467899999976543 2346799999999999 99999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhccC---------------------------------CCCCHHh-----hhccccCCeeecCC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQA---------------------------------ASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~~---------------------------------~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
.++||||+++|+|.+++.... .+|.++| |.||+|+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 999999999999999986532 1344555 45788999999999
Q ss_pred CCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++........ ......||+.|+|||.+....++.++||||||+++|||+| |+.||..... ...+.
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~ 258 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFY 258 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---hhHHH
Confidence 99999999999877544322 2233457889999999888899999999999999999999 9999854321 12222
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+...... . .+ ......+.+++.+||+.||.+|||+.|
T Consensus 259 ~~~~~~~~~-----~-~~-------~~~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 259 KMIKEGFRM-----L-SP-------EHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp HHHHHTCCC-----C-CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhccCCCC-----C-Cc-------ccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 222221110 0 00 111236889999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=296.46 Aligned_cols=236 Identities=19% Similarity=0.230 Sum_probs=170.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC------CCEEEEEEcccCCCcC-----------hHHHHHHHHHHhcCCCCCccce
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATGQG-----------DREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 207 (388)
.++|...+.||+|+||.||+|.+.. ++.||||.+....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999998754 4789999986543211 1234456667788899999999
Q ss_pred eeEEEeC----CeeEEEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeec--CCCC
Q 035768 208 LGYCSVD----EEKLLVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLN--DDFE 260 (388)
Q Consensus 208 ~g~~~~~----~~~~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~--~~~~ 260 (388)
++++... ...++||||+ +|+|.+++.... .+|.|+| |+||+|+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9999775 4579999999 999999986532 2455666 568889999999 8899
Q ss_pred EEEcccccceeccCCCcc------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCccc
Q 035768 261 AKISDFGLARLISDCESH------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN 334 (388)
Q Consensus 261 ~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~ 334 (388)
+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.... ....
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~---~~~~ 269 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL---KDPK 269 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT---TCHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc---cCHH
Confidence 999999999876432211 1123459999999999999899999999999999999999999986422 1222
Q ss_pred HHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 335 LVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........... .....+++.+.... ....+.+++..||+.||.+||++.+
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~ 319 (364)
T 3op5_A 270 YVRDSKIRYRE-NIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYEN 319 (364)
T ss_dssp HHHHHHHHHHH-CHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred HHHHHHHHhhh-hHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHH
Confidence 22222221111 12222222211111 1236889999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=289.61 Aligned_cols=234 Identities=24% Similarity=0.366 Sum_probs=168.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC--CCCCccceeeEEEeC----CeeE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMV--KHQNLVELLGYCSVD----EEKL 218 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~ 218 (388)
.++|...+.||+|+||.||+|++. ++.||||++... ....+.+|.+++..+ +||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 467999999999999999999985 899999998543 234555666666554 999999999999887 7889
Q ss_pred EEEeccCCCCHHHHHhcc--------------CCCCCHHh-------------hhccccCCeeecCCCCEEEccccccee
Q 035768 219 LVYEYMVKGSLDDWLRNQ--------------AASLDWGK-------------RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-------------~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
+||||+++|+|.++++.. ..+|.|+| |+||+|+|||++.++.+||+|||+++.
T Consensus 112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 999999999999998642 23556666 457889999999999999999999987
Q ss_pred ccCCCcce---eeccccccCccCccccCCCCCCcc------cchHhHHHHHHHHHhC----------CCCCCCCCCCCCc
Q 035768 272 ISDCESHV---STVVAGTIGYVPPEYGGTGKATER------GDVYSFGVILLELVTG----------KQPTGPEFEDKDG 332 (388)
Q Consensus 272 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gv~l~el~tg----------~~P~~~~~~~~~~ 332 (388)
........ .....||+.|+|||.+.....+.+ +|||||||++|||+|| +.||.........
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 64432221 124569999999999877766655 9999999999999999 6666443222111
Q ss_pred ccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 333 ENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... .................. ........+.+++.+||+.||++|||+.|
T Consensus 272 --~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 272 --YED-MREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp --HHH-HHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred --hhh-hHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 111 111111111111111110 12255667999999999999999999853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=285.99 Aligned_cols=220 Identities=25% Similarity=0.426 Sum_probs=169.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-C-------CEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-G-------KTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
++|...+.||+|+||+||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467788999999999999998643 3 46999999776656667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCC--------EEEccccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFE--------AKISDFGL 268 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~--------~kl~DfG~ 268 (388)
++||||+++|+|.+++.+.. .+|.|+| |.||+|+|||++.++. +||+|||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~ 167 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence 99999999999999986532 2455666 4578899999998887 99999999
Q ss_pred ceeccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 269 ARLISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
++.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+... .+......... ....
T Consensus 168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~---~~~~ 236 (289)
T 4fvq_A 168 SITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA---LDSQRKLQFYE---DRHQ 236 (289)
T ss_dssp CTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHHHHH---TTCC
T ss_pred cccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc---cchHHHHHHhh---ccCC
Confidence 975532 123458999999998876 67899999999999999999966554321 12221211111 1111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... ...+.+++.+||+.||++|||+.|
T Consensus 237 ~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ 265 (289)
T 4fvq_A 237 LPAPK------------AAELANLINNCMDYEPDHRPSFRA 265 (289)
T ss_dssp CCCCS------------SCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCC------------CHHHHHHHHHHcCCChhHCcCHHH
Confidence 11111 114788999999999999999753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=290.01 Aligned_cols=225 Identities=27% Similarity=0.458 Sum_probs=169.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCE----EEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKT----VAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||+||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999964 4443 7888875433 233456889999999999999999999986 567899
Q ss_pred EEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+++........
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999999998653 22456666 4578899999999999999999999887543322
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......||..|+|||.+....++.++|||||||++|||+| |+.||... ...++.+.+....... .+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~~~~------~~~~ 241 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL----RLAEVPDLLEKGERLA------QPQI 241 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----CTTHHHHHHHTTCBCC------CCTT
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc----CHHHHHHHHHcCCCCC------CCCc
Confidence 2334567889999999988899999999999999999999 99998542 2333433333211111 1111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...+.+++.+||+.||++|||+.|
T Consensus 242 ~-------~~~~~~li~~~l~~dp~~Rps~~e 266 (325)
T 3kex_A 242 C-------TIDVYMVMVKCWMIDENIRPTFKE 266 (325)
T ss_dssp B-------CTTTTHHHHHHTCSCTTTSCCHHH
T ss_pred C-------cHHHHHHHHHHcCCChhhCcCHHH
Confidence 1 114778999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=286.74 Aligned_cols=237 Identities=22% Similarity=0.282 Sum_probs=169.0
Q ss_pred cCCCc-CCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCE-ENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~-~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+.|.. .+.||+|+||+||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34666 37899999999999995 46899999999876656677899999999885 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCC---EEEcccccceeccCCCc--
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFE---AKISDFGLARLISDCES-- 277 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~---~kl~DfG~a~~~~~~~~-- 277 (388)
|+++|+|.+++... ..+|.|+| |.||+|+|||++.++. +||+|||+++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 99999999988542 23566777 4578899999998776 99999999986532211
Q ss_pred ----ceeeccccccCccCccccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCccc-------HHHHHHH
Q 035768 278 ----HVSTVVAGTIGYVPPEYGGT-----GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGEN-------LVDWVLH 341 (388)
Q Consensus 278 ----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~-------~~~~~~~ 341 (388)
.......||+.|+|||.+.. ..++.++|||||||++|||++|+.||........... ....+..
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 11223459999999998764 4588999999999999999999999865432111000 0011111
Q ss_pred hhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 342 MMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... .. ....... ....+.+++.+||+.||++|||+.|
T Consensus 252 ~i~~~~~-~~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 252 SIQEGKY-EF-PDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HHHHCCC-CC-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHhccCc-cc-Cchhccc----CCHHHHHHHHHHhhCChhhCCCHHH
Confidence 1111110 00 0000011 1236889999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.01 Aligned_cols=180 Identities=30% Similarity=0.402 Sum_probs=138.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCC-CCCccceeeEEEeCC--eeE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVK-HQNLVELLGYCSVDE--EKL 218 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 218 (388)
.++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 35788899999999999999985 468999999986542 233456889999999997 999999999997654 689
Q ss_pred EEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC---
Q 035768 219 LVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE--- 276 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~--- 276 (388)
+|||||+ |+|.++++. ...+|.|+| |+||+|+|||++.++.+||+|||+|+......
T Consensus 88 lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 9999996 689887754 234567777 45788999999999999999999998763311
Q ss_pred -----------------cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 277 -----------------SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 277 -----------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 112234579999999998876 6789999999999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=285.33 Aligned_cols=226 Identities=23% Similarity=0.339 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|...+.||+|+||.||+++.. +++.||+|.++.........+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46788899999999999999964 68999999998655445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCCcceee
Q 035768 225 VKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
++|+|.+++... ..++.++| |.||+|+||++ +.++.+||+|||+++..... ...
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~ 165 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMS 165 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTH
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccc
Confidence 999999987532 23566666 45788999999 78899999999999765432 122
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||... ....+.+.+...... . ......
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~-----~-~~~~~~--- 232 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE----TESKLFEKIKEGYYE-----F-ESPFWD--- 232 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHCCCC-----C-CTTTTT---
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcCCCC-----C-Cccccc---
Confidence 346899999999999999999999999999999999999998532 223333322221110 0 000111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 233 -~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 233 -DISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp -TSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 11236889999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=282.96 Aligned_cols=223 Identities=24% Similarity=0.365 Sum_probs=171.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
.++|...+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457888899999999999999864 57799999986432 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|||+++|+|.+++.+. ..++.++| |.||+|+||+++.++.+||+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence 9999999999887542 23556666 4578899999999999999999998654332 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||... +..+....+.... ......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~--~~~~~~--------- 229 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVE--FTFPDF--------- 229 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTC--CCCCTT---------
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC----cHHHHHHHHHhCC--CCCCCc---------
Confidence 3456899999999998889999999999999999999999998532 2222222222110 011111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||++|
T Consensus 230 ---~~~~~~~li~~~l~~~p~~Rps~~e 254 (279)
T 3fdn_A 230 ---VTEGARDLISRLLKHNPSQRPMLRE 254 (279)
T ss_dssp ---SCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ---CCHHHHHHHHHHhccChhhCCCHHH
Confidence 1225789999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=283.60 Aligned_cols=225 Identities=24% Similarity=0.402 Sum_probs=176.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+.|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4578889999999999999985 468999999997543 33457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 224 MVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 224 ~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+++++|.+++... ..++.++| |.||+|+||+++.++.+||+|||++........ ......
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 180 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFV 180 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCCC
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCccC
Confidence 9999999988642 23455666 457789999999999999999999987754322 223456
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
||+.|+|||.+....++.++||||||+++|||++|+.||... ........+.. ... +......
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~----~~~-----~~~~~~~---- 243 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL----HPMKVLFLIPK----NNP-----PTLEGNY---- 243 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHH----SCC-----CCCCSSC----
T ss_pred CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc----CHHHHHHHhhc----CCC-----CCCcccc----
Confidence 899999999999899999999999999999999999998532 22222222211 111 1111111
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+.+++.+||+.||++|||+.|
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ 267 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKE 267 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHH
Confidence 225889999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=293.83 Aligned_cols=233 Identities=26% Similarity=0.444 Sum_probs=177.7
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEE
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYC 211 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 211 (388)
+++....++|...+.||+|+||.||+|.+. +++.||||.+..... .....+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344455678899999999999999999854 367899999975433 2345689999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhcc-------------------------CCCCCHHh-----hhccccCCeeecCCCCE
Q 035768 212 SVDEEKLLVYEYMVKGSLDDWLRNQ-------------------------AASLDWGK-----RCKIVASNILLNDDFEA 261 (388)
Q Consensus 212 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~ 261 (388)
...+..++||||+++|+|.+++... ..+|.++| |.||+|+||+++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999988642 22455666 45788999999999999
Q ss_pred EEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHH
Q 035768 262 KISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 262 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~ 339 (388)
||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||... +...+...+
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~ 253 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVLRFV 253 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC----CHHHHHHHH
Confidence 99999999866432221 1223456889999999988889999999999999999999 88887532 223333322
Q ss_pred HHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 340 LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ...... .......+.+++.+||+.||++|||+.|
T Consensus 254 ~~----~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (322)
T 1p4o_A 254 ME----GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLE 289 (322)
T ss_dssp HT----TCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred Hc----CCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 21 111110 0111235889999999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=286.82 Aligned_cols=219 Identities=28% Similarity=0.419 Sum_probs=162.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||+||+|.+ .++.||||.+... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 4577789999999999999998 4788999999643 34567999999999999999999999886 45799999999
Q ss_pred CCCHHHHHhccC------------------CCCCHHhh--------hccccCCeeecCCCC-EEEcccccceeccCCCcc
Q 035768 226 KGSLDDWLRNQA------------------ASLDWGKR--------CKIVASNILLNDDFE-AKISDFGLARLISDCESH 278 (388)
Q Consensus 226 ~g~L~~~l~~~~------------------~~l~~~~~--------~~i~~~NiLl~~~~~-~kl~DfG~a~~~~~~~~~ 278 (388)
+|+|.+++.... .++.|+|. .||+|+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999986431 24556664 478899999998886 799999999765432
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ....+.. .... .... ....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~---~~~~-~~~~-----~~~~ 227 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG--PAFRIMW---AVHN-GTRP-----PLIK 227 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS--SHHHHHH---HHHT-TCCC-----CCBT
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc--cHHHHHH---HHhc-CCCC-----Cccc
Confidence 2234589999999999988999999999999999999999999864211 1111111 1111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ...+.+++.+||+.||++|||++|
T Consensus 228 ~~----~~~l~~li~~~l~~dp~~Rps~~e 253 (307)
T 2eva_A 228 NL----PKPIESLMTRCWSKDPSQRPSMEE 253 (307)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cc----CHHHHHHHHHHhcCChhhCcCHHH
Confidence 11 235789999999999999999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=279.90 Aligned_cols=230 Identities=16% Similarity=0.201 Sum_probs=175.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.+++++ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4688889999999999999995 578999999986443 234688999999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCC-----EEEcccccceeccCCCc
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFE-----AKISDFGLARLISDCES 277 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~-----~kl~DfG~a~~~~~~~~ 277 (388)
+ +|+|.+++.... .++.++| |.||+|+|||++.++. +||+|||+++.......
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 999999987432 2455666 4578899999987776 99999999988754332
Q ss_pred c------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 278 H------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 278 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........+...........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~- 244 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQSTPLRE- 244 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-CHHHHHHHHHHHHHHSCHHH-
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-ccHHHHHHHHhhccCccHHH-
Confidence 1 233456999999999999889999999999999999999999998653221 22222222222111111111
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... ....+.+++.+||+.||++|||++|
T Consensus 245 ----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~ 273 (298)
T 1csn_A 245 ----LCAG----FPEEFYKYMHYARNLAFDATPDYDY 273 (298)
T ss_dssp ----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred ----HHhh----CcHHHHHHHHHHhcCCcccCCCHHH
Confidence 0111 1236889999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.44 Aligned_cols=238 Identities=25% Similarity=0.338 Sum_probs=170.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||+||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888899999999999999975 5899999998654322 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++++|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++....... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDD 161 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCC
Confidence 99999998876532 23566777 457889999999999999999999987654322 2234
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc-----------c-c-
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE-----------Q-A- 348 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----------~-~- 348 (388)
..||+.|+|||.+.+ ..++.++||||||+++|||++|+.||... ...+....+....... . .
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK----SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhcccccccccccccccccc
Confidence 568999999998765 67899999999999999999999998543 2222222222211110 0 0
Q ss_pred -cccCCccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 -DEVLDPAVLNA---NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 -~~~~~~~~~~~---~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....++..... ........+.+++.+||+.||++|||++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 281 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence 00111100000 00112235789999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.99 Aligned_cols=228 Identities=25% Similarity=0.361 Sum_probs=173.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46788899999999999999965 689999999865432 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-ceeec
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-HVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 282 (388)
+++|+|.+++... ..+|.++| |.||+|+||+++.++.+||+|||++........ .....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 9999998877532 23566666 457789999999999999999999987643221 12234
Q ss_pred cccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..||+.|+|||.+....+ +.++||||||+++|||++|+.||..... .......+... .. ...+ .
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~----~~---~~~~------~ 231 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEK----KT---YLNP------W 231 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT--TSHHHHHHHTT----CT---TSTT------G
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHhhhc----cc---ccCc------h
Confidence 568999999999877665 7899999999999999999999864321 11122222111 00 0000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||++|
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 011225788999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=282.44 Aligned_cols=226 Identities=24% Similarity=0.389 Sum_probs=169.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.++|...+.||+|+||+||+|.+.+ +..||+|.+..... ...+.|.+|++++++++||||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4568888999999999999998532 34699999976532 345679999999999999999999999864 55789
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++.... .++.++| |.||+|+||+++.++.+||+|||+++........
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 999999999999986432 2455666 4578899999999999999999999876554333
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......+|+.|+|||.+....++.++||||||+++|||+| |+.||... ...+....+....... .+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~----~~~~~~~~~~~~~~~~------~~--- 236 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL----ENKDVIGVLEKGDRLP------KP--- 236 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CGGGHHHHHHHTCCCC------CC---
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC----ChHHHHHHHhcCCCCC------CC---
Confidence 3344557889999999988889999999999999999999 99998532 2333433332211110 01
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ....+.+++.+||+.||++|||+.|
T Consensus 237 ~~----~~~~l~~li~~~l~~~p~~Rps~~e 263 (281)
T 3cc6_A 237 DL----CPPVLYTLMTRCWDYDPSDRPRFTE 263 (281)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CC----CCHHHHHHHHHHccCCchhCcCHHH
Confidence 01 1235889999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=292.79 Aligned_cols=218 Identities=23% Similarity=0.330 Sum_probs=171.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc--------ChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ--------GDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
.++|...+.||+|+||.||+|.. .+++.||||.++..... ....+.+|++++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35688899999999999999985 56889999999754321 2345778999999999999999999999999
Q ss_pred eeEEEEeccCCC-CHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 216 EKLLVYEYMVKG-SLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 216 ~~~lv~e~~~~g-~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
..++||||+.+| +|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999999877 999988643 23566677 457889999999999999999999988754
Q ss_pred CCcceeeccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..... .... ....
T Consensus 183 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~----~~~~ 243 (335)
T 3dls_A 183 GKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TVEA----AIHP 243 (335)
T ss_dssp TCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GTTT----CCCC
T ss_pred CCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HHhh----ccCC
Confidence 332 233569999999999888776 8899999999999999999999853110 0000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+. . ....+.+++.+||+.||++|||+.|
T Consensus 244 ~~---~----~~~~l~~li~~~L~~dP~~Rps~~e 271 (335)
T 3dls_A 244 PY---L----VSKELMSLVSGLLQPVPERRTTLEK 271 (335)
T ss_dssp SS---C----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred Cc---c----cCHHHHHHHHHHccCChhhCcCHHH
Confidence 10 0 1225889999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=284.56 Aligned_cols=233 Identities=25% Similarity=0.378 Sum_probs=170.9
Q ss_pred CCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKL 218 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 218 (388)
.|...+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 477788999999999999983 368899999997543 33457799999999999999999999999876 6689
Q ss_pred EEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++.... .+|.++| |.||+|+||+++.++.+||+|||+++.......
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCc
Confidence 9999999999999985432 2455666 457889999999999999999999988754432
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC-------CCCcccHHHHHHHhhccccc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFE-------DKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 348 (388)
.......||..|+|||.+.+..++.++||||||+++|||+||..|+..... ..........+.........
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC
T ss_pred ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCC
Confidence 122345688889999999888899999999999999999999998532110 00011111111111111110
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ........+.+++.+||+.||++|||+.|
T Consensus 262 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 292 (302)
T 4e5w_A 262 LP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292 (302)
T ss_dssp CC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHH
Confidence 00 01112236889999999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=279.91 Aligned_cols=224 Identities=22% Similarity=0.386 Sum_probs=153.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688889999999999999996 578999999986432 223467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 222 EYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||+++|+|.+++.+... ++.++| |.||+|+||+++.++.+||+|||++........ ..
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 169 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KH 169 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cc
Confidence 99999999999875422 345566 457889999999999999999999987653222 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||.+....++.++||||||+++|||++|+.||..... ..... .... .....+ ..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~---~~~~----~~~~~~---~~- 234 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV----KNTLN---KVVL----ADYEMP---SF- 234 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSC----C--------CCS----SCCCCC---TT-
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH----HHHHH---HHhh----cccCCc---cc-
Confidence 235689999999999888899999999999999999999999864321 11111 1000 000001 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||++|
T Consensus 235 ---~~~~~~~li~~~l~~dp~~Rps~~~ 259 (278)
T 3cok_A 235 ---LSIEAKDLIHQLLRRNPADRLSLSS 259 (278)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ---cCHHHHHHHHHHcccCHhhCCCHHH
Confidence 1236789999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.21 Aligned_cols=185 Identities=25% Similarity=0.325 Sum_probs=154.0
Q ss_pred cccHHHHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-----CCCcccee
Q 035768 135 KLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-----HQNLVELL 208 (388)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~ 208 (388)
.+++.+.....++|...+.||+|+||+||+|+. .+++.||||+++... ...+.+..|+++++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344444445567899999999999999999996 468899999996432 33456788999999986 99999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecC---------
Q 035768 209 GYCSVDEEKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLND--------- 257 (388)
Q Consensus 209 g~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~--------- 257 (388)
+++...+..++||||+ +++|.+++... ..+|.|+| |+||+|+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 99999988643 23456666 4578899999975
Q ss_pred ----------------CCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCC
Q 035768 258 ----------------DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQ 321 (388)
Q Consensus 258 ----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~ 321 (388)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999875432 234568999999999999999999999999999999999999
Q ss_pred CCCC
Q 035768 322 PTGP 325 (388)
Q Consensus 322 P~~~ 325 (388)
||..
T Consensus 258 pf~~ 261 (360)
T 3llt_A 258 LFRT 261 (360)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 9854
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=287.87 Aligned_cols=237 Identities=24% Similarity=0.307 Sum_probs=172.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-----CcChHHHHHHHHHHhcCC---CCCccceeeEEEeCC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-----GQGDREFAAEMETLGMVK---HQNLVELLGYCSVDE 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~ 215 (388)
.++|...+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999996 568999999986432 122356778888877764 999999999998765
Q ss_pred -----eeEEEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEccccc
Q 035768 216 -----EKLLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGL 268 (388)
Q Consensus 216 -----~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~ 268 (388)
..++||||+. |+|.+++.... .+|.|+| |.||+|+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 5789999996 69999886532 2455666 457889999999999999999999
Q ss_pred ceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 269 ARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
++...... ......||+.|+|||.+....++.++|||||||++|||++|+.||... +..+....+.........
T Consensus 167 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN----SEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS----SHHHHHHHHHHHHCCCCT
T ss_pred ccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCh
Confidence 98764322 234467899999999998889999999999999999999999998542 333333333332221111
Q ss_pred cccCC----c--cccC--CCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLD----P--AVLN--ANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~----~--~~~~--~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.. + .... ... ......+.+++.+||+.||++|||+.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 293 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence 10000 0 0000 000 112246789999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=281.58 Aligned_cols=222 Identities=26% Similarity=0.357 Sum_probs=166.7
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEE
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKLLV 220 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv 220 (388)
|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 56677899999999999986 468899999987543 2334568999999999999999999999875 3568999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHhh-------hccccCCeeec-CCCCEEEcccccceeccCCCc
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGKR-------CKIVASNILLN-DDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~-------~~i~~~NiLl~-~~~~~kl~DfG~a~~~~~~~~ 277 (388)
|||+++|+|.+++... ..++.|+|. .||+|+|||++ .++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 185 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999988642 234556664 46779999998 7899999999999765432
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......||+.|+|||.+. ..++.++|||||||++|||++|+.||.... ....+...+..... ... ..
T Consensus 186 -~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~----~~~----~~ 252 (290)
T 1t4h_A 186 -FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVK----PAS----FD 252 (290)
T ss_dssp -SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHHHHHHTTTCC----CGG----GG
T ss_pred -ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC---cHHHHHHHHhccCC----ccc----cC
Confidence 223456899999999876 468999999999999999999999985321 22222221111111 111 11
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+ ..+.+++.+||+.||.+|||+.|
T Consensus 253 ~~~~----~~l~~li~~~l~~dp~~Rps~~e 279 (290)
T 1t4h_A 253 KVAI----PEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp GCCC----HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCC----HHHHHHHHHHccCChhhCCCHHH
Confidence 1111 25889999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=301.78 Aligned_cols=226 Identities=22% Similarity=0.307 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+.|...+.||+|+||+||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45888899999999999999965 68899999997543 2345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecC---CCCEEEcccccceeccCCCcce
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+++|+|.+++.. ...+|.|+| |+||+|+|||++. ++.+||+|||+++...... .
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~ 194 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--K 194 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--C
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--c
Confidence 9999999887643 234667777 4578899999976 4559999999998875432 2
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....||+.|+|||++. ..++.++|||||||++|||++|..||... ...++...+...... .+......
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~------~~~~~~~~ 263 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ----TDQEILRKVEKGKYT------FDSPEWKN 263 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC------CCSGGGTT
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCC------CCchhccc
Confidence 33456999999999876 56999999999999999999999998532 333343333322111 11111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...+.+++.+||+.||.+|||+.|
T Consensus 264 ~----s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 264 V----SEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp S----CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred C----CHHHHHHHHHHCCCChhhCccHHH
Confidence 1 225789999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=290.07 Aligned_cols=235 Identities=23% Similarity=0.343 Sum_probs=175.8
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhc--CCCCCccceeeEEEeCC----ee
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGM--VKHQNLVELLGYCSVDE----EK 217 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~ 217 (388)
..++|...+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++...+ ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 346799999999999999999998 5899999998643 34678889998887 79999999999998876 78
Q ss_pred EEEEeccCCCCHHHHHhcc--------------CCCCCHHh-------------hhccccCCeeecCCCCEEEcccccce
Q 035768 218 LLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-------------RCKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-------------~~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
++||||+++|+|.+++.+. +.++.++| |.||+|+|||++.++.+||+|||+++
T Consensus 116 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 9999999999999988642 23566777 45788999999999999999999998
Q ss_pred eccCCCcc---eeeccccccCccCccccCCC------CCCcccchHhHHHHHHHHHhC----------CCCCCCCCCCCC
Q 035768 271 LISDCESH---VSTVVAGTIGYVPPEYGGTG------KATERGDVYSFGVILLELVTG----------KQPTGPEFEDKD 331 (388)
Q Consensus 271 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~el~tg----------~~P~~~~~~~~~ 331 (388)
........ ......||+.|+|||.+... .++.++|||||||++|||+|| ..||.......
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~- 274 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD- 274 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc-
Confidence 77554322 12345699999999988665 334789999999999999999 77875433211
Q ss_pred cccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 332 GENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+... .........+.... ........+.+++.+||+.||++|||+.|
T Consensus 275 -~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 275 -PSVEEMRKV-VCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp -CCHHHHHHH-HTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred -ccHHHHHHH-HHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 122222221 11111111111111 12355667999999999999999999853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=293.63 Aligned_cols=225 Identities=30% Similarity=0.464 Sum_probs=160.3
Q ss_pred CCCcCCeeeccCCceEEEEEcC--C--CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP--D--GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv 220 (388)
.|...+.||+|+||+||+|.+. + +..||||.++.... ...+.|.+|+.++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556788999999999999863 2 23689999875432 345679999999999999999999999754 4578999
Q ss_pred EeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-
Q 035768 221 YEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~- 278 (388)
|||+++|+|.+++++.. .+|.|+| |+||+|+|||++.++.+||+|||+++........
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 99999999999986532 2455666 4578899999999999999999999876432211
Q ss_pred --eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 279 --VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 279 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
......+|+.|+|||.+....++.++|||||||++|||+| |.+||... ...++...+..... ...|.
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~----~~~~~~~~~~~~~~------~~~p~ 319 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLLQGRR------LLQPE 319 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CSSCHHHHHHTTCC------CCCCT
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC----CHHHHHHHHHcCCC------CCCCC
Confidence 1233457789999999988899999999999999999999 56666432 23334433322111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 320 -------~~~~~l~~li~~cl~~dp~~RPs~~e 345 (373)
T 3c1x_A 320 -------YCPDPLYEVMLKCWHPKAEMRPSFSE 345 (373)
T ss_dssp -------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 11236889999999999999999853
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.16 Aligned_cols=229 Identities=28% Similarity=0.416 Sum_probs=175.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCC------CCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
..++|...+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35678889999999999999998632 24799999976533 2345689999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc-----------------------------CCCCCHHh-----hhccccCCeeecCCCCE
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ-----------------------------AASLDWGK-----RCKIVASNILLNDDFEA 261 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~-----------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~ 261 (388)
..++||||+++|+|.+++... ..+|.++| |.||+|+|||++.++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 999999999999999988632 22455666 45788999999999999
Q ss_pred EEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHH
Q 035768 262 KISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWV 339 (388)
Q Consensus 262 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~ 339 (388)
||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |..||.... ....+...+
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~ 280 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL---VNSKFYKLV 280 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC---SSHHHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc---hhHHHHHHH
Confidence 99999999876433222 2233457889999999888889999999999999999999 889985432 112222222
Q ss_pred HHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 340 LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... ..+ .. ....+.+++.+||+.||.+|||+.|
T Consensus 281 ~~~~~~------~~~---~~----~~~~l~~li~~~l~~~p~~Rps~~~ 316 (333)
T 2i1m_A 281 KDGYQM------AQP---AF----APKNIYSIMQACWALEPTHRPTFQQ 316 (333)
T ss_dssp HHTCCC------CCC---TT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCC------CCC---CC----CCHHHHHHHHHHhccChhhCcCHHH
Confidence 221110 001 00 1236889999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=282.58 Aligned_cols=228 Identities=20% Similarity=0.352 Sum_probs=169.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+.|...+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457888999999999999999975 5899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++.+.. .++.++| |.||+|+||+++.++.+||+|||++....... .....
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 176 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDS 176 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC---
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccccc
Confidence 99999999876432 2455666 45788999999999999999999976432111 11223
Q ss_pred cccccCccCcccc-----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 283 VAGTIGYVPPEYG-----GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 283 ~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
..||+.|+|||.+ ....++.++||||||+++|||++|+.||... +..... ....... ......+.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~---~~~~~~~-~~~~~~~~-- 246 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVL---LKIAKSD-PPTLLTPS-- 246 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHH---HHHHHSC-CCCCSSGG--
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC----CHHHHH---HHHhccC-CcccCCcc--
Confidence 4689999999987 4677899999999999999999999998532 222221 1111111 11111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 247 -----~~~~~l~~li~~~l~~dp~~Rps~~~ 272 (302)
T 2j7t_A 247 -----KWSVEFRDFLKIALDKNPETRPSAAQ 272 (302)
T ss_dssp -----GSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred -----ccCHHHHHHHHHHcccChhhCCCHHH
Confidence 11236889999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=289.98 Aligned_cols=238 Identities=24% Similarity=0.342 Sum_probs=170.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999965 5899999998654332 23458899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
|+++++|.+++.. ...++.++| |.||+|+|||++.++.+||+|||+++....... ....
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 183 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDD 183 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCC
Confidence 9999988887542 233566676 457889999999999999999999987644322 2234
Q ss_pred cccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc------------cccc
Q 035768 283 VAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN------------EQAD 349 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 349 (388)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||... +..+....+...... ....
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD----SDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 5689999999988765 7899999999999999999999998543 222222211111100 0001
Q ss_pred ccCCccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+....... ......+.+++.+||+.||++|||+.|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 303 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence 111111111111 112346889999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.54 Aligned_cols=220 Identities=21% Similarity=0.320 Sum_probs=167.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 221 (388)
++|...+.||+|+||.||+|++. ++.||||.++.... ...+.|.+|+.++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46788899999999999999984 88999999975432 3345799999999999999999999999877 7789999
Q ss_pred eccCCCCHHHHHhccC-----------------CCCCHHh-------hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 222 EYMVKGSLDDWLRNQA-----------------ASLDWGK-------RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~-----------------~~l~~~~-------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
||+++|+|.+++.... .++.|+| |.||+|+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence 9999999999997542 2344555 446889999999999999999988754322
Q ss_pred ceeeccccccCccCccccCCCCCCc---ccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATE---RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
....||+.|+|||.+.+..++. ++|||||||++|||+||+.||... ........+ ...... +
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~---~~~~~~-----~ 230 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL----SNMEIGMKV---ALEGLR-----P 230 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS----CHHHHHHHH---HHSCCC-----C
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc----ChHHHHHHH---HhcCCC-----C
Confidence 2345899999999887665544 799999999999999999998532 222222111 111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... ....+.+++.+||+.||++|||++|
T Consensus 231 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ 260 (271)
T 3kmu_A 231 TIPPG----ISPHVSKLMKICMNEDPAKRPKFDM 260 (271)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCC----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence 11111 1236889999999999999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=286.87 Aligned_cols=226 Identities=27% Similarity=0.455 Sum_probs=166.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||.||+|.... +..||||.++.... .....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998642 23599999975432 234568999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++..... +|.++| |.||+|+||+++.++.+||+|||+++........
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 9999999999999865322 345555 4578899999999999999999999876543221
Q ss_pred --eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 279 --VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 279 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
......+|+.|+|||.+....++.++|||||||++|||++ |+.||... ...++...+..... .. .
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~----~~~~~~~~~~~~~~---~~---~-- 271 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAINDGFR---LP---T-- 271 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCC---CC---C--
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHHCCCc---CC---C--
Confidence 1222346788999999988899999999999999999999 99998532 22333332222111 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 272 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ 299 (333)
T 1mqb_A 272 -----PMDCPSAIYQLMMQCWQQERARRPKFAD 299 (333)
T ss_dssp -----CTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred -----cccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0112236889999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=280.90 Aligned_cols=229 Identities=27% Similarity=0.430 Sum_probs=162.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.++|...+.||+|+||+||+|+... .||||.++.... ...+.|.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4578888999999999999998643 599999875432 2345699999999999999999999965 4667899999
Q ss_pred ccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC-ccee
Q 035768 223 YMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE-SHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~-~~~~ 280 (388)
|+++++|.+++.... .+|.++| |.||+|+|||++.++.+||+|||+++...... ....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 999999999885432 2455666 45788999999999999999999998654321 1222
Q ss_pred eccccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 281 TVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
....||+.|+|||.+. ...++.++||||||+++|||++|+.||.... ....+.+.+............
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~------ 250 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIEMVGRGSLSPDLSKV------ 250 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC---CHHHHHHHHHHTSCCCCTTSS------
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc---hHHHHHHHhcccccCcchhhc------
Confidence 3456899999999875 6678899999999999999999999985421 222233332221111111110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 251 ---~~~~~~~l~~li~~~l~~~p~~Rps~~e 278 (289)
T 3og7_A 251 ---RSNCPKRMKRLMAECLKKKRDERPSFPR 278 (289)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 1112236889999999999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.54 Aligned_cols=228 Identities=23% Similarity=0.315 Sum_probs=164.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--------cChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--------QGDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
.++|...+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 568999999999999999999864 689999999864321 11234889999999999999999999985 55
Q ss_pred eeEEEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCC---CCEEEcccccceec
Q 035768 216 EKLLVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDD---FEAKISDFGLARLI 272 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~---~~~kl~DfG~a~~~ 272 (388)
..++||||+++|+|.+++.. ...+|.|+| |+||+|+|||++.+ +.+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 68999999999999887643 234567777 45788999999754 45999999999876
Q ss_pred cCCCcceeeccccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
... ......+||+.|+|||++. ...++.++|||||||++|||+||+.||.... ....+.+.+......
T Consensus 293 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~i~~~~~~---- 363 (419)
T 3i6u_A 293 GET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---TQVSLKDQITSGKYN---- 363 (419)
T ss_dssp C-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS---SSCCHHHHHHTTCCC----
T ss_pred CCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc---chHHHHHHHhcCCCC----
Confidence 532 2233467999999999875 3678899999999999999999999986432 223333333221110
Q ss_pred ccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+...... ...+.+++.+||+.||++|||++|
T Consensus 364 --~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e 396 (419)
T 3i6u_A 364 --FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEE 396 (419)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred --CCchhhccc----CHHHHHHHHHHccCChhHCcCHHH
Confidence 011111111 236889999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=288.24 Aligned_cols=175 Identities=18% Similarity=0.305 Sum_probs=148.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEe--CCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSV--DEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~ 221 (388)
++|...+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999985 57899999998643 3567999999999997 9999999999987 66789999
Q ss_pred eccCCCCHHHHHhc------------cCCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCcceeecc
Q 035768 222 EYMVKGSLDDWLRN------------QAASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 222 e~~~~g~L~~~l~~------------~~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
||+++++|.++++. ...++.|+| |.||+|+|||++.++ .+||+|||+++....... ....
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 190 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVR 190 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSC
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccc
Confidence 99999999987643 344677777 457889999999776 899999999987654322 2345
Q ss_pred ccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 284 AGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 284 ~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.||..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 68999999998876 6789999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=280.04 Aligned_cols=227 Identities=22% Similarity=0.297 Sum_probs=172.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45788899999999999999975 689999999865422 13567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC----CEEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF----EAKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~----~~kl~DfG~a~~~~~ 274 (388)
+||||+++++|.+++... ..+|.++| |.||+|+||+++.++ .+||+|||+++....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 999999999999988542 23556666 457889999998877 899999999987654
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.. ......||+.|+|||.+....++.++||||||+++|||++|+.||... ...+....+.... ...++
T Consensus 165 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~------~~~~~ 232 (283)
T 3bhy_A 165 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE----TKQETLTNISAVN------YDFDE 232 (283)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTTC------CCCCH
T ss_pred CC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc----chHHHHHHhHhcc------cCCcc
Confidence 32 223346899999999998889999999999999999999999998542 2222222221110 00111
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... ...+.+++.+||+.||++|||+.|
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ 262 (283)
T 3bhy_A 233 EYFSNT----SELAKDFIRRLLVKDPKRRMTIAQ 262 (283)
T ss_dssp HHHTTC----CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hhcccC----CHHHHHHHHHHccCCHhHCcCHHH
Confidence 111111 235789999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=287.93 Aligned_cols=237 Identities=23% Similarity=0.364 Sum_probs=156.9
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3567889999999999999999964 68899999986543 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-----------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceecc
Q 035768 222 EYMVKGSLDDWLRNQ-----------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-----------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
||+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++...
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 999999999988631 12455666 45788999999999999999999997654
Q ss_pred CCCc----ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 274 DCES----HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 274 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
.... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||... ..................
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY----PPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS----CGGGHHHHHHTSSCCCTT
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC----chhhHHHHHhccCCCccc
Confidence 3211 11233568999999998765 56899999999999999999999998542 222222111111110000
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....++......+ ..+.+++.+||+.||++|||+.|
T Consensus 249 ~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ 284 (303)
T 2vwi_A 249 TGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAE 284 (303)
T ss_dssp C-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHH
Confidence 1111111112222 36788999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=310.37 Aligned_cols=224 Identities=23% Similarity=0.296 Sum_probs=178.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC---CCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA---TGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 218 (388)
..++|...+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467889999999999999999964 5889999999753 223456788999999987 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||||+++|+|.+++++. ..+|.|+| |+||+|+|||++.++.+||+|||+++...... .
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 497 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 497 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-C
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-c
Confidence 999999999999988642 33567777 45788999999999999999999998653322 2
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....+||+.|+|||++....++.++|||||||++|||++|+.||... +..++.+.+... ......
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~--~~~~p~-------- 563 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEH--NVAYPK-------- 563 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHSS--CCCCCT--------
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC----CHHHHHHHHHhC--CCCCCc--------
Confidence 334567999999999999999999999999999999999999998532 333333333221 001111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
....++.+|+.+||+.||++||++
T Consensus 564 ----~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 564 ----SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----cCCHHHHHHHHHHccCCHHHCCCC
Confidence 112368899999999999999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=280.00 Aligned_cols=222 Identities=20% Similarity=0.318 Sum_probs=173.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 57889999986432 223467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||++....... ..
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 170 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RR 170 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---BC
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc---cc
Confidence 999999999988642 23456666 45788999999999999999999997664322 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||... ...+....+.. ... .....
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~----~~~------~~~~~-- 234 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP----SHTETHRRIVN----VDL------KFPPF-- 234 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHT----TCC------CCCTT--
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC----CHhHHHHHHhc----ccc------CCCCc--
Confidence 456899999999999889999999999999999999999998532 22222221111 100 00011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||.+|||++|
T Consensus 235 --~~~~~~~li~~~l~~~p~~Rps~~~ 259 (284)
T 2vgo_A 235 --LSDGSKDLISKLLRYHPPQRLPLKG 259 (284)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred --CCHHHHHHHHHHhhcCHhhCCCHHH
Confidence 1236789999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=286.82 Aligned_cols=237 Identities=21% Similarity=0.294 Sum_probs=167.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|... +++.||||+++..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999965 6899999999754322 122456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++ |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 159 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDN 159 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccccc
Confidence 96 6898887543 23455666 45788999999999999999999998654322 22233
Q ss_pred cccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc---ccCCc----
Q 035768 283 VAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD---EVLDP---- 354 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 354 (388)
..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+....+.......... .....
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS----TVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 468999999998765 57899999999999999999999998542 3334444443333221111 00000
Q ss_pred -----cccCCC----CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 -----AVLNAN----SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 -----~~~~~~----~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... .......+.+++.+||+.||++|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 278 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHH
Confidence 000000 0011235789999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.06 Aligned_cols=238 Identities=20% Similarity=0.258 Sum_probs=165.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||+||+|.. .+++.||||+++..... ....+.+|++++++++||||+++++++..++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 45788899999999999999985 46889999999754322 2456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeee-----cCCCCEEEcccccceeccCCC
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILL-----NDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl-----~~~~~~kl~DfG~a~~~~~~~ 276 (388)
||++ |+|.+++... ..+|.|+| |.||+|+|||+ +.++.+||+|||+++......
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 9997 5999887542 33566777 45788999999 455569999999998764322
Q ss_pred cceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC--
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD-- 353 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 353 (388)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||... ...+....+..............
T Consensus 192 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 192 -RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD----SEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC----CHHHHHHHHHHHhCCCchhhhhhhh
Confidence 222345689999999988764 5899999999999999999999998542 22222222222211111000000
Q ss_pred ---------ccccCCCCH-----HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 ---------PAVLNANSK-----PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ---------~~~~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+........ .....+.+++.+||+.||++|||++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 315 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 000000000 02246789999999999999999854
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=295.68 Aligned_cols=234 Identities=24% Similarity=0.362 Sum_probs=174.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEE--eCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS--VDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 218 (388)
++|...+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4678889999999999999984 358899999998765555667999999999999999999999987 456689
Q ss_pred EEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++... ..+|.++| |.||+|+|||++.++.+||+|||+++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 999999999999998642 22455666 457889999999999999999999988754332
Q ss_pred c--eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-------CCcccHHHHHHHhhccccc
Q 035768 278 H--VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED-------KDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 278 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 348 (388)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .........+.........
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC
Confidence 2 222345788899999998888999999999999999999999997432100 0000000111111111110
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .........+.+++.+||+.||++|||+.|
T Consensus 263 ~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 293 (327)
T 3lxl_A 263 L---------PAPPACPAEVHELMKLCWAPSPQDRPSFSA 293 (327)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C---------CCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence 0 011122336889999999999999999854
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=295.42 Aligned_cols=232 Identities=25% Similarity=0.384 Sum_probs=170.7
Q ss_pred CCcCCeeeccCCceEEEEEcC-----CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-----DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVD--EEKLL 219 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 219 (388)
|...+.||+|+||+||++.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377889999999999998642 578899999976532 3345689999999999999999999999884 67899
Q ss_pred EEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc--
Q 035768 220 VYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-- 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-- 278 (388)
||||+++|+|.+++... ..++.++| |.||+|+|||++.++.+||+|||+++........
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 192 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEE
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccc
Confidence 99999999999988643 23455666 4578899999999999999999999987543321
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-------CCcccHHHHHHHhhcccccccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFED-------KDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
......||..|+|||.+.+..++.++||||||+++|||+||+.||...... .....-...+.........
T Consensus 193 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 269 (318)
T 3lxp_A 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER--- 269 (318)
T ss_dssp C---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC---
T ss_pred cccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC---
Confidence 223345788899999998888999999999999999999999997532100 0000000011111111110
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..........+.+++.+||+.||++|||+.|
T Consensus 270 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 300 (318)
T 3lxp_A 270 ------LPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300 (318)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ------CCCCccccHHHHHHHHHHcCCCcccCcCHHH
Confidence 0011112236889999999999999999853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.12 Aligned_cols=219 Identities=27% Similarity=0.405 Sum_probs=165.2
Q ss_pred CeeeccCCceEEEEEcC---CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP---DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||.||+|.+. .++.||||+++.... ...++|.+|+++|++++|||||+++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999652 467899999976432 33568999999999999999999999996 4568899999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc--ceeeccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES--HVSTVVA 284 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~ 284 (388)
|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++.+..... .......
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 9999998642 23566676 457889999999999999999999987754332 1223345
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
+|+.|+|||++....++.++|||||||++|||+| |+.||... ...++...+...... .. ...
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----~~~~~~~~i~~~~~~----~~---------p~~ 596 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAMLEKGERM----GC---------PAG 596 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTTCCC----CC---------CTT
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCC----CC---------CCC
Confidence 6789999999988899999999999999999999 99998542 333333333221111 10 011
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~ 621 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAA 621 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 2236889999999999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=295.00 Aligned_cols=235 Identities=17% Similarity=0.187 Sum_probs=165.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCCc-----------ChHHHHHHHHHHhcCCCCCccceeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATGQ-----------GDREFAAEMETLGMVKHQNLVELLGY 210 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~ 210 (388)
++|...+.||+|+||.||+|... ++..||||++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999975 5778999998754321 12346788899999999999999999
Q ss_pred EEe----CCeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCCC--CEEEc
Q 035768 211 CSV----DEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDDF--EAKIS 264 (388)
Q Consensus 211 ~~~----~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~~--~~kl~ 264 (388)
+.. ....++||||+ +|+|.+++... ..+|.|+|. +||+|+|||++.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 988 67889999999 99999987542 335667774 57889999999887 99999
Q ss_pred ccccceeccCCCc------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHH
Q 035768 265 DFGLARLISDCES------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338 (388)
Q Consensus 265 DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 338 (388)
|||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... +.... ..
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~-~~ 272 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--DPVAV-QT 272 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--CHHHH-HH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--ccHHH-HH
Confidence 9999987643211 111345699999999999888999999999999999999999999853211 11111 11
Q ss_pred HHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......... ...+...... ......+.+++.+||+.||++|||+.|
T Consensus 273 ~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ 318 (345)
T 2v62_A 273 AKTNLLDEL-PQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQA 318 (345)
T ss_dssp HHHHHHHTT-THHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred HHHhhcccc-cHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHH
Confidence 111111110 1000000000 012236889999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=279.90 Aligned_cols=225 Identities=29% Similarity=0.421 Sum_probs=170.1
Q ss_pred CCcCCeeeccCCceEEEEEcC-CC---CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee-EEEE
Q 035768 148 FCEENVIGGGGFGTVFKGTMP-DG---KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK-LLVY 221 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~ 221 (388)
|...+.||+|+||+||+|.+. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 455688999999999999853 22 3799999976443 3346789999999999999999999999876655 9999
Q ss_pred eccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc---
Q 035768 222 EYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES--- 277 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~--- 277 (388)
||+.+|+|.+++.... .++.++| |.||+|+|||++.++.+||+|||+++.......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 9999999999987532 2455566 457889999999999999999999986543221
Q ss_pred ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 278 HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
.......+|+.|+|||...+..++.++||||||+++|||++|..|+.. ..+..++...+........ +
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~---~~~~~~~~~~~~~~~~~~~------~--- 250 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR---HIDPFDLTHFLAQGRRLPQ------P--- 250 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT---TSCGGGHHHHHHTTCCCCC------C---
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc---cCCHHHHHHHhhcCCCCCC------C---
Confidence 122335578999999999999999999999999999999997666532 2344444444333221110 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .....+.+++.+||+.||.+|||++|
T Consensus 251 ~----~~~~~l~~li~~~l~~~p~~Rps~~~ 277 (298)
T 3pls_A 251 E----YCPDSLYQVMQQCWEADPAVRPTFRV 277 (298)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred c----cchHHHHHHHHHHccCChhhCcCHHH
Confidence 0 11236889999999999999999753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.00 Aligned_cols=232 Identities=25% Similarity=0.441 Sum_probs=164.8
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEcC----CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTMP----DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV 213 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 213 (388)
++....++|...+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445567888999999999999999853 345899999975432 234568999999999999999999999987
Q ss_pred CC-----eeEEEEeccCCCCHHHHHhcc---------------------CCCCCHHh-----hhccccCCeeecCCCCEE
Q 035768 214 DE-----EKLLVYEYMVKGSLDDWLRNQ---------------------AASLDWGK-----RCKIVASNILLNDDFEAK 262 (388)
Q Consensus 214 ~~-----~~~lv~e~~~~g~L~~~l~~~---------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~k 262 (388)
.+ ..++||||+++|+|.+++... ..+|.|+| |.||+|+||+++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 55 349999999999999998421 22455666 457889999999999999
Q ss_pred EcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHH
Q 035768 263 ISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVL 340 (388)
Q Consensus 263 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~ 340 (388)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||... ....+...+.
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~~ 263 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV----QNHEMYDYLL 263 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC----CHHHHHHHHH
Confidence 999999987644322 12233457889999999988899999999999999999999 88887532 3334443332
Q ss_pred HhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 341 HMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... .. .....+.+++.+||+.||++|||+.|
T Consensus 264 ~~~~~~~---------~~----~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 264 HGHRLKQ---------PE----DCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp TTCCCCC---------BT----TCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred cCCCCCC---------Cc----cccHHHHHHHHHHcCCChhhCcCHHH
Confidence 2111100 01 11236889999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.53 Aligned_cols=235 Identities=27% Similarity=0.383 Sum_probs=177.5
Q ss_pred HHHHHHhhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceee
Q 035768 138 YDQIVAGTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLG 209 (388)
Q Consensus 138 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 209 (388)
...+....++|...+.||+|+||.||+|.+ .+++.||||.++.... ...+.+.+|++++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344455567899999999999999999973 3567899999976533 2345789999999999 7999999999
Q ss_pred EEEeCC-eeEEEEeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCC
Q 035768 210 YCSVDE-EKLLVYEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASN 252 (388)
Q Consensus 210 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~N 252 (388)
++...+ ..++||||+++|+|.+++.... .++.++| |.||+|+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 998755 4899999999999999986532 1344555 45788999
Q ss_pred eeecCCCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCC
Q 035768 253 ILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDK 330 (388)
Q Consensus 253 iLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~ 330 (388)
|+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--- 255 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--- 255 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc---
Confidence 9999999999999999987654332 22334567899999999988899999999999999999999 999985422
Q ss_pred CcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 331 DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+...+...... ... .. ....+.+++.+||+.||.+|||+.|
T Consensus 256 ~~~~~~~~~~~~~~~-~~~--------~~----~~~~l~~li~~~l~~dp~~Rps~~e 300 (316)
T 2xir_A 256 IDEEFCRRLKEGTRM-RAP--------DY----TTPEMYQTMLDCWHGEPSQRPTFSE 300 (316)
T ss_dssp CSHHHHHHHHHTCCC-CCC--------TT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhHHHHHHhccCccC-CCC--------CC----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence 112222222221110 000 11 1226889999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=300.25 Aligned_cols=226 Identities=23% Similarity=0.299 Sum_probs=173.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||+||+|... +++.||||++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46888899999999999999964 6899999998643 23345779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeec---CCCCEEEcccccceeccCCCcce
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLN---DDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~---~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+++|+|.+++.. ...++.|+| |+||+|+|||++ .++.+||+|||+++...... .
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--K 179 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--c
Confidence 9999999887743 234567777 457889999995 45689999999998764432 2
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||... ...++...+......... +. ..
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~-----~~-~~- 247 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK----NEYDILKRVETGKYAFDL-----PQ-WR- 247 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCSCS-----GG-GG-
T ss_pred cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCC-----cc-cC-
Confidence 234569999999999865 5999999999999999999999998532 333343333321111100 10 01
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 248 ---~~s~~~~~li~~~L~~dp~~R~t~~~ 273 (486)
T 3mwu_A 248 ---TISDDAKDLIRKMLTFHPSLRITATQ 273 (486)
T ss_dssp ---GSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 11236789999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=280.19 Aligned_cols=225 Identities=25% Similarity=0.399 Sum_probs=171.4
Q ss_pred cCCCcCC-eeeccCCceEEEEEcC---CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEEN-VIGGGGFGTVFKGTMP---DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+ .||+|+||.||+|.+. ++..||||.++.... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3454555 8999999999999853 577899999976533 3356799999999999999999999999 56678999
Q ss_pred EeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||+++|+|.+++..... +|.++| |.||+|+||+++.++.+||+|||+++.........
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 999999999999854322 445566 45788999999999999999999998875433221
Q ss_pred --eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 280 --STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 280 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.....||+.|+|||.+....++.++||||||+++|||+| |+.||... ...++...+..... .. .
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~i~~~~~----~~-----~ 234 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKR----ME-----C 234 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CTHHHHHHHHTTCC----CC-----C
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHhcCCc----CC-----C
Confidence 223346889999999888889999999999999999999 99998542 23333333322111 00 0
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. .....+.+++.+||+.||++|||+.|
T Consensus 235 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~ 262 (287)
T 1u59_A 235 PP----ECPPELYALMSDCWIYKWEDRPDFLT 262 (287)
T ss_dssp CT----TCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CC----CcCHHHHHHHHHHcCCChhhCcCHHH
Confidence 01 11236889999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=289.96 Aligned_cols=227 Identities=22% Similarity=0.279 Sum_probs=171.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.++|...+.||+|+||.||+|... +++.||||.+++... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356888899999999999999965 688999999976532 245688888887 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCC----CCEEEcccccceeccCCCcc
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDD----FEAKISDFGLARLISDCESH 278 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~----~~~kl~DfG~a~~~~~~~~~ 278 (388)
|+++|+|.+++... ..++.|+| |+||+|+|||+.++ +.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~- 175 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG- 175 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence 99999999987542 23566777 45788999998443 3599999999997654332
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....++...+.. +... +......
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~~~~i~~----~~~~--~~~~~~~ 248 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-DDTPEEILARIGS----GKFS--LSGGYWN 248 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-TSCHHHHHHHHHH----CCCC--CCSTTTT
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-cCCHHHHHHHHcc----CCcc--cCccccc
Confidence 2334578999999999887789999999999999999999999986421 1222233333222 1111 0000111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.....+.+++.+||+.||++|||+.
T Consensus 249 ----~~s~~~~~li~~~L~~dP~~R~t~~ 273 (342)
T 2qr7_A 249 ----SVSDTAKDLVSKMLHVDPHQRLTAA 273 (342)
T ss_dssp ----TSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ----cCCHHHHHHHHHHCCCChhHCcCHH
Confidence 1223678999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=303.08 Aligned_cols=226 Identities=23% Similarity=0.306 Sum_probs=176.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888899999999999999965 78999999986542 234577999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCCcc
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||+.+|+|.+++... ..+|.|+| |+||+|+|||+ +.++.+||+|||+++.......
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~- 184 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK- 184 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc-
Confidence 999999999887532 33566777 45788999999 5678999999999987654322
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....||+.|+|||.+.+ .++.++||||+||++|||++|+.||... +..++...+........ .+.. .
T Consensus 185 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~-----~~~~-~ 252 (484)
T 3nyv_A 185 -MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA----NEYDILKKVEKGKYTFE-----LPQW-K 252 (484)
T ss_dssp -HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCC-----SGGG-G
T ss_pred -cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcCCCCCC-----Cccc-c
Confidence 234569999999998865 6899999999999999999999998532 33334433332111100 0100 1
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 253 ----~~s~~~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 253 ----KVSESAKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp ----GSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----cCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11236789999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=278.71 Aligned_cols=226 Identities=23% Similarity=0.359 Sum_probs=170.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 457888999999999999999965 58999999997542 356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~ 184 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNT 184 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCc
Confidence 9999999998632 22455666 457789999999999999999999987654322 2234
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCH
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (388)
..||+.|+|||.+....++.++||||||+++|||++|+.||... ....... ... .........+..
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~---~~~-~~~~~~~~~~~~------ 250 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI----HPMRAIF---MIP-TNPPPTFRKPEL------ 250 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHH---HHH-HSCCCCCSSGGG------
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC----ChHHHHH---HHh-cCCCcccCCccc------
Confidence 56899999999998889999999999999999999999998532 1111111 111 111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 363 PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 363 ~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||.+|||+.|
T Consensus 251 -~~~~l~~li~~~l~~dp~~Rpt~~~ 275 (314)
T 3com_A 251 -WSDNFTDFVKQCLVKSPEQRATATQ 275 (314)
T ss_dssp -SCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHH
Confidence 1236889999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.83 Aligned_cols=230 Identities=23% Similarity=0.326 Sum_probs=174.9
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--------ChHHHHHHHHHHhcC-CCCCccceeeEEE
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--------GDREFAAEMETLGMV-KHQNLVELLGYCS 212 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 212 (388)
...++|...+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34467888999999999999999975 7999999998654321 134578999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceec
Q 035768 213 VDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLI 272 (388)
Q Consensus 213 ~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~ 272 (388)
..+..++||||+++|+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||++..+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999999988642 23556666 4578899999999999999999999877
Q ss_pred cCCCcceeeccccccCccCccccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGG------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||... ........+......
T Consensus 251 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~- 323 (365)
T 2y7j_A 251 EPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR----RQILMLRMIMEGQYQ- 323 (365)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC-
T ss_pred CCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCCC-
Confidence 5432 223457999999999864 346889999999999999999999998532 222222222221100
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+ ..... ...+.+++.+||+.||++|||+.|
T Consensus 324 ----~~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 324 ----FSSP-EWDDR----SSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp ----CCHH-HHSSS----CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----CCCc-ccccC----CHHHHHHHHHHcCCChhHCcCHHH
Confidence 0001 01111 235889999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.79 Aligned_cols=227 Identities=23% Similarity=0.273 Sum_probs=173.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-------------cChHHHHHHHHHHhcCCCCCccceeeE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-------------QGDREFAAEMETLGMVKHQNLVELLGY 210 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 210 (388)
.++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999965 588999999875421 234678999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC---CEEEcccc
Q 035768 211 CSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF---EAKISDFG 267 (388)
Q Consensus 211 ~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~---~~kl~DfG 267 (388)
+.+....++||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++ .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 99999999999999999999887532 33567777 457889999998775 69999999
Q ss_pred cceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 268 LARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 268 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
+++...... ......||+.|+|||.+. ..++.++||||+||++|||++|..||... ...++...+.....
T Consensus 195 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~--- 264 (504)
T 3q5i_A 195 LSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ----NDQDIIKKVEKGKY--- 264 (504)
T ss_dssp TCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC---
T ss_pred CCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCC---
Confidence 998875432 223456999999999886 56999999999999999999999998532 33334333332111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+....... ...+.+++.+||+.||.+|||+.|
T Consensus 265 ---~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e 298 (504)
T 3q5i_A 265 ---YFDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEE 298 (504)
T ss_dssp ---CCCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ---CCCccccCCC----CHHHHHHHHHHcCCChhHCCCHHH
Confidence 0111111111 236889999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=285.19 Aligned_cols=238 Identities=21% Similarity=0.296 Sum_probs=169.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc-----ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ-----GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
.++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467889999999999999999975 5899999999753221 1346889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++ +|.+++.... .+|.|+| |.||+|+|||++.++.+||+|||+++.......
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999975 8888876432 2456666 457889999999999999999999987644322
Q ss_pred ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC---
Q 035768 278 HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD--- 353 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 353 (388)
......||+.|+|||.+.+ ..++.++|||||||++|||++|.+||... +..+....+...........+.+
T Consensus 168 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 168 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2334568999999998865 45899999999999999999999997532 22333333322221111111100
Q ss_pred -cc-----ccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 -PA-----VLNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 -~~-----~~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+. ...... ......+.+++.+||+.||++|||+.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 288 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 00 000000 112246889999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=300.18 Aligned_cols=216 Identities=13% Similarity=0.124 Sum_probs=162.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHH---HHHhcCCCCCcccee-------eE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEM---ETLGMVKHQNLVELL-------GY 210 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 210 (388)
.++|...+.||+|+||+||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 56999999999743 223446789999 556666899999998 66
Q ss_pred EEeCC-----------------eeEEEEeccCCCCHHHHHhcc----------------------CCCCCHHh-----hh
Q 035768 211 CSVDE-----------------EKLLVYEYMVKGSLDDWLRNQ----------------------AASLDWGK-----RC 246 (388)
Q Consensus 211 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~----------------------~~~l~~~~-----~~ 246 (388)
+...+ ..++||||+ +|+|.+++... ..+|.|+| |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 65543 278999999 68999988631 22456666 45
Q ss_pred ccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccCCC-----------CCCcccchHhHHHHHHH
Q 035768 247 KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG-----------KATERGDVYSFGVILLE 315 (388)
Q Consensus 247 ~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gv~l~e 315 (388)
||+|+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 8889999999999999999999986432 2334567 999999998777 89999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 316 LVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 316 l~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
|+||+.||...... ... ..+... .... ...+.+++.+||+.||++|||+.|
T Consensus 306 lltg~~Pf~~~~~~----~~~------------~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 306 IWCADLPITKDAAL----GGS------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHSSCCC----------CCS------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHCCCCCcccccc----cch------------hhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHH
Confidence 99999998542211 000 000000 0111 136889999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.18 Aligned_cols=223 Identities=26% Similarity=0.390 Sum_probs=166.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888899999999999999975 78999999986432 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+++++|.+++... ..++.++| |.||+|+||+++.++.+||+|||++....... ...
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 168 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLR 168 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--cee
Confidence 999999999988542 23566666 45788999999999999999999998765432 223
Q ss_pred ccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...||+.|+|||.+.+..+ +.++||||||+++|||++|+.||... ....+.+.+..... .. + ..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~--~~-----~---~~- 233 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE----HVPTLFKKIRGGVF--YI-----P---EY- 233 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CC-----C---TT-
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHhhcCcc--cC-----c---hh-
Confidence 3468999999999887665 68999999999999999999998532 22233322222110 00 1 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||+.|
T Consensus 234 ---~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 234 ---LNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cCHHHHHHHHHHccCChhhCCCHHH
Confidence 1125788999999999999999753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.01 Aligned_cols=226 Identities=30% Similarity=0.451 Sum_probs=167.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 219 (388)
.+|...+.||+|+||.||+|++.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 356778899999999999998643 23589999876433 334678999999999999999999999754 567899
Q ss_pred EEeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-
Q 035768 220 VYEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES- 277 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~- 277 (388)
||||+++|+|.+++++... ++.++| |.||+|+||+++.++.+||+|||+++.......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 9999999999999865322 345556 457889999999999999999999987644321
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK-QPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.......||+.|+|||.+.+..++.++||||||+++|||++|. +||.. ....+....+...... ..+
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~------~~~ 254 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VNTFDITVYLLQGRRL------LQP 254 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT----SCTTTHHHHHHTTCCC------CCC
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc----CCHHHHHHHHhcCCCC------CCC
Confidence 1223345788999999998889999999999999999999955 45432 2333333333221111 111
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ....+.+++.+||+.||++|||+.|
T Consensus 255 ---~~----~~~~l~~li~~~l~~~p~~Rps~~e 281 (298)
T 3f66_A 255 ---EY----CPDPLYEVMLKCWHPKAEMRPSFSE 281 (298)
T ss_dssp ---TT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cc----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence 01 1126889999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=284.12 Aligned_cols=226 Identities=27% Similarity=0.383 Sum_probs=169.3
Q ss_pred hcCCCcCC-eeeccCCceEEEEEc---CCCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 145 TNKFCEEN-VIGGGGFGTVFKGTM---PDGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 145 ~~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
.++|...+ .||+|+||.||+|.+ .+++.||||.++..... ..+.+.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45666666 899999999999964 34678999999754322 246799999999999999999999999 567789
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||||+++|+|.+++.+. ..++.++| |.||+|+||+++.++.+||+|||+++........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999999999988643 23456666 4578899999999999999999999887544332
Q ss_pred e--eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 279 V--STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 279 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
. .....+|+.|+|||.+....++.++||||||+++|||+| |+.||... ....+...+... ....
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~----~~~~----- 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAMLEKG----ERMG----- 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTT----CCCC-----
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHcC----CCCC-----
Confidence 2 122346788999999888889999999999999999999 99997542 233333332221 1111
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... .....+.+++.+||+.||++|||+.|
T Consensus 241 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ 269 (291)
T 1xbb_A 241 CPA----GCPREMYDLMNLCWTYDVENRPGFAA 269 (291)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCC----CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 001 11236889999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=287.22 Aligned_cols=231 Identities=21% Similarity=0.358 Sum_probs=168.2
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEe----
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSV---- 213 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~---- 213 (388)
++....++|...+.||+|+||.||+|+. .+++.||||.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3444567899999999999999999996 478999999986543 3456799999999998 89999999999987
Q ss_pred --CCeeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 214 --DEEKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 214 --~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
.+..++||||+++|+|.+++... ..+|.++| |.||+|+||+++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 46789999999999999998642 12455666 4578899999999999999999999
Q ss_pred eeccCCCcceeeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 270 RLISDCESHVSTVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
........ ......||+.|+|||.+. ...++.++|||||||++|||++|+.||... ........+ ..
T Consensus 177 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~---~~ 248 (326)
T 2x7f_A 177 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM----HPMRALFLI---PR 248 (326)
T ss_dssp C--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH---HH
T ss_pred eecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHh---hc
Confidence 87643221 223356899999999876 567899999999999999999999998532 111111111 11
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........ .. ....+.+++.+||+.||.+|||+.|
T Consensus 249 -~~~~~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 249 -NPAPRLKS----KK----WSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp -SCCCCCSC----SC----SCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred -CccccCCc----cc----cCHHHHHHHHHHhccChhhCCCHHH
Confidence 11111111 11 1236889999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=279.42 Aligned_cols=218 Identities=21% Similarity=0.321 Sum_probs=168.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||+||+|... +++.||||.++.... .....+.+|+..+.++ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999975 799999999875432 3345688999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecC-------------------C
Q 035768 222 EYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLND-------------------D 258 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~-------------------~ 258 (388)
||+++|+|.+++... ..+|.++| |.||+|+|||++. .
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999998642 22456666 4578899999984 4
Q ss_pred CCEEEcccccceeccCCCcceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHH
Q 035768 259 FEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 337 (388)
..+||+|||.+....... ...||+.|+|||.+... .++.++|||||||++|||++|.+|+.. . ....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------~-~~~~ 238 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN------G-DQWH 238 (289)
T ss_dssp CCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS------S-HHHH
T ss_pred eEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc------h-hHHH
Confidence 489999999998765422 23489999999988765 667899999999999999999987532 1 1111
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.. ..... ..... ...+.+++.+||+.||++|||+.|
T Consensus 239 ~~~~----~~~~~-----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 239 EIRQ----GRLPR-----IPQVL----SQEFTELLKVMIHPDPERRPSAMA 276 (289)
T ss_dssp HHHT----TCCCC-----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHc----CCCCC-----CCccc----CHHHHHHHHHHhCCCcccCCCHHH
Confidence 1111 11111 11111 236889999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=280.29 Aligned_cols=215 Identities=27% Similarity=0.441 Sum_probs=168.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe-----------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV----------- 213 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------- 213 (388)
++|...+.||+|+||.||+|... +++.||+|.++... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 35788899999999999999975 79999999997543 457799999999999999999999864
Q ss_pred -----CCeeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEccc
Q 035768 214 -----DEEKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDF 266 (388)
Q Consensus 214 -----~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~Df 266 (388)
....++||||+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence 34578999999999999998642 12445566 4578899999999999999999
Q ss_pred ccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 267 GLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 267 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
|+++....... .....||+.|+|||.+....++.++||||||+++|||++|..|+.. ..... ......
T Consensus 167 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------~~~~~----~~~~~~ 234 (284)
T 2a19_B 167 GLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFF----TDLRDG 234 (284)
T ss_dssp TTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------HHHHH----HHHHTT
T ss_pred hhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------HHHHH----HHhhcc
Confidence 99988754322 2334689999999999888899999999999999999999988521 11111 111111
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+ + ..+.+++.+||+.||++|||+.|
T Consensus 235 ~~~~~~--------~----~~~~~li~~~l~~dp~~Rps~~e 264 (284)
T 2a19_B 235 IISDIF--------D----KKEKTLLQKLLSKKPEDRPNTSE 264 (284)
T ss_dssp CCCTTS--------C----HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cccccC--------C----HHHHHHHHHHccCChhhCcCHHH
Confidence 111111 1 25778999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.17 Aligned_cols=179 Identities=25% Similarity=0.321 Sum_probs=142.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC-----Ce
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD-----EE 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 216 (388)
.++|...+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888999999999999999964 588999999975432 2345789999999999999999999999776 57
Q ss_pred eEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
.|+||||+. |+|.++++.. ..+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 899999995 6999988643 23566777 45788999999999999999999999765432
Q ss_pred cc---------------------eeeccccccCccCcccc-CCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 035768 277 SH---------------------VSTVVAGTIGYVPPEYG-GTGKATERGDVYSFGVILLELVTGKQPTG 324 (388)
Q Consensus 277 ~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~ 324 (388)
.. ..+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 11 12456799999999975 56679999999999999999998665543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=274.65 Aligned_cols=231 Identities=19% Similarity=0.255 Sum_probs=170.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC-SVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 222 (388)
.++|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+|+++++.++|+|++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46789999999999999999995 5788999998754332 23588999999999998888777766 56778899999
Q ss_pred ccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCCcc
Q 035768 223 YMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 223 ~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|+ +|+|.+++... ..++.|+| |.||+|+|||+ +.++.+||+|||+++........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 99 99999998642 23456666 45788999999 78899999999999887543321
Q ss_pred ------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 279 ------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 279 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+...........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~-- 241 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTPIEV-- 241 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSCHHH--
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccccchhhh--
Confidence 223456899999999999999999999999999999999999998754322222 22222222111111000
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... ...+.+++.+||+.||++|||++|
T Consensus 242 ---~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~ 270 (296)
T 4hgt_A 242 ---LCKGY----PSEFATYLNFCRSLRFDDKPDYSY 270 (296)
T ss_dssp ---HTTTS----CHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred ---hhccC----CHHHHHHHHHHHhcCCCCCCCHHH
Confidence 00111 136889999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=280.33 Aligned_cols=226 Identities=23% Similarity=0.305 Sum_probs=171.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 219 (388)
.++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 356888899999999999999964 689999999975432 234568999999999999999999998854 568899
Q ss_pred EEeccCCCCHHHHHhcc-------------------CCCCCHHhh----------hccccCCeeecCCCCEEEcccccce
Q 035768 220 VYEYMVKGSLDDWLRNQ-------------------AASLDWGKR----------CKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-------------------~~~l~~~~~----------~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
||||+++|+|.+++... ..++.++|. .||+|+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999988642 224555564 3577999999999999999999998
Q ss_pred eccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccc
Q 035768 271 LISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350 (388)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (388)
....... ......||+.|+|||.+....++.++||||||+++|||++|+.||... +..++...+... ....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~i~~~----~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAGKIREG----KFRR 235 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHT----CCCC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc----CHHHHHHHHhhc----cccc
Confidence 7644221 122356899999999998888999999999999999999999997542 223333333221 1111
Q ss_pred cCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .. .....+.+++.+||+.||++|||+.|
T Consensus 236 ~-----~~----~~~~~l~~li~~~l~~~p~~Rps~~~ 264 (279)
T 2w5a_A 236 I-----PY----RYSDELNEIITRMLNLKDYHRPSVEE 264 (279)
T ss_dssp C-----CT----TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C-----Cc----ccCHHHHHHHHHHcCCCcccCCCHHH
Confidence 1 01 11236889999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=283.05 Aligned_cols=225 Identities=28% Similarity=0.431 Sum_probs=165.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCE----EEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKT----VAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|...+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888999999999999999954 4443 5788775433 345678999999999999999999999998654 789
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|+||+++|+|.+++.... .+|.|+| |.||+|+|||++.++.+||+|||+++........
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence 999999999999986532 2455666 4578899999999999999999999876433221
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||... ....+...+........ +
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~~~~~~~~~------~-- 241 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERLPQ------P-- 241 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHTTCCCCC------C--
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHcCCCCCC------C--
Confidence 2223456789999999988899999999999999999999 99998543 33344443322111100 0
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||.+|||+.|
T Consensus 242 -----~~~~~~l~~li~~~l~~dp~~Rps~~e 268 (327)
T 3lzb_A 242 -----PICTIDVYMIMRKCWMIDADSRPKFRE 268 (327)
T ss_dssp -----TTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 111225889999999999999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=288.28 Aligned_cols=238 Identities=24% Similarity=0.351 Sum_probs=165.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHH--HhcCCCCCccceeeEEEe-----CCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMET--LGMVKHQNLVELLGYCSV-----DEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~ 217 (388)
.++|...+.||+|+||.||+|+. +++.||||+++... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788889999999999999987 68899999986432 3445555555 456899999999986643 2356
Q ss_pred EEEEeccCCCCHHHHHhcc--------------CCCCCHHh--------------hhccccCCeeecCCCCEEEcccccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ--------------AASLDWGK--------------RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~--------------~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
++||||+++|+|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 8999999999999988542 23566666 3478899999999999999999999
Q ss_pred eeccCCC-------cceeeccccccCccCccccCC-------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccH
Q 035768 270 RLISDCE-------SHVSTVVAGTIGYVPPEYGGT-------GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335 (388)
Q Consensus 270 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~ 335 (388)
+.+.... ........||+.|+|||.+.+ ..++.++|||||||++|||+||..||............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 8765322 112224569999999998876 45678999999999999999998876443221111100
Q ss_pred H----------HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 336 V----------DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 336 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...............+.+. . .........+.+++.+||+.||++|||++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEA-W-KENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTT-C-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcc-c-ccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 0 0011111111111111110 0 112335567999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=280.27 Aligned_cols=220 Identities=30% Similarity=0.465 Sum_probs=164.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD-EEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~ 223 (388)
.++|...+.||+|+||.||++.. +++.||||.++... ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35688889999999999999987 48899999997543 456799999999999999999999997654 478999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++..... ..
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 172 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----cc
Confidence 9999999988542 23456666 4578899999999999999999999865432 12
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+++.|+|||.+....++.++||||||+++|||+| |+.||... ...++...+..... +....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~~~~~~~~~~~~---------~~~~~-- 237 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYK---------MDAPD-- 237 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHHTTTCC---------CCCCT--
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCC---------CCCcc--
Confidence 2357889999999988889999999999999999999 99997532 23333332221110 00111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||+.|
T Consensus 238 --~~~~~l~~li~~~l~~~p~~Rps~~~ 263 (278)
T 1byg_A 238 --GCPPAVYEVMKNCWHLDAAMRPSFLQ 263 (278)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --cCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 11236889999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=284.88 Aligned_cols=234 Identities=28% Similarity=0.426 Sum_probs=172.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc-----CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-----PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDE--EKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~ 218 (388)
++|...+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999983 368899999998765555678999999999999999999999987654 679
Q ss_pred EEEeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++.+... +|.++| |.||+|+||+++.++.+||+|||+++.......
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~ 200 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc
Confidence 99999999999999875432 345555 457889999999999999999999988754332
Q ss_pred ce--eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC--------CCCcccHHHHHHHhhcccc
Q 035768 278 HV--STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFE--------DKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 278 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~--------~~~~~~~~~~~~~~~~~~~ 347 (388)
.. .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... ..........+........
T Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (326)
T 2w1i_A 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280 (326)
T ss_dssp EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC
Confidence 21 2234567789999998888899999999999999999999998642100 0000111111111111111
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... . .......+.+++.+||+.||++|||+.|
T Consensus 281 ~~~-----~----~~~~~~~l~~li~~cl~~dP~~Rps~~e 312 (326)
T 2w1i_A 281 RLP-----R----PDGCPDEIYMIMTECWNNNVNQRPSFRD 312 (326)
T ss_dssp CCC-----C----CTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCC-----C----CCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence 000 0 1112236889999999999999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=298.55 Aligned_cols=174 Identities=25% Similarity=0.358 Sum_probs=130.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC-----Ce
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD-----EE 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 216 (388)
.++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|+++|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999864 689999999965432 2345789999999999999999999999543 56
Q ss_pred eEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
.|+||||+ +|+|.++++.. ..+|.|+| |+||+|+|||++.++.+||+|||+|+......
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999998 67898887542 33567777 45788999999999999999999998764321
Q ss_pred c--------------------------ceeeccccccCccCcccc-CCCCCCcccchHhHHHHHHHHHhC
Q 035768 277 S--------------------------HVSTVVAGTIGYVPPEYG-GTGKATERGDVYSFGVILLELVTG 319 (388)
Q Consensus 277 ~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~el~tg 319 (388)
. ...+..+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 1 122345789999999975 566799999999999999999994
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.86 Aligned_cols=229 Identities=23% Similarity=0.323 Sum_probs=168.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 219 (388)
.++|...+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788899999999999999996 5789999999876554556779999999999999999999999973 347789
Q ss_pred EEeccCCCCHHHHHhcc-------------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCC
Q 035768 220 VYEYMVKGSLDDWLRNQ-------------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
||||+++|+|.+++... ..+|.++| |.||+|+||+++.++.+||+|||+++.....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999999988642 12455566 4578899999999999999999998765321
Q ss_pred Ccc--------eeeccccccCccCccccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhc
Q 035768 276 ESH--------VSTVVAGTIGYVPPEYGGTGK---ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344 (388)
Q Consensus 276 ~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 344 (388)
... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||..... ....+...+....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~- 264 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ--KGDSVALAVQNQL- 264 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH--TTSCHHHHHHCC--
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc--ccchhhHHhhccC-
Confidence 100 011245799999999886554 68999999999999999999999843211 1112222111100
Q ss_pred cccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... .......+.+++.+||+.||.+|||+.|
T Consensus 265 -----~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ 296 (317)
T 2buj_A 265 -----SIPQ-------SPRHSSALWQLLNSMMTVDPHQRPHIPL 296 (317)
T ss_dssp ------CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----CCCc-------cccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 0000 0111236889999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=291.76 Aligned_cols=235 Identities=22% Similarity=0.304 Sum_probs=166.5
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC-------
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD------- 214 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 214 (388)
...++|...+.||+|+||+||+|.. .+++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3456789999999999999999985 5799999999865432 234799999999999999999998543
Q ss_pred -------------------------------CeeEEEEeccCCCCHHHHHhc-------------------cCCCCCHHh
Q 035768 215 -------------------------------EEKLLVYEYMVKGSLDDWLRN-------------------QAASLDWGK 244 (388)
Q Consensus 215 -------------------------------~~~~lv~e~~~~g~L~~~l~~-------------------~~~~l~~~~ 244 (388)
...++||||++ |+|.+.+.. ...+|.|+|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999997 587776642 233566677
Q ss_pred -----hhccccCCeeec-CCCCEEEcccccceeccCCCcceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHH
Q 035768 245 -----RCKIVASNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELV 317 (388)
Q Consensus 245 -----~~~i~~~NiLl~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~ 317 (388)
|+||+|+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|||+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 457889999998 688999999999997654332 2345689999999987664 5899999999999999999
Q ss_pred hCCCCCCCCCCCCCcccHHHHHHHhhcccc----------ccccCCccccCC-----CCHHHHHHHHHHHHhcccCCCCC
Q 035768 318 TGKQPTGPEFEDKDGENLVDWVLHMMKNEQ----------ADEVLDPAVLNA-----NSKPTMLKMLQIATGCISNDPTV 382 (388)
Q Consensus 318 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~ 382 (388)
+|+.||... +..+....+........ .....-+..... ........+.+++.+||+.||++
T Consensus 237 ~g~~pf~~~----~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 237 LGKPLFSGE----TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred hCCCCCCCC----ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999998542 22222222222111110 000000100000 01112335889999999999999
Q ss_pred CCCCCC
Q 035768 383 RPTMLH 388 (388)
Q Consensus 383 RPt~~e 388 (388)
|||+.|
T Consensus 313 R~t~~e 318 (383)
T 3eb0_A 313 RINPYE 318 (383)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.07 Aligned_cols=245 Identities=20% Similarity=0.229 Sum_probs=170.7
Q ss_pred cHHHHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcC-----------hHHHHHHHHHHhcCCCCCcc
Q 035768 137 TYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG-----------DREFAAEMETLGMVKHQNLV 205 (388)
Q Consensus 137 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv 205 (388)
...++....++|...+.||+|+||.||+|...+++.||||++....... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3457777889999999999999999999998889999999986432211 26789999999999999999
Q ss_pred ceeeEEEeC-----CeeEEEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCC
Q 035768 206 ELLGYCSVD-----EEKLLVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDF 259 (388)
Q Consensus 206 ~l~g~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~ 259 (388)
++++++... ...++||||++ |+|.+++.... .+|.|+| |.||+|+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN 171 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence 999999543 35799999997 78888775432 2455666 457889999999999
Q ss_pred CEEEcccccceeccCCCcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHH
Q 035768 260 EAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338 (388)
Q Consensus 260 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 338 (388)
.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... ...+....
T Consensus 172 ~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~ 245 (362)
T 3pg1_A 172 DITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS----TFYNQLNK 245 (362)
T ss_dssp CEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHH
T ss_pred CEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence 99999999998654322 2234568999999998766 67899999999999999999999998543 22222222
Q ss_pred HHHhhcccccc-----------ccCCccc---cCC----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQAD-----------EVLDPAV---LNA----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~~~-----------~~~~~~~---~~~----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.......... ....... ... ........+.+++.+||+.||++|||+.|
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 22211111000 0000000 000 00111235889999999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.50 Aligned_cols=231 Identities=19% Similarity=0.258 Sum_probs=173.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC-SVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 222 (388)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+|+.+++.++|++++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 35788899999999999999995 578999999986543 234689999999999998877777666 55677899999
Q ss_pred ccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCCcc
Q 035768 223 YMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 223 ~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
|+ +|+|.+++... ..++.|+| |.||+|+|||+ +.++.+||+|||+++........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99 99999998632 22455666 45788999999 58899999999999887554321
Q ss_pred ------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 279 ------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 279 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +.......+..........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~--- 240 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTPIE--- 240 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSCHH---
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch-hhhhhhhhhcccccCCchH---
Confidence 123457999999999999999999999999999999999999998753322 2222222222211111100
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... ...+.+++.+||+.||++|||+.|
T Consensus 241 --~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ 270 (296)
T 3uzp_A 241 --VLCKGY----PSEFATYLNFCRSLRFDDKPDYSY 270 (296)
T ss_dssp --HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred --HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHH
Confidence 000111 136889999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=287.77 Aligned_cols=227 Identities=27% Similarity=0.416 Sum_probs=169.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
.++|...+.||+|+||.||+|++ .+++.||||.+..... .....+.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35688889999999999999984 2477899999975432 3345789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC----------------------CCCCHHh-----hhccccCCeeecC---CCCEEEcccc
Q 035768 218 LLVYEYMVKGSLDDWLRNQA----------------------ASLDWGK-----RCKIVASNILLND---DFEAKISDFG 267 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG 267 (388)
++||||+++|+|.+++.... .+|.++| |.||+|+|||++. +..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999999997532 1344555 4578899999984 4569999999
Q ss_pred cceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhcc
Q 035768 268 LARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKN 345 (388)
Q Consensus 268 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 345 (388)
+++....... .......||+.|+|||.+....++.++||||||+++|||+| |+.||... ....+.+.+......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFVTSGGRM 264 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHTTCCC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc----CHHHHHHHHhcCCCC
Confidence 9986543222 12233457899999999888889999999999999999999 99997532 333333333221110
Q ss_pred ccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 EQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ... .....+.+++.+||+.||.+|||+.|
T Consensus 265 ----~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ 294 (327)
T 2yfx_A 265 ----D-----PPK----NCPGPVYRIMTQCWQHQPEDRPNFAI 294 (327)
T ss_dssp ----C-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----C-----CCC----CCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0 001 11236889999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=280.39 Aligned_cols=238 Identities=24% Similarity=0.288 Sum_probs=172.0
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe--------C
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV--------D 214 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 214 (388)
++|...+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688889999999999999996 5789999999865432 234578899999999999999999999987 3
Q ss_pred CeeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceecc
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
+..++||||++ |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++...
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 46899999996 5777766543 33566666 45788999999999999999999998764
Q ss_pred CCC---cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 274 DCE---SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 274 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||... ........+..........
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN----TEQHQLALISQLCGSITPE 251 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCChh
Confidence 322 122234568999999998765 46899999999999999999999998542 3333333333322211100
Q ss_pred ---ccCCccc--------cCCCC-HHH------HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 ---EVLDPAV--------LNANS-KPT------MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ---~~~~~~~--------~~~~~-~~~------~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..-.... ..... ... ...+.+++.+||+.||++|||++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 0000000 00000 111 234789999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=289.70 Aligned_cols=234 Identities=23% Similarity=0.284 Sum_probs=166.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE------ 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 215 (388)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688889999999999999996 4699999999965432 22456889999999999999999999997653
Q ss_pred eeEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
..++||||+ +++|.+++... ..+|.|+| |+||+|+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 459999999 88999887542 33566777 4578899999999999999999999876432
Q ss_pred cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc--------
Q 035768 277 SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ-------- 347 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------- 347 (388)
.....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||... +..+....+........
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS----DHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 234568999999998766 68999999999999999999999998542 22222222222111100
Q ss_pred ----------ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ----------ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ----------~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......... ..........+.+++.+||+.||++|||+.|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 000000000 0000111236889999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=277.87 Aligned_cols=226 Identities=20% Similarity=0.303 Sum_probs=156.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc-Ch-HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ-GD-REFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||+||+|.. .+++.||||+++..... .. +.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45788889999999999999996 57899999999754322 22 23445556688899999999999999999999999
Q ss_pred eccCCCCHHHHHhc-------------------cCCCCCHHhhh------ccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 222 EYMVKGSLDDWLRN-------------------QAASLDWGKRC------KIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 222 e~~~~g~L~~~l~~-------------------~~~~l~~~~~~------~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
||++ |+|.+++.. ...++.|+|.. ||+|+||+++.++.+||+|||+++......
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 9996 588777643 22356677743 677999999999999999999998765432
Q ss_pred cceeeccccccCccCcccc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccC
Q 035768 277 SHVSTVVAGTIGYVPPEYG----GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
......||+.|+|||.+ ....++.++|||||||++|||+||+.||.... .....+. ....... ....
T Consensus 165 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~----~~~~~~~-~~~~ 235 (290)
T 3fme_A 165 --AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG--TPFQQLK----QVVEEPS-PQLP 235 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS--CHHHHHH----HHHHSCC-CCCC
T ss_pred --cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC--chHHHHH----HHhccCC-CCcc
Confidence 22334689999999985 56678999999999999999999999985321 1111111 1111111 0100
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ......+.+++.+||+.||++|||+.|
T Consensus 236 ~--------~~~~~~~~~li~~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 236 A--------DKFSAEFVDFTSQCLKKNSKERPTYPE 263 (290)
T ss_dssp T--------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred c--------ccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence 0 011236889999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=285.70 Aligned_cols=224 Identities=29% Similarity=0.452 Sum_probs=167.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCE--EEEEEcccCC-CcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKT--VAVKKLSQAT-GQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||.||+|+.. ++.. ||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46888899999999999999964 4554 4999987532 23446799999999999 999999999999999999999
Q ss_pred EeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 221 YEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
|||+++|+|.+++.... .+|.++| |.||+|+|||++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999999986532 1345555 45788999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhh
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
|||+++..... .......+++.|+|||.+....++.++|||||||++|||+| |+.||... ...++.+. .
T Consensus 185 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~----~~~~~~~~----~ 254 (327)
T 1fvr_A 185 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEK----L 254 (327)
T ss_dssp CTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHH----G
T ss_pred ccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC----cHHHHHHH----h
Confidence 99999754221 11223457889999999988889999999999999999998 99998532 22222221 1
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... . .......+.+++.+||+.||++|||+.|
T Consensus 255 ~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 255 PQGYRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp GGTCCCC-----C----CTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCCC-----C----CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111000 0 0111236889999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=290.31 Aligned_cols=228 Identities=12% Similarity=0.034 Sum_probs=154.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---cChHHHHHHH---HHHhcCCCCCcccee-------eEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---QGDREFAAEM---ETLGMVKHQNLVELL-------GYC 211 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~ 211 (388)
.+|...+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+ +.|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45788899999999999999964 789999999986543 2234577785 45555 799988754 444
Q ss_pred EeC-----------------CeeEEEEeccCCCCHHHHHhcc----------------------CCCCCHHh-----hhc
Q 035768 212 SVD-----------------EEKLLVYEYMVKGSLDDWLRNQ----------------------AASLDWGK-----RCK 247 (388)
Q Consensus 212 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~----------------------~~~l~~~~-----~~~ 247 (388)
... ...++||||++ |+|.+++... ..+|.|+| |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33799999998 9999988642 22455566 568
Q ss_pred cccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 248 IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 248 i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
|+|+|||++.++.+||+|||+++.... ......+|+.|+|||.+.. ..++.++|||||||++|||+||+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 899999999999999999999987643 1223457799999999877 6799999999999999999999999865
Q ss_pred CCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 326 EFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... ..........................+.+++.+||+.||++|||+.|
T Consensus 296 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 296 VTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp CCTTCTT---------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred cCccccc---------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 4221100 00000000000000000000112336889999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=286.31 Aligned_cols=177 Identities=25% Similarity=0.292 Sum_probs=138.5
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE------E 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 216 (388)
++|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999854 688999999975422 23456889999999999999999999997654 7
Q ss_pred eEEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 217 KLLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
.++||||++ |+|.+++. +...+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 181 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 181 (371)
T ss_dssp EEEEEECCS-EEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred eEEEEEcCC-CCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc--
Confidence 899999996 57877664 2334667777 45788999999999999999999998764321
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345689999999999888999999999999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=284.77 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVD-----EEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 217 (388)
.++|...+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888999999999999999864 6889999999754322 336789999999999999999999999765 368
Q ss_pred EEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 218 LLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||||+. |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||+++........
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 99999996 6998877542 33566777 4578899999999999999999999876432221
Q ss_pred e--eeccccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc---ccC
Q 035768 279 V--STVVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD---EVL 352 (388)
Q Consensus 279 ~--~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 352 (388)
. .....||+.|+|||.+. ...++.++|||||||++|||++|+.||... +..+....+.......... ...
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK----HYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS----SGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC----ChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 23457999999999754 456899999999999999999999998543 3333333332222111100 000
Q ss_pred Cc-------cc--cCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DP-------AV--LNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~-------~~--~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+. .. ..... ......+.+++.+||+.||++|||+.|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 310 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00 00 00000 011236889999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=289.23 Aligned_cols=173 Identities=24% Similarity=0.303 Sum_probs=130.0
Q ss_pred CCeeeccCCceEEEEEcC---CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccC
Q 035768 151 ENVIGGGGFGTVFKGTMP---DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLLVYEYMV 225 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 225 (388)
.++||+|+||+||+|++. +++.||||++.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 457999999999999965 57899999997542 34578899999999999999999999965 678899999995
Q ss_pred CCCHHHHHh------------------------ccCCCCCHHh-----hhccccCCeee----cCCCCEEEcccccceec
Q 035768 226 KGSLDDWLR------------------------NQAASLDWGK-----RCKIVASNILL----NDDFEAKISDFGLARLI 272 (388)
Q Consensus 226 ~g~L~~~l~------------------------~~~~~l~~~~-----~~~i~~~NiLl----~~~~~~kl~DfG~a~~~ 272 (388)
|+|.+++. +...+|.|+| |+||+|+|||+ +.++.+||+|||+++..
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 182 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence 57777664 2234566777 45788999999 77899999999999876
Q ss_pred cCCCc--ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 035768 273 SDCES--HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPE 326 (388)
Q Consensus 273 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~ 326 (388)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 43221 22234678999999998876 45899999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=284.26 Aligned_cols=227 Identities=24% Similarity=0.339 Sum_probs=168.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 216 (388)
++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 46888899999999999999964 588999999865321 12235889999999999999999999987654
Q ss_pred eEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCC---EEEcccccceecc
Q 035768 217 KLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFE---AKISDFGLARLIS 273 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~---~kl~DfG~a~~~~ 273 (388)
.++||||+++|+|.+++... ..+|.++| |.||+|+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 89999999999999887532 33566777 4578899999987654 9999999998765
Q ss_pred CCCcceeeccccccCccCcccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccc
Q 035768 274 DCESHVSTVVAGTIGYVPPEYG---GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (388)
... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||.... ....+...+......
T Consensus 169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~----- 238 (322)
T 2ycf_A 169 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---TQVSLKDQITSGKYN----- 238 (322)
T ss_dssp CCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT---CSSCHHHHHHHTCCC-----
T ss_pred ccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---hHHHHHHHHHhCccc-----
Confidence 422 22345689999999985 35678999999999999999999999986432 222333333221110
Q ss_pred cCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+...... ...+.+++.+||+.||++|||+.|
T Consensus 239 -~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~ 271 (322)
T 2ycf_A 239 -FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEE 271 (322)
T ss_dssp -CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred -cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHH
Confidence 111111111 236889999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=276.00 Aligned_cols=228 Identities=22% Similarity=0.283 Sum_probs=173.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC---------cChHHHHHHHHHHhcCC-CCCccceeeEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG---------QGDREFAAEMETLGMVK-HQNLVELLGYCSV 213 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 213 (388)
.++|...+.||+|+||.||+|... +++.||||.++.... ...+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 357888899999999999999975 688999999865431 11345789999999996 9999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceecc
Q 035768 214 DEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 214 ~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
.+..++||||+++|+|.+++.+. ..+|.++| |.||+|+||+++.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999998643 23456666 45778999999999999999999998765
Q ss_pred CCCcceeeccccccCccCccccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGG------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||... ........+......
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~-- 247 (298)
T 1phk_A 176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMIMSGNYQ-- 247 (298)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC--
T ss_pred CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc----cHHHHHHHHhcCCcc--
Confidence 432 223456899999999863 557899999999999999999999998532 222222222221110
Q ss_pred ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+. .......+.+++.+||+.||++|||+.|
T Consensus 248 ---~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (298)
T 1phk_A 248 ---FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEE 280 (298)
T ss_dssp ---CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ---cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 00010 0112236889999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=304.69 Aligned_cols=228 Identities=23% Similarity=0.370 Sum_probs=171.2
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEK 217 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 217 (388)
...++|...+.||+|+||.||+|.+.. +..||||+++.... ...+.|.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345678888999999999999998642 45799999875433 23467999999999999999999999985 5678
Q ss_pred EEEEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 218 LLVYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
++||||+++|+|.++++... .+|.|+| |+||+|+|||++.++.+||+|||+++......
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999999999986432 2455666 45788999999999999999999998875543
Q ss_pred cceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
........+|+.|+|||.+....++.++|||||||++|||++ |..||... ...++...+...... .
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~----~~~~~~~~i~~~~~~----~----- 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIENGERL----P----- 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHHTCCC----C-----
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCC----C-----
Confidence 333344557889999999988899999999999999999997 99997532 233333333221111 0
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... .....+.+++.+||+.||++|||+.|
T Consensus 613 ~~~----~~~~~l~~li~~~l~~dP~~RPs~~e 641 (656)
T 2j0j_A 613 MPP----NCPPTLYSLMTKCWAYDPSRRPRFTE 641 (656)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCc----cccHHHHHHHHHHcCCChhHCcCHHH
Confidence 001 11236889999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.10 Aligned_cols=233 Identities=23% Similarity=0.304 Sum_probs=164.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe------eEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE------KLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 219 (388)
.+|...+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45888899999999999999987777799999865332 22379999999999999999999965443 789
Q ss_pred EEeccCCCCHHHH------------------HhccCCCCCHHh-----hhccccCCeeec-CCCCEEEcccccceeccCC
Q 035768 220 VYEYMVKGSLDDW------------------LRNQAASLDWGK-----RCKIVASNILLN-DDFEAKISDFGLARLISDC 275 (388)
Q Consensus 220 v~e~~~~g~L~~~------------------l~~~~~~l~~~~-----~~~i~~~NiLl~-~~~~~kl~DfG~a~~~~~~ 275 (388)
||||++++.+... +.+...+|.|+| |+||+|+|||++ .++.+||+|||+++.....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9999976543322 223344677777 457889999999 7999999999999886443
Q ss_pred CcceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc-------
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ------- 347 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 347 (388)
.. .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||... +..+....+........
T Consensus 196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 196 EP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE----SGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHhh
Confidence 32 2345689999999987654 5899999999999999999999998543 22222222222111100
Q ss_pred ---ccccCCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ---ADEVLDPAVLNA-----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ---~~~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....-+..... ........+.+++.+||+.||++|||+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHH
Confidence 000000000000 00112236889999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=282.23 Aligned_cols=228 Identities=21% Similarity=0.264 Sum_probs=170.4
Q ss_pred hcCCCcC-CeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEE-NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 219 (388)
.+.|... +.||+|+||.||+|... +++.||+|+++... ......+.+|+.++.+++ ||||+++++++...+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3456555 78999999999999965 68999999987543 234567999999999994 6999999999999999999
Q ss_pred EEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecC---CCCEEEcccccceeccC
Q 035768 220 VYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLISD 274 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~~ 274 (388)
||||+++|+|.+++... ..+|.++| |.||+|+|||++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999887432 23456666 4578899999998 78999999999987654
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.. ......||+.|+|||.+....++.++|||||||++|||++|+.||... +.......+....... .+
T Consensus 187 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~------~~ 254 (327)
T 3lm5_A 187 AC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE----DNQETYLNISQVNVDY------SE 254 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCC------CT
T ss_pred cc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CchHHHHHHHhccccc------Cc
Confidence 32 223456999999999999999999999999999999999999998532 2222222222111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
... ......+.+++.+||+.||++|||++|
T Consensus 255 ~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 255 ETF----SSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp TTT----TTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhh----cccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 000 112235789999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=282.39 Aligned_cols=218 Identities=13% Similarity=0.128 Sum_probs=168.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEE------cCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC---CCCccceeeEEEeC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGT------MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK---HQNLVELLGYCSVD 214 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 214 (388)
..++|...+.||+|+||+||+|. ..+++.||||+++.. ...++..|++++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678888999999999999994 346889999999653 3567888888888887 99999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc--------------------CCCCCHHh-----hhccccCCeeecC-----------C
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ--------------------AASLDWGK-----RCKIVASNILLND-----------D 258 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~--------------------~~~l~~~~-----~~~i~~~NiLl~~-----------~ 258 (388)
+..++||||+++|+|.+++... ..+|.|+| |+||+|+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 9999999999999999998631 22455666 5688999999998 8
Q ss_pred CCEEEcccccceeccC-CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHH
Q 035768 259 FEAKISDFGLARLISD-CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVD 337 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 337 (388)
+.+||+|||+|+.+.. .........+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~---- 292 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG---GE---- 292 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET---TE----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC---Cc----
Confidence 9999999999987542 222334556799999999999999999999999999999999999999743211 00
Q ss_pred HHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
......+. .... ...+.+++..|++.+|.+||+.
T Consensus 293 --------~~~~~~~~----~~~~---~~~~~~~~~~~l~~~p~~r~~~ 326 (365)
T 3e7e_A 293 --------CKPEGLFR----RLPH---LDMWNEFFHVMLNIPDCHHLPS 326 (365)
T ss_dssp --------EEECSCCT----TCSS---HHHHHHHHHHHHCCCCTTCCCC
T ss_pred --------eeechhcc----ccCc---HHHHHHHHHHHcCCCCCCcchH
Confidence 00001110 1111 2245678889999999999653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=284.34 Aligned_cols=230 Identities=13% Similarity=0.184 Sum_probs=169.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC---------CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccc----------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD---------GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVE---------- 206 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 206 (388)
++|...+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999753 789999998653 46889999999999999988
Q ss_pred -----eeeEEEe-CCeeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCC
Q 035768 207 -----LLGYCSV-DEEKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 207 -----l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
+++++.. ++..++||||+ +|+|.+++... ..+|.|+| |+||+|+|||++.+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 6777776 67889999999 99999998753 22455666 45788999999999
Q ss_pred C--CEEEcccccceeccCCCcc------eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC
Q 035768 259 F--EAKISDFGLARLISDCESH------VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK 330 (388)
Q Consensus 259 ~--~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~ 330 (388)
+ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 273 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP-- 273 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc--
Confidence 8 9999999999876432211 11334799999999999988999999999999999999999999854221
Q ss_pred CcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 331 DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.......... .....++.... ......+.+++.+||+.||++|||++|
T Consensus 274 ~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 274 NTEDIMKQKQKFVDK--PGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp CHHHHHHHHHHHHHS--CCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred CHHHHHHHHHhccCC--hhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 222233222221111 11111110000 001136889999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=284.52 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=162.3
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCe-
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEE- 216 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 216 (388)
.......++|...+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344556788999999999999999999964 68999999986543 233467788888999999999999999976443
Q ss_pred ------eEEEEeccCCCCHHHHHh-------------------ccCCCCCHHh-------hhccccCCeeecC-CCCEEE
Q 035768 217 ------KLLVYEYMVKGSLDDWLR-------------------NQAASLDWGK-------RCKIVASNILLND-DFEAKI 263 (388)
Q Consensus 217 ------~~lv~e~~~~g~L~~~l~-------------------~~~~~l~~~~-------~~~i~~~NiLl~~-~~~~kl 263 (388)
.++||||+++ +|.+.+. +...++.++| |+||+|+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999976 4444332 2233456666 4688899999997 899999
Q ss_pred cccccceeccCCCcceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHh
Q 035768 264 SDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHM 342 (388)
Q Consensus 264 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 342 (388)
+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|||+||+.||... +.......+...
T Consensus 174 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~----~~~~~~~~~~~~ 247 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD----NSAGQLHEIVRV 247 (360)
T ss_dssp CCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHH
T ss_pred eeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC----ChHHHHHHHHHH
Confidence 99999987654332 2345689999999987654 5899999999999999999999998542 222222222221
Q ss_pred hcccc------------ccccCC------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 343 MKNEQ------------ADEVLD------PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 343 ~~~~~------------~~~~~~------~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... .....+ ..............+.+++.+||+.||.+|||+.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 11100 000000 00001111123457889999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.19 Aligned_cols=174 Identities=24% Similarity=0.298 Sum_probs=145.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcC------CCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMV------KHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~ 218 (388)
.+|...+.||+|+||+||+|... +++.||||+++... ...+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46888999999999999999864 58899999997532 2345677888888776 6789999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCC--EEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFE--AKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~--~kl~DfG~a~~~~~ 274 (388)
+||||+. |+|.+++... ..+|.|+| |+||+|+|||++.++. +||+|||+++....
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9999995 7999887643 23456666 4578899999999887 99999999987543
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 255 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 255 R----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp C----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 2 2235689999999999888999999999999999999999999854
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=283.70 Aligned_cols=223 Identities=21% Similarity=0.278 Sum_probs=152.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEE--------eC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCS--------VD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~~ 214 (388)
..+|...+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34688889999999999999996 468999999986655455667899999999996 999999999994 33
Q ss_pred CeeEEEEeccCCCCHHHHHhcc------------------CCCCCHHh-------hhccccCCeeecCCCCEEEcccccc
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ------------------AASLDWGK-------RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~------------------~~~l~~~~-------~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
...++||||+. |+|.+++... ..+|.|+| |.||+|+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 45789999995 8999887541 22455555 3467899999999999999999999
Q ss_pred eeccCCCcc-----------eeeccccccCccCcccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccH
Q 035768 270 RLISDCESH-----------VSTVVAGTIGYVPPEYG---GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335 (388)
Q Consensus 270 ~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~ 335 (388)
+........ ......||+.|+|||.+ ....++.++|||||||++|||+||+.||.... ...+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~ 261 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh----HHHh
Confidence 876542211 11134589999999987 56678999999999999999999999985321 1111
Q ss_pred HHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 336 VDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+....... .. .. ....+.+++.+||+.||++|||+.|
T Consensus 262 ---~~~~~~~~-~~--------~~----~~~~~~~li~~~l~~~p~~Rps~~e 298 (337)
T 3ll6_A 262 ---VNGKYSIP-PH--------DT----QYTVFHSLIRAMLQVNPEERLSIAE 298 (337)
T ss_dssp -------CCCC-TT--------CC----SSGGGHHHHHHHSCSSGGGSCCHHH
T ss_pred ---hcCcccCC-cc--------cc----cchHHHHHHHHHccCChhhCcCHHH
Confidence 11100000 00 00 0114778999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=284.13 Aligned_cols=237 Identities=19% Similarity=0.268 Sum_probs=175.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcC-----------------hHHHHHHHHHHhcCCCCCccce
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQG-----------------DREFAAEMETLGMVKHQNLVEL 207 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 207 (388)
.++|...+.||+|+||.||+|.. +++.||||.+....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999999 89999999986432111 1789999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHH------Hhc-----------------cCCCCCHHhh------hccccCCeeecCC
Q 035768 208 LGYCSVDEEKLLVYEYMVKGSLDDW------LRN-----------------QAASLDWGKR------CKIVASNILLNDD 258 (388)
Q Consensus 208 ~g~~~~~~~~~lv~e~~~~g~L~~~------l~~-----------------~~~~l~~~~~------~~i~~~NiLl~~~ 258 (388)
++++...+..++||||+++|+|.++ +.. ...++.++|. .||+|+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999887 432 2235567775 4677999999999
Q ss_pred CCEEEcccccceeccCCCcceeeccccccCccCccccCCC-CCCc-ccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG-KATE-RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++..... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||.... ...++.
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~ 262 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLVELF 262 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS---CSHHHH
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHH
Confidence 99999999999876543 33445689999999998877 6766 9999999999999999999986432 113333
Q ss_pred HHHHHhhccccc--cccCCccc---cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQA--DEVLDPAV---LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+......... .....+.. ...........+.+++.+||+.||.+|||+.|
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 319 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 332211100000 00000000 00000122346889999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=272.75 Aligned_cols=224 Identities=21% Similarity=0.321 Sum_probs=167.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC----CcChHHHHHHHHHHhcCCCCCccceeeEEE--eCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT----GQGDREFAAEMETLGMVKHQNLVELLGYCS--VDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 218 (388)
++|...+.||+|+||.||++... +++.||+|.++... ......+.+|++++++++||||+++++++. ..+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57899999999999999999964 68899999997532 233567999999999999999999999984 455789
Q ss_pred EEEeccCCCCHHHHHhc-----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 219 LVYEYMVKGSLDDWLRN-----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~-----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
+||||+++| |.+++.. ...+|.++| |.||+|+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999876 6666543 223456666 45788999999999999999999998764322
Q ss_pred -cceeeccccccCccCccccCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 277 -SHVSTVVAGTIGYVPPEYGGTGK--ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 277 -~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
........||+.|+|||...+.. ++.++||||||+++|||++|+.||... +...+.+.+.. ... .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~i~~----~~~-~--- 231 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGK----GSY-A--- 231 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHH----CCC-C---
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc----hHHHHHHHHhc----CCC-C---
Confidence 22233456899999999886543 478999999999999999999998532 22222222221 110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... ....+.+++.+||+.||++|||+.|
T Consensus 232 --~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ 260 (305)
T 2wtk_C 232 --IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQ 260 (305)
T ss_dssp --CCSS----SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred --CCCc----cCHHHHHHHHHHccCChhhCCCHHH
Confidence 0011 1226789999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.07 Aligned_cols=226 Identities=27% Similarity=0.404 Sum_probs=162.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC--CCC--EEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP--DGK--TVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|...+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46888899999999999999853 333 68999987542 233467899999999999999999999998654 88
Q ss_pred EEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++... ..++.++| |.||+|+||+++.++.+||+|||+++.......
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence 999999999999988643 22456666 457889999999999999999999988754332
Q ss_pred c--eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 278 H--VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 278 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
. ......+|..|+|||.+....++.++||||||+++|||++ |+.||... ....+...+. ....... .
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~---~~~~~~~--~- 246 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKID---KEGERLP--R- 246 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHH---TSCCCCC--C-
T ss_pred chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC----CHHHHHHHHH---ccCCCCC--C-
Confidence 2 1223457889999999888889999999999999999999 99998532 2223322221 1111000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.......+.+++.+||+.||++|||+.|
T Consensus 247 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 274 (291)
T 1u46_A 247 ------PEDCPQDIYNVMVQCWAHKPEDRPTFVA 274 (291)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ------CcCcCHHHHHHHHHHccCCcccCcCHHH
Confidence 0112236889999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=285.87 Aligned_cols=234 Identities=24% Similarity=0.305 Sum_probs=155.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC------Ce
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD------EE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 216 (388)
++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5788899999999999999985 5689999999975432 2345688999999999999999999999754 56
Q ss_pred eEEEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 217 KLLVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
.++|+||+ +++|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+++.....
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-- 185 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-- 185 (367)
T ss_dssp CEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred EEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--
Confidence 79999999 7888877643 234566777 4578899999999999999999999875432
Q ss_pred ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVLD 353 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 353 (388)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+....+........ ...+..
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred --CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 234568999999998776 67899999999999999999999998542 33333333322221110 000000
Q ss_pred cc-------c--cCCCCH-----HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PA-------V--LNANSK-----PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~-------~--~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. + ...... .....+.+++.+||+.||++|||+.|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 00 0 000000 11235789999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=278.83 Aligned_cols=238 Identities=23% Similarity=0.303 Sum_probs=171.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc--CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcC---CCCCccceeeEEE----
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM--PDGKTVAVKKLSQATG--QGDREFAAEMETLGMV---KHQNLVELLGYCS---- 212 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 212 (388)
..++|...+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346788999999999999999997 4678999999864322 2234577788777666 8999999999997
Q ss_pred -eCCeeEEEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccc
Q 035768 213 -VDEEKLLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLA 269 (388)
Q Consensus 213 -~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a 269 (388)
.....++||||++ |+|.+++.... .+|.++| |.||+|+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 4567899999997 79999886432 2455666 4578899999999999999999999
Q ss_pred eeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc
Q 035768 270 RLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD 349 (388)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (388)
+..... .......||+.|+|||.+....++.++|||||||++|||++|+.||... ...+....+..........
T Consensus 168 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 168 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS----SDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCGG
T ss_pred ccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHHHcCCCCcc
Confidence 876432 1223456899999999998889999999999999999999999998542 2233333333222111100
Q ss_pred ccC----Ccc---------ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 350 EVL----DPA---------VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 350 ~~~----~~~---------~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+. .+. ............+.+++.+||+.||++|||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 293 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 000 000 000001112236789999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.66 Aligned_cols=224 Identities=22% Similarity=0.320 Sum_probs=163.1
Q ss_pred CCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 148 FCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4446789999999998776668999999998643 245678999999876 89999999999999999999999995
Q ss_pred CCHHHHHhcc----------------------CCCCCHHh-----hhccccCCeeecCC-------------CCEEEccc
Q 035768 227 GSLDDWLRNQ----------------------AASLDWGK-----RCKIVASNILLNDD-------------FEAKISDF 266 (388)
Q Consensus 227 g~L~~~l~~~----------------------~~~l~~~~-----~~~i~~~NiLl~~~-------------~~~kl~Df 266 (388)
|+|.+++... ..+|.|+| |+||+|+|||++.+ +.+||+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 7999988642 12455666 45788999999754 58999999
Q ss_pred ccceeccCCCcc---eeeccccccCccCccccCC-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccH
Q 035768 267 GLARLISDCESH---VSTVVAGTIGYVPPEYGGT-------GKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENL 335 (388)
Q Consensus 267 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 335 (388)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||..... ..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~ 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-----RE 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-----HH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-----hH
Confidence 999987543321 1234579999999998765 678999999999999999999 9999854321 11
Q ss_pred HHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 336 VDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+...... +.............+.+++.+||+.||++|||+.|
T Consensus 248 ~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 248 SNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292 (434)
T ss_dssp HHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence 1111111100 00111123455667899999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=280.74 Aligned_cols=229 Identities=21% Similarity=0.342 Sum_probs=166.6
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeE
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--QGDREFAAEMETLGMVK--HQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~ 218 (388)
...++|...+.||+|+||.||++...+++.||||++..... ...+.+.+|++++++++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 34567888999999999999999988899999999865432 23467899999999997 599999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+||| +.+|+|.+++... ..+|.++| |.||+|+|||+++ +.+||+|||+++........
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 9999 5589999988643 23456666 4578899999975 89999999999876443221
Q ss_pred -eeeccccccCccCccccCC-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGT-----------GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE 346 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 346 (388)
......||+.|+|||.+.. ..++.++|||||||++|||++|+.||..... ....+.......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~ 256 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIIDPN 256 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHCTT
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHHHHhcc
Confidence 2234568999999998765 4788999999999999999999999854221 111122222111
Q ss_pred cccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 QADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... .... ...+.+++.+||+.||++|||+.|
T Consensus 257 ~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~e 289 (313)
T 3cek_A 257 HEIEF-----PDIP----EKDLQDVLKCCLKRDPKQRISIPE 289 (313)
T ss_dssp SCCCC-----CCCS----CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cccCC-----cccc----hHHHHHHHHHHccCCcccCcCHHH
Confidence 11000 0111 236789999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=278.03 Aligned_cols=238 Identities=21% Similarity=0.277 Sum_probs=164.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEE------------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCS------------ 212 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~------------ 212 (388)
++|...+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 46888899999999999999975 48999999997655455677999999999999999999999873
Q ss_pred --eCCeeEEEEeccCCCCHHHHHhcc--------------CCCCCHHh-----hhccccCCeeec-CCCCEEEcccccce
Q 035768 213 --VDEEKLLVYEYMVKGSLDDWLRNQ--------------AASLDWGK-----RCKIVASNILLN-DDFEAKISDFGLAR 270 (388)
Q Consensus 213 --~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~l~~~~-----~~~i~~~NiLl~-~~~~~kl~DfG~a~ 270 (388)
.....++||||++ |+|.+++.+. ..++.++| |.||+|+|||++ +++.+||+|||+++
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred ccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 3467899999997 7999887542 23566677 457889999997 56799999999998
Q ss_pred eccCCCc--ceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc
Q 035768 271 LISDCES--HVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347 (388)
Q Consensus 271 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (388)
....... .......+|..|+|||.+.. ..++.++|||||||++|||+||+.||... ...+....+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA----HELEQMQLILESIPVVH 245 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHSCCCC
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCc
Confidence 7643221 11233457899999997654 67899999999999999999999998543 22222222221111000
Q ss_pred ---cc---ccC----Ccccc-CCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 ---AD---EVL----DPAVL-NANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 ---~~---~~~----~~~~~-~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ..+ ..... .... ......+.+++.+||+.||++|||+.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 00 000 00000 0000 012246889999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=289.13 Aligned_cols=232 Identities=25% Similarity=0.311 Sum_probs=163.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD------EEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 218 (388)
.+|...+.||+|+||.||+|++. +++.||||++.... ..+.+|++++++++|||||++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35788899999999999999975 68999999986532 2234799999999999999999998542 2367
Q ss_pred EEEeccCCCCHHHHHh-------------------ccCCCCCHHh-----hhccccCCeeecCC-CCEEEcccccceecc
Q 035768 219 LVYEYMVKGSLDDWLR-------------------NQAASLDWGK-----RCKIVASNILLNDD-FEAKISDFGLARLIS 273 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~-------------------~~~~~l~~~~-----~~~i~~~NiLl~~~-~~~kl~DfG~a~~~~ 273 (388)
+||||+++ +|.+++. +...+|.|+| |+||+|+|||++.+ +.+||+|||+++.+.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999975 5555443 2334667777 56888999999965 678999999999765
Q ss_pred CCCcceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc------
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE------ 346 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~------ 346 (388)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||... +..+....+.......
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~----~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD----SGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCSCCHHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHH
Confidence 4322 2345689999999988654 7899999999999999999999998542 2222222221111110
Q ss_pred ----cccccCCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 ----QADEVLDPAVLNA-----NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ----~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+...+..... ........+.+|+.+||+.||++|||+.|
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e 333 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH
Confidence 0011111111000 00111246889999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=270.62 Aligned_cols=226 Identities=23% Similarity=0.294 Sum_probs=172.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46888999999999999999965 68999999986532 2345779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeecCC---CCEEEcccccceeccCCCcce
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLNDD---FEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~~~---~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+++++|.+++... ..++.++|. .||+|+||+++.+ +.+||+|||+++.......
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-- 179 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--
Confidence 99999998877532 235566664 4778999999754 4799999999987644322
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....||+.|+|||.+.+ .++.++||||||+++|||++|+.||... ...++...+....... +......
T Consensus 180 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~------~~~~~~~ 248 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK----NEYDILKRVETGKYAF------DLPQWRT 248 (287)
T ss_dssp CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCC------CSGGGTT
T ss_pred cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCC------Cchhhhh
Confidence 223458999999998765 5899999999999999999999998542 2233333222211100 0000111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...+.+++.+||+.||++|||+.|
T Consensus 249 ~----~~~~~~li~~~l~~dp~~Rps~~e 273 (287)
T 2wei_A 249 I----SDDAKDLIRKMLTFHPSLRITATQ 273 (287)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred c----CHHHHHHHHHHcccChhhCcCHHH
Confidence 1 236889999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=280.28 Aligned_cols=234 Identities=23% Similarity=0.274 Sum_probs=167.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCee-----
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEEK----- 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----- 217 (388)
++|...+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57888899999999999999864 6899999999754322 245788999999999999999999999877655
Q ss_pred -EEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 218 -LLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 218 -~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||||+. |+|.+++. +...+|.|+| |.||+|+|||++.++.+||+|||+++.....
T Consensus 122 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--- 197 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 197 (371)
T ss_dssp CEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred EEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC---
Confidence 99999996 78887653 3344677777 4578899999999999999999999865432
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc---cccCCc
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA---DEVLDP 354 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 354 (388)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+....+......... ....+.
T Consensus 198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 198 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred -cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 234568999999998876 68899999999999999999999998542 222222222221111000 000000
Q ss_pred ----------cccCCC----CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 ----------AVLNAN----SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ----------~~~~~~----~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... .......+.+++.+||+.||++|||+.|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 320 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH
Confidence 000000 0011346889999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=277.50 Aligned_cols=229 Identities=24% Similarity=0.381 Sum_probs=148.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEME-TLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||.||+|... +++.||||+++.... .....+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357888899999999999999974 689999999976432 23345666666 778889999999999999999999999
Q ss_pred eccCCCCHHHHHhc--------------------cCCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCC
Q 035768 222 EYMVKGSLDDWLRN--------------------QAASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDC 275 (388)
Q Consensus 222 e~~~~g~L~~~l~~--------------------~~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~ 275 (388)
||++ |+|.+++.. ...++.++|. .||+|+|||++.++.+||+|||+++.....
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 9997 477776642 1224556664 377899999999999999999999876443
Q ss_pred CcceeeccccccCccCcccc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 276 ESHVSTVVAGTIGYVPPEYG----GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
. ......||+.|+|||.+ ....++.++|||||||++|||++|+.||..... ..+.+..... ...
T Consensus 180 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~-~~~--- 247 (327)
T 3aln_A 180 I--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------VFDQLTQVVK-GDP--- 247 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCC-SCC---
T ss_pred c--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch------HHHHHHHHhc-CCC---
Confidence 2 22234689999999988 456789999999999999999999999853211 1111111110 110
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+...........+.+++.+||+.||++|||+.|
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 282 (327)
T 3aln_A 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282 (327)
T ss_dssp --CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 11111001112236889999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.32 Aligned_cols=229 Identities=19% Similarity=0.246 Sum_probs=171.5
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKH-QNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+|+++++.++| ++|..+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 5788999999999999999995 5689999998765432 2358899999999987 5566666667778889999999
Q ss_pred cCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeee---cCCCCEEEcccccceeccCCCcc-
Q 035768 224 MVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILL---NDDFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 224 ~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl---~~~~~~kl~DfG~a~~~~~~~~~- 278 (388)
+ +|+|.+++... ..+|.|+| |+||+|+|||+ +.++.+||+|||+++........
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 9 99999998642 23456666 45788999999 68899999999999987553321
Q ss_pred -----eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 279 -----VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 279 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........+...........
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~--- 239 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVATSIEA--- 239 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SHHHHHHHHHHHHHHSCHHH---
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-hHHHHHHHHhhccccccHHH---
Confidence 122467999999999999999999999999999999999999998653221 11222222211111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+.... ..++.+++..||+.+|++||++.
T Consensus 240 --l~~~~----p~~l~~li~~cl~~dP~~RPs~~ 267 (483)
T 3sv0_A 240 --LCRGY----PTEFASYFHYCRSLRFDDKPDYS 267 (483)
T ss_dssp --HHTTS----CHHHHHHHHHHHTCCTTCCCCHH
T ss_pred --HhcCC----cHHHHHHHHHHhcCChhhCcCHH
Confidence 00111 23688999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=278.53 Aligned_cols=239 Identities=23% Similarity=0.317 Sum_probs=170.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVD-----EEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 217 (388)
.++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888999999999999999965 688999999975432 2345688999999999999999999988764 678
Q ss_pred EEEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 218 LLVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||||+. |+|.+++.. ...+|.++| |+||+|+|||++.++.+||+|||+++........
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 99999996 689887754 233566777 4578899999999999999999999876432211
Q ss_pred ---------eeeccccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 279 ---------VSTVVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 279 ---------~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||... +..+....+.........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR----DYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCS
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCch
Confidence 112346899999999764 467899999999999999999999998542 222222222221111100
Q ss_pred cc----cCCcc-------c--cCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DE----VLDPA-------V--LNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~----~~~~~-------~--~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ...+. + ..... ......+.+++.+||+.||++|||+.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 00 00000 0 00000 012246789999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.68 Aligned_cols=228 Identities=18% Similarity=0.255 Sum_probs=166.5
Q ss_pred HHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 142 VAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 142 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
....++|...+.||+|+||.||+|...+ .||+|.++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3345678899999999999999999754 49999987543 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC--
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE-- 276 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~-- 276 (388)
||||+++++|.+++.... .++.++| |.||+|+||+++ ++.+||+|||+++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999999986532 2445566 457889999998 6799999999987653211
Q ss_pred --cceeeccccccCccCccccCC---------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc
Q 035768 277 --SHVSTVVAGTIGYVPPEYGGT---------GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN 345 (388)
Q Consensus 277 --~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 345 (388)
........||+.|+|||.+.. ..++.++|||||||++|||++|+.||... ....+...+...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~--- 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ----PAEAIIWQMGTG--- 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC----CHHHHHHHHHTT---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhccC---
Confidence 112223458999999998753 45789999999999999999999998532 222222222111
Q ss_pred ccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 EQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......... ....+.+++.+||+.||++|||+.|
T Consensus 259 -~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~ 292 (319)
T 2y4i_B 259 -MKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTK 292 (319)
T ss_dssp -CCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHH
T ss_pred -CCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHH
Confidence 111111100 1124789999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=274.77 Aligned_cols=233 Identities=19% Similarity=0.287 Sum_probs=172.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc--CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC------ccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM--PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN------LVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 217 (388)
++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++++.++|+| ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4688899999999999999985 368899999996532 33456889999998886654 99999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecC------------------
Q 035768 218 LLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLND------------------ 257 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~------------------ 257 (388)
++||||+ +++|.+++.... .+|.|+| |.||+|+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 899999886432 2455666 4578899999987
Q ss_pred -CCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHH
Q 035768 258 -DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 258 -~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 336 (388)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||... +..+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~ 243 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH----DSKEHL 243 (339)
T ss_dssp SCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS----CHHHHH
T ss_pred cCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----ChHHHH
Confidence 678999999999875432 23356899999999998889999999999999999999999998542 222222
Q ss_pred HHHHHhhccccc--------ccc---------------------CCcc-ccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 337 DWVLHMMKNEQA--------DEV---------------------LDPA-VLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 337 ~~~~~~~~~~~~--------~~~---------------------~~~~-~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
..+......... ... ..+. ............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 222221111000 000 0000 0011123445678999999999999999997
Q ss_pred CC
Q 035768 387 LH 388 (388)
Q Consensus 387 ~e 388 (388)
.|
T Consensus 324 ~e 325 (339)
T 1z57_A 324 RE 325 (339)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=270.46 Aligned_cols=226 Identities=25% Similarity=0.351 Sum_probs=162.0
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe-----------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV----------- 213 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------- 213 (388)
++|...+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4688889999999999999996 47899999999643 2334678999999999999999999999865
Q ss_pred --CCeeEEEEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccce
Q 035768 214 --DEEKLLVYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLAR 270 (388)
Q Consensus 214 --~~~~~lv~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~ 270 (388)
.+..++||||+++|+|.+++... ..++.++| |.||+|+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 35678999999999999998642 22455666 45788999999999999999999998
Q ss_pred eccCCC-------------cceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHH
Q 035768 271 LISDCE-------------SHVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 271 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 336 (388)
...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||... .+...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---~~~~~~~ 238 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---MERVNIL 238 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---hhHHHHH
Confidence 764321 1122345689999999988754 78999999999999999998 54211 1111222
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.. .. ....+. ........+.+++.+||+.||.+|||+.|
T Consensus 239 ~~~~~----~~--~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 239 KKLRS----VS--IEFPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp HHHHS----TT--CCCCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred Hhccc----cc--cccCcc----ccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 22111 10 001111 11222335789999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=278.86 Aligned_cols=175 Identities=26% Similarity=0.303 Sum_probs=144.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CC-----CccceeeEEEeCCee
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQ-----NLVELLGYCSVDEEK 217 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~ 217 (388)
.++|...+.||+|+||+||+|... +++.||||+++... ....++..|+++++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 467889999999999999999864 68899999997432 23456778888888875 55 499999999999999
Q ss_pred EEEEeccCCCCHHHHHhccC-----------------CCCCHHh-------hhccccCCeeec--CCCCEEEccccccee
Q 035768 218 LLVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-------RCKIVASNILLN--DDFEAKISDFGLARL 271 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-------~~~i~~~NiLl~--~~~~~kl~DfG~a~~ 271 (388)
++||||++ |+|.+++.... .+|.++| |+||+|+|||++ .++.+||+|||+++.
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999995 69999886432 2445555 458899999994 578899999999988
Q ss_pred ccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7432 2345689999999999998999999999999999999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=284.27 Aligned_cols=226 Identities=23% Similarity=0.383 Sum_probs=161.6
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEe
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 222 (388)
+..+|...+.||+|+||+||.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345688889999999999665555588999999996533 22366899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeec-----CCCCEEEcccccceeccCCC
Q 035768 223 YMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLN-----DDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 223 ~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~-----~~~~~kl~DfG~a~~~~~~~ 276 (388)
|+. |+|.+++.+.. .+|.|+| |+||+|+|||++ ....+||+|||+++......
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 995 69999886432 2456666 457889999994 33468899999998775432
Q ss_pred c--ceeeccccccCccCccccC---CCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccc
Q 035768 277 S--HVSTVVAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350 (388)
Q Consensus 277 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (388)
. .......||+.|+|||++. ...++.++|||||||++|||+| |..||.... ...... ...... ..
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-----~~~~~~---~~~~~~-~~ 248 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-----QRQANI---LLGACS-LD 248 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-----THHHHH---HTTCCC-CT
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-----HHHHHH---HhccCC-cc
Confidence 1 2233467999999999987 4567889999999999999999 889974321 111111 111111 11
Q ss_pred cCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...+ .......+.+++.+||+.||++|||+.|
T Consensus 249 ~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e 280 (432)
T 3p23_A 249 CLHP------EKHEDVIARELIEKMIAMDPQKRPSAKH 280 (432)
T ss_dssp TSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccCc------cccccHHHHHHHHHHHhCCHhhCCCHHH
Confidence 1111 1223345789999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=277.32 Aligned_cols=233 Identities=22% Similarity=0.257 Sum_probs=167.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc--ChHHHHHHHHHHhcCCCCCccceeeEEEeCCe------
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ--GDREFAAEMETLGMVKHQNLVELLGYCSVDEE------ 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 216 (388)
++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46888899999999999999964 6899999999754322 24568899999999999999999999987654
Q ss_pred eEEEEeccCCCCHHHHHh-------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 217 KLLVYEYMVKGSLDDWLR-------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~-------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
.++||||++ |+|.+++. +...+|.++| |.||+|+||+++.++.+||+|||+++.....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 179 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 179 (353)
T ss_dssp CEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred EEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC---
Confidence 499999996 68876543 3344677777 4578899999999999999999999865432
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc----------
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---------- 347 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------- 347 (388)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+....+........
T Consensus 180 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS----CHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred -ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 233568999999998776 67899999999999999999999998532 22222222222111000
Q ss_pred --------ccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 348 --------ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 348 --------~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.. ..........+.+++.+||+.||++|||+.|
T Consensus 255 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp HHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 000000000 0001122346889999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=275.86 Aligned_cols=227 Identities=21% Similarity=0.252 Sum_probs=142.6
Q ss_pred hcCCCcC-CeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeE
Q 035768 145 TNKFCEE-NVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKL 218 (388)
Q Consensus 145 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 218 (388)
.++|... ++||+|+||+||+|... +++.||||++... .....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3567774 46999999999999975 6899999998643 1222223344667799999999999976 44589
Q ss_pred EEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecC---CCCEEEcccccceecc
Q 035768 219 LVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLIS 273 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~ 273 (388)
+||||+++|+|.+++.... .+|.|+| |.||+|+|||++. ++.+||+|||+++...
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999999986532 2455666 4578899999976 4569999999998764
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
.. ......||+.|+|||.+....++.++|||||||++|||++|+.||..... ................ ....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~-~~~~ 254 (336)
T 3fhr_A 183 QN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG----QAISPGMKRRIRLGQY-GFPN 254 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CCCT
T ss_pred cc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc----hhhhhhHHHhhhcccc-ccCc
Confidence 32 22345689999999999888999999999999999999999999854322 1111111111110000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ ........+.+++.+||+.||++|||+.|
T Consensus 255 ~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 284 (336)
T 3fhr_A 255 P-----EWSEVSEDAKQLIRLLLKTDPTERLTITQ 284 (336)
T ss_dssp T-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred h-----hhccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 00112236889999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=278.52 Aligned_cols=237 Identities=21% Similarity=0.222 Sum_probs=172.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC--------CCCccceeeEEE----
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK--------HQNLVELLGYCS---- 212 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~---- 212 (388)
++|...+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+++++.++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 5788999999999999999985 46889999999743 233467889999999885 788999999987
Q ss_pred eCCeeEEEEeccCCCCHHHHHhc-----------------cCCCCCHHhh------hccccCCeeecCCC----------
Q 035768 213 VDEEKLLVYEYMVKGSLDDWLRN-----------------QAASLDWGKR------CKIVASNILLNDDF---------- 259 (388)
Q Consensus 213 ~~~~~~lv~e~~~~g~L~~~l~~-----------------~~~~l~~~~~------~~i~~~NiLl~~~~---------- 259 (388)
.....++||||+ +|+|.+++.. ...+|.|+|. +||+|+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456789999999 6676665532 2235667774 36789999999775
Q ss_pred ---------------------------------------CEEEcccccceeccCCCcceeeccccccCccCccccCCCCC
Q 035768 260 ---------------------------------------EAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKA 300 (388)
Q Consensus 260 ---------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 300 (388)
.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 8999999999876432 233468999999999988899
Q ss_pred CcccchHhHHHHHHHHHhCCCCCCCCCCCCC--cccHHHHHHHhhcccc---------ccccCCcc--------------
Q 035768 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKD--GENLVDWVLHMMKNEQ---------ADEVLDPA-------------- 355 (388)
Q Consensus 301 ~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~---------~~~~~~~~-------------- 355 (388)
+.++|||||||++|||+||+.||........ ..+....+........ ....+...
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999865332211 1111111111111100 00000000
Q ss_pred ---c--cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 ---V--LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 ---~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ ...........+.+++.+||+.||++|||++|
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 0 01124566678999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=292.83 Aligned_cols=235 Identities=24% Similarity=0.333 Sum_probs=170.8
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEe------CCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSV------DEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 217 (388)
++|...+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5789999999999999999996 468999999987543 2334568999999999999999999998765 6678
Q ss_pred EEEEeccCCCCHHHHHhccC------------------CCCCHHh-----hhccccCCeeecCCCC---EEEccccccee
Q 035768 218 LLVYEYMVKGSLDDWLRNQA------------------ASLDWGK-----RCKIVASNILLNDDFE---AKISDFGLARL 271 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~-----~~~i~~~NiLl~~~~~---~kl~DfG~a~~ 271 (388)
++||||+++|+|.+++.... .++.|+| |.||+|+||+++.++. +||+|||+++.
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999999987532 2455666 4578899999997665 99999999987
Q ss_pred ccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccc-----
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNE----- 346 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----- 346 (388)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....|........
T Consensus 174 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~------~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 174 LDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW------QPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp TTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC------HHHHSSTTCC------CC
T ss_pred ccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc------chhhhhhhhhcccchhhh
Confidence 65432 2234569999999999999999999999999999999999999985421 1111111000000
Q ss_pred ---ccccc--CCccc--cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 347 ---QADEV--LDPAV--LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 347 ---~~~~~--~~~~~--~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..... ..... ...........+.+++.+||+.||++|||+.|
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 00000 11123345567899999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=265.95 Aligned_cols=227 Identities=22% Similarity=0.312 Sum_probs=150.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc-Ch-HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ-GD-REFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
.++|...+.||+|+||.||+|... +++.||||++...... .. +.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999975 6899999999764332 22 23445556788899999999999999999999999
Q ss_pred eccCCCCHHHHHh----------------ccCCCCCHHhh------hccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 222 EYMVKGSLDDWLR----------------NQAASLDWGKR------CKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~----------------~~~~~l~~~~~------~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||+ ++.+..+.. +...++.++|. .||+|+||+++.++.+||+|||+++...... .
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 180 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--A 180 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--c
Confidence 999 555554443 22335667774 3677999999999999999999998764422 2
Q ss_pred eeccccccCccCccccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 280 STVVAGTIGYVPPEYGG-----TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.....||+.|+|||.+. ...++.++|||||||++|||++|+.||.... ...+....+. .... ......
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~---~~~~-~~~~~~ 253 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK---TDFEVLTKVL---QEEP-PLLPGH 253 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC---SHHHHHHHHH---HSCC-CCCCSS
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccHHHHHHHh---ccCC-CCCCcc
Confidence 23346899999999874 5678899999999999999999999985321 2222222221 1111 100000
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .....+.+++.+||+.||.+|||++|
T Consensus 254 ---~----~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (318)
T 2dyl_A 254 ---M----GFSGDFQSFVKDCLTKDHRKRPKYNK 280 (318)
T ss_dssp ---S----CCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred ---C----CCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0 11226889999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=275.42 Aligned_cols=218 Identities=24% Similarity=0.396 Sum_probs=168.7
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc------ChHHHHHHHHHHhcCC--CCCccceeeEEEeC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ------GDREFAAEMETLGMVK--HQNLVELLGYCSVD 214 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~ 214 (388)
..++|...+.||+|+||.||+|.. .+++.||||.++..... ....+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 356788999999999999999985 56889999998754321 2245778999999996 59999999999999
Q ss_pred CeeEEEEeccCC-CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeec-CCCCEEEcccccceec
Q 035768 215 EEKLLVYEYMVK-GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLN-DDFEAKISDFGLARLI 272 (388)
Q Consensus 215 ~~~~lv~e~~~~-g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~-~~~~~kl~DfG~a~~~ 272 (388)
+..++||||+.+ ++|.+++.+. ..+|.++| |.||+|+|||++ +++.+||+|||+++..
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999999976 8999987642 33566666 457889999999 7899999999999877
Q ss_pred cCCCcceeeccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 273 SDCESHVSTVVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
.... .....||+.|+|||.+....+ +.++|||||||++|||++|+.||... ... . . . . ..
T Consensus 201 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~---~-~---~-~--~~ 261 (320)
T 3a99_A 201 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEI---I-R---G-Q--VF 261 (320)
T ss_dssp CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH---H-H---C-C--CC
T ss_pred cccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhh---h-c---c-c--cc
Confidence 5422 233568999999998876665 78899999999999999999998421 111 1 0 0 0 00
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ... ...+.+++.+||+.||++|||++|
T Consensus 262 ~~----~~~----~~~~~~li~~~l~~dp~~Rps~~~ 290 (320)
T 3a99_A 262 FR----QRV----SSECQHLIRWCLALRPSDRPTFEE 290 (320)
T ss_dssp CS----SCC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cc----ccC----CHHHHHHHHHHccCChhhCcCHHH
Confidence 00 111 126789999999999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=272.38 Aligned_cols=217 Identities=26% Similarity=0.409 Sum_probs=161.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc------ChHHHHHHHHHHhcC----CCCCccceeeEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ------GDREFAAEMETLGMV----KHQNLVELLGYCSV 213 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g~~~~ 213 (388)
.++|...+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 46799999999999999999986 46889999999754321 223466799999888 89999999999999
Q ss_pred CCeeEEEEec-cCCCCHHHHHhcc---------------CCCCCHHhh-----hccccCCeeec-CCCCEEEccccccee
Q 035768 214 DEEKLLVYEY-MVKGSLDDWLRNQ---------------AASLDWGKR-----CKIVASNILLN-DDFEAKISDFGLARL 271 (388)
Q Consensus 214 ~~~~~lv~e~-~~~g~L~~~l~~~---------------~~~l~~~~~-----~~i~~~NiLl~-~~~~~kl~DfG~a~~ 271 (388)
.+..++|||| +.+++|.+++... ..+|.++|. .||+|+||+++ .++.+||+|||+++.
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 9999999999 7899999988642 235667774 57789999999 889999999999987
Q ss_pred ccCCCcceeeccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (388)
..... .....||..|+|||.+....+ +.++||||||+++|||++|+.||... ..+ .. ......
T Consensus 190 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~----~~--~~~~~~- 253 (312)
T 2iwi_A 190 LHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEI----LE--AELHFP- 253 (312)
T ss_dssp CCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH----HH--TCCCCC-
T ss_pred cccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHH----hh--hccCCc-
Confidence 75432 234568999999998876665 45899999999999999999998421 111 11 000000
Q ss_pred cCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 351 ~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ....+.+++.+||+.||++|||+.|
T Consensus 254 -------~~----~~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 254 -------AH----VSPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp -------TT----SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred -------cc----CCHHHHHHHHHHccCChhhCcCHHH
Confidence 11 1226789999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=270.90 Aligned_cols=233 Identities=18% Similarity=0.278 Sum_probs=170.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CC-CEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC------ccceeeEEEeCCee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DG-KTVAVKKLSQATGQGDREFAAEMETLGMVKHQN------LVELLGYCSVDEEK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 217 (388)
++|...+.||+|+||+||+|... ++ +.||+|+++... ...+.+.+|++++++++|+| ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888999999999999999864 34 689999996532 33456888999999987766 99999999999999
Q ss_pred EEEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeee-------------------c
Q 035768 218 LLVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILL-------------------N 256 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl-------------------~ 256 (388)
++||||+ +|+|.+++... ..+|.|+| |.||+|+|||+ +
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 9999999 67777766432 22455666 45788999999 6
Q ss_pred CCCCEEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHH
Q 035768 257 DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 257 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 336 (388)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||... +..+..
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~ 248 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH----ENREHL 248 (355)
T ss_dssp SCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHH
T ss_pred CCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHH
Confidence 6889999999999875432 23356899999999999889999999999999999999999998642 222222
Q ss_pred HHHHHhhccccc--------cc-cCC--------------------c-cccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 337 DWVLHMMKNEQA--------DE-VLD--------------------P-AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 337 ~~~~~~~~~~~~--------~~-~~~--------------------~-~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
..+......... .. ... + .............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 222222111000 00 000 0 00001122344578899999999999999997
Q ss_pred CC
Q 035768 387 LH 388 (388)
Q Consensus 387 ~e 388 (388)
.|
T Consensus 329 ~e 330 (355)
T 2eu9_A 329 AE 330 (355)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=276.81 Aligned_cols=237 Identities=19% Similarity=0.222 Sum_probs=170.3
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-----------CCCccceeeEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-----------HQNLVELLGYCSV 213 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 213 (388)
++|...+.||+|+||+||+|+. .+++.||||++.... .....+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688899999999999999996 568899999997432 23456889999998886 8999999999986
Q ss_pred CC----eeEEEEeccCCCCHHHHHhcc-----------------CCCCCHHhhh------ccccCCeeec------CCCC
Q 035768 214 DE----EKLLVYEYMVKGSLDDWLRNQ-----------------AASLDWGKRC------KIVASNILLN------DDFE 260 (388)
Q Consensus 214 ~~----~~~lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~~~------~i~~~NiLl~------~~~~ 260 (388)
.+ ..++||||+ +++|.+++... ..+|.|+|.. ||+|+|||++ ..+.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 54 789999999 99999988642 2346667754 6789999994 4458
Q ss_pred EEEcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCC--cccHHHH
Q 035768 261 AKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD--GENLVDW 338 (388)
Q Consensus 261 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~ 338 (388)
+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||........ .......
T Consensus 177 ~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 177 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 999999999876432 2234689999999999888999999999999999999999999864321110 1111111
Q ss_pred HHHhhcccc-------------------ccccCCcc---------ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 339 VLHMMKNEQ-------------------ADEVLDPA---------VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 339 ~~~~~~~~~-------------------~~~~~~~~---------~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+........ ...+.... ............+.+++.+||+.||++|||++|
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 111111000 00000000 011234566778999999999999999999754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=293.17 Aligned_cols=211 Identities=24% Similarity=0.339 Sum_probs=163.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcC--CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----e
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP--DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEE-----K 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 217 (388)
++|...+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999964 588999999875432 334568899999999999999999999987665 6
Q ss_pred EEEEeccCCCCHHHHHhc-------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 218 LLVYEYMVKGSLDDWLRN-------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~-------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|+||||+++++|.+++.+ ...+|.|+| |+||+|+|||++.+ .+||+|||+++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---- 234 (681)
T ss_dssp EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----
T ss_pred EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC----
Confidence 999999999999887643 234566777 45788999999986 8999999999876542
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
....||+.|+|||++... ++.++|||||||++|||++|..|+...+... ... ..+
T Consensus 235 -~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~~~-~~~----- 289 (681)
T 2pzi_A 235 -GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPE-DDP----- 289 (681)
T ss_dssp -SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------CCT-TCH-----
T ss_pred -CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------------ccc-ccc-----
Confidence 345699999999987654 4899999999999999999998864321100 000 000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.......+.+++.+||+.||++||+..
T Consensus 290 -~~~~~~~l~~li~~~l~~dP~~R~~~~ 316 (681)
T 2pzi_A 290 -VLKTYDSYGRLLRRAIDPDPRQRFTTA 316 (681)
T ss_dssp -HHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred -ccccCHHHHHHHhhhccCChhhCCCHH
Confidence 011224688999999999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=271.33 Aligned_cols=215 Identities=13% Similarity=0.109 Sum_probs=154.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC---cChHHHHHHHHHHhcCCC-CCcccee---------eE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG---QGDREFAAEMETLGMVKH-QNLVELL---------GY 210 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~---------g~ 210 (388)
+.+|...+.||+|+||+||+|++ .+|+.||||+++.... ...+.|.+|+.+++.++| +|..... ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34566778999999999999994 5799999999874322 235679999999999987 3222111 11
Q ss_pred ------------EEe-----CCeeEEEEeccCCCCHHHHHh----------------------ccCCCCCHHh-----hh
Q 035768 211 ------------CSV-----DEEKLLVYEYMVKGSLDDWLR----------------------NQAASLDWGK-----RC 246 (388)
Q Consensus 211 ------------~~~-----~~~~~lv~e~~~~g~L~~~l~----------------------~~~~~l~~~~-----~~ 246 (388)
+.. ....+++|+++ +|+|.+++. +...+|.|+| |+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111 12346777766 789988873 2344677777 56
Q ss_pred ccccCCeeecCCCCEEEcccccceeccCCCcceeeccccccCccCcccc----------CCCCCCcccchHhHHHHHHHH
Q 035768 247 KIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG----------GTGKATERGDVYSFGVILLEL 316 (388)
Q Consensus 247 ~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S~Gv~l~el 316 (388)
||+|+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 88999999999999999999999875432 344567 999999988 666789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 317 VTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 317 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
+||+.||...... ... ..++.. .... ...+.+++.+||+.||++|||+.
T Consensus 311 ltg~~Pf~~~~~~----~~~------------~~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 311 WCADLPNTDDAAL----GGS------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHSSCCCCTTGGG----SCS------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHCCCCCCCcchh----hhH------------HHHHhh--cccC----CHHHHHHHHHHccCChhhCcCHH
Confidence 9999998643211 100 011100 0011 13688999999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=252.91 Aligned_cols=203 Identities=15% Similarity=0.156 Sum_probs=151.8
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcC---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQG---DREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|...+.||+|+||.||+|+.. +++.||||.+....... .+.|.+|+.++++++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999975 48999999997654322 367899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 222 EYMVKGSLDDWLRNQ-------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
||+++++|.+++++. ..+|.|+| |+||+|+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------------
T ss_pred EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------------
Confidence 999999999988542 23566777 45788999999999999998543
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
|++| ++.++|||||||++|||+||+.||............ .. ........+.... ..
T Consensus 175 -----~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~-~~~~~~~~~~~~~---~~ 231 (286)
T 3uqc_A 175 -----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ER-DTAGQPIEPADID---RD 231 (286)
T ss_dssp -----CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CB-CTTSCBCCHHHHC---TT
T ss_pred -----ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HH-HhccCCCChhhcc---cC
Confidence 3333 688999999999999999999998653221100000 00 0000000110000 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++| |+.|
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~e 255 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SAST 255 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHH
Confidence 12358899999999999999 8753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=253.11 Aligned_cols=204 Identities=18% Similarity=0.247 Sum_probs=148.0
Q ss_pred cCCCcC-CeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHH-hcCCCCCccceeeEEEe----CCeeE
Q 035768 146 NKFCEE-NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETL-GMVKHQNLVELLGYCSV----DEEKL 218 (388)
Q Consensus 146 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 218 (388)
++|... +.||+|+||.||++.. .+++.||+|.++. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 7799999999999996 4689999999854 34677899888 66799999999999987 67789
Q ss_pred EEEeccCCCCHHHHHhccC-----------------CCCCHHh-----hhccccCCeeecC---CCCEEEcccccceecc
Q 035768 219 LVYEYMVKGSLDDWLRNQA-----------------ASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLIS 273 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~ 273 (388)
+||||+++|+|.+++.... .+|.|+| |.||+|+|||++. ++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999999986532 2455666 4578899999998 7899999999987543
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc-C
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV-L 352 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 352 (388)
...++.++|||||||++|||+||+.||..... ..... ........... .
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~----~~~~~---~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISP---GMKTRIRMGQYEF 221 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------C---CSCCSSCTTCCSS
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc----hhhhH---HHHHHHhhccccC
Confidence 13467899999999999999999999854321 00000 00000000000 0
Q ss_pred CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 ~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+.... .....+.+++.+||+.||++|||+.|
T Consensus 222 ~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~e 253 (299)
T 3m2w_A 222 PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITE 253 (299)
T ss_dssp CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred Cchhcc----cCCHHHHHHHHHHcccChhhCCCHHH
Confidence 000001 12236889999999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=256.50 Aligned_cols=171 Identities=21% Similarity=0.203 Sum_probs=136.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCC--------CcChHHHHHHHHHHhcCC---------CCCccce
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT--------GQGDREFAAEMETLGMVK---------HQNLVEL 207 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 207 (388)
.++|...+.||+|+||+||+|+. +++.||||+++... ....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34677889999999999999998 78999999997542 123367899999988886 7777766
Q ss_pred eeEEE-----------------e-------------CCeeEEEEeccCCCCHHHHH--------------hccCCCCCHH
Q 035768 208 LGYCS-----------------V-------------DEEKLLVYEYMVKGSLDDWL--------------RNQAASLDWG 243 (388)
Q Consensus 208 ~g~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l--------------~~~~~~l~~~ 243 (388)
.+++. + .+..++||||+++|++.+.+ .+...+|.|+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 66543 2 67899999999999655443 2334577888
Q ss_pred h-h-----hccccCCeeecCCC--------------------CEEEcccccceeccCCCcceeeccccccCccCccccCC
Q 035768 244 K-R-----CKIVASNILLNDDF--------------------EAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT 297 (388)
Q Consensus 244 ~-~-----~~i~~~NiLl~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 297 (388)
| . +||+|+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCC
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcC
Confidence 8 3 57889999999887 8999999999876532 2469999999999876
Q ss_pred CCCCcccchHhHHHH-HHHHHhCCCCC
Q 035768 298 GKATERGDVYSFGVI-LLELVTGKQPT 323 (388)
Q Consensus 298 ~~~~~~~Dv~S~Gv~-l~el~tg~~P~ 323 (388)
.. +.++||||+|++ .+++++|..||
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred CC-ccceehhhhhCCCCcccccccCCC
Confidence 66 899999998777 77888899996
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.4e-27 Score=233.05 Aligned_cols=167 Identities=16% Similarity=0.015 Sum_probs=112.3
Q ss_pred eeeccCCceEEEEE-cCCCCEEEEEEcccCCC----------cChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATG----------QGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 153 ~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
..+.|++|.+..++ .-.|+.+|||.+..... ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666777666554 23588899999865321 1235699999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhcc------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 221 YEYMVKGSLDDWLRNQ------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
|||++||+|.++|.+. ..+|.|+| |+||||+|||+++++.+||+|||+|+....... .....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~ 399 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNL 399 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHH
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCc
Confidence 9999999999988643 34677888 568899999999999999999999987754332 23456
Q ss_pred ccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCC
Q 035768 284 AGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQ 321 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~ 321 (388)
+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 400 vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 400 VQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHHC------------------CCCCTTHH
T ss_pred eechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 79999999999865 46778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-24 Score=213.33 Aligned_cols=172 Identities=16% Similarity=0.128 Sum_probs=132.2
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc--------ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ--------GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
...+.||+|+||+||+|.. .++.+++|+....... ..+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 5788999986542211 123488999999999999999777777788888999
Q ss_pred EeccCCCCHHHHHhc-------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce------eec
Q 035768 221 YEYMVKGSLDDWLRN-------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV------STV 282 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~-------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~------~~~ 282 (388)
|||+++|+|.+++.+ ...++.|+| |+||+|+|||++. .+||+|||+++......... ...
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~ 495 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKA 495 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhh
Confidence 999999999998754 344677777 5688999999999 99999999999875432211 235
Q ss_pred cccccCccCccccCC--CCCCcccchHhHHHHHHHHHhCCCCC
Q 035768 283 VAGTIGYVPPEYGGT--GKATERGDVYSFGVILLELVTGKQPT 323 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~el~tg~~P~ 323 (388)
..||+.|||||++.. ..|+..+|+||..+-.++-+.++.+|
T Consensus 496 ~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 496 VLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 679999999998876 56888899999999999999888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-20 Score=168.55 Aligned_cols=139 Identities=14% Similarity=0.019 Sum_probs=106.2
Q ss_pred HHHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc------------------ChHHHHHHHHHHhcCC
Q 035768 139 DQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ------------------GDREFAAEMETLGMVK 200 (388)
Q Consensus 139 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~ 200 (388)
..+......|...+.||+|+||.||+|...+|+.||||.++..... ....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444455566677999999999999999977999999999643211 2346889999999999
Q ss_pred CCCccceeeEEEeCCeeEEEEeccCCCCHHH--------HHhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccc
Q 035768 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDD--------WLRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFG 267 (388)
Q Consensus 201 H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~--------~l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG 267 (388)
| +++.+++.. +..++||||+++|+|.+ ++.+...++.++| |+||+|+|||++ ++.+||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 5 777776543 56699999999999876 2233445677777 457889999999 9999999999
Q ss_pred cceeccCCCcceeeccccccCccCccccC
Q 035768 268 LARLISDCESHVSTVVAGTIGYVPPEYGG 296 (388)
Q Consensus 268 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 296 (388)
+|+. +..|+|||++.
T Consensus 238 ~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TCEE--------------TTSTTHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHH
Confidence 9964 34578888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.6e-15 Score=133.92 Aligned_cols=120 Identities=22% Similarity=0.201 Sum_probs=89.1
Q ss_pred CCcCCeeeccCCceEEEEEc-CCCCE--EEEEEcccCCCcC------------------------hHHHHHHHHHHhcCC
Q 035768 148 FCEENVIGGGGFGTVFKGTM-PDGKT--VAVKKLSQATGQG------------------------DREFAAEMETLGMVK 200 (388)
Q Consensus 148 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 200 (388)
|...+.||+|+||.||+|.. .+|+. ||||.++...... ...+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678899999999999997 67888 9999875431110 125789999999998
Q ss_pred CCCc--cceeeEEEeCCeeEEEEeccCC-C----CHHHHHhc------------cCCCCCHHh------hhccccCCeee
Q 035768 201 HQNL--VELLGYCSVDEEKLLVYEYMVK-G----SLDDWLRN------------QAASLDWGK------RCKIVASNILL 255 (388)
Q Consensus 201 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----~L~~~l~~------------~~~~l~~~~------~~~i~~~NiLl 255 (388)
|+++ ..++++ +..++||||+.+ | +|.++... ...++.++| |.||+|+|||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl 204 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY 204 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 8865 333332 356899999942 4 67765432 234567777 56888999999
Q ss_pred cCCCCEEEcccccceecc
Q 035768 256 NDDFEAKISDFGLARLIS 273 (388)
Q Consensus 256 ~~~~~~kl~DfG~a~~~~ 273 (388)
+. .++|+|||+|....
T Consensus 205 ~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 205 ID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SS--SEEECCCTTCEETT
T ss_pred cC--cEEEEECcccccCC
Confidence 98 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-12 Score=123.20 Aligned_cols=132 Identities=11% Similarity=0.048 Sum_probs=86.6
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCC--------------cChHHH--------HHHHHHHh
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATG--------------QGDREF--------AAEMETLG 197 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~ 197 (388)
.+.....-|.....||+|+||.||+|..++|+.||||+++.... ...... .+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33443344888899999999999999998999999998753210 011112 24555666
Q ss_pred cCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHH---------hccCCCCCHHh-----hhccccCCeeecCCC----
Q 035768 198 MVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL---------RNQAASLDWGK-----RCKIVASNILLNDDF---- 259 (388)
Q Consensus 198 ~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l---------~~~~~~l~~~~-----~~~i~~~NiLl~~~~---- 259 (388)
++.+.++.-..-+.. ...+|||||+++++|.++. .+...++.++| |.|++|.|||+++++
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 664444322111111 2237999999988876542 23334555666 457889999998876
Q ss_pred ------CEEEcccccceecc
Q 035768 260 ------EAKISDFGLARLIS 273 (388)
Q Consensus 260 ------~~kl~DfG~a~~~~ 273 (388)
.+.|+||+-+....
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECCCTTCEETT
T ss_pred ccccccceEEEEeCCcccCC
Confidence 38999999886544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=2.2e-08 Score=89.52 Aligned_cols=86 Identities=10% Similarity=-0.009 Sum_probs=69.3
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+.|.....++.|+.+.||+.... ++.+++|............+.+|+++++.+. |..+.++++++...+..|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 45766777888899999999864 6889999986532223346889999999884 677889999999999999999999
Q ss_pred CCCCHHHH
Q 035768 225 VKGSLDDW 232 (388)
Q Consensus 225 ~~g~L~~~ 232 (388)
+|.+|.+.
T Consensus 93 ~G~~l~~~ 100 (263)
T 3tm0_A 93 DGVLCSEE 100 (263)
T ss_dssp SSEEHHHH
T ss_pred CCeehhhc
Confidence 99988763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.60 E-value=1.8e-08 Score=89.69 Aligned_cols=73 Identities=15% Similarity=0.084 Sum_probs=57.6
Q ss_pred eccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEeccCCCCHH
Q 035768 155 GGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN--LVELLGYCSVDEEKLLVYEYMVKGSLD 230 (388)
Q Consensus 155 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~ 230 (388)
+.|..+.||+....+|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 456669999998877888999997543 2245788999998886544 456888888778899999999998774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.92 E-value=9.6e-06 Score=75.76 Aligned_cols=79 Identities=13% Similarity=0.265 Sum_probs=56.7
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEcc--cCCC-cChHHHHHHHHHHhcCC--CCCccceeeEEEeC---CeeEEEE
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKLS--QATG-QGDREFAAEMETLGMVK--HQNLVELLGYCSVD---EEKLLVY 221 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~ 221 (388)
..+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|..+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678999999999998754 678888775 3221 22346888999999887 45678899988766 4589999
Q ss_pred eccCCCCH
Q 035768 222 EYMVKGSL 229 (388)
Q Consensus 222 e~~~~g~L 229 (388)
||++|..+
T Consensus 121 e~v~G~~l 128 (359)
T 3dxp_A 121 EFVSGRVL 128 (359)
T ss_dssp ECCCCBCC
T ss_pred EecCCeec
Confidence 99998766
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.68 E-value=1e-06 Score=86.03 Aligned_cols=31 Identities=13% Similarity=0.043 Sum_probs=25.7
Q ss_pred ChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 185 GDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 185 ~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
..++|..|++.+++++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 3567999999999999999999999997643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.61 E-value=5.4e-06 Score=75.60 Aligned_cols=75 Identities=12% Similarity=0.116 Sum_probs=50.6
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCC--ccceeeEEEeCC---eeEEEEecc
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQN--LVELLGYCSVDE---EKLLVYEYM 224 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~e~~ 224 (388)
.+.++.|....||+.. ..+++|..... .....+.+|+++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999863 46888886432 23456889999998873 333 334444433332 348999999
Q ss_pred CCCCHHH
Q 035768 225 VKGSLDD 231 (388)
Q Consensus 225 ~~g~L~~ 231 (388)
+|.+|.+
T Consensus 99 ~G~~l~~ 105 (304)
T 3sg8_A 99 KGVPLTP 105 (304)
T ss_dssp CCEECCH
T ss_pred CCeECCc
Confidence 9877653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=3.3e-05 Score=79.74 Aligned_cols=42 Identities=33% Similarity=0.519 Sum_probs=19.4
Q ss_pred CCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
+|++|++||||+|+|+|.|| ..+. .+|+.|++++|+++|.+|
T Consensus 654 ~l~~L~~L~Ls~N~l~g~ip-~~l~~L~~L~~LdLs~N~l~g~ip 697 (768)
T 3rgz_A 654 SMPYLFILNLGHNDISGSIP-DEVGDLRGLNILDLSSNKLDGRIP 697 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCC-GGGGGCTTCCEEECCSSCCEECCC
T ss_pred ccccCCEEeCcCCccCCCCC-hHHhCCCCCCEEECCCCcccCcCC
Confidence 44455555555555555555 2122 244445555554444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00046 Score=58.11 Aligned_cols=46 Identities=15% Similarity=0.121 Sum_probs=35.3
Q ss_pred CCCCCCCCeeeccCCcCccccCccc-ccCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSG-ICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~-~~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|||++|+|++..|... ...+|+.|++++|++.+..|.
T Consensus 74 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 120 (192)
T 1w8a_A 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120 (192)
T ss_dssp TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTT
T ss_pred cCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHH
Confidence 4678899999999999998877321 124899999999988876553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00025 Score=73.15 Aligned_cols=47 Identities=21% Similarity=0.274 Sum_probs=36.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKIMG 47 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~~~ 47 (388)
++++++|++||||+|+|+|.||.. +...+|+.|++++|+++|.+|..
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~ 675 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChH
Confidence 356788899999999999999833 22348888999999998888753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0023 Score=56.65 Aligned_cols=76 Identities=12% Similarity=0.095 Sum_probs=55.9
Q ss_pred eeeccCCc-eEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 153 VIGGGGFG-TVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 153 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
.+..|..| .||+.... ++..+.+|.-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34556555 69988754 4667888876432 2456888999988774 33366888999999999999999998776
Q ss_pred HH
Q 035768 230 DD 231 (388)
Q Consensus 230 ~~ 231 (388)
.+
T Consensus 108 ~~ 109 (272)
T 4gkh_A 108 FQ 109 (272)
T ss_dssp HH
T ss_pred cc
Confidence 54
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00098 Score=61.52 Aligned_cols=44 Identities=20% Similarity=0.136 Sum_probs=32.3
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~ 44 (388)
|++|++|++||||+|+|+|.+|.. ....+|..|+|++|++.+-.
T Consensus 52 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 96 (347)
T 2ifg_A 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLS 96 (347)
T ss_dssp SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCC
T ss_pred hccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeC
Confidence 467888888888888888877733 12238888888888877543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0011 Score=54.52 Aligned_cols=44 Identities=23% Similarity=0.153 Sum_probs=34.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
|++|++|++|||++|+|++-.| ..+ ..+|+.|++++|++.+-.+
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~l~~-~~f~~l~~L~~L~L~~N~l~~~~~ 95 (170)
T 3g39_A 50 FDRLTQLTRLDLDNNQLTVLPA-GVFDKLTQLTQLSLNDNQLKSIPR 95 (170)
T ss_dssp TTTCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hcCcccCCEEECCCCCcCccCh-hhccCCCCCCEEECCCCccCEeCH
Confidence 4678999999999999996555 322 3489999999998876444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00088 Score=61.03 Aligned_cols=45 Identities=27% Similarity=0.289 Sum_probs=25.8
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIMG 47 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~~ 47 (388)
+.+++|++|||++|+++|.+| ..+. .+|+.+++++|++.|.+|..
T Consensus 241 ~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 241 GLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCC-GGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cccCCCCEEECcCCcccCcCC-hHHhcCcCCCEEECcCCcccccCCCC
Confidence 345566666666666666666 2222 25666666666666555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0016 Score=54.71 Aligned_cols=44 Identities=27% Similarity=0.282 Sum_probs=35.6
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
+++++|++|||++|+|++.+| ..+. .+|+.|++++|++.+..+.
T Consensus 51 ~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~ 96 (192)
T 1w8a_A 51 GRLPHLVKLELKRNQLTGIEP-NAFEGASHIQELQLGENKIKEISNK 96 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSCCCCEECSS
T ss_pred ccCCCCCEEECCCCCCCCcCH-hHcCCcccCCEEECCCCcCCccCHH
Confidence 578899999999999999888 4333 3899999999998875543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0024 Score=52.47 Aligned_cols=41 Identities=20% Similarity=0.084 Sum_probs=30.8
Q ss_pred CCCCeeeccCCcCccccCccc-ccCCCCeeEecCCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSG-ICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~-~~~~l~~~~~s~N~~~~~~~ 45 (388)
++|++|||++|+|++..|... ...+|+.|++++|++.+-.+
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 71 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPA 71 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccCh
Confidence 578999999999998877331 12389999999998875433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0023 Score=52.81 Aligned_cols=43 Identities=21% Similarity=0.144 Sum_probs=33.7
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~ 44 (388)
+++|++|++|||++|+|++-.| ..+ ..+|+.|++++|++..-.
T Consensus 53 ~~~l~~L~~L~Ls~N~l~~i~~-~~~~~l~~L~~L~L~~N~l~~l~ 97 (174)
T 2r9u_A 53 FDHLVNLQQLYFNSNKLTAIPT-GVFDKLTQLTQLDLNDNHLKSIP 97 (174)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCC
T ss_pred hcCCcCCCEEECCCCCCCccCh-hHhCCcchhhEEECCCCccceeC
Confidence 4678999999999999997444 322 348999999999887543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0022 Score=58.88 Aligned_cols=45 Identities=22% Similarity=0.169 Sum_probs=27.4
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
+++++|++|||++|++.|.+|.. ....+|+.+++++|++.+.+|.
T Consensus 226 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~ 271 (328)
T 4fcg_A 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271 (328)
T ss_dssp GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCT
T ss_pred ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcch
Confidence 45666777777777777777632 1122666677777666665553
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0017 Score=55.89 Aligned_cols=45 Identities=20% Similarity=0.119 Sum_probs=36.4
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
+++|++|++|||++|++++..| ..+. .+|+.|++++|++.+..|.
T Consensus 101 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 101 FKGLESLKTLMLRSNRITCVGN-DSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp GTTCSSCCEEECTTSCCCCBCT-TSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred hcCCcCCCEEECCCCcCCeECH-hHcCCCccCCEEECCCCcCCEECHH
Confidence 3578999999999999999888 3333 3899999999998876553
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0017 Score=51.86 Aligned_cols=42 Identities=17% Similarity=0.149 Sum_probs=25.6
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~ 44 (388)
+.+++|++|+|++|++++. +.-....+|+.+++++|.+.+.+
T Consensus 39 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~ 80 (149)
T 2je0_A 39 DEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGL 80 (149)
T ss_dssp TTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCT
T ss_pred hhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchH
Confidence 4566777777777777665 31222336777777777666543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0032 Score=51.98 Aligned_cols=40 Identities=20% Similarity=0.065 Sum_probs=31.3
Q ss_pred CCCCeeeccCCcCccccCccc-ccCCCCeeEecCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSG-ICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~-~~~~l~~~~~s~N~~~~~~ 44 (388)
++|++|||++|+|++.+|... ...+|+.|++++|++.+-.
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~ 73 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIP 73 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccC
Confidence 578999999999998888331 2248999999999887643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0033 Score=54.05 Aligned_cols=45 Identities=20% Similarity=0.166 Sum_probs=36.4
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|||++|+|++..| ..+ ..+|+.|++++|.+.+..|.
T Consensus 77 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~ 123 (220)
T 2v70_A 77 FEGASGVNEILLTSNRLENVQH-KMFKGLESLKTLMLRSNRITCVGND 123 (220)
T ss_dssp TTTCTTCCEEECCSSCCCCCCG-GGGTTCSSCCEEECTTSCCCCBCTT
T ss_pred hCCCCCCCEEECCCCccCccCH-hHhcCCcCCCEEECCCCcCCeECHh
Confidence 4688999999999999998777 323 24899999999998876553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0029 Score=51.62 Aligned_cols=42 Identities=33% Similarity=0.413 Sum_probs=26.1
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc-cCCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI-CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~-~~~l~~~~~s~N~~~~ 42 (388)
++.+++|++|||++|++++.+|.... +.+|+.+++++|.+.+
T Consensus 67 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 109 (168)
T 2ell_A 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109 (168)
T ss_dssp CCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS
T ss_pred hccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc
Confidence 35566777777777777776662211 3467777777776554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0048 Score=51.84 Aligned_cols=39 Identities=21% Similarity=0.345 Sum_probs=19.2
Q ss_pred CCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLC 42 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~ 42 (388)
++++|++|||++|++++..| ..+. .+|+.|++++|.+.+
T Consensus 52 ~l~~L~~L~Ls~N~i~~i~~-~~f~~l~~L~~L~Ls~N~l~~ 92 (193)
T 2wfh_A 52 NYKHLTLIDLSNNRISTLSN-QSFSNMTQLLTLILSYNRLRC 92 (193)
T ss_dssp GCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCB
T ss_pred cccCCCEEECCCCcCCEeCH-hHccCCCCCCEEECCCCccCE
Confidence 44555555555555554443 2111 255555555555444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0021 Score=57.01 Aligned_cols=41 Identities=37% Similarity=0.553 Sum_probs=33.5
Q ss_pred CCCCCCeeeccCCcCcc--ccCcc-cccCCCCeeEecCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEG--EVPRS-GICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G--~iP~~-~~~~~l~~~~~s~N~~~~~ 43 (388)
++++|+.||||+|+|+| .||.. ..+.+|+.|+|++|.+.+.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 47899999999999999 77722 2345999999999998753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0039 Score=51.37 Aligned_cols=42 Identities=21% Similarity=0.180 Sum_probs=33.7
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~ 43 (388)
++++++|++|||++|+|++..| ..+ ..+|+.+++++|.+.+-
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~ 115 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPN-GVFDKLTQLKELALDTNQLKSV 115 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCSCC
T ss_pred ccCCCccCEEECCCCCccccCH-HHhhCCcccCEEECcCCcceEe
Confidence 4678999999999999997666 322 34899999999988743
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.003 Score=65.79 Aligned_cols=21 Identities=33% Similarity=0.237 Sum_probs=11.9
Q ss_pred CCCCCCCeeeccCCcCccccC
Q 035768 2 CSLPNLLYLNLADNRLEGEVP 22 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP 22 (388)
++|++|++||||+|+|++-.|
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~ 521 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSH 521 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCC
T ss_pred cchhhhheeECCCCCCCccCh
Confidence 455666666666666655433
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0037 Score=62.27 Aligned_cols=45 Identities=20% Similarity=0.169 Sum_probs=35.3
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
|++|++|++||||+|+|++-.| ..+. .+|+.|++++|++++..|.
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L~Ls~N~l~~~~~~ 560 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDT-FPYKCLNSLQVLDYSLNHIMTSKKQ 560 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCC-GGGTTCTTCCEEECTTSCCCBCCSS
T ss_pred HcCCCCCCEEECCCCcCCCCCh-hHHhCCCCCCEEECCCCcCCCCCHH
Confidence 4678899999999999998777 3232 4889999999988876654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0056 Score=54.34 Aligned_cols=45 Identities=22% Similarity=0.091 Sum_probs=34.1
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|||++|++++..|.. ....+|+.+++++|++.+..+
T Consensus 153 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred hccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 367889999999999999766622 123489999999998876544
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.01 Score=36.26 Aligned_cols=30 Identities=13% Similarity=0.311 Sum_probs=15.6
Q ss_pred eeeehHHHHHHHHHHHHHHHHHHHHhhccC
Q 035768 58 LALVGIVVGSVLVIAIIVSVLWWWIQRSNR 87 (388)
Q Consensus 58 ~~~i~~~~~~~~~~~~~~~~~~~~~~r~~~ 87 (388)
..+++.++++++++++++++++++.+|++.
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 344555565555555555555555554433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0048 Score=56.53 Aligned_cols=46 Identities=20% Similarity=0.184 Sum_probs=35.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKIMG 47 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~~~ 47 (388)
+++|++|++|+|++|++++ +|.. ....+|+.|++++|++.+.+|..
T Consensus 202 l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~ 248 (328)
T 4fcg_A 202 IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248 (328)
T ss_dssp GGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCC
T ss_pred hcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHH
Confidence 3578899999999999996 5523 22348999999999988877753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.016 Score=51.82 Aligned_cols=77 Identities=18% Similarity=0.250 Sum_probs=56.6
Q ss_pred CcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCC---CccceeeEEEeCCeeEEEEeccC
Q 035768 149 CEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ---NLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
...+.+|.|..+.||+.+..+|+.|.+|+-..........|..|+..|+.+.-. -+.+++++ +..++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeec
Confidence 345678999999999999999999999987654444455788999998887422 23444443 23478999998
Q ss_pred CCCH
Q 035768 226 KGSL 229 (388)
Q Consensus 226 ~g~L 229 (388)
.+..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=95.98 E-value=0.0047 Score=53.04 Aligned_cols=44 Identities=25% Similarity=0.168 Sum_probs=35.5
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
+..|++|++|||++|++++..| ..+. .+|+.|++++|.+.+-.+
T Consensus 100 f~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 100 FEGLFSLQLLLLNANKINCLRV-DAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred ccCCCCCCEEECCCCCCCEeCH-HHcCCCCCCCEEECCCCcCCEECH
Confidence 3578999999999999998887 3333 389999999998876544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0061 Score=53.35 Aligned_cols=44 Identities=25% Similarity=0.217 Sum_probs=33.9
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|||++|+|++..| ..+ ..+|+.|++++|++.+..+
T Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 127 FDRLTKLKELRLNTNQLQSIPA-GAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred hccCCcccEEECcCCcCCccCH-HHcCcCcCCCEEECCCCcCCccCH
Confidence 3578999999999999996665 323 3489999999998875443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.011 Score=53.49 Aligned_cols=75 Identities=15% Similarity=0.128 Sum_probs=54.2
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCC---CccceeeEEE-eCCeeEEEEeccCC
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ---NLVELLGYCS-VDEEKLLVYEYMVK 226 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~~ 226 (388)
.+.++.|....||+. +..+++|.-.. ......+.+|.++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888998899987 56788887432 12345788999999998753 2556666664 34567899999998
Q ss_pred CCHHH
Q 035768 227 GSLDD 231 (388)
Q Consensus 227 g~L~~ 231 (388)
..|.+
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 77654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0079 Score=51.60 Aligned_cols=45 Identities=29% Similarity=0.369 Sum_probs=35.3
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~~ 46 (388)
|++|++|++|||++|+|+ .||...+ ..+|+.|++++|.+.+..|.
T Consensus 76 ~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~ 122 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVD 122 (220)
T ss_dssp TTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred hhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHH
Confidence 468899999999999999 5553322 24899999999998876543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.006 Score=51.24 Aligned_cols=35 Identities=23% Similarity=0.420 Sum_probs=17.4
Q ss_pred CCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLC 42 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~ 42 (388)
+|++|+|++|+++ .|| ..+. .+|+.|++++|.+..
T Consensus 32 ~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~ 68 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRIST 68 (193)
T ss_dssp TCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCC
T ss_pred CCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCE
Confidence 4555555555555 455 2222 255555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0092 Score=49.07 Aligned_cols=44 Identities=23% Similarity=0.184 Sum_probs=34.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|||++|+|++..| ..+ ..+|+.+++++|.+.+..+
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~ 93 (177)
T 2o6r_A 48 FDKLTQLTKLSLSQNQIQSLPD-GVFDKLTKLTILYLHENKLQSLPN 93 (177)
T ss_dssp TTTCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hcCcccccEEECCCCcceEeCh-hHccCCCccCEEECCCCCccccCH
Confidence 4678999999999999996555 322 3489999999999886544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0055 Score=60.67 Aligned_cols=43 Identities=26% Similarity=0.218 Sum_probs=32.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~ 44 (388)
+++|++|++||||+|+|+| ||.-+...+|..|++++|++.+..
T Consensus 482 ~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~ 524 (567)
T 1dce_A 482 LAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSA 524 (567)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSS
T ss_pred hhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCC
Confidence 3567888899999998887 772233348888888888887664
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0059 Score=56.21 Aligned_cols=42 Identities=31% Similarity=0.308 Sum_probs=33.5
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc-CCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC-QNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~-~~l~~~~~s~N~~~~~ 43 (388)
|++|++|++|||++|+|++-.| ..+. ..|..|++.+|++.|.
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSW-KTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCS-TTTCSCCCCEEECCSSCCCCC
T ss_pred hcCCcCCCEEeCCCCccceeCH-HHcccCCceEEEeeCCCccCC
Confidence 4679999999999999996554 3222 2699999999999875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0051 Score=55.88 Aligned_cols=38 Identities=24% Similarity=0.257 Sum_probs=20.6
Q ss_pred CCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 7 LLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 7 L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
|++|||++|+++|.+| ..+. .+|+.+++++|.+.+..|
T Consensus 199 L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 238 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDAS-VLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CSEEECCSSEEEECCG-GGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccEEECcCCcccCcCC-HHHhcCCCCCEEECCCCceeeecC
Confidence 6666666666666555 2221 256666666665554443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.76 E-value=0.0094 Score=50.40 Aligned_cols=43 Identities=21% Similarity=0.101 Sum_probs=33.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~ 44 (388)
++++++|++|||++|++++..| ..+ ..+|+.+++++|.+.+-.
T Consensus 96 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~ 140 (208)
T 2o6s_A 96 FDKLTQLKELALNTNQLQSLPD-GVFDKLTQLKDLRLYQNQLKSVP 140 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCSCCC
T ss_pred hcCccCCCEEEcCCCcCcccCH-hHhccCCcCCEEECCCCccceeC
Confidence 4678999999999999997665 322 348999999999887543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0059 Score=61.35 Aligned_cols=46 Identities=11% Similarity=0.106 Sum_probs=38.9
Q ss_pred CCCCCCCCeeeccCCcCccc-----------------cCccccc----CCCCeeEecCCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGE-----------------VPRSGIC----QNLSIMSLTGNKDLCGKIMG 47 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~-----------------iP~~~~~----~~l~~~~~s~N~~~~~~~~~ 47 (388)
+++|++|++|||++|+|+|+ ||.. +. .+|+.|++++|.+.+.+|..
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~~~p~~ 268 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLTKLPTF 268 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCSSCCTT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCccChHH
Confidence 46789999999999999997 9944 43 49999999999999988753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.011 Score=51.12 Aligned_cols=40 Identities=25% Similarity=0.131 Sum_probs=24.4
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~ 41 (388)
++|++|++|||++|+|++..|.. ....+|+.|++++|++.
T Consensus 85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT 125 (229)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence 46677777777777777544411 11236677777777655
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.0071 Score=50.79 Aligned_cols=44 Identities=11% Similarity=0.153 Sum_probs=31.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~ 44 (388)
++.+++|++|+|++|++++..|.. ..+.+|+.+++++|.+....
T Consensus 84 l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~ 128 (197)
T 4ezg_A 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128 (197)
T ss_dssp GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGG
T ss_pred hhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHh
Confidence 356788888888888888876623 12238888888888876533
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.0099 Score=46.47 Aligned_cols=37 Identities=24% Similarity=0.255 Sum_probs=26.7
Q ss_pred CCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCG 43 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~ 43 (388)
+|++|||++|+|+ .||...+. .+|+.+++++|.+.|.
T Consensus 32 ~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 32 DTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp TCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred CCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeecc
Confidence 6888888888888 46633222 2788888888888774
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=95.58 E-value=0.012 Score=46.83 Aligned_cols=41 Identities=15% Similarity=0.098 Sum_probs=33.0
Q ss_pred CCCCCCeeeccCCcCc-cccCcc-cccCCCCeeEecCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLE-GEVPRS-GICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~-G~iP~~-~~~~~l~~~~~s~N~~~~~ 43 (388)
..++|+.|+|++|+++ |.+|.. ..+.+|+.+++++|.+...
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 57 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI 57 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc
Confidence 4578999999999999 999943 2234899999999987754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=95.57 E-value=0.0099 Score=48.86 Aligned_cols=39 Identities=23% Similarity=0.087 Sum_probs=18.3
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKD 40 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~ 40 (388)
+++++|++|||++|++++-.|.. ..+.+|+.+++++|.+
T Consensus 61 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i 100 (176)
T 1a9n_A 61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100 (176)
T ss_dssp CCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred ccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC
Confidence 44555555555555555332211 1123555555555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=95.55 E-value=0.0073 Score=59.77 Aligned_cols=43 Identities=21% Similarity=0.245 Sum_probs=35.3
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
+++|++|++||||+|+|+ .|| ..+. .+|+.|++++|.+.+ +|.
T Consensus 459 ~~~l~~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~Ls~N~l~~-lp~ 503 (567)
T 1dce_A 459 LEQLLLVTHLDLSHNRLR-ALP-PALAALRCLEVLQASDNALEN-VDG 503 (567)
T ss_dssp GGGGTTCCEEECCSSCCC-CCC-GGGGGCTTCCEEECCSSCCCC-CGG
T ss_pred ccccccCcEeecCccccc-ccc-hhhhcCCCCCEEECCCCCCCC-Ccc
Confidence 357889999999999999 999 4344 399999999999886 553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=95.52 E-value=0.012 Score=58.50 Aligned_cols=45 Identities=22% Similarity=0.323 Sum_probs=35.2
Q ss_pred CCCCCCCCeeeccCCcCccccCccc-ccCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSG-ICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~-~~~~l~~~~~s~N~~~~~~~ 45 (388)
++.|++|++||||+|+|++.+|... ...+|+.|++++|++.+-.+
T Consensus 490 ~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 535 (635)
T 4g8a_A 490 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 535 (635)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCC
T ss_pred hhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCCh
Confidence 4678899999999999999888331 12489999999998876544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.014 Score=50.23 Aligned_cols=44 Identities=27% Similarity=0.249 Sum_probs=33.1
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|+|++|+|+ .||...+ ..+|+.|++++|.+..-.+
T Consensus 60 ~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~ 105 (229)
T 3e6j_A 60 FDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPS 105 (229)
T ss_dssp TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccCh
Confidence 467899999999999996 5552322 3489999999998875433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.46 E-value=0.0082 Score=54.11 Aligned_cols=45 Identities=20% Similarity=0.169 Sum_probs=34.9
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|||++|++++..| ..+. .+|+.+++++|++.+..|.
T Consensus 195 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (306)
T 2z66_A 195 FNSLSSLQVLNMSHNNFFSLDT-FPYKCLNSLQVLDYSLNHIMTSKKQ 241 (306)
T ss_dssp TTTCTTCCEEECTTSCCSBCCS-GGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred hcCCCCCCEEECCCCccCccCh-hhccCcccCCEeECCCCCCcccCHH
Confidence 4678899999999999997655 3232 4899999999988876654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.0083 Score=50.35 Aligned_cols=43 Identities=16% Similarity=0.095 Sum_probs=31.2
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~ 45 (388)
..+++|++|+|++|.++. +|.-..+.+|+.+++++|.+.+..+
T Consensus 63 ~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~ 105 (197)
T 4ezg_A 63 EYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKI 105 (197)
T ss_dssp GGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGS
T ss_pred hcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccC
Confidence 468899999999996653 2312233589999999999876433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=95.34 E-value=0.016 Score=50.53 Aligned_cols=37 Identities=16% Similarity=0.054 Sum_probs=16.7
Q ss_pred CCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~ 42 (388)
+|+.|+|++|++++..|.. ....+|+.|++++|.+.+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 73 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT 73 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc
Confidence 3455555555555444411 111245555555554443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=95.26 E-value=0.015 Score=55.46 Aligned_cols=43 Identities=21% Similarity=0.163 Sum_probs=33.5
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~ 44 (388)
++++++|++|||++|++++.+| ..+. .+|+.+++++|++.+-.
T Consensus 343 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~ 387 (455)
T 3v47_A 343 FENLDKLEVLDLSYNHIRALGD-QSFLGLPNLKELALDTNQLKSVP 387 (455)
T ss_dssp GTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCSCCC
T ss_pred hcCcccCCEEECCCCcccccCh-hhccccccccEEECCCCccccCC
Confidence 3578899999999999998888 3333 48999999999887543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.02 Score=48.29 Aligned_cols=44 Identities=25% Similarity=0.238 Sum_probs=34.5
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|||++|++++..| ..+ ..+|+.+++++|.+.+-.+
T Consensus 72 ~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 117 (208)
T 2o6s_A 72 FNKLTSLTYLNLSTNQLQSLPN-GVFDKLTQLKELALNTNQLQSLPD 117 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cCCCCCcCEEECCCCcCCccCH-hHhcCccCCCEEEcCCCcCcccCH
Confidence 3678999999999999996555 322 3499999999998875443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0098 Score=61.89 Aligned_cols=46 Identities=11% Similarity=0.016 Sum_probs=38.1
Q ss_pred CCCCCCCCeeeccCCcCcc-----------------ccCccc---ccCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEG-----------------EVPRSG---ICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G-----------------~iP~~~---~~~~l~~~~~s~N~~~~~~~~ 46 (388)
|++|++|++|||++|+|+| .||... ...+|+.|++++|++.+.+|.
T Consensus 444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~ 509 (876)
T 4ecn_A 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509 (876)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCG
T ss_pred HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChH
Confidence 4678999999999999999 499442 234999999999999988874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.017 Score=56.84 Aligned_cols=45 Identities=22% Similarity=0.326 Sum_probs=35.0
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~ 45 (388)
++.+++|++|||++|++++.+|.. ..+.+|+.+++++|++.+..+
T Consensus 466 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 511 (570)
T 2z63_A 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511 (570)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred hhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCH
Confidence 467889999999999999888833 123489999999998876544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.0093 Score=55.02 Aligned_cols=42 Identities=26% Similarity=0.316 Sum_probs=32.5
Q ss_pred CCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~ 44 (388)
+++++|++|||++|+|+ .||...+ ..+|+.+++++|++.|..
T Consensus 274 ~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 274 NQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred hcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 36789999999999998 7883322 238899999999888764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=95.06 E-value=0.022 Score=50.41 Aligned_cols=45 Identities=31% Similarity=0.266 Sum_probs=34.9
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|||++|++++..|.. ....+|+.+++++|++.+..+
T Consensus 129 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 129 FDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 467899999999999999766622 223489999999998875544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=95.03 E-value=0.011 Score=57.87 Aligned_cols=44 Identities=23% Similarity=0.275 Sum_probs=36.1
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
+++++|++|||++|+|+ .||......+|+.+++++|++.+.+|.
T Consensus 448 ~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~ 491 (549)
T 2z81_A 448 LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDG 491 (549)
T ss_dssp CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTT
T ss_pred ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHH
Confidence 47899999999999999 898544455999999999998876553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.94 E-value=0.016 Score=52.51 Aligned_cols=43 Identities=16% Similarity=0.042 Sum_probs=32.0
Q ss_pred CCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++|++||||+|+++|.+|.... ..+|+.+++++|.+. .+|.
T Consensus 226 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp TTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCS
T ss_pred cCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhh
Confidence 578899999999999988763322 248888899988877 5554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.019 Score=51.96 Aligned_cols=43 Identities=21% Similarity=0.103 Sum_probs=30.1
Q ss_pred CCCCCCeeeccCCcCccccCcc-ccc---CCCCeeEecCCCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRS-GIC---QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~-~~~---~~l~~~~~s~N~~~~~~~~ 46 (388)
++++|++||||+|+|++.+|.. ..+ .+|+.|++++|++. .+|.
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~ 268 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPK 268 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCS
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhh
Confidence 4678888888888888887633 112 37888888888777 4443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=94.92 E-value=0.0087 Score=60.12 Aligned_cols=42 Identities=10% Similarity=0.097 Sum_probs=32.8
Q ss_pred CCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCC-CCC-CCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNK-DLC-GKI 45 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~-~~~-~~~ 45 (388)
+|++|++|+|++|+++|.+| ..+. .+|+.|++++|. +.| .+|
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~~l~~~~lp 292 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLP-TFLKALPEMQLINVACNRGISGEQLK 292 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCC-TTTTTCSSCCEEECTTCTTSCHHHHH
T ss_pred ccCCCCEEEecCCcCCccCh-HHHhcCCCCCEEECcCCCCCccccch
Confidence 78889999999999999998 4343 388889999887 665 444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=94.91 E-value=0.015 Score=47.25 Aligned_cols=41 Identities=17% Similarity=0.135 Sum_probs=33.0
Q ss_pred CCCCCCeeeccCCcCc-cccCcc-cccCCCCeeEecCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLE-GEVPRS-GICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~-G~iP~~-~~~~~l~~~~~s~N~~~~~ 43 (388)
..++|+.|+|++|+++ |.||.. ..+.+|+.|++++|.+...
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~ 64 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV 64 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh
Confidence 4578999999999998 999944 2234899999999987654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=94.91 E-value=0.022 Score=51.09 Aligned_cols=41 Identities=32% Similarity=0.430 Sum_probs=31.7
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~ 42 (388)
+..+++|+.|||++|+|+ .+|...+ ..+|+.+++++|.+..
T Consensus 144 ~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~ 186 (290)
T 1p9a_G 144 LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT 186 (290)
T ss_dssp TTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred cccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCCc
Confidence 357889999999999999 4552322 2489999999998873
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.034 Score=33.90 Aligned_cols=28 Identities=14% Similarity=0.379 Sum_probs=14.6
Q ss_pred eehHHHHHHHHHHHHHHHHHHHHhhccC
Q 035768 60 LVGIVVGSVLVIAIIVSVLWWWIQRSNR 87 (388)
Q Consensus 60 ~i~~~~~~~~~~~~~~~~~~~~~~r~~~ 87 (388)
+++.+++++++++++++.++++.||++.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 4445555555555555555555554443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=94.75 E-value=0.014 Score=52.03 Aligned_cols=43 Identities=23% Similarity=0.135 Sum_probs=34.8
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~ 44 (388)
++++++|++|||++|++++.+| ..+. .+|+.+++++|.+.+..
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~ 217 (285)
T 1ozn_A 173 FRGLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFANNLSALP 217 (285)
T ss_dssp TTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCSCCC
T ss_pred hcCccccCEEECCCCcccccCH-hHccCcccccEeeCCCCcCCcCC
Confidence 4578999999999999999888 4333 38999999999887643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.028 Score=50.78 Aligned_cols=44 Identities=20% Similarity=0.098 Sum_probs=34.4
Q ss_pred CCCCCCCeeeccCCcCcc--ccCccc--ccCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEG--EVPRSG--ICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G--~iP~~~--~~~~l~~~~~s~N~~~~~~~ 45 (388)
+++++|++|||++|++++ .+|... ...+|+.+++++|.+.+..|
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 689999999999999994 555221 12489999999999887653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.013 Score=53.01 Aligned_cols=45 Identities=16% Similarity=0.093 Sum_probs=33.3
Q ss_pred CCCCCCCeeeccCCcCc--cccCcc--cccCCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLE--GEVPRS--GICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~--G~iP~~--~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
+++++|++|+|++|+++ +.+|.. ....+|+.|++++|.+.+..|.
T Consensus 194 ~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~ 242 (310)
T 4glp_A 194 HKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNP 242 (310)
T ss_dssp TSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCS
T ss_pred hcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchh
Confidence 57899999999999997 333311 1225899999999998877553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.67 E-value=0.02 Score=59.49 Aligned_cols=38 Identities=32% Similarity=0.511 Sum_probs=30.4
Q ss_pred CCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~ 44 (388)
++|++||||+|+|+|.+| . ...+|..+++++|++.|..
T Consensus 526 ~~L~~L~Ls~N~l~~~~~-~-~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 526 ANLEILDISRNQLLAPNP-D-VFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp SCCCEEEEEEECCCCCCS-C-CCSSCCEEEEEEECCCCSS
T ss_pred ccccEEECCCCcCCCCCh-h-HhCCcCEEEecCCCccccc
Confidence 578889999999998888 3 3457888899999888844
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=94.66 E-value=0.011 Score=60.52 Aligned_cols=43 Identities=26% Similarity=0.287 Sum_probs=34.9
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
|++|++|++||||+|+|+ .|| ..+. .+|+.|++++|.+. .+|.
T Consensus 266 ~~~l~~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~L~~N~l~-~lp~ 310 (727)
T 4b8c_D 266 IKNLSNLRVLDLSHNRLT-SLP-AELGSCFQLKYFYFFDNMVT-TLPW 310 (727)
T ss_dssp GGGGTTCCEEECTTSCCS-SCC-SSGGGGTTCSEEECCSSCCC-CCCS
T ss_pred hhCCCCCCEEeCcCCcCC-ccC-hhhcCCCCCCEEECCCCCCC-ccCh
Confidence 457899999999999999 899 4343 49999999999875 5554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=94.64 E-value=0.019 Score=58.59 Aligned_cols=42 Identities=29% Similarity=0.313 Sum_probs=34.3
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
.+|++|++|||++|+|+ .|| ..+. .+|+.|+|++|.+. .+|.
T Consensus 244 ~~l~~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~Ls~N~l~-~lp~ 287 (727)
T 4b8c_D 244 FKYDFLTRLYLNGNSLT-ELP-AEIKNLSNLRVLDLSHNRLT-SLPA 287 (727)
T ss_dssp GGCCSCSCCBCTTSCCS-CCC-GGGGGGTTCCEEECTTSCCS-SCCS
T ss_pred cCCCCCCEEEeeCCcCc-ccC-hhhhCCCCCCEEeCcCCcCC-ccCh
Confidence 46889999999999999 899 4343 48999999999988 5554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=94.63 E-value=0.027 Score=50.05 Aligned_cols=45 Identities=22% Similarity=0.153 Sum_probs=35.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|||++|++++..| ..+ ..+|+.+++++|.+.+..|.
T Consensus 149 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~ 195 (285)
T 1ozn_A 149 FRDLGNLTHLFLHGNRISSVPE-RAFRGLHSLDRLLLHQNRVAHVHPH 195 (285)
T ss_dssp TTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTT
T ss_pred hccCCCccEEECCCCcccccCH-HHhcCccccCEEECCCCcccccCHh
Confidence 4678999999999999996555 323 34899999999988765443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.033 Score=49.15 Aligned_cols=42 Identities=21% Similarity=0.177 Sum_probs=32.1
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~ 43 (388)
++.+++|++|+|++|++++..| ..+ ..+|+.+++++|++..-
T Consensus 153 ~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 153 FDKLTSLKELRLYNNQLKRVPE-GAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCT-TTTTTCTTCCEEECCSSCCSCC
T ss_pred ccCCcccceeEecCCcCcEeCh-hHhccCCCcCEEECCCCcCCcC
Confidence 3578899999999999987555 323 24899999999987753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=94.62 E-value=0.033 Score=54.52 Aligned_cols=38 Identities=18% Similarity=0.117 Sum_probs=25.4
Q ss_pred CCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
++|++||||+|+|+|.++ ...+|+.+++++|++. .+|.
T Consensus 431 ~~L~~L~Ls~N~l~~~~~---~l~~L~~L~Ls~N~l~-~ip~ 468 (549)
T 2z81_A 431 QTLEVLDVSNNNLDSFSL---FLPRLQELYISRNKLK-TLPD 468 (549)
T ss_dssp TTCSEEECCSSCCSCCCC---CCTTCCEEECCSSCCS-SCCC
T ss_pred CCceEEECCCCChhhhcc---cCChhcEEECCCCccC-cCCC
Confidence 467777777777777542 3457777777777766 4443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=94.59 E-value=0.096 Score=47.44 Aligned_cols=76 Identities=18% Similarity=0.205 Sum_probs=60.6
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCC
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK---HQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
..+.|+.|....+|+... ++..+++|..... ....|..|.+.|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345789999999999986 4678888886532 2456889999888873 35688899988888889999999998
Q ss_pred CCH
Q 035768 227 GSL 229 (388)
Q Consensus 227 g~L 229 (388)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=94.59 E-value=0.038 Score=49.65 Aligned_cols=44 Identities=23% Similarity=0.397 Sum_probs=35.1
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
++.+++|++|||++|++++..| ..+. .+|+.+++++|.+.+..+
T Consensus 171 ~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 171 FTELRNLTFLDLSQCQLEQLSP-TAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp CTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCSBCCS
T ss_pred HhhCcCCCEEECCCCCcCCcCH-HHhcCCCCCCEEECCCCccCccCh
Confidence 4678999999999999998877 4333 489999999998876433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=94.54 E-value=0.013 Score=61.04 Aligned_cols=42 Identities=14% Similarity=0.138 Sum_probs=34.5
Q ss_pred CCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCC-CCC-CCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNK-DLC-GKI 45 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~-~~~-~~~ 45 (388)
+|++|++|+|++|+++|.+| ..+. .+|+.|++++|+ +.| .+|
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP-~~l~~L~~L~~L~Ls~N~~lsg~~iP 534 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLK 534 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCC-GGGGGCSSCCEEECTTCTTSCHHHHH
T ss_pred cCCCCCEEECcCCCCCccCh-HHHhCCCCCCEEECcCCCCcccccch
Confidence 78999999999999999999 4343 389999999998 766 444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.49 E-value=0.023 Score=54.10 Aligned_cols=43 Identities=16% Similarity=0.054 Sum_probs=32.9
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~ 44 (388)
+.++++|++|+|++|++++..| ..+. .+|+.|++++|++..-.
T Consensus 227 ~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~ 271 (440)
T 3zyj_A 227 FQGLMHLQKLWMIQSQIQVIER-NAFDNLQSLVEINLAHNNLTLLP 271 (440)
T ss_dssp TTTCTTCCEEECTTCCCCEECT-TSSTTCTTCCEEECTTSCCCCCC
T ss_pred hccCccCCEEECCCCceeEECh-hhhcCCCCCCEEECCCCCCCccC
Confidence 4678899999999999998777 3232 38889999999877543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.41 E-value=0.032 Score=54.94 Aligned_cols=46 Identities=20% Similarity=0.096 Sum_probs=30.7
Q ss_pred CCCCCCCCeeeccCCcCcc--ccCcc-cccCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEG--EVPRS-GICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G--~iP~~-~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|+|++|++++ .+|.. ....+|+.+++++|.+.+.+|.
T Consensus 373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 421 (562)
T 3a79_B 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421 (562)
T ss_dssp CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS
T ss_pred hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh
Confidence 3567788888888888886 44411 1223788888888887764553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=94.34 E-value=0.032 Score=49.30 Aligned_cols=42 Identities=17% Similarity=0.124 Sum_probs=31.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~ 42 (388)
++++++|++|+|++|++++..+.. ....+|+.+++++|.+..
T Consensus 96 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp TTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred hcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccce
Confidence 467889999999999998765522 223488999999998765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.024 Score=55.12 Aligned_cols=46 Identities=17% Similarity=0.148 Sum_probs=31.4
Q ss_pred CCCCCCCCeeeccCCcCcc--ccCcc-cccCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEG--EVPRS-GICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G--~iP~~-~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|+|++|++++ .+|.. ....+|+.+++++|.+.+.+|.
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~ 392 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc
Confidence 3567888888888888886 66622 1223788888888887764553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=94.25 E-value=0.031 Score=53.21 Aligned_cols=42 Identities=19% Similarity=0.171 Sum_probs=22.3
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCG 43 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~ 43 (388)
++|++|++|||++|.+++.||...+. .+|+.|++++|.+...
T Consensus 51 ~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~ 94 (455)
T 3v47_A 51 SRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL 94 (455)
T ss_dssp SSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEE
T ss_pred ccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCcc
Confidence 45556666666666665555422222 2566666666655443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=94.24 E-value=0.028 Score=53.69 Aligned_cols=43 Identities=14% Similarity=0.039 Sum_probs=33.6
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~ 44 (388)
++++++|++|+|++|++++..| ..+. .+|+.|++++|++.+-.
T Consensus 238 ~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~ 282 (452)
T 3zyi_A 238 FHGLSSLKKLWVMNSQVSLIER-NAFDGLASLVELNLAHNNLSSLP 282 (452)
T ss_dssp GTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSCCC
T ss_pred ccCccCCCEEEeCCCcCceECH-HHhcCCCCCCEEECCCCcCCccC
Confidence 4678899999999999998877 3233 48999999999887543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.21 E-value=0.036 Score=51.32 Aligned_cols=39 Identities=28% Similarity=0.265 Sum_probs=25.0
Q ss_pred CCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLC 42 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~ 42 (388)
++++|++|+|++|+|++..| ..+. .+|+.|++++|++..
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~-~~~~~l~~L~~L~Ls~N~l~~ 102 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISS-EAFVPVPNLRYLDLSSNHLHT 102 (361)
T ss_dssp CCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCE
T ss_pred cccccCEEECCCCcCCccCh-hhccCCCCCCEEECCCCcCCc
Confidence 56777777777777776555 2222 267777777776654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=94.19 E-value=0.064 Score=50.27 Aligned_cols=75 Identities=15% Similarity=0.054 Sum_probs=49.7
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-------cChHHHHHHHHHHhcCCC--CC-ccceeeEEEeCCeeEE
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-------QGDREFAAEMETLGMVKH--QN-LVELLGYCSVDEEKLL 219 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 219 (388)
.+.||.|.++.||++... +++.++||....... .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999864 468899998643211 123457789888887632 33 3455543 3556789
Q ss_pred EEeccCCC
Q 035768 220 VYEYMVKG 227 (388)
Q Consensus 220 v~e~~~~g 227 (388)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=94.09 E-value=0.049 Score=48.73 Aligned_cols=42 Identities=24% Similarity=0.297 Sum_probs=29.9
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~ 44 (388)
+.+++|++|||++|+|+ .+|.. ....+|+.|++++|++..-.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~ 116 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccC
Confidence 46788888888888887 67732 11237888888888876543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.053 Score=52.00 Aligned_cols=39 Identities=15% Similarity=0.110 Sum_probs=23.0
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
+.+++|++|||++|+|+| || -..+.+|+.+++++|++.+
T Consensus 209 ~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 209 NQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp TTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSC
T ss_pred ccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCC
Confidence 455666666666666666 55 3333466666666666554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.046 Score=54.01 Aligned_cols=35 Identities=29% Similarity=0.463 Sum_probs=16.6
Q ss_pred CCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
++|++|||++|+|++ || . +..+|+.|++++|++.+
T Consensus 100 ~~L~~L~Ls~N~l~~-ip-~-l~~~L~~L~Ls~N~l~~ 134 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LP-E-LPASLKHLDVDNNQLTM 134 (571)
T ss_dssp TTCCEEECCSSCCSC-CC-C-CCTTCCEEECCSSCCSC
T ss_pred CCCCEEEccCCCCCC-cc-h-hhcCCCEEECCCCcCCC
Confidence 445555555555554 44 2 33345555555554443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.049 Score=53.45 Aligned_cols=45 Identities=20% Similarity=0.202 Sum_probs=35.3
Q ss_pred CCCCCCCCeeeccCCcCc-cccCcccc--cCCCCeeEecCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLE-GEVPRSGI--CQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~-G~iP~~~~--~~~l~~~~~s~N~~~~~~~~ 46 (388)
++++++|++|+|++|+++ |.+| ..+ +.+|+.+++++|.+.+..|.
T Consensus 441 ~~~l~~L~~L~l~~n~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~ 488 (570)
T 2z63_A 441 FNGLSSLEVLKMAGNSFQENFLP-DIFTELRNLTFLDLSQCQLEQLSPT 488 (570)
T ss_dssp TTTCTTCCEEECTTCEEGGGEEC-SCCTTCTTCCEEECTTSCCCEECTT
T ss_pred hhcCCcCcEEECcCCcCccccch-hhhhcccCCCEEECCCCccccCChh
Confidence 457899999999999998 6888 433 34899999999988766553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.91 E-value=0.048 Score=50.46 Aligned_cols=42 Identities=29% Similarity=0.338 Sum_probs=26.7
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~ 43 (388)
|++|++|++|||++|+|++..| ..+ ..+|+.|++++|.+...
T Consensus 84 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~ 127 (361)
T 2xot_A 84 FVPVPNLRYLDLSSNHLHTLDE-FLFSDLQALEVLLLYNNHIVVV 127 (361)
T ss_dssp TTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEE
T ss_pred ccCCCCCCEEECCCCcCCcCCH-HHhCCCcCCCEEECCCCcccEE
Confidence 3567777777777777775544 222 23677777777766543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=93.90 E-value=0.038 Score=54.83 Aligned_cols=44 Identities=18% Similarity=0.192 Sum_probs=29.6
Q ss_pred CCCCCCCCeeeccCCcCccc-cCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGE-VPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~-iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|+|++|+++|. +| ..+ ..+|+.+++++|.+.+..|
T Consensus 444 ~~~l~~L~~L~l~~n~l~~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~ 490 (606)
T 3vq2_A 444 FLGLTSLNTLKMAGNSFKDNTLS-NVFANTTNLTFLDLSKCQLEQISW 490 (606)
T ss_dssp TTTCTTCCEEECTTCEEGGGEEC-SCCTTCTTCCEEECTTSCCCEECT
T ss_pred hcCCCCCCEEECCCCcCCCcchH-HhhccCCCCCEEECCCCcCCccCh
Confidence 35677788888888888874 55 322 2377788888887765544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=93.86 E-value=0.046 Score=54.23 Aligned_cols=44 Identities=18% Similarity=0.089 Sum_probs=28.6
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~~ 45 (388)
+.+++|++|||++|++++.+|.. ....+|+.+++++|++.+..|
T Consensus 473 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 517 (606)
T 3t6q_A 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517 (606)
T ss_dssp GGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGG
T ss_pred ccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCCh
Confidence 45677777777777777776632 112377777777777766544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=93.83 E-value=0.051 Score=49.37 Aligned_cols=39 Identities=26% Similarity=0.279 Sum_probs=21.3
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~ 41 (388)
+++++|++|||++|++++..| ..+. .+|+.+++++|.+.
T Consensus 73 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~ 113 (330)
T 1xku_A 73 KNLKNLHTLILINNKISKISP-GAFAPLVKLERLYLSKNQLK 113 (330)
T ss_dssp TTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSSCCS
T ss_pred ccCCCCCEEECCCCcCCeeCH-HHhcCCCCCCEEECCCCcCC
Confidence 455666666666666665555 2222 25666666666544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=93.80 E-value=0.059 Score=49.05 Aligned_cols=40 Identities=18% Similarity=0.249 Sum_probs=32.0
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDL 41 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~ 41 (388)
++++++|++|||++|++++..| ..+. .+|+.+++++|.+.
T Consensus 74 ~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 115 (332)
T 2ft3_A 74 FKGLQHLYALVLVNNKISKIHE-KAFSPLRKLQKLYISKNHLV 115 (332)
T ss_dssp TTTCTTCCEEECCSSCCCEECG-GGSTTCTTCCEEECCSSCCC
T ss_pred hhCCCCCcEEECCCCccCccCH-hHhhCcCCCCEEECCCCcCC
Confidence 4678899999999999998777 3333 38999999999876
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.023 Score=55.04 Aligned_cols=41 Identities=20% Similarity=0.154 Sum_probs=26.0
Q ss_pred CCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
+++|++|||++|++++..| ..+. .+|+.|++++|.+.+..|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~ 75 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISA-ADLAPFTKLELLNLSSNVLYETLD 75 (487)
T ss_dssp GGGCCEEECCSSCCCCCCG-GGGTTCTTCCEEECTTSCCEEEEE
T ss_pred CCCccEEEeeCCcCCCCCH-HHHhCCCCCCEEEeeCCCCCCCcc
Confidence 3467777777777777655 3222 377777777777665443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.054 Score=52.63 Aligned_cols=45 Identities=11% Similarity=0.136 Sum_probs=34.2
Q ss_pred CCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~~ 46 (388)
+++++|++||||+|++++.+|.... ..+|+.+++++|.+.+..|.
T Consensus 371 ~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 417 (520)
T 2z7x_B 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417 (520)
T ss_dssp TTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGG
T ss_pred hhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhh
Confidence 5788999999999999988884322 23888889999888765553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=93.64 E-value=0.067 Score=47.21 Aligned_cols=43 Identities=26% Similarity=0.276 Sum_probs=32.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~ 44 (388)
++++++|++|||++|++++..| ..+ ..+|+.+++++|.+.+..
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~ 92 (276)
T 2z62_A 48 FFSFPELQVLDLSRCEIQTIED-GAYQSLSHLSTLILTGNPIQSLA 92 (276)
T ss_dssp TTTCTTCSEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCCEEC
T ss_pred hccccCCcEEECCCCcCCccCH-HHccCCcCCCEEECCCCccCccC
Confidence 4678899999999999987655 323 238999999999876544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=93.62 E-value=0.063 Score=48.84 Aligned_cols=40 Identities=23% Similarity=0.182 Sum_probs=29.8
Q ss_pred CCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
++|++|||++|++++..| ..+. .+|+.+++++|.+.+..|
T Consensus 54 ~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~ 95 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRK-DDFKGLQHLYALVLVNNKISKIHE 95 (332)
T ss_dssp TTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECG
T ss_pred CCCeEEECCCCcCCccCH-hHhhCCCCCcEEECCCCccCccCH
Confidence 578899999999987666 3233 388999999998775444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.053 Score=47.75 Aligned_cols=40 Identities=28% Similarity=0.381 Sum_probs=18.9
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
+++++|++|||++|++++. |.-....+|+.+++++|.+.+
T Consensus 125 ~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 125 IHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp TTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCB
T ss_pred cCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcc
Confidence 3455555555555555542 211222355555555555443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=93.56 E-value=0.057 Score=49.06 Aligned_cols=41 Identities=24% Similarity=0.292 Sum_probs=34.6
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
+++|++|++|||++|+++ .+| .....+|+.+++++|.+.+.
T Consensus 96 ~~~l~~L~~L~Ls~n~l~-~l~-~~~~~~L~~L~l~~n~l~~~ 136 (330)
T 1xku_A 96 FAPLVKLERLYLSKNQLK-ELP-EKMPKTLQELRVHENEITKV 136 (330)
T ss_dssp TTTCTTCCEEECCSSCCS-BCC-SSCCTTCCEEECCSSCCCBB
T ss_pred hcCCCCCCEEECCCCcCC-ccC-hhhcccccEEECCCCccccc
Confidence 467899999999999998 788 44567999999999987643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.55 E-value=0.06 Score=49.45 Aligned_cols=36 Identities=31% Similarity=0.372 Sum_probs=20.9
Q ss_pred CCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~ 42 (388)
+|++|||++|++++..| ..+ +.+|+.+++++|.+.+
T Consensus 53 ~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~ 90 (353)
T 2z80_A 53 AVKSLDLSNNRITYISN-SDLQRCVNLQALVLTSNGINT 90 (353)
T ss_dssp TCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCCE
T ss_pred cCcEEECCCCcCcccCH-HHhccCCCCCEEECCCCccCc
Confidence 56677777777665333 222 2366667777666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=93.49 E-value=0.065 Score=51.16 Aligned_cols=41 Identities=20% Similarity=0.138 Sum_probs=24.6
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~ 42 (388)
|++|++|++|||++|++++..| ..+. .+|+.|++++|.+..
T Consensus 95 ~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~ 137 (452)
T 3zyi_A 95 FRHLHHLEVLQLGRNSIRQIEV-GAFNGLASLNTLELFDNWLTV 137 (452)
T ss_dssp TTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCSB
T ss_pred cCCCCCCCEEECCCCccCCcCh-hhccCcccCCEEECCCCcCCc
Confidence 3456667777777777766555 2222 266677777766553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=93.42 E-value=0.03 Score=49.57 Aligned_cols=43 Identities=33% Similarity=0.262 Sum_probs=31.8
Q ss_pred CCCCCCeeeccCCcCccccCcccccC-CCCeeEecCCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQ-NLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~-~l~~~~~s~N~~~~~~~ 45 (388)
.|++|++||||+|+|++.-.-..+.. +|..|++++|++.+..|
T Consensus 194 ~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 194 KAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccC
Confidence 58999999999999998511112222 89999999998765443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.39 E-value=0.061 Score=53.43 Aligned_cols=44 Identities=20% Similarity=0.126 Sum_probs=31.9
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
|++|++|++|||++|+|++-.| ..+ ..+|..|++++|.+.+..|
T Consensus 119 ~~~l~~L~~L~L~~n~l~~l~~-~~~~~l~~L~~L~Ls~N~l~~~~~ 164 (597)
T 3oja_B 119 FQNVPLLTVLVLERNDLSSLPR-GIFHNTPKLTTLSMSNNNLERIED 164 (597)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCBCCT
T ss_pred HcCCCCCCEEEeeCCCCCCCCH-HHhccCCCCCEEEeeCCcCCCCCh
Confidence 4678889999999998884433 322 3488888999888776554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=93.38 E-value=0.081 Score=46.57 Aligned_cols=44 Identities=25% Similarity=0.169 Sum_probs=34.0
Q ss_pred CCCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|+|++|++++..| ..+ ..+|+.+++++|.+....+
T Consensus 129 ~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 129 FDSLTKLTYLSLGYNELQSLPK-GVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred hCcCcCCCEEECCCCcCCccCH-hHccCCcccceeEecCCcCcEeCh
Confidence 4678999999999999996544 322 3489999999998876443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=93.35 E-value=0.056 Score=53.59 Aligned_cols=40 Identities=23% Similarity=0.220 Sum_probs=18.4
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~ 41 (388)
++|++|++|||++|++++..|.. ....+|+.+++++|.+.
T Consensus 54 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 94 (606)
T 3t6q_A 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94 (606)
T ss_dssp TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCS
T ss_pred ccCccceEEECCCCccceeChhhccCccccCeeeCCCCccc
Confidence 34555555555555555544421 11124555555555443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.33 E-value=0.066 Score=51.33 Aligned_cols=41 Identities=10% Similarity=-0.053 Sum_probs=28.6
Q ss_pred CCCCCCCeeeccCCcCccccCccc---------ccCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSG---------ICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~---------~~~~l~~~~~s~N~~~~ 42 (388)
++|++|+.|||++|.+.|.+|... .+.+|+.+++++|++.+
T Consensus 283 ~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~ 332 (457)
T 3bz5_A 283 EGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE 332 (457)
T ss_dssp TTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC
T ss_pred cccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccc
Confidence 467888888888888888887320 11266777788887776
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=93.26 E-value=0.076 Score=52.60 Aligned_cols=41 Identities=24% Similarity=0.283 Sum_probs=18.8
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~ 42 (388)
+++++|++|||++|++++..|.. ....+|+.|++++|.+.+
T Consensus 53 ~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~ 94 (606)
T 3vq2_A 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94 (606)
T ss_dssp TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred cCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence 34455555555555555444421 111245555555554443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=93.25 E-value=0.048 Score=54.36 Aligned_cols=43 Identities=23% Similarity=0.164 Sum_probs=23.6
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~ 45 (388)
+.|++|+.|+|++|+|++. +.-..+.+|+.|++++|.+.+..|
T Consensus 128 ~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 128 VHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp GGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred cCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh
Confidence 3456666666666666654 311223366666666666554433
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.13 E-value=0.068 Score=52.57 Aligned_cols=40 Identities=23% Similarity=0.241 Sum_probs=24.1
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDL 41 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~ 41 (388)
++++++|++|||++|++++..| ..+. .+|+.|++++|.+.
T Consensus 72 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 72 ISFLSELRVLRLSHNRIRSLDF-HVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp TTTCTTCCEEECCSCCCCEECT-TTTTTCTTCCEEECTTSCCC
T ss_pred hccCCCccEEECCCCCCCcCCH-HHhCCCCCCCEEECCCCcCC
Confidence 3456667777777777766655 2222 26666666666655
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.09 E-value=0.084 Score=52.42 Aligned_cols=40 Identities=15% Similarity=0.059 Sum_probs=17.8
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~ 41 (388)
++|++|++|||++|++++..|.. +...+|+.|++++|.+.
T Consensus 96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 136 (597)
T 3oja_B 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136 (597)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC
Confidence 34445555555555555444311 11224555555555444
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=93.07 E-value=0.038 Score=50.53 Aligned_cols=38 Identities=21% Similarity=0.191 Sum_probs=17.7
Q ss_pred CCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
.+++|++|+|++|++++. |.-....+|+.+++++|.+.
T Consensus 263 ~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 263 DLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp TCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC
T ss_pred cCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCC
Confidence 445555555555555542 31122235555555555443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=93.06 E-value=0.053 Score=48.53 Aligned_cols=43 Identities=23% Similarity=0.164 Sum_probs=29.5
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~ 45 (388)
+.|++|++|||++|++++. +.-....+|+.|++++|.+.+..+
T Consensus 131 ~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 131 VHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp GGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 4677888888888888864 422333478888888887765443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=93.04 E-value=0.052 Score=44.44 Aligned_cols=39 Identities=10% Similarity=0.091 Sum_probs=24.9
Q ss_pred CCCCCCeeeccCCcCccccCcccccC-CCCeeEecCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQ-NLSIMSLTGNKDLC 42 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~-~l~~~~~s~N~~~~ 42 (388)
++++|+.|+|++|+++ .||.-.... +|+.+++++|.+.+
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~ 56 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK 56 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE
T ss_pred CcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCc
Confidence 4567777777777777 455222222 67777777776654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=92.95 E-value=0.061 Score=47.33 Aligned_cols=38 Identities=24% Similarity=0.227 Sum_probs=16.9
Q ss_pred CCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
.+++|++|+|++|++++..| -....+|+.|++++|++.
T Consensus 61 ~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~ 98 (263)
T 1xeu_A 61 FFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK 98 (263)
T ss_dssp GCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS
T ss_pred hCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC
Confidence 34445555555555554332 111224555555555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=92.92 E-value=0.032 Score=50.53 Aligned_cols=41 Identities=22% Similarity=0.203 Sum_probs=26.4
Q ss_pred CCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~ 44 (388)
.+++|++|||++|++++..| ..+. .+|+.+++++|.+.+..
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~ 74 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISA-ADLAPFTKLELLNLSSNVLYETL 74 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCH-HHHTTCTTCCEEECTTSCCEEEE
T ss_pred cCCCCCEEECcCCccCcCCH-HHhhCCCcCCEEECCCCcCCcch
Confidence 34577777777777777655 3222 37777777777765433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=92.87 E-value=0.054 Score=50.50 Aligned_cols=40 Identities=23% Similarity=0.308 Sum_probs=26.2
Q ss_pred CCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~ 42 (388)
+++++|++|||++|++++.+| ..+ ..+|+.+++++|++.+
T Consensus 245 ~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~ 286 (390)
T 3o6n_A 245 LNYPGLVEVDLSYNELEKIMY-HPFVKMQRLERLYISNNRLVA 286 (390)
T ss_dssp GGCTTCSEEECCSSCCCEEES-GGGTTCSSCCEEECCSSCCCE
T ss_pred cCCCCccEEECCCCcCCCcCh-hHccccccCCEEECCCCcCcc
Confidence 356677777777777777666 322 2367777777776654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.86 E-value=0.093 Score=49.86 Aligned_cols=44 Identities=18% Similarity=0.148 Sum_probs=34.2
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
+..+++|++|||++|++++..| ..+. .+|+.|++++|.+....+
T Consensus 203 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 203 LTPLIKLDELDLSGNHLSAIRP-GSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp CTTCSSCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECT
T ss_pred cCCCcccCEEECCCCccCccCh-hhhccCccCCEEECCCCceeEECh
Confidence 4578899999999999998877 3333 389999999998776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=92.76 E-value=0.091 Score=51.89 Aligned_cols=36 Identities=25% Similarity=0.380 Sum_probs=20.4
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
+++|++|||++|+|++ ||. ...+|+.|++++|++.+
T Consensus 139 l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 139 PALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC
T ss_pred CccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC
Confidence 4456666666666665 552 33456666666665544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.1 Score=50.10 Aligned_cols=39 Identities=21% Similarity=0.206 Sum_probs=16.3
Q ss_pred CCCCCCeeeccCCcCccccCccc-ccCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSG-ICQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~-~~~~l~~~~~s~N~~~ 41 (388)
++++|++|+|++|++++..|... .+.+|+.|++++|.+.
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 309 (477)
T 2id5_A 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309 (477)
T ss_dssp TCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS
T ss_pred ccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc
Confidence 34444444444444444444110 1124555555555444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.66 E-value=0.1 Score=50.04 Aligned_cols=42 Identities=26% Similarity=0.315 Sum_probs=26.5
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~ 42 (388)
|+++++|++|||++|++++..|.. ..+.+|+.|++++|.+..
T Consensus 52 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 94 (477)
T 2id5_A 52 FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL 94 (477)
T ss_dssp TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc
Confidence 356677777777777777766622 112367777777776553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=92.58 E-value=0.018 Score=48.24 Aligned_cols=37 Identities=30% Similarity=0.251 Sum_probs=18.9
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
+++|++|||++|++++ ||.-....+|+.+++++|.+.
T Consensus 47 l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~ 83 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp TTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC
T ss_pred CCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc
Confidence 4555566666665555 551112235555666655544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=92.55 E-value=0.14 Score=49.04 Aligned_cols=37 Identities=30% Similarity=0.400 Sum_probs=18.6
Q ss_pred CCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
++|++|||++|++++ ||.-....+|+.+++++|++.+
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~ 167 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK 167 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc
Confidence 355566666666654 5511112255555555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=92.45 E-value=0.096 Score=47.21 Aligned_cols=41 Identities=22% Similarity=0.267 Sum_probs=26.5
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
+++++|++|||++|++++..| -....+|+.+++++|.+.+-
T Consensus 148 ~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 148 AGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp GGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC
T ss_pred cCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcC
Confidence 456777788888887776433 22234777777777766543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.34 E-value=0.16 Score=30.90 Aligned_cols=26 Identities=27% Similarity=0.542 Sum_probs=11.3
Q ss_pred eehHHHHHHHHHHHHHHHHHHHHhhcc
Q 035768 60 LVGIVVGSVLVIAIIVSVLWWWIQRSN 86 (388)
Q Consensus 60 ~i~~~~~~~~~~~~~~~~~~~~~~r~~ 86 (388)
+++.++| +++++++.+++.++.||++
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 4455555 3333333333334444433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=92.29 E-value=0.088 Score=47.05 Aligned_cols=42 Identities=21% Similarity=0.108 Sum_probs=33.3
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
++.+++|++|||++|++++ +|.-....+|+.|++++|.+.+.
T Consensus 108 l~~l~~L~~L~L~~n~i~~-~~~l~~l~~L~~L~l~~n~l~~~ 149 (291)
T 1h6t_A 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI 149 (291)
T ss_dssp GTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCCC
T ss_pred hccCCCCCEEECCCCcCCC-ChhhcCCCCCCEEEccCCcCCcc
Confidence 4678999999999999997 45223345899999999987754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=92.18 E-value=0.13 Score=51.68 Aligned_cols=41 Identities=22% Similarity=0.153 Sum_probs=20.1
Q ss_pred CCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~ 43 (388)
++|++|++|||++|++++..| ..+ +.+|+.+++++|.+.+.
T Consensus 94 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~ 136 (680)
T 1ziw_A 94 AFCTNLTELHLMSNSIQKIKN-NPFVKQKNLITLDLSHNGLSST 136 (680)
T ss_dssp TTCTTCSEEECCSSCCCCCCS-CTTTTCTTCCEEECCSSCCSCC
T ss_pred ccCCCCCEEECCCCccCccCh-hHccccCCCCEEECCCCccccc
Confidence 345555555555555554333 212 12555555555555443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=92.16 E-value=0.14 Score=47.69 Aligned_cols=39 Identities=15% Similarity=0.106 Sum_probs=17.8
Q ss_pred CCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~ 42 (388)
+++|++|||++|++++..|.. ....+|+.|++++|.+.+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 107 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY 107 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc
Confidence 455555555555555433311 111255555555554443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=92.08 E-value=0.11 Score=52.28 Aligned_cols=44 Identities=27% Similarity=0.240 Sum_probs=33.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~~~ 44 (388)
+++|++|++|||++|++++.+|.. ..+.+|+.+++++|.+.+..
T Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp TTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred ccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 467889999999999999887732 12348888899888876544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=92.00 E-value=0.065 Score=49.92 Aligned_cols=40 Identities=30% Similarity=0.223 Sum_probs=26.9
Q ss_pred CCCCCCCeeeccCCcCccc----cCcccc----cCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGE----VPRSGI----CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~----iP~~~~----~~~l~~~~~s~N~~~~ 42 (388)
..+++|++|||++|++++. +| ..+ +.+|+.|++++|.+..
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~l~-~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAAVV-DAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHH-HHHHTCSSCCCCEEECCSSCCBH
T ss_pred ccCCCcCEEECCCCCCchhhHHHHH-HHHhhccCCCeEEEECcCCcCCH
Confidence 4567778888888887765 44 222 3477777887777655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=91.79 E-value=0.072 Score=53.20 Aligned_cols=40 Identities=23% Similarity=0.153 Sum_probs=29.9
Q ss_pred CCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~~ 46 (388)
.+++|++||||+|+|+ .|| . ...+|+.|++++|++. .+|.
T Consensus 239 ~l~~L~~L~Ls~N~L~-~lp-~-~~~~L~~L~Ls~N~L~-~lp~ 278 (622)
T 3g06_A 239 LPSELKELMVSGNRLT-SLP-M-LPSGLLSLSVYRNQLT-RLPE 278 (622)
T ss_dssp CCTTCCEEECCSSCCS-CCC-C-CCTTCCEEECCSSCCC-SCCG
T ss_pred CCCcCcEEECCCCCCC-cCC-c-ccccCcEEeCCCCCCC-cCCH
Confidence 4577888888888888 577 3 4568889999999877 4443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=91.74 E-value=0.097 Score=50.14 Aligned_cols=43 Identities=28% Similarity=0.221 Sum_probs=30.2
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~ 45 (388)
+.+++|++|+|++|++++..| -..+.+|+.+++++|++.+..|
T Consensus 284 ~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 284 AGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp TTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG
T ss_pred cCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh
Confidence 467788888888888887655 3344578888888887766544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=91.72 E-value=0.14 Score=46.17 Aligned_cols=43 Identities=19% Similarity=0.186 Sum_probs=31.0
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~ 44 (388)
++.+++|++|||++|++++ +|.-....+|+.|++++|.+.+..
T Consensus 103 ~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~ 145 (308)
T 1h6u_A 103 IAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLDLNQITNIS 145 (308)
T ss_dssp GTTCTTCCEEECTTSCCCC-CGGGTTCTTCCEEECCSSCCCCCG
T ss_pred hcCCCCCCEEECCCCCCCC-chhhcCCCCCCEEECCCCccCcCc
Confidence 3578889999999999887 442233348888888888776543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=91.64 E-value=0.15 Score=46.07 Aligned_cols=39 Identities=26% Similarity=0.277 Sum_probs=22.8
Q ss_pred CCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
.+++|++|||++|++++-.|.-....+|+.+++++|.+.
T Consensus 189 ~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 189 VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred ccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 356667777777777654331111236777777777665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=91.62 E-value=0.1 Score=52.01 Aligned_cols=42 Identities=21% Similarity=0.108 Sum_probs=28.8
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
|+.|++|+.|+|++|+|++ +|.-..+.+|+.|++++|.+.+.
T Consensus 105 l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l 146 (605)
T 1m9s_A 105 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI 146 (605)
T ss_dssp STTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC
T ss_pred hccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc
Confidence 4567788888888888876 44223344788888888876653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=91.59 E-value=0.1 Score=30.76 Aligned_cols=26 Identities=23% Similarity=0.518 Sum_probs=15.4
Q ss_pred eeehHHHHHHHHHHHHHHHHHHHHhh
Q 035768 59 ALVGIVVGSVLVIAIIVSVLWWWIQR 84 (388)
Q Consensus 59 ~~i~~~~~~~~~~~~~~~~~~~~~~r 84 (388)
.+.+++++.++.+++++.+.+++.+|
T Consensus 12 aIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 12 EIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ceeeeehHHHHHHHHHHHHHHHHeec
Confidence 45677777766666555555544433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=91.27 E-value=0.15 Score=48.80 Aligned_cols=44 Identities=20% Similarity=0.151 Sum_probs=35.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~ 45 (388)
++++++|++|+|++|++++..| -..+.+|+.+++++|.+.+..+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~ 304 (466)
T 1o6v_A 261 LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP 304 (466)
T ss_dssp GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG
T ss_pred hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh
Confidence 3578999999999999998665 3345599999999998876543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=90.95 E-value=0.2 Score=45.98 Aligned_cols=39 Identities=23% Similarity=0.211 Sum_probs=24.0
Q ss_pred CCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLC 42 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~ 42 (388)
.++|+.|+|++|+..+.||...+. .+|+.|++++|++..
T Consensus 176 ~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 346677777776666677733222 267777777776653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.86 E-value=0.035 Score=53.35 Aligned_cols=60 Identities=7% Similarity=-0.015 Sum_probs=18.2
Q ss_pred CCeeeccCCceEEEEEcCC-CCEEEE------EEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe
Q 035768 151 ENVIGGGGFGTVFKGTMPD-GKTVAV------KKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV 213 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 213 (388)
.+.|| ||.||+|.+.. ...||| |+.+... ......|.+|..+++.++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45566 99999999854 467888 7665422 1223468899999999999999999988754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=90.76 E-value=0.22 Score=47.59 Aligned_cols=33 Identities=24% Similarity=0.271 Sum_probs=17.0
Q ss_pred CCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
+|++|||++|+++| || . ...+|+.+++++|.+.
T Consensus 318 ~L~~L~Ls~N~l~~-lp-~-~~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 318 SLEELNVSNNKLIE-LP-A-LPPRLERLIASFNHLA 350 (454)
T ss_dssp TCCEEECCSSCCSC-CC-C-CCTTCCEEECCSSCCS
T ss_pred cCCEEECCCCcccc-cc-c-cCCcCCEEECCCCccc
Confidence 55556666655554 44 1 1245555555555444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=90.56 E-value=0.081 Score=49.24 Aligned_cols=15 Identities=13% Similarity=0.153 Sum_probs=7.4
Q ss_pred CCCCCeeeccCCcCc
Q 035768 4 LPNLLYLNLADNRLE 18 (388)
Q Consensus 4 l~~L~~L~ls~N~l~ 18 (388)
+++|++|+|++|+++
T Consensus 186 ~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIR 200 (386)
T ss_dssp CTTCCEEECCSSCCC
T ss_pred CCCcCEEECcCCCCC
Confidence 344555555555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=90.53 E-value=0.1 Score=44.96 Aligned_cols=41 Identities=10% Similarity=0.237 Sum_probs=29.4
Q ss_pred CCCCCCCCeeeccCCc-CccccCcccc--cCCCCeeEecC-CCCCC
Q 035768 1 MCSLPNLLYLNLADNR-LEGEVPRSGI--CQNLSIMSLTG-NKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~-l~G~iP~~~~--~~~l~~~~~s~-N~~~~ 42 (388)
++++++|++|||++|+ ++ .||...+ +.+|+.+++++ |.+..
T Consensus 51 ~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~ 95 (239)
T 2xwt_C 51 FSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTY 95 (239)
T ss_dssp TTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCE
T ss_pred ccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeE
Confidence 4578899999999997 55 4542323 24889999998 77664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=90.18 E-value=0.29 Score=45.59 Aligned_cols=73 Identities=18% Similarity=0.240 Sum_probs=44.5
Q ss_pred CeeeccCCceEEEEEcCC--------CCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEe
Q 035768 152 NVIGGGGFGTVFKGTMPD--------GKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 222 (388)
+.|..|-...+|+...++ ++.+++|+.... ......+.+|.++++.+. +.-..++++.+.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457778888999998752 478889886332 223456778999988774 3223566666542 39999
Q ss_pred ccCCCCH
Q 035768 223 YMVKGSL 229 (388)
Q Consensus 223 ~~~~g~L 229 (388)
|++|..|
T Consensus 131 ~i~G~~l 137 (379)
T 3feg_A 131 YIPSRPL 137 (379)
T ss_dssp CCSEEEC
T ss_pred EecCccC
Confidence 9987543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=90.08 E-value=0.18 Score=46.29 Aligned_cols=41 Identities=15% Similarity=0.168 Sum_probs=30.6
Q ss_pred CCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKIM 46 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~~ 46 (388)
++|++|||++|+++ .||...+. .+|+.|++++|+....+|.
T Consensus 30 ~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp TTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred CCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 46899999999998 57633232 3899999999987765554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=90.06 E-value=0.2 Score=42.94 Aligned_cols=40 Identities=18% Similarity=0.139 Sum_probs=29.4
Q ss_pred CCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++|++|+|++|++++..| ..+ +.+|+.+++++|.....++
T Consensus 31 ~~l~~L~l~~n~l~~i~~-~~~~~l~~L~~L~l~~n~~l~~i~ 72 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPS-HAFSNLPNISRIYVSIDVTLQQLE 72 (239)
T ss_dssp TTCCEEEEESCCCSEECT-TTTTTCTTCCEEEEECCSSCCEEC
T ss_pred CcccEEEEeCCcceEECH-HHccCCCCCcEEeCCCCCCcceeC
Confidence 379999999999997655 323 3489999999997333443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=90.02 E-value=0.023 Score=47.66 Aligned_cols=40 Identities=18% Similarity=0.262 Sum_probs=30.1
Q ss_pred CCCCCCCeeeccCCcCccccCccc-ccCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSG-ICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~-~~~~l~~~~~s~N~~~~ 42 (388)
+++++|++|||++|+++ .||... .+.+|+.+++++|.+.+
T Consensus 67 ~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~ 107 (198)
T 1ds9_A 67 SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp HHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC
T ss_pred ccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc
Confidence 35688999999999998 688321 12489999999997764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=89.34 E-value=0.12 Score=46.88 Aligned_cols=42 Identities=19% Similarity=0.182 Sum_probs=31.1
Q ss_pred CCCCCCCeeeccCCcCccc-cCcc-cccCCCCeeEecCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGE-VPRS-GICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~-iP~~-~~~~~l~~~~~s~N~~~~~ 43 (388)
.++++|++|||++|++++. +|.. ..+.+|+.|++++|.+...
T Consensus 90 ~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~ 133 (336)
T 2ast_B 90 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDP 133 (336)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHH
T ss_pred ccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHH
Confidence 4578899999999998876 7622 2234889999998876543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=89.30 E-value=0.14 Score=46.94 Aligned_cols=78 Identities=8% Similarity=-0.001 Sum_probs=53.9
Q ss_pred Cee-eccCCceEEEEEcC-------CCCEEEEEEcccCC---CcChHHHHHHHHHHhcCC-C--CCccceeeEEEeC---
Q 035768 152 NVI-GGGGFGTVFKGTMP-------DGKTVAVKKLSQAT---GQGDREFAAEMETLGMVK-H--QNLVELLGYCSVD--- 214 (388)
Q Consensus 152 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--- 214 (388)
+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 78888999998754 26678888765422 111245778888888774 2 3567788877654
Q ss_pred CeeEEEEeccCCCCH
Q 035768 215 EEKLLVYEYMVKGSL 229 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L 229 (388)
+..++||||++|..+
T Consensus 106 g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 106 GTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSCEEEEECCCCBCC
T ss_pred CCceEEEEecCCCCh
Confidence 356899999987654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=88.65 E-value=0.11 Score=47.85 Aligned_cols=39 Identities=18% Similarity=0.133 Sum_probs=23.1
Q ss_pred CCCCeeeccCCcCccccCc----c-cccC-CCCeeEecCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPR----S-GICQ-NLSIMSLTGNKDLCG 43 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~----~-~~~~-~l~~~~~s~N~~~~~ 43 (388)
++|++||||+|++++.-+. . .... +|+.|++++|.+...
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 66 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK 66 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGS
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHH
Confidence 4477777777777755431 1 0112 577777777766543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=88.64 E-value=0.38 Score=48.00 Aligned_cols=36 Identities=25% Similarity=0.331 Sum_probs=29.1
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
+++|++||||+|+|++ || ....+|+.|++++|++..
T Consensus 220 ~~~L~~L~Ls~N~L~~-lp--~~l~~L~~L~Ls~N~L~~ 255 (622)
T 3g06_A 220 PSGLKELIVSGNRLTS-LP--VLPSELKELMVSGNRLTS 255 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC--CCCTTCCEEECCSSCCSC
T ss_pred CCCCCEEEccCCccCc-CC--CCCCcCcEEECCCCCCCc
Confidence 4788999999999987 77 345689999999998764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=87.92 E-value=0.44 Score=43.25 Aligned_cols=42 Identities=17% Similarity=0.142 Sum_probs=29.9
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
++++++|++|+|++|++++ +|.-..+.+|+.+++++|.+..-
T Consensus 84 ~~~l~~L~~L~L~~n~i~~-~~~~~~l~~L~~L~l~~n~i~~~ 125 (347)
T 4fmz_A 84 LSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNEDNISDI 125 (347)
T ss_dssp GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECTTSCCCCC
T ss_pred hhcCCcCCEEEccCCcccC-chHHcCCCcCCEEECcCCcccCc
Confidence 3577888888888888875 55223334888888888876643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=86.85 E-value=0.23 Score=44.90 Aligned_cols=38 Identities=5% Similarity=-0.014 Sum_probs=31.4
Q ss_pred CCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
++|+.|+|++|.++|.+|....+.+|+.+++++|.+..
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECH
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCH
Confidence 78999999999999998844444599999999998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=86.84 E-value=0.34 Score=43.30 Aligned_cols=71 Identities=15% Similarity=0.120 Sum_probs=43.8
Q ss_pred CCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEecc-CCCC
Q 035768 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNL-VELLGYCSVDEEKLLVYEYM-VKGS 228 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~g~ 228 (388)
.+.|+.|....+|+. ..+++|........ .....+|+.+++.+...++ .+++++ +.+.-++++||+ ++-+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567899999999998 55888887543211 1123467777776643233 355543 344457999999 5543
Q ss_pred H
Q 035768 229 L 229 (388)
Q Consensus 229 L 229 (388)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=85.66 E-value=1.3 Score=39.91 Aligned_cols=73 Identities=16% Similarity=0.332 Sum_probs=42.3
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcC-----CCCCcccee-e--EEEeCCeeEEEEec
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMV-----KHQNLVELL-G--YCSVDEEKLLVYEY 223 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lv~e~ 223 (388)
+.|+.|..+.||+....+| .+++|..... ...+..|..+++.+ ..|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987555 4889988652 23344455555444 234444311 1 22346778999999
Q ss_pred cCCCCH
Q 035768 224 MVKGSL 229 (388)
Q Consensus 224 ~~~g~L 229 (388)
++|..+
T Consensus 113 i~G~~~ 118 (346)
T 2q83_A 113 IEGRPF 118 (346)
T ss_dssp CCCBCC
T ss_pred ecCccC
Confidence 998654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=82.95 E-value=0.35 Score=44.48 Aligned_cols=40 Identities=23% Similarity=0.263 Sum_probs=28.4
Q ss_pred CCCCeeeccCCcCccccCc---cccc---CCCCeeEecCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPR---SGIC---QNLSIMSLTGNKDLCGK 44 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~---~~~~---~~l~~~~~s~N~~~~~~ 44 (388)
++|++|||++|++++.-+. ..+. .+|+.|++++|.+....
T Consensus 138 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred CceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 5899999999999864331 1111 27999999999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=81.15 E-value=8.2 Score=34.34 Aligned_cols=75 Identities=8% Similarity=0.004 Sum_probs=49.1
Q ss_pred CeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCC--CccceeeE-----EEeCCeeEEEEecc
Q 035768 152 NVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQ--NLVELLGY-----CSVDEEKLLVYEYM 224 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~~ 224 (388)
..++ |....||+....+|+.+++|...... .....+..|..++..+... .+.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889999887777789999986332 2345667788777766321 23444432 22355678899999
Q ss_pred CCCC
Q 035768 225 VKGS 228 (388)
Q Consensus 225 ~~g~ 228 (388)
+|..
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8743
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=80.78 E-value=1.3 Score=34.03 Aligned_cols=34 Identities=18% Similarity=0.271 Sum_probs=29.1
Q ss_pred CeeeccCCcCc-cccCcccccCCCCeeEecCCCCCC
Q 035768 8 LYLNLADNRLE-GEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 8 ~~L~ls~N~l~-G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
..+|.|+|+|+ -+|| .++..+++.|+|++|++..
T Consensus 11 ~~v~Cs~~~L~~~~vP-~~lp~~l~~L~Ls~N~l~~ 45 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLP-TAFPVDTTELVLTGNNLTA 45 (130)
T ss_dssp TEEECCSSCCCTTTSC-SCCCTTCSEEECTTSCCSS
T ss_pred CEEEeCCCCCccccCC-CCCCcCCCEEECCCCcCCc
Confidence 58999999998 7889 5566799999999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=80.77 E-value=0.43 Score=46.85 Aligned_cols=37 Identities=19% Similarity=0.180 Sum_probs=19.6
Q ss_pred CCCCCeeeccCCcCcc-ccCcc-cccCCCCeeEecCCCC
Q 035768 4 LPNLLYLNLADNRLEG-EVPRS-GICQNLSIMSLTGNKD 40 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G-~iP~~-~~~~~l~~~~~s~N~~ 40 (388)
+++|++|+|++|++++ .+|.. ..+.+|+.|++++|.+
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 5566666666666665 22311 1123566666666654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=80.46 E-value=0.57 Score=44.33 Aligned_cols=40 Identities=28% Similarity=0.271 Sum_probs=28.2
Q ss_pred CCCCCCeeeccCCcCccccCcc---cc---cCCCCeeEecCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRS---GI---CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~---~~---~~~l~~~~~s~N~~~~ 42 (388)
++++|++||||+|++++..+.. .+ ..+|+.+++++|.+..
T Consensus 339 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred hCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 4688888888888888765422 11 2378888888887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 388 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-57
Identities = 63/266 (23%), Positives = 103/266 (38%), Gaps = 38/266 (14%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+ IG G FGTV+KG V + ++ T Q + F E+ L +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------------- 249
+GY + + +V ++ SL L + K I
Sbjct: 68 LFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII 126
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCE-SHVSTVVAGTIGYVPPEY---GGTGKA 300
++NI L++D KI DFGLA + S SH ++G+I ++ PE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
+ + DVY+FG++L EL+TG+ P N D ++ M+ L N
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPY-------SNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 361 SKPTMLKMLQIATGCISNDPTVRPTM 386
M ++ C+ RP
Sbjct: 240 K-----AMKRLMAECLKKKRDERPLF 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 59/262 (22%), Positives = 100/262 (38%), Gaps = 38/262 (14%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+G G FG V G VA+K + + + + EF E + + + H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------------- 249
+L G C+ ++ EYM G L ++LR + ++
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
A N L+ND K+SDFGL+R + D E S + + PPE K + +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
D+++FGV++ E+ + + F + + + L + + A E
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------------- 228
Query: 365 MLKMLQIATGCISNDPTVRPTM 386
K+ I C RPT
Sbjct: 229 --KVYTIMYSCWHEKADERPTF 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-54
Identities = 74/279 (26%), Positives = 114/279 (40%), Gaps = 40/279 (14%)
Query: 130 EPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREF 189
+P Q L D E +G G FG V+ GT VA+K L T F
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAF 59
Query: 190 AAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ------------- 236
E + + ++H+ LV+L S + +V EYM KGSL D+L+ +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 237 ----AASLDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTI 287
A+ + + +R V A+NIL+ ++ K++DFGLARLI D E I
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347
+ PE G+ T + DV+SFG++L EL T + + ++D V +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVERGYRMPC 235
Query: 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
E + + + C +P RPT
Sbjct: 236 PPECPE-------------SLHDLMCQCWRKEPEERPTF 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 9e-54
Identities = 69/263 (26%), Positives = 103/263 (39%), Gaps = 40/263 (15%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+G G FG V+ G VAVK L Q + F AE + ++HQ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAA-SLDWGKRCKIVA-------------- 250
L + E ++ EYM GSL D+L+ + L K + A
Sbjct: 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 251 -------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATER 303
+NIL++D KI+DFGLARLI D E I + PE G T +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363
DV+SFG++L E+VT + + ++ + + + D +
Sbjct: 191 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPE---------- 237
Query: 364 TMLKMLQIATGCISNDPTVRPTM 386
++ Q+ C P RPT
Sbjct: 238 ---ELYQLMRLCWKERPEDRPTF 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-53
Identities = 58/262 (22%), Positives = 100/262 (38%), Gaps = 38/262 (14%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
++ IG G FG V G + VA+K + + + +F E E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------------- 249
+L G C LV+E+M G L D+LR Q +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
A N L+ ++ K+SDFG+ R + D + ST + + PE + + +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
DV+SFGV++ E+ + + +E++ +V+ + + +
Sbjct: 184 DVWSFGVLMWEVFSEGKIP---YENRSNSEVVEDISTGFRLYKPRLAST----------- 229
Query: 365 MLKMLQIATGCISNDPTVRPTM 386
+ QI C P RP
Sbjct: 230 --HVYQIMNHCWKERPEDRPAF 249
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-51
Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 47/296 (15%)
Query: 122 LSINLAMFEPSLQKLTYDQIVAGTNKFCE-ENVIGGGGFGTVFKGTMPDGKT----VAVK 176
+ I+L+ P L + ++ ++ VIG G FG V+ GT+ D AVK
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 177 KLSQATGQGD-REFAAEMETLGMVKHQNLVELLGYCSVDEEK-LLVYEYMVKGSLDDWLR 234
L++ T G+ +F E + H N++ LLG C E L+V YM G L +++R
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 235 NQAASLDWGKRCKIVA---------------------SNILLNDDFEAKISDFGLARLIS 273
N+ + N +L++ F K++DFGLAR +
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181
Query: 274 DCES---HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDK 330
D E H T + ++ E T K T + DV+SFGV+L EL+T P + D
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDV 238
Query: 331 DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ ++ ++L + Q + DP + ++ C +RP+
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPDP-------------LYEVMLKCWHPKAEMRPSF 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (425), Expect = 6e-50
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 55/289 (19%)
Query: 137 TYDQIVAGTNKFCEE---------NVIGGGGFGTVFKGTMP----DGKTVAVKKL-SQAT 182
T++ +F +E VIG G FG V G + VA+K L S T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 183 GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDW 242
+ R+F +E +G H N++ L G + +++ E+M GSLD +LR
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 243 GKRCKIV---------------------ASNILLNDDFEAKISDFGLARLISDCESHVST 281
+ ++ A NIL+N + K+SDFGL+R + D S +
Sbjct: 128 IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 282 VVA----GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVD 337
A I + PE K T DV+S+G+++ E+++ + + D +++++
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVIN 244
Query: 338 WVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + + + Q+ C D RP
Sbjct: 245 AIEQDYRLPPPMDCPS-------------ALHQLMLDCWQKDRNHRPKF 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-49
Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 50/282 (17%)
Query: 151 ENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
+ IG G FG V++G G+ VAVK S + AE+ M++H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 211 CSVDEEKL----LVYEYMVKGSLDDWLRNQAASLDWGKRCKIV----------------- 249
+ D LV +Y GSL D+L ++ K+
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 250 ------------ASNILLNDDFEAKISDFGLARLI---SDCESHVSTVVAGTIGYVPPEY 294
+ NIL+ + I+D GLA +D GT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 295 ------GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKD---GENLVDWVLHMMKN 345
++ +R D+Y+ G++ E+ G + + D + M+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 346 EQADEVLDPAVLN-ANSKPTMLKMLQIATGCISNDPTVRPTM 386
++ L P + N S + M +I C + R T
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-48
Identities = 58/265 (21%), Positives = 106/265 (40%), Gaps = 46/265 (17%)
Query: 150 EENVIGGGGFGTVFKGTMPDGKT---VAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
+ +G G FG+V +G K VA+K L Q T + D E E + + + + +V
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------------- 249
L+G C E +LV E G L +L + + +++
Sbjct: 73 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 250 -----ASNILLNDDFEAKISDFGLARLISDCESH--VSTVVAGTIGYVPPEYGGTGKATE 302
A N+LL + AKISDFGL++ + +S+ + + + PE K +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 303 RGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
R DV+S+GV + E ++ G++P ++ G ++ ++ + E E
Sbjct: 192 RSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGKRMECPPECPP-------- 239
Query: 362 KPTMLKMLQIATGCISNDPTVRPTM 386
++ + + C RP
Sbjct: 240 -----ELYALMSDCWIYKWEDRPDF 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-48
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 45/270 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDG-----KTVAVKKLSQATGQGDR-EFAAEMETLGMV 199
+ + VIG G FG V+KG + VA+K L + R +F E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 200 KHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV---------- 249
H N++ L G S + +++ EYM G+LD +LR + + ++
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 250 -----------ASNILLNDDFEAKISDFGLARLISDCE--SHVSTVVAGTIGYVPPEYGG 296
A NIL+N + K+SDFGL+R++ D ++ ++ I + PE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356
K T DV+SFG+++ E++T + E + + ++ +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS------ 240
Query: 357 LNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ Q+ C + RP
Sbjct: 241 ----------AIYQLMMQCWQQERARRPKF 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-47
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 32/215 (14%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQ 202
+ F + + +G G G VFK + P G +A K + R E++ L
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------------ 250
+V G D E + E+M GSLD L+ + K+
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK 123
Query: 251 ----------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKA 300
SNIL+N E K+ DFG++ + D ++ GT Y+ PE
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENL 335
+ + D++S G+ L+E+ G+ P D + L
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYP----IPPPDAKEL 211
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (409), Expect = 1e-47
Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 40/276 (14%)
Query: 134 QKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAE 192
YD+ ++ +GGG +G V++G TVAVK L + T + EF E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 193 METLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWL-RNQAASLDWGKRCKIV-- 249
+ +KH NLV+LLG C+ + ++ E+M G+L D+L + +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 250 -------------------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYV 290
A N L+ ++ K++DFGL+RL++ I +
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 291 PPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADE 350
PE K + + DV++FGV+L E+ T + D + + + + E+ +
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---YPGIDLSQVYELLEKDYRMERPEG 240
Query: 351 VLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ K+ ++ C +P+ RP+
Sbjct: 241 CPE-------------KVYELMRACWQWNPSDRPSF 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-47
Identities = 58/264 (21%), Positives = 109/264 (41%), Gaps = 40/264 (15%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQN 203
K+ IG G GTV+ + G+ VA+++++ E+ + K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------------- 250
+V L V +E +V EY+ GSL D + +D G+ +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 251 --------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
NILL D K++DFG I+ +S ST+V GT ++ PE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
+ D++S G++ +E++ G+ P + +++ L+++ E+ +P L+A +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP----YLNENPLR----ALYLIATNGTPELQNPEKLSAIFR 247
Query: 363 PTMLKMLQIATGCISNDPTVRPTM 386
+ + L + D R +
Sbjct: 248 DFLNRCLDM-------DVEKRGSA 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 1e-47
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 52/285 (18%)
Query: 130 EPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD-- 186
+P + +L + F + IG G FG V+ + + + VA+KK+S + Q +
Sbjct: 1 DPDVAELFFKDDP--EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 187 -REFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKR 245
++ E+ L ++H N ++ G + LV EY + + D ++ L +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI 117
Query: 246 CKIV---------------------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
+ A NILL++ K+ DFG A +++ S V
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----- 172
Query: 285 GTIGYVPPEY---GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLH 341
GT ++ PE G+ + DV+S G+ +EL K P N + + H
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------FNMNAMSALYH 225
Query: 342 MMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ +NE L + + + LQ P RPT
Sbjct: 226 IAQNE--SPALQSGHWSEYFRNFVDSCLQK-------IPQDRPTS 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-47
Identities = 67/264 (25%), Positives = 107/264 (40%), Gaps = 46/264 (17%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLV 205
+ IG G FG V G G VAVK + + F AE + ++H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 206 ELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQAAS-LDWGKRCKIV-------------- 249
+LLG ++ L +V EYM KGSL D+LR++ S L K
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 250 -------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
A N+L+++D AK+SDFGL + S + + + PE K +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFST 179
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
+ DV+SFG++L E+ + + + +++V V K + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDAPDGCPP--------- 227
Query: 363 PTMLKMLQIATGCISNDPTVRPTM 386
+ ++ C D +RP+
Sbjct: 228 ----AVYEVMKNCWHLDAAMRPSF 247
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-47
Identities = 47/262 (17%), Positives = 94/262 (35%), Gaps = 43/262 (16%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGY 210
+G G FG V+K A K + + + ++ E++ L H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 211 CSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA-------------------- 250
+ ++ E+ G++D + L + +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137
Query: 251 -SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY-----GGTGKATERG 304
NIL D + K++DFG++ + + + GT ++ PE +
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKA 196
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
DV+S G+ L+E+ + P + + VL + + + P+ ++N K
Sbjct: 197 DVWSLGITLIEMAEIEPP----HHELNPMR----VLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 365 MLKMLQIATGCISNDPTVRPTM 386
+ K L+ + R T
Sbjct: 249 LKKCLEK-------NVDARWTT 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 3e-46
Identities = 66/308 (21%), Positives = 109/308 (35%), Gaps = 73/308 (23%)
Query: 131 PSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ 184
P L L Y + N IG G FG VF+ P VAVK L +
Sbjct: 3 PKLLSLEYPR-----NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA 57
Query: 185 GDR-EFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ------- 236
+ +F E + + N+V+LLG C+V + L++EYM G L+++LR+
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117
Query: 237 ----------------AASLDWGKRCKIV---------------------ASNILLNDDF 259
L ++ I N L+ ++
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 177
Query: 260 EAKISDFGLARLISDCE-SHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT 318
KI+DFGL+R I + A I ++PPE + T DV+++GV+L E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 319 GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISN 378
+ E ++ +V + ++ + C S
Sbjct: 238 YGLQP---YYGMAHEEVIYYVRDGNILACPENCPL-------------ELYNLMRLCWSK 281
Query: 379 DPTVRPTM 386
P RP+
Sbjct: 282 LPADRPSF 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-46
Identities = 60/265 (22%), Positives = 96/265 (36%), Gaps = 46/265 (17%)
Query: 150 EENVIGGGGFGTVFKGTMPD---GKTVAVKKLSQATGQGD--REFAAEMETLGMVKHQNL 204
E+ +G G FGTV KG KTVAVK L E AE + + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV--------------- 249
V ++G C E +LV E G L+ +L+ + ++V
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 250 ------ASNILLNDDFEAKISDFGLARLISDCESHVST--VVAGTIGYVPPEYGGTGKAT 301
A N+LL AKISDFGL++ + E++ + + PE K +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
+ DV+SFGV++ E + Q + G + + +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEVTAMLEKGERMGCPAGCPR-------- 237
Query: 362 KPTMLKMLQIATGCISNDPTVRPTM 386
+M + C + D RP
Sbjct: 238 -----EMYDLMNLCWTYDVENRPGF 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-45
Identities = 63/267 (23%), Positives = 96/267 (35%), Gaps = 51/267 (19%)
Query: 151 ENVIGGGGFGTVFKGTMPD-GKTVAVKKLS--QATGQGDREFAAEMETLGMVKHQNLVEL 207
+ IG G F TV+KG + VA +L + T + F E E L ++H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 208 LGYCSVDEEK----LLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV-------------- 249
+ +LV E M G+L +L+ +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 250 ---------ASNILLND-DFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
NI + KI D GLA L + + V GT ++ PE K
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY-EEK 188
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
E DVY+FG+ +LE+ T + P E ++ + V +K D+V P V
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386
I GCI + R ++
Sbjct: 245 -----------IIEGCIRQNKDERYSI 260
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-44
Identities = 64/282 (22%), Positives = 106/282 (37%), Gaps = 59/282 (20%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKT---VAVKKLSQ-ATGQGDREFAAEMETLGMV-K 200
N ++VIG G FG V K + A+K++ + A+ R+FA E+E L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 201 HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKR 245
H N++ LLG C L EY G+L D+LR A++L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 246 CKIVA---------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284
A NIL+ +++ AKI+DFGL+R T+
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
+ ++ E T DV+S+GV+L E+V+ + L + + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELYEKLPQGYR 244
Query: 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
E+ D ++ + C P RP+
Sbjct: 245 LEKPLNCDD-------------EVYDLMRQCWREKPYERPSF 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-44
Identities = 54/269 (20%), Positives = 89/269 (33%), Gaps = 52/269 (19%)
Query: 152 NVIGGGGFGTVFKGTM-PDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQNLVELL 208
IG G +G K DGK + K+L T + +E+ L +KH N+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 209 GYCSVDEEKLL--VYEYMVKGSLDDWLRN---QAASLDWGKRCKIVA------------- 250
L V EY G L + + LD +++
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 251 -------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT 297
+N+ L+ K+ DFGLAR+++ ++ + GT Y+ PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSPEQMNR 188
Query: 298 GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357
E+ D++S G +L EL P F + L + D
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREGKFRRIPYRYSDELN- 243
Query: 358 NANSKPTMLKMLQIATGCISNDPTVRPTM 386
+I T ++ RP++
Sbjct: 244 ------------EIITRMLNLKDYHRPSV 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (382), Expect = 5e-43
Identities = 55/282 (19%), Positives = 107/282 (37%), Gaps = 43/282 (15%)
Query: 129 FEPSLQKLTYDQIVAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDR 187
+ P ++ +D ++ + + +G G FG V + T G A K +
Sbjct: 12 YYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68
Query: 188 EFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK 247
E++T+ +++H LV L D E +++YE+M G L + + ++ + + +
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 248 IVA---------------------SNILLNDDF--EAKISDFGLARLISDCESHVSTVVA 284
+ NI+ E K+ DFGL + +S T
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-- 186
Query: 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
GT + PE D++S GV+ L++G P GEN + + ++
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-------FGGENDDETLRNVKS 239
Query: 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + + ++ + K + K+L DP R T+
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRKLLLA-------DPNTRMTI 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 55/266 (20%), Positives = 98/266 (36%), Gaps = 47/266 (17%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGD---REFAAEMETLGMVKH 201
F +G G FG V+ +A+K L +A + + E+E ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA----------- 250
N++ L GY L+ EY G++ L+ + D + +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124
Query: 251 ----------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKA 300
N+LL E KI+DFG + + GT+ Y+PPE
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMH 181
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360
E+ D++S GV+ E + GK P FE + + + E P +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRV-------EFTFPDFVTEG 230
Query: 361 SKPTMLKMLQIATGCISNDPTVRPTM 386
++ + ++L+ +P+ RP +
Sbjct: 231 ARDLISRLLKH-------NPSQRPML 249
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 53/262 (20%), Positives = 94/262 (35%), Gaps = 43/262 (16%)
Query: 151 ENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLV 205
IG G FG V +G VA+K T RE F E T+ H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--------------- 250
+L+G + + ++ E G L +L+ + SLD
Sbjct: 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 130
Query: 251 ------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERG 304
N+L++ + K+ DFGL+R + D + ++ I ++ PE + T
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
DV+ FGV + E++ F+ +++ + + +
Sbjct: 191 DVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIENGERLPMPPNCPPTLY-------- 239
Query: 365 MLKMLQIATGCISNDPTVRPTM 386
+ T C + DP+ RP
Sbjct: 240 -----SLMTKCWAYDPSRRPRF 256
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-42
Identities = 61/279 (21%), Positives = 107/279 (38%), Gaps = 54/279 (19%)
Query: 146 NKFCEENVIGGGGFGTVFKGT------MPDGKTVAVKKLSQATGQGDR-EFAAEMETLGM 198
K +G G FG V++G VA+K +++A +R EF E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 199 VKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------AASLDWGKRCKIV 249
++V LLG S + L++ E M +G L +LR+ A K ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 250 ---------------------ASNILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTI 287
A N ++ +DF KI DFG+ R I + + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347
++ PE G T DV+SFGV+L E+ T + ++ E ++ +V+ ++
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDK 256
Query: 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
D D + ++ C +P +RP+
Sbjct: 257 PDNCPD-------------MLFELMRMCWQYNPKMRPSF 282
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-42
Identities = 60/267 (22%), Positives = 103/267 (38%), Gaps = 45/267 (16%)
Query: 148 FCEENVIGGGGFGTVFKGT-MPDGKT----VAVKKLSQAT-GQGDREFAAEMETLGMVKH 201
F + V+G G FGTV+KG +P+G+ VA+K+L +AT + ++E E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV------------ 249
++ LLG C + L+ + M G L D++R ++
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 250 ---------ASNILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGK 299
A N+L+ KI+DFGLA+L+ E + + I ++ E
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
T + DV+S+GV + EL+T ++ + + + Q
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEISSILEKGERLPQPPICTI------ 240
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386
+ I C D RP
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKF 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-42
Identities = 57/265 (21%), Positives = 88/265 (33%), Gaps = 46/265 (17%)
Query: 152 NVIGGGGFGTVFKGTMP----DGKTVAVKKLSQ---ATGQGDREFAAEMETLGMVKHQNL 204
+G G FG V +G +VAVK L + + +F E+ + + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV--------------- 249
+ L G +V E GSL D LR G +
Sbjct: 74 IRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 250 ------ASNILLNDDFEAKISDFGLARLISDCESH--VSTVVAGTIGYVPPEYGGTGKAT 301
A N+LL KI DFGL R + + H + + PE T +
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
D + FGV L E+ T Q + +G ++ + + E
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ------- 242
Query: 362 KPTMLKMLQIATGCISNDPTVRPTM 386
+ + C ++ P RPT
Sbjct: 243 -----DIYNVMVQCWAHKPEDRPTF 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (373), Expect = 9e-42
Identities = 47/258 (18%), Positives = 85/258 (32%), Gaps = 40/258 (15%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
+G G FG V + G+ K ++ E+ + + H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--------------------- 250
E +L+ E++ G L D + + + + +
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 251 SNILL--NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
NI+ KI DFGLA ++ E T T + PE D+++
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWA 213
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368
GV+ L++G P F +D + V D + ++ +K + +
Sbjct: 214 IGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDWEFDEDA---FSSVSPEAKDFIKNL 266
Query: 369 LQIATGCISNDPTVRPTM 386
LQ +P R T+
Sbjct: 267 LQK-------EPRKRLTV 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-41
Identities = 51/260 (19%), Positives = 92/260 (35%), Gaps = 41/260 (15%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQNLVELLG 209
+G G +G V + VAVK + E E+ M+ H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 210 YCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------------------- 250
+ + L EY G L D + + +
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 129
Query: 251 --SNILLNDDFEAKISDFGLARLI-SDCESHVSTVVAGTIGYVPPEY-GGTGKATERGDV 306
N+LL++ KISDFGLA + + + + GT+ YV PE E DV
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 307 YSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTML 366
+S G++L ++ G+ ++ + E+ + +++ +
Sbjct: 190 WSCGIVLTAMLAGE----LPWDQPSDSC----QEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 367 KMLQIATGCISNDPTVRPTM 386
K+L +P+ R T+
Sbjct: 242 KILVE-------NPSARITI 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-41
Identities = 67/288 (23%), Positives = 103/288 (35%), Gaps = 62/288 (21%)
Query: 146 NKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATGQGDRE-FAAEMETLGM 198
N+ +G G FG V + T TVAVK L + +RE +E++ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 199 VK-HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR-----------------NQAASL 240
+ H N+V LLG C++ L++ EY G L ++LR + +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 241 DWGKRCKIV---------------------ASNILLNDDFEAKISDFGLARLISDCESH- 278
D A NILL KI DFGLAR I + ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338
V + ++ PE T DV+S+G+ L EL +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------P 247
Query: 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
M + + +++ + + +M I C DP RPT
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-41
Identities = 54/261 (20%), Positives = 98/261 (37%), Gaps = 43/261 (16%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD---REFAAEMETLGMVKHQNLVE 206
++G G F TV + + A+K L + + E + + + H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 207 LLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV-- 249
L DE+ Y G L ++R ++L++ I+
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 250 ---ASNILLNDDFEAKISDFGLARLIS-DCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
NILLN+D +I+DFG A+++S + + + GT YV PE A + D
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD 192
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
+++ G I+ +LV G P F + + ++ + E P ++ +
Sbjct: 193 LWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKL-------EYDFPEKFFPKARDLV 241
Query: 366 LKMLQIATGCISNDPTVRPTM 386
K+L + D T R
Sbjct: 242 EKLLVL-------DATKRLGC 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 1e-40
Identities = 56/267 (20%), Positives = 98/267 (36%), Gaps = 41/267 (15%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQ 202
+ + +V+G G F V K VA+K +++ +G E+ L +KH
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCK 247
N+V L L+ + + G L D + + ++ +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 248 IV--------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
IV L++D + ISDFGL+++ V + GT GYV PE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKP 185
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359
++ D +S GVI L+ G P EN ++K E + ++
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPF-------YDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386
++K + +++ DP R T
Sbjct: 239 SAKDFIRHLMEK-------DPEKRFTC 258
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-39
Identities = 62/293 (21%), Positives = 103/293 (35%), Gaps = 67/293 (22%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPD------GKTVAVKKLSQATGQGDRE-FAAEMETLG- 197
V+G G FG V T VAVK L + +RE +E++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 198 MVKHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ--------------------- 236
+ H+N+V LLG C++ L++EY G L ++LR++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 237 -AASLDWGKRCKIV---------------------ASNILLNDDFEAKISDFGLARLISD 274
L + A N+L+ KI DFGLAR I
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 275 CESHVS-TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGE 333
++V + ++ PE G T + DV+S+G++L E+ + P
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDA 274
Query: 334 NLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
N + + K +Q + ++ I C + D RP+
Sbjct: 275 NFYKLIQNGFKMDQPFYATE-------------EIYIIMQSCWAFDSRKRPSF 314
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-39
Identities = 41/258 (15%), Positives = 92/258 (35%), Gaps = 41/258 (15%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYC 211
+G G FG V + KT K + G E+ L + +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 212 SVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--------------------- 250
EE ++++E++ + + + A L+ + V
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 251 SNILLNDDFEA--KISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYS 308
NI+ + KI +FG AR + ++ ++ Y PE + D++S
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 309 FGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKM 368
G ++ L++G P F + + +++ +++ + ++ + + ++
Sbjct: 189 LGTLVYVLLSGINP----FLAETNQQIIENIMNAEYTFDEEA---FKEISIEAMDFVDRL 241
Query: 369 LQIATGCISNDPTVRPTM 386
L + R T
Sbjct: 242 LVK-------ERKSRMTA 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-38
Identities = 60/261 (22%), Positives = 95/261 (36%), Gaps = 44/261 (16%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAAEMETLGMV-KHQNLV 205
++G G FG VF + A+K L + D + E L + +H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV- 249
+ E V EY+ G L +++ L + IV
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 126
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGD 305
NILL+ D KI+DFG+ + ++ +T GT Y+ PE K D
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSVD 185
Query: 306 VYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365
+SFGV+L E++ G+ P F +D E L + D P L +K +
Sbjct: 186 WWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRM-------DNPFYPRWLEKEAKDLL 234
Query: 366 LKMLQIATGCISNDPTVRPTM 386
+K+ +P R +
Sbjct: 235 VKLFVR-------EPEKRLGV 248
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (332), Expect = 1e-36
Identities = 56/272 (20%), Positives = 103/272 (37%), Gaps = 46/272 (16%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD---REFAAEMETLGMVK 200
++++ ++G GG V + + VAVK L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 201 HQNLVELLGYCSVDEEKL----LVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------ 250
H +V + + +V EY+ +L D + + + + +++A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124
Query: 251 ---------------SNILLNDDFEAKISDFGLARLISDCESHV--STVVAGTIGYVPPE 293
+NI+++ K+ DFG+AR I+D + V + V GT Y+ PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 294 YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
R DVYS G +L E++TG+ P G++ V ++ +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPF-------TGDSPVSVAYQHVREDPIPPSAR 237
Query: 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPT 385
L+A+ +LK L +P R
Sbjct: 238 HEGLSADLDAVVLKALAK-------NPENRYQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-36
Identities = 66/287 (22%), Positives = 103/287 (35%), Gaps = 61/287 (21%)
Query: 146 NKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATGQGD-REFAAEMETLGM 198
++ +G G FG V + +TVAVK L + + R +E++ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 199 VKHQ-NLVELLGYCSVDEEKL-LVYEYMVKGSLDDWLRNQ---------------AASLD 241
+ H N+V LLG C+ L ++ E+ G+L +LR++ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 242 WGKRCKIV---------------------ASNILLNDDFEAKISDFGLARLISDCESHV- 279
A NILL++ KI DFGLAR I +V
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWV 339
+ ++ PE T + DV+SFGV+L E+ + P G + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEF 246
Query: 340 LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+K D T +M Q C +P+ RPT
Sbjct: 247 CRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTF 284
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-35
Identities = 64/288 (22%), Positives = 105/288 (36%), Gaps = 63/288 (21%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMP--------DGKTVAVKKLSQATGQGD-REFAAEMETL 196
++ +G G FG V VAVK L + D + +EME +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 197 GMV-KHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLR---------------NQAASL 240
M+ KH+N++ LLG C+ D ++ EY KG+L ++L+ N L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 241 DWGKRCKIV---------------------ASNILLNDDFEAKISDFGLARLISDCESHV 279
A N+L+ +D KI+DFGLAR I + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 280 ST-VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDW 338
T + ++ PE T + DV+SFGV+L E+ T + E L
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---YPGVPVEELFKL 249
Query: 339 VLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + ++ + ++ + C P+ RPT
Sbjct: 250 LKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQRPTF 284
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (326), Expect = 3e-35
Identities = 55/260 (21%), Positives = 101/260 (38%), Gaps = 46/260 (17%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAAEMETLGMVKHQNLVEL 207
+G G FG V +G+ A+K L + ++ E L +V H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 208 LGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV--- 249
G ++ ++ +Y+ G L LR +L++ I+
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 250 --ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVY 307
NILL+ + KI+DFG A+ + D + GT Y+ PE T + D +
Sbjct: 130 LKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 308 SFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLK 367
SFG+++ E++ G P F D + + +L+ E+ P N + K + +
Sbjct: 186 SFGILIYEMLAGYTP----FYDSNTMKTYEKILN-------AELRFPPFFNEDVKDLLSR 234
Query: 368 MLQIATGCISNDPTVRPTML 387
++ D + R L
Sbjct: 235 LITR-------DLSQRLGNL 247
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (327), Expect = 4e-35
Identities = 63/271 (23%), Positives = 95/271 (35%), Gaps = 46/271 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQA---TGQGDREFAAEMETLGMVK- 200
N F +IG GGFG V+ D GK A+K L + QG+ E L +V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 201 --HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWG 243
+V + ++ + + M G L L L+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 244 KRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTG 298
+V +NILL++ +ISD GLA S + H S GT GY+ PE G
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 180
Query: 299 KA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357
A D +S G +L +L+ G P F ++ + + V P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK----HEIDRMTLTMAVELPDSF 232
Query: 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388
+ + + +LQ D R L
Sbjct: 233 SPELRSLLEGLLQR-------DVNRRLGCLG 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-34
Identities = 55/265 (20%), Positives = 93/265 (35%), Gaps = 47/265 (17%)
Query: 153 VIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDR------EFAAEMETLGMVKHQNLV 205
+G G F V K G A K + + + R + E+ L ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDW---------------LRNQAASLDWGKRCKIV- 249
L + +L+ E + G L D+ L+ + + +I
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 250 ----ASNILLNDD----FEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKAT 301
NI+L D KI DFGLA I + GT +V PE
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLG 194
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
D++S GVI L++G P G+ + + ++ E + +A +
Sbjct: 195 LEADMWSIGVITYILLSGASPF-------LGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 362 KPTMLKMLQIATGCISNDPTVRPTM 386
K + ++L DP R T+
Sbjct: 248 KDFIRRLLVK-------DPKKRMTI 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (315), Expect = 4e-34
Identities = 57/278 (20%), Positives = 95/278 (34%), Gaps = 55/278 (19%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGD---------REFAAEMETL 196
+ + ++G G V + P K AVK + G E++ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 197 GMVK-HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA----- 250
V H N+++L + LV++ M KG L D+L + +L + KI+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEV 122
Query: 251 ----------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY 294
NILL+DD K++DFG + + V GT Y+ PE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAPEI 180
Query: 295 ------GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348
+ D++S GVI+ L+ G P F + + +M
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----F---WHRKQMLMLRMIMSGNYQ 233
Query: 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ + K + + L + P R T
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVV-------QPQKRYTA 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-34
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 38/272 (13%)
Query: 152 NVIGGGGFGTVFKGT-MPDGKTVAVKKL-----SQATGQGDREFAAEMETLGMVKHQNLV 205
+ +G G F TV+K + VA+KK+ S+A +R E++ L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 206 ELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKIV- 249
LL LV+++M N L++ + I+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 250 ----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE-YGGTGKATERG 304
+N+LL+++ K++DFGLA+ + T T Y PE G
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 305 DVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364
D+++ G IL EL+ + + + + + + + D P + S P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 365 ML----------KMLQIATGCISNDPTVRPTM 386
+ +L + G +P R T
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-34
Identities = 59/289 (20%), Positives = 105/289 (36%), Gaps = 53/289 (18%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE-FAAEMETLGMVKHQ 202
++ + IG G +G V + VA+KK+S Q + E++ L +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 203 NLVELLGYCSVDEEKLLVYEYMV----KGSLDDWLRNQAASLDWGKRCKIVA-------- 250
N++ + + + Y+V L L+ Q L C +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKY 124
Query: 251 -------------SNILLNDDFEAKISDFGLARLISDCESHVS--TVVAGTIGYVPPEYG 295
SN+LLN + KI DFGLAR+ H T T Y PE
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 296 GTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
K T+ D++S G IL E+++ + F K + ++ +L ++ + +++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPI----FPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 355 AVLNANSKPTML-----------------KMLQIATGCISNDPTVRPTM 386
L A + L K L + ++ +P R +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (313), Expect = 9e-34
Identities = 53/278 (19%), Positives = 99/278 (35%), Gaps = 41/278 (14%)
Query: 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQN 203
K+ IG G +G V+K G+T A+KK+ + E+ L +KH N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCKI 248
+V+L + +LV+E++ + + + + ++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 249 V-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATER 303
+ N+L+N + E KI+DFGLAR + + P G+ K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 304 GDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM---------------KNEQA 348
D++S G I E+V G F + + + ++ K +
Sbjct: 182 IDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
V +P + K + + + + DP R T
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-33
Identities = 54/282 (19%), Positives = 94/282 (33%), Gaps = 49/282 (17%)
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQN 203
F + IG G +G V+K G+ VA+KK+ T E+ L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 204 LVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV-------------- 249
+V+LL + + LV+E++ + + + +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 250 -------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
N+L+N + K++DFGLAR + V P G +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 303 RGDVYSFGVILLELVTGKQP------------------TGPEFEDKDGENLVDWVLHMMK 344
D++S G I E+VT + T E ++ D+ K
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 345 NEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ D L+ + + + +ML DP R +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHY-------DPNKRISA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-32
Identities = 51/284 (17%), Positives = 94/284 (33%), Gaps = 44/284 (15%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT--MPDGKTVAVKKLSQATGQGDRE-----FAAEMETLG 197
++ IG G +G VFK G+ VA+K++ TG+ A + L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 198 MVKHQNLVELLGYCSVDEEKLLVYEYMV-----KGSLDDWLRNQAASLDWGKRCKIVA-- 250
+H N+V L C+V +V + + + ++
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 251 -------------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVP 291
NIL+ + K++DFGLAR+ S + S V T+ Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRA 183
Query: 292 PEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351
PE D++S G I E+ K + ++D + + + +V
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 352 LDPAVLNANSKPTMLK---------MLQIATGCISNDPTVRPTM 386
P + ++ + C++ +P R +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (303), Expect = 3e-32
Identities = 38/279 (13%), Positives = 78/279 (27%), Gaps = 47/279 (16%)
Query: 141 IVAGTNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMV 199
+V + IG G FG +F+GT + + + VA+K + + E T ++
Sbjct: 2 VVGV--HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLL 57
Query: 200 KHQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA--------- 250
+ + Y + ++ ++ SL+D L
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 251 ------------SNILLNDDFE-----AKISDFGLARLISDCESHV------STVVAGTI 287
N L+ + DFG+ + D + ++GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 288 GYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ 347
Y+ + + R D+ + G + + + G P G + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-------WQGLKAATNKQKYERIGE 230
Query: 348 ADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+ L A K + + P
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDY 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 6e-32
Identities = 44/272 (16%), Positives = 84/272 (30%), Gaps = 43/272 (15%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNL 204
N++ IG G FG ++ GT + G+ VA+K T + E + M++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 205 VELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK----------------- 247
+ + +C + + ++ ++ SL+D +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 248 ----IVASNILLND---DFEAKISDFGLARLISDCESHV------STVVAGTIGYVPPEY 294
+ N L+ I DFGLA+ D +H + + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 295 GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354
+ + R D+ S G +L+ G ++ + + + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMST---PI 237
Query: 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
VL L C S +P
Sbjct: 238 EVLCKGYPSEFATYLN---FCRSLRFDDKPDY 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-32
Identities = 53/273 (19%), Positives = 93/273 (34%), Gaps = 59/273 (21%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE------FAAEMETLGM 198
+++ ++G GGFG+V+ G + D VA+K + + E E+ L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 199 VK--HQNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIVA------ 250
V ++ LL + + +L+ E + +L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 251 ---------------SNILLN-DDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEY 294
NIL++ + E K+ DFG L+ D V T GT Y PPE+
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEW 180
Query: 295 -GGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353
V+S G++L ++V G P FE + +V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE-------------EIIRGQVFF 223
Query: 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+++ + + L + P+ RPT
Sbjct: 224 RQRVSSECQHLIRWCLAL-------RPSDRPTF 249
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-31
Identities = 59/265 (22%), Positives = 97/265 (36%), Gaps = 43/265 (16%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAAEMETLGMVKH 201
N F ++G G FG V G+ A+K L + E E L +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 202 QNLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRC 246
L L + V EY G L L + ++L++
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 247 KIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKAT 301
+V N++L+ D KI+DFGL + + + T GT Y+ PE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 183
Query: 302 ERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361
D + GV++ E++ G+ P F ++D E L + +L +E+ P L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILM-------EEIRFPRTLSPEA 232
Query: 362 KPTMLKMLQIATGCISNDPTVRPTM 386
K + +L+ DP R
Sbjct: 233 KSLLAGLLKK-------DPKQRLGG 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 6e-31
Identities = 61/297 (20%), Positives = 104/297 (35%), Gaps = 63/297 (21%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQ 202
+K+ + IG G FG VFK G+ VA+KK+ E++ L ++KH+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 203 NLVELLGYCSVDEEK--------LLVYEYMVKGSLDDWLRNQ---------------AAS 239
N+V L+ C LV+++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 240 LDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCES---HVSTVVAGTIGYVP 291
L + R KI+ A+N+L+ D K++DFGLAR S ++ + T T+ Y P
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 292 PE-YGGTGKATERGDVYSFGVILLELVTGKQP------------------TGPEFEDKDG 332
PE G D++ G I+ E+ T + +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 333 ENLVDWV---LHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
+N + L + + + L V + + + K+L + DP R
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-------DPAQRIDS 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 5e-30
Identities = 57/283 (20%), Positives = 96/283 (33%), Gaps = 49/283 (17%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKL--SQATGQGDREFAAEMETLGMVKHQ 202
K+ + IG G +GTVFK + VA+K++ E+ L +KH+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCK 247
N+V L D++ LV+E+ + + L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 248 IV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
++ N+L+N + E K+++FGLAR S V P G +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 303 RGDVYSFGVILLELVTGKQP-------------------TGPEFEDKDGENLVDWVLHMM 343
D++S G I EL +P T E + L D+ + M
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
V LNA + + +L+ +P R +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKC-------NPVQRISA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-30
Identities = 49/267 (18%), Positives = 96/267 (35%), Gaps = 48/267 (17%)
Query: 151 ENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLG 209
V+G G G V + + A+K L + RE + ++V ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRAS---QCPHIVRIVD 72
Query: 210 YC----SVDEEKLLVYEYMVKGSLDDWLRNQAA-SLDWGKRCKIVA-------------- 250
+ + L+V E + G L ++++ + + +I+
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 251 -------SNILLNDDFE---AKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKA 300
N+L K++DFG A+ + S + T YV PE G K
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKY 190
Query: 301 TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD-EVLDPAVLNA 359
+ D++S GVI+ L+ G P F G + + ++ Q + + + ++
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 360 NSKPTMLKMLQIATGCISNDPTVRPTM 386
K + +L+ +PT R T+
Sbjct: 247 EVKMLIRNLLKT-------EPTQRMTI 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-29
Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 55/285 (19%)
Query: 148 FCEENVIGGGGFGTVFKGTMPD-GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVE 206
+ + VIG G FG V++ + D G+ VA+KK+ Q R E++ + + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVR 77
Query: 207 LLGYCSVDEEK------LLVYEYMVKGSLDDWLR--NQAASLDWGKRCKIVA-------- 250
L + EK LV +Y+ + +L +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 251 --------------SNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGG 296
+ +L D K+ DFG A+ + E +VS + P G
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYRAPELIFG 196
Query: 297 TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356
T DV+S G +L EL+ G+ F G + + ++ ++ +++ +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 357 LNANSKPTMLK---------------MLQIATGCISNDPTVRPTM 386
K +K + + + + PT R T
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-28
Identities = 61/274 (22%), Positives = 104/274 (37%), Gaps = 45/274 (16%)
Query: 144 GTNKFCEENVIGGGGFGTVFKG----TMPDGKTVAVKKLSQAT----GQGDREFAAEMET 195
G F V+G G +G VF GK A+K L +AT + E +
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 196 LGMVKHQ-NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AAS 239
L ++ LV L + + L+ +Y+ G L L + +
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 240 LDWGKRCKIV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPE- 293
L+ + I+ NILL+ + ++DFGL++ E+ + GTI Y+ P+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 294 -YGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVL 352
GG + D +S GV++ EL+TG P F + + + + E
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASP----F---TVDGEKNSQAEISRRILKSEPP 254
Query: 353 DPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386
P ++A +K + ++L DP R
Sbjct: 255 YPQEMSALAKDLIQRLLMK-------DPKKRLGC 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 9e-26
Identities = 55/284 (19%), Positives = 98/284 (34%), Gaps = 49/284 (17%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQ--ATGQGDREFAAEMETLGMVKHQ 202
+ + +G G +G V G VA+KKL + + + E+ L ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 203 NLVELLGYCSVDE------EKLLVYEYMVKGSLDDWLRNQAASLDWGKRCKIV------- 249
N++ LL + DE + LV +M L ++++ L + +V
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGL 134
Query: 250 --------------ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG 295
N+ +N+D E KI DFGLAR +S ++ V P
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVIL 191
Query: 296 GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355
+ T+ D++S G I+ E++TGK + ++ D A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 356 VLNANSKPTMLK-------------MLQIATGCISNDPTVRPTM 386
P + K + + + D R T
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 6e-25
Identities = 54/322 (16%), Positives = 110/322 (34%), Gaps = 72/322 (22%)
Query: 87 RQSDPEETRESKRNSISDQNRKSISDRSSSALMEHLSINLAMFEPSLQKLTYDQIVAGTN 146
+ S+ E +E + D +K + ++A ++ +D+I
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ----------------FDRI----- 46
Query: 147 KFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDRE---FAAEMETLGMVKHQ 202
+G G FG V G A+K L + ++ E L V
Sbjct: 47 -----KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 203 NLVELLGYCSVDEEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGKRCK 247
LV+L + +V EY+ G + LR + ++
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 248 IV-----ASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATE 302
++ N+L++ +++DFG A+ + + GT + PE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNK 217
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSK 362
D ++ GV++ E+ G P F + + ++ +V P+ +++ K
Sbjct: 218 AVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSG-------KVRFPSHFSSDLK 266
Query: 363 PTMLKMLQIATGCISNDPTVRP 384
+ +LQ+ D T R
Sbjct: 267 DLLRNLLQV-------DLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 100 bits (249), Expect = 2e-24
Identities = 35/218 (16%), Positives = 82/218 (37%), Gaps = 28/218 (12%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQN 203
+ + +G G + VF+ + + + V VK L ++ E++ L ++ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 204 LVELLGYCSVDEEKL--LVYEYMVKGSLDD------------WLRNQAASLDWGKRCKIV 249
++ L + LV+E++ ++ +LD+ I+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 250 -----ASNILL-NDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYG-GTGKATE 302
N+++ ++ + ++ D+GLA + + V + + PE
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQMYDY 209
Query: 303 RGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVL 340
D++S G +L ++ K+P ++ D + VL
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 5e-24
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 51/286 (17%)
Query: 145 TNKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKH 201
++ + +G G +G+V G VAVKKLS+ + + E+ L +KH
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 202 QNLVELLGYCS-----VDEEKLLVYEYMVKGSLDDWLRNQAASLDWGKRCK--------- 247
+N++ LL + + + + +++ L++ ++ Q + D +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 248 ----------IVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGT 297
+ SN+ +N+D E KI DFGLAR + ++ VA P
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNW 193
Query: 298 GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357
+ D++S G I+ EL+TG+ F D + + +L ++ A+ + +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 358 NANSKPTMLK-----------------MLQIATGCISNDPTVRPTM 386
+A + L + + + D R T
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 1e-22
Identities = 51/224 (22%), Positives = 81/224 (36%), Gaps = 32/224 (14%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQ 202
++ IG G G V + VA+KKLS+ + E+ + V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 203 NLVELLGYCSVD------EEKLLVYEYMVKGSLDDWLRN----QAASL------------ 240
N++ LL + ++ LV E M + + L
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 241 -DWGKRCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGK 299
+ SNI++ D KI DFGLAR + S + T T Y PE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 300 ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMM 343
E D++S G I+ E+V K F +D + + V+ +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKVIEQL 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.8 bits (198), Expect = 2e-17
Identities = 38/239 (15%), Positives = 72/239 (30%), Gaps = 45/239 (18%)
Query: 146 NKFCEENVIGGGGFGTVFKGT-MPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNL 204
++ +G G F TV+ M + VA+K + + E++ L V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADN 71
Query: 205 VELLGYCSVDEEKLLVY---------------EYMVKGSLDDWLRNQAASLDWGKRCKIV 249
+ + KLL + E + + L + + + +I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 250 ----------------------ASNILLN-DDFEAKISDFGLARLISDCESHVSTV-VAG 285
N+L+ D + +A L + C
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMK 344
T Y PE D++S ++ EL+TG FE +G + H+ +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQ 246
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.0 bits (155), Expect = 1e-12
Identities = 23/148 (15%), Positives = 40/148 (27%), Gaps = 26/148 (17%)
Query: 152 NVIGGGGFGTVFKGTMPDGKTVAVK----------KLSQATGQGDREFAAEMETLGMVKH 201
++G G VF VK K+ + GD F+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 202 QNLVELLGYCSVD----EEKLLVYEYMVKGSLDDW--------LRNQAASLDWGKRCKIV 249
+ L +L G E ++ E + L L + IV
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 250 ----ASNILLNDDFEAKISDFGLARLIS 273
+ +L + I DF + +
Sbjct: 126 HGDLSQYNVLVSEEGIWIIDFPQSVEVG 153
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 2e-10
Identities = 16/43 (37%), Positives = 23/43 (53%)
Query: 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43
+ L L LN++ N L GE+P+ G Q + + NK LCG
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 388 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.74 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.65 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.41 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.02 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 96.71 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 96.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 96.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.28 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 96.12 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 95.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 95.18 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 95.11 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 94.99 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 94.86 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 94.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 94.05 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 94.03 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 93.66 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 93.53 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 93.18 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 92.67 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 92.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 92.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 91.84 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 91.1 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 90.49 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 89.57 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 89.06 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 88.77 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 88.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 88.29 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 88.09 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 87.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 84.06 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 83.94 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 81.66 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 80.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 80.16 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=357.62 Aligned_cols=226 Identities=26% Similarity=0.447 Sum_probs=169.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|...+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999888899999997643 446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+|+|.+++..... +|.|+| |+||+|+|||+++++.+||+|||+|+..............
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 163 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence 9999998865332 455555 5688899999999999999999999887654444444567
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPT 364 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (388)
||+.|+|||++....++.++|||||||++|||+|+..|+. ......++.+.+....+. ..|. ..
T Consensus 164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~---~~~~~~~~~~~i~~~~~~------~~p~-------~~ 227 (263)
T d1sm2a_ 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY---ENRSNSEVVEDISTGFRL------YKPR-------LA 227 (263)
T ss_dssp -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT---CSCCHHHHHHHHHHTCCC------CCCT-------TS
T ss_pred cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC---CCCCHHHHHHHHHhcCCC------CCcc-------cc
Confidence 8999999999999999999999999999999999655542 222334444444332111 1111 11
Q ss_pred HHHHHHHHHhcccCCCCCCCCCCC
Q 035768 365 MLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 365 ~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++.+++.+||+.||++||||+|
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~ 251 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSR 251 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHH
Confidence 236889999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=364.34 Aligned_cols=227 Identities=30% Similarity=0.442 Sum_probs=179.5
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
..++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++. ++..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 345788889999999999999999888899999997543 44578999999999999999999999875 4567999999
Q ss_pred cCCCCHHHHHhc-----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRN-----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~-----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++.. .+.++.|+| |+||+|+|||+++++.+||+|||+|+.+.........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 999999987642 234566777 5688999999999999999999999988665544455
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|||||++....++.++|||||||++|||+||..|+.. .....++...+....+. ..| .
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~---~~~~~~~~~~i~~~~~~------~~p---~--- 233 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQNLERGYRM------VRP---D--- 233 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST---TCCHHHHHHHHHTTCCC------CCC---T---
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC---CCCHHHHHHHHHhcCCC------CCc---c---
Confidence 56789999999999888999999999999999999997666532 22333444433322111 111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++||||+|
T Consensus 234 -~~~~~l~~li~~cl~~~P~~Rpt~~e 259 (272)
T d1qpca_ 234 -NCPEELYQLMRLCWKERPEDRPTFDY 259 (272)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -cChHHHHHHHHHHcCCCHhHCcCHHH
Confidence 11236889999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=356.28 Aligned_cols=227 Identities=24% Similarity=0.360 Sum_probs=182.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999996 469999999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecccc
Q 035768 225 VKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVAG 285 (388)
Q Consensus 225 ~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 285 (388)
++|+|.+++.+ ...+|.|+| |+||+|+|||++.++.+||+|||+|+.+..... .....+|
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~g 178 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 178 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCS
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccccccc
Confidence 99999987753 234677887 568889999999999999999999998754332 2345679
Q ss_pred ccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHH
Q 035768 286 TIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTM 365 (388)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (388)
|+.|+|||++.+..++.++|||||||++|||+||+.||... +..+....+.. ... .....+ ....
T Consensus 179 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~~~~---~~~-~~~~~~-------~~~s 243 (293)
T d1yhwa1 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----NPLRALYLIAT---NGT-PELQNP-------EKLS 243 (293)
T ss_dssp CGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHH---HCS-CCCSSG-------GGSC
T ss_pred CCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC----CHHHHHHHHHh---CCC-CCCCCc-------ccCC
Confidence 99999999999999999999999999999999999998532 22222222211 111 111111 1112
Q ss_pred HHHHHHHHhcccCCCCCCCCCCC
Q 035768 366 LKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 366 ~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+.+++.+||+.||++|||++|
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHH
Confidence 36889999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-50 Score=364.33 Aligned_cols=229 Identities=27% Similarity=0.438 Sum_probs=182.7
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
...++|...+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888899999999999999975 58899999997643 44678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 222 EYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
|||++|+|.+++.+. +.+|.|+| |+||+|+|||+++++.+||+|||+|+.........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999999988532 23566777 56888999999999999999999999876655555
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+.. ..+...+.+.+...... . ...
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~---~~~~~~~~~~i~~~~~~----~-----~~~- 239 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRM----E-----RPE- 239 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST---TCCHHHHHHHHHTTCCC----C-----CCT-
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC---cchHHHHHHHHhcCCCC----C-----CCc-
Confidence 5556689999999999999999999999999999999998777632 22333333333221111 0 111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++||||+|
T Consensus 240 ---~~~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 240 ---GCPEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 12236889999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=353.16 Aligned_cols=228 Identities=24% Similarity=0.317 Sum_probs=173.9
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|+..+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888899999999999999964 689999999975432 2345689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-ceeec
Q 035768 224 MVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-HVSTV 282 (388)
Q Consensus 224 ~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 282 (388)
|++|+|.+++.. ...++.|+| |+||+|+|||+++++.+||+|||+|+....... .....
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 999999988753 234677777 568889999999999999999999998754322 23345
Q ss_pred cccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
.+||+.|||||++.+..+ +.++|||||||++|||+||+.||.... +......... ..... ..+ .
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~~~~---~~~~~---~~~------~ 229 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWK---EKKTY---LNP------W 229 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS---TTSHHHHHHH---TTCTT---STT------G
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC---hHHHHHHHHh---cCCCC---CCc------c
Confidence 679999999999877776 678999999999999999999985422 1111111111 11000 000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||++|
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 011235778999999999999999854
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=354.41 Aligned_cols=225 Identities=22% Similarity=0.306 Sum_probs=170.0
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV--DEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 220 (388)
++|+..+.||+|+||+||+|+. .+|+.||||.++.... ...+.|.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788899999999999999986 4689999999976532 234568999999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHhc-------------------cCCCCCHHh----------hhccccCCeeecCCCCEEEccccccee
Q 035768 221 YEYMVKGSLDDWLRN-------------------QAASLDWGK----------RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~-------------------~~~~l~~~~----------~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
||||++|+|.+++.+ .+.+|.|+| |+||+|+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999998752 133566776 678999999999999999999999998
Q ss_pred ccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||... +..++...+.. ......
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~----~~~~~~~~i~~----~~~~~~ 234 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAGKIRE----GKFRRI 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHH----TCCCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC----CHHHHHHHHHc----CCCCCC
Confidence 754322 234567999999999999999999999999999999999999998532 33334333322 111111
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.... ..++.+++.+||+.||++|||++|
T Consensus 235 -----~~~~----s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 235 -----PYRY----SDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp -----CTTS----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----Cccc----CHHHHHHHHHHcCCChhHCcCHHH
Confidence 1111 226889999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=352.53 Aligned_cols=230 Identities=27% Similarity=0.412 Sum_probs=170.0
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
..++|...+.||+|+||+||+|++++ .||||+++... ....+.|.+|+++|++++|||||+++|++. ++..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 34678889999999999999998743 59999997543 334567999999999999999999999875 45689999
Q ss_pred eccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-ce
Q 035768 222 EYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-HV 279 (388)
Q Consensus 222 e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~ 279 (388)
|||++|+|.++++... .++.|+| |+||+|+|||++.++.+||+|||+|+....... ..
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 9999999999986432 3456666 568889999999999999999999987654322 23
Q ss_pred eeccccccCccCccccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 280 STVVAGTIGYVPPEYGGT---GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.....||+.|||||++.. ..|+.++|||||||++|||+||+.||.... ....+...+........... .
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~~p~~~~-----~ 234 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIFMVGRGYLSPDLSK-----V 234 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CHHHHHHHHHHTSCCCCGGG-----S
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC---hHHHHHHHHhcCCCCCcchh-----c
Confidence 345679999999998753 458999999999999999999999985421 22222222222211111111 1
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. .....+.+++.+||+.||++||||+|
T Consensus 235 ~~----~~~~~l~~li~~cl~~dp~~RPt~~~ 262 (276)
T d1uwha_ 235 RS----NCPKAMKRLMAECLKKKRDERPLFPQ 262 (276)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cc----cchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 11 12236889999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=344.70 Aligned_cols=225 Identities=26% Similarity=0.441 Sum_probs=183.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMV 225 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 225 (388)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788899999999999999999888899999997654 346789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcc----------------CCCCCHHhh-----hccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 226 KGSLDDWLRNQ----------------AASLDWGKR-----CKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 226 ~g~L~~~l~~~----------------~~~l~~~~~-----~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
+|+|.+++... +.++.|+|. +||+|+|||+++++.+||+|||+++..............
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 99999886432 346667774 467799999999999999999999877655544444567
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
||+.|+|||.+....++.++|||||||++|||+| |+.||... +..++...+....+ ...|. .
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~----~~~~~~~~i~~~~~------~~~p~-------~ 225 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQGLR------LYRPH-------L 225 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----CHHHHHHHHHTTCC------CCCCT-------T
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC----CHHHHHHHHHhCCC------CCCcc-------c
Confidence 8999999999999999999999999999999998 89997532 33344443332111 11111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++||||+|
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~e 250 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKI 250 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHH
Confidence 1236889999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=347.18 Aligned_cols=222 Identities=24% Similarity=0.373 Sum_probs=178.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999974 6899999998643 2234567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|||++|+|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+|+...... ..
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---CE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc---cc
Confidence 99999999998753 234677777 56888999999999999999999998765432 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|||||++.+..++.++|||||||++|||+||+.||.. .+..++.+.+.... ..... .
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~----~~~~~~~~~i~~~~--~~~p~--------~-- 226 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVE--FTFPD--------F-- 226 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHTTC--CCCCT--------T--
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC----CCHHHHHHHHHcCC--CCCCc--------c--
Confidence 46799999999999999999999999999999999999999853 23333333222110 01111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++.+++.+||+.||++|||++|
T Consensus 227 --~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 227 --VTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHH
Confidence 1236788999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-48 Score=353.92 Aligned_cols=226 Identities=27% Similarity=0.442 Sum_probs=165.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-C---CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-G---KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|+..+.||+|+||+||+|++.. + ..||||++..... ...++|.+|+++|++++|||||+++|+|..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345667899999999999999743 3 2589999875433 3346799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhccCC----------------CCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 221 YEYMVKGSLDDWLRNQAA----------------SLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~~~----------------~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
||||++|+|.+++..... +|.|+| |+||+|+|||++.++.+||+|||+|+.+.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 999999999998865433 445555 56889999999999999999999998775432211
Q ss_pred ----eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 280 ----STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 280 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.....||+.|||||.+....++.++|||||||++|||+| |+.||... ...++...+....+...
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~----~~~~~~~~i~~~~~~~~------- 254 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINAIEQDYRLPP------- 254 (299)
T ss_dssp ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCCCCC-------
T ss_pred eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCCCCC-------
Confidence 122457899999999999999999999999999999998 89997532 33444444432211110
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+......+.+++.+||+.||++||||+|
T Consensus 255 ------~~~~~~~l~~li~~cl~~~P~~RPs~~e 282 (299)
T d1jpaa_ 255 ------PMDCPSALHQLMLDCWQKDRNHRPKFGQ 282 (299)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ------CccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 1112236889999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=348.13 Aligned_cols=227 Identities=19% Similarity=0.288 Sum_probs=179.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+.|+..+.||+|+||+||+|+. .+++.||||+++.......+.|.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4578889999999999999996 468999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+|+...... ......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~ 170 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF 170 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccc
Confidence 999999987542 23566777 56889999999999999999999998754321 122345
Q ss_pred ccccCccCcccc-----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 284 AGTIGYVPPEYG-----GTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 284 ~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.||+.|||||++ ....|+.++|||||||++|||+||+.||... +..++...+.... ......+
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~----~~~~~~~~i~~~~----~~~~~~~---- 238 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL----NPMRVLLKIAKSE----PPTLAQP---- 238 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS----CGGGHHHHHHHSC----CCCCSSG----
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHHcCC----CCCCCcc----
Confidence 799999999986 3556899999999999999999999998542 3334433332211 1111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++|||++|
T Consensus 239 ---~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 239 ---SRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp ---GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ---ccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 111236889999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=349.01 Aligned_cols=225 Identities=22% Similarity=0.325 Sum_probs=177.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+. .+++.||||++++. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688899999999999999996 46899999998643 2234567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-cee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES-HVS 280 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~ 280 (388)
|||++|+|.+++.. ...+|.|+| |+||+|+|||+++++.+||+|||+|+.+..... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999998753 234677777 567889999999999999999999998754322 233
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+||+.|||||++.+..++.++|||||||++|||+||+.||... +...+.+.+.. ... . .....
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~----~~~-~-----~p~~~ 233 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEYLIFQKIIK----LEY-D-----FPEKF 233 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHT----TCC-C-----CCTTC
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CHHHHHHHHHc----CCC-C-----CCccC
Confidence 4467999999999999999999999999999999999999998532 33333333222 111 0 11111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++.+++.+||+.||++|||++|
T Consensus 234 ----s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 234 ----FPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred ----CHHHHHHHHHHccCCHhHCcCHHH
Confidence 225789999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=353.39 Aligned_cols=227 Identities=30% Similarity=0.450 Sum_probs=171.9
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
..++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|. ++..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 346788899999999999999999888899999997543 44678999999999999999999999985 5668999999
Q ss_pred cCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 224 MVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 224 ~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
+++|+|.+++... +.++.|+| |+||+|+|||+|+++.+||+|||+|+...........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9999999887532 33556666 4588899999999999999999999887654444445
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||++....++.++|||||||++|||+||..|+.. .....++...+....... .. .
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~---~~~~~~~~~~i~~~~~~~-----~~----~--- 237 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP---GMVNREVLDQVERGYRMP-----CP----P--- 237 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST---TCCHHHHHHHHHTTCCCC-----CC----T---
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC---CCCHHHHHHHHHhcCCCC-----CC----c---
Confidence 56799999999999999999999999999999999997777532 223344444443321111 01 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....++.+++.+||+.||++||||+|
T Consensus 238 -~~~~~l~~li~~cl~~dP~~Rps~~~ 263 (285)
T d1fmka3 238 -ECPESLHDLMCQCWRKEPEERPTFEY 263 (285)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -ccCHHHHHHHHHHcccCHhHCcCHHH
Confidence 12236889999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=344.68 Aligned_cols=221 Identities=26% Similarity=0.367 Sum_probs=167.9
Q ss_pred CcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEE
Q 035768 149 CEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSV----DEEKLLVY 221 (388)
Q Consensus 149 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 221 (388)
+..+.||+|+||+||+|++. +++.||+|++.... ....+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999964 68899999986543 2334579999999999999999999999875 34578999
Q ss_pred eccCCCCHHHHHhcc---------------CCCCCHHh-------hhccccCCeeec-CCCCEEEcccccceeccCCCcc
Q 035768 222 EYMVKGSLDDWLRNQ---------------AASLDWGK-------RCKIVASNILLN-DDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 222 e~~~~g~L~~~l~~~---------------~~~l~~~~-------~~~i~~~NiLl~-~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||+++|+|.+++.+. +.+|.|+| |+||+|+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 999999999988542 34667776 467889999996 5789999999999865432
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccC
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLN 358 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (388)
.....+||+.|||||++.+ +++.++|||||||++|||+||+.||... .+...+.+.+....... ....
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~---~~~~~~~~~i~~~~~~~--------~~~~ 236 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGVKPA--------SFDK 236 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC---SSHHHHHHHHTTTCCCG--------GGGG
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc---ccHHHHHHHHHcCCCCc--------ccCc
Confidence 2334679999999998864 6999999999999999999999998532 12222332222111111 1111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 359 ANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 359 ~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+ .++.+++.+||+.||++|||++|
T Consensus 237 ~~~----~~~~~li~~~l~~dp~~R~s~~e 262 (270)
T d1t4ha_ 237 VAI----PEVKEIIEGCIRQNKDERYSIKD 262 (270)
T ss_dssp CCC----HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cCC----HHHHHHHHHHccCCHhHCcCHHH
Confidence 111 25788999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=356.61 Aligned_cols=178 Identities=28% Similarity=0.416 Sum_probs=153.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.++|+..+.||+|+||+||+|+. .+|+.||+|+++.... .....+.+|+++|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788899999999999999996 4689999999976433 334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcc---------------CCCCCHHh------hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 223 YMVKGSLDDWLRNQ---------------AASLDWGK------RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 223 ~~~~g~L~~~l~~~---------------~~~l~~~~------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||++|+|.+++.+. ..+|.|+| |+||||+|||++.++.+||+|||+|+..... ...
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~ 161 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 161 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC-
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---ccc
Confidence 99999999988532 34677777 3588899999999999999999999876432 223
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
..+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 46799999999999999999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=344.93 Aligned_cols=227 Identities=26% Similarity=0.425 Sum_probs=168.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCC-----CEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDG-----KTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
+.|+..++||+|+||+||+|.+++. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999986532 3699999975433 234569999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc-
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES- 277 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~- 277 (388)
|||||.+|++.+++.... .++.|+| |+||+|+|||++.++.+||+|||+|+.+.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999999998775432 3455666 568899999999999999999999988754322
Q ss_pred -ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 278 -HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 278 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
.......||+.|||||++....++.++|||||||++|||+||..|+... ....++.+.+....+...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~~~~~~~--------- 234 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---LSNHEVMKAINDGFRLPT--------- 234 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHHTTCCCCC---------
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc---CCHHHHHHHHhccCCCCC---------
Confidence 2223456899999999999999999999999999999999977665322 233344443332211110
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+......+.+|+.+||+.||++||||.|
T Consensus 235 ----~~~~~~~l~~li~~cl~~~p~~RPt~~e 262 (283)
T d1mqba_ 235 ----PMDCPSAIYQLMMQCWQQERARRPKFAD 262 (283)
T ss_dssp ----CTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ----chhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence 1112236889999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=344.48 Aligned_cols=224 Identities=25% Similarity=0.415 Sum_probs=173.3
Q ss_pred cCCCcCCe-eeccCCceEEEEEcC---CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENV-IGGGGFGTVFKGTMP---DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~-lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+. ||+|+||+||+|.++ ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 44555564 999999999999864 345799999976543 335679999999999999999999999864 568999
Q ss_pred EeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc-
Q 035768 221 YEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~- 278 (388)
||||++|+|.+++... +.+|.|+| |+||+|+|||++.++.+||+|||+|+.+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999999987543 23556666 4688899999999999999999999987654332
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......||+.|||||++....++.++|||||||++|||+| |+.||... ...++...+....+ ...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~----~~~~~~~~i~~~~~----~~~----- 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKR----MEC----- 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CTHHHHHHHHTTCC----CCC-----
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC----CHHHHHHHHHcCCC----CCC-----
Confidence 2234568999999999988899999999999999999998 89998542 23344443332211 111
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
.. ....++.+|+.+||+.||++||||.
T Consensus 234 p~----~~~~~l~~li~~cl~~~p~~RPs~~ 260 (285)
T d1u59a_ 234 PP----ECPPELYALMSDCWIYKWEDRPDFL 260 (285)
T ss_dssp CT----TCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CC----cCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 11 1223688999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=343.97 Aligned_cols=219 Identities=28% Similarity=0.410 Sum_probs=167.3
Q ss_pred CeeeccCCceEEEEEcC---CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 035768 152 NVIGGGGFGTVFKGTMP---DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYMVK 226 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 226 (388)
+.||+|+||+||+|.+. .++.||||+++.... ...++|.+|+++|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 356899999975432 234679999999999999999999999964 567899999999
Q ss_pred CCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce--eeccc
Q 035768 227 GSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV--STVVA 284 (388)
Q Consensus 227 g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~ 284 (388)
|+|.+++++. +.+|.|+| |+||+|+|||++.++.+||+|||+|+.+....... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 9999988643 33566776 56889999999999999999999999875443322 23456
Q ss_pred cccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCCHH
Q 035768 285 GTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKP 363 (388)
Q Consensus 285 gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (388)
||+.|||||.+....++.++|||||||++|||+| |+.||... +..++...+... ..... | . .
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~----~~~~~~~~i~~~----~~~~~--p---~----~ 234 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAMLEKG----ERMGC--P---A----G 234 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTT----CCCCC--C---T----T
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC----CHHHHHHHHHcC----CCCCC--C---c----c
Confidence 8999999999988999999999999999999998 89997532 333444433321 11110 0 1 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 364 TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 364 ~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++.+|+.+||+.||++||||+|
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 1236889999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=350.67 Aligned_cols=229 Identities=26% Similarity=0.405 Sum_probs=175.4
Q ss_pred hhcCCCcCCeeeccCCceEEEEEcCC-C-----CEEEEEEcccC-CCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTMPD-G-----KTVAVKKLSQA-TGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
..++|...+.||+|+||+||+|++.. + ..||||.+... .......|.+|+.+|.++ +|||||+++++|.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678888999999999999998632 2 36999998654 334456799999999998 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc--------------------------------------CCCCCHHh-----hhccccCC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ--------------------------------------AASLDWGK-----RCKIVASN 252 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~--------------------------------------~~~l~~~~-----~~~i~~~N 252 (388)
..++|||||++|+|.++|+.. +.++.|+| |+||+|+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999998643 22445555 56889999
Q ss_pred eeecCCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCC
Q 035768 253 ILLNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDK 330 (388)
Q Consensus 253 iLl~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~ 330 (388)
||++.++.+||+|||+|+........ ......||+.|||||.+....++.++|||||||++|||+| |+.||....
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~--- 271 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--- 271 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC---
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999999876544332 2334668999999999999999999999999999999998 899985421
Q ss_pred CcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 331 DGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+.+....+. .. +......+.+|+.+||+.||++||||+|
T Consensus 272 ~~~~~~~~~~~~~~~---------~~----p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 272 VDANFYKLIQNGFKM---------DQ----PFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp CSHHHHHHHHTTCCC---------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhcCCCC---------CC----CCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 122233322221110 00 0111236889999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=345.30 Aligned_cols=227 Identities=23% Similarity=0.321 Sum_probs=162.6
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
+.|+..+.||+|+||+||+|+.. +++.||||++..... .....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888899999999999999964 689999999975432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeec---CCCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLN---DDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~---~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|++|+|.+++... ..+|.|+| |+||+|+|||+. +++.+||+|||+|+...... ..
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~ 166 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VL 166 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--ee
Confidence 9999999988542 33567777 568889999994 57899999999998765432 23
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
...+||+.|||||++.+..|+.++|||||||++|||+||+.||... ...++...+...... .......
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~~~~~------~~~~~~~-- 234 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE----NDAKLFEQILKAEYE------FDSPYWD-- 234 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHTTCCC------CCTTTTT--
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHhccCCC------CCCcccc--
Confidence 3467999999999999999999999999999999999999998532 333333333221111 0111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||++|
T Consensus 235 --~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 235 --DISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred --CCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 11236889999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=344.69 Aligned_cols=221 Identities=24% Similarity=0.330 Sum_probs=172.4
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc---ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ---GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
.|+..+.||+|+||+||+|+. .+++.||||+++..... ..+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478889999999999999985 46889999999765432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
||++|+|..++. +...+|.|+| |+||+|+|||++.++.+||+|||+|+.... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCc
Confidence 999999876653 2344677787 568889999999999999999999987543 223
Q ss_pred cccccCccCccccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCC
Q 035768 283 VAGTIGYVPPEYGG---TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNA 359 (388)
Q Consensus 283 ~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (388)
..||+.|||||++. ...|+.++|||||||++|||++|+.||... ...+....+ .... ...... .
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~----~~~~~~~~i---~~~~-~~~~~~----~- 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHI---AQNE-SPALQS----G- 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH---HHSC-CCCCSC----T-
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC----CHHHHHHHH---HhCC-CCCCCC----C-
Confidence 56999999999875 356899999999999999999999998532 222222222 1111 111111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 360 NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 360 ~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++|||++|
T Consensus 238 ---~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 238 ---HWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 11236889999999999999999854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-47 Score=346.90 Aligned_cols=232 Identities=28% Similarity=0.432 Sum_probs=178.7
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEE
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCS 212 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~ 212 (388)
++....++|+..+.||+|+||+||+|++. +++.||||+++..... ..++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999853 3578999999764433 3457999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhcc---------------------------------------CCCCCHHh-----hhcc
Q 035768 213 VDEEKLLVYEYMVKGSLDDWLRNQ---------------------------------------AASLDWGK-----RCKI 248 (388)
Q Consensus 213 ~~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~-----~~~i 248 (388)
..+..+++|||+++|+|.++++.. +.++.|+| |+||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999999999998532 12334455 5688
Q ss_pred ccCCeeecCCCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCC
Q 035768 249 VASNILLNDDFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK-QPTGPE 326 (388)
Q Consensus 249 ~~~NiLl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~-~P~~~~ 326 (388)
+|+|||+|.++.+||+|||+|+....... ...+...||+.|+|||.+....++.++|||||||++|||++|. +||..
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~- 245 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG- 245 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-
Confidence 99999999999999999999987644322 2233466899999999999999999999999999999999986 45432
Q ss_pred CCCCCcccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 327 FEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+..++...+... ..... +...+.++.+|+.+||+.||++||||.|
T Consensus 246 ---~~~~e~~~~v~~~----~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 246 ---MAHEEVIYYVRDG----NILAC---------PENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp ---SCHHHHHHHHHTT----CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCHHHHHHHHHcC----CCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 2344444444322 11111 1111236889999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-45 Score=344.70 Aligned_cols=227 Identities=20% Similarity=0.293 Sum_probs=180.6
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
+.|+..+.||+|+||+||+|+. .+|+.||||+++.........+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688899999999999999996 479999999997665455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeec--CCCCEEEcccccceeccCCCcceee
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLN--DDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~--~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
++|+|.+++... ..+|.|+| |+||+|+|||++ .++.+||+|||+|+.+.... ...
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~~ 186 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVK 186 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC--cee
Confidence 999999876532 33566777 568889999998 67899999999999876533 234
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|+|||++.+..++.++|||||||++|||+||+.||... +..++...+...... ..+.....
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~------~~~~~~~~-- 254 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETLQNVKRCDWE------FDEDAFSS-- 254 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHHCCCC------CCSSTTTT--
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCC------CCcccccC--
Confidence 456999999999999999999999999999999999999998532 333333333221111 01111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||.+|||+.|
T Consensus 255 --~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 255 --VSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp --SCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHH
Confidence 1236789999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=336.96 Aligned_cols=227 Identities=22% Similarity=0.284 Sum_probs=178.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC------cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG------QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
+.|+..+.||+|+||+||+|+. .+|+.||||++++... ...+.|.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688899999999999999996 4699999999864321 23567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCC----CEEEcccccceeccC
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDF----EAKISDFGLARLISD 274 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~----~~kl~DfG~a~~~~~ 274 (388)
+|||||++|+|.+++.+. ..+|.|+| |+||+|+|||++.++ .+||+|||+|+....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 999999999999988642 33667777 567889999998776 599999999988754
Q ss_pred CCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||... +..+....+...... ..+
T Consensus 170 ~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~~~~~------~~~ 237 (293)
T d1jksa_ 170 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANVSAVNYE------FED 237 (293)
T ss_dssp SC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHTTCCC------CCH
T ss_pred Cc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC----CHHHHHHHHHhcCCC------CCc
Confidence 32 233456899999999999999999999999999999999999998532 333333322221100 011
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...... ...+.+++.+||+.||++|||++|
T Consensus 238 ~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 238 EYFSNT----SALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp HHHTTS----CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hhcCCC----CHHHHHHHHHHccCChhHCcCHHH
Confidence 111111 235789999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=338.57 Aligned_cols=222 Identities=24% Similarity=0.288 Sum_probs=179.1
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999996 57999999999753 2234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|||++|+|.+++.+ ...+|.|+| |+||+|+|||++.++.+||+|||+|+...... ....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~ 163 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-cccc
Confidence 99999999998754 234677888 46788999999999999999999998764432 2334
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+||+.|+|||++.+..|+.++||||+||++|||++|+.||.. .+...+.+.+.... .... ...+
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~----~~~~~~~~~i~~~~--~~~p--------~~~s 229 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEE--IRFP--------RTLS 229 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCC--CCCC--------TTSC
T ss_pred cceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC----cCHHHHHHHHhcCC--CCCC--------ccCC
Confidence 56799999999999999999999999999999999999999753 23333433332211 1111 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.++.+++.+||+.||++||+.
T Consensus 230 ----~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 230 ----PEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp ----HHHHHHHHHHTCSSTTTSTTC
T ss_pred ----HHHHHHHHhhccCCchhhccc
Confidence 257889999999999999973
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-45 Score=341.26 Aligned_cols=227 Identities=23% Similarity=0.352 Sum_probs=180.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5788999999999999999996 468999999997765555677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeec--CCCCEEEcccccceeccCCCcceee
Q 035768 225 VKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLN--DDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 225 ~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~--~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
++|+|.+++... ..+|.|+| |+||+|+|||++ .++.+||+|||+|+.+.... ...
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~ 183 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVK 183 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--CEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--ccc
Confidence 999999988532 23566777 568889999995 46889999999999876533 234
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|||||++.+..++.++|||||||++|||+||+.||... +..++...+...... .++.....
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~------~~~~~~~~-- 251 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDWN------MDDSAFSG-- 251 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC------SCCGGGGG--
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCC------CCcccccC--
Confidence 467999999999999999999999999999999999999998532 333333333221110 01111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....+.+++.+||+.||++|||++|
T Consensus 252 --~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 252 --ISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp --CCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHH
Confidence 1235789999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=335.29 Aligned_cols=226 Identities=23% Similarity=0.375 Sum_probs=164.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC----CCEEEEEEcccCCCc-ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD----GKTVAVKKLSQATGQ-GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
.++|+..+.||+|+||+||+|++.. +..||||.++..... ..+.|.+|++++++++|||||+++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4568888999999999999998643 346899998754433 3456999999999999999999999995 567899
Q ss_pred EEeccCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
||||+++|+|.+++.... .++.|+| |+||+|+||+++.++.+||+|||+|+........
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 999999999999875432 3455566 5688899999999999999999999987654444
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
......||+.|+|||.+....++.++|||||||++|||+| |.+||... ...++...+...... . ..
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~----~~~~~~~~i~~~~~~----~-----~~ 231 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIENGERL----P-----MP 231 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHTTCCC----C-----CC
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC----CHHHHHHHHHcCCCC----C-----CC
Confidence 4455678999999999999999999999999999999998 88887542 344555444332111 1 11
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .....+.+++.+||+.||++||||.|
T Consensus 232 ~----~~~~~~~~li~~cl~~dp~~Rps~~e 258 (273)
T d1mp8a_ 232 P----NCPPTLYSLMTKCWAYDPSRRPRFTE 258 (273)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C----CCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 1 11236889999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-46 Score=332.74 Aligned_cols=219 Identities=30% Similarity=0.472 Sum_probs=165.7
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEecc
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEKLLVYEYM 224 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 224 (388)
++|+..+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4577788999999999999998 5788999999754 345679999999999999999999999965 45689999999
Q ss_pred CCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 225 VKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 225 ~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++|+|.++|... +.++.|+| |.||+|+|||++.++.+||+|||+++..... ...
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~ 159 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 159 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----Ccc
Confidence 999999998532 33566666 4577899999999999999999999876432 223
Q ss_pred cccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 283 VAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+|+.|+|||++.+..++.++|||||||++|||+| |+.||.. .+..++..++....+. + ....
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~----~~~~~~~~~i~~~~~~----~-----~~~~-- 224 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR----IPLKDVVPRVEKGYKM----D-----APDG-- 224 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT----SCGGGHHHHHTTTCCC----C-----CCTT--
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC----CCHHHHHHHHHcCCCC----C-----CCcc--
Confidence 458899999999988999999999999999999999 6777543 2445566555332111 1 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
...++.+++.+||+.||++||||.|
T Consensus 225 --~~~~~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 225 --CPPAVYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CCHHHHHHHHHHcccCHhHCcCHHH
Confidence 1236889999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.3e-45 Score=335.00 Aligned_cols=217 Identities=23% Similarity=0.351 Sum_probs=175.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999996 46999999999643 2234567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
|||++|+|..++.. ...++.|+| |+||+|+|||++.++.+||+|||+|+..... ..
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----cc
Confidence 99999999887653 334667777 5688999999999999999999999987543 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
..+||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..++...+... .......+
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~i~~~--~~~~p~~~--------- 224 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNA--ELRFPPFF--------- 224 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHHC--CCCCCTTS---------
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC----cCHHHHHHHHHcC--CCCCCCCC---------
Confidence 46799999999999999999999999999999999999999853 2333333333221 11111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
...+.+++.+||+.||.+||
T Consensus 225 ---s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 225 ---NEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCT
T ss_pred ---CHHHHHHHHHHhhhCHHhcc
Confidence 12578999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=332.89 Aligned_cols=223 Identities=23% Similarity=0.304 Sum_probs=177.1
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAAEMETLG-MVKHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv 220 (388)
++|...+.||+|+||+||+|+.. +++.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999964 68999999997532 234456777877765 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 221 YEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
||||++|+|.++++.. +.+|.|+| |+||+|+|||+++++.+||+|||+|+...... ...
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKT 160 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCB
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-ccc
Confidence 9999999999988642 34677777 45788999999999999999999998765433 233
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.. .+...+...+... ...... ..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~----~~~~~~~~~i~~~--~~~~p~--------~~ 226 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMD--NPFYPR--------WL 226 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHC--CCCCCT--------TS
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC----CCHHHHHHHHHcC--CCCCCc--------cC
Confidence 446799999999999999999999999999999999999999853 2333333333221 111111 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
...+.+++.+||+.||++|||+.
T Consensus 227 ----s~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 227 ----EKEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSBTTB
T ss_pred ----CHHHHHHHHHhcccCCCCCcCHH
Confidence 22588999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=333.48 Aligned_cols=234 Identities=26% Similarity=0.381 Sum_probs=167.7
Q ss_pred CCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHH--HHHHHHhcCCCCCccceeeEEEeCC----eeEEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFA--AEMETLGMVKHQNLVELLGYCSVDE----EKLLV 220 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv 220 (388)
+|...+.||+|+||+||+|++ +|+.||||+++... .+.+. .|+..+.+++|||||+++|+|.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455678899999999999997 68899999986432 33444 4555566789999999999998754 57899
Q ss_pred EeccCCCCHHHHHhcc--------------CCCCCHHh-------------hhccccCCeeecCCCCEEEcccccceecc
Q 035768 221 YEYMVKGSLDDWLRNQ--------------AASLDWGK-------------RCKIVASNILLNDDFEAKISDFGLARLIS 273 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~--------------~~~l~~~~-------------~~~i~~~NiLl~~~~~~kl~DfG~a~~~~ 273 (388)
||||++|+|.++|++. +.++.|+| |+||+|+|||++.++.+||+|||+++...
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999999998753 22445555 67899999999999999999999999875
Q ss_pred CCCcc---eeeccccccCccCccccCCC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCc-------ccHHH
Q 035768 274 DCESH---VSTVVAGTIGYVPPEYGGTG------KATERGDVYSFGVILLELVTGKQPTGPEFEDKDG-------ENLVD 337 (388)
Q Consensus 274 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~-------~~~~~ 337 (388)
..... ......||+.|+|||++... .++.++|||||||+||||+||..|+......... ....+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 54322 22346799999999987654 2678999999999999999998886432111100 01112
Q ss_pred HHHHhhccccccccCCccccCC-CCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 338 WVLHMMKNEQADEVLDPAVLNA-NSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+........ .+|.+... ...+....+.+++.+||+.||++||||.|
T Consensus 240 ~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 2222222221 12221111 12345567899999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=331.46 Aligned_cols=222 Identities=30% Similarity=0.475 Sum_probs=168.7
Q ss_pred CCeeeccCCceEEEEEcCCC----CEEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEecc
Q 035768 151 ENVIGGGGFGTVFKGTMPDG----KTVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSV-DEEKLLVYEYM 224 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 224 (388)
.++||+|+||+||+|++.++ ..||||+++... ....++|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996432 258999997543 3344679999999999999999999999876 45889999999
Q ss_pred CCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc---ee
Q 035768 225 VKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH---VS 280 (388)
Q Consensus 225 ~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~---~~ 280 (388)
++|+|.++++... .++.|+| |+||+|+|||+++++.+||+|||+++........ ..
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 9999999886443 2445555 4688899999999999999999999987543322 22
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||.+....++.++||||||+++|||+||+.||.... +..++..++....+. ..|.
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~---~~~~~~~~i~~g~~~------~~p~----- 257 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGRRL------LQPE----- 257 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTCCC------CCCT-----
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC---CHHHHHHHHHcCCCC------CCcc-----
Confidence 23568999999999999999999999999999999999888875322 233333433322111 1111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.....+.+++.+||+.||++||||.|
T Consensus 258 --~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 258 --YCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --cCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 11236889999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=338.64 Aligned_cols=224 Identities=28% Similarity=0.433 Sum_probs=168.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcCC-CC--EEEEEEcccC-CCcChHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPD-GK--TVAVKKLSQA-TGQGDREFAAEMETLGMV-KHQNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 220 (388)
++|+..+.||+|+||+||+|++.+ +. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567788999999999999999753 43 5788988644 333456799999999998 799999999999999999999
Q ss_pred EeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCeeecCCCCEEEc
Q 035768 221 YEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNILLNDDFEAKIS 264 (388)
Q Consensus 221 ~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~ 264 (388)
|||+++|+|.++|+.. +.++.|+| |+||+|+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999998632 12344445 46888999999999999999
Q ss_pred ccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCC-CCCCCCCCCCcccHHHHHHHhh
Q 035768 265 DFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQ-PTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 265 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~-P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
|||+|+...... ......||..|+|||.+....++.++|||||||++|||++|.. ||. ..+..++.+.+....
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~----~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCAELYEKLPQGY 243 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT----TCCHHHHHHHGGGTC
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC----CCCHHHHHHHHHhcC
Confidence 999998654322 2223468999999999999999999999999999999999765 543 223334433332211
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. +.. +.....++.+++.+||+.||++||||+|
T Consensus 244 ---~------~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 244 ---R------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp ---C------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---C------CCC----CccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1 101 1112236889999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=332.20 Aligned_cols=225 Identities=28% Similarity=0.435 Sum_probs=170.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCC----EEEEEEcccCC-CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGK----TVAVKKLSQAT-GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 219 (388)
++|+..++||+|+||+||+|.+. +|+ .||+|+++... ....++|.+|++++++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 35888999999999999999864 444 58999987543 3456789999999999999999999999986 45678
Q ss_pred EEeccCCCCHHHHHhcc----------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 220 VYEYMVKGSLDDWLRNQ----------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~~----------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
++||+.+|+|.+++... +.++.|+| |+||+|+|||++.++.+||+|||+|+........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 89999999999877543 33566666 5688899999999999999999999987543332
Q ss_pred -eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccc
Q 035768 279 -VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAV 356 (388)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (388)
......||+.|||||.+.++.++.++|||||||++|||+| |+.||... ...++...+....+... |
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~----~~~~~~~~i~~~~~~~~------p-- 235 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERLPQ------P-- 235 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----CGGGHHHHHHHTCCCCC------C--
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHcCCCCCC------C--
Confidence 2334568999999999989999999999999999999999 78886532 34445544433221110 1
Q ss_pred cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 357 LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 357 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......+.+++.+||+.||++||||.|
T Consensus 236 -----~~~~~~~~~li~~cl~~dP~~RPs~~e 262 (317)
T d1xkka_ 236 -----PICTIDVYMIMVKCWMIDADSRPKFRE 262 (317)
T ss_dssp -----TTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----cccCHHHHHHHHHhCCCChhhCcCHHH
Confidence 111236889999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-44 Score=333.91 Aligned_cols=223 Identities=22% Similarity=0.300 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCC---CcChHHHHH---HHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQAT---GQGDREFAA---EMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|+..+.||+|+||+||+|+.. +|+.||||++.+.. ......+.+ |+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999964 69999999986432 122233444 477788889999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 219 LVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
+|||||++|+|.+++.+. ..+|.|+| |+||+|+|||++.++.+||+|||+|+......
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-- 161 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc--
Confidence 999999999999988542 34677777 56889999999999999999999999775432
Q ss_pred eeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcccc
Q 035768 279 VSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVL 357 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (388)
....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||... ...+......... .... ...
T Consensus 162 -~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~~~~~~-~~~~------~~~ 229 (364)
T d1omwa3 162 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH----KTKDKHEIDRMTL-TMAV------ELP 229 (364)
T ss_dssp -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS----CSSCHHHHHHHSS-SCCC------CCC
T ss_pred -ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcc-cCCC------CCC
Confidence 234579999999998864 56899999999999999999999998643 2222222221111 1110 001
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 358 NANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 358 ~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
... ..++.+++.+||+.||++|||+
T Consensus 230 ~~~----s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 230 DSF----SPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp SSS----CHHHHHHHHHHTCSSTTTSTTT
T ss_pred CCC----CHHHHHHHHHHcccCHHHhCCC
Confidence 111 2257899999999999999995
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=336.37 Aligned_cols=229 Identities=27% Similarity=0.452 Sum_probs=176.1
Q ss_pred HhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 035768 143 AGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDE 215 (388)
Q Consensus 143 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 215 (388)
...++|...+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++|+|..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33467888899999999999999863 357899999975433 23346899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhc-------------------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcc
Q 035768 216 EKLLVYEYMVKGSLDDWLRN-------------------------QAASLDWGK-----RCKIVASNILLNDDFEAKISD 265 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~-------------------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~D 265 (388)
..++||||+++|+|.+++.. .+.++.|+| |+||+|+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 99999999999999998752 123455666 457889999999999999999
Q ss_pred cccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCCcccHHHHHHHhh
Q 035768 266 FGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK-QPTGPEFEDKDGENLVDWVLHMM 343 (388)
Q Consensus 266 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~ 343 (388)
||+|+.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||. +||.. .+...+.+.+..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~----~~~~~~~~~i~~-- 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG----LSNEQVLRFVME-- 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT----SCHHHHHHHHHT--
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHh--
Confidence 9999876543322 223346899999999999999999999999999999999985 55532 233333333322
Q ss_pred ccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 344 KNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+..... | . .....+.+++.+||+.||++||||.|
T Consensus 251 --~~~~~~--p---~----~~~~~l~~li~~cl~~~P~~RPs~~~ 284 (308)
T d1p4oa_ 251 --GGLLDK--P---D----NCPDMLFELMRMCWQYNPKMRPSFLE 284 (308)
T ss_dssp --TCCCCC--C---T----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CCCCCC--c---c----cchHHHHHHHHHHcCCChhHCcCHHH
Confidence 111111 0 1 11236889999999999999999853
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=326.54 Aligned_cols=226 Identities=26% Similarity=0.383 Sum_probs=164.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC--CC--CEEEEEEcccCC---CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP--DG--KTVAVKKLSQAT---GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKL 218 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 218 (388)
++|+..+.||+|+||+||+|++. ++ ..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45788899999999999999853 23 368999987542 2234679999999999999999999999965 5678
Q ss_pred EEEeccCCCCHHHHHhc----------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 219 LVYEYMVKGSLDDWLRN----------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~----------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
+||||+++|+|.+++.. .+.++.|+| |+||+|+|||++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999987643 234667777 457889999999999999999999998755433
Q ss_pred c--eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 278 H--VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 278 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
. ......||..|+|||.+.+..++.++|||||||++|||+| |+.||.. .+..++..++.. .....+.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~----~~~~~~~~~i~~---~~~~~~~--- 236 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDK---EGERLPR--- 236 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT----CCHHHHHHHHHT---SCCCCCC---
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC----cCHHHHHHHHHh---CCCCCCC---
Confidence 2 2233557889999999999999999999999999999998 8999753 233444443322 2111110
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. .....+.+++.+||+.||++||||.|
T Consensus 237 --~~----~~~~~l~~li~~cl~~dp~~RPt~~e 264 (273)
T d1u46a_ 237 --PE----DCPQDIYNVMVQCWAHKPEDRPTFVA 264 (273)
T ss_dssp --CT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --cc----cccHHHHHHHHHHcCCChhHCcCHHH
Confidence 11 11236889999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-44 Score=324.54 Aligned_cols=228 Identities=22% Similarity=0.375 Sum_probs=167.9
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcC---hHHHHHHHHHHhcCCCCCccceeeEEEeCC----ee
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQG---DREFAAEMETLGMVKHQNLVELLGYCSVDE----EK 217 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 217 (388)
++|...+.||+|+||+||+|+. .+|+.||||+++...... ...|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688899999999999999996 579999999997654322 346899999999999999999999997654 37
Q ss_pred EEEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 218 LLVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 218 ~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
|+||||+++|+|.+++.. ...+|.|+| |+||+|+|||++.++..+|+|||.++.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 899999999999987743 344677777 568889999999999999999999987643222
Q ss_pred --ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc
Q 035768 278 --HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA 355 (388)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
......+||+.|||||++.+..++.++|||||||++|||+||+.||... +..++. .......... +.
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~---~~~~~~~~~~----~~ 235 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVA---YQHVREDPIP----PS 235 (277)
T ss_dssp ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHH---HHHHHCCCCC----GG
T ss_pred cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc----CHHHHH---HHHHhcCCCC----Cc
Confidence 2334567999999999999999999999999999999999999998532 222222 2222221111 11
Q ss_pred ccCCCCHHHHHHHHHHHHhcccCCCCCCC-CCC
Q 035768 356 VLNANSKPTMLKMLQIATGCISNDPTVRP-TML 387 (388)
Q Consensus 356 ~~~~~~~~~~~~l~~l~~~C~~~~P~~RP-t~~ 387 (388)
.... ....++.+++.+||+.||++|| |++
T Consensus 236 ~~~~---~~s~~l~~li~~~L~~dp~~R~~sa~ 265 (277)
T d1o6ya_ 236 ARHE---GLSADLDAVVLKALAKNPENRYQTAA 265 (277)
T ss_dssp GTSS---SCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred hhcc---CCCHHHHHHHHHHccCCHhHCHhHHH
Confidence 1000 1123688899999999999999 543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=331.44 Aligned_cols=233 Identities=27% Similarity=0.371 Sum_probs=166.3
Q ss_pred HHHHhhcCCCcCCeeeccCCceEEEEEcC------CCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEE
Q 035768 140 QIVAGTNKFCEENVIGGGGFGTVFKGTMP------DGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYC 211 (388)
Q Consensus 140 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 211 (388)
.+....++|...+.||+|+||+||+|++. +++.||||+++.... ...+.+.+|...+.++ +|+|||.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33344567888999999999999999853 346899999975433 3345688888888776 689999999998
Q ss_pred EeC-CeeEEEEeccCCCCHHHHHhcc-------------------------------CCCCCHHh-----hhccccCCee
Q 035768 212 SVD-EEKLLVYEYMVKGSLDDWLRNQ-------------------------------AASLDWGK-----RCKIVASNIL 254 (388)
Q Consensus 212 ~~~-~~~~lv~e~~~~g~L~~~l~~~-------------------------------~~~l~~~~-----~~~i~~~NiL 254 (388)
... +..++|||||++|+|.++++.. +.++.|+| |+||+|+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 765 4689999999999999998532 23556666 5689999999
Q ss_pred ecCCCCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCCc
Q 035768 255 LNDDFEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGK-QPTGPEFEDKDG 332 (388)
Q Consensus 255 l~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~-~P~~~~~~~~~~ 332 (388)
+++++.+||+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||+||. .||... ...
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~---~~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---KID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CCS
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC---CHH
Confidence 999999999999999876543322 233467999999999999999999999999999999999975 565322 122
Q ss_pred ccHHHHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 333 ENLVDWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..+...+..... .... .. ...++.+++.+||+.||++||||+|
T Consensus 244 ~~~~~~~~~~~~----~~~~-----~~----~~~~l~~li~~cl~~dP~~Rpt~~e 286 (299)
T d1ywna1 244 EEFCRRLKEGTR----MRAP-----DY----TTPEMYQTMLDCWHGEPSQRPTFSE 286 (299)
T ss_dssp HHHHHHHHHTCC----CCCC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhcCCC----CCCC-----cc----CCHHHHHHHHHHcCCChhHCcCHHH
Confidence 223332222111 1110 11 1236889999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-43 Score=331.23 Aligned_cols=217 Identities=19% Similarity=0.250 Sum_probs=175.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC---CCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA---TGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|++ .+|+.||||++++. .....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5789999999999999999996 46999999998643 2234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceee
Q 035768 222 EYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVST 281 (388)
Q Consensus 222 e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~ 281 (388)
||+.+|+|.+++.. ...+|.|+| |+||+|+|||++.++.+||+|||+|+.+... ..
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----cc
Confidence 99999999988753 234677888 5688899999999999999999999987542 23
Q ss_pred ccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCCC
Q 035768 282 VVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNANS 361 (388)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (388)
...||+.|||||++.+..++.++|||||||++|||+||+.||.. .+...+...+.... ... | ..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~i~~~~--~~~-----p---~~-- 260 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGK--VRF-----P---SH-- 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCC--CCC-----C---TT--
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC----cCHHHHHHHHhcCC--CCC-----C---cc--
Confidence 45799999999999999999999999999999999999999853 23333333332211 011 1 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC
Q 035768 362 KPTMLKMLQIATGCISNDPTVRP 384 (388)
Q Consensus 362 ~~~~~~l~~l~~~C~~~~P~~RP 384 (388)
....+.+++.+||+.||.+|+
T Consensus 261 --~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 261 --FSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCT
T ss_pred --CCHHHHHHHHHHhhhCHHhcc
Confidence 122678999999999999995
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=327.40 Aligned_cols=233 Identities=20% Similarity=0.230 Sum_probs=170.4
Q ss_pred CCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCc-----ChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEecc
Q 035768 151 ENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQ-----GDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEYM 224 (388)
Q Consensus 151 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 224 (388)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999964 6899999999754321 1346889999999999999999999999999999999999
Q ss_pred CCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeeccc
Q 035768 225 VKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVVA 284 (388)
Q Consensus 225 ~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 284 (388)
.++++..+.. +...+|.|+| |+||+|+|||++.++.+||+|||+|+........ ....+
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~~~~ 161 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQV 161 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CCCSC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-cccee
Confidence 8887766543 3344677777 5688999999999999999999999876543322 23456
Q ss_pred cccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCcc--------
Q 035768 285 GTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPA-------- 355 (388)
Q Consensus 285 gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 355 (388)
||+.|+|||.+.. ..++.++|||||||++|||+||+.||... +..+....+.............+..
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~----~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC----CHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 9999999998764 46799999999999999999999997532 3344444443332221111110000
Q ss_pred -ccCCCCH-----HHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 356 -VLNANSK-----PTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 356 -~~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
....... .....+.+++.+||+.||++|||++|
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000000 11246889999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-43 Score=320.41 Aligned_cols=227 Identities=23% Similarity=0.300 Sum_probs=176.0
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc---------ChHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ---------GDREFAAEMETLGMVK-HQNLVELLGYCSVD 214 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 214 (388)
++|+..+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999996 57899999999754321 1235889999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhcc---------------CCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQ---------------AASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
+..|+|||||++|+|.++++.. ..++.|+| |+||+|+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 9999999999999999998542 33566777 457889999999999999999999998765
Q ss_pred CCcceeeccccccCccCccccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc
Q 035768 275 CESHVSTVVAGTIGYVPPEYGG------TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA 348 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (388)
.. ......||+.|+|||.+. ...++.++||||+||++|||+||+.||... +.....+.+... ..
T Consensus 163 ~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~----~~~~~~~~i~~~----~~ 232 (277)
T d1phka_ 163 GE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMIMSG----NY 232 (277)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHT----CC
T ss_pred CC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC----CHHHHHHHHHhC----CC
Confidence 32 234467999999999763 346789999999999999999999998532 333333323221 11
Q ss_pred cccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 DEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ...+. ......++.+++.+||+.||++|||++|
T Consensus 233 ~-~~~~~-----~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 233 Q-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp C-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred C-CCCcc-----cccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0 10110 0112236889999999999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=328.92 Aligned_cols=230 Identities=28% Similarity=0.424 Sum_probs=176.4
Q ss_pred hhcCCCcCCeeeccCCceEEEEEc------CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 035768 144 GTNKFCEENVIGGGGFGTVFKGTM------PDGKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVDE 215 (388)
Q Consensus 144 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 215 (388)
..++|+..+.||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346788889999999999999985 3467899999976543 3345699999999998 6999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhcc---------------------------------CCCCCHHh-----hhccccCCeeecC
Q 035768 216 EKLLVYEYMVKGSLDDWLRNQ---------------------------------AASLDWGK-----RCKIVASNILLND 257 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~~~---------------------------------~~~l~~~~-----~~~i~~~NiLl~~ 257 (388)
..++|||||++|+|.++++.. +.++.|+| |+||+|+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 999999999999999998642 22344555 5688899999999
Q ss_pred CCCEEEcccccceeccCCCc-ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHH
Q 035768 258 DFEAKISDFGLARLISDCES-HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 258 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 336 (388)
++.+|++|||+++....... .......||+.|+|||.+....++.++|||||||++|||+|++.|+..... ....+.
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--~~~~~~ 258 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDSKFY 258 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--SSHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence 99999999999998765433 333456799999999999999999999999999999999995555432111 122233
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+....+.. .+ ......+.+|+.+||+.||++||||.|
T Consensus 259 ~~i~~~~~~~------~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~~ 297 (311)
T d1t46a_ 259 KMIKEGFRML------SP-------EHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (311)
T ss_dssp HHHHHTCCCC------CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHhcCCCCC------Cc-------ccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 3333221111 01 111236889999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=320.73 Aligned_cols=227 Identities=18% Similarity=0.298 Sum_probs=177.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.++|...+.||+|+||+||+|... +++.||||.++... .....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 357888999999999999999964 68899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecC--CCCEEEcccccceeccCCCccee
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLND--DFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~--~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|++|+|.+++.... .++.|+| |+||+|+|||++. ...+||+|||+++...... ..
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~ 160 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF 160 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC--cc
Confidence 99999999986432 3456666 5688899999985 4589999999998875432 23
Q ss_pred eccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCccccCCC
Q 035768 281 TVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDPAVLNAN 360 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (388)
....||+.|+|||...+..++.++||||+||++|||++|+.||... +..++...+..... .++.......
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~----~~~~~~~~i~~~~~------~~~~~~~~~~ 230 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE----TNQQIIENIMNAEY------TFDEEAFKEI 230 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCC------CCCHHHHTTS
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCC------CCChhhccCC
Confidence 4456899999999999999999999999999999999999998542 33333333322110 0111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 361 SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 361 ~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
..++.+++.+||+.||++|||++|
T Consensus 231 ----s~~~~~li~~~L~~dp~~R~s~~e 254 (321)
T d1tkia_ 231 ----SIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHH
Confidence 225789999999999999999753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=326.79 Aligned_cols=227 Identities=28% Similarity=0.443 Sum_probs=170.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCC--------CCEEEEEEcccCCC-cChHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPD--------GKTVAVKKLSQATG-QGDREFAAEMETLGMV-KHQNLVELLGYCSVD 214 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 214 (388)
.++|...+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4567888999999999999998522 34799999976543 3346788999999888 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhccC-------------------------------CCCCHHh-----hhccccCCeeecCC
Q 035768 215 EEKLLVYEYMVKGSLDDWLRNQA-------------------------------ASLDWGK-----RCKIVASNILLNDD 258 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------~~l~~~~-----~~~i~~~NiLl~~~ 258 (388)
+..++||||+++|+|.++++... .++.|+| |+||+|+|||++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 99999999999999999986432 2345566 56889999999999
Q ss_pred CCEEEcccccceeccCCCcc-eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCCcccHH
Q 035768 259 FEAKISDFGLARLISDCESH-VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVT-GKQPTGPEFEDKDGENLV 336 (388)
Q Consensus 259 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 336 (388)
+.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |.+||.. .....+.
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~----~~~~~~~ 247 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELF 247 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHH
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC----CCHHHHH
Confidence 99999999999987543322 2344568999999999999999999999999999999998 6777642 2333343
Q ss_pred HHHHHhhccccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 337 DWVLHMMKNEQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.+...... .. | .. ....+.+++.+||+.||++||||.|
T Consensus 248 ~~i~~~~~~----~~--p---~~----~~~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 248 KLLKEGHRM----DK--P---SN----CTNELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp HHHHTTCCC----CC--C---SS----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHcCCCC----CC--C---cc----chHHHHHHHHHHccCCHhHCcCHHH
Confidence 333221111 11 1 11 1236889999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=328.60 Aligned_cols=226 Identities=21% Similarity=0.264 Sum_probs=168.5
Q ss_pred cCCCcC-CeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhc-CCCCCccceeeEEEe----CCeeE
Q 035768 146 NKFCEE-NVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGM-VKHQNLVELLGYCSV----DEEKL 218 (388)
Q Consensus 146 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 218 (388)
++|.+. ++||+|+||+||+|+. .+++.||||+++. ...+.+|++++.+ .+|||||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467765 4699999999999996 5789999999864 3467889998755 589999999999875 45689
Q ss_pred EEEeccCCCCHHHHHhcc-----------------CCCCCHHh-----hhccccCCeeecC---CCCEEEcccccceecc
Q 035768 219 LVYEYMVKGSLDDWLRNQ-----------------AASLDWGK-----RCKIVASNILLND---DFEAKISDFGLARLIS 273 (388)
Q Consensus 219 lv~e~~~~g~L~~~l~~~-----------------~~~l~~~~-----~~~i~~~NiLl~~---~~~~kl~DfG~a~~~~ 273 (388)
+|||||++|+|.+++.+. ..++.|+| |+||+|+|||+++ ++.+||+|||+|+...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999999999998653 22566666 5688899999985 5679999999999875
Q ss_pred CCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 274 DCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
.... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||... +.......+......... ....
T Consensus 166 ~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~----~~~~~~~~~~~~i~~~~~-~~~~ 238 (335)
T d2ozaa1 166 SHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN----HGLAISPGMKTRIRMGQY-EFPN 238 (335)
T ss_dssp CCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET----TCC--------CCCSCSS-SCCT
T ss_pred CCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC----CHHHHHHHHHHHHhcCCC-CCCC
Confidence 4332 33467999999999999999999999999999999999999998532 222222222221111110 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ .......++.+++.+||+.||++|||+.|
T Consensus 239 ~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 239 P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp T-----HHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred c-----ccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0 01122346889999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-42 Score=315.40 Aligned_cols=238 Identities=22% Similarity=0.254 Sum_probs=174.0
Q ss_pred cCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCC--CcChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQAT--GQGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|++++|+.||||+++... ....+.+.+|+.+|++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999899999999996543 23356899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHh---------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeecc
Q 035768 224 MVKGSLDDWLR---------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 224 ~~~g~L~~~l~---------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
+.++.+..+.. +...+|.|+| |+||+|+|||++.++.+||+|||.|........ .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHE 160 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-cccee
Confidence 98877766543 2234677777 568889999999999999999999987654322 22334
Q ss_pred ccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC--------c
Q 035768 284 AGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD--------P 354 (388)
Q Consensus 284 ~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 354 (388)
.|++.|+|||.+.. ..++.++|||||||++|||++|+.||... +..+....+.............+ .
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV----SEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC----CHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 58999999998765 45799999999999999999999998542 22223222222221111000000 0
Q ss_pred cc-------cCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 AV-------LNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ~~-------~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. ...........+.+++.+||+.||++|||++|
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e 277 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00 00001112236789999999999999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=311.04 Aligned_cols=237 Identities=23% Similarity=0.306 Sum_probs=171.0
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999996 5799999999965432 235679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHh-----------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCccee
Q 035768 223 YMVKGSLDDWLR-----------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVS 280 (388)
Q Consensus 223 ~~~~g~L~~~l~-----------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~ 280 (388)
|+.++ +.+++. +...+|.|+| |+||+|+|||++.++.+||+|||+|+....... ..
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~ 159 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 159 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CT
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc-cc
Confidence 99654 444332 2334566777 557889999999999999999999987654332 23
Q ss_pred eccccccCccCccccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccc---ccccC-C--
Q 035768 281 TVVAGTIGYVPPEYGGTGK-ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQ---ADEVL-D-- 353 (388)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~-- 353 (388)
....||+.|+|||...... ++.++|||||||++|||++|+.||... +..+....+........ ..... .
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD----SEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC----CHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3456999999999866654 588999999999999999999998532 22222222222111110 00000 0
Q ss_pred --ccc--cCCCC-----HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 --PAV--LNANS-----KPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 --~~~--~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+.. ..... ......+.+++.+||+.||++|||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e 279 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 000 00000 111246788999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=316.61 Aligned_cols=216 Identities=25% Similarity=0.403 Sum_probs=167.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCc------ChHHHHHHHHHHhcCC--CCCccceeeEEEeCCe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQ------GDREFAAEMETLGMVK--HQNLVELLGYCSVDEE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 216 (388)
++|...+.||+|+||+||+|+. .+|+.||||++++.... ....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688889999999999999996 47899999998653211 1234778999999986 8999999999999999
Q ss_pred eEEEEeccCC-CCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecC-CCCEEEcccccceeccC
Q 035768 217 KLLVYEYMVK-GSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLND-DFEAKISDFGLARLISD 274 (388)
Q Consensus 217 ~~lv~e~~~~-g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~-~~~~kl~DfG~a~~~~~ 274 (388)
.++||||+.+ +++.+++.. ...+|.|+| |+||+|+|||++. ++.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 678777643 334677777 5688899999985 47999999999987643
Q ss_pred CCcceeeccccccCccCccccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 275 CESHVSTVVAGTIGYVPPEYGGTGKA-TERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
. ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||... .. +.. .. ..+.
T Consensus 164 ~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~----i~~---~~---~~~~ 224 (273)
T d1xwsa_ 164 T---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EE----IIR---GQ---VFFR 224 (273)
T ss_dssp S---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HH----HHH---CC---CCCS
T ss_pred c---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hH----Hhh---cc---cCCC
Confidence 2 2334679999999999876665 67799999999999999999998521 11 111 10 0011
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+ ..+ .++.+++.+||+.||++|||++|
T Consensus 225 ~----~~s----~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 225 Q----RVS----SECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp S----CCC----HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C----CCC----HHHHHHHHHHccCCHhHCcCHHH
Confidence 1 111 26789999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=314.48 Aligned_cols=238 Identities=22% Similarity=0.272 Sum_probs=170.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CC-CCEEEEEEcccCC--CcChHHHHHHHHHHhcC---CCCCccceeeEEEe----
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PD-GKTVAVKKLSQAT--GQGDREFAAEMETLGMV---KHQNLVELLGYCSV---- 213 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 213 (388)
.++|+..+.||+|+||+||+|++ .+ ++.||||+++... ......+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36789999999999999999996 34 5679999986432 22234567788777665 89999999999863
Q ss_pred -CCeeEEEEeccCCCCHHHHH----------------hccCCCCCHHh-----hhccccCCeeecCCCCEEEccccccee
Q 035768 214 -DEEKLLVYEYMVKGSLDDWL----------------RNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARL 271 (388)
Q Consensus 214 -~~~~~lv~e~~~~g~L~~~l----------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~ 271 (388)
....+++|||+.+|++.... .+...+|.|+| |+||+|+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 34678999999888765433 33345677777 568889999999999999999999986
Q ss_pred ccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 272 ISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
.... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||... +..+....+...........+
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS----SDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC----CHHHHHHHHHHhhCCCchhcc
Confidence 5432 2334567999999999999999999999999999999999999998532 333333333332211110000
Q ss_pred CC----cc---------ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 352 LD----PA---------VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 352 ~~----~~---------~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. +. ............+.+|+.+||+.||++|||++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00 00 000001112235778999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=311.86 Aligned_cols=227 Identities=24% Similarity=0.311 Sum_probs=174.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc----CCCCEEEEEEcccCC----CcChHHHHHHHHHHhcCCC-CCccceeeEEEeCCe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM----PDGKTVAVKKLSQAT----GQGDREFAAEMETLGMVKH-QNLVELLGYCSVDEE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 216 (388)
++|+..+.||+|+||+||+|.. .+|+.||||.++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688899999999999999984 248899999986532 2234568899999999977 899999999999999
Q ss_pred eEEEEeccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 217 KLLVYEYMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
.+++|||+.+|+|.+++.. ...++.|+| |+||+|+|||++.++.+||+|||+|+......
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 9999999999999998753 234566777 45788999999999999999999998875544
Q ss_pred cceeeccccccCccCccccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCCc
Q 035768 277 SHVSTVVAGTIGYVPPEYGGTG--KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLDP 354 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (388)
........|++.|+|||.+... .++.++|||||||+||||+||+.||......... ..+.........
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEP------ 253 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCCC------
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccCCC------
Confidence 4444556799999999987654 4688999999999999999999998654332222 222221111110
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 355 AVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 355 ~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
.... ....++.+++.+||+.||++|||+
T Consensus 254 ~~~~----~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 254 PYPQ----EMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCcc----cCCHHHHHHHHHHcccCHHHcCCC
Confidence 0001 122368899999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=305.78 Aligned_cols=239 Identities=23% Similarity=0.253 Sum_probs=170.2
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccC--CCcChHHHHHHHHHHhcCCCCCccceeeEEEe--------C
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQA--TGQGDREFAAEMETLGMVKHQNLVELLGYCSV--------D 214 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 214 (388)
++|+..+.||+|+||+||+|+. .+|+.||||++... ......++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788899999999999999996 57999999998643 23345679999999999999999999999865 3
Q ss_pred CeeEEEEeccCCCCHHHHH---------------hccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccC
Q 035768 215 EEKLLVYEYMVKGSLDDWL---------------RNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISD 274 (388)
Q Consensus 215 ~~~~lv~e~~~~g~L~~~l---------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~ 274 (388)
+..++||||+.++++..+. ++...++.|+| |+||+|+|||++.++.+||+|||+++....
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 4578999999877665433 33445677877 567889999999999999999999987654
Q ss_pred CCcc---eeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccc--
Q 035768 275 CESH---VSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQA-- 348 (388)
Q Consensus 275 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 348 (388)
.... .....+||+.|+|||.+... .++.++|||||||++|||++|+.||... +.......+.........
T Consensus 170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN----TEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC----CHHHHHHHHHHhcCCCChhh
Confidence 3221 22235699999999987654 6899999999999999999999998542 333333333332221110
Q ss_pred -cccCCccc--------cCCCC-HH------HHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 349 -DEVLDPAV--------LNANS-KP------TMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 349 -~~~~~~~~--------~~~~~-~~------~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
........ ..... .+ ....+.+++.+||+.||++|||++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00000000 00000 11 1235678999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=300.08 Aligned_cols=239 Identities=22% Similarity=0.268 Sum_probs=177.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 222 (388)
++|+..+.||+|+||+||+|+. .+++.||||+++.... .....+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999996 5789999999865432 334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcceeec
Q 035768 223 YMVKGSLDDWLRN---------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHVSTV 282 (388)
Q Consensus 223 ~~~~g~L~~~l~~---------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~~~~ 282 (388)
++.+++|..++.. ...+|.|+| |+||+|+|||++.++.+||+|||.|+....... ....
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCS
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-ccee
Confidence 9999988876643 234677777 558889999999999999999999998754332 2233
Q ss_pred cccccCccCccccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc------CCc-
Q 035768 283 VAGTIGYVPPEYGGTGK-ATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV------LDP- 354 (388)
Q Consensus 283 ~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 354 (388)
..+++.|+|||.+.... ++.++|||||||++|||++|+.||.. ..+..+....+............ .+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC---CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC---CCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 45788999999876654 69999999999999999999999742 23333333333332221110000 000
Q ss_pred ---c-----ccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 355 ---A-----VLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 355 ---~-----~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. ............+.+++.+|++.||.+|||++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0 000011122235788999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=306.82 Aligned_cols=232 Identities=23% Similarity=0.270 Sum_probs=163.8
Q ss_pred CCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEE
Q 035768 147 KFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELLGYCSVD------EEKLL 219 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 219 (388)
+|...++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677889999999999999964 699999999975432 234799999999999999999998643 34789
Q ss_pred EEeccCCCCHHHHH------------------hccCCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCC
Q 035768 220 VYEYMVKGSLDDWL------------------RNQAASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDC 275 (388)
Q Consensus 220 v~e~~~~g~L~~~l------------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~ 275 (388)
|||||++|.+..+. .+...+|.|+| |+||+|+|||++.++ .+||+|||+++.....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 99999866433322 23344677777 568889999999775 8999999999887543
Q ss_pred CcceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc---------
Q 035768 276 ESHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN--------- 345 (388)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--------- 345 (388)
.. .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||... +..+....+......
T Consensus 177 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~----~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 177 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD----SGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp SC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC----CHHHHHHHHHHHhCCChHHhhhhh
Confidence 32 233569999999997654 57899999999999999999999998532 222222222111100
Q ss_pred ------ccccccCCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 ------EQADEVLDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 ------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
......................+.+|+.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000000000000001112335788999999999999999754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=304.74 Aligned_cols=239 Identities=21% Similarity=0.264 Sum_probs=167.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC-cChHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG-QGDREFAAEMETLGMVKHQNLVELLGYCSVDE----EKLL 219 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 219 (388)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688889999999999999985 5799999999975432 23457889999999999999999999997643 2345
Q ss_pred EEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc--
Q 035768 220 VYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH-- 278 (388)
Q Consensus 220 v~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~-- 278 (388)
+++|+.+|+|.+++.. ...+|.|+| |+||+|+|||+++++.+||+|||+|+........
T Consensus 88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence 5566779999998853 234677777 5688999999999999999999999876432221
Q ss_pred eeeccccccCccCccccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc---ccC--
Q 035768 279 VSTVVAGTIGYVPPEYGG-TGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD---EVL-- 352 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 352 (388)
.....+||+.|+|||.+. ...++.++||||+||++|||++|+.||... +..+............... ...
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK----HYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC----CHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 223456999999999874 456789999999999999999999998543 2222222211111110000 000
Q ss_pred --------CccccCCC----CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 353 --------DPAVLNAN----SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 353 --------~~~~~~~~----~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.+...... ......++.+++.+||+.||++|||+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00000000 0011135789999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=303.10 Aligned_cols=176 Identities=28% Similarity=0.371 Sum_probs=140.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVDE------ 215 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 215 (388)
.++|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788889999999999999996 4699999999975432 22456889999999999999999999997654
Q ss_pred eeEEEEeccCCCCHHHHHh--------------ccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCC
Q 035768 216 EKLLVYEYMVKGSLDDWLR--------------NQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCE 276 (388)
Q Consensus 216 ~~~lv~e~~~~g~L~~~l~--------------~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~ 276 (388)
..++||||+ +++|..+.+ +...+|.|+| |+||+|+|||++.++.+|++|||+|+.....
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 469999999 667777654 3345777888 5688899999999999999999999876542
Q ss_pred cceeeccccccCccCccccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 277 SHVSTVVAGTIGYVPPEYGGT-GKATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 234569999999998765 4678999999999999999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-39 Score=300.44 Aligned_cols=175 Identities=18% Similarity=0.287 Sum_probs=146.4
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEE
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVD--EEKLLVY 221 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~ 221 (388)
++|+..+.||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5789999999999999999996 56899999999653 3567899999999995 99999999999753 5689999
Q ss_pred eccCCCCHHHHH------------hccCCCCCHHh-----hhccccCCeeecCCC-CEEEcccccceeccCCCcceeecc
Q 035768 222 EYMVKGSLDDWL------------RNQAASLDWGK-----RCKIVASNILLNDDF-EAKISDFGLARLISDCESHVSTVV 283 (388)
Q Consensus 222 e~~~~g~L~~~l------------~~~~~~l~~~~-----~~~i~~~NiLl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~ 283 (388)
|||++|+|.++. .+...+|.|+| |+||+|+|||++.++ .+||+|||+|+...... .....
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~ 189 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVR 189 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSC
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC--ccccc
Confidence 999999987643 34456788888 568889999998655 69999999998875432 23445
Q ss_pred ccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCC
Q 035768 284 AGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGP 325 (388)
Q Consensus 284 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~ 325 (388)
.||+.|+|||.+... .++.++||||+||++|||++|+.||..
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 689999999987654 579999999999999999999999854
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-38 Score=290.49 Aligned_cols=229 Identities=19% Similarity=0.239 Sum_probs=164.7
Q ss_pred cCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCcccee-eEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNLVELL-GYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lv~e~ 223 (388)
++|+..+.||+|+||+||+|++ .+|+.||||.+..... ..++..|++++++++|+|++..+ ++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688899999999999999986 4689999999865432 34588999999999887766555 555677888999999
Q ss_pred cCCCCHHHHHhc----------------cCCCCCHHh-----hhccccCCeeec---CCCCEEEcccccceeccCCCcc-
Q 035768 224 MVKGSLDDWLRN----------------QAASLDWGK-----RCKIVASNILLN---DDFEAKISDFGLARLISDCESH- 278 (388)
Q Consensus 224 ~~~g~L~~~l~~----------------~~~~l~~~~-----~~~i~~~NiLl~---~~~~~kl~DfG~a~~~~~~~~~- 278 (388)
+ +|+|.+.+.. ...+|.|+| |+||+|+|||++ .+..+||+|||+|+.+......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 9 5667665542 234566777 568899999875 4567999999999987543321
Q ss_pred -----eeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhccccccccCC
Q 035768 279 -----VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEVLD 353 (388)
Q Consensus 279 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (388)
......||+.|||||...+..++.++|||||||++|||+||+.||..............+....... ...
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~---- 238 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE---- 238 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHH----
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Chh----
Confidence 2334679999999999999999999999999999999999999986543222222222211111111 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCCC
Q 035768 354 PAVLNANSKPTMLKMLQIATGCISNDPTVRPTML 387 (388)
Q Consensus 354 ~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~ 387 (388)
...... ..++.+++..||+.+|++||+++
T Consensus 239 -~~~~~~----p~~~~~li~~cl~~~p~~RP~~~ 267 (299)
T d1ckia_ 239 -VLCKGY----PSEFATYLNFCRSLRFDDKPDYS 267 (299)
T ss_dssp -HHTTTS----CHHHHHHHHHHHHSCTTCCCCHH
T ss_pred -HhccCC----CHHHHHHHHHHccCChhHCcCHH
Confidence 111111 13688999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-38 Score=288.66 Aligned_cols=228 Identities=16% Similarity=0.213 Sum_probs=171.2
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEec
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATGQGDREFAAEMETLGMVKH-QNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~ 223 (388)
++|...+.||+|+||+||+|++. +|+.||||.++... ....+.+|+++++.++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57888999999999999999964 68899999986543 23457789999999975 8999999999999999999999
Q ss_pred cCCCCHHHHHhccC----------------CCCCHHh-----hhccccCCeeecC-----CCCEEEcccccceeccCCCc
Q 035768 224 MVKGSLDDWLRNQA----------------ASLDWGK-----RCKIVASNILLND-----DFEAKISDFGLARLISDCES 277 (388)
Q Consensus 224 ~~~g~L~~~l~~~~----------------~~l~~~~-----~~~i~~~NiLl~~-----~~~~kl~DfG~a~~~~~~~~ 277 (388)
+ +|+|.++++... .++.++| |+||+|+|||++. ++.+||+|||+|+.......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 799999886432 2455666 5688999999974 57899999999998754321
Q ss_pred ------ceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccccc
Q 035768 278 ------HVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQADEV 351 (388)
Q Consensus 278 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (388)
.......||+.|||||.+.+..++.++|||||||++|||+||+.||...... ........+..........+
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~- 239 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQSTPLRE- 239 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-CHHHHHHHHHHHHHHSCHHH-
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-hHHHHHHHHHhccCCCChHH-
Confidence 1223467999999999999999999999999999999999999998643221 11122222222111111111
Q ss_pred CCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCC
Q 035768 352 LDPAVLNANSKPTMLKMLQIATGCISNDPTVRPTM 386 (388)
Q Consensus 352 ~~~~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~ 386 (388)
+....+ .++.+++..||+.+|++||++
T Consensus 240 ----l~~~~p----~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 240 ----LCAGFP----EEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp ----HTTTSC----HHHHHHHHHHHHCCTTCCCCH
T ss_pred ----hcCCCC----HHHHHHHHHHhcCCcccCcCH
Confidence 111111 358889999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-39 Score=300.34 Aligned_cols=237 Identities=23% Similarity=0.230 Sum_probs=163.4
Q ss_pred cCCCcCCeeeccCCceEEEEEcC-CCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEe------CCe
Q 035768 146 NKFCEENVIGGGGFGTVFKGTMP-DGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSV------DEE 216 (388)
Q Consensus 146 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 216 (388)
++|+..+.||+|+||+||+|++. +|+.||||+++.... .....+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999964 699999999975432 223468899999999999999999999964 367
Q ss_pred eEEEEeccCCCCHHHH------------HhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcce
Q 035768 217 KLLVYEYMVKGSLDDW------------LRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESHV 279 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~------------l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~~ 279 (388)
.|+|||||.++.+..+ +++...++.|+| |+||+|+|||++.++.+|++|||+++...... .
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--~ 174 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--M 174 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc--c
Confidence 8999999966544432 233445677777 45788999999999999999999998765422 3
Q ss_pred eeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcc--------------
Q 035768 280 STVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKN-------------- 345 (388)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------------- 345 (388)
.....||+.|+|||++.+..+++++||||+||++|||++|+.||... +.......+......
T Consensus 175 ~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR----DYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC----CHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 34456899999999999999999999999999999999999998532 222221111111110
Q ss_pred -----cc-c-----cccCCccccCCC---CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 346 -----EQ-A-----DEVLDPAVLNAN---SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 346 -----~~-~-----~~~~~~~~~~~~---~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
.. . ............ .......+.+++.+|++.||++|||++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00 0 000111111111 1234567899999999999999999764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-38 Score=294.31 Aligned_cols=236 Identities=23% Similarity=0.295 Sum_probs=167.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCC--cChHHHHHHHHHHhcCCCCCccceeeEEEeC-----Ce
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATG--QGDREFAAEMETLGMVKHQNLVELLGYCSVD-----EE 216 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 216 (388)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46788999999999999999995 5799999999975432 2335688999999999999999999998643 34
Q ss_pred eEEEEeccCCCCHHHHHhc--------------cCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCc
Q 035768 217 KLLVYEYMVKGSLDDWLRN--------------QAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCES 277 (388)
Q Consensus 217 ~~lv~e~~~~g~L~~~l~~--------------~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~ 277 (388)
.+++++|+.+|+|.+++.. ...+|.|+| |+||+|+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---
Confidence 4677788889999998753 234677777 568889999999999999999999976532
Q ss_pred ceeeccccccCccCccccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcccHHHHHHHhhcccccc--c-cCC
Q 035768 278 HVSTVVAGTIGYVPPEYGGTG-KATERGDVYSFGVILLELVTGKQPTGPEFEDKDGENLVDWVLHMMKNEQAD--E-VLD 353 (388)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~ 353 (388)
......||+.|+|||..... .++.++|||||||++|||++|+.||... +.......+.......... . ...
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCChHHhhhccc
Confidence 22345689999999976554 5689999999999999999999998532 2233333222221110000 0 000
Q ss_pred ----------ccccCCC----CHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 354 ----------PAVLNAN----SKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 354 ----------~~~~~~~----~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
+...... .......+.+++.+|++.||++|||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 0000000 0011235789999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=8.8e-34 Score=266.51 Aligned_cols=236 Identities=18% Similarity=0.166 Sum_probs=162.0
Q ss_pred CCCcCCeeeccCCceEEEEEc-CCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-----------CCCccceeeEEEe-
Q 035768 147 KFCEENVIGGGGFGTVFKGTM-PDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-----------HQNLVELLGYCSV- 213 (388)
Q Consensus 147 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~- 213 (388)
+|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999996 579999999997543 22456788999888775 5789999998864
Q ss_pred -CCeeEEEEeccCCCCHHH------------------HHhccCCCCCHHh------hhccccCCeeecCCC------CEE
Q 035768 214 -DEEKLLVYEYMVKGSLDD------------------WLRNQAASLDWGK------RCKIVASNILLNDDF------EAK 262 (388)
Q Consensus 214 -~~~~~lv~e~~~~g~L~~------------------~l~~~~~~l~~~~------~~~i~~~NiLl~~~~------~~k 262 (388)
....+++++++..+.... ++.+...++.++| |+||+|+|||++.++ .+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 355667777765543222 2233445666776 358889999998665 399
Q ss_pred EcccccceeccCCCcceeeccccccCccCccccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCCcc---cHHHHH
Q 035768 263 ISDFGLARLISDCESHVSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVILLELVTGKQPTGPEFEDKDGE---NLVDWV 339 (388)
Q Consensus 263 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~el~tg~~P~~~~~~~~~~~---~~~~~~ 339 (388)
++|||.|...... ....+||+.|+|||.+....++.++||||+||+++||++|+.||.......... .+...+
T Consensus 173 l~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 173 IADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp ECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred Eeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 9999999865432 234569999999999988999999999999999999999999986532211111 111111
Q ss_pred HHhhcc------------------ccccccCCc----------cccCCCCHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 035768 340 LHMMKN------------------EQADEVLDP----------AVLNANSKPTMLKMLQIATGCISNDPTVRPTMLH 388 (388)
Q Consensus 340 ~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~C~~~~P~~RPt~~e 388 (388)
. .... ......... .............+.+++.+|+..||.+|||++|
T Consensus 249 ~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 249 E-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp H-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred H-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1 1000 000000000 0011234566778999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.74 E-value=3.7e-19 Score=150.61 Aligned_cols=155 Identities=13% Similarity=0.063 Sum_probs=104.7
Q ss_pred cCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCc------------------ChHHHHHHHHHHhcCCCCCccceeeEE
Q 035768 150 EENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQ------------------GDREFAAEMETLGMVKHQNLVELLGYC 211 (388)
Q Consensus 150 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~g~~ 211 (388)
..+.||+|+||+||+|+..+|+.||||.++..... ....+.+|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45789999999999999888999999987532110 012345688899999999999887653
Q ss_pred EeCCeeEEEEeccCCCCHHH--------HHhccCCCCCHHh-----hhccccCCeeecCCCCEEEcccccceeccCCCcc
Q 035768 212 SVDEEKLLVYEYMVKGSLDD--------WLRNQAASLDWGK-----RCKIVASNILLNDDFEAKISDFGLARLISDCESH 278 (388)
Q Consensus 212 ~~~~~~~lv~e~~~~g~L~~--------~l~~~~~~l~~~~-----~~~i~~~NiLl~~~~~~kl~DfG~a~~~~~~~~~ 278 (388)
..+++|||++++.+.+ ++.+...++.++| |.||+|+|||++++ .++|+|||+|+........
T Consensus 84 ----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~ 158 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR 158 (191)
T ss_dssp ----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH
T ss_pred ----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH
Confidence 2379999998765543 4445555677777 45888999999965 4899999999876533211
Q ss_pred eeeccccccCccCccccCCCCCCcccchHhHHHHH
Q 035768 279 VSTVVAGTIGYVPPEYGGTGKATERGDVYSFGVIL 313 (388)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l 313 (388)
.. .......+ .+.+ ...|+.++|+||..--+
T Consensus 159 ~~--l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 159 EI--LERDVRNI-ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HH--HHHHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred HH--HHHHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence 10 00000000 0111 35678899999985433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.65 E-value=1.2e-05 Score=71.26 Aligned_cols=49 Identities=27% Similarity=0.292 Sum_probs=38.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccC--CCCeeEecCCCCCCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQ--NLSIMSLTGNKDLCGKIMGSDC 50 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~--~l~~~~~s~N~~~~~~~~~~~~ 50 (388)
++.+++|++||||+|+|+|.|| ..+.. +|+.|++++|+++|.+|....+
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP-~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L 290 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCC-GGGGGCTTCCEEECCSSEEEEECCCSTTG
T ss_pred cccccccccccCccCeecccCC-hHHhCCCCCCEEECcCCcccccCCCcccC
Confidence 3567889999999999999999 44443 8899999999988888765433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.41 E-value=0.00019 Score=61.42 Aligned_cols=86 Identities=10% Similarity=0.018 Sum_probs=59.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEec
Q 035768 145 TNKFCEENVIGGGGFGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVK-HQNLVELLGYCSVDEEKLLVYEY 223 (388)
Q Consensus 145 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 223 (388)
.+.|...+..+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+...++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34454444444455578999875 56677888876544344445778888877663 33356788888888999999999
Q ss_pred cCCCCHHH
Q 035768 224 MVKGSLDD 231 (388)
Q Consensus 224 ~~~g~L~~ 231 (388)
+++.++.+
T Consensus 92 l~G~~~~~ 99 (263)
T d1j7la_ 92 ADGVLCSE 99 (263)
T ss_dssp CSSEEHHH
T ss_pred cccccccc
Confidence 98877643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.02 E-value=7.1e-05 Score=66.07 Aligned_cols=44 Identities=25% Similarity=0.407 Sum_probs=31.4
Q ss_pred CCCCCCCCeeeccC-CcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLAD-NRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~-N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
|++|++|++|||++ |+|+|+|| ..+. .+|+.|++++|++.+..+
T Consensus 72 l~~L~~L~~L~Ls~~N~l~g~iP-~~i~~L~~L~~L~Ls~N~l~~~~~ 118 (313)
T d1ogqa_ 72 LANLPYLNFLYIGGINNLVGPIP-PAIAKLTQLHYLYITHTNVSGAIP 118 (313)
T ss_dssp GGGCTTCSEEEEEEETTEESCCC-GGGGGCTTCSEEEEEEECCEEECC
T ss_pred HhcCccccccccccccccccccc-cccccccccchhhhcccccccccc
Confidence 45678888888876 78888888 3333 378888888887766443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.71 E-value=0.00057 Score=58.58 Aligned_cols=42 Identities=26% Similarity=0.218 Sum_probs=25.6
Q ss_pred CCCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
..+++|+.|++++|+|++..| ..+ ..+|+.|++++|.+. .+|
T Consensus 145 ~~l~~l~~l~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 145 TPTPKLEKLSLANNNLTELPA-GLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp TTCTTCCEEECTTSCCSCCCT-TTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccccchhcccccccccccCc-cccccccccceeecccCCCc-ccC
Confidence 346677777777777776554 222 236777777777665 444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.47 E-value=0.00096 Score=52.20 Aligned_cols=41 Identities=22% Similarity=0.187 Sum_probs=32.7
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~ 42 (388)
|.+|++|+.|+|++|+|+.--| ..+. .+|+.+++++|++..
T Consensus 52 f~~l~~L~~L~Ls~N~l~~i~~-~~f~~l~~L~~L~Ls~N~l~~ 94 (156)
T d2ifga3 52 LRGLGELRNLTIVKSGLRFVAP-DAFHFTPRLSRLNLSFNALES 94 (156)
T ss_dssp SCSCCCCSEEECCSSCCCEECT-TGGGSCSCCCEEECCSSCCSC
T ss_pred hccccccCcceeeccccCCccc-ccccccccccceeccCCCCcc
Confidence 4678999999999999996555 3232 389999999999873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.38 E-value=0.001 Score=49.88 Aligned_cols=41 Identities=22% Similarity=0.283 Sum_probs=31.3
Q ss_pred CCCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~~ 42 (388)
+++|++|++||||+|+|+ .||.. ....+|+.+++++|.+..
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~ 57 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 57 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc
Confidence 356788999999999998 67733 223489999999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.28 E-value=0.0074 Score=50.62 Aligned_cols=73 Identities=15% Similarity=0.074 Sum_probs=52.0
Q ss_pred eeccC-CceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEEeccCCCCH
Q 035768 154 IGGGG-FGTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKH--QNLVELLGYCSVDEEKLLVYEYMVKGSL 229 (388)
Q Consensus 154 lG~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g~L 229 (388)
+..|. .+.||+....++..+.+|.-.... ...+..|+..++.+.. -.+.+++++..+++..++||+++++-++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 367999998788888889765432 2346778877776632 3356778888888889999999987654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=96.12 E-value=0.0021 Score=51.89 Aligned_cols=44 Identities=16% Similarity=0.198 Sum_probs=33.1
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
+..+++|++||||+|+|++-.| ..+. .+|+.|++++|.+.+-.+
T Consensus 74 ~~~~~~L~~L~Ls~N~l~~l~~-~~F~~l~~L~~L~L~~N~l~~i~~ 119 (192)
T d1w8aa_ 74 FEGASHIQELQLGENKIKEISN-KMFLGLHQLKTLNLYDNQISCVMP 119 (192)
T ss_dssp TTTCTTCCEEECCSCCCCEECS-SSSTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccceeeeccccccccCH-HHHhCCCcccccccCCccccccCH
Confidence 3568899999999999996555 3232 388999999998876443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.75 E-value=0.0045 Score=48.18 Aligned_cols=42 Identities=10% Similarity=0.002 Sum_probs=26.6
Q ss_pred CCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCG 43 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~ 43 (388)
..+++|++|+|++|+.--.||...+. .+|+.|++++|++..-
T Consensus 28 ~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i 71 (156)
T d2ifga3 28 PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71 (156)
T ss_dssp CSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred cCccccCeeecCCCccccccCchhhccccccCcceeeccccCCc
Confidence 45677888888776533356533332 2788888888876643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=95.18 E-value=0.0073 Score=48.51 Aligned_cols=44 Identities=27% Similarity=0.252 Sum_probs=34.2
Q ss_pred CCCCCCCeeeccCCcCccccCcccc-cCCCCeeEecCCCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGI-CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~-~~~l~~~~~s~N~~~~~~~ 45 (388)
+++++|+.|+|++|++++.+|.... ..+|..+++++|++..-.+
T Consensus 51 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~ 95 (192)
T d1w8aa_ 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISN 95 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECS
T ss_pred CCCceEeeeeccccccccccccccccccccceeeeccccccccCH
Confidence 5689999999999999988873322 2389999999998875433
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.11 E-value=0.0091 Score=50.64 Aligned_cols=35 Identities=17% Similarity=0.141 Sum_probs=20.5
Q ss_pred CCCeeeccCCcCccccCccccc--CCCCeeEecCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDL 41 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~ 41 (388)
+|++|||++|++++-.| ..+. .+|+.|++++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~-~~f~~l~~L~~L~L~~N~l~ 68 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELT 68 (266)
T ss_dssp TCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCC
T ss_pred CCCEEECcCCcCCCcCH-HHhhcccccccccccccccc
Confidence 46677777777764333 3222 26677777777654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.99 E-value=0.0078 Score=44.70 Aligned_cols=41 Identities=27% Similarity=0.229 Sum_probs=31.2
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
++.+++|++|+|++|++++ +|.-..+.+|+.+++++|.+..
T Consensus 39 ~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i~~ 79 (124)
T d1dcea3 39 LAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQ 79 (124)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCS
T ss_pred hhhhhcccccccccccccc-cCccccccccCeEECCCCccCC
Confidence 3568899999999999985 5622333489999999998764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.86 E-value=0.0056 Score=52.53 Aligned_cols=44 Identities=23% Similarity=0.127 Sum_probs=33.2
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
+.++++|++|+|++|++++..| ..+. .++..+++++|.+.+..+
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~-~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCSCCCH
T ss_pred hccccccchhhhhhccccccCh-hHhhhhhhcccccccccccccccc
Confidence 3578889999999999998777 4333 388889999888876543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.49 E-value=0.011 Score=46.07 Aligned_cols=38 Identities=8% Similarity=0.079 Sum_probs=24.3
Q ss_pred CCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~ 41 (388)
++..|++|||++|+++ .||.. .....|+.+++++|.+.
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~ 54 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC
Confidence 4556777888888876 34521 11237778888888655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.05 E-value=0.017 Score=44.97 Aligned_cols=40 Identities=13% Similarity=0.234 Sum_probs=27.3
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLC 42 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~ 42 (388)
..+++|+.||||+|+++ .|+.-....+|+.+++++|.+..
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~ 77 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICR 77 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCE
T ss_pred cccccCCEEECCCCCCC-ccCCcccCcchhhhhcccccccC
Confidence 34677888888888887 55521223478888888887654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.03 E-value=0.015 Score=50.18 Aligned_cols=38 Identities=26% Similarity=0.281 Sum_probs=17.9
Q ss_pred CCCCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~ 41 (388)
+++.+++|++++|++++-.| ..+ +.+|+.|++++|++.
T Consensus 193 ~~~~l~~L~~s~n~l~~~~~-~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 193 GLNNLAKLGLSFNSISAVDN-GSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp TCTTCCEEECCSSCCCEECT-TTGGGSTTCCEEECCSSCCS
T ss_pred cccccccccccccccccccc-ccccccccceeeeccccccc
Confidence 34455555555555554433 211 125555555555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=93.66 E-value=0.019 Score=46.64 Aligned_cols=39 Identities=33% Similarity=0.302 Sum_probs=24.7
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
..|++|++|||++|++++-.| .....+|+.+++++|++.
T Consensus 65 ~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 65 QYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK 103 (210)
T ss_dssp GGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred hhCCCCCEEeCCCccccCccc-cccCcccccccccccccc
Confidence 346677777777777776333 233346777777777654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=93.53 E-value=0.02 Score=50.72 Aligned_cols=36 Identities=31% Similarity=0.338 Sum_probs=15.9
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKD 40 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~ 40 (388)
+++|+.|||++|++++-.| -..+.+|+.+++++|++
T Consensus 306 ~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKV 341 (384)
T ss_dssp CTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCC
T ss_pred hcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCC
Confidence 3444555555555554322 12223455555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=93.18 E-value=0.026 Score=45.38 Aligned_cols=35 Identities=26% Similarity=0.343 Sum_probs=15.2
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNK 39 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~ 39 (388)
|++|++|||++|++++..| -....+|+.+++++|.
T Consensus 61 l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred CCCcCcCccccccccCccc-ccCCcccccccccccc
Confidence 4445555555555544322 1112244555555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.67 E-value=0.046 Score=46.41 Aligned_cols=44 Identities=23% Similarity=0.161 Sum_probs=33.4
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
++.+++|+.|+|++|+|++-.| ..+. .+|..+++++|++.+..|
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~-~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPE-RAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECT
T ss_pred hccccchhhcccccCcccccch-hhhccccccchhhhhhccccccCh
Confidence 3567889999999999987666 3232 389999999998876544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=92.58 E-value=0.033 Score=49.26 Aligned_cols=41 Identities=22% Similarity=0.151 Sum_probs=30.3
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
..|++|++|||++|++++-.| -....+|+.|++++|++.+-
T Consensus 63 ~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i 103 (384)
T d2omza2 63 EYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADI 103 (384)
T ss_dssp GGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC
T ss_pred ccCCCCCEEeCcCCcCCCCcc-ccCCcccccccccccccccc
Confidence 467889999999999886433 22345888899999887653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.14 E-value=0.023 Score=44.13 Aligned_cols=39 Identities=38% Similarity=0.541 Sum_probs=29.4
Q ss_pred CCCCCCeeeccCCcCccc--cCcc-cccCCCCeeEecCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGE--VPRS-GICQNLSIMSLTGNKDL 41 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~--iP~~-~~~~~l~~~~~s~N~~~ 41 (388)
.+++|++||||+|+++.- ++.. ..+.+|+.+++++|...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 478999999999999852 2211 22458999999999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=91.84 E-value=0.48 Score=41.97 Aligned_cols=75 Identities=16% Similarity=0.090 Sum_probs=47.2
Q ss_pred CeeeccCCceEEEEEcCC-CCEEEEEEccc----CC---CcChHHHHHHHHHHhcCC-C--CCccceeeEEEeCCeeEEE
Q 035768 152 NVIGGGGFGTVFKGTMPD-GKTVAVKKLSQ----AT---GQGDREFAAEMETLGMVK-H--QNLVELLGYCSVDEEKLLV 220 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lv 220 (388)
+.||.|....||+....+ ++.|+||.-.. .. .........|.+.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 67899996432 11 112234556777776552 2 345556544 45667899
Q ss_pred EeccCCCC
Q 035768 221 YEYMVKGS 228 (388)
Q Consensus 221 ~e~~~~g~ 228 (388)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=91.10 E-value=0.013 Score=47.36 Aligned_cols=39 Identities=28% Similarity=0.272 Sum_probs=30.6
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
++|++|++|||++|+++ .||.-..+.+|+.|++++|.+.
T Consensus 45 ~~L~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 45 STLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp HHTTTCCEEECSEEEES-CCCCHHHHTTCCEEECCEEEEC
T ss_pred hcccccceeECcccCCC-CcccccCCccccChhhcccccc
Confidence 45889999999999998 6762223459999999999764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=90.49 E-value=0.11 Score=44.93 Aligned_cols=39 Identities=26% Similarity=0.251 Sum_probs=31.6
Q ss_pred CCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~~~ 45 (388)
.+++|++|||++|+|+ .|| . ...+|+.|++++|++. .+|
T Consensus 282 ~~~~L~~L~Ls~N~l~-~lp-~-~~~~L~~L~L~~N~L~-~l~ 320 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLI-ELP-A-LPPRLERLIASFNHLA-EVP 320 (353)
T ss_dssp CCTTCCEEECCSSCCS-CCC-C-CCTTCCEEECCSSCCS-CCC
T ss_pred cCCCCCEEECCCCccC-ccc-c-ccCCCCEEECCCCcCC-ccc
Confidence 3578999999999999 788 3 3468999999999876 444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=89.57 E-value=0.12 Score=44.62 Aligned_cols=33 Identities=18% Similarity=0.179 Sum_probs=15.8
Q ss_pred CCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
+|+.||||+|+|+ +|| + ...+|+.|++++|++.
T Consensus 39 ~l~~LdLs~~~L~-~lp-~-~~~~L~~L~Ls~N~l~ 71 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLP-E-LPPHLESLVASCNSLT 71 (353)
T ss_dssp TCSEEECTTSCCS-CCC-S-CCTTCSEEECCSSCCS
T ss_pred CCCEEEeCCCCCC-CCC-C-CCCCCCEEECCCCCCc
Confidence 3445555555554 345 2 2234555555555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=89.06 E-value=0.14 Score=41.13 Aligned_cols=40 Identities=25% Similarity=0.288 Sum_probs=31.4
Q ss_pred CCCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
+++|++|++|+|++|++++ ||.-....+|+.+++++|...
T Consensus 86 ~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~ 125 (210)
T d1h6ta2 86 LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS 125 (210)
T ss_dssp GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC
T ss_pred cccCccccccccccccccc-ccccccccccccccccccccc
Confidence 3678999999999999995 662223358999999999764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=88.77 E-value=0.12 Score=41.96 Aligned_cols=39 Identities=15% Similarity=0.048 Sum_probs=23.5
Q ss_pred CCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCCCC
Q 035768 4 LPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDLCG 43 (388)
Q Consensus 4 l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~~~ 43 (388)
|.+|+.|++++|+++ .++.-..+.+|+.+++++|.+.+-
T Consensus 40 l~~L~~L~l~~~~i~-~l~~l~~l~~L~~L~ls~n~i~~~ 78 (227)
T d1h6ua2 40 LDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITDL 78 (227)
T ss_dssp HHTCCEEECTTSCCC-CCTTGGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCEEECCCCCCC-cchhHhcCCCCcEeecCCceeecc
Confidence 456777777777766 344112234777777777766543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=88.49 E-value=0.75 Score=39.42 Aligned_cols=67 Identities=10% Similarity=0.021 Sum_probs=45.3
Q ss_pred ceEEEEEcCCCCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCc-----ccee--eEEEeCCeeEEEEeccCCC
Q 035768 160 GTVFKGTMPDGKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNL-----VELL--GYCSVDEEKLLVYEYMVKG 227 (388)
Q Consensus 160 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~l~--g~~~~~~~~~lv~e~~~~g 227 (388)
-.||+.+.++|..+++|..+... ...+++..|...+..|....+ +..- ......+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 48999999999999999976532 245667888888776642222 1111 1234567788999999764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.29 E-value=0.091 Score=40.53 Aligned_cols=40 Identities=33% Similarity=0.287 Sum_probs=29.6
Q ss_pred CCCCCCeeeccCCcCccccCcc-ccc-CCCCeeEecCCCCCCC
Q 035768 3 SLPNLLYLNLADNRLEGEVPRS-GIC-QNLSIMSLTGNKDLCG 43 (388)
Q Consensus 3 ~l~~L~~L~ls~N~l~G~iP~~-~~~-~~l~~~~~s~N~~~~~ 43 (388)
.|++|+.||||+|+++- ++.- .+. .++..+++++|++.+.
T Consensus 89 ~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 89 KAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred hCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcC
Confidence 47899999999999984 4311 121 2789999999987654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.09 E-value=0.16 Score=41.56 Aligned_cols=39 Identities=15% Similarity=0.190 Sum_probs=29.8
Q ss_pred CCCeeeccCCcCccccCccccc--CCCCeeEecCCCCCCCCC
Q 035768 6 NLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 6 ~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N~~~~~~~ 45 (388)
++++|||++|+++ .||...+. .+|+.+++++|.....++
T Consensus 30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~ 70 (242)
T d1xwdc1 30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIE 70 (242)
T ss_dssp CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEEC
T ss_pred CCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceee
Confidence 7999999999997 56633332 389999999998776544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.34 E-value=0.25 Score=41.87 Aligned_cols=40 Identities=23% Similarity=0.291 Sum_probs=24.8
Q ss_pred CCCCeeeccCCcCccccCcccc--cCCCCeeEecCCCCCCCCC
Q 035768 5 PNLLYLNLADNRLEGEVPRSGI--CQNLSIMSLTGNKDLCGKI 45 (388)
Q Consensus 5 ~~L~~L~ls~N~l~G~iP~~~~--~~~l~~~~~s~N~~~~~~~ 45 (388)
++|++|||++|+++. ||...+ ..+|+.+++++|....-.|
T Consensus 31 ~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 31 PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp TTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CCCCEEECcCCcCCC-cChhHhhccccccccccccccccccch
Confidence 457778888887763 442222 2377777777777665433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=84.06 E-value=0.036 Score=44.55 Aligned_cols=39 Identities=18% Similarity=0.271 Sum_probs=29.5
Q ss_pred CCCCCCCeeeccCCcCccccCcc-cccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRS-GICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~-~~~~~l~~~~~s~N~~~ 41 (388)
++|++|++|||++|+++ .||.. ....+|..+++++|.+.
T Consensus 67 ~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~ 106 (198)
T d1m9la_ 67 SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp HHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC
T ss_pred cCCccccChhhcccccc-ccccccccccccccccccccccc
Confidence 35789999999999987 67622 22237999999999765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=83.94 E-value=0.44 Score=37.62 Aligned_cols=39 Identities=28% Similarity=0.277 Sum_probs=25.6
Q ss_pred CCCCCCCeeeccCCcCccccCcccccCCCCeeEecCCCCC
Q 035768 2 CSLPNLLYLNLADNRLEGEVPRSGICQNLSIMSLTGNKDL 41 (388)
Q Consensus 2 ~~l~~L~~L~ls~N~l~G~iP~~~~~~~l~~~~~s~N~~~ 41 (388)
+++++|+.|++++|.+....+ -..+.+|..+++++|.+.
T Consensus 103 ~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 103 ANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp TTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCC
T ss_pred ccccccccccccccccccccc-cchhhhhHHhhhhhhhhc
Confidence 567777788888777775433 222347777777777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.66 E-value=0.55 Score=38.04 Aligned_cols=38 Identities=8% Similarity=0.157 Sum_probs=28.7
Q ss_pred CCCCCCCCeeeccCCcCccccCccccc--CCCCeeEecCC
Q 035768 1 MCSLPNLLYLNLADNRLEGEVPRSGIC--QNLSIMSLTGN 38 (388)
Q Consensus 1 l~~l~~L~~L~ls~N~l~G~iP~~~~~--~~l~~~~~s~N 38 (388)
|.+|++|++|||++|.+...||...+. .++..+.+..+
T Consensus 49 f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 49 FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp TTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred hhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 467999999999999999888733322 36777777643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=80.87 E-value=0.5 Score=38.05 Aligned_cols=16 Identities=25% Similarity=0.079 Sum_probs=11.5
Q ss_pred cCCCCeeEecCCCCCC
Q 035768 27 CQNLSIMSLTGNKDLC 42 (388)
Q Consensus 27 ~~~l~~~~~s~N~~~~ 42 (388)
+.+|+.|++++|+++.
T Consensus 194 l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 194 LPNLIEVHLKNNQISD 209 (227)
T ss_dssp CTTCCEEECTTSCCCB
T ss_pred CCCCCEEECcCCcCCC
Confidence 3478888888887654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=80.16 E-value=0.78 Score=40.51 Aligned_cols=71 Identities=18% Similarity=0.243 Sum_probs=46.6
Q ss_pred CeeeccCCceEEEEEcCC--------CCEEEEEEcccCCCcChHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEe
Q 035768 152 NVIGGGGFGTVFKGTMPD--------GKTVAVKKLSQATGQGDREFAAEMETLGMVKHQNL-VELLGYCSVDEEKLLVYE 222 (388)
Q Consensus 152 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 222 (388)
+.|+.|-.-.+|+...++ .+.|.+++.-. ........+|..+++.+.-.++ .++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568888888999998654 24566665542 2233445678888887743344 477777642 68999
Q ss_pred ccCCCC
Q 035768 223 YMVKGS 228 (388)
Q Consensus 223 ~~~~g~ 228 (388)
|+++-.
T Consensus 122 fi~g~~ 127 (395)
T d1nw1a_ 122 YIPSRP 127 (395)
T ss_dssp CCCEEE
T ss_pred Eecccc
Confidence 997643
|